data_2keo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2keo _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.7 m . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.4 HD23 ' HB2' ' A' ' 99' ' ' LEU . 92.4 mt -98.47 108.83 21.62 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.092 0.557 . . . . 0.0 110.209 -177.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.9 t -94.38 132.84 37.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.493 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -102.24 171.18 7.63 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.499 0.72 . . . . 0.0 109.593 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.471 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 13.0 tt -60.72 -34.09 57.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.848 174.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.42 -49.79 76.02 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.352 0.661 . . . . 0.0 110.743 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.11 -42.98 95.89 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.626 0.77 . . . . 0.0 110.879 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 46.9 tp -58.24 -45.82 87.08 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.333 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 17.0 mm-40 -72.68 -52.97 13.05 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.541 0.736 . . . . 0.0 112.397 -177.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -71.16 -29.87 65.74 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -172.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -73.47 -27.46 61.41 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 120.553 0.216 . . . . 0.0 110.5 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -61.3 -39.31 89.99 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 120.961 0.41 . . . . 0.0 110.205 172.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -68.57 -32.3 72.11 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.534 0.733 . . . . 0.0 110.78 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -65.77 -19.52 65.92 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.897 0.879 . . . . 0.0 111.41 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.74 4.09 26.53 Favored Glycine 0 N--CA 1.475 1.234 0 CA-C-N 116.695 -0.23 . . . . 0.0 112.764 176.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -111.93 95.86 0.83 Allowed Glycine 0 C--N 1.34 0.776 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -75.8 116.6 16.67 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -104.66 -179.76 4.04 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.275 1.03 . . . . 0.0 109.961 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.4 t -155.83 159.15 39.14 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.698 0.799 . . . . 0.0 109.211 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 98.4 t -107.99 111.57 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 123.572 0.749 . . . . 0.0 109.258 177.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.574 HD12 HD21 ' A' ' 77' ' ' LEU . 48.8 mt -140.6 135.48 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.275 1.03 . . . . 0.0 108.631 175.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 63.59 32.31 14.1 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.675 1.19 . . . . 0.0 111.062 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.44 20.78 70.0 Favored Glycine 0 C--N 1.352 1.457 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.927 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.512 ' HD3' ' HA ' ' A' ' 97' ' ' GLN . 32.8 mmtp -128.59 162.98 26.02 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.792 1.237 . . . . 0.0 109.23 -177.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 90.9 t -119.28 119.28 60.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 123.629 0.772 . . . . 0.0 109.037 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -112.27 148.15 34.77 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.526 0.73 . . . . 0.0 109.909 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -86.56 100.7 12.6 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.404 HD13 HD22 ' A' ' 77' ' ' LEU . 31.5 mm -76.45 -29.64 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.418 0.687 . . . . 0.0 111.689 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -61.55 -47.7 84.34 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.467 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 27.5 t70 -73.97 -36.07 64.54 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.521 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -52.55 -53.31 48.09 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.958 0.903 . . . . 0.0 111.154 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.473 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 10.6 pt20 -67.36 -28.53 68.03 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.233 -177.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.8 m -64.01 -40.38 96.22 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.042 0.449 . . . . 0.0 110.407 175.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.586 ' HB2' HD11 ' A' ' 65' ' ' LEU . 51.9 mm-40 -72.46 -32.35 66.17 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.315 0.646 . . . . 0.0 109.974 177.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.5 t -68.09 -27.32 66.38 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.726 0.81 . . . . 0.0 111.283 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 55' ' ' GLN . 96.9 mt -80.75 -15.42 56.52 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.448 0.699 . . . . 0.0 111.597 175.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 45.1 m -90.16 124.68 35.04 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.207 0.603 . . . . 0.0 110.321 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -64.29 147.96 51.31 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.936 0.894 . . . . 0.0 110.284 175.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 75.45 -3.56 2.56 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.367 1.467 . . . . 0.0 112.854 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.0 m -81.06 149.85 29.06 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 172.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.627 ' HB ' HG21 ' A' ' 86' ' ' THR . 42.9 pt -61.97 -20.04 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.58 0.752 . . . . 0.0 112.478 -178.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' A' ' 57' ' ' GLN . 60.0 mt -95.05 -8.68 35.98 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.575 0.75 . . . . 0.0 111.725 -176.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.87 -25.76 65.68 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.272 0.629 . . . . 0.0 111.549 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -75.73 -20.53 58.27 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.806 0.842 . . . . 0.0 111.042 173.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.441 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 52.4 m-85 -102.89 12.82 35.65 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.275 1.03 . . . . 0.0 110.987 178.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.62 -26.16 64.3 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.329 0.651 . . . . 0.0 112.534 -175.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.53 -3.87 90.53 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-N 116.472 -0.331 . . . . 0.0 112.639 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -108.08 150.55 27.04 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.176 0.99 . . . . 0.0 110.136 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -55.98 124.72 60.18 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 123.723 0.809 . . . . 0.0 110.52 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -51.13 -33.51 44.05 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 123.549 2.832 . . . . 0.0 115.145 -173.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.2 t -70.79 -38.87 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.111 0.564 . . . . 0.0 110.49 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.5 t -74.13 -40.11 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.894 0.877 . . . . 0.0 110.062 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.441 ' HB2' ' HB3' ' A' ' 68' ' ' PHE . . . -65.49 -29.3 69.93 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.832 1.253 . . . . 0.0 110.896 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.581 HD11 ' SD ' ' A' ' 90' ' ' MET . 48.4 tp -63.98 -41.75 97.44 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.925 0.89 . . . . 0.0 110.536 174.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -65.65 -40.8 92.87 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.631 0.772 . . . . 0.0 110.998 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.43 -31.95 73.03 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.782 0.833 . . . . 0.0 110.688 175.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.14 -33.49 61.53 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.468 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.484 HD22 ' HG3' ' A' ' 90' ' ' MET . 95.6 mt -67.74 -40.12 84.2 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.156 0.582 . . . . 0.0 109.857 174.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -66.4 -41.5 89.24 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.858 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.436 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 9.8 t80 -87.5 127.7 35.24 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 120.982 0.42 . . . . 0.0 110.606 -175.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.81 -32.28 72.57 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.885 1.274 . . . . 0.0 113.63 -170.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -68.69 -51.4 42.1 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.154 0.502 . . . . 0.0 109.864 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.627 HG21 ' HB ' ' A' ' 64' ' ' ILE . 27.7 p -78.71 -16.78 56.83 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.197 -0.91 . . . . 0.0 113.149 -168.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.4 ptt85 -74.96 -11.42 60.11 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -75.34 -38.08 60.35 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.056 0.942 . . . . 0.0 111.256 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.2 t -77.64 -18.73 56.45 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.912 0.485 . . . . 0.0 110.743 175.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.581 ' SD ' HD11 ' A' ' 77' ' ' LEU . 37.4 mmt -65.01 -24.18 67.43 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.566 0.346 . . . . 0.0 110.887 176.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.464 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 86.2 m-70 -64.43 -26.57 68.51 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.841 0.856 . . . . 0.0 111.62 173.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.44 -35.95 46.17 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.476 0.71 . . . . 0.0 110.834 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -83.7 -24.37 31.29 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.477 0.311 . . . . 0.0 111.606 -176.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.464 ' SG ' ' HA ' ' A' ' 91' ' ' HIS . 29.5 p -72.05 101.32 2.71 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.001 0.429 . . . . 0.0 109.882 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.6 t -68.83 -37.71 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.056 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.02 -171.67 44.17 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.551 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.512 ' HA ' ' HD3' ' A' ' 47' ' ' LYS . 29.0 tt0 -88.78 135.68 33.39 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.909 0.884 . . . . 0.0 109.81 176.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -83.86 136.29 34.17 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.4 ' HB2' HD23 ' A' ' 25' ' ' LEU . 2.9 tt -139.7 122.88 16.91 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 173.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.444 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 46.7 mt-10 -70.74 145.05 91.73 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 123.973 0.909 . . . . 0.0 111.974 -176.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.5 -47.61 23.87 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 123.306 2.671 . . . . 0.0 112.303 173.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -67.61 -38.47 83.98 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.212 1.005 . . . . 0.0 111.846 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.444 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 26.4 tp60 . . . . . 0 N--CA 1.48 1.074 0 C-N-CA 124.032 0.933 . . . . 0.0 112.864 -168.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.9 m . . . . . 0 CA--C 1.544 0.72 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 89.4 mt -92.87 105.75 17.82 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.906 0.882 . . . . 0.0 109.634 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.6 t -93.93 126.21 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.37 1.068 . . . . 0.0 108.675 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -93.5 170.26 9.73 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.022 0.529 . . . . 0.0 110.792 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.7 tt -57.8 -36.61 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.19 0.996 . . . . 0.0 112.444 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.99 -40.0 95.4 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.378 0.671 . . . . 0.0 111.315 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.29 -34.75 77.19 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.235 1.014 . . . . 0.0 111.689 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.5 mt -58.75 -47.28 85.19 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.919 0.762 . . . . 0.0 110.01 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -71.62 -39.09 70.69 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.835 -174.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -62.22 -47.05 86.12 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.017 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -68.17 -35.39 77.96 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.333 0.653 . . . . 0.0 110.826 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.447 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 56.1 t30 -60.54 -42.97 97.62 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.267 178.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -78.16 -23.02 47.84 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.743 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -72.86 -36.59 67.43 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.903 0.881 . . . . 0.0 111.864 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 139.85 33.14 0.16 Allowed Glycine 0 N--CA 1.48 1.604 0 CA-C-N 116.968 -0.106 . . . . 0.0 113.121 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 35' ' ' ASN . . . -150.61 -178.31 25.35 Favored Glycine 0 C--N 1.343 0.948 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -134.59 110.23 9.18 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 117.582 0.691 . . . . 0.0 109.525 175.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 17.9 m0 -98.13 144.3 27.76 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.145 0.578 . . . . 0.0 110.508 174.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -136.87 141.84 42.79 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.192 0.997 . . . . 0.0 108.885 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.1 t -96.46 110.79 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 175.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 77.6 mt -131.24 130.22 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.1 t70 62.47 30.96 17.27 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 124.629 1.172 . . . . 0.0 111.617 175.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.55 12.83 77.71 Favored Glycine 0 N--CA 1.479 1.532 0 CA-C-N 116.198 -0.455 . . . . 0.0 113.378 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -119.14 160.33 22.32 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.724 1.21 . . . . 0.0 108.974 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.1 t -111.81 116.76 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.124 0.57 . . . . 0.0 109.525 176.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.418 ' HB2' HD22 ' A' ' 77' ' ' LEU . 49.8 m-85 -112.32 152.73 28.21 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.967 0.907 . . . . 0.0 109.352 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -100.88 107.25 18.72 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.571 0.348 . . . . 0.0 110.439 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.4 mm -60.31 -36.24 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 124.806 1.242 . . . . 0.0 111.724 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.436 ' HG3' ' HA2' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -58.49 -47.3 84.53 Favored 'General case' 0 CA--C 1.553 1.065 0 O-C-N 123.944 0.777 . . . . 0.0 109.184 -178.048 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.453 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 39.1 t70 -74.46 -34.41 63.14 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.706 0.402 . . . . 0.0 110.797 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -52.98 -55.97 19.51 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.928 0.891 . . . . 0.0 111.002 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -67.64 -28.24 67.55 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.413 0.685 . . . . 0.0 111.277 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.5 m -67.69 -37.44 82.3 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 123.505 0.722 . . . . 0.0 110.876 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 30.9 mm-40 -77.45 -28.07 52.3 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.437 0.695 . . . . 0.0 110.704 177.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.2 t -74.36 -3.63 31.51 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.732 0.813 . . . . 0.0 111.576 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.4 tt -63.2 -38.28 90.54 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.29 1.036 . . . . 0.0 110.129 172.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.6 m -76.81 135.33 38.93 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.495 0.718 . . . . 0.0 111.026 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -73.39 -35.23 65.86 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.997 0.919 . . . . 0.0 110.391 -178.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -87.78 60.41 5.91 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.526 0.679 . . . . 0.0 109.536 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.6 t -133.0 155.12 49.75 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.796 0.838 . . . . 0.0 109.419 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 86' ' ' THR . 27.3 pt -75.3 -10.71 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.587 0.755 . . . . 0.0 110.614 173.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.9 mt -93.46 -8.86 40.36 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.916 0.886 . . . . 0.0 110.734 176.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.07 -26.19 64.83 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.745 0.818 . . . . 0.0 111.46 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -74.65 -13.48 60.64 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.455 0.702 . . . . 0.0 110.963 174.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.508 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 67.6 m-85 -115.55 12.25 16.1 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.684 1.194 . . . . 0.0 110.963 177.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.73 -28.52 69.11 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.522 0.729 . . . . 0.0 112.109 -175.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.24 27.42 15.22 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.738 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -132.89 155.0 49.84 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.983 0.913 . . . . 0.0 109.499 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -54.39 129.05 60.8 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 124.305 1.042 . . . . 0.0 109.459 172.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.1 -35.32 90.25 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 123.433 2.755 . . . . 0.0 114.461 -172.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.0 t -74.66 -48.92 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 122.638 0.375 . . . . 0.0 110.441 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.0 t -63.08 -33.86 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.715 0.806 . . . . 0.0 110.713 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.508 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -64.71 -44.5 90.02 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.464 176.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.418 HD22 ' HB2' ' A' ' 49' ' ' TYR . 56.8 tp -66.89 -43.12 84.25 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.839 0.855 . . . . 0.0 111.306 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -58.89 -52.15 66.98 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.313 0.645 . . . . 0.0 110.259 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.14 -34.67 76.81 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.716 0.806 . . . . 0.0 111.229 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.99 -24.04 61.52 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.716 0.807 . . . . 0.0 112.291 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -70.81 -42.1 70.73 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 172.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -73.22 -28.34 62.11 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.049 0.54 . . . . 0.0 111.053 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -85.51 117.67 24.56 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -66.08 -27.56 68.17 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.908 0.883 . . . . 0.0 113.175 -169.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -76.16 -22.01 55.9 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.383 0.673 . . . . 0.0 112.423 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.562 ' HA ' HD12 ' A' ' 64' ' ' ILE . 19.1 p -109.28 -20.99 12.75 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -174.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.463 ' HA ' ' HG2' ' A' ' 90' ' ' MET . 40.3 ptt180 -67.66 -13.57 62.21 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -55.48 -49.58 72.17 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.414 1.086 . . . . 0.0 112.339 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.9 t -77.4 -15.72 59.21 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.932 0.493 . . . . 0.0 111.033 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.487 ' SD ' ' HD2' ' A' ' 93' ' ' PHE . 12.7 mmt -69.03 -16.81 63.8 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.828 0.451 . . . . 0.0 111.243 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -62.24 -39.72 93.78 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.941 0.496 . . . . 0.0 109.798 169.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.89 -37.13 62.2 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.75 0.82 . . . . 0.0 111.065 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.487 ' HD2' ' SD ' ' A' ' 90' ' ' MET . 45.9 m-85 -71.37 -23.93 61.99 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.012 0.525 . . . . 0.0 111.221 177.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 46.1 t -72.17 99.85 2.43 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.0 m -71.15 -26.32 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 123.408 0.683 . . . . 0.0 110.251 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 175.42 175.11 42.58 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.319 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -85.18 136.66 33.43 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 177.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -76.83 132.44 39.19 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.46 126.15 32.35 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 170.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 42.2 mt-10 -70.34 136.08 86.56 Favored Pre-proline 0 C--O 1.246 0.898 0 O-C-N 123.851 0.72 . . . . 0.0 110.3 177.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -59.27 -22.05 63.26 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.765 2.31 . . . . 0.0 112.609 175.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -86.61 -38.83 16.71 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.824 1.25 . . . . 0.0 111.224 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.498 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 8.5 tp-100 . . . . . 0 N--CA 1.492 1.631 0 C-N-CA 124.33 1.052 . . . . 0.0 111.586 -176.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 77.7 m . . . . . 0 CA--C 1.538 0.502 0 CA-C-O 121.247 0.546 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.2 mt -85.64 106.55 17.01 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.215 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.445 HG22 HG22 ' A' ' 95' ' ' VAL . 46.2 t -102.16 128.99 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.183 0.993 . . . . 0.0 109.043 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -101.98 170.28 8.23 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.379 0.672 . . . . 0.0 110.073 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.608 ' HB ' ' HH ' ' A' ' 98' ' ' TYR . 18.6 tt -67.96 -32.15 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.348 0.659 . . . . 0.0 111.98 -173.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.64 -35.58 72.73 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.199 0.6 . . . . 0.0 111.453 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -68.27 -42.26 79.83 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.788 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.4 mt -55.24 -40.64 71.13 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.785 0.834 . . . . 0.0 111.422 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 7.0 mm-40 -65.89 -41.6 91.33 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.444 -178.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -59.29 -50.62 73.29 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.569 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -64.41 -34.64 78.66 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.173 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -59.21 -39.16 81.79 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.07 0.548 . . . . 0.0 110.416 174.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -75.96 -19.49 58.69 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.017 0.927 . . . . 0.0 111.886 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -84.3 -20.16 32.58 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 122.665 0.386 . . . . 0.0 110.823 170.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.99 -13.48 52.66 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-N 116.456 -0.338 . . . . 0.0 112.414 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.413 ' HA2' ' HD3' ' A' ' 52' ' ' LYS . . . -76.72 88.59 0.95 Allowed Glycine 0 C--N 1.35 1.309 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 176.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -75.63 111.1 10.61 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -173.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 39.5 m0 -99.77 177.73 5.04 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.941 0.896 . . . . 0.0 110.066 175.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.9 t -157.6 151.27 23.99 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.71 0.804 . . . . 0.0 109.869 -178.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 p -103.0 112.12 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 171.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.5 mt -124.18 116.96 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.359 1.064 . . . . 0.0 109.223 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.3 t70 53.31 53.63 11.47 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.27 1.428 . . . . 0.0 111.834 175.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.55 -0.46 55.61 Favored Glycine 0 N--CA 1.475 1.273 0 N-CA-C 114.815 0.686 . . . . 0.0 114.815 176.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -112.59 167.83 10.15 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.131 0.972 . . . . 0.0 109.461 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 90.7 t -115.61 121.97 68.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 171.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.415 ' HB3' HD22 ' A' ' 77' ' ' LEU . 76.7 m-85 -115.3 170.62 8.25 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.831 1.253 . . . . 0.0 109.301 174.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -99.21 159.42 15.0 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.241 0.617 . . . . 0.0 109.835 171.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 35.1 mm -117.28 -29.21 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.359 1.064 . . . . 0.0 108.934 168.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.413 ' HD3' ' HA2' ' A' ' 39' ' ' GLY . 25.1 ttpt -53.89 -57.97 9.01 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.469 1.108 . . . . 0.0 111.965 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.443 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 27.4 t70 -74.39 -35.54 63.49 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.995 0.518 . . . . 0.0 110.121 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -51.09 -53.51 33.43 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.85 1.26 . . . . 0.0 111.775 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -67.62 -27.89 67.28 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.923 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.9 m -68.32 -42.15 79.79 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.932 174.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 77.7 mm-40 -68.56 -28.36 66.89 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 123.12 0.568 . . . . 0.0 110.519 178.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.0 t -72.71 -26.98 61.79 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.672 0.789 . . . . 0.0 110.996 175.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 47.5 tp -67.37 -27.29 66.99 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.876 0.87 . . . . 0.0 112.095 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.0 t -88.11 151.64 22.58 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.219 0.533 . . . . 0.0 111.478 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -79.05 155.46 28.79 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.434 1.093 . . . . 0.0 109.95 176.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 71.88 5.76 5.44 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.032 1.333 . . . . 0.0 112.095 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 37.7 t -74.81 155.33 37.7 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.386 0.674 . . . . 0.0 109.686 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.557 ' HB ' HG23 ' A' ' 86' ' ' THR . 47.5 pt -68.83 -19.76 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 122.788 0.435 . . . . 0.0 110.518 170.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.406 HD12 ' HB2' ' A' ' 57' ' ' GLN . 63.4 mt -96.94 0.32 48.78 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.783 1.233 . . . . 0.0 111.613 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.02 -27.68 68.98 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 122.983 0.513 . . . . 0.0 110.944 176.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -82.16 -24.79 34.83 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.88 0.872 . . . . 0.0 111.372 173.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.582 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 54.8 m-85 -91.84 2.53 56.46 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.979 0.911 . . . . 0.0 112.066 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.97 -29.77 69.71 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.371 0.668 . . . . 0.0 111.092 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.31 26.85 9.3 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-N 116.017 -0.538 . . . . 0.0 113.114 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -141.47 152.32 44.11 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.326 1.05 . . . . 0.0 108.611 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -52.61 127.86 42.7 Favored Pre-proline 0 N--CA 1.478 0.94 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.871 174.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.08 -34.2 86.45 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 123.215 2.61 . . . . 0.0 114.476 -172.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.7 t -73.0 -48.56 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.1 t -62.53 -34.76 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.934 0.894 . . . . 0.0 110.78 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.582 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -71.41 -35.18 70.9 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.994 1.318 . . . . 0.0 110.876 -178.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.415 HD22 ' HB3' ' A' ' 49' ' ' TYR . 17.2 tp -73.36 -40.01 64.72 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.682 176.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -62.31 -36.48 82.28 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.193 0.597 . . . . 0.0 110.267 172.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.5 -32.72 68.55 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.112 0.965 . . . . 0.0 110.612 176.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.23 -43.6 86.15 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.562 0.745 . . . . 0.0 111.151 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.83 -30.64 69.23 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.514 0.326 . . . . 0.0 111.504 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -72.91 -27.72 62.04 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.027 0.531 . . . . 0.0 110.734 176.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -95.96 119.49 34.54 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.294 0.638 . . . . 0.0 110.046 -176.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -58.88 -27.99 65.72 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.514 1.125 . . . . 0.0 113.067 -175.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -79.64 -20.01 47.8 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.029 0.932 . . . . 0.0 112.248 -174.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.557 HG23 ' HB ' ' A' ' 64' ' ' ILE . 41.5 p -123.61 -12.2 7.7 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -173.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -68.58 -26.56 65.45 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.554 0.742 . . . . 0.0 111.195 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -60.07 -54.4 46.36 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.258 1.023 . . . . 0.0 110.481 -172.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.8 m -64.52 -20.0 65.94 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.907 0.883 . . . . 0.0 112.48 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 20.6 mmt -74.09 -4.02 33.01 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.301 0.641 . . . . 0.0 112.495 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.94 -21.4 65.1 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.765 0.426 . . . . 0.0 110.565 169.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -89.06 -29.51 19.37 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.757 0.823 . . . . 0.0 111.086 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -80.8 -24.03 38.83 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.171 0.588 . . . . 0.0 111.443 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.9 p -76.25 110.98 11.21 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 173.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.445 HG22 HG22 ' A' ' 26' ' ' VAL . 27.5 m -70.29 -24.88 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.132 0.573 . . . . 0.0 110.122 174.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 167.59 -159.32 32.58 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.612 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -102.14 139.92 37.12 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.093 0.957 . . . . 0.0 109.807 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.608 ' HH ' ' HB ' ' A' ' 28' ' ' ILE . 84.2 t80 -78.94 124.25 28.06 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.378 0.671 . . . . 0.0 110.379 178.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.5 tt -115.86 120.9 40.76 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 172.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.714 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 42.9 mt-10 -68.86 143.09 94.32 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 123.613 0.765 . . . . 0.0 110.585 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -54.73 -31.18 70.41 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.856 2.371 . . . . 0.0 113.053 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -82.71 -29.01 30.15 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.86 0.864 . . . . 0.0 111.222 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.714 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 33.3 tt0 . . . . . 0 N--CA 1.483 1.179 0 C-N-CA 123.737 0.815 . . . . 0.0 112.036 -174.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.2 m . . . . . 0 CA--C 1.541 0.615 0 CA-C-O 120.731 0.3 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 83.6 mt -95.93 104.33 16.27 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.756 0.822 . . . . 0.0 109.727 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.506 ' HB ' HG22 ' A' ' 48' ' ' VAL . 59.2 t -95.5 121.78 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.568 1.147 . . . . 0.0 108.688 178.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -78.6 168.95 19.01 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 123.322 0.649 . . . . 0.0 110.312 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.443 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 11.4 tt -56.4 -46.08 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.877 174.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.98 -38.01 81.31 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.8 0.84 . . . . 0.0 111.707 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -66.34 -46.75 75.72 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.017 0.527 . . . . 0.0 111.593 -176.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 pp -72.11 -32.56 67.09 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.282 0.233 . . . . 0.0 111.61 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 68.2 mm-40 -63.73 -47.75 79.84 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.191 0.597 . . . . 0.0 110.816 174.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -77.32 -23.66 50.97 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.404 -175.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -72.63 -28.34 62.68 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -59.63 -47.58 85.04 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.115 0.566 . . . . 0.0 110.034 173.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -70.9 -26.7 63.34 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.101 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.71 -30.0 69.39 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.905 0.882 . . . . 0.0 111.276 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.58 34.88 0.68 Allowed Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.46 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.567 ' HA2' ' HD2' ' A' ' 52' ' ' LYS . . . -162.23 100.0 0.18 Allowed Glycine 0 C--N 1.346 1.131 0 CA-C-O 120.05 -0.306 . . . . 0.0 112.635 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -75.73 110.0 9.79 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -176.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -103.32 157.24 17.15 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.564 174.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.5 t -148.25 143.54 27.04 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.648 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 p -96.64 120.41 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-O 121.027 0.441 . . . . 0.0 110.623 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 78.6 mt -136.89 125.22 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 124.906 1.282 . . . . 0.0 108.194 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.1 t70 62.45 32.9 16.51 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.386 1.074 . . . . 0.0 111.548 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.14 19.57 77.39 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-N 115.818 -0.628 . . . . 0.0 113.401 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -125.24 145.35 50.03 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.187 0.995 . . . . 0.0 108.674 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.506 HG22 ' HB ' ' A' ' 26' ' ' VAL . 25.4 t -99.8 119.64 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -112.54 165.75 11.95 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.035 0.934 . . . . 0.0 109.056 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -93.76 161.55 14.28 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.565 0.698 . . . . 0.0 110.065 170.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.418 HG23 ' HB2' ' A' ' 73' ' ' PRO . 29.3 mm -115.88 -29.92 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.502 1.121 . . . . 0.0 109.744 172.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.567 ' HD2' ' HA2' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -57.36 -52.27 66.04 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 123.891 0.876 . . . . 0.0 112.655 -177.006 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -78.34 -31.38 48.62 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.278 1.031 . . . . 0.0 110.224 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -52.47 -60.81 2.79 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.843 1.257 . . . . 0.0 111.346 175.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -64.89 -28.65 69.69 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.558 -0.747 . . . . 0.0 112.177 -174.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.0 m -63.46 -45.04 92.65 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.298 0.639 . . . . 0.0 110.055 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -77.65 -13.54 59.88 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.369 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.6 m -71.15 -19.64 62.4 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.697 0.399 . . . . 0.0 111.015 172.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 61.0 mt -82.25 -5.89 58.85 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.993 0.917 . . . . 0.0 111.497 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 79.4 m -91.58 133.24 35.71 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.759 0.824 . . . . 0.0 109.722 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -62.91 -49.59 74.2 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.276 1.03 . . . . 0.0 111.644 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -86.51 45.41 1.24 Allowed 'General case' 0 CA--C 1.557 1.218 0 CA-C-O 121.91 0.862 . . . . 0.0 110.642 -177.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 75.7 m -122.81 144.74 48.99 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.181 0.992 . . . . 0.0 109.306 172.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.476 ' HB ' HG23 ' A' ' 86' ' ' THR . 35.0 pt -59.26 -25.92 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 124.029 0.932 . . . . 0.0 110.759 169.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.514 HD21 ' HE2' ' A' ' 90' ' ' MET . 36.7 mt -76.82 -10.15 59.17 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.276 1.031 . . . . 0.0 111.902 -178.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.84 -20.54 59.71 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.214 0.606 . . . . 0.0 111.535 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 2.2 pt20 -77.19 -29.37 54.3 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 171.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -87.94 2.78 50.81 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.402 1.081 . . . . 0.0 111.177 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.54 126.15 28.4 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.782 0.433 . . . . 0.0 110.112 177.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.31 -21.7 38.64 Favored Glycine 0 C--N 1.345 1.037 0 O-C-N 123.481 0.488 . . . . 0.0 112.528 -173.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -89.91 158.49 17.4 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.219 1.008 . . . . 0.0 109.809 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -61.23 132.55 92.57 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 123.204 0.602 . . . . 0.0 109.817 173.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.418 ' HB2' HG23 ' A' ' 51' ' ' ILE . 52.6 Cg_endo -64.53 -32.12 59.65 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.976 2.451 . . . . 0.0 113.899 -172.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.6 t -73.93 -45.82 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.8 t -61.15 -40.35 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.52 0.728 . . . . 0.0 110.478 177.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.02 -40.05 95.46 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.305 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 37.6 tp -71.81 -37.9 70.28 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.666 0.786 . . . . 0.0 110.917 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.23 -44.42 91.91 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.987 0.515 . . . . 0.0 110.318 176.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.51 -33.55 75.83 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.823 0.849 . . . . 0.0 110.873 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.79 -41.78 82.65 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.924 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.13 -23.28 64.88 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -82.76 -9.46 59.34 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.492 0.717 . . . . 0.0 112.071 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -125.89 124.85 41.77 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.206 0.602 . . . . 0.0 109.752 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.09 -42.0 84.71 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.411 1.084 . . . . 0.0 113.901 -169.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.42 -35.85 78.71 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.45 0.7 . . . . 0.0 111.285 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.476 HG23 ' HB ' ' A' ' 64' ' ' ILE . 31.6 p -98.26 -6.01 31.99 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.854 -174.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -90.48 -25.68 20.18 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 118.584 0.629 . . . . 0.0 110.433 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -75.72 -24.83 56.22 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.8 0.666 . . . . 0.0 112.8 -172.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.2 t -71.71 -23.97 61.73 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.145 171.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.514 ' HE2' HD21 ' A' ' 65' ' ' LEU . 12.6 mmt -75.58 -8.92 58.0 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.263 0.625 . . . . 0.0 111.663 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -70.3 -16.81 63.06 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.611 0.764 . . . . 0.0 110.507 169.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -88.66 -37.38 15.62 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.958 0.903 . . . . 0.0 110.857 170.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.433 ' HD2' ' HA ' ' A' ' 90' ' ' MET . 97.5 m-85 -80.79 -14.22 58.27 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.456 0.702 . . . . 0.0 112.192 -176.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 27.1 p -69.5 102.37 1.79 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.736 0.414 . . . . 0.0 110.647 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 26.2 m -77.56 -15.13 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 123.344 0.657 . . . . 0.0 111.201 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 168.84 -172.13 43.09 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.808 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -99.31 150.44 22.11 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 174.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -86.25 152.19 22.99 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.946 0.498 . . . . 0.0 110.553 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -146.65 121.34 9.84 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 172.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.465 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 38.3 mt-10 -71.46 129.01 89.32 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 123.232 0.613 . . . . 0.0 109.631 173.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.9 -32.27 56.29 Favored 'Trans proline' 0 CA--C 1.561 1.847 0 C-N-CA 122.848 2.365 . . . . 0.0 112.645 176.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -76.64 -32.47 58.02 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.624 0.77 . . . . 0.0 111.552 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.465 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 50.3 tp60 . . . . . 0 N--CA 1.479 0.994 0 C-N-CA 122.829 0.452 . . . . 0.0 110.262 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.1 m . . . . . 0 N--CA 1.468 0.455 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.4 mt -78.34 100.32 6.7 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.357 0.598 . . . . 0.0 109.64 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -92.53 114.37 29.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 38.3 mtp-105 -85.99 176.3 8.12 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.785 -175.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.5 tt -58.02 -37.44 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.728 175.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.75 -40.25 94.98 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.818 0.847 . . . . 0.0 111.264 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -74.28 -39.79 62.72 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.165 0.586 . . . . 0.0 110.788 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 45.6 tp -66.77 -50.15 63.6 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.035 0.534 . . . . 0.0 110.604 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -64.85 -48.11 75.52 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.63 0.772 . . . . 0.0 112.069 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -67.09 -47.96 69.62 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 123.488 0.493 . . . . 0.0 111.643 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -64.2 -36.77 85.16 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.525 0.33 . . . . 0.0 110.61 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -65.56 -39.69 91.96 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.067 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -67.79 -29.15 68.26 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.52 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -65.38 -23.2 66.91 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.184 0.594 . . . . 0.0 111.588 175.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.92 -26.74 6.09 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.55 ' HA2' ' HD2' ' A' ' 52' ' ' LYS . . . -69.62 89.55 0.29 Allowed Glycine 0 C--N 1.345 1.073 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 176.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -74.11 112.84 10.65 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -171.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 32.6 m0 -105.27 155.21 19.28 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.69 171.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 48' ' ' VAL . 13.6 t -129.55 160.72 32.35 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.516 0.726 . . . . 0.0 109.408 177.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 p -116.34 109.43 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 172.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.3 mt -134.37 133.76 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.002 1.321 . . . . 0.0 107.696 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.0 t70 63.2 29.4 16.0 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 124.473 1.109 . . . . 0.0 110.631 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.5 19.0 64.17 Favored Glycine 0 C--N 1.353 1.487 0 CA-C-N 115.121 -0.945 . . . . 0.0 113.497 -174.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.451 ' HB2' ' CE2' ' A' ' 49' ' ' TYR . 42.9 mmtm -116.82 152.33 34.65 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.449 1.1 . . . . 0.0 108.51 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 42' ' ' THR . 63.8 t -102.12 122.59 54.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 173.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 47' ' ' LYS . 96.4 m-85 -114.47 155.3 26.64 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.923 0.889 . . . . 0.0 110.427 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -94.63 107.12 19.12 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.436 0.694 . . . . 0.0 109.47 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.463 HG23 ' HB2' ' A' ' 73' ' ' PRO . 15.6 mm -75.77 -39.87 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.925 0.89 . . . . 0.0 112.288 -177.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.55 ' HD2' ' HA2' ' A' ' 39' ' ' GLY . 18.0 ptmt -67.08 -32.06 72.97 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 121.161 -0.216 . . . . 0.0 110.954 -174.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -73.7 -38.45 64.84 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -53.19 -54.17 39.88 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.503 1.121 . . . . 0.0 111.12 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -70.34 -27.56 64.45 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.411 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.1 m -72.52 -33.08 66.63 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 120.946 0.403 . . . . 0.0 110.241 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.493 ' HB2' HD13 ' A' ' 65' ' ' LEU . 82.6 mm-40 -69.65 -35.42 75.17 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 172.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.4 m -65.31 -27.12 68.38 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.301 0.64 . . . . 0.0 111.099 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.3 tt -61.63 -44.73 96.43 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.238 1.015 . . . . 0.0 109.297 173.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 88.8 m -66.91 120.31 13.38 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.38 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -65.49 -31.52 72.64 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.956 0.903 . . . . 0.0 111.308 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -69.66 -18.16 63.55 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.331 1.053 . . . . 0.0 111.766 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.8 t -76.04 152.66 36.84 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.877 0.471 . . . . 0.0 110.762 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.483 HD12 ' HA ' ' A' ' 86' ' ' THR . 32.4 pt -61.2 -26.8 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.711 170.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.493 HD13 ' HB2' ' A' ' 57' ' ' GLN . 46.6 mt -77.21 0.76 20.69 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.144 0.978 . . . . 0.0 111.971 -176.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.99 -30.4 70.91 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.363 0.665 . . . . 0.0 111.21 172.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 11.2 pt20 -73.99 -27.06 60.78 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.31 0.644 . . . . 0.0 110.689 175.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.532 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 41.8 m-85 -92.69 -6.44 49.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.255 1.022 . . . . 0.0 111.45 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.27 104.22 0.9 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.153 0.581 . . . . 0.0 109.824 174.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.47 -32.13 3.62 Favored Glycine 0 N--CA 1.472 1.046 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -174.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -77.62 151.14 34.5 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.425 0.69 . . . . 0.0 109.649 175.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -55.37 128.1 66.54 Favored Pre-proline 0 N--CA 1.48 1.067 0 CA-C-O 118.476 -0.773 . . . . 0.0 108.955 171.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.463 ' HB2' HG23 ' A' ' 51' ' ' ILE . 28.6 Cg_endo -58.0 -31.51 93.07 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.836 2.357 . . . . 0.0 113.973 -170.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.9 t -75.38 -50.27 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 123.058 0.543 . . . . 0.0 110.097 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.1 t -58.58 -35.26 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 124.035 0.934 . . . . 0.0 111.022 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.532 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -73.27 -34.98 66.1 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.701 1.2 . . . . 0.0 111.213 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.538 ' HG ' ' SD ' ' A' ' 90' ' ' MET . 4.6 tt -71.58 -35.78 70.67 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.504 0.722 . . . . 0.0 109.889 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -66.53 -40.72 89.29 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.426 0.69 . . . . 0.0 110.36 175.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.18 -32.95 74.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.638 0.775 . . . . 0.0 110.619 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.41 -40.82 73.65 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.878 177.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.9 mt -64.67 -36.68 85.04 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.251 0.621 . . . . 0.0 110.856 173.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -65.87 -36.81 84.46 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.637 0.775 . . . . 0.0 111.074 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.486 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 29.9 t80 -95.96 132.12 41.62 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -176.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -65.85 -36.81 84.49 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.174 0.99 . . . . 0.0 113.193 -168.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -74.98 -32.2 61.63 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.713 0.405 . . . . 0.0 111.063 -177.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.486 ' OG1' ' HB3' ' A' ' 83' ' ' PHE . 37.8 p -93.57 -10.65 34.02 Favored 'General case' 0 CA--C 1.555 1.161 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -172.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -78.51 -15.07 59.0 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -26.24 55.44 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.01 0.524 . . . . 0.0 112.198 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.6 t -73.73 -29.57 62.33 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.324 0.25 . . . . 0.0 110.38 171.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.538 ' SD ' ' HG ' ' A' ' 77' ' ' LEU . 32.1 mmt -64.94 -26.05 68.14 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.052 0.541 . . . . 0.0 110.406 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -59.91 -37.02 78.24 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.707 0.803 . . . . 0.0 110.63 174.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.36 -32.8 60.96 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.834 178.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -78.24 -24.09 47.1 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.255 0.222 . . . . 0.0 111.16 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 39.1 t -70.77 95.27 1.11 Allowed 'General case' 0 C--N 1.349 0.556 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 33.3 m -71.0 -22.77 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.238 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 169.75 -160.66 33.81 Favored Glycine 0 C--N 1.351 1.396 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.836 174.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -97.22 145.69 25.82 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.647 1.179 . . . . 0.0 109.133 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -80.26 108.79 14.16 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 173.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 3.0 tm? -92.31 114.58 27.17 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 103' ' ' GLN . 30.6 tt0 -80.03 140.71 53.86 Favored Pre-proline 0 CA--C 1.554 1.102 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 174.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -39.1 -51.2 2.56 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 124.356 3.371 . . . . 0.0 114.644 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -103.1 23.06 12.93 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.291 0.637 . . . . 0.0 111.655 -175.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.547 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 8.9 tp-100 . . . . . 0 N--CA 1.485 1.312 0 O-C-N 121.861 -0.524 . . . . 0.0 110.088 174.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.1 m . . . . . 0 CA--C 1.536 0.428 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.422 HD21 ' HB2' ' A' ' 99' ' ' LEU . 64.3 mt -79.35 110.59 14.79 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.1 t -91.87 119.31 39.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 124.069 0.948 . . . . 0.0 108.583 -176.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.495 ' HG2' ' HB2' ' A' ' 30' ' ' ASP . 1.5 ptm180 -81.27 162.0 23.69 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.421 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.5 tt -60.12 -36.8 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.757 0.823 . . . . 0.0 111.836 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.09 -32.21 64.84 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.485 0.714 . . . . 0.0 111.922 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.495 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 29.1 t70 -58.81 -43.26 90.51 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.403 0.681 . . . . 0.0 110.454 -176.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.9 mt -52.35 -43.85 64.86 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.511 1.124 . . . . 0.0 111.691 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -72.18 -37.83 69.22 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.506 -175.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -69.09 -40.06 78.65 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.934 0.494 . . . . 0.0 110.821 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -66.74 -40.4 88.3 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.17 0.588 . . . . 0.0 110.05 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -59.79 -40.49 88.49 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.973 0.509 . . . . 0.0 110.143 176.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -69.27 -31.64 70.3 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.753 0.821 . . . . 0.0 111.388 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -74.28 -30.44 62.1 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.783 0.833 . . . . 0.0 111.274 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 112.06 -7.15 27.21 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.688 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.483 ' HA2' ' HD2' ' A' ' 52' ' ' LYS . . . -75.36 83.46 0.87 Allowed Glycine 0 C--N 1.349 1.268 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 172.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -75.71 107.32 7.8 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -172.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 28.7 m0 -111.44 160.71 16.85 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.643 1.177 . . . . 0.0 110.425 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.8 t -149.36 144.75 26.61 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.421 1.088 . . . . 0.0 109.126 -177.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.557 HG22 HG23 ' A' ' 48' ' ' VAL . 95.9 t -111.36 119.17 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.3 0.64 . . . . 0.0 109.925 178.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.9 mt -127.54 106.12 14.67 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 124.031 0.932 . . . . 0.0 109.008 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.5 t70 55.94 54.55 7.91 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 124.599 1.16 . . . . 0.0 111.61 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.64 9.43 62.01 Favored Glycine 0 N--CA 1.475 1.296 0 CA-C-N 115.081 -0.963 . . . . 0.0 114.428 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -117.76 124.5 48.59 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.767 0.827 . . . . 0.0 108.866 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.557 HG23 HG22 ' A' ' 43' ' ' VAL . 15.2 t -97.11 127.51 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.475 ' HB2' HD21 ' A' ' 77' ' ' LEU . 79.7 m-85 -127.7 163.71 23.7 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.291 1.036 . . . . 0.0 109.035 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -93.39 160.23 14.9 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.529 0.68 . . . . 0.0 110.066 170.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.8 mm -113.14 -27.77 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.494 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.483 ' HD2' ' HA2' ' A' ' 39' ' ' GLY . 21.0 ptmt -70.26 -48.75 55.45 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.069 0.548 . . . . 0.0 112.252 -173.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.458 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 34.6 t70 -75.04 -36.78 61.85 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -49.81 -55.43 14.17 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.934 1.293 . . . . 0.0 112.217 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -67.65 -27.28 66.74 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.111 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.3 m -68.6 -32.05 71.67 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.296 0.638 . . . . 0.0 110.895 172.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 22.5 mm-40 -76.13 -21.4 56.66 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 121.908 -0.495 . . . . 0.0 111.123 178.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.0 m -68.84 -17.66 64.03 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.124 0.57 . . . . 0.0 111.081 172.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.3 tp -69.71 -25.59 63.93 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.709 0.804 . . . . 0.0 110.709 173.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.7 m -86.15 117.47 25.0 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -67.55 -28.36 67.73 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.404 0.681 . . . . 0.0 111.207 -177.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -88.78 63.43 6.85 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-O 121.924 0.869 . . . . 0.0 108.943 173.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 61.2 m -147.55 153.23 39.2 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.923 1.289 . . . . 0.0 108.304 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.462 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 31.8 pt -61.4 -25.6 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.465 0.706 . . . . 0.0 110.902 170.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.415 HD12 ' HB2' ' A' ' 57' ' ' GLN . 58.8 mt -84.31 0.34 49.47 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.368 1.067 . . . . 0.0 112.298 -175.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.91 -29.82 61.09 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.006 0.522 . . . . 0.0 110.744 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 10.6 pt20 -85.43 -6.82 59.18 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.223 0.609 . . . . 0.0 110.846 173.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -108.91 7.97 26.25 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.07 0.948 . . . . 0.0 110.477 174.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.21 126.53 30.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.076 0.55 . . . . 0.0 109.76 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.65 -31.85 8.09 Favored Glycine 0 N--CA 1.474 1.227 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 -173.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -75.28 152.8 38.21 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.948 0.899 . . . . 0.0 109.945 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -56.19 124.47 60.23 Favored Pre-proline 0 N--CA 1.476 0.858 0 C-N-CA 123.927 0.891 . . . . 0.0 109.749 175.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.13 -23.95 52.4 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.979 2.453 . . . . 0.0 113.938 -172.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.2 t -74.6 -47.58 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 176.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.88 -34.0 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.816 0.847 . . . . 0.0 111.085 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.08 -35.74 71.97 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.146 0.979 . . . . 0.0 110.516 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.611 HD11 ' SD ' ' A' ' 90' ' ' MET . 58.8 tp -68.99 -42.6 76.29 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.469 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -65.91 -42.38 90.26 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.604 0.761 . . . . 0.0 110.478 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.96 -37.36 86.77 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.607 0.763 . . . . 0.0 110.328 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.07 -42.47 89.39 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.293 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.7 mt -67.64 -33.41 74.9 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.88 0.872 . . . . 0.0 111.848 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -89.14 2.55 53.98 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.321 0.649 . . . . 0.0 111.809 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -129.82 125.46 35.78 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.93 0.492 . . . . 0.0 109.821 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -58.23 -38.96 77.85 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.758 1.223 . . . . 0.0 113.73 -169.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -71.46 -30.6 66.21 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.353 0.661 . . . . 0.0 111.473 -176.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.414 HG23 ' HB ' ' A' ' 64' ' ' ILE . 24.6 p -101.67 -7.88 22.28 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.366 0.666 . . . . 0.0 112.67 -173.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.69 1.02 53.47 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 118.305 0.502 . . . . 0.0 111.323 177.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -72.56 -49.66 30.94 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.022 0.929 . . . . 0.0 110.782 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 32.8 t -71.58 -18.86 62.21 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.608 0.763 . . . . 0.0 111.162 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.611 ' SD ' HD11 ' A' ' 77' ' ' LEU . 37.4 mmt -64.79 -21.01 66.69 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.456 0.702 . . . . 0.0 111.979 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -60.39 -34.44 73.9 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.446 0.699 . . . . 0.0 110.895 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.99 -45.71 69.91 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.126 0.57 . . . . 0.0 110.97 176.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.412 ' HD2' ' HA ' ' A' ' 90' ' ' MET . 60.1 m-85 -73.61 -16.21 61.24 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.294 0.638 . . . . 0.0 111.395 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 45.8 t -70.65 87.98 0.69 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.441 0.696 . . . . 0.0 109.608 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.8 m -77.1 -25.55 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.383 -176.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 172.82 177.7 42.33 Favored Glycine 0 C--N 1.343 0.921 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.462 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -98.61 133.93 42.26 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -72.55 129.23 37.82 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 173.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.422 ' HB2' HD21 ' A' ' 25' ' ' LEU . 3.0 tm? -132.59 127.87 35.94 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -82.33 141.95 46.51 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 123.718 0.807 . . . . 0.0 110.4 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -59.18 -34.6 98.43 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.773 2.315 . . . . 0.0 111.658 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -70.57 -39.75 73.71 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.211 175.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 . . . . . 0 N--CA 1.482 1.137 0 C-N-CA 123.285 0.634 . . . . 0.0 111.775 -176.385 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.0 m . . . . . 0 CA--C 1.541 0.634 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.511 HD13 HD21 ' A' ' 99' ' ' LEU . 92.3 mt -79.98 100.92 8.35 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.504 ' HB ' HG21 ' A' ' 48' ' ' VAL . 58.2 t -94.57 116.98 37.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 55.6 mtm180 -95.76 172.93 7.73 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.191 0.597 . . . . 0.0 110.84 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.491 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 19.9 tt -60.52 -36.65 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 123.757 0.661 . . . . 0.0 111.451 -174.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.39 -45.12 72.81 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.081 0.952 . . . . 0.0 110.761 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.2 -44.98 93.84 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.04 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.4 mt -59.21 -42.7 91.55 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.858 0.863 . . . . 0.0 111.972 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 9.9 mm-40 -63.45 -50.5 69.49 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 123.496 0.497 . . . . 0.0 111.162 -174.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -71.85 -33.96 68.87 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.575 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -72.29 -35.06 68.58 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.852 0.461 . . . . 0.0 110.442 -177.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -66.45 -39.2 88.73 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.915 0.886 . . . . 0.0 110.399 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -61.78 -32.42 72.7 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.72 0.808 . . . . 0.0 111.52 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -66.12 -34.15 77.41 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.916 0.487 . . . . 0.0 111.058 176.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.05 -18.83 7.41 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.789 -175.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.88 89.02 0.23 Allowed Glycine 0 C--N 1.353 1.506 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 174.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -77.46 108.77 10.86 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.171 0.589 . . . . 0.0 109.573 -175.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -105.83 165.65 11.04 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.264 1.026 . . . . 0.0 109.907 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.8 t -143.03 160.29 40.65 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.868 0.867 . . . . 0.0 109.859 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 47' ' ' LYS . 1.5 p -114.49 112.38 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 123.443 0.697 . . . . 0.0 109.468 170.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.545 HD13 HD22 ' A' ' 77' ' ' LEU . 39.9 mt -134.52 136.98 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.749 1.219 . . . . 0.0 107.872 175.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.0 t70 62.85 29.41 16.61 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 124.327 1.051 . . . . 0.0 110.447 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.48 23.24 68.41 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.11 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 27.5 mmtp -124.67 153.19 42.68 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.562 1.145 . . . . 0.0 108.671 -176.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.504 HG21 ' HB ' ' A' ' 26' ' ' VAL . 91.7 t -104.07 132.27 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 175.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -127.72 153.18 46.82 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.841 0.856 . . . . 0.0 109.908 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -92.42 106.18 18.23 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.409 HG13 HG23 ' A' ' 74' ' ' VAL . 35.8 mm -83.37 -29.6 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.75 0.82 . . . . 0.0 111.533 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.24 -47.56 84.9 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.474 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 28.5 t70 -69.37 -40.84 77.22 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.555 177.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -52.84 -55.0 26.25 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.421 1.089 . . . . 0.0 112.055 -177.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -66.44 -28.01 68.27 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.718 0.807 . . . . 0.0 111.583 -176.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.8 m -66.85 -37.06 83.74 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 122.918 0.487 . . . . 0.0 109.827 173.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 49.7 mm-40 -76.51 -24.63 53.73 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.285 0.634 . . . . 0.0 110.711 176.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.3 m -76.84 -19.69 57.22 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.52 0.728 . . . . 0.0 111.252 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.8 tt -74.05 -24.79 59.58 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.617 0.767 . . . . 0.0 110.321 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.7 m -58.8 137.47 57.7 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.904 0.881 . . . . 0.0 112.693 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -54.28 -45.69 72.55 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.016 1.327 . . . . 0.0 112.04 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -118.12 112.04 19.66 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 38.9 t -163.41 158.58 21.29 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.449 ' HB ' HG21 ' A' ' 86' ' ' THR . 35.9 pt -65.22 -24.63 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 166.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.5 mt -91.6 -2.04 57.26 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 124.759 1.224 . . . . 0.0 111.619 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.17 -31.97 68.33 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.938 0.495 . . . . 0.0 110.376 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 9.6 pt20 -76.51 -23.21 53.7 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.993 0.517 . . . . 0.0 110.652 172.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.518 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 29.4 m-85 -96.24 6.82 47.96 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.369 1.068 . . . . 0.0 111.688 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.52 -22.43 63.58 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.316 0.646 . . . . 0.0 112.1 -177.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.44 11.43 71.36 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-O 120.231 -0.205 . . . . 0.0 112.775 177.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -125.84 156.74 39.11 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.411 1.084 . . . . 0.0 109.694 -177.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -55.46 128.67 68.34 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 124.235 1.014 . . . . 0.0 109.354 170.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -59.74 -30.4 91.98 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.923 2.415 . . . . 0.0 113.946 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.409 HG23 HG13 ' A' ' 51' ' ' ILE . 21.9 t -75.18 -39.02 42.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 C-N-CA 122.588 0.355 . . . . 0.0 110.346 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.6 t -69.76 -39.8 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-O 121.49 0.662 . . . . 0.0 110.116 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.518 ' HB2' ' HB3' ' A' ' 68' ' ' PHE . . . -63.56 -34.49 77.93 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.114 1.366 . . . . 0.0 111.135 178.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.545 HD22 HD13 ' A' ' 44' ' ' ILE . 64.8 tp -61.09 -44.07 97.92 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.81 175.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.442 ' HG2' HG22 ' A' ' 44' ' ' ILE . 42.1 mt-10 -64.44 -40.82 96.47 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.77 0.828 . . . . 0.0 111.399 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.3 -38.5 91.38 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.529 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.81 -26.13 56.96 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.74 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 79.6 mt -72.13 -39.48 68.78 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.502 0.721 . . . . 0.0 109.95 174.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -67.91 -44.78 76.13 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.114 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -84.76 131.48 34.55 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 120.823 0.344 . . . . 0.0 110.209 -176.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -66.58 -41.33 88.71 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.263 1.025 . . . . 0.0 112.916 -171.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.58 -26.57 65.45 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.14 0.576 . . . . 0.0 111.412 -176.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.449 HG21 ' HB ' ' A' ' 64' ' ' ILE . 28.1 p -91.09 -34.22 15.16 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.21 0.604 . . . . 0.0 111.977 -177.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -66.83 -14.27 62.49 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -171.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -57.75 -36.88 72.7 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.252 0.621 . . . . 0.0 111.09 173.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.2 t -77.12 -35.44 56.27 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.346 0.659 . . . . 0.0 110.451 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.479 ' SD ' ' N ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -67.95 -21.64 65.08 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.71 0.804 . . . . 0.0 111.2 175.627 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -67.62 -21.57 65.38 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.35 1.06 . . . . 0.0 110.249 172.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -92.65 -29.95 15.84 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.872 0.869 . . . . 0.0 111.272 172.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -74.95 -23.35 58.3 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 122.962 0.505 . . . . 0.0 111.527 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 27.1 p -69.86 101.05 1.65 Allowed 'General case' 0 C--N 1.354 0.789 0 C-N-CA 122.869 0.468 . . . . 0.0 110.133 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.4 t -67.66 -31.07 50.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 123.91 0.884 . . . . 0.0 110.179 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 172.28 -160.29 31.63 Favored Glycine 0 C--N 1.339 0.721 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.465 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -102.89 133.79 47.38 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 175.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -75.65 131.07 39.68 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 123.273 0.358 . . . . 0.0 110.444 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.511 HD21 HD13 ' A' ' 25' ' ' LEU . 66.5 tp -121.56 134.97 55.03 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 33.4 mt-10 -85.66 137.89 35.93 Favored Pre-proline 0 C--O 1.244 0.815 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 171.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -60.85 -22.53 74.18 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.946 2.43 . . . . 0.0 112.635 175.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -85.1 -37.55 20.14 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.269 1.028 . . . . 0.0 110.853 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 9.5 tp-100 . . . . . 0 N--CA 1.491 1.615 0 C-N-CA 123.83 0.852 . . . . 0.0 111.277 -173.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.9 p . . . . . 0 CA--C 1.542 0.638 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.2 mt -81.73 117.66 22.23 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.3 t -92.13 125.3 44.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -175.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -67.97 152.7 45.13 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.47 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 18.9 tt -60.63 -44.56 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 117.711 0.232 . . . . 0.0 110.836 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.71 -31.45 69.47 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.457 0.703 . . . . 0.0 110.613 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.5 -37.78 80.39 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.927 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.4 tp -64.9 -51.66 60.71 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.664 0.786 . . . . 0.0 110.205 175.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 58.8 mm-40 -64.17 -53.57 47.3 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.997 0.919 . . . . 0.0 112.473 -171.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -74.55 -29.68 61.46 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -173.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -72.53 -37.49 68.29 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -63.12 -42.76 99.6 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.887 0.875 . . . . 0.0 109.486 174.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -68.6 -26.58 65.44 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.178 1.391 . . . . 0.0 111.671 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -66.53 -35.26 79.81 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.548 0.739 . . . . 0.0 111.538 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 129.64 -26.63 4.28 Favored Glycine 0 N--CA 1.467 0.738 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.24 81.55 0.36 Allowed Glycine 0 C--N 1.351 1.408 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 167.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -74.63 113.69 12.18 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -164.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 33.4 m0 -106.61 171.44 7.36 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.396 1.078 . . . . 0.0 110.548 177.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.8 t -157.66 142.17 16.36 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.335 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -104.03 112.8 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.107 0.563 . . . . 0.0 109.525 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.411 HD11 ' HG2' ' A' ' 78' ' ' GLU . 55.7 mt -127.39 120.18 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.109 0.964 . . . . 0.0 108.942 176.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 62.06 40.08 12.44 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 125.12 1.368 . . . . 0.0 110.691 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.59 15.59 73.33 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.033 -0.985 . . . . 0.0 113.551 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HD3' ' HG3' ' A' ' 97' ' ' GLN . 35.6 mmtp -118.65 148.17 43.0 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.086 0.955 . . . . 0.0 109.411 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.9 t -106.1 120.98 57.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -118.08 171.17 8.28 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.972 1.309 . . . . 0.0 108.887 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -102.14 159.41 15.41 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.4 0.619 . . . . 0.0 110.39 170.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.1 mm -114.28 -21.4 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 124.437 1.095 . . . . 0.0 109.136 168.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -56.99 6.99 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 122.994 0.517 . . . . 0.0 111.614 -175.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 23.7 t70 -67.43 -37.12 82.53 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.4 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 75.2 t80 -53.17 -52.21 59.55 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.637 1.575 . . . . 0.0 112.7 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -69.6 -27.13 64.83 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.778 -176.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.8 m -70.27 -34.36 72.7 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-O 121.056 0.455 . . . . 0.0 110.423 174.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 33.3 mm-40 -72.19 -24.27 61.39 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.649 0.78 . . . . 0.0 112.195 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.6 p -77.57 -6.82 55.05 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.34 -2.49 38.39 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.761 0.424 . . . . 0.0 111.134 168.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' A' ' 63' ' ' SER . 19.4 m -77.44 120.24 22.17 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 168.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.462 ' HG3' ' ND2' ' A' ' 62' ' ' ASN . 9.5 pt-20 -62.5 -36.9 84.01 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.417 0.687 . . . . 0.0 111.801 -178.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.462 ' ND2' ' HG3' ' A' ' 61' ' ' GLU . 34.5 m-80 -111.24 87.32 2.52 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.508 ' HB3' ' HB ' ' A' ' 60' ' ' THR . 91.9 p -147.13 164.7 32.25 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.994 0.917 . . . . 0.0 109.601 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.538 ' HB ' HG23 ' A' ' 86' ' ' THR . 29.5 pt -68.43 -17.77 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 122.694 0.397 . . . . 0.0 111.019 171.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.6 mt -96.65 -8.87 30.49 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.978 0.911 . . . . 0.0 111.35 -177.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.54 -33.4 74.04 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.469 0.708 . . . . 0.0 110.773 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -76.69 -19.83 57.28 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.663 0.785 . . . . 0.0 111.239 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.478 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . 25.5 m-85 -107.38 7.28 29.01 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.128 0.971 . . . . 0.0 111.1 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.26 -38.07 89.16 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.303 0.641 . . . . 0.0 111.539 -175.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -79.18 -8.3 87.91 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.594 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -95.66 155.46 16.73 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.454 0.702 . . . . 0.0 109.437 175.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -49.22 131.16 16.86 Favored Pre-proline 0 N--CA 1.485 1.324 0 C-N-CA 124.432 1.093 . . . . 0.0 110.417 172.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -61.72 -33.41 85.83 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.748 2.299 . . . . 0.0 113.859 -172.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.1 t -74.55 -41.27 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.66 -32.56 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 123.633 0.773 . . . . 0.0 110.373 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 68' ' ' PHE . . . -68.83 -36.72 78.54 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.554 1.142 . . . . 0.0 110.505 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.693 HD11 ' SD ' ' A' ' 90' ' ' MET . 59.0 tp -64.77 -42.74 94.87 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.079 175.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.411 ' HG2' HD11 ' A' ' 44' ' ' ILE . 48.1 mt-10 -63.49 -40.87 98.22 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.44 0.696 . . . . 0.0 111.594 177.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.11 -34.39 77.96 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.669 0.787 . . . . 0.0 110.307 177.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.36 -26.32 51.86 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.324 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 92.0 mt -75.53 -30.92 59.91 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.1 0.56 . . . . 0.0 110.612 172.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -75.0 -45.87 38.99 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.724 -176.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.411 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 35.3 t80 -82.04 137.88 34.98 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 122.579 0.352 . . . . 0.0 110.579 -174.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.11 -37.15 85.04 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.368 1.067 . . . . 0.0 113.493 -169.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -66.04 -44.26 85.14 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.381 0.61 . . . . 0.0 110.624 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.538 HG23 ' HB ' ' A' ' 64' ' ' ILE . 25.5 p -81.89 -28.6 32.83 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.921 -169.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -64.87 -27.1 68.63 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.124 0.569 . . . . 0.0 111.964 -173.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -79.54 -22.77 43.46 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.392 0.677 . . . . 0.0 110.698 -178.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.5 t -80.68 -28.67 36.7 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.59 0.756 . . . . 0.0 110.381 171.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.693 ' SD ' HD11 ' A' ' 77' ' ' LEU . 36.2 mmt -64.45 -16.71 62.91 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.72 0.808 . . . . 0.0 111.889 176.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -57.79 -33.96 69.11 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.772 1.229 . . . . 0.0 111.531 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.6 -37.24 84.47 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.486 0.714 . . . . 0.0 111.254 176.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.452 ' HD2' ' HA ' ' A' ' 90' ' ' MET . 63.6 m-85 -85.66 -13.03 49.83 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.518 0.727 . . . . 0.0 111.326 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.4 t -71.54 92.61 1.14 Allowed 'General case' 0 C--N 1.351 0.66 0 C-N-CA 123.239 0.615 . . . . 0.0 109.605 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.9 m -83.16 -12.53 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.582 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 165.86 -169.46 40.18 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.772 172.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.445 ' HG3' ' HD3' ' A' ' 47' ' ' LYS . 30.6 tt0 -108.84 139.9 43.04 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.411 1.084 . . . . 0.0 108.156 172.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -71.62 136.62 47.45 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.002 0.43 . . . . 0.0 110.439 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -117.15 121.75 42.13 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 171.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.662 ' HB3' ' HB2' ' A' ' 103' ' ' GLN . 33.1 tt0 -73.5 133.16 80.55 Favored Pre-proline 0 CA--C 1.552 1.056 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.25 174.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.58 -13.85 41.59 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.239 2.626 . . . . 0.0 113.762 -170.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -104.19 -18.32 14.54 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.876 0.471 . . . . 0.0 110.626 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.662 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 8.5 tp-100 . . . . . 0 N--CA 1.478 0.963 0 C-N-CA 124.068 0.947 . . . . 0.0 112.748 -170.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.7 m . . . . . 0 CA--C 1.542 0.645 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.519 HD13 HD11 ' A' ' 99' ' ' LEU . 83.1 mt -92.93 103.11 15.47 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.114 0.565 . . . . 0.0 109.558 -178.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.41 ' HB ' HG23 ' A' ' 48' ' ' VAL . 69.0 t -92.97 115.92 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 124.02 0.928 . . . . 0.0 108.618 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -84.26 164.83 18.8 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.01 0.924 . . . . 0.0 108.975 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.514 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 17.2 tt -51.23 -44.99 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.455 0.702 . . . . 0.0 112.412 -176.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.43 -44.2 92.95 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.159 0.584 . . . . 0.0 111.641 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -67.63 -35.11 78.32 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.718 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.8 tp -62.91 -42.56 99.83 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.037 0.535 . . . . 0.0 110.203 176.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 12.0 mm-40 -67.55 -55.36 13.78 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.675 0.79 . . . . 0.0 111.578 -175.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -71.13 -35.35 71.7 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.891 -173.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -70.17 -36.66 74.83 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.544 0.338 . . . . 0.0 110.207 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -56.59 -40.69 75.71 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.691 0.619 . . . . 0.0 110.125 175.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -86.89 -15.72 38.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.285 1.034 . . . . 0.0 111.929 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -67.52 -32.18 72.8 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.633 0.773 . . . . 0.0 110.474 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 142.29 -28.6 2.21 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.467 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.0 98.03 2.02 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 174.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -73.28 118.26 16.03 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 -173.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.4 m0 -119.38 154.65 33.29 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.882 0.873 . . . . 0.0 111.554 -169.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.5 t -150.88 151.98 33.02 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.892 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 47' ' ' LYS . 1.6 p -97.77 117.94 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 169.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.7 mt -138.37 131.92 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.8 t70 61.39 29.27 18.43 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 122.31 1.052 . . . . 0.0 110.722 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.87 1.59 47.9 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 114.984 -1.007 . . . . 0.0 114.068 -176.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 41.2 mmtm -96.96 172.69 7.7 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.129 0.972 . . . . 0.0 109.145 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.41 HG23 ' HB ' ' A' ' 26' ' ' VAL . 85.0 t -120.38 119.33 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 172.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -112.34 148.92 33.24 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.236 0.615 . . . . 0.0 110.346 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -92.2 98.79 11.74 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 123.055 0.542 . . . . 0.0 109.736 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.1 mm -61.79 -27.72 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 124.941 1.297 . . . . 0.0 112.122 175.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.618 ' HZ2' ' HB3' ' A' ' 52' ' ' LYS . 5.8 ttpm? -59.39 -51.67 68.89 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-O 120.889 0.376 . . . . 0.0 110.325 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.466 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 31.4 t70 -67.61 -39.57 84.73 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.652 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.418 ' HA ' ' HE2' ' A' ' 93' ' ' PHE . 54.5 t80 -49.05 -48.29 44.09 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.197 0.999 . . . . 0.0 110.886 174.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -71.83 -31.21 66.3 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.41 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.0 m -62.47 -37.83 87.48 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-O 121.052 0.453 . . . . 0.0 110.106 172.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.575 ' HB2' HD13 ' A' ' 65' ' ' LEU . 66.3 mm-40 -78.37 -25.96 46.47 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.311 0.644 . . . . 0.0 111.693 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 92.7 p -85.79 -8.84 57.86 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.903 -0.498 . . . . 0.0 110.995 174.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.6 tt -75.86 -42.54 49.13 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.007 0.923 . . . . 0.0 109.179 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.2 t -75.64 157.49 33.65 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.054 -176.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -67.87 -73.56 0.14 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.363 1.065 . . . . 0.0 111.06 -171.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -86.2 100.58 12.33 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.58 0.705 . . . . 0.0 109.414 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 48.1 t -155.72 163.94 39.22 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.609 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.563 ' HB ' HG22 ' A' ' 86' ' ' THR . 43.2 pt -67.79 -18.54 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 123.572 0.749 . . . . 0.0 111.48 173.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.575 HD13 ' HB2' ' A' ' 57' ' ' GLN . 82.6 mt -104.33 6.33 35.16 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.761 0.825 . . . . 0.0 112.388 -174.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.54 -27.23 62.1 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.108 0.48 . . . . 0.0 110.13 173.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -80.19 -4.97 55.21 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.917 0.887 . . . . 0.0 111.842 173.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.51 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 64.8 m-85 -117.06 9.28 13.58 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.151 0.98 . . . . 0.0 110.56 177.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.98 103.39 2.24 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.684 0.793 . . . . 0.0 110.722 -177.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.45 -37.21 2.39 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -70.1 147.08 50.41 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.017 0.927 . . . . 0.0 110.345 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -53.1 131.22 50.56 Favored Pre-proline 0 N--CA 1.484 1.234 0 C-N-CA 123.625 0.77 . . . . 0.0 110.558 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -47.23 -45.86 20.99 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 123.921 3.081 . . . . 0.0 114.52 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.83 -44.17 45.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.433 -173.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.6 t -66.4 -37.61 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 123.502 0.721 . . . . 0.0 111.052 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.51 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -67.22 -31.84 72.49 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.612 1.165 . . . . 0.0 111.002 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 tt -72.18 -36.46 69.26 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.024 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.69 -39.26 80.62 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.634 0.374 . . . . 0.0 110.763 175.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.62 -32.44 74.01 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.836 0.855 . . . . 0.0 110.525 174.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.08 -35.13 69.16 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.392 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 66.0 mt -74.84 -24.14 58.55 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.588 0.355 . . . . 0.0 111.242 177.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -74.97 -39.6 61.2 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.064 0.546 . . . . 0.0 109.957 173.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -81.98 114.07 20.3 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.919 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -56.62 -32.57 65.44 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.476 1.11 . . . . 0.0 113.263 -172.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -68.05 -40.95 82.69 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.632 0.773 . . . . 0.0 111.744 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.563 HG22 ' HB ' ' A' ' 64' ' ' ILE . 34.9 p -95.75 -17.98 20.8 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -171.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -71.92 -35.45 69.68 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 122.99 0.516 . . . . 0.0 111.34 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.69 -25.99 64.14 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.023 0.929 . . . . 0.0 111.27 -175.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.8 t -80.92 -17.28 51.06 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.483 0.713 . . . . 0.0 110.862 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.405 ' HA ' ' HD1' ' A' ' 93' ' ' PHE . 23.8 mmt -72.21 0.49 9.66 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.292 0.637 . . . . 0.0 112.684 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.423 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 9.1 p80 -62.56 -33.36 74.79 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.376 0.67 . . . . 0.0 110.819 171.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.41 -23.26 46.79 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.23 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.418 ' HE2' ' HA ' ' A' ' 54' ' ' PHE . 54.4 m-85 -90.55 -25.21 20.34 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.325 0.65 . . . . 0.0 110.933 -178.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.423 ' SG ' ' HA ' ' A' ' 91' ' ' HIS . 28.5 p -79.82 106.99 12.25 Favored 'General case' 0 C--N 1.357 0.922 0 CA-C-O 121.042 0.449 . . . . 0.0 109.896 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.0 t -75.7 -29.22 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.274 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -177.91 -166.64 34.74 Favored Glycine 0 C--N 1.345 1.064 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.425 177.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -98.83 138.68 35.62 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.876 0.87 . . . . 0.0 108.961 170.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -78.95 118.8 21.3 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.569 0.748 . . . . 0.0 110.061 173.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.519 HD11 HD13 ' A' ' 25' ' ' LEU . 2.2 tt -99.55 114.36 27.31 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 170.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -80.92 129.68 66.68 Favored Pre-proline 0 CA--C 1.548 0.902 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -53.0 -33.09 61.02 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 123.518 2.812 . . . . 0.0 113.539 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -65.66 -44.68 85.57 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.79 0.836 . . . . 0.0 110.489 178.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 . . . . . 0 N--CA 1.485 1.304 0 C-N-CA 124.032 0.933 . . . . 0.0 111.081 -179.969 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.1 m . . . . . 0 C--O 1.238 0.493 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.416 HD13 HD11 ' A' ' 99' ' ' LEU . 96.0 mt -78.6 101.28 7.36 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.438 ' HB ' HG22 ' A' ' 48' ' ' VAL . 60.9 t -94.94 136.12 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.683 -177.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -106.45 166.86 10.24 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.732 0.813 . . . . 0.0 109.128 -178.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.7 tt -54.7 -41.53 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.438 1.095 . . . . 0.0 113.447 -171.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.83 -34.73 71.99 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.252 0.221 . . . . 0.0 111.408 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.49 -34.06 76.94 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.257 0.623 . . . . 0.0 110.598 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.5 mt -61.89 -57.06 13.24 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.38 0.672 . . . . 0.0 110.027 174.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -62.14 -40.29 95.45 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 124.208 0.943 . . . . 0.0 111.71 -174.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -72.84 -38.08 67.21 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.682 0.793 . . . . 0.0 111.366 -176.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -73.06 -39.25 66.05 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.886 0.474 . . . . 0.0 109.993 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -67.75 -50.05 59.29 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.595 1.158 . . . . 0.0 110.756 -175.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -69.11 -28.52 66.55 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.652 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -68.68 -23.99 64.46 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.208 0.603 . . . . 0.0 111.223 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 139.64 -26.86 2.63 Favored Glycine 0 C--N 1.355 1.585 0 CA-C-N 116.651 -0.25 . . . . 0.0 113.447 174.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.62 103.57 2.91 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -75.12 108.23 7.73 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 117.659 0.73 . . . . 0.0 109.591 -168.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -107.93 138.55 43.99 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.038 0.935 . . . . 0.0 110.147 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.3 t -145.21 156.13 43.67 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.909 0.884 . . . . 0.0 109.038 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.453 HG23 HG21 ' A' ' 48' ' ' VAL . 88.7 t -108.47 118.31 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.263 0.625 . . . . 0.0 110.169 -177.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.45 HD12 HD22 ' A' ' 77' ' ' LEU . 34.5 mt -126.25 127.51 70.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 174.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.8 t70 63.23 30.71 15.82 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 124.656 1.182 . . . . 0.0 111.156 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.1 1.66 80.58 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.318 -0.856 . . . . 0.0 113.603 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.498 ' HD2' ' SG ' ' A' ' 94' ' ' CYS . 69.9 mmtt -109.09 149.65 29.0 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.925 0.89 . . . . 0.0 109.802 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.453 HG21 HG23 ' A' ' 43' ' ' VAL . 47.9 t -99.5 134.41 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.885 0.874 . . . . 0.0 109.992 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -134.1 157.97 44.8 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.097 0.959 . . . . 0.0 109.573 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -106.61 115.97 31.12 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.3 mm -70.73 -33.68 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.568 1.147 . . . . 0.0 112.027 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -69.03 -44.27 73.05 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.937 0.495 . . . . 0.0 110.392 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -66.58 -40.6 89.01 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.068 0.947 . . . . 0.0 110.103 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -52.47 -49.77 64.02 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.08 1.352 . . . . 0.0 111.199 172.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -71.29 -31.36 67.37 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.686 0.795 . . . . 0.0 112.242 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.5 m -64.33 -35.27 80.33 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.308 174.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -74.89 -28.39 60.62 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.684 0.794 . . . . 0.0 111.258 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.439 ' HA ' ' HB2' ' A' ' 65' ' ' LEU . 15.5 m -68.75 -27.55 66.01 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.166 0.586 . . . . 0.0 111.159 177.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.0 tp -63.2 -27.12 69.14 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.782 0.833 . . . . 0.0 111.162 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.4 m -77.87 132.04 37.78 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 122.833 0.453 . . . . 0.0 110.349 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -75.55 -35.34 60.7 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.395 0.678 . . . . 0.0 112.042 -173.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -80.13 -7.75 59.07 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.844 0.457 . . . . 0.0 111.97 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 74.4 m -75.41 151.52 38.13 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.439 0.696 . . . . 0.0 110.656 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.452 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 15.2 pt -63.39 -23.25 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.842 0.857 . . . . 0.0 112.176 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 82.8 mt -78.51 1.9 20.86 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.811 0.845 . . . . 0.0 112.228 -178.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.71 -33.33 75.63 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.4 0.68 . . . . 0.0 110.77 172.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 9.8 pt20 -77.17 -22.7 52.09 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.019 0.528 . . . . 0.0 110.617 176.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.556 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 46.3 m-85 -97.66 4.53 50.06 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.408 1.083 . . . . 0.0 111.444 -178.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.24 -19.86 60.98 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.174 0.589 . . . . 0.0 111.291 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.65 0.02 73.21 Favored Glycine 0 C--N 1.352 1.421 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.896 174.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -109.75 157.76 18.81 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.335 1.054 . . . . 0.0 109.768 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -57.01 130.86 79.83 Favored Pre-proline 0 CA--C 1.551 0.993 0 CA-C-O 118.177 -0.915 . . . . 0.0 109.265 171.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -45.41 -50.22 9.43 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 124.189 3.259 . . . . 0.0 115.431 -177.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.9 t -74.38 -42.32 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -174.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.3 t -64.96 -29.73 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 123.864 0.865 . . . . 0.0 111.217 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.556 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -71.61 -35.91 70.64 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.693 1.197 . . . . 0.0 110.364 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.45 HD22 HD12 ' A' ' 44' ' ' ILE . 3.7 tt -72.01 -37.74 69.74 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.544 177.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -63.63 -43.54 96.5 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.362 0.665 . . . . 0.0 110.375 175.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.16 -34.87 78.49 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.028 0.931 . . . . 0.0 110.942 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.1 -42.44 72.69 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.215 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 72.6 mt -61.62 -46.5 89.54 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.306 0.642 . . . . 0.0 110.46 174.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -61.07 -37.58 83.19 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.314 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -89.64 117.93 28.88 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 121.207 0.527 . . . . 0.0 109.951 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -53.63 -30.32 42.29 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.956 1.702 . . . . 0.0 113.93 -173.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -77.7 -48.34 16.96 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.743 0.417 . . . . 0.0 110.613 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.4 p -84.53 -9.36 58.41 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -169.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -67.04 -16.87 64.63 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 122.731 0.412 . . . . 0.0 111.953 -178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -23.51 65.85 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.111 0.964 . . . . 0.0 113.205 -176.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.0 t -82.01 -32.21 30.68 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 118.089 0.404 . . . . 0.0 110.64 174.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.485 ' SD ' ' N ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -74.54 -15.57 60.85 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.546 0.738 . . . . 0.0 110.814 177.536 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -57.64 -43.82 85.16 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.917 0.887 . . . . 0.0 109.651 167.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.95 -38.86 66.61 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.335 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -71.65 -16.9 62.27 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 122.596 0.358 . . . . 0.0 111.951 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.498 ' SG ' ' HD2' ' A' ' 47' ' ' LYS . 43.5 t -71.35 83.86 0.78 Allowed 'General case' 0 C--N 1.354 0.761 0 C-N-CA 123.883 0.873 . . . . 0.0 109.537 175.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.62 -32.24 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.397 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -176.37 -175.77 43.99 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.291 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -107.53 137.61 45.24 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.226 1.01 . . . . 0.0 109.113 175.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -74.59 121.23 21.27 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.218 0.607 . . . . 0.0 110.259 173.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.416 HD11 HD13 ' A' ' 25' ' ' LEU . 6.4 tt -100.81 117.48 34.98 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 168.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.55 ' HB3' ' HB2' ' A' ' 103' ' ' GLN . 38.9 tt0 -70.87 129.51 89.58 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.54 0.736 . . . . 0.0 109.626 176.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -57.01 -25.8 65.03 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 123.033 2.489 . . . . 0.0 113.117 -177.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -86.16 -27.91 24.27 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.301 0.64 . . . . 0.0 111.604 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.55 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 56.9 tp60 . . . . . 0 N--CA 1.494 1.731 0 C-N-CA 124.4 1.08 . . . . 0.0 112.35 -175.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.6 m . . . . . 0 N--CA 1.466 0.355 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.422 HD13 HD12 ' A' ' 99' ' ' LEU . 84.0 mt -99.12 103.22 15.11 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 177.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.514 ' HB ' HG22 ' A' ' 48' ' ' VAL . 58.5 t -93.22 117.35 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -176.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -90.64 164.62 14.1 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.302 0.641 . . . . 0.0 109.906 174.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.458 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 11.8 tt -58.72 -33.62 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.15 0.58 . . . . 0.0 111.604 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.18 -50.29 74.25 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.451 0.7 . . . . 0.0 110.512 176.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -67.0 -33.42 75.53 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.746 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 43.5 tp -61.22 -45.43 94.61 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.995 0.918 . . . . 0.0 110.435 178.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 16.2 mm-40 -62.9 -54.26 41.33 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.032 0.933 . . . . 0.0 110.973 178.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -59.22 -49.22 78.68 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.572 -174.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -69.64 -32.45 71.13 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.047 -175.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -64.23 -47.62 78.97 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.258 177.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 -72.31 -24.11 61.27 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.713 0.805 . . . . 0.0 111.218 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -67.79 -24.62 65.33 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.094 0.958 . . . . 0.0 110.681 174.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 129.94 -27.72 4.03 Favored Glycine 0 C--N 1.344 1.019 0 N-CA-C 112.022 -0.431 . . . . 0.0 112.022 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.24 91.62 1.14 Allowed Glycine 0 C--N 1.341 0.813 0 N-CA-C 111.364 -0.695 . . . . 0.0 111.364 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -74.95 109.92 8.81 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -175.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 47.5 m0 -104.97 172.93 6.53 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.111 0.965 . . . . 0.0 110.188 175.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.9 t -158.9 135.51 9.4 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.265 1.026 . . . . 0.0 108.945 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.495 HG21 HG21 ' A' ' 48' ' ' VAL . 61.7 t -92.95 111.74 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 122.985 0.514 . . . . 0.0 109.891 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.3 mt -123.67 113.08 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 123.974 0.91 . . . . 0.0 109.213 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 63.15 45.23 5.26 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.882 1.273 . . . . 0.0 111.89 172.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.09 7.86 77.57 Favored Glycine 0 N--CA 1.476 1.337 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.545 177.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -118.51 156.13 29.63 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.237 1.015 . . . . 0.0 108.742 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.514 HG22 ' HB ' ' A' ' 26' ' ' VAL . 24.3 t -115.53 116.02 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -111.15 156.61 21.13 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.166 0.986 . . . . 0.0 108.847 174.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -93.34 149.96 20.84 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.233 0.54 . . . . 0.0 110.227 173.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.9 mm -103.91 -22.97 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 124.288 1.035 . . . . 0.0 108.909 167.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.64 -59.42 5.23 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.175 0.99 . . . . 0.0 111.015 -175.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 20.8 t70 -76.38 -30.87 57.7 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.301 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -52.21 -54.77 26.77 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.689 1.196 . . . . 0.0 112.255 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -67.34 -26.86 66.7 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.084 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 51.7 m -67.86 -36.11 79.71 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.509 172.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 22.7 mm-40 -77.39 -25.4 50.82 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.945 0.498 . . . . 0.0 111.994 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.5 p -74.68 -7.23 52.61 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.7 tt -63.46 -40.45 97.15 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.991 0.916 . . . . 0.0 109.134 167.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.569 ' HB ' ' HB3' ' A' ' 63' ' ' SER . 27.1 m -65.51 119.29 10.8 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.532 0.733 . . . . 0.0 109.478 -177.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -74.27 -14.91 60.98 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 120.768 0.318 . . . . 0.0 111.119 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -101.06 10.4 41.06 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.794 0.838 . . . . 0.0 111.189 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.569 ' HB3' ' HB ' ' A' ' 60' ' ' THR . 81.8 p -87.17 162.22 17.62 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.554 ' HB ' HG23 ' A' ' 86' ' ' THR . 45.9 pt -66.9 -22.25 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.067 0.547 . . . . 0.0 110.816 170.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.422 HD21 ' HE2' ' A' ' 90' ' ' MET . 51.8 mt -85.26 -7.76 58.85 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.978 0.911 . . . . 0.0 111.721 -178.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.24 -33.04 74.85 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.492 0.717 . . . . 0.0 111.785 177.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 11.3 pt20 -76.06 -26.39 56.48 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.286 175.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.434 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . 80.2 m-85 -87.63 -5.39 58.74 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.881 0.872 . . . . 0.0 111.387 176.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.26 99.14 0.67 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.057 0.543 . . . . 0.0 110.188 176.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 142.86 -29.41 2.1 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -172.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -93.81 153.95 18.01 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.253 1.021 . . . . 0.0 109.765 172.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -57.74 127.76 79.12 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 124.051 0.94 . . . . 0.0 110.231 175.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -46.31 -39.81 21.74 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 123.984 3.123 . . . . 0.0 115.88 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.44 -49.42 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 122.559 0.344 . . . . 0.0 110.355 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.0 t -61.65 -40.87 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.871 0.868 . . . . 0.0 110.503 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 68' ' ' PHE . . . -67.72 -33.46 74.93 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.463 -1.244 . . . . 0.0 111.429 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 5.1 tt -68.6 -46.7 68.61 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.692 0.797 . . . . 0.0 109.49 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -63.92 -40.98 97.74 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.382 0.673 . . . . 0.0 111.265 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.27 -37.74 88.45 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.613 0.765 . . . . 0.0 110.545 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.03 -22.81 59.42 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.434 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 87.2 mt -74.59 -37.16 62.97 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 120.878 0.371 . . . . 0.0 110.06 173.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -73.04 -26.98 61.49 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.472 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -95.43 121.08 36.73 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 123.123 0.569 . . . . 0.0 109.531 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.1 -35.97 82.49 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.088 0.955 . . . . 0.0 113.032 -172.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.26 -12.81 61.32 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.283 0.633 . . . . 0.0 112.175 -176.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.554 HG23 ' HB ' ' A' ' 64' ' ' ILE . 24.6 p -117.8 -13.9 10.13 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.272 0.629 . . . . 0.0 112.577 -177.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -75.12 -21.23 59.01 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.035 0.445 . . . . 0.0 111.238 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -35.7 80.97 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.768 0.827 . . . . 0.0 112.121 -176.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.7 t -78.3 -22.09 48.72 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.422 ' HE2' HD21 ' A' ' 65' ' ' LEU . 21.3 mmt -71.54 -4.74 28.56 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.29 0.636 . . . . 0.0 111.785 177.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -69.55 -27.83 65.48 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.114 0.565 . . . . 0.0 109.809 169.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.76 -41.08 15.4 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.807 0.843 . . . . 0.0 110.746 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -66.79 -22.97 66.01 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.089 0.556 . . . . 0.0 111.594 177.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 43.8 t -71.13 92.57 0.99 Allowed 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.9 m -69.82 -19.05 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.243 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 171.94 177.59 41.64 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.328 175.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -96.97 138.56 34.31 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 174.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -72.85 145.6 46.82 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.065 0.46 . . . . 0.0 111.105 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.422 HD12 HD13 ' A' ' 25' ' ' LEU . 5.7 tt -136.07 121.81 19.77 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.693 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 23.3 mt-10 -79.53 132.52 61.67 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 123.41 0.684 . . . . 0.0 109.947 175.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.8 -30.04 87.99 Favored 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 122.305 2.003 . . . . 0.0 112.258 175.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -76.37 -26.58 55.8 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.076 0.95 . . . . 0.0 111.634 177.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.693 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 6.2 tp-100 . . . . . 0 N--CA 1.485 1.291 0 C-N-CA 123.857 0.863 . . . . 0.0 110.343 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.498 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 17.4 m . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 110.517 -0.179 . . . . 0.0 110.517 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.446 HD11 HD22 ' A' ' 99' ' ' LEU . 72.7 mt -83.24 100.01 10.33 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.276 0.56 . . . . 0.0 109.562 177.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.415 HG22 HG21 ' A' ' 95' ' ' VAL . 84.6 t -95.48 116.05 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.164 177.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 18.4 mtm180 -91.41 172.44 8.52 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.338 0.655 . . . . 0.0 110.143 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.505 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 15.7 tt -61.9 -31.2 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 122.458 0.303 . . . . 0.0 110.552 177.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.38 -52.24 59.94 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.767 0.827 . . . . 0.0 110.804 172.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.413 ' HA ' ' ND2' ' A' ' 33' ' ' ASN . 3.4 m-20 -62.26 -42.22 99.13 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.398 1.079 . . . . 0.0 110.703 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 44.1 tp -59.71 -44.83 93.53 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.969 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 20.4 mm-40 -71.05 -48.97 49.75 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.755 -176.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.413 ' ND2' ' HA ' ' A' ' 30' ' ' ASP . 10.2 p30 -72.08 -33.4 67.89 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.1 0.25 . . . . 0.0 111.33 -174.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -73.82 -35.94 64.92 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.792 0.437 . . . . 0.0 110.189 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -69.47 -34.21 74.03 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.694 0.398 . . . . 0.0 110.429 176.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -73.16 -26.89 61.37 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.072 0.549 . . . . 0.0 110.434 175.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.07 -28.63 68.98 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.457 1.103 . . . . 0.0 110.603 172.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.65 -24.14 6.88 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 -177.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.583 ' HA2' ' HD2' ' A' ' 52' ' ' LYS . . . -70.03 89.97 0.33 Allowed Glycine 0 C--N 1.347 1.144 0 O-C-N 123.895 0.409 . . . . 0.0 112.113 177.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -75.55 107.74 7.9 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -175.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 34.5 m0 -104.31 166.28 10.5 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.247 175.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.1 t -147.67 139.29 23.91 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.175 0.99 . . . . 0.0 108.579 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.459 HG22 HG23 ' A' ' 48' ' ' VAL . 95.8 t -98.18 111.39 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.424 HG23 ' HG2' ' A' ' 78' ' ' GLU . 70.7 mt -140.59 139.14 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.572 1.149 . . . . 0.0 108.28 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.5 t70 63.07 30.85 16.16 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 124.537 1.135 . . . . 0.0 111.177 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.43 15.45 68.18 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.898 -0.592 . . . . 0.0 113.32 -177.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.442 ' HB2' ' CE1' ' A' ' 49' ' ' TYR . 25.6 mmtp -119.21 176.74 5.17 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.805 1.242 . . . . 0.0 108.283 -178.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.459 HG23 HG22 ' A' ' 43' ' ' VAL . 53.1 t -125.06 115.48 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 171.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.442 ' CE1' ' HB2' ' A' ' 47' ' ' LYS . 85.2 m-85 -108.16 159.41 16.62 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.347 1.059 . . . . 0.0 109.467 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -90.89 160.72 15.55 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 120.958 0.409 . . . . 0.0 110.081 171.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 28.1 mm -120.97 -26.71 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.998 0.919 . . . . 0.0 109.958 173.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.583 ' HD2' ' HA2' ' A' ' 39' ' ' GLY . 19.2 ptmt -67.96 -47.04 69.72 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 122.915 0.486 . . . . 0.0 111.953 -175.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -76.81 -33.27 58.0 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.67 0.388 . . . . 0.0 109.99 177.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -53.05 -50.05 65.11 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.616 1.566 . . . . 0.0 111.849 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -67.8 -28.33 67.49 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.145 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.0 m -73.02 -33.68 65.89 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.052 0.541 . . . . 0.0 110.08 176.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -73.9 -29.34 62.02 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.148 0.979 . . . . 0.0 111.838 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.7 p -73.6 -8.59 56.57 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.936 0.494 . . . . 0.0 112.236 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.0 mt -77.86 -12.38 59.97 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.4 0.68 . . . . 0.0 111.683 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 35.4 m -82.32 132.02 35.22 Favored 'General case' 0 C--N 1.361 1.074 0 C-N-CA 122.777 0.431 . . . . 0.0 110.061 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -67.77 -30.54 70.02 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.618 0.767 . . . . 0.0 111.528 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -112.52 74.26 0.85 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.4 m -150.91 165.05 34.85 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.137 0.975 . . . . 0.0 109.962 178.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.501 HD13 ' HB3' ' A' ' 89' ' ' SER . 9.3 pt -67.1 -25.73 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.194 177.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.446 ' HG ' HG13 ' A' ' 64' ' ' ILE . 71.0 mt -95.21 2.65 54.99 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.863 0.865 . . . . 0.0 111.588 -176.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.41 -34.53 70.42 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.315 0.579 . . . . 0.0 110.422 176.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -72.28 -23.42 61.19 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.395 173.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -100.0 7.34 44.82 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.574 1.15 . . . . 0.0 111.038 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.01 80.21 3.55 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.478 0.711 . . . . 0.0 110.057 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 147.77 -24.14 1.48 Allowed Glycine 0 N--CA 1.471 0.993 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.001 -170.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -84.16 151.91 24.59 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.919 0.888 . . . . 0.0 109.902 175.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -55.69 125.57 61.64 Favored Pre-proline 0 N--CA 1.481 1.125 0 CA-C-O 118.27 -0.871 . . . . 0.0 109.589 174.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.71 -36.83 91.23 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 123.191 2.594 . . . . 0.0 114.86 -175.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.0 t -74.73 -36.22 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.262 0.625 . . . . 0.0 110.314 -177.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.7 t -72.3 -36.91 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.979 0.912 . . . . 0.0 110.622 175.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.26 -29.19 65.92 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.638 1.175 . . . . 0.0 110.572 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.537 HD21 ' SD ' ' A' ' 90' ' ' MET . 1.8 tm? -63.36 -48.85 76.21 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.48 1.112 . . . . 0.0 109.156 173.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.424 ' HG2' HG23 ' A' ' 44' ' ' ILE . 23.2 mt-10 -68.44 -39.72 81.39 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.291 -178.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.98 -34.19 77.42 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.863 0.865 . . . . 0.0 110.453 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.28 -39.65 82.07 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.892 174.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 66.5 mt -67.29 -29.38 68.96 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.366 0.666 . . . . 0.0 112.157 177.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -72.3 -43.42 64.22 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.686 0.795 . . . . 0.0 110.519 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -85.35 114.66 22.59 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -54.66 -33.39 60.64 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.541 1.136 . . . . 0.0 113.077 -172.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -64.79 -52.63 55.85 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.708 0.803 . . . . 0.0 111.115 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.488 HG23 ' HB ' ' A' ' 64' ' ' ILE . 38.5 p -81.23 -13.99 57.95 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.567 -171.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.56 -18.16 57.19 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 120.956 0.408 . . . . 0.0 110.927 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -64.72 -45.29 87.18 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.939 0.896 . . . . 0.0 110.061 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.501 ' HB3' HD13 ' A' ' 64' ' ' ILE . 46.6 t -71.27 -17.6 62.47 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.949 0.899 . . . . 0.0 112.325 -178.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.537 ' SD ' HD21 ' A' ' 77' ' ' LEU . 30.3 mmt -63.49 -15.23 57.25 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.551 0.741 . . . . 0.0 112.123 177.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.471 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 3.3 p80 -57.89 -33.09 68.36 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.681 0.793 . . . . 0.0 111.194 175.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.09 -33.46 70.21 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.103 0.961 . . . . 0.0 111.193 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -90.89 -26.11 19.5 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.494 -174.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.471 ' SG ' ' HA ' ' A' ' 91' ' ' HIS . 26.8 p -76.84 105.4 7.88 Favored 'General case' 0 C--N 1.358 0.971 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.415 HG21 HG22 ' A' ' 26' ' ' VAL . 35.9 m -69.48 -25.46 29.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 123.114 0.565 . . . . 0.0 110.692 174.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.498 ' HA3' ' HB ' ' A' ' 24' ' ' THR . . . 170.07 -165.69 38.99 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.557 174.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -88.58 140.57 29.32 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.18 0.992 . . . . 0.0 109.609 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -77.16 135.82 38.55 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 122.706 0.402 . . . . 0.0 110.782 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 66.4 tp -121.97 130.84 53.65 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.641 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 37.9 mt-10 -83.37 148.37 55.51 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 171.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.13 -7.28 20.44 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.51 2.14 . . . . 0.0 112.716 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -109.62 -16.93 13.83 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.359 1.064 . . . . 0.0 110.847 178.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.641 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 9.1 tp-100 . . . . . 0 N--CA 1.484 1.271 0 C-N-CA 123.773 0.829 . . . . 0.0 112.355 -172.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.6 p . . . . . 0 CA--C 1.545 0.782 0 CA-C-O 121.109 0.481 . . . . 0.0 111.453 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.3 mt -78.78 106.58 10.88 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.566 0.746 . . . . 0.0 109.521 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.408 ' HB ' HG21 ' A' ' 48' ' ' VAL . 39.8 t -93.61 121.33 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 123.69 0.796 . . . . 0.0 109.074 -175.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -72.13 151.18 43.19 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.778 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.5 tt -61.3 -39.23 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 120.724 0.297 . . . . 0.0 111.41 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.26 -29.27 70.63 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.922 0.889 . . . . 0.0 111.328 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 34' ' ' HIS . 11.0 t70 -62.54 -47.42 83.96 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.077 0.551 . . . . 0.0 109.789 178.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.0 mp -58.54 -48.36 81.13 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 123.76 0.663 . . . . 0.0 110.28 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -55.04 -44.75 74.96 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 124.375 1.047 . . . . 0.0 111.358 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -73.9 -39.79 63.62 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.755 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.428 ' HB2' ' O ' ' A' ' 30' ' ' ASP . 1.6 t60 -68.32 -39.15 82.05 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.34 0.656 . . . . 0.0 111.44 -167.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -70.07 -33.01 71.37 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.545 0.338 . . . . 0.0 110.97 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -68.53 -30.46 69.27 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.495 0.718 . . . . 0.0 110.074 178.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -70.3 -33.74 71.91 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.402 0.681 . . . . 0.0 110.429 173.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 134.96 -27.55 3.16 Favored Glycine 0 C--N 1.344 1.019 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.95 87.99 0.97 Allowed Glycine 0 C--N 1.347 1.154 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.406 ' HB3' ' HB ' ' A' ' 51' ' ' ILE . 26.3 t80 -74.8 109.37 8.22 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -171.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 36.6 m0 -105.15 146.83 28.66 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.598 0.759 . . . . 0.0 109.783 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.0 t -144.22 136.95 26.99 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.173 0.589 . . . . 0.0 110.352 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -88.02 112.05 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 121.466 0.651 . . . . 0.0 109.696 174.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.433 HD13 HD21 ' A' ' 77' ' ' LEU . 84.6 mt -132.38 131.18 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.149 1.38 . . . . 0.0 107.794 175.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.2 t70 60.53 29.89 19.35 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-O 121.819 0.818 . . . . 0.0 111.634 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.23 4.33 73.08 Favored Glycine 0 C--N 1.353 1.499 0 CA-C-N 115.565 -0.743 . . . . 0.0 114.01 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.448 ' HD2' ' SG ' ' A' ' 94' ' ' CYS . 71.8 mmtt -111.56 139.3 47.12 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.212 1.005 . . . . 0.0 109.142 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.408 HG21 ' HB ' ' A' ' 26' ' ' VAL . 52.9 t -89.96 123.22 42.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 170.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -110.71 169.76 8.54 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.686 0.795 . . . . 0.0 109.815 177.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -105.03 142.46 34.78 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.706 172.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.406 ' HB ' ' HB3' ' A' ' 40' ' ' PHE . 25.6 mm -112.56 -29.81 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.876 0.87 . . . . 0.0 110.982 -175.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -66.76 -30.73 71.02 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.578 0.627 . . . . 0.0 109.727 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 37.1 t70 -74.81 -49.59 20.16 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.847 0.859 . . . . 0.0 110.048 172.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.411 ' HA ' ' HE2' ' A' ' 93' ' ' PHE . 48.6 t80 -48.45 -50.93 29.34 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.814 1.246 . . . . 0.0 112.117 -178.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -68.64 -27.92 66.43 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.438 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 89.2 m -70.23 -36.44 74.52 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.284 0.634 . . . . 0.0 110.37 173.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 84.3 mm-40 -73.76 -23.53 59.74 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.695 0.798 . . . . 0.0 112.213 -176.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 64.3 p -75.04 -13.75 60.53 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.5 mp -71.67 -24.81 61.9 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.253 0.621 . . . . 0.0 110.568 173.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.5 m -71.22 121.96 19.35 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 122.638 0.375 . . . . 0.0 110.08 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.62 -37.62 85.24 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.346 0.659 . . . . 0.0 110.958 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -91.14 78.36 5.88 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 175.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.6 t -157.38 158.52 36.07 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.914 0.886 . . . . 0.0 109.299 -178.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.54 ' HB ' HG22 ' A' ' 86' ' ' THR . 38.9 pt -68.07 -23.5 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.832 170.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.6 mt -88.2 -0.34 56.98 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.697 0.799 . . . . 0.0 112.441 -177.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.36 -36.63 81.77 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.061 0.544 . . . . 0.0 110.914 176.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -73.0 -27.3 61.71 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.148 0.579 . . . . 0.0 110.853 175.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -90.62 1.54 56.69 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.822 0.849 . . . . 0.0 111.489 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.65 94.39 0.43 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.07 0.548 . . . . 0.0 110.652 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.64 -27.87 2.69 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.547 -176.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -77.43 151.8 34.58 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.65 0.78 . . . . 0.0 109.882 175.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -56.16 130.15 74.17 Favored Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 123.463 0.705 . . . . 0.0 109.697 173.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.99 -40.92 58.29 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.334 2.69 . . . . 0.0 114.69 -174.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.414 HG11 HD11 ' A' ' 44' ' ' ILE . 65.1 t -73.98 -43.04 52.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 122.959 0.504 . . . . 0.0 110.509 -176.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.8 t -65.4 -39.48 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 123.44 0.696 . . . . 0.0 110.901 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.86 -36.21 82.81 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.556 1.142 . . . . 0.0 110.76 177.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.433 HD21 HD13 ' A' ' 44' ' ' ILE . 31.5 tp -69.44 -38.94 78.04 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.618 178.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -60.74 -48.45 81.73 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.868 0.467 . . . . 0.0 110.249 175.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.78 -32.68 73.88 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.871 0.868 . . . . 0.0 111.242 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.07 -33.35 73.42 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.281 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.6 -38.96 70.8 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.298 0.239 . . . . 0.0 110.619 174.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -66.82 -29.2 69.07 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.293 0.637 . . . . 0.0 111.582 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.4 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 65.4 t80 -98.53 139.22 34.58 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.032 0.444 . . . . 0.0 110.163 177.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -62.07 -54.24 44.15 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.603 1.161 . . . . 0.0 113.945 -170.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.57 -38.37 90.79 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.228 0.611 . . . . 0.0 111.277 -175.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.54 HG22 ' HB ' ' A' ' 64' ' ' ILE . 36.6 p -80.54 -17.67 50.76 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 115.254 -0.884 . . . . 0.0 112.051 -172.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.9 ptt-85 -78.82 -23.17 45.24 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.158 0.504 . . . . 0.0 110.201 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -67.83 -38.03 82.67 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.258 1.023 . . . . 0.0 112.262 -173.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 32.0 t -73.91 -24.17 59.65 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.558 175.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 18.8 mmt -72.19 -7.84 51.45 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -65.23 -33.81 76.88 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.705 0.402 . . . . 0.0 109.955 169.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.05 -37.79 64.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.42 0.688 . . . . 0.0 111.448 175.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.411 ' HE2' ' HA ' ' A' ' 54' ' ' PHE . 90.4 m-85 -73.9 -23.71 59.6 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 122.895 0.478 . . . . 0.0 111.446 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.448 ' SG ' ' HD2' ' A' ' 47' ' ' LYS . 53.1 t -70.09 102.7 2.11 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.251 0.62 . . . . 0.0 109.714 177.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.3 m -73.2 -20.65 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.453 0.701 . . . . 0.0 110.677 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 170.46 -177.67 43.53 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.996 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -85.65 150.61 24.5 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 173.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -77.6 142.58 38.85 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.136 0.574 . . . . 0.0 110.124 173.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -133.76 130.0 37.44 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.839 0.856 . . . . 0.0 108.747 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 43.8 mt-10 -85.99 129.61 53.48 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.489 1.116 . . . . 0.0 109.482 175.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -55.29 -35.21 90.89 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 123.112 2.541 . . . . 0.0 112.752 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -71.47 -36.23 71.1 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.011 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.422 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 51.5 tp60 . . . . . 0 N--CA 1.485 1.31 0 C-N-CA 123.874 0.87 . . . . 0.0 111.393 -175.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.2 m . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.454 HD22 ' HB2' ' A' ' 99' ' ' LEU . 45.9 mt -97.55 119.07 35.45 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.146 0.498 . . . . 0.0 109.95 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.477 HG12 ' HB2' ' A' ' 30' ' ' ASP . 86.3 t -106.69 131.35 56.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -104.06 170.28 8.01 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 173.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.4 tt -58.15 -31.53 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.065 0.546 . . . . 0.0 111.974 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.69 -42.44 83.67 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.545 0.738 . . . . 0.0 111.319 177.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.477 ' HB2' HG12 ' A' ' 26' ' ' VAL . 38.4 m-20 -63.59 -36.27 83.25 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.165 0.586 . . . . 0.0 111.325 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.8 mt -63.88 -51.58 63.91 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 123.904 0.752 . . . . 0.0 109.748 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -59.18 -46.26 88.87 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.555 -1.202 . . . . 0.0 112.262 -172.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -77.08 -30.17 55.3 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 111.479 0.178 . . . . 0.0 111.479 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -73.44 -26.36 60.91 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.745 0.418 . . . . 0.0 110.844 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -61.28 -37.56 83.61 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.745 0.818 . . . . 0.0 110.377 172.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -70.62 -32.97 70.51 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.988 0.915 . . . . 0.0 110.789 174.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -64.56 -33.42 75.87 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.94 0.896 . . . . 0.0 110.819 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 125.46 -27.14 5.32 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 116.434 -0.348 . . . . 0.0 112.271 175.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.09 107.85 2.36 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 175.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -80.27 108.02 13.54 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -99.79 154.8 18.04 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.055 0.942 . . . . 0.0 110.031 176.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.3 t -147.96 164.63 33.18 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.093 0.957 . . . . 0.0 109.093 172.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.515 HG22 HG22 ' A' ' 48' ' ' VAL . 98.2 t -120.68 117.39 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.201 0.601 . . . . 0.0 110.796 -176.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.6 mt -138.77 138.13 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.698 1.199 . . . . 0.0 107.919 174.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.6 t70 63.08 30.64 16.16 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.475 1.11 . . . . 0.0 111.004 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.43 18.08 69.28 Favored Glycine 0 C--N 1.355 1.627 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.539 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.435 ' HD2' ' SG ' ' A' ' 94' ' ' CYS . 75.0 mmtt -124.15 148.75 46.97 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.273 1.029 . . . . 0.0 109.203 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.515 HG22 HG22 ' A' ' 43' ' ' VAL . 39.1 t -100.08 128.94 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.509 0.724 . . . . 0.0 109.212 174.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -122.33 144.9 48.72 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.856 0.862 . . . . 0.0 109.254 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -87.43 104.62 16.62 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 174.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.469 HG22 ' HB2' ' A' ' 73' ' ' PRO . 24.6 mm -62.59 -31.89 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.223 1.009 . . . . 0.0 111.082 174.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.0 ttpp -60.01 -36.97 78.36 Favored 'General case' 0 CA--C 1.554 1.125 0 O-C-N 123.597 0.561 . . . . 0.0 110.291 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.418 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 33.0 t70 -75.3 -42.5 54.52 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.281 0.633 . . . . 0.0 111.209 174.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.422 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 50.5 t80 -51.08 -51.76 50.15 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.704 1.202 . . . . 0.0 111.21 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -67.66 -27.73 67.11 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.837 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 58.8 m -68.34 -38.82 81.87 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.599 0.36 . . . . 0.0 110.773 174.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.442 ' HB2' HD11 ' A' ' 65' ' ' LEU . 78.6 mm-40 -74.39 -27.24 60.55 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.305 0.642 . . . . 0.0 111.345 -177.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.0 p -74.06 -10.42 59.61 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.023 0.529 . . . . 0.0 112.168 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.8 mp -71.32 -17.21 62.46 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 122.974 0.51 . . . . 0.0 111.352 171.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.3 m -88.04 133.44 33.97 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -75.11 -31.9 61.26 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.135 0.493 . . . . 0.0 109.719 173.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -83.49 63.12 7.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.79 0.836 . . . . 0.0 109.664 174.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.8 p -146.49 160.19 42.43 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.547 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.601 ' HB ' HG21 ' A' ' 86' ' ' THR . 40.0 pt -68.03 -22.73 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.688 170.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.442 HD11 ' HB2' ' A' ' 57' ' ' GLN . 44.3 mt -91.49 2.49 56.39 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.186 0.995 . . . . 0.0 112.208 -174.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.38 -33.34 75.32 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.067 0.547 . . . . 0.0 110.989 174.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -75.82 -29.87 58.8 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.679 0.792 . . . . 0.0 110.659 175.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -90.8 1.54 56.83 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.369 1.068 . . . . 0.0 111.688 -178.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.3 -25.87 67.82 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.624 0.77 . . . . 0.0 111.394 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -103.97 30.7 9.72 Favored Glycine 0 C--N 1.35 1.309 0 CA-C-N 116.547 -0.297 . . . . 0.0 112.431 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -139.11 154.49 48.15 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.403 1.081 . . . . 0.0 108.717 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -59.79 131.68 88.92 Favored Pre-proline 0 N--CA 1.48 1.052 0 CA-C-O 118.209 -0.9 . . . . 0.0 109.788 175.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.469 ' HB2' HG22 ' A' ' 51' ' ' ILE . 27.7 Cg_endo -58.29 -36.98 97.14 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 123.208 2.605 . . . . 0.0 114.329 -173.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.1 t -74.67 -45.68 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 122.893 0.477 . . . . 0.0 110.439 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.8 t -66.3 -35.83 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.686 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.81 -34.68 74.02 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.229 1.011 . . . . 0.0 110.627 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.6 HD12 ' SD ' ' A' ' 90' ' ' MET . 51.0 tp -66.15 -38.59 88.49 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.845 0.858 . . . . 0.0 110.486 177.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -58.73 -50.18 74.85 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.78 0.432 . . . . 0.0 110.049 174.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.47 -34.08 76.12 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.956 0.903 . . . . 0.0 111.012 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.73 -28.74 61.86 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.818 0.847 . . . . 0.0 111.506 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -71.83 -28.99 63.94 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.333 0.253 . . . . 0.0 111.107 172.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -90.45 -25.01 20.56 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.529 0.732 . . . . 0.0 111.728 -174.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.41 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 40.7 t80 -91.57 133.78 35.24 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.653 0.381 . . . . 0.0 110.576 -176.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.14 -36.98 85.41 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.957 1.303 . . . . 0.0 113.96 -168.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -74.23 -27.27 60.7 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.32 0.648 . . . . 0.0 111.309 -176.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.601 HG21 ' HB ' ' A' ' 64' ' ' ILE . 39.4 p -101.53 -31.02 11.07 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.588 -170.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.416 ' HD2' ' N ' ' A' ' 88' ' ' GLU . 6.0 ppt_? -60.12 -32.03 70.61 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 123.794 0.837 . . . . 0.0 112.387 -174.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.416 ' N ' ' HD2' ' A' ' 87' ' ' ARG . 7.8 pt-20 -64.45 -43.4 94.39 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.49 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.0 t -78.43 -16.69 57.33 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.621 0.768 . . . . 0.0 111.632 -176.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.6 ' SD ' HD12 ' A' ' 77' ' ' LEU . 36.1 mmt -61.11 -28.24 68.95 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.282 0.633 . . . . 0.0 111.556 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -64.52 -25.64 68.08 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.673 0.789 . . . . 0.0 111.416 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.46 -25.68 57.62 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.535 0.734 . . . . 0.0 111.454 175.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.422 ' CE1' ' HA ' ' A' ' 54' ' ' PHE . 98.5 m-85 -86.44 -20.65 27.84 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.472 0.709 . . . . 0.0 111.374 176.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.435 ' SG ' ' HD2' ' A' ' 47' ' ' LYS . 47.6 t -67.07 97.88 0.54 Allowed 'General case' 0 C--N 1.351 0.646 0 O-C-N 123.814 0.696 . . . . 0.0 110.749 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.7 m -74.76 -10.58 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.874 0.869 . . . . 0.0 111.42 177.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 169.18 175.68 38.64 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 174.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.409 ' HG2' ' NZ ' ' A' ' 47' ' ' LYS . 15.2 mt-30 -80.53 163.51 23.67 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.362 0.665 . . . . 0.0 109.753 171.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -118.23 146.57 44.16 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.774 0.429 . . . . 0.0 109.891 175.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.454 ' HB2' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -142.43 125.76 16.57 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 174.112 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.7 mp0 -69.8 137.93 87.91 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 123.167 0.587 . . . . 0.0 110.479 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -51.69 -42.55 56.15 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.868 2.378 . . . . 0.0 112.013 169.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -59.23 -52.32 66.2 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.774 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 . . . . . 0 N--CA 1.481 1.087 0 C-N-CA 124.381 1.072 . . . . 0.0 110.97 -178.49 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.3 m . . . . . 0 CA--C 1.542 0.641 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.5 mt -77.22 102.39 6.63 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.524 ' HB ' HG22 ' A' ' 48' ' ' VAL . 94.6 t -93.51 116.74 35.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.042 -177.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.426 ' HD2' ' HB3' ' A' ' 101' ' ' PRO . 71.6 mtm180 -82.34 166.49 19.43 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.223 176.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.0 tt -56.28 -37.69 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.296 0.639 . . . . 0.0 110.609 172.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.61 -47.55 83.97 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.969 0.908 . . . . 0.0 111.212 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.521 ' HA ' ' ND2' ' A' ' 33' ' ' ASN . 53.7 m-20 -67.18 -37.47 83.77 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.83 0.852 . . . . 0.0 110.935 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.401 ' HA ' ' HE3' ' A' ' 41' ' ' TRP . 36.3 tp -59.13 -45.14 91.71 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.75 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -72.28 -49.69 32.82 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.131 0.973 . . . . 0.0 112.11 -177.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.521 ' ND2' ' HA ' ' A' ' 30' ' ' ASP . 14.2 p30 -70.67 -33.68 71.19 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -170.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.401 ' CE1' ' HA3' ' A' ' 39' ' ' GLY . 43.4 t-80 -73.59 -30.91 63.3 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 120.564 0.221 . . . . 0.0 110.708 178.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -66.99 -38.64 86.38 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 173.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -65.4 -34.12 77.56 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.444 0.698 . . . . 0.0 110.363 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -65.16 -34.17 77.75 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.9 0.88 . . . . 0.0 110.514 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 139.08 -27.19 2.67 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 111.999 -0.44 . . . . 0.0 111.999 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.401 ' HA3' ' CE1' ' A' ' 34' ' ' HIS . . . -81.13 97.74 1.8 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 112.014 -0.434 . . . . 0.0 112.014 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -75.58 113.51 13.08 Favored 'General case' 0 C--N 1.347 0.469 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.401 ' HE3' ' HA ' ' A' ' 31' ' ' LEU . 43.7 m0 -98.09 164.5 12.31 Favored 'General case' 0 C--O 1.24 0.591 0 O-C-N 123.863 0.727 . . . . 0.0 109.799 176.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.418 HG21 HD13 ' A' ' 51' ' ' ILE . 15.3 t -147.05 133.9 20.13 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.659 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.519 HG22 HG21 ' A' ' 48' ' ' VAL . 82.2 t -95.95 107.03 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.6 mt -118.25 113.86 43.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 123.938 0.895 . . . . 0.0 108.844 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.3 t70 62.04 32.84 17.48 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.334 1.053 . . . . 0.0 111.272 174.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.99 5.66 85.85 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 115.255 -0.884 . . . . 0.0 114.081 177.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -115.65 150.4 36.8 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.495 0.718 . . . . 0.0 109.341 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.524 HG22 ' HB ' ' A' ' 26' ' ' VAL . 60.4 t -113.68 121.4 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 123.674 0.79 . . . . 0.0 109.856 -175.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -124.46 155.39 38.98 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.928 0.891 . . . . 0.0 109.175 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.433 ' HB3' ' HB2' ' A' ' 53' ' ' ASP . 7.7 t70 -97.09 120.29 37.17 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.438 ' O ' ' HG3' ' A' ' 55' ' ' GLN . 33.4 mm -73.68 -32.73 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.589 0.756 . . . . 0.0 111.599 -178.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -63.71 -45.99 87.48 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.433 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . 2.1 m-20 -65.51 -36.73 84.69 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.644 175.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -58.69 -51.88 68.06 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.609 0.764 . . . . 0.0 110.499 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.468 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 28.0 mt-30 -63.26 -29.23 70.6 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.889 -174.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.3 m -56.12 -36.75 68.57 Favored 'General case' 0 CA--C 1.553 1.088 0 O-C-N 123.862 0.726 . . . . 0.0 111.73 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -76.67 -30.99 56.99 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.281 0.632 . . . . 0.0 111.701 178.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 62.8 p -81.42 1.35 33.48 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 55' ' ' GLN . 83.1 mt -82.18 9.27 9.0 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.367 0.667 . . . . 0.0 112.33 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.5 t -128.53 165.5 20.63 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.226 0.61 . . . . 0.0 110.736 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -70.95 -60.83 2.02 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.73 0.812 . . . . 0.0 110.484 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -83.05 90.4 7.03 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.276 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.5 t -143.48 149.86 38.15 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.651 -1.158 . . . . 0.0 108.907 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.52 ' HB ' HG22 ' A' ' 86' ' ' THR . 37.2 pt -67.79 -19.94 25.53 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 C-N-CA 122.834 0.454 . . . . 0.0 110.843 171.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.47 HD22 ' HE3' ' A' ' 90' ' ' MET . 60.1 mt -95.71 -1.76 49.3 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.351 1.06 . . . . 0.0 111.755 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.2 -29.68 69.41 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.947 0.499 . . . . 0.0 111.014 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -71.66 -19.96 62.02 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.786 0.834 . . . . 0.0 111.671 175.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.547 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . 78.1 m-85 -99.89 10.72 40.83 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.344 1.058 . . . . 0.0 111.613 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.21 -26.1 68.36 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.309 0.643 . . . . 0.0 112.408 -176.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.57 18.84 53.98 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 116.393 -0.367 . . . . 0.0 113.245 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -132.88 151.11 52.09 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.788 0.835 . . . . 0.0 109.721 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -55.38 128.46 67.38 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 124.488 1.115 . . . . 0.0 109.924 172.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -54.76 -29.44 62.37 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.431 2.754 . . . . 0.0 114.626 -173.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.42 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 34.0 t -74.72 -49.37 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.5 t -68.8 -30.01 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 123.991 0.916 . . . . 0.0 111.017 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.547 ' HB3' ' HB3' ' A' ' 68' ' ' PHE . . . -68.74 -40.63 79.74 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.865 1.266 . . . . 0.0 109.895 176.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.514 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 41.4 tp -63.5 -40.85 98.17 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.684 175.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 35.3 mt-10 -58.39 -47.66 83.16 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.283 0.633 . . . . 0.0 111.384 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.99 -35.33 80.86 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.954 175.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.54 -18.1 59.89 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.126 0.97 . . . . 0.0 112.629 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 89.1 mt -77.06 -36.56 55.82 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 173.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -76.21 -21.21 56.69 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.577 175.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -90.84 115.9 28.25 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.842 0.857 . . . . 0.0 110.099 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.75 -23.24 65.22 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.164 0.985 . . . . 0.0 113.366 -173.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.89 -14.49 57.97 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.286 0.634 . . . . 0.0 112.044 -178.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.52 HG22 ' HB ' ' A' ' 64' ' ' ILE . 7.2 p -110.47 -29.78 7.94 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.328 0.651 . . . . 0.0 112.682 -177.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -50.62 -27.39 6.77 Favored 'General case' 0 N--CA 1.507 2.397 0 C-N-CA 124.32 1.048 . . . . 0.0 113.247 -174.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -55.15 -48.54 73.57 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.245 1.418 . . . . 0.0 112.648 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.7 m -76.88 -20.25 56.48 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.116 0.566 . . . . 0.0 111.787 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.552 ' N ' ' SD ' ' A' ' 90' ' ' MET . 0.1 OUTLIER -74.76 -13.27 60.57 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.774 0.829 . . . . 0.0 111.274 176.52 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.447 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 28.4 m170 -75.0 -23.19 58.2 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.061 0.544 . . . . 0.0 110.017 171.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.86 -30.22 23.08 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.56 0.744 . . . . 0.0 110.728 172.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -83.59 -23.91 31.73 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.439 0.296 . . . . 0.0 111.481 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.447 ' SG ' ' HA ' ' A' ' 91' ' ' HIS . 31.0 p -73.42 109.93 7.31 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-O 120.959 0.409 . . . . 0.0 109.98 -177.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.8 t -68.96 -45.89 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.938 172.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 175.0 -150.12 10.89 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.857 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -115.46 137.57 51.92 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.035 1.334 . . . . 0.0 109.044 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -71.14 134.03 46.66 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.132 0.573 . . . . 0.0 110.37 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -143.78 122.89 12.88 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.405 ' HB2' ' CB ' ' A' ' 103' ' ' GLN . 47.1 mt-10 -66.12 133.83 94.76 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.446 0.699 . . . . 0.0 110.687 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.426 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 17.4 Cg_endo -57.48 -25.49 66.76 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 123.263 2.642 . . . . 0.0 113.139 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -79.66 -43.12 23.37 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.388 0.675 . . . . 0.0 110.4 173.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.405 ' CB ' ' HB2' ' A' ' 100' ' ' GLU . 9.6 tt0 . . . . . 0 N--CA 1.483 1.209 0 C-N-CA 123.874 0.87 . . . . 0.0 111.846 -175.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.8 m . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.4 mt -86.86 111.01 20.36 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.6 t -91.19 114.15 28.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.8 ptp85 -70.67 158.05 36.9 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.484 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.451 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 10.1 tt -55.64 -44.68 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 123.352 0.407 . . . . 0.0 111.214 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.9 -33.41 75.26 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.578 0.751 . . . . 0.0 111.496 -177.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -74.55 -40.83 61.44 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.594 0.358 . . . . 0.0 110.105 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 57.2 tp -60.81 -53.25 59.6 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.115 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 51.4 mm-40 -58.88 -51.87 68.18 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.096 0.958 . . . . 0.0 111.827 -177.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -68.51 -41.06 80.51 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -175.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 66.2 t-80 -71.74 -42.66 67.0 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 118.033 0.379 . . . . 0.0 110.631 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -64.08 -51.14 65.47 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.823 0.849 . . . . 0.0 110.883 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -79.44 5.99 11.37 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.795 0.838 . . . . 0.0 111.994 -177.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -91.44 -8.42 47.83 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.884 0.874 . . . . 0.0 110.844 174.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.49 -26.26 12.23 Favored Glycine 0 C--N 1.344 0.987 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -175.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.582 ' HA2' ' HD3' ' A' ' 52' ' ' LYS . . . -75.35 77.73 1.18 Allowed Glycine 0 C--N 1.348 1.249 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 171.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.402 ' HD1' ' HB ' ' A' ' 51' ' ' ILE . 17.1 t80 -72.96 117.91 15.27 Favored 'General case' 0 C--N 1.345 0.404 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -163.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 29.0 m0 -110.26 172.0 7.12 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.883 1.273 . . . . 0.0 109.912 175.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.7 t -147.51 149.49 32.74 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.0 175.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 p -109.98 110.01 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.8 mt -124.77 124.0 67.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 124.076 0.95 . . . . 0.0 108.761 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.9 t70 63.0 32.91 15.23 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.483 1.113 . . . . 0.0 111.025 174.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.35 2.35 87.44 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.914 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 97' ' ' GLN . 46.4 mmtm -110.2 147.76 33.13 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.071 0.949 . . . . 0.0 109.261 177.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.8 t -102.43 127.66 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 122.842 0.457 . . . . 0.0 109.922 175.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -121.82 169.49 10.72 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.851 1.261 . . . . 0.0 108.987 175.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -94.64 157.07 16.13 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.65 0.738 . . . . 0.0 109.715 168.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.466 HG21 ' HB2' ' A' ' 73' ' ' PRO . 30.8 mm -121.05 -30.02 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.144 1.378 . . . . 0.0 108.911 172.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.582 ' HD3' ' HA2' ' A' ' 39' ' ' GLY . 35.7 ttpt -54.97 -58.0 9.39 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.86 0.864 . . . . 0.0 111.044 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -74.27 -36.34 63.8 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.149 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -51.95 -55.99 16.93 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.721 1.208 . . . . 0.0 111.846 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -68.33 -26.78 65.78 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.987 -176.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.9 m -66.78 -47.38 72.31 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 172.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -76.75 -13.67 60.01 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.025 0.93 . . . . 0.0 112.844 -176.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.527 ' HA ' ' HB2' ' A' ' 65' ' ' LEU . 90.8 p -67.96 -20.13 65.02 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -91.47 -0.16 57.58 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.612 0.365 . . . . 0.0 111.862 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.8 m -75.23 126.35 30.85 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 175.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -57.31 -48.4 79.05 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.389 1.076 . . . . 0.0 111.888 -170.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -82.59 -12.27 57.82 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.041 0.536 . . . . 0.0 112.431 -173.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 65.8 m -67.61 151.44 47.3 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 120.995 0.426 . . . . 0.0 111.232 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.545 ' HB ' HG21 ' A' ' 86' ' ' THR . 43.5 pt -61.04 -23.61 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.211 1.004 . . . . 0.0 111.468 174.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.527 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 63.1 mt -86.1 0.22 54.02 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.304 1.041 . . . . 0.0 111.961 -175.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.91 -33.24 71.92 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 122.969 0.507 . . . . 0.0 111.007 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -74.67 -25.58 59.27 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.582 0.753 . . . . 0.0 110.565 172.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.515 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 38.2 m-85 -95.99 3.7 53.25 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.317 1.047 . . . . 0.0 111.531 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.47 -29.35 69.45 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.57 0.748 . . . . 0.0 111.011 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.12 23.22 22.12 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.88 176.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -135.06 155.84 50.05 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.316 1.046 . . . . 0.0 108.912 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.84 131.28 78.98 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 124.222 1.009 . . . . 0.0 109.901 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.466 ' HB2' HG21 ' A' ' 51' ' ' ILE . 18.9 Cg_endo -55.4 -33.59 86.2 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 123.484 2.79 . . . . 0.0 114.303 -174.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.8 t -74.51 -46.99 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.4 t -64.1 -35.26 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 123.465 0.706 . . . . 0.0 110.58 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.515 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -67.41 -37.49 83.15 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.065 1.346 . . . . 0.0 110.56 178.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.686 HD12 ' SD ' ' A' ' 90' ' ' MET . 58.3 tp -67.2 -43.4 82.2 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.08 0.952 . . . . 0.0 110.466 176.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -64.6 -37.61 88.16 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.83 0.852 . . . . 0.0 111.2 178.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.29 -33.42 69.7 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.824 0.85 . . . . 0.0 110.473 176.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.49 -23.38 53.78 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.481 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.447 HD21 ' HG3' ' A' ' 90' ' ' MET . 90.1 mt -72.28 -39.96 67.93 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.891 0.476 . . . . 0.0 109.83 170.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -68.65 -43.0 77.16 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.605 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.414 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 5.1 t80 -82.58 124.6 30.29 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -176.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.31 -27.97 69.39 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.712 1.205 . . . . 0.0 112.737 -172.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -71.0 -35.9 72.24 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.471 0.709 . . . . 0.0 110.935 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.545 HG21 ' HB ' ' A' ' 64' ' ' ILE . 30.9 p -94.96 -21.25 18.74 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.534 0.734 . . . . 0.0 112.959 -171.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -66.01 -24.44 66.77 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.452 0.701 . . . . 0.0 112.078 -174.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -66.26 -37.54 85.72 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.724 0.81 . . . . 0.0 111.329 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.5 t -76.7 -24.19 53.15 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.452 0.701 . . . . 0.0 110.943 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.686 ' SD ' HD12 ' A' ' 77' ' ' LEU . 33.1 mmt -63.27 -20.88 65.86 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.737 0.815 . . . . 0.0 111.686 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 27.7 m170 -64.46 -31.78 73.13 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.638 0.775 . . . . 0.0 111.036 176.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.82 -43.84 74.72 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.796 175.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -73.33 -23.82 60.29 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.555 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 35.5 t -74.29 104.32 5.01 Favored 'General case' 0 C--N 1.349 0.581 0 C-N-CA 123.291 0.636 . . . . 0.0 109.346 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.2 m -80.65 -9.43 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 123.302 0.641 . . . . 0.0 110.483 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 156.6 -164.77 32.74 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.577 172.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 43.1 tt0 -99.13 142.5 30.54 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.517 1.127 . . . . 0.0 109.228 171.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -74.57 137.82 42.62 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 122.901 0.481 . . . . 0.0 110.158 172.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -135.23 120.08 18.48 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 44.7 mt-10 -80.78 146.31 59.78 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 123.704 0.802 . . . . 0.0 110.026 174.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.6 -24.84 41.28 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.497 2.131 . . . . 0.0 111.865 -176.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -84.14 -28.35 27.5 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.956 0.902 . . . . 0.0 110.663 175.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.526 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 61.0 tp60 . . . . . 0 N--CA 1.479 1.024 0 C-N-CA 123.077 0.551 . . . . 0.0 111.577 -176.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.4 m . . . . . 0 CA--C 1.544 0.747 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.443 HD22 HD21 ' A' ' 99' ' ' LEU . 86.4 mt -81.9 104.2 12.1 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 172.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.9 t -93.84 118.99 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -85.33 165.7 17.06 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.5 tt -57.0 -36.25 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 123.085 0.554 . . . . 0.0 112.244 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.11 -41.57 83.84 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.426 0.69 . . . . 0.0 111.077 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -64.71 -34.4 78.23 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.809 0.844 . . . . 0.0 111.495 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.7 mt -60.76 -47.15 87.63 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 123.545 0.528 . . . . 0.0 109.83 175.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -65.69 -44.75 85.25 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.828 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -62.65 -49.91 73.26 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.988 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -69.26 -35.21 75.85 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.757 0.423 . . . . 0.0 110.232 -174.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -62.99 -42.91 99.97 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.438 0.695 . . . . 0.0 109.766 174.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -67.31 -31.64 72.07 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.892 0.877 . . . . 0.0 111.096 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -72.03 -18.49 61.95 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.348 0.659 . . . . 0.0 111.078 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.93 32.56 3.51 Favored Glycine 0 C--N 1.345 1.049 0 O-C-N 123.144 0.278 . . . . 0.0 112.804 176.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -140.36 104.81 0.42 Allowed Glycine 0 C--N 1.343 0.927 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 177.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -75.6 110.63 10.16 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.769 0.428 . . . . 0.0 110.076 -168.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -100.04 145.38 27.98 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.176 0.99 . . . . 0.0 110.375 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.3 t -140.56 151.51 44.77 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.257 1.023 . . . . 0.0 109.358 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.4 p -102.96 120.35 52.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 172.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.6 mt -131.49 123.82 53.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.614 1.166 . . . . 0.0 108.446 176.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.7 t70 62.33 31.81 17.22 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.413 1.085 . . . . 0.0 111.721 175.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.95 7.13 87.56 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-N 115.673 -0.694 . . . . 0.0 113.337 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.449 ' HB3' ' HG ' ' A' ' 94' ' ' CYS . 72.4 mmtt -110.69 159.54 17.51 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.664 1.186 . . . . 0.0 108.442 178.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 75.6 t -114.96 139.8 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 122.957 0.503 . . . . 0.0 109.698 174.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -133.92 155.73 49.38 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.324 1.05 . . . . 0.0 110.289 -175.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -102.52 106.91 17.7 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 173.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.529 HG21 ' HB2' ' A' ' 73' ' ' PRO . 30.8 mm -68.02 -34.31 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.636 1.174 . . . . 0.0 112.183 -178.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -59.82 -41.4 91.19 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 123.667 0.604 . . . . 0.0 110.29 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 33.7 t70 -68.83 -45.53 70.92 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.943 0.897 . . . . 0.0 110.655 177.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.438 ' HA ' ' HE2' ' A' ' 93' ' ' PHE . 77.2 t80 -47.56 -60.57 2.44 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.544 1.138 . . . . 0.0 111.704 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -63.57 -29.81 71.02 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.521 -178.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 96.9 m -69.37 -35.08 75.47 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 122.788 0.435 . . . . 0.0 111.168 178.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 23.2 mm-40 -70.74 -14.35 62.41 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.787 0.435 . . . . 0.0 111.479 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.2 t -84.63 12.37 7.23 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.85 0.86 . . . . 0.0 111.588 174.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -64.75 -28.89 69.89 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.095 0.558 . . . . 0.0 111.365 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.6 m -88.9 133.2 34.37 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.729 0.812 . . . . 0.0 109.646 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -28.11 68.12 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.51 0.724 . . . . 0.0 111.207 178.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -103.72 89.33 3.3 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.94 0.896 . . . . 0.0 108.982 171.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.3 p -147.6 169.55 19.39 Favored 'General case' 0 C--O 1.245 0.838 0 C-N-CA 123.835 0.854 . . . . 0.0 109.241 177.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.585 ' HB ' HG23 ' A' ' 86' ' ' THR . 48.2 pt -68.49 -22.29 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.658 172.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.469 HD21 ' HE3' ' A' ' 90' ' ' MET . 66.5 mt -101.4 5.51 42.15 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.248 1.019 . . . . 0.0 111.715 -176.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.11 -30.19 71.27 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.261 0.625 . . . . 0.0 110.779 173.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -79.56 -23.84 42.53 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.224 1.01 . . . . 0.0 111.079 174.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.56 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 55.1 m-85 -99.3 0.39 42.91 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.226 1.01 . . . . 0.0 111.801 -177.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.73 -23.28 64.33 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.794 0.838 . . . . 0.0 111.87 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -101.86 24.39 31.53 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 116.61 -0.268 . . . . 0.0 113.063 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -136.12 158.89 43.33 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.034 0.934 . . . . 0.0 109.665 -175.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -56.24 129.74 74.35 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 123.947 0.899 . . . . 0.0 109.728 174.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.529 ' HB2' HG21 ' A' ' 51' ' ' ILE . 37.3 Cg_endo -60.62 -31.49 92.24 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.648 2.232 . . . . 0.0 114.064 -170.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.465 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 37.0 t -75.31 -53.27 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.3 t -61.47 -36.14 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 123.59 0.756 . . . . 0.0 111.308 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.56 ' HB2' ' HB3' ' A' ' 68' ' ' PHE . . . -66.92 -37.09 83.69 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.506 1.122 . . . . 0.0 111.105 178.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.3 tp -68.39 -38.56 81.45 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.881 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 35.9 mt-10 -65.23 -41.64 94.2 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.211 0.604 . . . . 0.0 110.041 177.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.23 -33.42 75.71 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.707 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.12 -34.88 71.5 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.856 0.862 . . . . 0.0 111.643 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.4 mt -67.42 -40.57 85.54 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.144 0.578 . . . . 0.0 110.15 175.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -73.52 -25.0 60.23 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.235 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -79.46 114.39 18.35 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -54.57 -29.61 51.85 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.665 1.586 . . . . 0.0 112.933 -177.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -70.88 -58.45 3.58 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.274 0.63 . . . . 0.0 110.83 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.585 HG23 ' HB ' ' A' ' 64' ' ' ILE . 67.4 p -87.72 -10.81 50.06 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -166.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -65.8 -31.99 73.26 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.103 0.561 . . . . 0.0 111.907 -172.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -29.39 64.27 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.516 -173.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.6 t -74.93 -23.87 58.4 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.581 0.752 . . . . 0.0 110.995 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.469 ' HE3' HD21 ' A' ' 65' ' ' LEU . 21.8 mmt -73.91 0.35 13.68 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.833 0.853 . . . . 0.0 112.669 -177.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -63.83 -31.13 72.2 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.616 0.766 . . . . 0.0 110.778 170.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.06 -31.08 39.45 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.17 0.988 . . . . 0.0 111.052 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.438 ' HE2' ' HA ' ' A' ' 54' ' ' PHE . 60.2 m-85 -81.27 -24.83 37.03 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.527 0.731 . . . . 0.0 110.685 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.449 ' HG ' ' HB3' ' A' ' 47' ' ' LYS . 42.1 t -78.31 108.65 11.79 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 123.437 0.695 . . . . 0.0 109.341 176.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.3 p -79.28 -19.55 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.495 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 155.35 -156.53 27.03 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 116.387 -0.369 . . . . 0.0 112.391 176.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.42 ' HB2' HD21 ' A' ' 25' ' ' LEU . 16.6 mm100 -78.58 164.77 24.39 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.778 1.231 . . . . 0.0 111.306 174.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -109.62 143.33 39.49 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 162.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.443 HD21 HD22 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -137.64 123.95 20.6 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.17 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.605 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 1.7 mp0 -73.24 143.3 83.09 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 123.212 0.605 . . . . 0.0 110.397 178.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -58.82 -32.5 97.31 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.918 2.412 . . . . 0.0 112.739 175.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -82.78 -29.13 29.86 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.082 0.553 . . . . 0.0 110.446 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.605 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 55.9 tp60 . . . . . 0 N--CA 1.484 1.257 0 C-N-CA 123.333 0.653 . . . . 0.0 110.903 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.4 m . . . . . 0 CA--C 1.545 0.771 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.49 HD13 HD22 ' A' ' 99' ' ' LEU . 85.8 mt -83.31 106.07 14.78 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.414 ' HB ' HG22 ' A' ' 48' ' ' VAL . 59.7 t -94.31 124.76 46.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 124.216 1.006 . . . . 0.0 110.164 -170.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.548 ' HB2' ' HB2' ' A' ' 30' ' ' ASP . 54.0 mtm180 -73.25 164.23 26.97 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.909 1.283 . . . . 0.0 110.521 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.5 tt -66.87 -42.61 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 118.203 0.456 . . . . 0.0 111.598 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.35 -29.45 68.18 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.763 177.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.548 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 23.3 t0 -59.28 -38.64 80.67 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.596 1.159 . . . . 0.0 110.944 -175.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.8 mp -57.46 -48.35 79.4 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 123.844 0.715 . . . . 0.0 110.727 173.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -67.92 -42.47 81.02 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.284 1.033 . . . . 0.0 111.479 -172.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -71.76 -40.35 69.37 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.374 0.67 . . . . 0.0 111.109 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -66.79 -33.39 75.52 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 176.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -64.52 -44.29 91.34 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.237 1.015 . . . . 0.0 111.029 175.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -64.59 -31.56 72.83 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.432 0.693 . . . . 0.0 110.521 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -66.93 -34.69 78.32 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.048 0.939 . . . . 0.0 110.846 176.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 128.19 25.43 1.08 Allowed Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.028 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -134.59 100.4 0.37 Allowed Glycine 0 C--N 1.344 0.997 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -178.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -75.1 107.57 7.27 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -170.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 25.7 m0 -103.22 131.71 50.05 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.742 0.817 . . . . 0.0 109.852 177.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -127.78 144.81 51.07 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.818 1.247 . . . . 0.0 109.106 177.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 p -96.28 112.35 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 120.976 0.417 . . . . 0.0 110.197 176.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.4 mt -122.26 118.62 55.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 123.81 0.844 . . . . 0.0 109.113 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.2 t70 62.57 32.84 16.26 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.832 1.253 . . . . 0.0 112.577 172.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.02 7.29 85.64 Favored Glycine 0 N--CA 1.477 1.408 0 CA-C-N 116.073 -0.512 . . . . 0.0 113.635 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.4 ' HB2' ' CE1' ' A' ' 49' ' ' TYR . 32.4 mmtp -117.87 161.78 19.19 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.269 1.027 . . . . 0.0 108.853 176.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.414 HG22 ' HB ' ' A' ' 26' ' ' VAL . 96.4 t -113.54 124.41 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 174.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.4 ' CE1' ' HB2' ' A' ' 47' ' ' LYS . 76.9 m-85 -117.79 156.25 28.65 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.34 1.056 . . . . 0.0 109.366 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -98.79 147.1 25.24 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 173.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.5 mm -109.46 -33.6 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.305 1.042 . . . . 0.0 111.402 -172.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.1 -29.29 62.82 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 118.566 0.621 . . . . 0.0 110.081 176.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -70.9 -39.15 72.95 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.118 0.967 . . . . 0.0 110.712 172.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -54.1 -54.51 38.51 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.935 0.894 . . . . 0.0 109.852 171.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -66.86 -28.55 68.43 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.952 0.901 . . . . 0.0 112.398 -173.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.4 m -58.25 -47.75 82.58 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.136 0.493 . . . . 0.0 110.195 171.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -77.31 -18.18 57.72 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.578 0.751 . . . . 0.0 111.523 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.483 ' HA ' ' HB2' ' A' ' 65' ' ' LEU . 25.9 t -75.6 -22.36 56.96 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.688 0.395 . . . . 0.0 111.031 177.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.8 mt -83.81 7.65 17.26 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.025 0.53 . . . . 0.0 110.986 172.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.405 ' HB ' ' HG ' ' A' ' 63' ' ' SER . 26.9 m -105.97 134.36 49.21 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.892 0.877 . . . . 0.0 109.657 177.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -75.26 -40.33 58.94 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.717 0.807 . . . . 0.0 112.715 -173.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -82.15 0.77 39.38 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.293 0.637 . . . . 0.0 111.944 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.405 ' HG ' ' HB ' ' A' ' 60' ' ' THR . 69.9 m -81.33 151.08 28.18 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 122.679 0.392 . . . . 0.0 109.996 170.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.524 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 24.5 pt -55.3 -30.61 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.577 0.751 . . . . 0.0 110.986 170.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.483 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 49.5 mt -73.88 -0.93 17.52 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.261 1.024 . . . . 0.0 113.049 -173.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.48 -41.26 96.58 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.649 0.78 . . . . 0.0 110.905 171.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.524 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 8.2 pt20 -76.65 -20.79 56.29 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.16 0.584 . . . . 0.0 110.937 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.451 ' HD2' ' HA ' ' A' ' 65' ' ' LEU . 75.5 m-85 -92.51 2.62 56.58 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.03 0.932 . . . . 0.0 111.33 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.39 111.83 4.88 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.153 0.581 . . . . 0.0 110.349 177.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.61 -29.33 7.93 Favored Glycine 0 N--CA 1.474 1.232 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 -175.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -79.92 151.62 30.01 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.618 0.767 . . . . 0.0 109.299 173.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.441 ' HB3' HG12 ' A' ' 75' ' ' VAL . 26.3 t70 -59.32 126.74 82.93 Favored Pre-proline 0 N--CA 1.483 1.182 0 CA-C-O 118.908 -0.568 . . . . 0.0 110.154 -178.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.07 -34.8 88.62 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 123.319 2.68 . . . . 0.0 114.11 -174.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.459 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 60.2 t -73.63 -49.66 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.182 -178.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.441 HG12 ' HB3' ' A' ' 72' ' ' ASP . 3.8 p -68.43 -28.59 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 122.791 0.436 . . . . 0.0 111.126 -177.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.06 -36.56 75.06 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.059 0.943 . . . . 0.0 109.767 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.648 ' HG ' ' SD ' ' A' ' 90' ' ' MET . 4.4 tt -71.81 -37.98 70.28 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.178 0.991 . . . . 0.0 110.029 176.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 44.3 mt-10 -64.34 -49.29 72.29 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.094 0.958 . . . . 0.0 110.87 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.03 -29.55 69.39 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.812 0.845 . . . . 0.0 111.019 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.62 -35.03 72.74 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.904 177.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.0 mt -63.34 -35.53 80.69 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.742 0.417 . . . . 0.0 110.771 175.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -67.07 -47.73 70.38 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.388 175.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.456 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 23.1 t80 -81.87 119.82 24.41 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 121.205 0.526 . . . . 0.0 110.936 -173.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -53.99 -34.21 59.21 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.785 1.634 . . . . 0.0 114.682 -171.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -79.87 -33.73 39.81 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.934 0.494 . . . . 0.0 111.735 -177.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.456 ' OG1' ' HB3' ' A' ' 83' ' ' PHE . 25.3 p -93.33 -13.53 28.02 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.393 0.677 . . . . 0.0 112.805 -173.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -73.82 -20.02 60.58 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 122.779 0.432 . . . . 0.0 110.385 178.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -63.74 -38.12 89.93 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.358 1.063 . . . . 0.0 111.314 -175.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.6 t -77.4 -31.4 54.11 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.009 0.524 . . . . 0.0 110.389 177.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.648 ' SD ' ' HG ' ' A' ' 77' ' ' LEU . 15.7 mmt -70.46 -21.84 62.75 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.221 0.608 . . . . 0.0 111.149 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -60.74 -35.6 76.78 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.656 0.782 . . . . 0.0 109.724 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.2 -38.57 42.99 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.615 0.766 . . . . 0.0 111.06 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.517 ' HD2' ' SD ' ' A' ' 90' ' ' MET . 29.8 m-85 -72.16 -14.39 61.8 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 122.761 0.425 . . . . 0.0 111.886 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 49.2 t -68.89 83.19 0.31 Allowed 'General case' 0 C--N 1.36 1.031 0 C-N-CA 123.397 0.679 . . . . 0.0 109.593 175.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.3 m -73.51 -16.39 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.12 0.968 . . . . 0.0 111.754 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.29 -175.58 41.16 Favored Glycine 0 C--N 1.343 0.972 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.146 174.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -119.1 134.42 55.21 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -76.37 143.02 40.97 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.213 0.605 . . . . 0.0 111.755 -171.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.49 HD22 HD13 ' A' ' 25' ' ' LEU . 54.8 tp -140.78 128.92 22.17 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.507 1.123 . . . . 0.0 108.243 176.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.643 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 46.9 mt-10 -91.89 140.84 24.96 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 123.732 0.813 . . . . 0.0 110.657 -178.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.81 -26.45 67.7 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 123.188 2.592 . . . . 0.0 112.434 173.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -78.97 -24.58 43.76 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.121 0.568 . . . . 0.0 110.485 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.643 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 47.3 tp60 . . . . . 0 N--CA 1.479 0.995 0 C-N-CA 123.674 0.79 . . . . 0.0 111.036 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.6 m . . . . . 0 CA--C 1.539 0.552 0 N-CA-C 110.718 -0.105 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.5 mt -77.94 103.24 7.76 Favored 'General case' 0 C--N 1.347 0.466 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 174.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.46 ' HB ' HG23 ' A' ' 48' ' ' VAL . 44.6 t -98.47 139.16 21.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.052 0.941 . . . . 0.0 108.989 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.495 ' HD3' ' H ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -112.43 162.05 16.02 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.987 0.915 . . . . 0.0 109.31 178.743 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.5 tt -56.31 -38.1 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 C-N-CA 123.412 0.685 . . . . 0.0 111.93 -176.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.03 -37.47 79.89 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.543 0.737 . . . . 0.0 111.196 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -70.93 -34.67 71.72 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.105 -178.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.458 HD22 HG22 ' A' ' 43' ' ' VAL . 8.3 mp -59.99 -46.65 88.77 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 122.665 0.386 . . . . 0.0 110.707 171.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -64.27 -42.76 96.31 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.296 1.038 . . . . 0.0 112.224 -173.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -69.7 -41.22 75.7 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.95 177.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -66.96 -28.46 68.29 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.209 0.603 . . . . 0.0 110.95 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -65.11 -49.84 68.41 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.912 0.885 . . . . 0.0 110.049 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -75.08 -14.94 60.63 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.599 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -68.33 -34.31 75.88 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.555 0.742 . . . . 0.0 110.184 170.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 119.95 36.68 0.81 Allowed Glycine 0 C--N 1.348 1.226 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.27 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.53 107.66 0.36 Allowed Glycine 0 C--N 1.342 0.909 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -75.05 125.01 28.02 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -174.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 9.5 m0 -115.72 151.83 34.36 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.216 1.006 . . . . 0.0 110.183 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.6 t -143.13 164.69 29.45 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.559 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.491 HG23 HG22 ' A' ' 48' ' ' VAL . 72.1 t -116.82 111.43 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 176.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.447 HG13 ' HG ' ' A' ' 77' ' ' LEU . 14.8 mm -108.49 103.79 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 175.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.2 t70 60.21 41.81 16.21 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 124.472 1.109 . . . . 0.0 112.298 171.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.63 12.31 75.41 Favored Glycine 0 N--CA 1.475 1.28 0 CA-C-N 116.09 -0.505 . . . . 0.0 113.87 175.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -124.2 144.2 50.08 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.853 0.861 . . . . 0.0 108.84 172.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.491 HG22 HG23 ' A' ' 43' ' ' VAL . 45.0 t -99.09 137.23 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 122.967 0.507 . . . . 0.0 109.761 178.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -127.74 154.95 44.76 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.532 1.133 . . . . 0.0 110.327 -175.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -96.52 101.68 13.34 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.7 mm -64.09 -33.09 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 124.1 0.96 . . . . 0.0 111.901 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -64.19 -43.66 94.41 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 24.6 t70 -66.94 -40.05 87.48 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.86 0.864 . . . . 0.0 110.211 177.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -55.85 -55.24 34.8 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.809 1.244 . . . . 0.0 111.613 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -69.82 -26.2 64.13 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.506 0.722 . . . . 0.0 111.23 -177.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.7 m -62.87 -41.82 99.52 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 122.717 0.407 . . . . 0.0 111.023 171.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 31.0 mm-40 -70.22 -26.8 64.03 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.133 0.573 . . . . 0.0 110.76 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.3 t -77.86 10.64 2.65 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.961 0.904 . . . . 0.0 111.501 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 45.2 tp -67.59 -39.65 84.8 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.273 0.629 . . . . 0.0 110.779 171.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.2 t -99.7 146.98 25.9 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.158 0.583 . . . . 0.0 111.829 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.38 -19.41 53.4 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.764 175.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -63.73 -28.05 69.62 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 123.435 0.694 . . . . 0.0 110.182 175.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.3 t -66.96 152.24 46.12 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.462 0.705 . . . . 0.0 110.46 175.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.535 ' HB ' HG22 ' A' ' 86' ' ' THR . 26.4 pt -63.24 -17.76 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.475 1.11 . . . . 0.0 111.612 172.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.445 HD21 ' HE2' ' A' ' 90' ' ' MET . 50.9 mt -85.19 9.58 14.67 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.64 1.176 . . . . 0.0 111.657 -178.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.57 -40.51 97.16 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.117 0.967 . . . . 0.0 111.24 174.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -73.77 -13.61 60.98 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.323 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.549 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 28.7 m-85 -110.13 4.91 21.56 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.567 1.147 . . . . 0.0 111.888 -176.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.74 -36.83 85.56 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.765 0.826 . . . . 0.0 112.589 -172.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -101.16 6.7 56.43 Favored Glycine 0 N--CA 1.479 1.53 0 CA-C-N 116.405 -0.361 . . . . 0.0 113.027 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -98.52 152.54 19.45 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.336 1.054 . . . . 0.0 109.065 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -54.12 124.88 47.61 Favored Pre-proline 0 N--CA 1.48 1.038 0 CA-C-O 118.354 -0.831 . . . . 0.0 109.08 172.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -57.5 -31.03 90.34 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.136 2.557 . . . . 0.0 114.03 -170.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 67.5 t -74.43 -48.55 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 122.868 0.467 . . . . 0.0 110.211 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.71 -38.15 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 123.504 0.722 . . . . 0.0 110.564 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.549 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -63.14 -40.89 98.89 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 114.074 -1.421 . . . . 0.0 110.944 177.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.447 ' HG ' HG13 ' A' ' 44' ' ' ILE . 37.1 tp -71.38 -36.82 71.56 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.027 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 82' ' ' GLN . 48.4 mt-10 -60.92 -47.07 88.1 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.866 0.466 . . . . 0.0 110.085 174.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.19 -32.11 73.63 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.843 0.857 . . . . 0.0 111.046 177.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.49 -28.57 64.01 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.477 0.711 . . . . 0.0 111.752 178.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.534 ' HA ' ' HB3' ' A' ' 87' ' ' ARG . 3.8 mm? -75.26 -28.34 59.79 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.267 0.227 . . . . 0.0 111.008 173.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 71.5 mt-30 -78.24 -41.22 34.86 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.979 0.512 . . . . 0.0 110.579 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -79.71 123.36 27.6 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -59.91 -41.35 91.49 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.044 0.937 . . . . 0.0 113.135 -169.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -68.18 -36.31 79.4 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.893 0.477 . . . . 0.0 111.572 -175.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.535 HG22 ' HB ' ' A' ' 64' ' ' ILE . 12.8 p -81.64 -30.46 32.79 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.133 -175.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.534 ' HB3' ' HA ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -74.96 -12.66 60.39 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -67.2 -35.88 80.56 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.237 0.615 . . . . 0.0 110.319 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.8 t -77.86 -29.91 50.63 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.428 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.445 ' HE2' HD21 ' A' ' 65' ' ' LEU . 14.9 mmt -70.95 -9.7 58.36 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.628 0.771 . . . . 0.0 112.104 -177.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -62.07 -30.92 71.32 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.936 0.894 . . . . 0.0 110.662 171.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.17 -35.98 25.07 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.463 0.705 . . . . 0.0 111.466 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -75.03 -23.16 58.13 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.245 0.618 . . . . 0.0 111.762 -173.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 25.9 p -71.48 99.44 2.02 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.4 m -69.47 -30.06 44.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 123.902 0.881 . . . . 0.0 111.502 -177.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.14 179.94 44.23 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.005 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -91.03 136.47 33.05 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.55 0.74 . . . . 0.0 109.094 176.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -82.45 142.84 31.58 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 174.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.0 tt -136.27 112.81 10.03 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 170.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.549 ' HB3' ' HB2' ' A' ' 103' ' ' GLN . 26.0 tt0 -72.65 141.96 83.11 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.571 0.748 . . . . 0.0 109.96 -177.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -42.21 -60.86 0.61 Allowed 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 123.598 2.865 . . . . 0.0 114.113 176.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -81.88 -8.18 59.66 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.822 0.849 . . . . 0.0 112.377 -172.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.549 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 54.4 tp60 . . . . . 0 N--CA 1.495 1.796 0 C-N-CA 123.845 0.858 . . . . 0.0 110.898 175.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.5 m . . . . . 0 CA--C 1.542 0.662 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.478 HD13 HD21 ' A' ' 99' ' ' LEU . 92.6 mt -86.93 111.95 21.32 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.512 -178.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.491 ' HB ' HG22 ' A' ' 48' ' ' VAL . 48.4 t -94.72 125.82 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 174.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -92.32 167.62 11.88 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.29 0.636 . . . . 0.0 111.123 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.0 tt -67.65 -34.2 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.194 -177.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.95 -33.5 71.99 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.41 0.684 . . . . 0.0 110.589 177.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.08 -44.43 63.29 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.144 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.1 mt -57.35 -52.8 63.89 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.883 0.873 . . . . 0.0 112.03 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -63.89 -48.94 74.67 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.901 0.88 . . . . 0.0 111.789 -173.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -63.53 -34.32 77.53 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.062 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 50.7 t60 -73.4 -34.6 65.59 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.312 0.645 . . . . 0.0 110.721 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -60.64 -40.5 92.23 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.207 1.003 . . . . 0.0 110.107 176.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -69.7 -26.43 64.35 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.117 0.967 . . . . 0.0 111.409 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -70.14 -19.91 63.19 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.004 0.522 . . . . 0.0 111.518 174.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 114.88 -21.47 13.65 Favored Glycine 0 C--N 1.341 0.83 0 N-CA-C 111.796 -0.521 . . . . 0.0 111.796 -175.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.496 ' HA2' ' HG2' ' A' ' 52' ' ' LYS . . . -73.65 92.23 0.69 Allowed Glycine 0 C--N 1.345 1.048 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -78.33 110.95 13.82 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 38.9 m0 -105.23 174.09 6.03 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.198 0.999 . . . . 0.0 109.399 170.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.4 t -151.13 162.92 39.96 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.811 0.844 . . . . 0.0 108.862 172.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.494 HG21 HG21 ' A' ' 48' ' ' VAL . 73.8 t -119.79 113.52 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.296 0.638 . . . . 0.0 109.338 175.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.542 HD11 HD23 ' A' ' 77' ' ' LEU . 51.3 mt -135.79 133.48 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 176.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.1 t70 63.07 30.33 16.21 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 125.048 1.339 . . . . 0.0 110.477 -175.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.13 26.49 67.64 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.729 -175.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.438 ' HB2' ' CE2' ' A' ' 49' ' ' TYR . 44.3 mmtm -121.16 134.1 55.21 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.681 0.792 . . . . 0.0 108.891 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.494 HG21 HG21 ' A' ' 43' ' ' VAL . 93.1 t -84.66 111.15 19.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 174.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' A' ' 47' ' ' LYS . 85.0 m-85 -108.46 150.17 27.78 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.674 0.79 . . . . 0.0 110.351 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -88.12 138.98 30.97 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.836 175.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.483 HD11 HD21 ' A' ' 77' ' ' LEU . 33.6 mm -116.32 -40.18 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.552 0.741 . . . . 0.0 111.513 -174.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.496 ' HG2' ' HA2' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -69.25 -32.33 71.47 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.299 0.24 . . . . 0.0 111.02 -179.245 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.427 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 33.6 t70 -76.03 -37.85 57.9 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.252 0.621 . . . . 0.0 110.687 172.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -55.34 -48.48 74.14 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.18 0.992 . . . . 0.0 111.527 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -69.83 -27.25 64.71 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.794 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.3 m -66.74 -38.19 86.16 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.95 0.5 . . . . 0.0 110.04 172.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.478 ' HB2' HD12 ' A' ' 65' ' ' LEU . 52.7 mm-40 -76.49 -15.3 59.93 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.09 0.556 . . . . 0.0 110.892 176.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.5 t -90.67 -9.9 45.15 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.008 0.923 . . . . 0.0 111.199 175.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.4 tp -83.05 -5.87 59.27 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.843 0.857 . . . . 0.0 111.489 -178.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.0 t -119.54 152.67 36.6 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.611 0.764 . . . . 0.0 110.848 -174.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -73.89 -51.09 17.31 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.69 1.196 . . . . 0.0 111.362 -174.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -78.21 72.47 4.74 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.592 0.71 . . . . 0.0 109.589 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.2 m -163.16 147.59 11.17 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.884 1.273 . . . . 0.0 108.726 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.602 ' HB ' HG22 ' A' ' 86' ' ' THR . 33.2 pt -67.26 -19.91 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 124.274 1.03 . . . . 0.0 111.558 175.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.478 HD12 ' HB2' ' A' ' 57' ' ' GLN . 65.6 mt -92.53 7.99 40.81 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.001 0.92 . . . . 0.0 111.669 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.51 -23.52 64.55 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.562 0.345 . . . . 0.0 110.772 175.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -75.52 -11.87 60.11 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.606 0.763 . . . . 0.0 111.408 172.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -112.97 20.88 15.98 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.024 0.93 . . . . 0.0 110.953 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.36 -26.03 68.57 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.675 0.79 . . . . 0.0 112.752 -174.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -111.87 5.27 27.45 Favored Glycine 0 N--CA 1.478 1.481 0 C-N-CA 122.753 0.216 . . . . 0.0 113.137 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -96.03 151.07 19.79 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.075 0.95 . . . . 0.0 109.961 -177.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -63.39 127.1 90.73 Favored Pre-proline 0 N--CA 1.48 1.051 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 171.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.415 ' HB2' HG22 ' A' ' 51' ' ' ILE . 18.7 Cg_endo -56.68 -34.0 94.92 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.501 2.801 . . . . 0.0 114.729 -174.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.2 t -75.05 -39.35 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 121.052 0.453 . . . . 0.0 110.445 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.1 t -68.16 -40.76 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.309 0.644 . . . . 0.0 110.017 177.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.5 -33.06 75.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.065 1.346 . . . . 0.0 111.208 176.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.542 HD23 HD11 ' A' ' 44' ' ' ILE . 34.0 tp -59.69 -51.89 67.84 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 124.164 0.915 . . . . 0.0 111.185 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -63.06 -39.67 95.42 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.056 0.543 . . . . 0.0 111.655 -178.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.93 -42.64 99.87 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.555 177.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.6 -17.69 50.57 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.99 0.916 . . . . 0.0 112.176 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.1 mp -70.51 -45.4 65.67 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.922 0.889 . . . . 0.0 109.004 171.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -75.33 -27.98 59.45 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.781 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.404 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 3.0 t80 -81.81 114.28 20.33 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -64.99 -26.46 68.3 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.098 0.959 . . . . 0.0 112.653 -172.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -65.94 -41.97 90.65 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.387 0.675 . . . . 0.0 110.676 177.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.602 HG22 ' HB ' ' A' ' 64' ' ' ILE . 20.1 p -95.86 -18.87 20.02 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.004 0.921 . . . . 0.0 113.152 -171.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -63.33 -21.18 66.11 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -176.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.4 ' HG3' ' N ' ' A' ' 89' ' ' SER . 4.5 pt-20 -54.27 -48.4 71.25 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.898 0.879 . . . . 0.0 111.682 177.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.4 ' N ' ' HG3' ' A' ' 88' ' ' GLU . 14.4 t -73.6 -15.69 61.26 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.671 0.788 . . . . 0.0 111.785 -172.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 24.7 mmt -64.4 -17.63 63.94 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.736 0.815 . . . . 0.0 112.211 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -61.06 -29.33 69.67 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.211 0.605 . . . . 0.0 110.894 174.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.64 -32.39 19.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.101 0.96 . . . . 0.0 111.413 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -79.93 -26.06 40.26 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.599 0.36 . . . . 0.0 110.936 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 28.6 p -79.76 103.25 9.53 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.29 -35.75 72.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 124.372 1.069 . . . . 0.0 110.21 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 174.31 -170.57 43.7 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.293 176.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -89.67 135.96 33.31 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -78.9 128.58 33.51 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.272 0.629 . . . . 0.0 110.774 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.478 HD21 HD13 ' A' ' 25' ' ' LEU . 64.0 tp -105.32 117.1 33.15 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 166.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -73.48 133.1 80.65 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 173.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.52 -42.76 64.7 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.271 2.648 . . . . 0.0 113.632 -174.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -87.76 -7.7 56.98 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.71 0.404 . . . . 0.0 111.252 -176.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 . . . . . 0 N--CA 1.484 1.257 0 C-N-CA 123.65 0.78 . . . . 0.0 110.728 174.376 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.98 151.22 49.39 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.028 0.931 . . . . 0.0 109.733 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.1 p -94.0 112.78 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-O 121.193 0.52 . . . . 0.0 109.907 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.7 m -70.95 109.06 4.85 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 173.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.4 HD23 ' HB2' ' A' ' 99' ' ' LEU . 92.4 mt -98.47 108.83 21.62 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.092 0.557 . . . . 0.0 110.209 -177.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.9 t -94.38 132.84 37.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.493 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -102.24 171.18 7.63 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.499 0.72 . . . . 0.0 109.593 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.471 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 13.0 tt -60.72 -34.09 57.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.848 174.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.42 -49.79 76.02 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.352 0.661 . . . . 0.0 110.743 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.11 -42.98 95.89 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.626 0.77 . . . . 0.0 110.879 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 46.9 tp -58.24 -45.82 87.08 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.333 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 17.0 mm-40 -72.68 -52.97 13.05 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.541 0.736 . . . . 0.0 112.397 -177.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -71.16 -29.87 65.74 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -172.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -73.47 -27.46 61.41 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 120.553 0.216 . . . . 0.0 110.5 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -61.3 -39.31 89.99 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 120.961 0.41 . . . . 0.0 110.205 172.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -68.57 -32.3 72.11 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.534 0.733 . . . . 0.0 110.78 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -65.77 -19.52 65.92 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.897 0.879 . . . . 0.0 111.41 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.74 4.09 26.53 Favored Glycine 0 N--CA 1.475 1.234 0 CA-C-N 116.695 -0.23 . . . . 0.0 112.764 176.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -111.93 95.86 0.83 Allowed Glycine 0 C--N 1.34 0.776 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -75.8 116.6 16.67 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -104.66 -179.76 4.04 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.275 1.03 . . . . 0.0 109.961 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.4 t -155.83 159.15 39.14 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.698 0.799 . . . . 0.0 109.211 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 98.4 t -107.99 111.57 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 123.572 0.749 . . . . 0.0 109.258 177.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.574 HD12 HD21 ' A' ' 77' ' ' LEU . 48.8 mt -140.6 135.48 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.275 1.03 . . . . 0.0 108.631 175.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 63.59 32.31 14.1 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.675 1.19 . . . . 0.0 111.062 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.44 20.78 70.0 Favored Glycine 0 C--N 1.352 1.457 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.927 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.512 ' HD3' ' HA ' ' A' ' 97' ' ' GLN . 32.8 mmtp -128.59 162.98 26.02 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.792 1.237 . . . . 0.0 109.23 -177.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 90.9 t -119.28 119.28 60.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 123.629 0.772 . . . . 0.0 109.037 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -112.27 148.15 34.77 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.526 0.73 . . . . 0.0 109.909 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -86.56 100.7 12.6 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.404 HD13 HD22 ' A' ' 77' ' ' LEU . 31.5 mm -76.45 -29.64 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.418 0.687 . . . . 0.0 111.689 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -61.55 -47.7 84.34 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.467 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 27.5 t70 -73.97 -36.07 64.54 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.521 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -52.55 -53.31 48.09 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.958 0.903 . . . . 0.0 111.154 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.473 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 10.6 pt20 -67.36 -28.53 68.03 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.233 -177.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.8 m -64.01 -40.38 96.22 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.042 0.449 . . . . 0.0 110.407 175.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.586 ' HB2' HD11 ' A' ' 65' ' ' LEU . 51.9 mm-40 -72.46 -32.35 66.17 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.315 0.646 . . . . 0.0 109.974 177.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.5 t -68.09 -27.32 66.38 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.726 0.81 . . . . 0.0 111.283 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 55' ' ' GLN . 96.9 mt -80.75 -15.42 56.52 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.448 0.699 . . . . 0.0 111.597 175.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 45.1 m -90.16 124.68 35.04 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.207 0.603 . . . . 0.0 110.321 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -64.29 147.96 51.31 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.936 0.894 . . . . 0.0 110.284 175.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 75.45 -3.56 2.56 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.367 1.467 . . . . 0.0 112.854 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.0 m -81.06 149.85 29.06 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 172.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.627 ' HB ' HG21 ' A' ' 86' ' ' THR . 42.9 pt -61.97 -20.04 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.58 0.752 . . . . 0.0 112.478 -178.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.586 HD11 ' HB2' ' A' ' 57' ' ' GLN . 60.0 mt -95.05 -8.68 35.98 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.575 0.75 . . . . 0.0 111.725 -176.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.87 -25.76 65.68 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.272 0.629 . . . . 0.0 111.549 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -75.73 -20.53 58.27 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.806 0.842 . . . . 0.0 111.042 173.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.441 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 52.4 m-85 -102.89 12.82 35.65 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.275 1.03 . . . . 0.0 110.987 178.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.62 -26.16 64.3 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.329 0.651 . . . . 0.0 112.534 -175.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.53 -3.87 90.53 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-N 116.472 -0.331 . . . . 0.0 112.639 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -108.08 150.55 27.04 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.176 0.99 . . . . 0.0 110.136 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -55.98 124.72 60.18 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 123.723 0.809 . . . . 0.0 110.52 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -51.13 -33.51 44.05 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 123.549 2.832 . . . . 0.0 115.145 -173.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.2 t -70.79 -38.87 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.111 0.564 . . . . 0.0 110.49 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.5 t -74.13 -40.11 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.894 0.877 . . . . 0.0 110.062 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.441 ' HB2' ' HB3' ' A' ' 68' ' ' PHE . . . -65.49 -29.3 69.93 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.832 1.253 . . . . 0.0 110.896 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.581 HD11 ' SD ' ' A' ' 90' ' ' MET . 48.4 tp -63.98 -41.75 97.44 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.925 0.89 . . . . 0.0 110.536 174.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -65.65 -40.8 92.87 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.631 0.772 . . . . 0.0 110.998 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.43 -31.95 73.03 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.782 0.833 . . . . 0.0 110.688 175.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.14 -33.49 61.53 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.468 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.484 HD22 ' HG3' ' A' ' 90' ' ' MET . 95.6 mt -67.74 -40.12 84.2 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.156 0.582 . . . . 0.0 109.857 174.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -66.4 -41.5 89.24 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.858 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.436 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 9.8 t80 -87.5 127.7 35.24 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 120.982 0.42 . . . . 0.0 110.606 -175.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.81 -32.28 72.57 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.885 1.274 . . . . 0.0 113.63 -170.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -68.69 -51.4 42.1 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.154 0.502 . . . . 0.0 109.864 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.627 HG21 ' HB ' ' A' ' 64' ' ' ILE . 27.7 p -78.71 -16.78 56.83 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.197 -0.91 . . . . 0.0 113.149 -168.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.4 ptt85 -74.96 -11.42 60.11 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -75.34 -38.08 60.35 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.056 0.942 . . . . 0.0 111.256 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.2 t -77.64 -18.73 56.45 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.912 0.485 . . . . 0.0 110.743 175.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.581 ' SD ' HD11 ' A' ' 77' ' ' LEU . 37.4 mmt -65.01 -24.18 67.43 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.566 0.346 . . . . 0.0 110.887 176.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.464 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 86.2 m-70 -64.43 -26.57 68.51 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.841 0.856 . . . . 0.0 111.62 173.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.44 -35.95 46.17 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.476 0.71 . . . . 0.0 110.834 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -83.7 -24.37 31.29 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.477 0.311 . . . . 0.0 111.606 -176.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.464 ' SG ' ' HA ' ' A' ' 91' ' ' HIS . 29.5 p -72.05 101.32 2.71 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.001 0.429 . . . . 0.0 109.882 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.6 t -68.83 -37.71 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.056 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.02 -171.67 44.17 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.551 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.512 ' HA ' ' HD3' ' A' ' 47' ' ' LYS . 29.0 tt0 -88.78 135.68 33.39 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.909 0.884 . . . . 0.0 109.81 176.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -83.86 136.29 34.17 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.4 ' HB2' HD23 ' A' ' 25' ' ' LEU . 2.9 tt -139.7 122.88 16.91 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 173.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.444 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 46.7 mt-10 -70.74 145.05 91.73 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 123.973 0.909 . . . . 0.0 111.974 -176.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.5 -47.61 23.87 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 123.306 2.671 . . . . 0.0 112.303 173.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -67.61 -38.47 83.98 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.212 1.005 . . . . 0.0 111.846 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.444 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 26.4 tp60 -59.85 -45.51 92.19 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.032 0.933 . . . . 0.0 112.864 -168.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -90.13 -8.37 51.47 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -101.69 24.95 29.73 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 123.188 0.305 . . . . 0.0 113.234 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.21 138.8 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.34 0.656 . . . . 0.0 110.391 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.6 t -89.75 119.75 30.41 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 167.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.4 mt -104.9 109.45 63.16 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.05 150.74 87.56 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.841 2.361 . . . . 0.0 110.902 168.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -75.19 84.14 2.38 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 122.205 1.002 . . . . 0.0 110.048 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.4 tp -132.07 -20.1 2.49 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.19 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.383 0 CA-C-O 119.118 -0.823 . . . . 0.0 111.452 175.711 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.471 0.177 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -107.97 90.18 3.22 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.806 0.842 . . . . 0.0 109.189 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.82 143.91 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.078 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.9 m -65.4 109.15 2.19 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 89.4 mt -92.87 105.75 17.82 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.906 0.882 . . . . 0.0 109.634 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.6 t -93.93 126.21 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.37 1.068 . . . . 0.0 108.675 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -93.5 170.26 9.73 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.022 0.529 . . . . 0.0 110.792 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.7 tt -57.8 -36.61 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.19 0.996 . . . . 0.0 112.444 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.99 -40.0 95.4 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.378 0.671 . . . . 0.0 111.315 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.29 -34.75 77.19 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.235 1.014 . . . . 0.0 111.689 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.5 mt -58.75 -47.28 85.19 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.919 0.762 . . . . 0.0 110.01 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -71.62 -39.09 70.69 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.835 -174.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -62.22 -47.05 86.12 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.017 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -68.17 -35.39 77.96 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.333 0.653 . . . . 0.0 110.826 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.447 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 56.1 t30 -60.54 -42.97 97.62 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.267 178.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -78.16 -23.02 47.84 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.743 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -72.86 -36.59 67.43 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.903 0.881 . . . . 0.0 111.864 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 139.85 33.14 0.16 Allowed Glycine 0 N--CA 1.48 1.604 0 CA-C-N 116.968 -0.106 . . . . 0.0 113.121 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 35' ' ' ASN . . . -150.61 -178.31 25.35 Favored Glycine 0 C--N 1.343 0.948 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -134.59 110.23 9.18 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 117.582 0.691 . . . . 0.0 109.525 175.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 17.9 m0 -98.13 144.3 27.76 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.145 0.578 . . . . 0.0 110.508 174.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -136.87 141.84 42.79 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.192 0.997 . . . . 0.0 108.885 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.1 t -96.46 110.79 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 175.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 77.6 mt -131.24 130.22 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.1 t70 62.47 30.96 17.27 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 124.629 1.172 . . . . 0.0 111.617 175.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.55 12.83 77.71 Favored Glycine 0 N--CA 1.479 1.532 0 CA-C-N 116.198 -0.455 . . . . 0.0 113.378 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -119.14 160.33 22.32 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.724 1.21 . . . . 0.0 108.974 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.1 t -111.81 116.76 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.124 0.57 . . . . 0.0 109.525 176.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.418 ' HB2' HD22 ' A' ' 77' ' ' LEU . 49.8 m-85 -112.32 152.73 28.21 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.967 0.907 . . . . 0.0 109.352 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -100.88 107.25 18.72 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.571 0.348 . . . . 0.0 110.439 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.4 mm -60.31 -36.24 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 124.806 1.242 . . . . 0.0 111.724 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.436 ' HG3' ' HA2' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -58.49 -47.3 84.53 Favored 'General case' 0 CA--C 1.553 1.065 0 O-C-N 123.944 0.777 . . . . 0.0 109.184 -178.048 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.453 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 39.1 t70 -74.46 -34.41 63.14 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.706 0.402 . . . . 0.0 110.797 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -52.98 -55.97 19.51 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.928 0.891 . . . . 0.0 111.002 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -67.64 -28.24 67.55 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.413 0.685 . . . . 0.0 111.277 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.5 m -67.69 -37.44 82.3 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 123.505 0.722 . . . . 0.0 110.876 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 30.9 mm-40 -77.45 -28.07 52.3 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.437 0.695 . . . . 0.0 110.704 177.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.2 t -74.36 -3.63 31.51 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.732 0.813 . . . . 0.0 111.576 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.4 tt -63.2 -38.28 90.54 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.29 1.036 . . . . 0.0 110.129 172.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.6 m -76.81 135.33 38.93 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.495 0.718 . . . . 0.0 111.026 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -73.39 -35.23 65.86 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.997 0.919 . . . . 0.0 110.391 -178.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -87.78 60.41 5.91 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.526 0.679 . . . . 0.0 109.536 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.6 t -133.0 155.12 49.75 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.796 0.838 . . . . 0.0 109.419 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 86' ' ' THR . 27.3 pt -75.3 -10.71 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.587 0.755 . . . . 0.0 110.614 173.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.9 mt -93.46 -8.86 40.36 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.916 0.886 . . . . 0.0 110.734 176.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.07 -26.19 64.83 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.745 0.818 . . . . 0.0 111.46 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -74.65 -13.48 60.64 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.455 0.702 . . . . 0.0 110.963 174.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.508 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 67.6 m-85 -115.55 12.25 16.1 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.684 1.194 . . . . 0.0 110.963 177.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.73 -28.52 69.11 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.522 0.729 . . . . 0.0 112.109 -175.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.24 27.42 15.22 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.738 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -132.89 155.0 49.84 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.983 0.913 . . . . 0.0 109.499 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -54.39 129.05 60.8 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 124.305 1.042 . . . . 0.0 109.459 172.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.1 -35.32 90.25 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 123.433 2.755 . . . . 0.0 114.461 -172.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.0 t -74.66 -48.92 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 122.638 0.375 . . . . 0.0 110.441 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.0 t -63.08 -33.86 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.715 0.806 . . . . 0.0 110.713 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.508 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -64.71 -44.5 90.02 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.464 176.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.418 HD22 ' HB2' ' A' ' 49' ' ' TYR . 56.8 tp -66.89 -43.12 84.25 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.839 0.855 . . . . 0.0 111.306 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -58.89 -52.15 66.98 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.313 0.645 . . . . 0.0 110.259 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.14 -34.67 76.81 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.716 0.806 . . . . 0.0 111.229 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.99 -24.04 61.52 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.716 0.807 . . . . 0.0 112.291 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -70.81 -42.1 70.73 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 172.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -73.22 -28.34 62.11 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.049 0.54 . . . . 0.0 111.053 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -85.51 117.67 24.56 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -66.08 -27.56 68.17 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.908 0.883 . . . . 0.0 113.175 -169.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -76.16 -22.01 55.9 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.383 0.673 . . . . 0.0 112.423 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.562 ' HA ' HD12 ' A' ' 64' ' ' ILE . 19.1 p -109.28 -20.99 12.75 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -174.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.463 ' HA ' ' HG2' ' A' ' 90' ' ' MET . 40.3 ptt180 -67.66 -13.57 62.21 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -55.48 -49.58 72.17 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.414 1.086 . . . . 0.0 112.339 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.9 t -77.4 -15.72 59.21 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.932 0.493 . . . . 0.0 111.033 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.487 ' SD ' ' HD2' ' A' ' 93' ' ' PHE . 12.7 mmt -69.03 -16.81 63.8 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.828 0.451 . . . . 0.0 111.243 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -62.24 -39.72 93.78 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.941 0.496 . . . . 0.0 109.798 169.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.89 -37.13 62.2 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.75 0.82 . . . . 0.0 111.065 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.487 ' HD2' ' SD ' ' A' ' 90' ' ' MET . 45.9 m-85 -71.37 -23.93 61.99 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.012 0.525 . . . . 0.0 111.221 177.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 46.1 t -72.17 99.85 2.43 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.0 m -71.15 -26.32 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 123.408 0.683 . . . . 0.0 110.251 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 175.42 175.11 42.58 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.319 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -85.18 136.66 33.43 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 177.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -76.83 132.44 39.19 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.441 HD12 ' HG3' ' A' ' 104' ' ' GLU . 0.1 OUTLIER -132.46 126.15 32.35 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 170.821 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 42.2 mt-10 -70.34 136.08 86.56 Favored Pre-proline 0 C--O 1.246 0.898 0 O-C-N 123.851 0.72 . . . . 0.0 110.3 177.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -59.27 -22.05 63.26 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.765 2.31 . . . . 0.0 112.609 175.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -86.61 -38.83 16.71 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.824 1.25 . . . . 0.0 111.224 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.498 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 8.5 tp-100 -61.78 -30.73 71.0 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 124.33 1.052 . . . . 0.0 111.586 -176.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.441 ' HG3' HD12 ' A' ' 99' ' ' LEU . 40.9 mt-10 -61.25 -34.51 75.27 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.868 0.867 . . . . 0.0 112.069 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -84.44 -80.69 1.06 Allowed Glycine 0 C--N 1.341 0.848 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.8 p -87.21 107.92 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.7 t -95.58 129.54 42.73 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 122.856 0.463 . . . . 0.0 109.973 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 56.7 mt -103.95 110.82 64.67 Favored Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -79.15 172.02 15.4 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 122.722 2.282 . . . . 0.0 111.852 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.26 83.47 0.55 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.455 0.702 . . . . 0.0 110.237 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 34.7 tp -176.76 -57.59 0.01 OUTLIER 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.073 1.349 . . . . 0.0 107.813 -178.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.328 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.284 -176.924 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 121.162 0.506 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -88.34 97.95 11.32 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 124.137 0.975 . . . . 0.0 109.391 -174.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.0 p -68.72 110.73 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.27 175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 77.7 m -71.03 108.16 4.46 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.247 0.546 . . . . 0.0 109.575 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.2 mt -85.64 106.55 17.01 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.215 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.445 HG22 HG22 ' A' ' 95' ' ' VAL . 46.2 t -102.16 128.99 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.183 0.993 . . . . 0.0 109.043 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -101.98 170.28 8.23 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.379 0.672 . . . . 0.0 110.073 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.608 ' HB ' ' HH ' ' A' ' 98' ' ' TYR . 18.6 tt -67.96 -32.15 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.348 0.659 . . . . 0.0 111.98 -173.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.64 -35.58 72.73 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.199 0.6 . . . . 0.0 111.453 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -68.27 -42.26 79.83 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.788 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.4 mt -55.24 -40.64 71.13 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.785 0.834 . . . . 0.0 111.422 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 7.0 mm-40 -65.89 -41.6 91.33 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.444 -178.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -59.29 -50.62 73.29 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.569 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -64.41 -34.64 78.66 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.173 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -59.21 -39.16 81.79 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.07 0.548 . . . . 0.0 110.416 174.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -75.96 -19.49 58.69 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.017 0.927 . . . . 0.0 111.886 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -84.3 -20.16 32.58 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 122.665 0.386 . . . . 0.0 110.823 170.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.99 -13.48 52.66 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-N 116.456 -0.338 . . . . 0.0 112.414 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.413 ' HA2' ' HD3' ' A' ' 52' ' ' LYS . . . -76.72 88.59 0.95 Allowed Glycine 0 C--N 1.35 1.309 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 176.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -75.63 111.1 10.61 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -173.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 39.5 m0 -99.77 177.73 5.04 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.941 0.896 . . . . 0.0 110.066 175.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.9 t -157.6 151.27 23.99 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.71 0.804 . . . . 0.0 109.869 -178.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 p -103.0 112.12 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 171.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.5 mt -124.18 116.96 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.359 1.064 . . . . 0.0 109.223 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.3 t70 53.31 53.63 11.47 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.27 1.428 . . . . 0.0 111.834 175.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.55 -0.46 55.61 Favored Glycine 0 N--CA 1.475 1.273 0 N-CA-C 114.815 0.686 . . . . 0.0 114.815 176.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -112.59 167.83 10.15 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.131 0.972 . . . . 0.0 109.461 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 90.7 t -115.61 121.97 68.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 171.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.415 ' HB3' HD22 ' A' ' 77' ' ' LEU . 76.7 m-85 -115.3 170.62 8.25 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.831 1.253 . . . . 0.0 109.301 174.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -99.21 159.42 15.0 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.241 0.617 . . . . 0.0 109.835 171.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 35.1 mm -117.28 -29.21 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.359 1.064 . . . . 0.0 108.934 168.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.413 ' HD3' ' HA2' ' A' ' 39' ' ' GLY . 25.1 ttpt -53.89 -57.97 9.01 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.469 1.108 . . . . 0.0 111.965 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.443 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 27.4 t70 -74.39 -35.54 63.49 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.995 0.518 . . . . 0.0 110.121 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -51.09 -53.51 33.43 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.85 1.26 . . . . 0.0 111.775 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -67.62 -27.89 67.28 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.923 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.9 m -68.32 -42.15 79.79 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.932 174.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 77.7 mm-40 -68.56 -28.36 66.89 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 123.12 0.568 . . . . 0.0 110.519 178.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.0 t -72.71 -26.98 61.79 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.672 0.789 . . . . 0.0 110.996 175.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 47.5 tp -67.37 -27.29 66.99 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.876 0.87 . . . . 0.0 112.095 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.0 t -88.11 151.64 22.58 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.219 0.533 . . . . 0.0 111.478 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -79.05 155.46 28.79 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.434 1.093 . . . . 0.0 109.95 176.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 71.88 5.76 5.44 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.032 1.333 . . . . 0.0 112.095 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 37.7 t -74.81 155.33 37.7 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.386 0.674 . . . . 0.0 109.686 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.557 ' HB ' HG23 ' A' ' 86' ' ' THR . 47.5 pt -68.83 -19.76 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 122.788 0.435 . . . . 0.0 110.518 170.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.406 HD12 ' HB2' ' A' ' 57' ' ' GLN . 63.4 mt -96.94 0.32 48.78 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.783 1.233 . . . . 0.0 111.613 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.02 -27.68 68.98 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 122.983 0.513 . . . . 0.0 110.944 176.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -82.16 -24.79 34.83 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.88 0.872 . . . . 0.0 111.372 173.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.582 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 54.8 m-85 -91.84 2.53 56.46 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.979 0.911 . . . . 0.0 112.066 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.97 -29.77 69.71 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.371 0.668 . . . . 0.0 111.092 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.31 26.85 9.3 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-N 116.017 -0.538 . . . . 0.0 113.114 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -141.47 152.32 44.11 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.326 1.05 . . . . 0.0 108.611 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -52.61 127.86 42.7 Favored Pre-proline 0 N--CA 1.478 0.94 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.871 174.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.08 -34.2 86.45 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 123.215 2.61 . . . . 0.0 114.476 -172.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.7 t -73.0 -48.56 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.1 t -62.53 -34.76 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.934 0.894 . . . . 0.0 110.78 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.582 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -71.41 -35.18 70.9 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.994 1.318 . . . . 0.0 110.876 -178.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.415 HD22 ' HB3' ' A' ' 49' ' ' TYR . 17.2 tp -73.36 -40.01 64.72 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.682 176.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -62.31 -36.48 82.28 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.193 0.597 . . . . 0.0 110.267 172.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.5 -32.72 68.55 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.112 0.965 . . . . 0.0 110.612 176.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.23 -43.6 86.15 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.562 0.745 . . . . 0.0 111.151 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.83 -30.64 69.23 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.514 0.326 . . . . 0.0 111.504 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -72.91 -27.72 62.04 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.027 0.531 . . . . 0.0 110.734 176.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -95.96 119.49 34.54 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.294 0.638 . . . . 0.0 110.046 -176.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -58.88 -27.99 65.72 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.514 1.125 . . . . 0.0 113.067 -175.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -79.64 -20.01 47.8 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.029 0.932 . . . . 0.0 112.248 -174.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.557 HG23 ' HB ' ' A' ' 64' ' ' ILE . 41.5 p -123.61 -12.2 7.7 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -173.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -68.58 -26.56 65.45 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.554 0.742 . . . . 0.0 111.195 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -60.07 -54.4 46.36 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.258 1.023 . . . . 0.0 110.481 -172.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.8 m -64.52 -20.0 65.94 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.907 0.883 . . . . 0.0 112.48 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 20.6 mmt -74.09 -4.02 33.01 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.301 0.641 . . . . 0.0 112.495 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.94 -21.4 65.1 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.765 0.426 . . . . 0.0 110.565 169.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -89.06 -29.51 19.37 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.757 0.823 . . . . 0.0 111.086 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -80.8 -24.03 38.83 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.171 0.588 . . . . 0.0 111.443 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.9 p -76.25 110.98 11.21 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 173.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.445 HG22 HG22 ' A' ' 26' ' ' VAL . 27.5 m -70.29 -24.88 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.132 0.573 . . . . 0.0 110.122 174.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 167.59 -159.32 32.58 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.612 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -102.14 139.92 37.12 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.093 0.957 . . . . 0.0 109.807 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.608 ' HH ' ' HB ' ' A' ' 28' ' ' ILE . 84.2 t80 -78.94 124.25 28.06 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.378 0.671 . . . . 0.0 110.379 178.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.5 tt -115.86 120.9 40.76 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 172.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.714 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 42.9 mt-10 -68.86 143.09 94.32 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 123.613 0.765 . . . . 0.0 110.585 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -54.73 -31.18 70.41 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.856 2.371 . . . . 0.0 113.053 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -82.71 -29.01 30.15 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.86 0.864 . . . . 0.0 111.222 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.714 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 33.3 tt0 -68.09 -22.65 64.9 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.737 0.815 . . . . 0.0 112.036 -174.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -61.57 -34.44 75.6 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 120.919 0.39 . . . . 0.0 110.324 173.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.32 -64.15 1.95 Allowed Glycine 0 C--N 1.343 0.929 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.107 177.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.2 p -100.79 147.0 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-O 121.119 0.485 . . . . 0.0 111.519 -174.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 t -107.89 131.75 54.19 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 168.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 55.1 mt -82.01 122.93 80.17 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 122.954 0.502 . . . . 0.0 109.815 -175.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.19 126.05 11.39 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.664 2.242 . . . . 0.0 112.2 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -81.97 108.0 15.12 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 pp -96.31 -12.38 24.54 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.317 0.647 . . . . 0.0 110.943 174.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.351 1.391 0 CA-C-O 118.951 -0.916 . . . . 0.0 112.35 179.535 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.485 1.317 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -141.63 156.94 45.64 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.775 1.23 . . . . 0.0 109.549 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.8 p -147.4 126.22 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 122.568 0.347 . . . . 0.0 111.264 -177.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.2 m -72.25 116.02 12.19 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.397 0.679 . . . . 0.0 110.548 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 83.6 mt -95.93 104.33 16.27 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.756 0.822 . . . . 0.0 109.727 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.506 ' HB ' HG22 ' A' ' 48' ' ' VAL . 59.2 t -95.5 121.78 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.568 1.147 . . . . 0.0 108.688 178.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -78.6 168.95 19.01 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 123.322 0.649 . . . . 0.0 110.312 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.443 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 11.4 tt -56.4 -46.08 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.877 174.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.98 -38.01 81.31 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.8 0.84 . . . . 0.0 111.707 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -66.34 -46.75 75.72 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.017 0.527 . . . . 0.0 111.593 -176.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 pp -72.11 -32.56 67.09 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.282 0.233 . . . . 0.0 111.61 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 68.2 mm-40 -63.73 -47.75 79.84 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.191 0.597 . . . . 0.0 110.816 174.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -77.32 -23.66 50.97 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.404 -175.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -72.63 -28.34 62.68 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -59.63 -47.58 85.04 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.115 0.566 . . . . 0.0 110.034 173.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -70.9 -26.7 63.34 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.101 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.71 -30.0 69.39 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.905 0.882 . . . . 0.0 111.276 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.58 34.88 0.68 Allowed Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.46 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.567 ' HA2' ' HD2' ' A' ' 52' ' ' LYS . . . -162.23 100.0 0.18 Allowed Glycine 0 C--N 1.346 1.131 0 CA-C-O 120.05 -0.306 . . . . 0.0 112.635 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -75.73 110.0 9.79 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -176.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -103.32 157.24 17.15 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.564 174.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.5 t -148.25 143.54 27.04 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.648 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 p -96.64 120.41 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-O 121.027 0.441 . . . . 0.0 110.623 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 78.6 mt -136.89 125.22 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 124.906 1.282 . . . . 0.0 108.194 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.1 t70 62.45 32.9 16.51 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.386 1.074 . . . . 0.0 111.548 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.14 19.57 77.39 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-N 115.818 -0.628 . . . . 0.0 113.401 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -125.24 145.35 50.03 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.187 0.995 . . . . 0.0 108.674 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.506 HG22 ' HB ' ' A' ' 26' ' ' VAL . 25.4 t -99.8 119.64 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -112.54 165.75 11.95 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.035 0.934 . . . . 0.0 109.056 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -93.76 161.55 14.28 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.565 0.698 . . . . 0.0 110.065 170.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.418 HG23 ' HB2' ' A' ' 73' ' ' PRO . 29.3 mm -115.88 -29.92 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.502 1.121 . . . . 0.0 109.744 172.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.567 ' HD2' ' HA2' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -57.36 -52.27 66.04 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 123.891 0.876 . . . . 0.0 112.655 -177.006 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -78.34 -31.38 48.62 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.278 1.031 . . . . 0.0 110.224 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -52.47 -60.81 2.79 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.843 1.257 . . . . 0.0 111.346 175.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -64.89 -28.65 69.69 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.558 -0.747 . . . . 0.0 112.177 -174.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.0 m -63.46 -45.04 92.65 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.298 0.639 . . . . 0.0 110.055 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -77.65 -13.54 59.88 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.369 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.6 m -71.15 -19.64 62.4 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.697 0.399 . . . . 0.0 111.015 172.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 61.0 mt -82.25 -5.89 58.85 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.993 0.917 . . . . 0.0 111.497 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 79.4 m -91.58 133.24 35.71 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.759 0.824 . . . . 0.0 109.722 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -62.91 -49.59 74.2 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.276 1.03 . . . . 0.0 111.644 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -86.51 45.41 1.24 Allowed 'General case' 0 CA--C 1.557 1.218 0 CA-C-O 121.91 0.862 . . . . 0.0 110.642 -177.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 75.7 m -122.81 144.74 48.99 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.181 0.992 . . . . 0.0 109.306 172.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.476 ' HB ' HG23 ' A' ' 86' ' ' THR . 35.0 pt -59.26 -25.92 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 124.029 0.932 . . . . 0.0 110.759 169.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.514 HD21 ' HE2' ' A' ' 90' ' ' MET . 36.7 mt -76.82 -10.15 59.17 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.276 1.031 . . . . 0.0 111.902 -178.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.84 -20.54 59.71 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.214 0.606 . . . . 0.0 111.535 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 2.2 pt20 -77.19 -29.37 54.3 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 171.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -87.94 2.78 50.81 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.402 1.081 . . . . 0.0 111.177 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.54 126.15 28.4 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.782 0.433 . . . . 0.0 110.112 177.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.31 -21.7 38.64 Favored Glycine 0 C--N 1.345 1.037 0 O-C-N 123.481 0.488 . . . . 0.0 112.528 -173.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -89.91 158.49 17.4 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.219 1.008 . . . . 0.0 109.809 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -61.23 132.55 92.57 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 123.204 0.602 . . . . 0.0 109.817 173.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.418 ' HB2' HG23 ' A' ' 51' ' ' ILE . 52.6 Cg_endo -64.53 -32.12 59.65 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.976 2.451 . . . . 0.0 113.899 -172.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.6 t -73.93 -45.82 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.8 t -61.15 -40.35 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.52 0.728 . . . . 0.0 110.478 177.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.02 -40.05 95.46 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.305 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 37.6 tp -71.81 -37.9 70.28 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.666 0.786 . . . . 0.0 110.917 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.23 -44.42 91.91 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.987 0.515 . . . . 0.0 110.318 176.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.51 -33.55 75.83 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.823 0.849 . . . . 0.0 110.873 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.79 -41.78 82.65 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.924 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.13 -23.28 64.88 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -82.76 -9.46 59.34 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.492 0.717 . . . . 0.0 112.071 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -125.89 124.85 41.77 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.206 0.602 . . . . 0.0 109.752 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.09 -42.0 84.71 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.411 1.084 . . . . 0.0 113.901 -169.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.42 -35.85 78.71 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.45 0.7 . . . . 0.0 111.285 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.476 HG23 ' HB ' ' A' ' 64' ' ' ILE . 31.6 p -98.26 -6.01 31.99 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.854 -174.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -90.48 -25.68 20.18 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 118.584 0.629 . . . . 0.0 110.433 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -75.72 -24.83 56.22 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.8 0.666 . . . . 0.0 112.8 -172.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.2 t -71.71 -23.97 61.73 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.145 171.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.514 ' HE2' HD21 ' A' ' 65' ' ' LEU . 12.6 mmt -75.58 -8.92 58.0 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.263 0.625 . . . . 0.0 111.663 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -70.3 -16.81 63.06 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.611 0.764 . . . . 0.0 110.507 169.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -88.66 -37.38 15.62 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.958 0.903 . . . . 0.0 110.857 170.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.433 ' HD2' ' HA ' ' A' ' 90' ' ' MET . 97.5 m-85 -80.79 -14.22 58.27 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.456 0.702 . . . . 0.0 112.192 -176.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 27.1 p -69.5 102.37 1.79 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.736 0.414 . . . . 0.0 110.647 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 26.2 m -77.56 -15.13 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 123.344 0.657 . . . . 0.0 111.201 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 168.84 -172.13 43.09 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.808 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -99.31 150.44 22.11 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 174.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -86.25 152.19 22.99 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.946 0.498 . . . . 0.0 110.553 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -146.65 121.34 9.84 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 172.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.465 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 38.3 mt-10 -71.46 129.01 89.32 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 123.232 0.613 . . . . 0.0 109.631 173.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.9 -32.27 56.29 Favored 'Trans proline' 0 CA--C 1.561 1.847 0 C-N-CA 122.848 2.365 . . . . 0.0 112.645 176.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -76.64 -32.47 58.02 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.624 0.77 . . . . 0.0 111.552 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.465 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 50.3 tp60 -63.46 -31.05 72.11 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.829 0.452 . . . . 0.0 110.262 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -71.84 98.43 1.99 Allowed 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 167.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -175.21 -168.8 36.24 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.32 147.6 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.125 0.97 . . . . 0.0 110.791 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.1 t -104.53 128.56 52.53 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 170.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 75.6 mt -86.79 120.69 71.87 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.85 103.13 0.27 Allowed 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.435 2.09 . . . . 0.0 111.492 171.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -75.7 86.77 2.74 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.469 0.708 . . . . 0.0 109.666 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.3 tt -74.06 -37.64 64.19 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.03 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.487 0 CA-C-O 118.43 -1.205 . . . . 0.0 111.171 -176.01 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.55 148.48 40.82 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.772 0.429 . . . . 0.0 110.306 176.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.5 p -108.33 130.97 60.05 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.1 m -80.05 118.43 21.76 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.625 0.77 . . . . 0.0 110.169 -177.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.4 mt -78.34 100.32 6.7 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.357 0.598 . . . . 0.0 109.64 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -92.53 114.37 29.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 38.3 mtp-105 -85.99 176.3 8.12 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.785 -175.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.5 tt -58.02 -37.44 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.728 175.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.75 -40.25 94.98 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.818 0.847 . . . . 0.0 111.264 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -74.28 -39.79 62.72 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.165 0.586 . . . . 0.0 110.788 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 45.6 tp -66.77 -50.15 63.6 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.035 0.534 . . . . 0.0 110.604 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -64.85 -48.11 75.52 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.63 0.772 . . . . 0.0 112.069 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -67.09 -47.96 69.62 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 123.488 0.493 . . . . 0.0 111.643 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -64.2 -36.77 85.16 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.525 0.33 . . . . 0.0 110.61 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -65.56 -39.69 91.96 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.067 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -67.79 -29.15 68.26 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.52 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -65.38 -23.2 66.91 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.184 0.594 . . . . 0.0 111.588 175.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.92 -26.74 6.09 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.55 ' HA2' ' HD2' ' A' ' 52' ' ' LYS . . . -69.62 89.55 0.29 Allowed Glycine 0 C--N 1.345 1.073 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 176.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -74.11 112.84 10.65 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -171.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 32.6 m0 -105.27 155.21 19.28 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.69 171.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 48' ' ' VAL . 13.6 t -129.55 160.72 32.35 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.516 0.726 . . . . 0.0 109.408 177.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 p -116.34 109.43 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 172.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.3 mt -134.37 133.76 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.002 1.321 . . . . 0.0 107.696 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.0 t70 63.2 29.4 16.0 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 124.473 1.109 . . . . 0.0 110.631 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.5 19.0 64.17 Favored Glycine 0 C--N 1.353 1.487 0 CA-C-N 115.121 -0.945 . . . . 0.0 113.497 -174.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.451 ' HB2' ' CE2' ' A' ' 49' ' ' TYR . 42.9 mmtm -116.82 152.33 34.65 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.449 1.1 . . . . 0.0 108.51 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 42' ' ' THR . 63.8 t -102.12 122.59 54.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 173.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 47' ' ' LYS . 96.4 m-85 -114.47 155.3 26.64 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.923 0.889 . . . . 0.0 110.427 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -94.63 107.12 19.12 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.436 0.694 . . . . 0.0 109.47 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.463 HG23 ' HB2' ' A' ' 73' ' ' PRO . 15.6 mm -75.77 -39.87 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.925 0.89 . . . . 0.0 112.288 -177.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.55 ' HD2' ' HA2' ' A' ' 39' ' ' GLY . 18.0 ptmt -67.08 -32.06 72.97 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 121.161 -0.216 . . . . 0.0 110.954 -174.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -73.7 -38.45 64.84 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -53.19 -54.17 39.88 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.503 1.121 . . . . 0.0 111.12 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -70.34 -27.56 64.45 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.411 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.1 m -72.52 -33.08 66.63 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 120.946 0.403 . . . . 0.0 110.241 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.493 ' HB2' HD13 ' A' ' 65' ' ' LEU . 82.6 mm-40 -69.65 -35.42 75.17 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 172.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.4 m -65.31 -27.12 68.38 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.301 0.64 . . . . 0.0 111.099 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.3 tt -61.63 -44.73 96.43 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.238 1.015 . . . . 0.0 109.297 173.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 88.8 m -66.91 120.31 13.38 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.38 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -65.49 -31.52 72.64 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.956 0.903 . . . . 0.0 111.308 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -69.66 -18.16 63.55 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.331 1.053 . . . . 0.0 111.766 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.8 t -76.04 152.66 36.84 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.877 0.471 . . . . 0.0 110.762 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.483 HD12 ' HA ' ' A' ' 86' ' ' THR . 32.4 pt -61.2 -26.8 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.711 170.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.493 HD13 ' HB2' ' A' ' 57' ' ' GLN . 46.6 mt -77.21 0.76 20.69 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.144 0.978 . . . . 0.0 111.971 -176.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.99 -30.4 70.91 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.363 0.665 . . . . 0.0 111.21 172.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 11.2 pt20 -73.99 -27.06 60.78 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.31 0.644 . . . . 0.0 110.689 175.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.532 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 41.8 m-85 -92.69 -6.44 49.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.255 1.022 . . . . 0.0 111.45 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.27 104.22 0.9 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.153 0.581 . . . . 0.0 109.824 174.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.47 -32.13 3.62 Favored Glycine 0 N--CA 1.472 1.046 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -174.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -77.62 151.14 34.5 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.425 0.69 . . . . 0.0 109.649 175.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -55.37 128.1 66.54 Favored Pre-proline 0 N--CA 1.48 1.067 0 CA-C-O 118.476 -0.773 . . . . 0.0 108.955 171.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.463 ' HB2' HG23 ' A' ' 51' ' ' ILE . 28.6 Cg_endo -58.0 -31.51 93.07 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.836 2.357 . . . . 0.0 113.973 -170.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.9 t -75.38 -50.27 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 123.058 0.543 . . . . 0.0 110.097 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.1 t -58.58 -35.26 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 124.035 0.934 . . . . 0.0 111.022 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.532 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -73.27 -34.98 66.1 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.701 1.2 . . . . 0.0 111.213 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.538 ' HG ' ' SD ' ' A' ' 90' ' ' MET . 4.6 tt -71.58 -35.78 70.67 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.504 0.722 . . . . 0.0 109.889 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -66.53 -40.72 89.29 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.426 0.69 . . . . 0.0 110.36 175.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.18 -32.95 74.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.638 0.775 . . . . 0.0 110.619 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.41 -40.82 73.65 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.878 177.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.9 mt -64.67 -36.68 85.04 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.251 0.621 . . . . 0.0 110.856 173.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -65.87 -36.81 84.46 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.637 0.775 . . . . 0.0 111.074 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.486 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 29.9 t80 -95.96 132.12 41.62 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -176.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -65.85 -36.81 84.49 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.174 0.99 . . . . 0.0 113.193 -168.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -74.98 -32.2 61.63 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.713 0.405 . . . . 0.0 111.063 -177.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.486 ' OG1' ' HB3' ' A' ' 83' ' ' PHE . 37.8 p -93.57 -10.65 34.02 Favored 'General case' 0 CA--C 1.555 1.161 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -172.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -78.51 -15.07 59.0 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -26.24 55.44 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.01 0.524 . . . . 0.0 112.198 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.6 t -73.73 -29.57 62.33 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.324 0.25 . . . . 0.0 110.38 171.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.538 ' SD ' ' HG ' ' A' ' 77' ' ' LEU . 32.1 mmt -64.94 -26.05 68.14 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.052 0.541 . . . . 0.0 110.406 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -59.91 -37.02 78.24 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.707 0.803 . . . . 0.0 110.63 174.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.36 -32.8 60.96 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.834 178.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -78.24 -24.09 47.1 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.255 0.222 . . . . 0.0 111.16 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 39.1 t -70.77 95.27 1.11 Allowed 'General case' 0 C--N 1.349 0.556 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 33.3 m -71.0 -22.77 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.238 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 169.75 -160.66 33.81 Favored Glycine 0 C--N 1.351 1.396 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.836 174.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -97.22 145.69 25.82 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.647 1.179 . . . . 0.0 109.133 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -80.26 108.79 14.16 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 173.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 3.0 tm? -92.31 114.58 27.17 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 103' ' ' GLN . 30.6 tt0 -80.03 140.71 53.86 Favored Pre-proline 0 CA--C 1.554 1.102 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 174.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -39.1 -51.2 2.56 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 124.356 3.371 . . . . 0.0 114.644 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -103.1 23.06 12.93 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.291 0.637 . . . . 0.0 111.655 -175.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.547 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 8.9 tp-100 -81.09 -27.59 35.58 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.861 -0.524 . . . . 0.0 110.088 174.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -69.63 96.52 0.95 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.695 0.798 . . . . 0.0 109.449 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 117.15 38.89 0.84 Allowed Glycine 0 C--N 1.341 0.854 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.339 -174.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.5 p -61.27 124.66 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.398 0.679 . . . . 0.0 110.982 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.0 t -77.64 125.97 30.15 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.254 0.55 . . . . 0.0 110.094 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.4 mt -111.76 93.64 21.12 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.96 87.08 1.52 Allowed 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.651 2.234 . . . . 0.0 111.374 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -81.86 93.59 6.91 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.076 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.0 mp -76.9 -15.58 59.64 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.041 172.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.164 0 CA-C-O 118.861 -0.966 . . . . 0.0 112.71 172.801 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.55 153.94 42.73 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 172.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.1 p -132.35 150.92 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 120.959 0.409 . . . . 0.0 110.859 -173.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.1 m -90.92 115.3 27.84 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.861 0.865 . . . . 0.0 108.712 173.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.422 HD21 ' HB2' ' A' ' 99' ' ' LEU . 64.3 mt -79.35 110.59 14.79 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.1 t -91.87 119.31 39.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 124.069 0.948 . . . . 0.0 108.583 -176.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.495 ' HG2' ' HB2' ' A' ' 30' ' ' ASP . 1.5 ptm180 -81.27 162.0 23.69 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.421 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.5 tt -60.12 -36.8 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.757 0.823 . . . . 0.0 111.836 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.09 -32.21 64.84 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.485 0.714 . . . . 0.0 111.922 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.495 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 29.1 t70 -58.81 -43.26 90.51 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.403 0.681 . . . . 0.0 110.454 -176.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.9 mt -52.35 -43.85 64.86 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.511 1.124 . . . . 0.0 111.691 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -72.18 -37.83 69.22 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.506 -175.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -69.09 -40.06 78.65 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.934 0.494 . . . . 0.0 110.821 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -66.74 -40.4 88.3 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.17 0.588 . . . . 0.0 110.05 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -59.79 -40.49 88.49 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.973 0.509 . . . . 0.0 110.143 176.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -69.27 -31.64 70.3 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.753 0.821 . . . . 0.0 111.388 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -74.28 -30.44 62.1 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.783 0.833 . . . . 0.0 111.274 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 112.06 -7.15 27.21 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.688 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.483 ' HA2' ' HD2' ' A' ' 52' ' ' LYS . . . -75.36 83.46 0.87 Allowed Glycine 0 C--N 1.349 1.268 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 172.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -75.71 107.32 7.8 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -172.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 28.7 m0 -111.44 160.71 16.85 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.643 1.177 . . . . 0.0 110.425 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.8 t -149.36 144.75 26.61 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.421 1.088 . . . . 0.0 109.126 -177.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.557 HG22 HG23 ' A' ' 48' ' ' VAL . 95.9 t -111.36 119.17 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.3 0.64 . . . . 0.0 109.925 178.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.9 mt -127.54 106.12 14.67 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 124.031 0.932 . . . . 0.0 109.008 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.5 t70 55.94 54.55 7.91 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 124.599 1.16 . . . . 0.0 111.61 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.64 9.43 62.01 Favored Glycine 0 N--CA 1.475 1.296 0 CA-C-N 115.081 -0.963 . . . . 0.0 114.428 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -117.76 124.5 48.59 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.767 0.827 . . . . 0.0 108.866 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.557 HG23 HG22 ' A' ' 43' ' ' VAL . 15.2 t -97.11 127.51 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.475 ' HB2' HD21 ' A' ' 77' ' ' LEU . 79.7 m-85 -127.7 163.71 23.7 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.291 1.036 . . . . 0.0 109.035 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -93.39 160.23 14.9 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.529 0.68 . . . . 0.0 110.066 170.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.8 mm -113.14 -27.77 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.494 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.483 ' HD2' ' HA2' ' A' ' 39' ' ' GLY . 21.0 ptmt -70.26 -48.75 55.45 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.069 0.548 . . . . 0.0 112.252 -173.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.458 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 34.6 t70 -75.04 -36.78 61.85 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -49.81 -55.43 14.17 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.934 1.293 . . . . 0.0 112.217 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -67.65 -27.28 66.74 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.111 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.3 m -68.6 -32.05 71.67 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.296 0.638 . . . . 0.0 110.895 172.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 22.5 mm-40 -76.13 -21.4 56.66 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 121.908 -0.495 . . . . 0.0 111.123 178.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.0 m -68.84 -17.66 64.03 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.124 0.57 . . . . 0.0 111.081 172.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.3 tp -69.71 -25.59 63.93 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.709 0.804 . . . . 0.0 110.709 173.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.7 m -86.15 117.47 25.0 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -67.55 -28.36 67.73 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.404 0.681 . . . . 0.0 111.207 -177.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -88.78 63.43 6.85 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-O 121.924 0.869 . . . . 0.0 108.943 173.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 61.2 m -147.55 153.23 39.2 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.923 1.289 . . . . 0.0 108.304 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.462 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 31.8 pt -61.4 -25.6 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.465 0.706 . . . . 0.0 110.902 170.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.415 HD12 ' HB2' ' A' ' 57' ' ' GLN . 58.8 mt -84.31 0.34 49.47 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.368 1.067 . . . . 0.0 112.298 -175.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.91 -29.82 61.09 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.006 0.522 . . . . 0.0 110.744 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 10.6 pt20 -85.43 -6.82 59.18 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.223 0.609 . . . . 0.0 110.846 173.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -108.91 7.97 26.25 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.07 0.948 . . . . 0.0 110.477 174.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.21 126.53 30.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.076 0.55 . . . . 0.0 109.76 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.65 -31.85 8.09 Favored Glycine 0 N--CA 1.474 1.227 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 -173.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -75.28 152.8 38.21 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.948 0.899 . . . . 0.0 109.945 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -56.19 124.47 60.23 Favored Pre-proline 0 N--CA 1.476 0.858 0 C-N-CA 123.927 0.891 . . . . 0.0 109.749 175.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.13 -23.95 52.4 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.979 2.453 . . . . 0.0 113.938 -172.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.2 t -74.6 -47.58 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 176.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.88 -34.0 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.816 0.847 . . . . 0.0 111.085 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.08 -35.74 71.97 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.146 0.979 . . . . 0.0 110.516 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.611 HD11 ' SD ' ' A' ' 90' ' ' MET . 58.8 tp -68.99 -42.6 76.29 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.469 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -65.91 -42.38 90.26 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.604 0.761 . . . . 0.0 110.478 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.96 -37.36 86.77 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.607 0.763 . . . . 0.0 110.328 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.07 -42.47 89.39 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.293 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.7 mt -67.64 -33.41 74.9 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.88 0.872 . . . . 0.0 111.848 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -89.14 2.55 53.98 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.321 0.649 . . . . 0.0 111.809 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -129.82 125.46 35.78 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.93 0.492 . . . . 0.0 109.821 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -58.23 -38.96 77.85 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.758 1.223 . . . . 0.0 113.73 -169.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -71.46 -30.6 66.21 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.353 0.661 . . . . 0.0 111.473 -176.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.414 HG23 ' HB ' ' A' ' 64' ' ' ILE . 24.6 p -101.67 -7.88 22.28 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.366 0.666 . . . . 0.0 112.67 -173.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.69 1.02 53.47 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 118.305 0.502 . . . . 0.0 111.323 177.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -72.56 -49.66 30.94 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.022 0.929 . . . . 0.0 110.782 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 32.8 t -71.58 -18.86 62.21 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.608 0.763 . . . . 0.0 111.162 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.611 ' SD ' HD11 ' A' ' 77' ' ' LEU . 37.4 mmt -64.79 -21.01 66.69 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.456 0.702 . . . . 0.0 111.979 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -60.39 -34.44 73.9 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.446 0.699 . . . . 0.0 110.895 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.99 -45.71 69.91 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.126 0.57 . . . . 0.0 110.97 176.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.412 ' HD2' ' HA ' ' A' ' 90' ' ' MET . 60.1 m-85 -73.61 -16.21 61.24 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.294 0.638 . . . . 0.0 111.395 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 45.8 t -70.65 87.98 0.69 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.441 0.696 . . . . 0.0 109.608 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.8 m -77.1 -25.55 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.383 -176.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 172.82 177.7 42.33 Favored Glycine 0 C--N 1.343 0.921 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.462 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -98.61 133.93 42.26 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -72.55 129.23 37.82 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 173.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.422 ' HB2' HD21 ' A' ' 25' ' ' LEU . 3.0 tm? -132.59 127.87 35.94 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -82.33 141.95 46.51 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 123.718 0.807 . . . . 0.0 110.4 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -59.18 -34.6 98.43 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.773 2.315 . . . . 0.0 111.658 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -70.57 -39.75 73.71 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.211 175.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -67.11 -32.39 73.5 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.285 0.634 . . . . 0.0 111.775 -176.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.38 -49.78 68.0 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -69.44 -37.62 79.26 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 114.858 -1.065 . . . . 0.0 113.826 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.4 p -149.95 136.33 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.426 0.69 . . . . 0.0 110.361 -175.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.2 t -106.19 125.0 50.46 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 172.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.1 mt -71.32 127.53 91.22 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 123.554 0.742 . . . . 0.0 109.961 -175.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.87 170.64 8.44 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.76 2.307 . . . . 0.0 112.548 176.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -86.24 23.22 1.6 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.543 0.737 . . . . 0.0 111.679 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.3 mt -78.88 85.71 4.83 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.211 1.004 . . . . 0.0 109.913 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.13 0 CA-C-O 118.785 -1.008 . . . . 0.0 111.848 178.154 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -89.39 96.29 10.65 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 170.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.1 p -84.12 124.45 39.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.0 m -69.46 109.92 4.47 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 122.711 0.405 . . . . 0.0 109.973 -177.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.511 HD13 HD21 ' A' ' 99' ' ' LEU . 92.3 mt -79.98 100.92 8.35 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.504 ' HB ' HG21 ' A' ' 48' ' ' VAL . 58.2 t -94.57 116.98 37.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 55.6 mtm180 -95.76 172.93 7.73 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.191 0.597 . . . . 0.0 110.84 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.491 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 19.9 tt -60.52 -36.65 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 123.757 0.661 . . . . 0.0 111.451 -174.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.39 -45.12 72.81 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.081 0.952 . . . . 0.0 110.761 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.2 -44.98 93.84 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.04 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.4 mt -59.21 -42.7 91.55 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.858 0.863 . . . . 0.0 111.972 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 9.9 mm-40 -63.45 -50.5 69.49 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 123.496 0.497 . . . . 0.0 111.162 -174.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -71.85 -33.96 68.87 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.575 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -72.29 -35.06 68.58 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.852 0.461 . . . . 0.0 110.442 -177.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -66.45 -39.2 88.73 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.915 0.886 . . . . 0.0 110.399 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -61.78 -32.42 72.7 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.72 0.808 . . . . 0.0 111.52 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -66.12 -34.15 77.41 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.916 0.487 . . . . 0.0 111.058 176.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.05 -18.83 7.41 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.789 -175.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.88 89.02 0.23 Allowed Glycine 0 C--N 1.353 1.506 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 174.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -77.46 108.77 10.86 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.171 0.589 . . . . 0.0 109.573 -175.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -105.83 165.65 11.04 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.264 1.026 . . . . 0.0 109.907 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.8 t -143.03 160.29 40.65 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.868 0.867 . . . . 0.0 109.859 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 47' ' ' LYS . 1.5 p -114.49 112.38 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 123.443 0.697 . . . . 0.0 109.468 170.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.545 HD13 HD22 ' A' ' 77' ' ' LEU . 39.9 mt -134.52 136.98 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.749 1.219 . . . . 0.0 107.872 175.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.0 t70 62.85 29.41 16.61 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 124.327 1.051 . . . . 0.0 110.447 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.48 23.24 68.41 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.11 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 27.5 mmtp -124.67 153.19 42.68 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.562 1.145 . . . . 0.0 108.671 -176.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.504 HG21 ' HB ' ' A' ' 26' ' ' VAL . 91.7 t -104.07 132.27 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 175.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -127.72 153.18 46.82 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.841 0.856 . . . . 0.0 109.908 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -92.42 106.18 18.23 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.409 HG13 HG23 ' A' ' 74' ' ' VAL . 35.8 mm -83.37 -29.6 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.75 0.82 . . . . 0.0 111.533 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.24 -47.56 84.9 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.474 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 28.5 t70 -69.37 -40.84 77.22 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.555 177.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -52.84 -55.0 26.25 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.421 1.089 . . . . 0.0 112.055 -177.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -66.44 -28.01 68.27 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.718 0.807 . . . . 0.0 111.583 -176.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.8 m -66.85 -37.06 83.74 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 122.918 0.487 . . . . 0.0 109.827 173.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 49.7 mm-40 -76.51 -24.63 53.73 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.285 0.634 . . . . 0.0 110.711 176.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.3 m -76.84 -19.69 57.22 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.52 0.728 . . . . 0.0 111.252 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.8 tt -74.05 -24.79 59.58 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.617 0.767 . . . . 0.0 110.321 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.7 m -58.8 137.47 57.7 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.904 0.881 . . . . 0.0 112.693 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -54.28 -45.69 72.55 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.016 1.327 . . . . 0.0 112.04 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -118.12 112.04 19.66 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 38.9 t -163.41 158.58 21.29 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.449 ' HB ' HG21 ' A' ' 86' ' ' THR . 35.9 pt -65.22 -24.63 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 166.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.5 mt -91.6 -2.04 57.26 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 124.759 1.224 . . . . 0.0 111.619 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.17 -31.97 68.33 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.938 0.495 . . . . 0.0 110.376 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 9.6 pt20 -76.51 -23.21 53.7 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.993 0.517 . . . . 0.0 110.652 172.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.518 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 29.4 m-85 -96.24 6.82 47.96 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.369 1.068 . . . . 0.0 111.688 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.52 -22.43 63.58 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.316 0.646 . . . . 0.0 112.1 -177.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.44 11.43 71.36 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-O 120.231 -0.205 . . . . 0.0 112.775 177.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -125.84 156.74 39.11 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.411 1.084 . . . . 0.0 109.694 -177.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -55.46 128.67 68.34 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 124.235 1.014 . . . . 0.0 109.354 170.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -59.74 -30.4 91.98 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.923 2.415 . . . . 0.0 113.946 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.409 HG23 HG13 ' A' ' 51' ' ' ILE . 21.9 t -75.18 -39.02 42.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 C-N-CA 122.588 0.355 . . . . 0.0 110.346 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.6 t -69.76 -39.8 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-O 121.49 0.662 . . . . 0.0 110.116 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.518 ' HB2' ' HB3' ' A' ' 68' ' ' PHE . . . -63.56 -34.49 77.93 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.114 1.366 . . . . 0.0 111.135 178.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.545 HD22 HD13 ' A' ' 44' ' ' ILE . 64.8 tp -61.09 -44.07 97.92 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.81 175.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.442 ' HG2' HG22 ' A' ' 44' ' ' ILE . 42.1 mt-10 -64.44 -40.82 96.47 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.77 0.828 . . . . 0.0 111.399 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.3 -38.5 91.38 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.529 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.81 -26.13 56.96 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.74 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 79.6 mt -72.13 -39.48 68.78 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.502 0.721 . . . . 0.0 109.95 174.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -67.91 -44.78 76.13 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.114 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -84.76 131.48 34.55 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 120.823 0.344 . . . . 0.0 110.209 -176.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -66.58 -41.33 88.71 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.263 1.025 . . . . 0.0 112.916 -171.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.58 -26.57 65.45 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.14 0.576 . . . . 0.0 111.412 -176.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.449 HG21 ' HB ' ' A' ' 64' ' ' ILE . 28.1 p -91.09 -34.22 15.16 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.21 0.604 . . . . 0.0 111.977 -177.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -66.83 -14.27 62.49 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -171.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -57.75 -36.88 72.7 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.252 0.621 . . . . 0.0 111.09 173.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.2 t -77.12 -35.44 56.27 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.346 0.659 . . . . 0.0 110.451 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.479 ' SD ' ' N ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -67.95 -21.64 65.08 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.71 0.804 . . . . 0.0 111.2 175.627 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -67.62 -21.57 65.38 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.35 1.06 . . . . 0.0 110.249 172.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -92.65 -29.95 15.84 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.872 0.869 . . . . 0.0 111.272 172.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -74.95 -23.35 58.3 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 122.962 0.505 . . . . 0.0 111.527 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 27.1 p -69.86 101.05 1.65 Allowed 'General case' 0 C--N 1.354 0.789 0 C-N-CA 122.869 0.468 . . . . 0.0 110.133 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.4 t -67.66 -31.07 50.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 123.91 0.884 . . . . 0.0 110.179 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 172.28 -160.29 31.63 Favored Glycine 0 C--N 1.339 0.721 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.465 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -102.89 133.79 47.38 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 175.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -75.65 131.07 39.68 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 123.273 0.358 . . . . 0.0 110.444 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.511 HD21 HD13 ' A' ' 25' ' ' LEU . 66.5 tp -121.56 134.97 55.03 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 33.4 mt-10 -85.66 137.89 35.93 Favored Pre-proline 0 C--O 1.244 0.815 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 171.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -60.85 -22.53 74.18 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.946 2.43 . . . . 0.0 112.635 175.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -85.1 -37.55 20.14 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.269 1.028 . . . . 0.0 110.853 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 9.5 tp-100 -63.16 -41.86 99.33 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.83 0.852 . . . . 0.0 111.277 -173.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -61.6 -37.03 82.41 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.288 0.635 . . . . 0.0 111.215 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.52 78.85 1.32 Allowed Glycine 0 C--N 1.348 1.234 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.8 p -144.58 137.4 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.156 0.582 . . . . 0.0 110.073 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.9 t -126.1 133.5 51.64 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 172.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 63.4 mt -96.4 116.69 66.28 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.19 154.46 51.83 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 122.599 2.199 . . . . 0.0 111.602 171.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -61.91 113.31 2.72 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.212 0.605 . . . . 0.0 111.073 -174.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -169.2 103.28 0.37 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.33 0 CA-C-O 119.007 -0.885 . . . . 0.0 112.236 173.736 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -68.48 137.9 54.8 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.994 0.518 . . . . 0.0 110.836 174.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.7 p -119.86 141.2 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.12 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.9 p -71.86 108.01 4.93 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.2 mt -81.73 117.66 22.23 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.3 t -92.13 125.3 44.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -175.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -67.97 152.7 45.13 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.47 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 18.9 tt -60.63 -44.56 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 117.711 0.232 . . . . 0.0 110.836 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.71 -31.45 69.47 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.457 0.703 . . . . 0.0 110.613 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.5 -37.78 80.39 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.927 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.4 tp -64.9 -51.66 60.71 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.664 0.786 . . . . 0.0 110.205 175.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 58.8 mm-40 -64.17 -53.57 47.3 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.997 0.919 . . . . 0.0 112.473 -171.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -74.55 -29.68 61.46 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -173.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -72.53 -37.49 68.29 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -63.12 -42.76 99.6 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.887 0.875 . . . . 0.0 109.486 174.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -68.6 -26.58 65.44 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.178 1.391 . . . . 0.0 111.671 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -66.53 -35.26 79.81 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.548 0.739 . . . . 0.0 111.538 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 129.64 -26.63 4.28 Favored Glycine 0 N--CA 1.467 0.738 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.24 81.55 0.36 Allowed Glycine 0 C--N 1.351 1.408 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 167.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -74.63 113.69 12.18 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -164.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 33.4 m0 -106.61 171.44 7.36 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.396 1.078 . . . . 0.0 110.548 177.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.8 t -157.66 142.17 16.36 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.335 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -104.03 112.8 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.107 0.563 . . . . 0.0 109.525 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.411 HD11 ' HG2' ' A' ' 78' ' ' GLU . 55.7 mt -127.39 120.18 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.109 0.964 . . . . 0.0 108.942 176.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 62.06 40.08 12.44 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 125.12 1.368 . . . . 0.0 110.691 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.59 15.59 73.33 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.033 -0.985 . . . . 0.0 113.551 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HD3' ' HG3' ' A' ' 97' ' ' GLN . 35.6 mmtp -118.65 148.17 43.0 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.086 0.955 . . . . 0.0 109.411 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.9 t -106.1 120.98 57.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -118.08 171.17 8.28 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.972 1.309 . . . . 0.0 108.887 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -102.14 159.41 15.41 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.4 0.619 . . . . 0.0 110.39 170.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.1 mm -114.28 -21.4 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 124.437 1.095 . . . . 0.0 109.136 168.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -56.99 6.99 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 122.994 0.517 . . . . 0.0 111.614 -175.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 23.7 t70 -67.43 -37.12 82.53 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.4 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 75.2 t80 -53.17 -52.21 59.55 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.637 1.575 . . . . 0.0 112.7 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -69.6 -27.13 64.83 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.778 -176.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.8 m -70.27 -34.36 72.7 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-O 121.056 0.455 . . . . 0.0 110.423 174.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 33.3 mm-40 -72.19 -24.27 61.39 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.649 0.78 . . . . 0.0 112.195 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.6 p -77.57 -6.82 55.05 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.34 -2.49 38.39 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.761 0.424 . . . . 0.0 111.134 168.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' A' ' 63' ' ' SER . 19.4 m -77.44 120.24 22.17 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 168.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.462 ' HG3' ' ND2' ' A' ' 62' ' ' ASN . 9.5 pt-20 -62.5 -36.9 84.01 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.417 0.687 . . . . 0.0 111.801 -178.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.462 ' ND2' ' HG3' ' A' ' 61' ' ' GLU . 34.5 m-80 -111.24 87.32 2.52 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.508 ' HB3' ' HB ' ' A' ' 60' ' ' THR . 91.9 p -147.13 164.7 32.25 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.994 0.917 . . . . 0.0 109.601 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.538 ' HB ' HG23 ' A' ' 86' ' ' THR . 29.5 pt -68.43 -17.77 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 122.694 0.397 . . . . 0.0 111.019 171.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.6 mt -96.65 -8.87 30.49 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.978 0.911 . . . . 0.0 111.35 -177.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.54 -33.4 74.04 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.469 0.708 . . . . 0.0 110.773 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -76.69 -19.83 57.28 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.663 0.785 . . . . 0.0 111.239 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.478 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . 25.5 m-85 -107.38 7.28 29.01 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.128 0.971 . . . . 0.0 111.1 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.26 -38.07 89.16 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.303 0.641 . . . . 0.0 111.539 -175.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -79.18 -8.3 87.91 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.594 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -95.66 155.46 16.73 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.454 0.702 . . . . 0.0 109.437 175.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -49.22 131.16 16.86 Favored Pre-proline 0 N--CA 1.485 1.324 0 C-N-CA 124.432 1.093 . . . . 0.0 110.417 172.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -61.72 -33.41 85.83 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.748 2.299 . . . . 0.0 113.859 -172.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.1 t -74.55 -41.27 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.66 -32.56 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 123.633 0.773 . . . . 0.0 110.373 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 68' ' ' PHE . . . -68.83 -36.72 78.54 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.554 1.142 . . . . 0.0 110.505 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.693 HD11 ' SD ' ' A' ' 90' ' ' MET . 59.0 tp -64.77 -42.74 94.87 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.079 175.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.411 ' HG2' HD11 ' A' ' 44' ' ' ILE . 48.1 mt-10 -63.49 -40.87 98.22 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.44 0.696 . . . . 0.0 111.594 177.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.11 -34.39 77.96 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.669 0.787 . . . . 0.0 110.307 177.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.36 -26.32 51.86 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.324 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 92.0 mt -75.53 -30.92 59.91 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.1 0.56 . . . . 0.0 110.612 172.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -75.0 -45.87 38.99 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.724 -176.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.411 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 35.3 t80 -82.04 137.88 34.98 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 122.579 0.352 . . . . 0.0 110.579 -174.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.11 -37.15 85.04 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.368 1.067 . . . . 0.0 113.493 -169.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -66.04 -44.26 85.14 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.381 0.61 . . . . 0.0 110.624 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.538 HG23 ' HB ' ' A' ' 64' ' ' ILE . 25.5 p -81.89 -28.6 32.83 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.921 -169.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -64.87 -27.1 68.63 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.124 0.569 . . . . 0.0 111.964 -173.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -79.54 -22.77 43.46 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.392 0.677 . . . . 0.0 110.698 -178.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.5 t -80.68 -28.67 36.7 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.59 0.756 . . . . 0.0 110.381 171.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.693 ' SD ' HD11 ' A' ' 77' ' ' LEU . 36.2 mmt -64.45 -16.71 62.91 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.72 0.808 . . . . 0.0 111.889 176.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -57.79 -33.96 69.11 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.772 1.229 . . . . 0.0 111.531 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.6 -37.24 84.47 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.486 0.714 . . . . 0.0 111.254 176.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.452 ' HD2' ' HA ' ' A' ' 90' ' ' MET . 63.6 m-85 -85.66 -13.03 49.83 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.518 0.727 . . . . 0.0 111.326 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.4 t -71.54 92.61 1.14 Allowed 'General case' 0 C--N 1.351 0.66 0 C-N-CA 123.239 0.615 . . . . 0.0 109.605 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.9 m -83.16 -12.53 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.582 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 165.86 -169.46 40.18 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.772 172.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.445 ' HG3' ' HD3' ' A' ' 47' ' ' LYS . 30.6 tt0 -108.84 139.9 43.04 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.411 1.084 . . . . 0.0 108.156 172.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -71.62 136.62 47.45 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.002 0.43 . . . . 0.0 110.439 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -117.15 121.75 42.13 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 171.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.662 ' HB3' ' HB2' ' A' ' 103' ' ' GLN . 33.1 tt0 -73.5 133.16 80.55 Favored Pre-proline 0 CA--C 1.552 1.056 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.25 174.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.58 -13.85 41.59 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.239 2.626 . . . . 0.0 113.762 -170.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -104.19 -18.32 14.54 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.876 0.471 . . . . 0.0 110.626 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.662 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 8.5 tp-100 -65.26 -28.92 69.68 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.068 0.947 . . . . 0.0 112.748 -170.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -76.21 -2.88 33.46 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -167.69 51.8 0.23 Allowed Glycine 0 C--N 1.349 1.303 0 N-CA-C 112.212 -0.355 . . . . 0.0 112.212 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.4 p -90.36 113.0 25.66 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 123.183 0.593 . . . . 0.0 111.27 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.0 t -98.1 150.92 20.92 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 167.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 71.2 mt -121.3 127.38 26.16 Favored Pre-proline 0 N--CA 1.482 1.153 0 C-N-CA 122.955 0.502 . . . . 0.0 109.693 -175.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.98 138.49 57.44 Favored 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 122.698 2.266 . . . . 0.0 111.261 173.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 60.57 28.91 18.6 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.304 1.042 . . . . 0.0 111.869 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 43.6 tp -66.52 -42.21 87.63 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.338 0.655 . . . . 0.0 109.941 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.045 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.734 176.572 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.59 147.94 27.45 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 169.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.75 136.61 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-O 121.32 0.581 . . . . 0.0 112.295 -173.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.7 m -82.2 108.86 15.98 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 168.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.519 HD13 HD11 ' A' ' 99' ' ' LEU . 83.1 mt -92.93 103.11 15.47 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.114 0.565 . . . . 0.0 109.558 -178.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.41 ' HB ' HG23 ' A' ' 48' ' ' VAL . 69.0 t -92.97 115.92 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 124.02 0.928 . . . . 0.0 108.618 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -84.26 164.83 18.8 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.01 0.924 . . . . 0.0 108.975 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.514 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 17.2 tt -51.23 -44.99 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.455 0.702 . . . . 0.0 112.412 -176.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.43 -44.2 92.95 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.159 0.584 . . . . 0.0 111.641 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -67.63 -35.11 78.32 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.718 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.8 tp -62.91 -42.56 99.83 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.037 0.535 . . . . 0.0 110.203 176.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 12.0 mm-40 -67.55 -55.36 13.78 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.675 0.79 . . . . 0.0 111.578 -175.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -71.13 -35.35 71.7 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.891 -173.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -70.17 -36.66 74.83 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.544 0.338 . . . . 0.0 110.207 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -56.59 -40.69 75.71 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.691 0.619 . . . . 0.0 110.125 175.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -86.89 -15.72 38.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.285 1.034 . . . . 0.0 111.929 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -67.52 -32.18 72.8 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.633 0.773 . . . . 0.0 110.474 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 142.29 -28.6 2.21 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.467 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.0 98.03 2.02 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 174.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -73.28 118.26 16.03 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 -173.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.4 m0 -119.38 154.65 33.29 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.882 0.873 . . . . 0.0 111.554 -169.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.5 t -150.88 151.98 33.02 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.892 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 47' ' ' LYS . 1.6 p -97.77 117.94 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 169.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.7 mt -138.37 131.92 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.8 t70 61.39 29.27 18.43 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 122.31 1.052 . . . . 0.0 110.722 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.87 1.59 47.9 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 114.984 -1.007 . . . . 0.0 114.068 -176.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 41.2 mmtm -96.96 172.69 7.7 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.129 0.972 . . . . 0.0 109.145 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.41 HG23 ' HB ' ' A' ' 26' ' ' VAL . 85.0 t -120.38 119.33 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 172.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -112.34 148.92 33.24 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.236 0.615 . . . . 0.0 110.346 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -92.2 98.79 11.74 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 123.055 0.542 . . . . 0.0 109.736 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.1 mm -61.79 -27.72 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 124.941 1.297 . . . . 0.0 112.122 175.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.618 ' HZ2' ' HB3' ' A' ' 52' ' ' LYS . 5.8 ttpm? -59.39 -51.67 68.89 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-O 120.889 0.376 . . . . 0.0 110.325 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.466 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 31.4 t70 -67.61 -39.57 84.73 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.652 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.418 ' HA ' ' HE2' ' A' ' 93' ' ' PHE . 54.5 t80 -49.05 -48.29 44.09 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.197 0.999 . . . . 0.0 110.886 174.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -71.83 -31.21 66.3 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.41 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.0 m -62.47 -37.83 87.48 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-O 121.052 0.453 . . . . 0.0 110.106 172.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.575 ' HB2' HD13 ' A' ' 65' ' ' LEU . 66.3 mm-40 -78.37 -25.96 46.47 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.311 0.644 . . . . 0.0 111.693 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 92.7 p -85.79 -8.84 57.86 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.903 -0.498 . . . . 0.0 110.995 174.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.6 tt -75.86 -42.54 49.13 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.007 0.923 . . . . 0.0 109.179 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.2 t -75.64 157.49 33.65 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.054 -176.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -67.87 -73.56 0.14 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.363 1.065 . . . . 0.0 111.06 -171.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -86.2 100.58 12.33 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.58 0.705 . . . . 0.0 109.414 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 48.1 t -155.72 163.94 39.22 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.609 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.563 ' HB ' HG22 ' A' ' 86' ' ' THR . 43.2 pt -67.79 -18.54 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 123.572 0.749 . . . . 0.0 111.48 173.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.575 HD13 ' HB2' ' A' ' 57' ' ' GLN . 82.6 mt -104.33 6.33 35.16 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.761 0.825 . . . . 0.0 112.388 -174.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.54 -27.23 62.1 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.108 0.48 . . . . 0.0 110.13 173.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -80.19 -4.97 55.21 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.917 0.887 . . . . 0.0 111.842 173.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.51 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 64.8 m-85 -117.06 9.28 13.58 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.151 0.98 . . . . 0.0 110.56 177.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.98 103.39 2.24 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.684 0.793 . . . . 0.0 110.722 -177.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.45 -37.21 2.39 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -70.1 147.08 50.41 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.017 0.927 . . . . 0.0 110.345 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -53.1 131.22 50.56 Favored Pre-proline 0 N--CA 1.484 1.234 0 C-N-CA 123.625 0.77 . . . . 0.0 110.558 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -47.23 -45.86 20.99 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 123.921 3.081 . . . . 0.0 114.52 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.83 -44.17 45.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.433 -173.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.6 t -66.4 -37.61 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 123.502 0.721 . . . . 0.0 111.052 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.51 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -67.22 -31.84 72.49 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.612 1.165 . . . . 0.0 111.002 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 tt -72.18 -36.46 69.26 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.024 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.69 -39.26 80.62 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.634 0.374 . . . . 0.0 110.763 175.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.62 -32.44 74.01 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.836 0.855 . . . . 0.0 110.525 174.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.08 -35.13 69.16 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.392 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 66.0 mt -74.84 -24.14 58.55 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.588 0.355 . . . . 0.0 111.242 177.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -74.97 -39.6 61.2 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.064 0.546 . . . . 0.0 109.957 173.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -81.98 114.07 20.3 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.919 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -56.62 -32.57 65.44 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.476 1.11 . . . . 0.0 113.263 -172.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -68.05 -40.95 82.69 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.632 0.773 . . . . 0.0 111.744 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.563 HG22 ' HB ' ' A' ' 64' ' ' ILE . 34.9 p -95.75 -17.98 20.8 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -171.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -71.92 -35.45 69.68 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 122.99 0.516 . . . . 0.0 111.34 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.69 -25.99 64.14 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.023 0.929 . . . . 0.0 111.27 -175.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.8 t -80.92 -17.28 51.06 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.483 0.713 . . . . 0.0 110.862 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.405 ' HA ' ' HD1' ' A' ' 93' ' ' PHE . 23.8 mmt -72.21 0.49 9.66 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.292 0.637 . . . . 0.0 112.684 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.423 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 9.1 p80 -62.56 -33.36 74.79 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.376 0.67 . . . . 0.0 110.819 171.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.41 -23.26 46.79 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.23 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.418 ' HE2' ' HA ' ' A' ' 54' ' ' PHE . 54.4 m-85 -90.55 -25.21 20.34 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.325 0.65 . . . . 0.0 110.933 -178.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.423 ' SG ' ' HA ' ' A' ' 91' ' ' HIS . 28.5 p -79.82 106.99 12.25 Favored 'General case' 0 C--N 1.357 0.922 0 CA-C-O 121.042 0.449 . . . . 0.0 109.896 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.0 t -75.7 -29.22 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.274 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -177.91 -166.64 34.74 Favored Glycine 0 C--N 1.345 1.064 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.425 177.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -98.83 138.68 35.62 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.876 0.87 . . . . 0.0 108.961 170.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -78.95 118.8 21.3 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.569 0.748 . . . . 0.0 110.061 173.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.519 HD11 HD13 ' A' ' 25' ' ' LEU . 2.2 tt -99.55 114.36 27.31 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 170.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -80.92 129.68 66.68 Favored Pre-proline 0 CA--C 1.548 0.902 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -53.0 -33.09 61.02 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 123.518 2.812 . . . . 0.0 113.539 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -65.66 -44.68 85.57 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.79 0.836 . . . . 0.0 110.489 178.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -58.67 -34.68 71.52 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.032 0.933 . . . . 0.0 111.081 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.438 ' HB2' HD23 ' A' ' 99' ' ' LEU . 13.2 tp10 -78.94 -40.71 31.23 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.042 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.21 -63.91 3.37 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.899 -0.591 . . . . 0.0 113.04 -176.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.5 p -159.21 135.72 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 123.811 0.844 . . . . 0.0 110.13 177.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 t -114.81 124.96 53.08 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.052 0.941 . . . . 0.0 108.894 173.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 64.3 mt -90.8 118.14 68.43 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 122.846 0.458 . . . . 0.0 110.0 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -87.62 101.82 0.49 Allowed 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.835 2.357 . . . . 0.0 112.096 174.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -73.62 138.77 45.05 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.409 0.684 . . . . 0.0 111.185 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.6 mp -90.94 -40.23 11.82 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.564 0.746 . . . . 0.0 109.469 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.058 0 CA-C-O 118.641 -1.088 . . . . 0.0 112.247 -177.008 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 . . . . . 0 N--CA 1.484 1.268 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.79 174.75 9.19 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.566 0.746 . . . . 0.0 110.217 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.4 p -124.48 93.25 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 170.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.1 m -72.48 109.32 6.08 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.106 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.416 HD13 HD11 ' A' ' 99' ' ' LEU . 96.0 mt -78.6 101.28 7.36 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.438 ' HB ' HG22 ' A' ' 48' ' ' VAL . 60.9 t -94.94 136.12 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.683 -177.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -106.45 166.86 10.24 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.732 0.813 . . . . 0.0 109.128 -178.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.7 tt -54.7 -41.53 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.438 1.095 . . . . 0.0 113.447 -171.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.83 -34.73 71.99 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.252 0.221 . . . . 0.0 111.408 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.49 -34.06 76.94 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.257 0.623 . . . . 0.0 110.598 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.5 mt -61.89 -57.06 13.24 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.38 0.672 . . . . 0.0 110.027 174.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -62.14 -40.29 95.45 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 124.208 0.943 . . . . 0.0 111.71 -174.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -72.84 -38.08 67.21 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.682 0.793 . . . . 0.0 111.366 -176.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -73.06 -39.25 66.05 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.886 0.474 . . . . 0.0 109.993 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -67.75 -50.05 59.29 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.595 1.158 . . . . 0.0 110.756 -175.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -69.11 -28.52 66.55 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.652 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -68.68 -23.99 64.46 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.208 0.603 . . . . 0.0 111.223 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 139.64 -26.86 2.63 Favored Glycine 0 C--N 1.355 1.585 0 CA-C-N 116.651 -0.25 . . . . 0.0 113.447 174.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.62 103.57 2.91 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -75.12 108.23 7.73 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 117.659 0.73 . . . . 0.0 109.591 -168.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -107.93 138.55 43.99 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.038 0.935 . . . . 0.0 110.147 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.3 t -145.21 156.13 43.67 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.909 0.884 . . . . 0.0 109.038 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.453 HG23 HG21 ' A' ' 48' ' ' VAL . 88.7 t -108.47 118.31 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.263 0.625 . . . . 0.0 110.169 -177.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.45 HD12 HD22 ' A' ' 77' ' ' LEU . 34.5 mt -126.25 127.51 70.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 174.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.8 t70 63.23 30.71 15.82 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 124.656 1.182 . . . . 0.0 111.156 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.1 1.66 80.58 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.318 -0.856 . . . . 0.0 113.603 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.498 ' HD2' ' SG ' ' A' ' 94' ' ' CYS . 69.9 mmtt -109.09 149.65 29.0 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.925 0.89 . . . . 0.0 109.802 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.453 HG21 HG23 ' A' ' 43' ' ' VAL . 47.9 t -99.5 134.41 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.885 0.874 . . . . 0.0 109.992 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -134.1 157.97 44.8 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.097 0.959 . . . . 0.0 109.573 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -106.61 115.97 31.12 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.3 mm -70.73 -33.68 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.568 1.147 . . . . 0.0 112.027 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -69.03 -44.27 73.05 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.937 0.495 . . . . 0.0 110.392 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -66.58 -40.6 89.01 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.068 0.947 . . . . 0.0 110.103 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -52.47 -49.77 64.02 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.08 1.352 . . . . 0.0 111.199 172.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -71.29 -31.36 67.37 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.686 0.795 . . . . 0.0 112.242 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.5 m -64.33 -35.27 80.33 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.308 174.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -74.89 -28.39 60.62 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.684 0.794 . . . . 0.0 111.258 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.439 ' HA ' ' HB2' ' A' ' 65' ' ' LEU . 15.5 m -68.75 -27.55 66.01 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.166 0.586 . . . . 0.0 111.159 177.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.0 tp -63.2 -27.12 69.14 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.782 0.833 . . . . 0.0 111.162 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.4 m -77.87 132.04 37.78 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 122.833 0.453 . . . . 0.0 110.349 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -75.55 -35.34 60.7 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.395 0.678 . . . . 0.0 112.042 -173.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -80.13 -7.75 59.07 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.844 0.457 . . . . 0.0 111.97 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 74.4 m -75.41 151.52 38.13 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.439 0.696 . . . . 0.0 110.656 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.452 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 15.2 pt -63.39 -23.25 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.842 0.857 . . . . 0.0 112.176 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 82.8 mt -78.51 1.9 20.86 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.811 0.845 . . . . 0.0 112.228 -178.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.71 -33.33 75.63 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.4 0.68 . . . . 0.0 110.77 172.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 9.8 pt20 -77.17 -22.7 52.09 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.019 0.528 . . . . 0.0 110.617 176.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.556 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 46.3 m-85 -97.66 4.53 50.06 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.408 1.083 . . . . 0.0 111.444 -178.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.24 -19.86 60.98 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.174 0.589 . . . . 0.0 111.291 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.65 0.02 73.21 Favored Glycine 0 C--N 1.352 1.421 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.896 174.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -109.75 157.76 18.81 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.335 1.054 . . . . 0.0 109.768 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -57.01 130.86 79.83 Favored Pre-proline 0 CA--C 1.551 0.993 0 CA-C-O 118.177 -0.915 . . . . 0.0 109.265 171.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -45.41 -50.22 9.43 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 124.189 3.259 . . . . 0.0 115.431 -177.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.9 t -74.38 -42.32 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -174.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.3 t -64.96 -29.73 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 123.864 0.865 . . . . 0.0 111.217 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.556 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -71.61 -35.91 70.64 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.693 1.197 . . . . 0.0 110.364 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.45 HD22 HD12 ' A' ' 44' ' ' ILE . 3.7 tt -72.01 -37.74 69.74 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.544 177.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -63.63 -43.54 96.5 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.362 0.665 . . . . 0.0 110.375 175.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.16 -34.87 78.49 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.028 0.931 . . . . 0.0 110.942 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.1 -42.44 72.69 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.215 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 72.6 mt -61.62 -46.5 89.54 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.306 0.642 . . . . 0.0 110.46 174.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -61.07 -37.58 83.19 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.314 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -89.64 117.93 28.88 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 121.207 0.527 . . . . 0.0 109.951 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -53.63 -30.32 42.29 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.956 1.702 . . . . 0.0 113.93 -173.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -77.7 -48.34 16.96 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.743 0.417 . . . . 0.0 110.613 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.4 p -84.53 -9.36 58.41 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -169.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -67.04 -16.87 64.63 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 122.731 0.412 . . . . 0.0 111.953 -178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -23.51 65.85 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.111 0.964 . . . . 0.0 113.205 -176.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.0 t -82.01 -32.21 30.68 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 118.089 0.404 . . . . 0.0 110.64 174.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.485 ' SD ' ' N ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -74.54 -15.57 60.85 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.546 0.738 . . . . 0.0 110.814 177.536 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -57.64 -43.82 85.16 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.917 0.887 . . . . 0.0 109.651 167.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.95 -38.86 66.61 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.335 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -71.65 -16.9 62.27 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 122.596 0.358 . . . . 0.0 111.951 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.498 ' SG ' ' HD2' ' A' ' 47' ' ' LYS . 43.5 t -71.35 83.86 0.78 Allowed 'General case' 0 C--N 1.354 0.761 0 C-N-CA 123.883 0.873 . . . . 0.0 109.537 175.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.62 -32.24 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.397 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -176.37 -175.77 43.99 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.291 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -107.53 137.61 45.24 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.226 1.01 . . . . 0.0 109.113 175.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -74.59 121.23 21.27 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.218 0.607 . . . . 0.0 110.259 173.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.416 HD11 HD13 ' A' ' 25' ' ' LEU . 6.4 tt -100.81 117.48 34.98 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 168.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.55 ' HB3' ' HB2' ' A' ' 103' ' ' GLN . 38.9 tt0 -70.87 129.51 89.58 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.54 0.736 . . . . 0.0 109.626 176.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -57.01 -25.8 65.03 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 123.033 2.489 . . . . 0.0 113.117 -177.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -86.16 -27.91 24.27 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.301 0.64 . . . . 0.0 111.604 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.55 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 56.9 tp60 -53.86 -31.65 50.35 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.4 1.08 . . . . 0.0 112.35 -175.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -66.85 -40.83 88.02 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.99 0.916 . . . . 0.0 111.703 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.73 -32.62 9.9 Favored Glycine 0 N--CA 1.473 1.15 0 N-CA-C 114.473 0.549 . . . . 0.0 114.473 -173.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.3 p -76.55 109.57 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 CA-C-O 121.659 0.742 . . . . 0.0 110.79 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.5 t -134.08 134.94 42.9 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.498 1.119 . . . . 0.0 109.054 175.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 53.9 mt -89.87 113.17 55.99 Favored Pre-proline 0 N--CA 1.477 0.923 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -79.5 178.14 7.71 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 122.58 2.186 . . . . 0.0 111.655 175.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -78.15 134.71 37.62 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -162.5 -55.92 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.276 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.934 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.449 ' HG3' ' HG3' ' A' ' 22' ' ' LYS . 10.6 pt-20 . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.472 0.177 . . . . 0.0 110.969 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.449 ' HG3' ' HG3' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -153.59 170.04 21.79 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.515 0.726 . . . . 0.0 111.199 -177.742 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.47 135.62 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 123.608 0.763 . . . . 0.0 109.146 171.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.6 m -111.98 109.45 19.22 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 173.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.422 HD13 HD12 ' A' ' 99' ' ' LEU . 84.0 mt -99.12 103.22 15.11 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 177.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.514 ' HB ' HG22 ' A' ' 48' ' ' VAL . 58.5 t -93.22 117.35 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -176.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -90.64 164.62 14.1 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.302 0.641 . . . . 0.0 109.906 174.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.458 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 11.8 tt -58.72 -33.62 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.15 0.58 . . . . 0.0 111.604 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.18 -50.29 74.25 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.451 0.7 . . . . 0.0 110.512 176.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -67.0 -33.42 75.53 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.746 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 43.5 tp -61.22 -45.43 94.61 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.995 0.918 . . . . 0.0 110.435 178.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 16.2 mm-40 -62.9 -54.26 41.33 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.032 0.933 . . . . 0.0 110.973 178.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -59.22 -49.22 78.68 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.572 -174.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -69.64 -32.45 71.13 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.047 -175.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -64.23 -47.62 78.97 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.258 177.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 -72.31 -24.11 61.27 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.713 0.805 . . . . 0.0 111.218 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -67.79 -24.62 65.33 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.094 0.958 . . . . 0.0 110.681 174.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 129.94 -27.72 4.03 Favored Glycine 0 C--N 1.344 1.019 0 N-CA-C 112.022 -0.431 . . . . 0.0 112.022 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.24 91.62 1.14 Allowed Glycine 0 C--N 1.341 0.813 0 N-CA-C 111.364 -0.695 . . . . 0.0 111.364 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -74.95 109.92 8.81 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -175.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 47.5 m0 -104.97 172.93 6.53 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.111 0.965 . . . . 0.0 110.188 175.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.9 t -158.9 135.51 9.4 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.265 1.026 . . . . 0.0 108.945 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.495 HG21 HG21 ' A' ' 48' ' ' VAL . 61.7 t -92.95 111.74 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 122.985 0.514 . . . . 0.0 109.891 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.3 mt -123.67 113.08 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 123.974 0.91 . . . . 0.0 109.213 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 63.15 45.23 5.26 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.882 1.273 . . . . 0.0 111.89 172.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.09 7.86 77.57 Favored Glycine 0 N--CA 1.476 1.337 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.545 177.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -118.51 156.13 29.63 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.237 1.015 . . . . 0.0 108.742 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.514 HG22 ' HB ' ' A' ' 26' ' ' VAL . 24.3 t -115.53 116.02 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -111.15 156.61 21.13 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.166 0.986 . . . . 0.0 108.847 174.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -93.34 149.96 20.84 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.233 0.54 . . . . 0.0 110.227 173.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.9 mm -103.91 -22.97 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 124.288 1.035 . . . . 0.0 108.909 167.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.64 -59.42 5.23 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.175 0.99 . . . . 0.0 111.015 -175.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 20.8 t70 -76.38 -30.87 57.7 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.301 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -52.21 -54.77 26.77 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.689 1.196 . . . . 0.0 112.255 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -67.34 -26.86 66.7 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.084 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 51.7 m -67.86 -36.11 79.71 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.509 172.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 22.7 mm-40 -77.39 -25.4 50.82 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.945 0.498 . . . . 0.0 111.994 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.5 p -74.68 -7.23 52.61 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.7 tt -63.46 -40.45 97.15 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.991 0.916 . . . . 0.0 109.134 167.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.569 ' HB ' ' HB3' ' A' ' 63' ' ' SER . 27.1 m -65.51 119.29 10.8 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.532 0.733 . . . . 0.0 109.478 -177.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -74.27 -14.91 60.98 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 120.768 0.318 . . . . 0.0 111.119 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -101.06 10.4 41.06 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.794 0.838 . . . . 0.0 111.189 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.569 ' HB3' ' HB ' ' A' ' 60' ' ' THR . 81.8 p -87.17 162.22 17.62 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.554 ' HB ' HG23 ' A' ' 86' ' ' THR . 45.9 pt -66.9 -22.25 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.067 0.547 . . . . 0.0 110.816 170.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.422 HD21 ' HE2' ' A' ' 90' ' ' MET . 51.8 mt -85.26 -7.76 58.85 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.978 0.911 . . . . 0.0 111.721 -178.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.24 -33.04 74.85 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.492 0.717 . . . . 0.0 111.785 177.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 11.3 pt20 -76.06 -26.39 56.48 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.286 175.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.434 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . 80.2 m-85 -87.63 -5.39 58.74 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.881 0.872 . . . . 0.0 111.387 176.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.26 99.14 0.67 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.057 0.543 . . . . 0.0 110.188 176.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 142.86 -29.41 2.1 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -172.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -93.81 153.95 18.01 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.253 1.021 . . . . 0.0 109.765 172.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -57.74 127.76 79.12 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 124.051 0.94 . . . . 0.0 110.231 175.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -46.31 -39.81 21.74 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 123.984 3.123 . . . . 0.0 115.88 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.44 -49.42 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 122.559 0.344 . . . . 0.0 110.355 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.0 t -61.65 -40.87 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.871 0.868 . . . . 0.0 110.503 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 68' ' ' PHE . . . -67.72 -33.46 74.93 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.463 -1.244 . . . . 0.0 111.429 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 5.1 tt -68.6 -46.7 68.61 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.692 0.797 . . . . 0.0 109.49 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -63.92 -40.98 97.74 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.382 0.673 . . . . 0.0 111.265 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.27 -37.74 88.45 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.613 0.765 . . . . 0.0 110.545 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.03 -22.81 59.42 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.434 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 87.2 mt -74.59 -37.16 62.97 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 120.878 0.371 . . . . 0.0 110.06 173.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -73.04 -26.98 61.49 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.472 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -95.43 121.08 36.73 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 123.123 0.569 . . . . 0.0 109.531 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.1 -35.97 82.49 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.088 0.955 . . . . 0.0 113.032 -172.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.26 -12.81 61.32 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.283 0.633 . . . . 0.0 112.175 -176.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.554 HG23 ' HB ' ' A' ' 64' ' ' ILE . 24.6 p -117.8 -13.9 10.13 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.272 0.629 . . . . 0.0 112.577 -177.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -75.12 -21.23 59.01 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.035 0.445 . . . . 0.0 111.238 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -35.7 80.97 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.768 0.827 . . . . 0.0 112.121 -176.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.7 t -78.3 -22.09 48.72 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.422 ' HE2' HD21 ' A' ' 65' ' ' LEU . 21.3 mmt -71.54 -4.74 28.56 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.29 0.636 . . . . 0.0 111.785 177.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -69.55 -27.83 65.48 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.114 0.565 . . . . 0.0 109.809 169.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.76 -41.08 15.4 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.807 0.843 . . . . 0.0 110.746 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -66.79 -22.97 66.01 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.089 0.556 . . . . 0.0 111.594 177.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 43.8 t -71.13 92.57 0.99 Allowed 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.9 m -69.82 -19.05 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.243 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 171.94 177.59 41.64 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.328 175.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -96.97 138.56 34.31 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 174.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -72.85 145.6 46.82 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.065 0.46 . . . . 0.0 111.105 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.422 HD12 HD13 ' A' ' 25' ' ' LEU . 5.7 tt -136.07 121.81 19.77 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.693 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 23.3 mt-10 -79.53 132.52 61.67 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 123.41 0.684 . . . . 0.0 109.947 175.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.8 -30.04 87.99 Favored 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 122.305 2.003 . . . . 0.0 112.258 175.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -76.37 -26.58 55.8 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.076 0.95 . . . . 0.0 111.634 177.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.693 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 6.2 tp-100 -66.53 -28.89 68.9 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.857 0.863 . . . . 0.0 110.343 177.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -65.56 103.71 0.89 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.883 171.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 83.59 38.88 10.14 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.138 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.32 129.04 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 123.289 0.636 . . . . 0.0 110.673 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.2 t -85.0 132.05 34.39 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.952 0.501 . . . . 0.0 110.137 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 76.9 mt -98.69 121.63 55.68 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 123.646 0.778 . . . . 0.0 109.305 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -87.75 166.11 7.43 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.882 2.388 . . . . 0.0 112.581 175.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -99.81 -21.23 15.83 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.3 0.64 . . . . 0.0 110.64 174.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.9 mp -79.35 79.5 5.79 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 170.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.944 0 CA-C-O 118.942 -0.921 . . . . 0.0 112.683 179.617 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 N--CA 1.484 1.228 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -114.2 89.2 3.03 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.441 0.697 . . . . 0.0 109.253 176.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.3 p -86.8 143.32 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 122.994 0.518 . . . . 0.0 110.228 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.498 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 17.4 m -69.77 111.08 5.28 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.817 0.847 . . . . 0.0 110.517 -179.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.446 HD11 HD22 ' A' ' 99' ' ' LEU . 72.7 mt -83.24 100.01 10.33 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.276 0.56 . . . . 0.0 109.562 177.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.415 HG22 HG21 ' A' ' 95' ' ' VAL . 84.6 t -95.48 116.05 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.164 177.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 18.4 mtm180 -91.41 172.44 8.52 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.338 0.655 . . . . 0.0 110.143 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.505 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 15.7 tt -61.9 -31.2 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 122.458 0.303 . . . . 0.0 110.552 177.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.38 -52.24 59.94 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.767 0.827 . . . . 0.0 110.804 172.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.413 ' HA ' ' ND2' ' A' ' 33' ' ' ASN . 3.4 m-20 -62.26 -42.22 99.13 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.398 1.079 . . . . 0.0 110.703 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 44.1 tp -59.71 -44.83 93.53 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.969 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 20.4 mm-40 -71.05 -48.97 49.75 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.755 -176.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.413 ' ND2' ' HA ' ' A' ' 30' ' ' ASP . 10.2 p30 -72.08 -33.4 67.89 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.1 0.25 . . . . 0.0 111.33 -174.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -73.82 -35.94 64.92 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.792 0.437 . . . . 0.0 110.189 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -69.47 -34.21 74.03 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.694 0.398 . . . . 0.0 110.429 176.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -73.16 -26.89 61.37 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.072 0.549 . . . . 0.0 110.434 175.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.07 -28.63 68.98 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.457 1.103 . . . . 0.0 110.603 172.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.65 -24.14 6.88 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 -177.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.583 ' HA2' ' HD2' ' A' ' 52' ' ' LYS . . . -70.03 89.97 0.33 Allowed Glycine 0 C--N 1.347 1.144 0 O-C-N 123.895 0.409 . . . . 0.0 112.113 177.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -75.55 107.74 7.9 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -175.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 34.5 m0 -104.31 166.28 10.5 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.247 175.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.1 t -147.67 139.29 23.91 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.175 0.99 . . . . 0.0 108.579 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.459 HG22 HG23 ' A' ' 48' ' ' VAL . 95.8 t -98.18 111.39 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.424 HG23 ' HG2' ' A' ' 78' ' ' GLU . 70.7 mt -140.59 139.14 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.572 1.149 . . . . 0.0 108.28 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.5 t70 63.07 30.85 16.16 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 124.537 1.135 . . . . 0.0 111.177 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.43 15.45 68.18 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.898 -0.592 . . . . 0.0 113.32 -177.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.442 ' HB2' ' CE1' ' A' ' 49' ' ' TYR . 25.6 mmtp -119.21 176.74 5.17 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.805 1.242 . . . . 0.0 108.283 -178.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.459 HG23 HG22 ' A' ' 43' ' ' VAL . 53.1 t -125.06 115.48 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 171.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.442 ' CE1' ' HB2' ' A' ' 47' ' ' LYS . 85.2 m-85 -108.16 159.41 16.62 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.347 1.059 . . . . 0.0 109.467 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -90.89 160.72 15.55 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 120.958 0.409 . . . . 0.0 110.081 171.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 28.1 mm -120.97 -26.71 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.998 0.919 . . . . 0.0 109.958 173.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.583 ' HD2' ' HA2' ' A' ' 39' ' ' GLY . 19.2 ptmt -67.96 -47.04 69.72 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 122.915 0.486 . . . . 0.0 111.953 -175.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -76.81 -33.27 58.0 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.67 0.388 . . . . 0.0 109.99 177.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -53.05 -50.05 65.11 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.616 1.566 . . . . 0.0 111.849 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -67.8 -28.33 67.49 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.145 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.0 m -73.02 -33.68 65.89 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.052 0.541 . . . . 0.0 110.08 176.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -73.9 -29.34 62.02 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.148 0.979 . . . . 0.0 111.838 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.7 p -73.6 -8.59 56.57 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.936 0.494 . . . . 0.0 112.236 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.0 mt -77.86 -12.38 59.97 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.4 0.68 . . . . 0.0 111.683 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 35.4 m -82.32 132.02 35.22 Favored 'General case' 0 C--N 1.361 1.074 0 C-N-CA 122.777 0.431 . . . . 0.0 110.061 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -67.77 -30.54 70.02 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.618 0.767 . . . . 0.0 111.528 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -112.52 74.26 0.85 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.4 m -150.91 165.05 34.85 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.137 0.975 . . . . 0.0 109.962 178.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.501 HD13 ' HB3' ' A' ' 89' ' ' SER . 9.3 pt -67.1 -25.73 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.194 177.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.446 ' HG ' HG13 ' A' ' 64' ' ' ILE . 71.0 mt -95.21 2.65 54.99 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.863 0.865 . . . . 0.0 111.588 -176.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.41 -34.53 70.42 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.315 0.579 . . . . 0.0 110.422 176.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -72.28 -23.42 61.19 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.395 173.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -100.0 7.34 44.82 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.574 1.15 . . . . 0.0 111.038 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.01 80.21 3.55 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.478 0.711 . . . . 0.0 110.057 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 147.77 -24.14 1.48 Allowed Glycine 0 N--CA 1.471 0.993 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.001 -170.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -84.16 151.91 24.59 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.919 0.888 . . . . 0.0 109.902 175.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -55.69 125.57 61.64 Favored Pre-proline 0 N--CA 1.481 1.125 0 CA-C-O 118.27 -0.871 . . . . 0.0 109.589 174.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.71 -36.83 91.23 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 123.191 2.594 . . . . 0.0 114.86 -175.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.0 t -74.73 -36.22 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.262 0.625 . . . . 0.0 110.314 -177.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.7 t -72.3 -36.91 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.979 0.912 . . . . 0.0 110.622 175.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.26 -29.19 65.92 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.638 1.175 . . . . 0.0 110.572 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.537 HD21 ' SD ' ' A' ' 90' ' ' MET . 1.8 tm? -63.36 -48.85 76.21 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.48 1.112 . . . . 0.0 109.156 173.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.424 ' HG2' HG23 ' A' ' 44' ' ' ILE . 23.2 mt-10 -68.44 -39.72 81.39 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.291 -178.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.98 -34.19 77.42 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.863 0.865 . . . . 0.0 110.453 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.28 -39.65 82.07 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.892 174.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 66.5 mt -67.29 -29.38 68.96 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.366 0.666 . . . . 0.0 112.157 177.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -72.3 -43.42 64.22 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.686 0.795 . . . . 0.0 110.519 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -85.35 114.66 22.59 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -54.66 -33.39 60.64 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.541 1.136 . . . . 0.0 113.077 -172.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -64.79 -52.63 55.85 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.708 0.803 . . . . 0.0 111.115 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.488 HG23 ' HB ' ' A' ' 64' ' ' ILE . 38.5 p -81.23 -13.99 57.95 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.567 -171.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.56 -18.16 57.19 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 120.956 0.408 . . . . 0.0 110.927 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -64.72 -45.29 87.18 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.939 0.896 . . . . 0.0 110.061 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.501 ' HB3' HD13 ' A' ' 64' ' ' ILE . 46.6 t -71.27 -17.6 62.47 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.949 0.899 . . . . 0.0 112.325 -178.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.537 ' SD ' HD21 ' A' ' 77' ' ' LEU . 30.3 mmt -63.49 -15.23 57.25 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.551 0.741 . . . . 0.0 112.123 177.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.471 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 3.3 p80 -57.89 -33.09 68.36 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.681 0.793 . . . . 0.0 111.194 175.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.09 -33.46 70.21 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.103 0.961 . . . . 0.0 111.193 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -90.89 -26.11 19.5 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.494 -174.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.471 ' SG ' ' HA ' ' A' ' 91' ' ' HIS . 26.8 p -76.84 105.4 7.88 Favored 'General case' 0 C--N 1.358 0.971 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.415 HG21 HG22 ' A' ' 26' ' ' VAL . 35.9 m -69.48 -25.46 29.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 123.114 0.565 . . . . 0.0 110.692 174.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.498 ' HA3' ' HB ' ' A' ' 24' ' ' THR . . . 170.07 -165.69 38.99 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.557 174.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -88.58 140.57 29.32 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.18 0.992 . . . . 0.0 109.609 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -77.16 135.82 38.55 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 122.706 0.402 . . . . 0.0 110.782 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 66.4 tp -121.97 130.84 53.65 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.641 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 37.9 mt-10 -83.37 148.37 55.51 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 171.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.13 -7.28 20.44 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.51 2.14 . . . . 0.0 112.716 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -109.62 -16.93 13.83 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.359 1.064 . . . . 0.0 110.847 178.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.641 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 9.1 tp-100 -73.94 -31.13 62.9 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.773 0.829 . . . . 0.0 112.355 -172.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -64.18 -33.37 75.63 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.102 0.477 . . . . 0.0 110.331 174.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -102.74 31.84 8.27 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.944 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.5 p -70.24 147.7 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.087 0.555 . . . . 0.0 110.866 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.4 t -126.22 148.75 49.4 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 171.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 62.7 mt -120.64 97.48 48.56 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -83.44 155.02 14.11 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.75 2.3 . . . . 0.0 112.178 175.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -70.78 123.38 21.8 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.542 0.737 . . . . 0.0 110.545 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -145.09 -71.17 0.27 Allowed 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.258 0 CA-C-O 118.802 -0.999 . . . . 0.0 111.464 -175.563 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -84.06 136.76 33.89 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.666 176.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.8 p -147.81 97.05 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.6 p -63.02 113.14 2.93 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.537 0.735 . . . . 0.0 111.453 -175.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.3 mt -78.78 106.58 10.88 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.566 0.746 . . . . 0.0 109.521 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.408 ' HB ' HG21 ' A' ' 48' ' ' VAL . 39.8 t -93.61 121.33 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 123.69 0.796 . . . . 0.0 109.074 -175.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -72.13 151.18 43.19 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.778 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.5 tt -61.3 -39.23 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 120.724 0.297 . . . . 0.0 111.41 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.26 -29.27 70.63 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.922 0.889 . . . . 0.0 111.328 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 34' ' ' HIS . 11.0 t70 -62.54 -47.42 83.96 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.077 0.551 . . . . 0.0 109.789 178.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.0 mp -58.54 -48.36 81.13 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 123.76 0.663 . . . . 0.0 110.28 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -55.04 -44.75 74.96 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 124.375 1.047 . . . . 0.0 111.358 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -73.9 -39.79 63.62 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.755 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.428 ' HB2' ' O ' ' A' ' 30' ' ' ASP . 1.6 t60 -68.32 -39.15 82.05 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.34 0.656 . . . . 0.0 111.44 -167.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -70.07 -33.01 71.37 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.545 0.338 . . . . 0.0 110.97 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -68.53 -30.46 69.27 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.495 0.718 . . . . 0.0 110.074 178.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -70.3 -33.74 71.91 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.402 0.681 . . . . 0.0 110.429 173.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 134.96 -27.55 3.16 Favored Glycine 0 C--N 1.344 1.019 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.95 87.99 0.97 Allowed Glycine 0 C--N 1.347 1.154 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.406 ' HB3' ' HB ' ' A' ' 51' ' ' ILE . 26.3 t80 -74.8 109.37 8.22 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -171.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 36.6 m0 -105.15 146.83 28.66 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.598 0.759 . . . . 0.0 109.783 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.0 t -144.22 136.95 26.99 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.173 0.589 . . . . 0.0 110.352 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -88.02 112.05 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 121.466 0.651 . . . . 0.0 109.696 174.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.433 HD13 HD21 ' A' ' 77' ' ' LEU . 84.6 mt -132.38 131.18 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.149 1.38 . . . . 0.0 107.794 175.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.2 t70 60.53 29.89 19.35 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-O 121.819 0.818 . . . . 0.0 111.634 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.23 4.33 73.08 Favored Glycine 0 C--N 1.353 1.499 0 CA-C-N 115.565 -0.743 . . . . 0.0 114.01 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.448 ' HD2' ' SG ' ' A' ' 94' ' ' CYS . 71.8 mmtt -111.56 139.3 47.12 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.212 1.005 . . . . 0.0 109.142 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.408 HG21 ' HB ' ' A' ' 26' ' ' VAL . 52.9 t -89.96 123.22 42.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 170.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -110.71 169.76 8.54 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.686 0.795 . . . . 0.0 109.815 177.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -105.03 142.46 34.78 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.706 172.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.406 ' HB ' ' HB3' ' A' ' 40' ' ' PHE . 25.6 mm -112.56 -29.81 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.876 0.87 . . . . 0.0 110.982 -175.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -66.76 -30.73 71.02 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.578 0.627 . . . . 0.0 109.727 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 37.1 t70 -74.81 -49.59 20.16 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.847 0.859 . . . . 0.0 110.048 172.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.411 ' HA ' ' HE2' ' A' ' 93' ' ' PHE . 48.6 t80 -48.45 -50.93 29.34 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.814 1.246 . . . . 0.0 112.117 -178.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -68.64 -27.92 66.43 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.438 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 89.2 m -70.23 -36.44 74.52 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.284 0.634 . . . . 0.0 110.37 173.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 84.3 mm-40 -73.76 -23.53 59.74 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.695 0.798 . . . . 0.0 112.213 -176.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 64.3 p -75.04 -13.75 60.53 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.5 mp -71.67 -24.81 61.9 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.253 0.621 . . . . 0.0 110.568 173.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.5 m -71.22 121.96 19.35 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 122.638 0.375 . . . . 0.0 110.08 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.62 -37.62 85.24 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.346 0.659 . . . . 0.0 110.958 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -91.14 78.36 5.88 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 175.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.6 t -157.38 158.52 36.07 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.914 0.886 . . . . 0.0 109.299 -178.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.54 ' HB ' HG22 ' A' ' 86' ' ' THR . 38.9 pt -68.07 -23.5 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.832 170.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.6 mt -88.2 -0.34 56.98 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.697 0.799 . . . . 0.0 112.441 -177.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.36 -36.63 81.77 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.061 0.544 . . . . 0.0 110.914 176.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -73.0 -27.3 61.71 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.148 0.579 . . . . 0.0 110.853 175.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -90.62 1.54 56.69 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.822 0.849 . . . . 0.0 111.489 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.65 94.39 0.43 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.07 0.548 . . . . 0.0 110.652 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.64 -27.87 2.69 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.547 -176.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -77.43 151.8 34.58 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.65 0.78 . . . . 0.0 109.882 175.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -56.16 130.15 74.17 Favored Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 123.463 0.705 . . . . 0.0 109.697 173.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.99 -40.92 58.29 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.334 2.69 . . . . 0.0 114.69 -174.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.414 HG11 HD11 ' A' ' 44' ' ' ILE . 65.1 t -73.98 -43.04 52.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 122.959 0.504 . . . . 0.0 110.509 -176.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.8 t -65.4 -39.48 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 123.44 0.696 . . . . 0.0 110.901 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.86 -36.21 82.81 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.556 1.142 . . . . 0.0 110.76 177.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.433 HD21 HD13 ' A' ' 44' ' ' ILE . 31.5 tp -69.44 -38.94 78.04 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.618 178.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -60.74 -48.45 81.73 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.868 0.467 . . . . 0.0 110.249 175.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.78 -32.68 73.88 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.871 0.868 . . . . 0.0 111.242 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.07 -33.35 73.42 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.281 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.6 -38.96 70.8 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.298 0.239 . . . . 0.0 110.619 174.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -66.82 -29.2 69.07 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.293 0.637 . . . . 0.0 111.582 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.4 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 65.4 t80 -98.53 139.22 34.58 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.032 0.444 . . . . 0.0 110.163 177.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -62.07 -54.24 44.15 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.603 1.161 . . . . 0.0 113.945 -170.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.57 -38.37 90.79 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.228 0.611 . . . . 0.0 111.277 -175.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.54 HG22 ' HB ' ' A' ' 64' ' ' ILE . 36.6 p -80.54 -17.67 50.76 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 115.254 -0.884 . . . . 0.0 112.051 -172.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.9 ptt-85 -78.82 -23.17 45.24 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.158 0.504 . . . . 0.0 110.201 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -67.83 -38.03 82.67 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.258 1.023 . . . . 0.0 112.262 -173.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 32.0 t -73.91 -24.17 59.65 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.558 175.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 18.8 mmt -72.19 -7.84 51.45 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -65.23 -33.81 76.88 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.705 0.402 . . . . 0.0 109.955 169.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.05 -37.79 64.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.42 0.688 . . . . 0.0 111.448 175.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.411 ' HE2' ' HA ' ' A' ' 54' ' ' PHE . 90.4 m-85 -73.9 -23.71 59.6 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 122.895 0.478 . . . . 0.0 111.446 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.448 ' SG ' ' HD2' ' A' ' 47' ' ' LYS . 53.1 t -70.09 102.7 2.11 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.251 0.62 . . . . 0.0 109.714 177.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.3 m -73.2 -20.65 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.453 0.701 . . . . 0.0 110.677 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 170.46 -177.67 43.53 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.996 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -85.65 150.61 24.5 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 173.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -77.6 142.58 38.85 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.136 0.574 . . . . 0.0 110.124 173.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -133.76 130.0 37.44 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.839 0.856 . . . . 0.0 108.747 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 43.8 mt-10 -85.99 129.61 53.48 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.489 1.116 . . . . 0.0 109.482 175.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -55.29 -35.21 90.89 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 123.112 2.541 . . . . 0.0 112.752 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -71.47 -36.23 71.1 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.011 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.422 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 51.5 tp60 -63.29 -35.76 81.43 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.874 0.87 . . . . 0.0 111.393 -175.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -66.96 102.34 0.96 Allowed 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.921 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 149.34 -84.47 0.17 Allowed Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.064 172.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.0 p -124.97 155.12 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.874 0.87 . . . . 0.0 110.42 -172.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.5 t -122.06 133.67 54.78 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.828 0.851 . . . . 0.0 109.587 175.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.9 mm -101.86 128.14 29.45 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 123.747 0.819 . . . . 0.0 108.898 175.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -81.8 -168.05 0.56 Allowed 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.653 2.236 . . . . 0.0 111.581 174.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -91.09 129.32 37.1 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 172.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -159.46 -45.88 0.05 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.5 0.72 . . . . 0.0 110.748 175.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.232 0 CA-C-O 119.064 -0.853 . . . . 0.0 111.405 -179.153 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.248 0.071 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.34 149.66 50.04 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 173.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -103.15 137.39 31.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 121.007 0.432 . . . . 0.0 110.781 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.2 m -114.45 107.45 15.56 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 166.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.454 HD22 ' HB2' ' A' ' 99' ' ' LEU . 45.9 mt -97.55 119.07 35.45 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.146 0.498 . . . . 0.0 109.95 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.477 HG12 ' HB2' ' A' ' 30' ' ' ASP . 86.3 t -106.69 131.35 56.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -104.06 170.28 8.01 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 173.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.4 tt -58.15 -31.53 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.065 0.546 . . . . 0.0 111.974 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.69 -42.44 83.67 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.545 0.738 . . . . 0.0 111.319 177.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.477 ' HB2' HG12 ' A' ' 26' ' ' VAL . 38.4 m-20 -63.59 -36.27 83.25 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.165 0.586 . . . . 0.0 111.325 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.8 mt -63.88 -51.58 63.91 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 123.904 0.752 . . . . 0.0 109.748 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -59.18 -46.26 88.87 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.555 -1.202 . . . . 0.0 112.262 -172.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -77.08 -30.17 55.3 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 111.479 0.178 . . . . 0.0 111.479 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -73.44 -26.36 60.91 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.745 0.418 . . . . 0.0 110.844 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -61.28 -37.56 83.61 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.745 0.818 . . . . 0.0 110.377 172.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -70.62 -32.97 70.51 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.988 0.915 . . . . 0.0 110.789 174.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -64.56 -33.42 75.87 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.94 0.896 . . . . 0.0 110.819 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 125.46 -27.14 5.32 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 116.434 -0.348 . . . . 0.0 112.271 175.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.09 107.85 2.36 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 175.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -80.27 108.02 13.54 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -99.79 154.8 18.04 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.055 0.942 . . . . 0.0 110.031 176.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.3 t -147.96 164.63 33.18 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.093 0.957 . . . . 0.0 109.093 172.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.515 HG22 HG22 ' A' ' 48' ' ' VAL . 98.2 t -120.68 117.39 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.201 0.601 . . . . 0.0 110.796 -176.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.6 mt -138.77 138.13 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.698 1.199 . . . . 0.0 107.919 174.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.6 t70 63.08 30.64 16.16 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.475 1.11 . . . . 0.0 111.004 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.43 18.08 69.28 Favored Glycine 0 C--N 1.355 1.627 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.539 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.435 ' HD2' ' SG ' ' A' ' 94' ' ' CYS . 75.0 mmtt -124.15 148.75 46.97 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.273 1.029 . . . . 0.0 109.203 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.515 HG22 HG22 ' A' ' 43' ' ' VAL . 39.1 t -100.08 128.94 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.509 0.724 . . . . 0.0 109.212 174.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -122.33 144.9 48.72 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.856 0.862 . . . . 0.0 109.254 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -87.43 104.62 16.62 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 174.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.469 HG22 ' HB2' ' A' ' 73' ' ' PRO . 24.6 mm -62.59 -31.89 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.223 1.009 . . . . 0.0 111.082 174.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.0 ttpp -60.01 -36.97 78.36 Favored 'General case' 0 CA--C 1.554 1.125 0 O-C-N 123.597 0.561 . . . . 0.0 110.291 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.418 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 33.0 t70 -75.3 -42.5 54.52 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.281 0.633 . . . . 0.0 111.209 174.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.422 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 50.5 t80 -51.08 -51.76 50.15 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.704 1.202 . . . . 0.0 111.21 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -67.66 -27.73 67.11 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.837 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 58.8 m -68.34 -38.82 81.87 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.599 0.36 . . . . 0.0 110.773 174.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.442 ' HB2' HD11 ' A' ' 65' ' ' LEU . 78.6 mm-40 -74.39 -27.24 60.55 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.305 0.642 . . . . 0.0 111.345 -177.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.0 p -74.06 -10.42 59.61 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.023 0.529 . . . . 0.0 112.168 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.8 mp -71.32 -17.21 62.46 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 122.974 0.51 . . . . 0.0 111.352 171.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.3 m -88.04 133.44 33.97 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -75.11 -31.9 61.26 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.135 0.493 . . . . 0.0 109.719 173.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -83.49 63.12 7.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.79 0.836 . . . . 0.0 109.664 174.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.8 p -146.49 160.19 42.43 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.547 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.601 ' HB ' HG21 ' A' ' 86' ' ' THR . 40.0 pt -68.03 -22.73 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.688 170.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.442 HD11 ' HB2' ' A' ' 57' ' ' GLN . 44.3 mt -91.49 2.49 56.39 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.186 0.995 . . . . 0.0 112.208 -174.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.38 -33.34 75.32 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.067 0.547 . . . . 0.0 110.989 174.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -75.82 -29.87 58.8 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.679 0.792 . . . . 0.0 110.659 175.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -90.8 1.54 56.83 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.369 1.068 . . . . 0.0 111.688 -178.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.3 -25.87 67.82 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.624 0.77 . . . . 0.0 111.394 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -103.97 30.7 9.72 Favored Glycine 0 C--N 1.35 1.309 0 CA-C-N 116.547 -0.297 . . . . 0.0 112.431 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -139.11 154.49 48.15 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.403 1.081 . . . . 0.0 108.717 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -59.79 131.68 88.92 Favored Pre-proline 0 N--CA 1.48 1.052 0 CA-C-O 118.209 -0.9 . . . . 0.0 109.788 175.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.469 ' HB2' HG22 ' A' ' 51' ' ' ILE . 27.7 Cg_endo -58.29 -36.98 97.14 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 123.208 2.605 . . . . 0.0 114.329 -173.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.1 t -74.67 -45.68 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 122.893 0.477 . . . . 0.0 110.439 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.8 t -66.3 -35.83 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.686 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.81 -34.68 74.02 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.229 1.011 . . . . 0.0 110.627 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.6 HD12 ' SD ' ' A' ' 90' ' ' MET . 51.0 tp -66.15 -38.59 88.49 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.845 0.858 . . . . 0.0 110.486 177.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -58.73 -50.18 74.85 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.78 0.432 . . . . 0.0 110.049 174.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.47 -34.08 76.12 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.956 0.903 . . . . 0.0 111.012 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.73 -28.74 61.86 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.818 0.847 . . . . 0.0 111.506 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -71.83 -28.99 63.94 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.333 0.253 . . . . 0.0 111.107 172.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -90.45 -25.01 20.56 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.529 0.732 . . . . 0.0 111.728 -174.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.41 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 40.7 t80 -91.57 133.78 35.24 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.653 0.381 . . . . 0.0 110.576 -176.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.14 -36.98 85.41 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.957 1.303 . . . . 0.0 113.96 -168.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -74.23 -27.27 60.7 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.32 0.648 . . . . 0.0 111.309 -176.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.601 HG21 ' HB ' ' A' ' 64' ' ' ILE . 39.4 p -101.53 -31.02 11.07 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.588 -170.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.416 ' HD2' ' N ' ' A' ' 88' ' ' GLU . 6.0 ppt_? -60.12 -32.03 70.61 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 123.794 0.837 . . . . 0.0 112.387 -174.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.416 ' N ' ' HD2' ' A' ' 87' ' ' ARG . 7.8 pt-20 -64.45 -43.4 94.39 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.49 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.0 t -78.43 -16.69 57.33 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.621 0.768 . . . . 0.0 111.632 -176.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.6 ' SD ' HD12 ' A' ' 77' ' ' LEU . 36.1 mmt -61.11 -28.24 68.95 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.282 0.633 . . . . 0.0 111.556 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -64.52 -25.64 68.08 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.673 0.789 . . . . 0.0 111.416 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.46 -25.68 57.62 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.535 0.734 . . . . 0.0 111.454 175.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.422 ' CE1' ' HA ' ' A' ' 54' ' ' PHE . 98.5 m-85 -86.44 -20.65 27.84 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.472 0.709 . . . . 0.0 111.374 176.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.435 ' SG ' ' HD2' ' A' ' 47' ' ' LYS . 47.6 t -67.07 97.88 0.54 Allowed 'General case' 0 C--N 1.351 0.646 0 O-C-N 123.814 0.696 . . . . 0.0 110.749 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.7 m -74.76 -10.58 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.874 0.869 . . . . 0.0 111.42 177.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 169.18 175.68 38.64 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 174.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.409 ' HG2' ' NZ ' ' A' ' 47' ' ' LYS . 15.2 mt-30 -80.53 163.51 23.67 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.362 0.665 . . . . 0.0 109.753 171.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -118.23 146.57 44.16 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.774 0.429 . . . . 0.0 109.891 175.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.454 ' HB2' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -142.43 125.76 16.57 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 174.112 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.7 mp0 -69.8 137.93 87.91 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 123.167 0.587 . . . . 0.0 110.479 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -51.69 -42.55 56.15 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.868 2.378 . . . . 0.0 112.013 169.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -59.23 -52.32 66.2 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.774 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -58.91 -35.89 73.82 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.381 1.072 . . . . 0.0 110.97 -178.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.5 -42.05 79.14 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.98 -177.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -73.56 -79.47 0.51 Allowed Glycine 0 C--N 1.346 1.13 0 N-CA-C 112.135 -0.386 . . . . 0.0 112.135 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -139.75 129.61 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.2 t -82.67 139.04 33.93 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.035 0.534 . . . . 0.0 110.19 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.9 mt -93.85 111.05 51.24 Favored Pre-proline 0 CA--C 1.545 0.774 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.65 126.82 13.83 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 122.534 2.156 . . . . 0.0 110.566 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -64.59 105.44 0.96 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.866 0.467 . . . . 0.0 110.292 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.0 tt -165.26 131.57 2.77 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -176.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.278 0 CA-C-O 119.101 -0.833 . . . . 0.0 113.015 -177.829 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 . . . . . 0 N--CA 1.486 1.342 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.52 163.69 33.95 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.603 0.761 . . . . 0.0 109.653 176.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.7 p -153.64 129.08 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 172.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.3 m -68.24 110.87 4.24 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.341 0.656 . . . . 0.0 110.024 -178.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.5 mt -77.22 102.39 6.63 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.524 ' HB ' HG22 ' A' ' 48' ' ' VAL . 94.6 t -93.51 116.74 35.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.042 -177.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.426 ' HD2' ' HB3' ' A' ' 101' ' ' PRO . 71.6 mtm180 -82.34 166.49 19.43 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.223 176.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.0 tt -56.28 -37.69 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.296 0.639 . . . . 0.0 110.609 172.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.61 -47.55 83.97 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.969 0.908 . . . . 0.0 111.212 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.521 ' HA ' ' ND2' ' A' ' 33' ' ' ASN . 53.7 m-20 -67.18 -37.47 83.77 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.83 0.852 . . . . 0.0 110.935 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.401 ' HA ' ' HE3' ' A' ' 41' ' ' TRP . 36.3 tp -59.13 -45.14 91.71 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.75 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -72.28 -49.69 32.82 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.131 0.973 . . . . 0.0 112.11 -177.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.521 ' ND2' ' HA ' ' A' ' 30' ' ' ASP . 14.2 p30 -70.67 -33.68 71.19 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -170.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.401 ' CE1' ' HA3' ' A' ' 39' ' ' GLY . 43.4 t-80 -73.59 -30.91 63.3 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 120.564 0.221 . . . . 0.0 110.708 178.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -66.99 -38.64 86.38 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 173.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -65.4 -34.12 77.56 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.444 0.698 . . . . 0.0 110.363 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -65.16 -34.17 77.75 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.9 0.88 . . . . 0.0 110.514 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 139.08 -27.19 2.67 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 111.999 -0.44 . . . . 0.0 111.999 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.401 ' HA3' ' CE1' ' A' ' 34' ' ' HIS . . . -81.13 97.74 1.8 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 112.014 -0.434 . . . . 0.0 112.014 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -75.58 113.51 13.08 Favored 'General case' 0 C--N 1.347 0.469 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.401 ' HE3' ' HA ' ' A' ' 31' ' ' LEU . 43.7 m0 -98.09 164.5 12.31 Favored 'General case' 0 C--O 1.24 0.591 0 O-C-N 123.863 0.727 . . . . 0.0 109.799 176.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.418 HG21 HD13 ' A' ' 51' ' ' ILE . 15.3 t -147.05 133.9 20.13 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.659 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.519 HG22 HG21 ' A' ' 48' ' ' VAL . 82.2 t -95.95 107.03 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.6 mt -118.25 113.86 43.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 123.938 0.895 . . . . 0.0 108.844 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.3 t70 62.04 32.84 17.48 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.334 1.053 . . . . 0.0 111.272 174.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.99 5.66 85.85 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 115.255 -0.884 . . . . 0.0 114.081 177.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -115.65 150.4 36.8 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.495 0.718 . . . . 0.0 109.341 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.524 HG22 ' HB ' ' A' ' 26' ' ' VAL . 60.4 t -113.68 121.4 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 123.674 0.79 . . . . 0.0 109.856 -175.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -124.46 155.39 38.98 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.928 0.891 . . . . 0.0 109.175 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.433 ' HB3' ' HB2' ' A' ' 53' ' ' ASP . 7.7 t70 -97.09 120.29 37.17 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.438 ' O ' ' HG3' ' A' ' 55' ' ' GLN . 33.4 mm -73.68 -32.73 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.589 0.756 . . . . 0.0 111.599 -178.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -63.71 -45.99 87.48 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.433 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . 2.1 m-20 -65.51 -36.73 84.69 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.644 175.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -58.69 -51.88 68.06 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.609 0.764 . . . . 0.0 110.499 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.468 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 28.0 mt-30 -63.26 -29.23 70.6 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.889 -174.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.3 m -56.12 -36.75 68.57 Favored 'General case' 0 CA--C 1.553 1.088 0 O-C-N 123.862 0.726 . . . . 0.0 111.73 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -76.67 -30.99 56.99 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.281 0.632 . . . . 0.0 111.701 178.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 62.8 p -81.42 1.35 33.48 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 55' ' ' GLN . 83.1 mt -82.18 9.27 9.0 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.367 0.667 . . . . 0.0 112.33 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.5 t -128.53 165.5 20.63 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.226 0.61 . . . . 0.0 110.736 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -70.95 -60.83 2.02 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.73 0.812 . . . . 0.0 110.484 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -83.05 90.4 7.03 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.276 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.5 t -143.48 149.86 38.15 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.651 -1.158 . . . . 0.0 108.907 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.52 ' HB ' HG22 ' A' ' 86' ' ' THR . 37.2 pt -67.79 -19.94 25.53 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 C-N-CA 122.834 0.454 . . . . 0.0 110.843 171.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.47 HD22 ' HE3' ' A' ' 90' ' ' MET . 60.1 mt -95.71 -1.76 49.3 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.351 1.06 . . . . 0.0 111.755 -178.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.2 -29.68 69.41 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.947 0.499 . . . . 0.0 111.014 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -71.66 -19.96 62.02 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.786 0.834 . . . . 0.0 111.671 175.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.547 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . 78.1 m-85 -99.89 10.72 40.83 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.344 1.058 . . . . 0.0 111.613 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.21 -26.1 68.36 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.309 0.643 . . . . 0.0 112.408 -176.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.57 18.84 53.98 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 116.393 -0.367 . . . . 0.0 113.245 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -132.88 151.11 52.09 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.788 0.835 . . . . 0.0 109.721 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -55.38 128.46 67.38 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 124.488 1.115 . . . . 0.0 109.924 172.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -54.76 -29.44 62.37 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.431 2.754 . . . . 0.0 114.626 -173.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.42 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 34.0 t -74.72 -49.37 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.5 t -68.8 -30.01 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 123.991 0.916 . . . . 0.0 111.017 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.547 ' HB3' ' HB3' ' A' ' 68' ' ' PHE . . . -68.74 -40.63 79.74 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.865 1.266 . . . . 0.0 109.895 176.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.514 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 41.4 tp -63.5 -40.85 98.17 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.684 175.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 35.3 mt-10 -58.39 -47.66 83.16 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.283 0.633 . . . . 0.0 111.384 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.99 -35.33 80.86 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.954 175.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.54 -18.1 59.89 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.126 0.97 . . . . 0.0 112.629 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 89.1 mt -77.06 -36.56 55.82 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 173.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -76.21 -21.21 56.69 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.577 175.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -90.84 115.9 28.25 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.842 0.857 . . . . 0.0 110.099 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.75 -23.24 65.22 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.164 0.985 . . . . 0.0 113.366 -173.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.89 -14.49 57.97 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.286 0.634 . . . . 0.0 112.044 -178.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.52 HG22 ' HB ' ' A' ' 64' ' ' ILE . 7.2 p -110.47 -29.78 7.94 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.328 0.651 . . . . 0.0 112.682 -177.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -50.62 -27.39 6.77 Favored 'General case' 0 N--CA 1.507 2.397 0 C-N-CA 124.32 1.048 . . . . 0.0 113.247 -174.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -55.15 -48.54 73.57 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.245 1.418 . . . . 0.0 112.648 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.7 m -76.88 -20.25 56.48 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.116 0.566 . . . . 0.0 111.787 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.552 ' N ' ' SD ' ' A' ' 90' ' ' MET . 0.1 OUTLIER -74.76 -13.27 60.57 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.774 0.829 . . . . 0.0 111.274 176.52 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.447 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 28.4 m170 -75.0 -23.19 58.2 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.061 0.544 . . . . 0.0 110.017 171.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.86 -30.22 23.08 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.56 0.744 . . . . 0.0 110.728 172.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -83.59 -23.91 31.73 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.439 0.296 . . . . 0.0 111.481 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.447 ' SG ' ' HA ' ' A' ' 91' ' ' HIS . 31.0 p -73.42 109.93 7.31 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-O 120.959 0.409 . . . . 0.0 109.98 -177.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.8 t -68.96 -45.89 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.938 172.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 175.0 -150.12 10.89 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.857 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -115.46 137.57 51.92 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.035 1.334 . . . . 0.0 109.044 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -71.14 134.03 46.66 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.132 0.573 . . . . 0.0 110.37 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -143.78 122.89 12.88 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.405 ' HB2' ' CB ' ' A' ' 103' ' ' GLN . 47.1 mt-10 -66.12 133.83 94.76 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.446 0.699 . . . . 0.0 110.687 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.426 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 17.4 Cg_endo -57.48 -25.49 66.76 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 123.263 2.642 . . . . 0.0 113.139 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -79.66 -43.12 23.37 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.388 0.675 . . . . 0.0 110.4 173.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.405 ' CB ' ' HB2' ' A' ' 100' ' ' GLU . 9.6 tt0 -67.77 -8.93 39.71 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.874 0.87 . . . . 0.0 111.846 -175.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -57.43 -48.51 78.95 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.856 0.862 . . . . 0.0 110.165 173.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -96.81 -8.05 57.29 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.634 -0.712 . . . . 0.0 114.221 -175.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.6 p -132.38 135.39 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 117.699 0.749 . . . . 0.0 110.752 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.8 t -121.31 154.23 36.67 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.961 0.904 . . . . 0.0 110.206 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.3 mm -119.99 104.41 44.08 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -80.81 71.9 6.81 Favored 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 122.391 2.061 . . . . 0.0 111.634 176.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -74.75 147.86 40.94 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.538 -178.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -90.51 -39.92 12.3 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.654 0.782 . . . . 0.0 110.155 -176.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.97 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -177.577 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 110.563 -0.162 . . . . 0.0 110.563 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.23 150.23 45.47 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.671 0.388 . . . . 0.0 110.806 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.1 p -99.01 115.32 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.8 m -72.72 107.92 5.43 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.4 mt -86.86 111.01 20.36 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.6 t -91.19 114.15 28.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.8 ptp85 -70.67 158.05 36.9 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.484 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.451 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 10.1 tt -55.64 -44.68 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 123.352 0.407 . . . . 0.0 111.214 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.9 -33.41 75.26 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.578 0.751 . . . . 0.0 111.496 -177.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -74.55 -40.83 61.44 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.594 0.358 . . . . 0.0 110.105 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 57.2 tp -60.81 -53.25 59.6 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.115 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 51.4 mm-40 -58.88 -51.87 68.18 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.096 0.958 . . . . 0.0 111.827 -177.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -68.51 -41.06 80.51 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -175.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 66.2 t-80 -71.74 -42.66 67.0 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 118.033 0.379 . . . . 0.0 110.631 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -64.08 -51.14 65.47 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.823 0.849 . . . . 0.0 110.883 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -79.44 5.99 11.37 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.795 0.838 . . . . 0.0 111.994 -177.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -91.44 -8.42 47.83 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.884 0.874 . . . . 0.0 110.844 174.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.49 -26.26 12.23 Favored Glycine 0 C--N 1.344 0.987 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -175.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.582 ' HA2' ' HD3' ' A' ' 52' ' ' LYS . . . -75.35 77.73 1.18 Allowed Glycine 0 C--N 1.348 1.249 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 171.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.402 ' HD1' ' HB ' ' A' ' 51' ' ' ILE . 17.1 t80 -72.96 117.91 15.27 Favored 'General case' 0 C--N 1.345 0.404 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -163.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 29.0 m0 -110.26 172.0 7.12 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.883 1.273 . . . . 0.0 109.912 175.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.7 t -147.51 149.49 32.74 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.0 175.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 p -109.98 110.01 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.8 mt -124.77 124.0 67.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 124.076 0.95 . . . . 0.0 108.761 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.9 t70 63.0 32.91 15.23 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.483 1.113 . . . . 0.0 111.025 174.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.35 2.35 87.44 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.914 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 97' ' ' GLN . 46.4 mmtm -110.2 147.76 33.13 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.071 0.949 . . . . 0.0 109.261 177.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.8 t -102.43 127.66 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 122.842 0.457 . . . . 0.0 109.922 175.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -121.82 169.49 10.72 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.851 1.261 . . . . 0.0 108.987 175.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -94.64 157.07 16.13 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.65 0.738 . . . . 0.0 109.715 168.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.466 HG21 ' HB2' ' A' ' 73' ' ' PRO . 30.8 mm -121.05 -30.02 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.144 1.378 . . . . 0.0 108.911 172.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.582 ' HD3' ' HA2' ' A' ' 39' ' ' GLY . 35.7 ttpt -54.97 -58.0 9.39 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.86 0.864 . . . . 0.0 111.044 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -74.27 -36.34 63.8 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.149 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -51.95 -55.99 16.93 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.721 1.208 . . . . 0.0 111.846 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -68.33 -26.78 65.78 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.987 -176.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.9 m -66.78 -47.38 72.31 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 172.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -76.75 -13.67 60.01 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.025 0.93 . . . . 0.0 112.844 -176.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.527 ' HA ' ' HB2' ' A' ' 65' ' ' LEU . 90.8 p -67.96 -20.13 65.02 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -91.47 -0.16 57.58 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.612 0.365 . . . . 0.0 111.862 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.8 m -75.23 126.35 30.85 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 175.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -57.31 -48.4 79.05 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.389 1.076 . . . . 0.0 111.888 -170.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -82.59 -12.27 57.82 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.041 0.536 . . . . 0.0 112.431 -173.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 65.8 m -67.61 151.44 47.3 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 120.995 0.426 . . . . 0.0 111.232 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.545 ' HB ' HG21 ' A' ' 86' ' ' THR . 43.5 pt -61.04 -23.61 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.211 1.004 . . . . 0.0 111.468 174.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.527 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 63.1 mt -86.1 0.22 54.02 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.304 1.041 . . . . 0.0 111.961 -175.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.91 -33.24 71.92 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 122.969 0.507 . . . . 0.0 111.007 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -74.67 -25.58 59.27 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.582 0.753 . . . . 0.0 110.565 172.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.515 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 38.2 m-85 -95.99 3.7 53.25 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.317 1.047 . . . . 0.0 111.531 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.47 -29.35 69.45 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.57 0.748 . . . . 0.0 111.011 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.12 23.22 22.12 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.88 176.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -135.06 155.84 50.05 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.316 1.046 . . . . 0.0 108.912 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.84 131.28 78.98 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 124.222 1.009 . . . . 0.0 109.901 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.466 ' HB2' HG21 ' A' ' 51' ' ' ILE . 18.9 Cg_endo -55.4 -33.59 86.2 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 123.484 2.79 . . . . 0.0 114.303 -174.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.8 t -74.51 -46.99 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.4 t -64.1 -35.26 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 123.465 0.706 . . . . 0.0 110.58 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.515 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -67.41 -37.49 83.15 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.065 1.346 . . . . 0.0 110.56 178.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.686 HD12 ' SD ' ' A' ' 90' ' ' MET . 58.3 tp -67.2 -43.4 82.2 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.08 0.952 . . . . 0.0 110.466 176.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -64.6 -37.61 88.16 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.83 0.852 . . . . 0.0 111.2 178.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.29 -33.42 69.7 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.824 0.85 . . . . 0.0 110.473 176.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.49 -23.38 53.78 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.481 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.447 HD21 ' HG3' ' A' ' 90' ' ' MET . 90.1 mt -72.28 -39.96 67.93 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.891 0.476 . . . . 0.0 109.83 170.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -68.65 -43.0 77.16 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.605 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.414 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 5.1 t80 -82.58 124.6 30.29 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -176.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.31 -27.97 69.39 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.712 1.205 . . . . 0.0 112.737 -172.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -71.0 -35.9 72.24 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.471 0.709 . . . . 0.0 110.935 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.545 HG21 ' HB ' ' A' ' 64' ' ' ILE . 30.9 p -94.96 -21.25 18.74 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.534 0.734 . . . . 0.0 112.959 -171.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -66.01 -24.44 66.77 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.452 0.701 . . . . 0.0 112.078 -174.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -66.26 -37.54 85.72 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.724 0.81 . . . . 0.0 111.329 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.5 t -76.7 -24.19 53.15 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.452 0.701 . . . . 0.0 110.943 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.686 ' SD ' HD12 ' A' ' 77' ' ' LEU . 33.1 mmt -63.27 -20.88 65.86 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.737 0.815 . . . . 0.0 111.686 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 27.7 m170 -64.46 -31.78 73.13 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.638 0.775 . . . . 0.0 111.036 176.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.82 -43.84 74.72 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.796 175.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -73.33 -23.82 60.29 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.555 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 35.5 t -74.29 104.32 5.01 Favored 'General case' 0 C--N 1.349 0.581 0 C-N-CA 123.291 0.636 . . . . 0.0 109.346 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.2 m -80.65 -9.43 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 123.302 0.641 . . . . 0.0 110.483 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 156.6 -164.77 32.74 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.577 172.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 43.1 tt0 -99.13 142.5 30.54 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.517 1.127 . . . . 0.0 109.228 171.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -74.57 137.82 42.62 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 122.901 0.481 . . . . 0.0 110.158 172.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -135.23 120.08 18.48 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 44.7 mt-10 -80.78 146.31 59.78 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 123.704 0.802 . . . . 0.0 110.026 174.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.6 -24.84 41.28 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.497 2.131 . . . . 0.0 111.865 -176.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -84.14 -28.35 27.5 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.956 0.902 . . . . 0.0 110.663 175.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.526 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 61.0 tp60 -66.25 -36.54 83.27 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.077 0.551 . . . . 0.0 111.577 -176.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -85.97 -33.73 21.03 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.18 176.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.83 -33.65 86.07 Favored Glycine 0 C--N 1.354 1.562 0 CA-C-N 116.124 -0.489 . . . . 0.0 113.099 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -152.82 127.98 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 124.838 1.255 . . . . 0.0 107.861 172.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.7 t -129.99 145.62 51.65 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.9 mt -84.74 118.11 70.28 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -83.98 51.23 3.34 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.847 2.364 . . . . 0.0 112.501 -177.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 37.8 t70 63.38 26.58 15.03 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.381 1.073 . . . . 0.0 110.542 -176.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.5 tt -71.41 -44.09 65.57 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.0 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.299 0 CA-C-O 118.864 -0.965 . . . . 0.0 111.651 179.36 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.925 0.393 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.77 143.69 28.84 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.206 1.003 . . . . 0.0 109.101 177.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.6 p -111.37 150.87 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 123.492 0.717 . . . . 0.0 110.029 -176.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.4 m -78.72 110.96 14.34 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.827 0.851 . . . . 0.0 110.147 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.443 HD22 HD21 ' A' ' 99' ' ' LEU . 86.4 mt -81.9 104.2 12.1 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 172.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.9 t -93.84 118.99 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -85.33 165.7 17.06 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.5 tt -57.0 -36.25 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 123.085 0.554 . . . . 0.0 112.244 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.11 -41.57 83.84 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.426 0.69 . . . . 0.0 111.077 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -64.71 -34.4 78.23 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.809 0.844 . . . . 0.0 111.495 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.7 mt -60.76 -47.15 87.63 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 123.545 0.528 . . . . 0.0 109.83 175.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -65.69 -44.75 85.25 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.828 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -62.65 -49.91 73.26 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.988 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -69.26 -35.21 75.85 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.757 0.423 . . . . 0.0 110.232 -174.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -62.99 -42.91 99.97 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.438 0.695 . . . . 0.0 109.766 174.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -67.31 -31.64 72.07 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.892 0.877 . . . . 0.0 111.096 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -72.03 -18.49 61.95 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.348 0.659 . . . . 0.0 111.078 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.93 32.56 3.51 Favored Glycine 0 C--N 1.345 1.049 0 O-C-N 123.144 0.278 . . . . 0.0 112.804 176.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -140.36 104.81 0.42 Allowed Glycine 0 C--N 1.343 0.927 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 177.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -75.6 110.63 10.16 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.769 0.428 . . . . 0.0 110.076 -168.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -100.04 145.38 27.98 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.176 0.99 . . . . 0.0 110.375 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.3 t -140.56 151.51 44.77 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.257 1.023 . . . . 0.0 109.358 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.4 p -102.96 120.35 52.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 172.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.6 mt -131.49 123.82 53.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.614 1.166 . . . . 0.0 108.446 176.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.7 t70 62.33 31.81 17.22 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.413 1.085 . . . . 0.0 111.721 175.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.95 7.13 87.56 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-N 115.673 -0.694 . . . . 0.0 113.337 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.449 ' HB3' ' HG ' ' A' ' 94' ' ' CYS . 72.4 mmtt -110.69 159.54 17.51 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.664 1.186 . . . . 0.0 108.442 178.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 75.6 t -114.96 139.8 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 122.957 0.503 . . . . 0.0 109.698 174.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -133.92 155.73 49.38 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.324 1.05 . . . . 0.0 110.289 -175.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -102.52 106.91 17.7 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 173.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.529 HG21 ' HB2' ' A' ' 73' ' ' PRO . 30.8 mm -68.02 -34.31 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.636 1.174 . . . . 0.0 112.183 -178.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -59.82 -41.4 91.19 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 123.667 0.604 . . . . 0.0 110.29 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 33.7 t70 -68.83 -45.53 70.92 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.943 0.897 . . . . 0.0 110.655 177.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.438 ' HA ' ' HE2' ' A' ' 93' ' ' PHE . 77.2 t80 -47.56 -60.57 2.44 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.544 1.138 . . . . 0.0 111.704 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -63.57 -29.81 71.02 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.521 -178.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 96.9 m -69.37 -35.08 75.47 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 122.788 0.435 . . . . 0.0 111.168 178.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 23.2 mm-40 -70.74 -14.35 62.41 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.787 0.435 . . . . 0.0 111.479 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.2 t -84.63 12.37 7.23 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.85 0.86 . . . . 0.0 111.588 174.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -64.75 -28.89 69.89 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.095 0.558 . . . . 0.0 111.365 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.6 m -88.9 133.2 34.37 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.729 0.812 . . . . 0.0 109.646 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -28.11 68.12 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.51 0.724 . . . . 0.0 111.207 178.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -103.72 89.33 3.3 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.94 0.896 . . . . 0.0 108.982 171.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.3 p -147.6 169.55 19.39 Favored 'General case' 0 C--O 1.245 0.838 0 C-N-CA 123.835 0.854 . . . . 0.0 109.241 177.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.585 ' HB ' HG23 ' A' ' 86' ' ' THR . 48.2 pt -68.49 -22.29 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.658 172.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.469 HD21 ' HE3' ' A' ' 90' ' ' MET . 66.5 mt -101.4 5.51 42.15 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.248 1.019 . . . . 0.0 111.715 -176.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.11 -30.19 71.27 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.261 0.625 . . . . 0.0 110.779 173.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -79.56 -23.84 42.53 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.224 1.01 . . . . 0.0 111.079 174.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.56 ' HB3' ' HB2' ' A' ' 76' ' ' ALA . 55.1 m-85 -99.3 0.39 42.91 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.226 1.01 . . . . 0.0 111.801 -177.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.73 -23.28 64.33 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.794 0.838 . . . . 0.0 111.87 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -101.86 24.39 31.53 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 116.61 -0.268 . . . . 0.0 113.063 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -136.12 158.89 43.33 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.034 0.934 . . . . 0.0 109.665 -175.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -56.24 129.74 74.35 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 123.947 0.899 . . . . 0.0 109.728 174.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.529 ' HB2' HG21 ' A' ' 51' ' ' ILE . 37.3 Cg_endo -60.62 -31.49 92.24 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.648 2.232 . . . . 0.0 114.064 -170.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.465 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 37.0 t -75.31 -53.27 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.3 t -61.47 -36.14 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 123.59 0.756 . . . . 0.0 111.308 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.56 ' HB2' ' HB3' ' A' ' 68' ' ' PHE . . . -66.92 -37.09 83.69 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.506 1.122 . . . . 0.0 111.105 178.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.3 tp -68.39 -38.56 81.45 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.881 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 35.9 mt-10 -65.23 -41.64 94.2 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.211 0.604 . . . . 0.0 110.041 177.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.23 -33.42 75.71 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.707 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.12 -34.88 71.5 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.856 0.862 . . . . 0.0 111.643 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.4 mt -67.42 -40.57 85.54 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.144 0.578 . . . . 0.0 110.15 175.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -73.52 -25.0 60.23 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.235 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -79.46 114.39 18.35 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -54.57 -29.61 51.85 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.665 1.586 . . . . 0.0 112.933 -177.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -70.88 -58.45 3.58 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.274 0.63 . . . . 0.0 110.83 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.585 HG23 ' HB ' ' A' ' 64' ' ' ILE . 67.4 p -87.72 -10.81 50.06 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -166.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -65.8 -31.99 73.26 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.103 0.561 . . . . 0.0 111.907 -172.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -29.39 64.27 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.516 -173.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.6 t -74.93 -23.87 58.4 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.581 0.752 . . . . 0.0 110.995 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.469 ' HE3' HD21 ' A' ' 65' ' ' LEU . 21.8 mmt -73.91 0.35 13.68 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.833 0.853 . . . . 0.0 112.669 -177.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -63.83 -31.13 72.2 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.616 0.766 . . . . 0.0 110.778 170.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.06 -31.08 39.45 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.17 0.988 . . . . 0.0 111.052 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.438 ' HE2' ' HA ' ' A' ' 54' ' ' PHE . 60.2 m-85 -81.27 -24.83 37.03 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.527 0.731 . . . . 0.0 110.685 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.449 ' HG ' ' HB3' ' A' ' 47' ' ' LYS . 42.1 t -78.31 108.65 11.79 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 123.437 0.695 . . . . 0.0 109.341 176.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.3 p -79.28 -19.55 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.495 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 155.35 -156.53 27.03 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 116.387 -0.369 . . . . 0.0 112.391 176.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.42 ' HB2' HD21 ' A' ' 25' ' ' LEU . 16.6 mm100 -78.58 164.77 24.39 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.778 1.231 . . . . 0.0 111.306 174.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -109.62 143.33 39.49 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 162.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.443 HD21 HD22 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -137.64 123.95 20.6 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.17 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.605 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 1.7 mp0 -73.24 143.3 83.09 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 123.212 0.605 . . . . 0.0 110.397 178.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -58.82 -32.5 97.31 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.918 2.412 . . . . 0.0 112.739 175.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -82.78 -29.13 29.86 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.082 0.553 . . . . 0.0 110.446 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.605 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 55.9 tp60 -66.75 -24.7 66.25 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.333 0.653 . . . . 0.0 110.903 -177.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -63.35 -34.34 77.49 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.568 0.747 . . . . 0.0 111.537 176.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -129.95 31.82 3.27 Favored Glycine 0 C--N 1.349 1.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 113.094 -177.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.4 p -84.48 131.06 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-O 121.11 0.481 . . . . 0.0 110.24 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.3 t -132.87 131.9 41.48 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.041 0.936 . . . . 0.0 108.869 173.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.5 mt -110.8 122.8 37.16 Favored Pre-proline 0 N--CA 1.473 0.704 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -72.73 158.52 50.28 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 123.046 2.497 . . . . 0.0 112.061 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -75.05 86.11 2.33 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 52.9 tp -99.35 -56.64 2.35 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.359 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.262 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 176.465 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 119.627 -0.225 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -54.91 101.89 0.06 Allowed 'General case' 0 C--N 1.364 1.22 0 C-N-CA 124.435 1.094 . . . . 0.0 110.887 -178.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 p -77.36 139.22 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.526 0.731 . . . . 0.0 110.905 -174.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.4 m -75.46 110.34 9.75 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.497 0.719 . . . . 0.0 109.978 177.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.49 HD13 HD22 ' A' ' 99' ' ' LEU . 85.8 mt -83.31 106.07 14.78 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.414 ' HB ' HG22 ' A' ' 48' ' ' VAL . 59.7 t -94.31 124.76 46.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 124.216 1.006 . . . . 0.0 110.164 -170.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.548 ' HB2' ' HB2' ' A' ' 30' ' ' ASP . 54.0 mtm180 -73.25 164.23 26.97 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.909 1.283 . . . . 0.0 110.521 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.5 tt -66.87 -42.61 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 118.203 0.456 . . . . 0.0 111.598 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.35 -29.45 68.18 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.763 177.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.548 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 23.3 t0 -59.28 -38.64 80.67 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.596 1.159 . . . . 0.0 110.944 -175.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.8 mp -57.46 -48.35 79.4 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 123.844 0.715 . . . . 0.0 110.727 173.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -67.92 -42.47 81.02 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.284 1.033 . . . . 0.0 111.479 -172.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -71.76 -40.35 69.37 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.374 0.67 . . . . 0.0 111.109 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -66.79 -33.39 75.52 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 176.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -64.52 -44.29 91.34 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.237 1.015 . . . . 0.0 111.029 175.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -64.59 -31.56 72.83 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.432 0.693 . . . . 0.0 110.521 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -66.93 -34.69 78.32 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.048 0.939 . . . . 0.0 110.846 176.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 128.19 25.43 1.08 Allowed Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.028 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -134.59 100.4 0.37 Allowed Glycine 0 C--N 1.344 0.997 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -178.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -75.1 107.57 7.27 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -170.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 25.7 m0 -103.22 131.71 50.05 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.742 0.817 . . . . 0.0 109.852 177.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -127.78 144.81 51.07 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.818 1.247 . . . . 0.0 109.106 177.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 p -96.28 112.35 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 120.976 0.417 . . . . 0.0 110.197 176.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.4 mt -122.26 118.62 55.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 123.81 0.844 . . . . 0.0 109.113 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.2 t70 62.57 32.84 16.26 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.832 1.253 . . . . 0.0 112.577 172.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.02 7.29 85.64 Favored Glycine 0 N--CA 1.477 1.408 0 CA-C-N 116.073 -0.512 . . . . 0.0 113.635 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.4 ' HB2' ' CE1' ' A' ' 49' ' ' TYR . 32.4 mmtp -117.87 161.78 19.19 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.269 1.027 . . . . 0.0 108.853 176.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.414 HG22 ' HB ' ' A' ' 26' ' ' VAL . 96.4 t -113.54 124.41 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 174.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.4 ' CE1' ' HB2' ' A' ' 47' ' ' LYS . 76.9 m-85 -117.79 156.25 28.65 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.34 1.056 . . . . 0.0 109.366 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -98.79 147.1 25.24 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 173.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.5 mm -109.46 -33.6 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.305 1.042 . . . . 0.0 111.402 -172.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.1 -29.29 62.82 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 118.566 0.621 . . . . 0.0 110.081 176.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -70.9 -39.15 72.95 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.118 0.967 . . . . 0.0 110.712 172.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -54.1 -54.51 38.51 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.935 0.894 . . . . 0.0 109.852 171.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -66.86 -28.55 68.43 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.952 0.901 . . . . 0.0 112.398 -173.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.4 m -58.25 -47.75 82.58 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.136 0.493 . . . . 0.0 110.195 171.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -77.31 -18.18 57.72 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.578 0.751 . . . . 0.0 111.523 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.483 ' HA ' ' HB2' ' A' ' 65' ' ' LEU . 25.9 t -75.6 -22.36 56.96 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.688 0.395 . . . . 0.0 111.031 177.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.8 mt -83.81 7.65 17.26 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.025 0.53 . . . . 0.0 110.986 172.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.405 ' HB ' ' HG ' ' A' ' 63' ' ' SER . 26.9 m -105.97 134.36 49.21 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.892 0.877 . . . . 0.0 109.657 177.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -75.26 -40.33 58.94 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.717 0.807 . . . . 0.0 112.715 -173.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -82.15 0.77 39.38 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.293 0.637 . . . . 0.0 111.944 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.405 ' HG ' ' HB ' ' A' ' 60' ' ' THR . 69.9 m -81.33 151.08 28.18 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 122.679 0.392 . . . . 0.0 109.996 170.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.524 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 24.5 pt -55.3 -30.61 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.577 0.751 . . . . 0.0 110.986 170.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.483 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 49.5 mt -73.88 -0.93 17.52 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.261 1.024 . . . . 0.0 113.049 -173.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.48 -41.26 96.58 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.649 0.78 . . . . 0.0 110.905 171.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.524 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 8.2 pt20 -76.65 -20.79 56.29 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.16 0.584 . . . . 0.0 110.937 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.451 ' HD2' ' HA ' ' A' ' 65' ' ' LEU . 75.5 m-85 -92.51 2.62 56.58 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.03 0.932 . . . . 0.0 111.33 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.39 111.83 4.88 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.153 0.581 . . . . 0.0 110.349 177.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.61 -29.33 7.93 Favored Glycine 0 N--CA 1.474 1.232 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 -175.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -79.92 151.62 30.01 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.618 0.767 . . . . 0.0 109.299 173.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.441 ' HB3' HG12 ' A' ' 75' ' ' VAL . 26.3 t70 -59.32 126.74 82.93 Favored Pre-proline 0 N--CA 1.483 1.182 0 CA-C-O 118.908 -0.568 . . . . 0.0 110.154 -178.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.07 -34.8 88.62 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 123.319 2.68 . . . . 0.0 114.11 -174.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.459 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 60.2 t -73.63 -49.66 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.182 -178.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.441 HG12 ' HB3' ' A' ' 72' ' ' ASP . 3.8 p -68.43 -28.59 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 122.791 0.436 . . . . 0.0 111.126 -177.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.06 -36.56 75.06 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.059 0.943 . . . . 0.0 109.767 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.648 ' HG ' ' SD ' ' A' ' 90' ' ' MET . 4.4 tt -71.81 -37.98 70.28 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.178 0.991 . . . . 0.0 110.029 176.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 44.3 mt-10 -64.34 -49.29 72.29 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.094 0.958 . . . . 0.0 110.87 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.03 -29.55 69.39 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.812 0.845 . . . . 0.0 111.019 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.62 -35.03 72.74 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.904 177.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.0 mt -63.34 -35.53 80.69 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.742 0.417 . . . . 0.0 110.771 175.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -67.07 -47.73 70.38 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.388 175.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.456 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 23.1 t80 -81.87 119.82 24.41 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 121.205 0.526 . . . . 0.0 110.936 -173.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -53.99 -34.21 59.21 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.785 1.634 . . . . 0.0 114.682 -171.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -79.87 -33.73 39.81 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.934 0.494 . . . . 0.0 111.735 -177.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.456 ' OG1' ' HB3' ' A' ' 83' ' ' PHE . 25.3 p -93.33 -13.53 28.02 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.393 0.677 . . . . 0.0 112.805 -173.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -73.82 -20.02 60.58 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 122.779 0.432 . . . . 0.0 110.385 178.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -63.74 -38.12 89.93 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.358 1.063 . . . . 0.0 111.314 -175.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.6 t -77.4 -31.4 54.11 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.009 0.524 . . . . 0.0 110.389 177.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.648 ' SD ' ' HG ' ' A' ' 77' ' ' LEU . 15.7 mmt -70.46 -21.84 62.75 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.221 0.608 . . . . 0.0 111.149 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -60.74 -35.6 76.78 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.656 0.782 . . . . 0.0 109.724 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.2 -38.57 42.99 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.615 0.766 . . . . 0.0 111.06 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.517 ' HD2' ' SD ' ' A' ' 90' ' ' MET . 29.8 m-85 -72.16 -14.39 61.8 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 122.761 0.425 . . . . 0.0 111.886 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 49.2 t -68.89 83.19 0.31 Allowed 'General case' 0 C--N 1.36 1.031 0 C-N-CA 123.397 0.679 . . . . 0.0 109.593 175.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.3 m -73.51 -16.39 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.12 0.968 . . . . 0.0 111.754 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.29 -175.58 41.16 Favored Glycine 0 C--N 1.343 0.972 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.146 174.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -119.1 134.42 55.21 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -76.37 143.02 40.97 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.213 0.605 . . . . 0.0 111.755 -171.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.49 HD22 HD13 ' A' ' 25' ' ' LEU . 54.8 tp -140.78 128.92 22.17 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.507 1.123 . . . . 0.0 108.243 176.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.643 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 46.9 mt-10 -91.89 140.84 24.96 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 123.732 0.813 . . . . 0.0 110.657 -178.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.81 -26.45 67.7 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 123.188 2.592 . . . . 0.0 112.434 173.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -78.97 -24.58 43.76 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.121 0.568 . . . . 0.0 110.485 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.643 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 47.3 tp60 -74.41 -6.81 50.38 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.674 0.79 . . . . 0.0 111.036 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -63.63 -23.82 67.54 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.23 0.612 . . . . 0.0 111.641 171.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -166.53 66.53 0.2 Allowed Glycine 0 C--N 1.349 1.286 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.9 p -85.05 140.86 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 122.981 0.512 . . . . 0.0 109.981 176.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.6 t -118.08 119.45 34.78 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.408 0.683 . . . . 0.0 109.648 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 55.4 mt -121.49 99.42 45.39 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 123.533 0.733 . . . . 0.0 109.144 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -59.93 147.55 92.28 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 123.271 2.647 . . . . 0.0 113.295 173.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -73.74 104.28 4.59 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.202 0.601 . . . . 0.0 109.87 174.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 83.5 mt -115.94 25.85 10.41 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.77 0.828 . . . . 0.0 109.447 176.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 1.541 0 CA-C-O 119.525 -0.597 . . . . 0.0 112.58 -177.68 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 N--CA 1.479 1.025 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.9 mmmm -74.28 98.95 3.33 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 172.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.8 p -67.27 132.01 32.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.6 m -64.87 112.77 3.43 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.269 0.628 . . . . 0.0 110.718 -176.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.5 mt -77.94 103.24 7.76 Favored 'General case' 0 C--N 1.347 0.466 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 174.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.46 ' HB ' HG23 ' A' ' 48' ' ' VAL . 44.6 t -98.47 139.16 21.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.052 0.941 . . . . 0.0 108.989 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.495 ' HD3' ' H ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -112.43 162.05 16.02 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.987 0.915 . . . . 0.0 109.31 178.743 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.5 tt -56.31 -38.1 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 C-N-CA 123.412 0.685 . . . . 0.0 111.93 -176.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.03 -37.47 79.89 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.543 0.737 . . . . 0.0 111.196 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -70.93 -34.67 71.72 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.105 -178.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.458 HD22 HG22 ' A' ' 43' ' ' VAL . 8.3 mp -59.99 -46.65 88.77 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 122.665 0.386 . . . . 0.0 110.707 171.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -64.27 -42.76 96.31 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.296 1.038 . . . . 0.0 112.224 -173.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -69.7 -41.22 75.7 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.95 177.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -66.96 -28.46 68.29 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.209 0.603 . . . . 0.0 110.95 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -65.11 -49.84 68.41 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.912 0.885 . . . . 0.0 110.049 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -75.08 -14.94 60.63 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.599 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -68.33 -34.31 75.88 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.555 0.742 . . . . 0.0 110.184 170.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 119.95 36.68 0.81 Allowed Glycine 0 C--N 1.348 1.226 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.27 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.53 107.66 0.36 Allowed Glycine 0 C--N 1.342 0.909 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -75.05 125.01 28.02 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -174.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 9.5 m0 -115.72 151.83 34.36 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.216 1.006 . . . . 0.0 110.183 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.6 t -143.13 164.69 29.45 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.559 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.491 HG23 HG22 ' A' ' 48' ' ' VAL . 72.1 t -116.82 111.43 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 176.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.447 HG13 ' HG ' ' A' ' 77' ' ' LEU . 14.8 mm -108.49 103.79 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 175.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.2 t70 60.21 41.81 16.21 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 124.472 1.109 . . . . 0.0 112.298 171.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.63 12.31 75.41 Favored Glycine 0 N--CA 1.475 1.28 0 CA-C-N 116.09 -0.505 . . . . 0.0 113.87 175.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -124.2 144.2 50.08 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.853 0.861 . . . . 0.0 108.84 172.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.491 HG22 HG23 ' A' ' 43' ' ' VAL . 45.0 t -99.09 137.23 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 122.967 0.507 . . . . 0.0 109.761 178.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -127.74 154.95 44.76 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.532 1.133 . . . . 0.0 110.327 -175.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -96.52 101.68 13.34 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.7 mm -64.09 -33.09 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 124.1 0.96 . . . . 0.0 111.901 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -64.19 -43.66 94.41 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 24.6 t70 -66.94 -40.05 87.48 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.86 0.864 . . . . 0.0 110.211 177.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -55.85 -55.24 34.8 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.809 1.244 . . . . 0.0 111.613 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -69.82 -26.2 64.13 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.506 0.722 . . . . 0.0 111.23 -177.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.7 m -62.87 -41.82 99.52 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 122.717 0.407 . . . . 0.0 111.023 171.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 31.0 mm-40 -70.22 -26.8 64.03 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.133 0.573 . . . . 0.0 110.76 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.3 t -77.86 10.64 2.65 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.961 0.904 . . . . 0.0 111.501 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 45.2 tp -67.59 -39.65 84.8 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.273 0.629 . . . . 0.0 110.779 171.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.2 t -99.7 146.98 25.9 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.158 0.583 . . . . 0.0 111.829 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.38 -19.41 53.4 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.764 175.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -63.73 -28.05 69.62 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 123.435 0.694 . . . . 0.0 110.182 175.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.3 t -66.96 152.24 46.12 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.462 0.705 . . . . 0.0 110.46 175.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.535 ' HB ' HG22 ' A' ' 86' ' ' THR . 26.4 pt -63.24 -17.76 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.475 1.11 . . . . 0.0 111.612 172.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.445 HD21 ' HE2' ' A' ' 90' ' ' MET . 50.9 mt -85.19 9.58 14.67 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.64 1.176 . . . . 0.0 111.657 -178.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.57 -40.51 97.16 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.117 0.967 . . . . 0.0 111.24 174.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -73.77 -13.61 60.98 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.323 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.549 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 28.7 m-85 -110.13 4.91 21.56 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.567 1.147 . . . . 0.0 111.888 -176.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.74 -36.83 85.56 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.765 0.826 . . . . 0.0 112.589 -172.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -101.16 6.7 56.43 Favored Glycine 0 N--CA 1.479 1.53 0 CA-C-N 116.405 -0.361 . . . . 0.0 113.027 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -98.52 152.54 19.45 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.336 1.054 . . . . 0.0 109.065 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -54.12 124.88 47.61 Favored Pre-proline 0 N--CA 1.48 1.038 0 CA-C-O 118.354 -0.831 . . . . 0.0 109.08 172.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -57.5 -31.03 90.34 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.136 2.557 . . . . 0.0 114.03 -170.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 67.5 t -74.43 -48.55 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 122.868 0.467 . . . . 0.0 110.211 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.71 -38.15 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 123.504 0.722 . . . . 0.0 110.564 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.549 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -63.14 -40.89 98.89 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 114.074 -1.421 . . . . 0.0 110.944 177.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.447 ' HG ' HG13 ' A' ' 44' ' ' ILE . 37.1 tp -71.38 -36.82 71.56 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.027 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 82' ' ' GLN . 48.4 mt-10 -60.92 -47.07 88.1 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.866 0.466 . . . . 0.0 110.085 174.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.19 -32.11 73.63 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.843 0.857 . . . . 0.0 111.046 177.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.49 -28.57 64.01 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.477 0.711 . . . . 0.0 111.752 178.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.534 ' HA ' ' HB3' ' A' ' 87' ' ' ARG . 3.8 mm? -75.26 -28.34 59.79 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.267 0.227 . . . . 0.0 111.008 173.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 71.5 mt-30 -78.24 -41.22 34.86 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.979 0.512 . . . . 0.0 110.579 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -79.71 123.36 27.6 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -59.91 -41.35 91.49 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.044 0.937 . . . . 0.0 113.135 -169.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -68.18 -36.31 79.4 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.893 0.477 . . . . 0.0 111.572 -175.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.535 HG22 ' HB ' ' A' ' 64' ' ' ILE . 12.8 p -81.64 -30.46 32.79 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.133 -175.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.534 ' HB3' ' HA ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -74.96 -12.66 60.39 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -67.2 -35.88 80.56 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.237 0.615 . . . . 0.0 110.319 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.8 t -77.86 -29.91 50.63 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.428 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.445 ' HE2' HD21 ' A' ' 65' ' ' LEU . 14.9 mmt -70.95 -9.7 58.36 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.628 0.771 . . . . 0.0 112.104 -177.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -62.07 -30.92 71.32 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.936 0.894 . . . . 0.0 110.662 171.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.17 -35.98 25.07 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.463 0.705 . . . . 0.0 111.466 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -75.03 -23.16 58.13 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.245 0.618 . . . . 0.0 111.762 -173.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 25.9 p -71.48 99.44 2.02 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.4 m -69.47 -30.06 44.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 123.902 0.881 . . . . 0.0 111.502 -177.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.14 179.94 44.23 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.005 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -91.03 136.47 33.05 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.55 0.74 . . . . 0.0 109.094 176.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -82.45 142.84 31.58 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 174.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.0 tt -136.27 112.81 10.03 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 170.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.549 ' HB3' ' HB2' ' A' ' 103' ' ' GLN . 26.0 tt0 -72.65 141.96 83.11 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.571 0.748 . . . . 0.0 109.96 -177.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -42.21 -60.86 0.61 Allowed 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 123.598 2.865 . . . . 0.0 114.113 176.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -81.88 -8.18 59.66 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.822 0.849 . . . . 0.0 112.377 -172.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.549 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 54.4 tp60 -54.81 -34.8 63.2 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.845 0.858 . . . . 0.0 110.898 175.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.48 -27.05 68.21 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.854 -178.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.5 -88.83 0.34 Allowed Glycine 0 C--N 1.345 1.035 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 175.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.7 p -149.72 123.08 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 123.514 0.726 . . . . 0.0 109.432 172.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.4 t -84.1 121.54 27.57 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 175.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.8 mm -95.29 113.93 62.69 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.362 0.665 . . . . 0.0 109.556 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.52 170.16 13.25 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 123.067 2.511 . . . . 0.0 112.296 175.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -109.81 106.96 16.77 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.222 1.009 . . . . 0.0 109.963 -175.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.7 mp -89.35 -63.32 1.31 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.858 0.863 . . . . 0.0 109.782 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.904 0 CA-C-O 118.918 -0.935 . . . . 0.0 112.286 179.69 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.248 0.071 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.43 143.39 38.63 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 122.615 0.366 . . . . 0.0 110.191 176.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.6 p -84.01 116.15 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 CA-C-O 121.176 0.512 . . . . 0.0 110.155 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.5 m -82.7 110.11 17.46 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 175.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.478 HD13 HD21 ' A' ' 99' ' ' LEU . 92.6 mt -86.93 111.95 21.32 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.512 -178.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.491 ' HB ' HG22 ' A' ' 48' ' ' VAL . 48.4 t -94.72 125.82 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 174.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -92.32 167.62 11.88 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.29 0.636 . . . . 0.0 111.123 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.0 tt -67.65 -34.2 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.194 -177.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.95 -33.5 71.99 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.41 0.684 . . . . 0.0 110.589 177.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.08 -44.43 63.29 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.144 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.1 mt -57.35 -52.8 63.89 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.883 0.873 . . . . 0.0 112.03 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -63.89 -48.94 74.67 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.901 0.88 . . . . 0.0 111.789 -173.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -63.53 -34.32 77.53 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.062 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 50.7 t60 -73.4 -34.6 65.59 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.312 0.645 . . . . 0.0 110.721 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -60.64 -40.5 92.23 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.207 1.003 . . . . 0.0 110.107 176.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -69.7 -26.43 64.35 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.117 0.967 . . . . 0.0 111.409 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -70.14 -19.91 63.19 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.004 0.522 . . . . 0.0 111.518 174.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 114.88 -21.47 13.65 Favored Glycine 0 C--N 1.341 0.83 0 N-CA-C 111.796 -0.521 . . . . 0.0 111.796 -175.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.496 ' HA2' ' HG2' ' A' ' 52' ' ' LYS . . . -73.65 92.23 0.69 Allowed Glycine 0 C--N 1.345 1.048 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -78.33 110.95 13.82 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 38.9 m0 -105.23 174.09 6.03 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.198 0.999 . . . . 0.0 109.399 170.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.4 t -151.13 162.92 39.96 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.811 0.844 . . . . 0.0 108.862 172.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.494 HG21 HG21 ' A' ' 48' ' ' VAL . 73.8 t -119.79 113.52 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.296 0.638 . . . . 0.0 109.338 175.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.542 HD11 HD23 ' A' ' 77' ' ' LEU . 51.3 mt -135.79 133.48 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 176.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.1 t70 63.07 30.33 16.21 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 125.048 1.339 . . . . 0.0 110.477 -175.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.13 26.49 67.64 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.729 -175.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.438 ' HB2' ' CE2' ' A' ' 49' ' ' TYR . 44.3 mmtm -121.16 134.1 55.21 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.681 0.792 . . . . 0.0 108.891 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.494 HG21 HG21 ' A' ' 43' ' ' VAL . 93.1 t -84.66 111.15 19.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 174.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' A' ' 47' ' ' LYS . 85.0 m-85 -108.46 150.17 27.78 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.674 0.79 . . . . 0.0 110.351 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -88.12 138.98 30.97 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.836 175.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.483 HD11 HD21 ' A' ' 77' ' ' LEU . 33.6 mm -116.32 -40.18 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.552 0.741 . . . . 0.0 111.513 -174.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.496 ' HG2' ' HA2' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -69.25 -32.33 71.47 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.299 0.24 . . . . 0.0 111.02 -179.245 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.427 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 33.6 t70 -76.03 -37.85 57.9 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.252 0.621 . . . . 0.0 110.687 172.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -55.34 -48.48 74.14 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.18 0.992 . . . . 0.0 111.527 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -69.83 -27.25 64.71 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.794 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.3 m -66.74 -38.19 86.16 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.95 0.5 . . . . 0.0 110.04 172.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.478 ' HB2' HD12 ' A' ' 65' ' ' LEU . 52.7 mm-40 -76.49 -15.3 59.93 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.09 0.556 . . . . 0.0 110.892 176.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.5 t -90.67 -9.9 45.15 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.008 0.923 . . . . 0.0 111.199 175.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.4 tp -83.05 -5.87 59.27 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.843 0.857 . . . . 0.0 111.489 -178.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.0 t -119.54 152.67 36.6 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.611 0.764 . . . . 0.0 110.848 -174.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -73.89 -51.09 17.31 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.69 1.196 . . . . 0.0 111.362 -174.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -78.21 72.47 4.74 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.592 0.71 . . . . 0.0 109.589 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.2 m -163.16 147.59 11.17 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.884 1.273 . . . . 0.0 108.726 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.602 ' HB ' HG22 ' A' ' 86' ' ' THR . 33.2 pt -67.26 -19.91 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 124.274 1.03 . . . . 0.0 111.558 175.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.478 HD12 ' HB2' ' A' ' 57' ' ' GLN . 65.6 mt -92.53 7.99 40.81 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.001 0.92 . . . . 0.0 111.669 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.51 -23.52 64.55 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.562 0.345 . . . . 0.0 110.772 175.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -75.52 -11.87 60.11 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.606 0.763 . . . . 0.0 111.408 172.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -112.97 20.88 15.98 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.024 0.93 . . . . 0.0 110.953 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.36 -26.03 68.57 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.675 0.79 . . . . 0.0 112.752 -174.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -111.87 5.27 27.45 Favored Glycine 0 N--CA 1.478 1.481 0 C-N-CA 122.753 0.216 . . . . 0.0 113.137 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -96.03 151.07 19.79 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.075 0.95 . . . . 0.0 109.961 -177.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -63.39 127.1 90.73 Favored Pre-proline 0 N--CA 1.48 1.051 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 171.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.415 ' HB2' HG22 ' A' ' 51' ' ' ILE . 18.7 Cg_endo -56.68 -34.0 94.92 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.501 2.801 . . . . 0.0 114.729 -174.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.2 t -75.05 -39.35 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 121.052 0.453 . . . . 0.0 110.445 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.1 t -68.16 -40.76 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.309 0.644 . . . . 0.0 110.017 177.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.5 -33.06 75.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.065 1.346 . . . . 0.0 111.208 176.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.542 HD23 HD11 ' A' ' 44' ' ' ILE . 34.0 tp -59.69 -51.89 67.84 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 124.164 0.915 . . . . 0.0 111.185 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -63.06 -39.67 95.42 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.056 0.543 . . . . 0.0 111.655 -178.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.93 -42.64 99.87 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.555 177.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.6 -17.69 50.57 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.99 0.916 . . . . 0.0 112.176 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.1 mp -70.51 -45.4 65.67 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.922 0.889 . . . . 0.0 109.004 171.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -75.33 -27.98 59.45 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.781 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.404 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 3.0 t80 -81.81 114.28 20.33 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -64.99 -26.46 68.3 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.098 0.959 . . . . 0.0 112.653 -172.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -65.94 -41.97 90.65 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.387 0.675 . . . . 0.0 110.676 177.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.602 HG22 ' HB ' ' A' ' 64' ' ' ILE . 20.1 p -95.86 -18.87 20.02 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.004 0.921 . . . . 0.0 113.152 -171.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -63.33 -21.18 66.11 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -176.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.4 ' HG3' ' N ' ' A' ' 89' ' ' SER . 4.5 pt-20 -54.27 -48.4 71.25 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.898 0.879 . . . . 0.0 111.682 177.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.4 ' N ' ' HG3' ' A' ' 88' ' ' GLU . 14.4 t -73.6 -15.69 61.26 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.671 0.788 . . . . 0.0 111.785 -172.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 24.7 mmt -64.4 -17.63 63.94 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.736 0.815 . . . . 0.0 112.211 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -61.06 -29.33 69.67 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.211 0.605 . . . . 0.0 110.894 174.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.64 -32.39 19.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.101 0.96 . . . . 0.0 111.413 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -79.93 -26.06 40.26 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.599 0.36 . . . . 0.0 110.936 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 28.6 p -79.76 103.25 9.53 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.29 -35.75 72.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 124.372 1.069 . . . . 0.0 110.21 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 174.31 -170.57 43.7 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.293 176.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -89.67 135.96 33.31 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -78.9 128.58 33.51 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.272 0.629 . . . . 0.0 110.774 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.478 HD21 HD13 ' A' ' 25' ' ' LEU . 64.0 tp -105.32 117.1 33.15 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 166.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -73.48 133.1 80.65 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 173.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.52 -42.76 64.7 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.271 2.648 . . . . 0.0 113.632 -174.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -87.76 -7.7 56.98 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.71 0.404 . . . . 0.0 111.252 -176.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -76.5 -20.53 56.86 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.65 0.78 . . . . 0.0 110.728 174.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -51.02 -53.94 29.04 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.826 1.25 . . . . 0.0 111.184 -173.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -67.84 -87.76 0.08 OUTLIER Glycine 0 C--N 1.345 1.074 0 O-C-N 123.79 0.681 . . . . 0.0 112.967 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.5 p -161.56 132.51 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 123.338 0.655 . . . . 0.0 110.286 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.9 t -104.27 97.66 7.57 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 174.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.8 mt -71.26 124.6 91.24 Favored Pre-proline 0 CA--C 1.555 1.148 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.45 168.39 24.92 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.654 2.236 . . . . 0.0 112.037 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -75.98 71.72 2.79 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.408 0.683 . . . . 0.0 109.821 175.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -68.48 -31.85 71.43 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.298 -171.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.192 0 CA-C-O 119.203 -0.776 . . . . 0.0 111.862 -178.607 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.7 m . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.42 HD22 ' HB2' ' A' ' 99' ' ' LEU . 92.4 mt -98.47 108.83 21.62 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.092 0.557 . . . . 0.0 110.209 -177.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.9 t -94.38 132.84 37.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.493 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -102.24 171.18 7.63 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.499 0.72 . . . . 0.0 109.593 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.474 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 13.0 tt -60.72 -34.09 57.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.848 174.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.42 -49.79 76.02 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.352 0.661 . . . . 0.0 110.743 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.11 -42.98 95.89 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.626 0.77 . . . . 0.0 110.879 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 46.9 tp -58.24 -45.82 87.08 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.333 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 17.0 mm-40 -72.68 -52.97 13.05 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.541 0.736 . . . . 0.0 112.397 -177.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -71.16 -29.87 65.74 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -172.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -73.47 -27.46 61.41 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 120.553 0.216 . . . . 0.0 110.5 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -61.3 -39.31 89.99 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 120.961 0.41 . . . . 0.0 110.205 172.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -68.57 -32.3 72.11 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.534 0.733 . . . . 0.0 110.78 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -65.77 -19.52 65.92 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.897 0.879 . . . . 0.0 111.41 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.74 4.09 26.53 Favored Glycine 0 N--CA 1.475 1.234 0 CA-C-N 116.695 -0.23 . . . . 0.0 112.764 176.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -111.93 95.86 0.83 Allowed Glycine 0 C--N 1.34 0.776 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.415 ' H ' ' HB2' ' A' ' 52' ' ' LYS . 89.7 t80 -75.8 116.6 16.67 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -104.66 -179.76 4.04 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.275 1.03 . . . . 0.0 109.961 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.4 t -155.83 159.15 39.14 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.698 0.799 . . . . 0.0 109.211 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 98.4 t -107.99 111.57 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 123.572 0.749 . . . . 0.0 109.258 177.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.729 HD12 HD23 ' A' ' 77' ' ' LEU . 48.8 mt -140.6 135.48 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.275 1.03 . . . . 0.0 108.631 175.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 63.59 32.31 14.1 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.675 1.19 . . . . 0.0 111.062 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.44 20.78 70.0 Favored Glycine 0 C--N 1.352 1.457 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.927 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.516 ' HD3' ' HA ' ' A' ' 97' ' ' GLN . 32.8 mmtp -128.59 162.98 26.02 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.792 1.237 . . . . 0.0 109.23 -177.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 90.9 t -119.28 119.28 60.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 123.629 0.772 . . . . 0.0 109.037 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -112.27 148.15 34.77 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.526 0.73 . . . . 0.0 109.909 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -86.56 100.7 12.6 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.518 HD11 HD22 ' A' ' 77' ' ' LEU . 31.5 mm -76.45 -29.64 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.418 0.687 . . . . 0.0 111.689 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.415 ' HB2' ' H ' ' A' ' 40' ' ' PHE . 1.7 tmmm? -61.55 -47.7 84.34 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.472 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 27.5 t70 -73.97 -36.07 64.54 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.521 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -52.55 -53.31 48.09 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.958 0.903 . . . . 0.0 111.154 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.487 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 20.2 pt20 -67.36 -28.53 68.03 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.233 -177.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.8 m -64.01 -40.38 96.22 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.042 0.449 . . . . 0.0 110.407 175.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.607 ' HB2' HD12 ' A' ' 65' ' ' LEU . 51.9 mm-40 -72.46 -32.35 66.17 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.315 0.646 . . . . 0.0 109.974 177.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.5 t -68.09 -27.32 66.38 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.726 0.81 . . . . 0.0 111.283 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 55' ' ' GLN . 96.9 mt -80.75 -15.42 56.52 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.448 0.699 . . . . 0.0 111.597 175.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 45.1 m -90.16 124.68 35.04 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.207 0.603 . . . . 0.0 110.321 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -64.29 147.96 51.31 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.936 0.894 . . . . 0.0 110.284 175.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 75.45 -3.56 2.56 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.367 1.467 . . . . 0.0 112.854 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.0 m -81.06 149.85 29.06 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 172.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.645 ' HB ' HG22 ' A' ' 86' ' ' THR . 42.9 pt -61.97 -20.04 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.58 0.752 . . . . 0.0 112.478 -178.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.607 HD12 ' HB2' ' A' ' 57' ' ' GLN . 60.0 mt -95.05 -8.68 35.98 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.575 0.75 . . . . 0.0 111.725 -176.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.87 -25.76 65.68 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.272 0.629 . . . . 0.0 111.549 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -75.73 -20.53 58.27 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.806 0.842 . . . . 0.0 111.042 173.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.423 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 52.4 m-85 -102.89 12.82 35.65 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.275 1.03 . . . . 0.0 110.987 178.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.62 -26.16 64.3 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.329 0.651 . . . . 0.0 112.534 -175.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.53 -3.87 90.53 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-N 116.472 -0.331 . . . . 0.0 112.639 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -108.08 150.55 27.04 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.176 0.99 . . . . 0.0 110.136 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -55.98 124.72 60.18 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 123.723 0.809 . . . . 0.0 110.52 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -51.13 -33.51 44.05 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 123.549 2.832 . . . . 0.0 115.145 -173.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.2 t -70.79 -38.87 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.111 0.564 . . . . 0.0 110.49 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.5 t -74.13 -40.11 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.894 0.877 . . . . 0.0 110.062 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.423 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -65.49 -29.3 69.93 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.832 1.253 . . . . 0.0 110.896 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.729 HD23 HD12 ' A' ' 44' ' ' ILE . 48.4 tp -63.98 -41.75 97.44 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.925 0.89 . . . . 0.0 110.536 174.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -65.65 -40.8 92.87 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.631 0.772 . . . . 0.0 110.998 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.43 -31.95 73.03 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.782 0.833 . . . . 0.0 110.688 175.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.14 -33.49 61.53 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.468 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.492 HD23 ' HG3' ' A' ' 90' ' ' MET . 95.6 mt -67.74 -40.12 84.2 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.156 0.582 . . . . 0.0 109.857 174.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -66.4 -41.5 89.24 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.858 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.444 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 9.8 t80 -87.5 127.7 35.24 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 120.982 0.42 . . . . 0.0 110.606 -175.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.81 -32.28 72.57 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.885 1.274 . . . . 0.0 113.63 -170.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -68.69 -51.4 42.1 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.154 0.502 . . . . 0.0 109.864 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.645 HG22 ' HB ' ' A' ' 64' ' ' ILE . 27.7 p -78.71 -16.78 56.83 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.197 -0.91 . . . . 0.0 113.149 -168.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.4 ptt85 -74.96 -11.42 60.11 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -75.34 -38.08 60.35 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.056 0.942 . . . . 0.0 111.256 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.407 ' HB3' HD11 ' A' ' 64' ' ' ILE . 24.2 t -77.64 -18.73 56.45 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.912 0.485 . . . . 0.0 110.743 175.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.592 ' SD ' HD12 ' A' ' 77' ' ' LEU . 37.4 mmt -65.01 -24.18 67.43 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.566 0.346 . . . . 0.0 110.887 176.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.468 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 86.2 m-70 -64.43 -26.57 68.51 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.841 0.856 . . . . 0.0 111.62 173.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.44 -35.95 46.17 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.476 0.71 . . . . 0.0 110.834 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -83.7 -24.37 31.29 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.477 0.311 . . . . 0.0 111.606 -176.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.468 ' SG ' ' HA ' ' A' ' 91' ' ' HIS . 29.5 p -72.05 101.32 2.71 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.001 0.429 . . . . 0.0 109.882 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.6 t -68.83 -37.71 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.056 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.02 -171.67 44.17 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.551 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.516 ' HA ' ' HD3' ' A' ' 47' ' ' LYS . 29.0 tt0 -88.78 135.68 33.39 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.909 0.884 . . . . 0.0 109.81 176.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -83.86 136.29 34.17 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.42 ' HB2' HD22 ' A' ' 25' ' ' LEU . 2.9 tt -139.7 122.88 16.91 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 173.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 46.7 mt-10 -70.74 145.05 91.73 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 123.973 0.909 . . . . 0.0 111.974 -176.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.5 -47.61 23.87 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 123.306 2.671 . . . . 0.0 112.303 173.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -67.61 -38.47 83.98 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.212 1.005 . . . . 0.0 111.846 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.468 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 26.4 tp60 . . . . . 0 N--CA 1.48 1.074 0 C-N-CA 124.032 0.933 . . . . 0.0 112.864 -168.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.9 m . . . . . 0 CA--C 1.544 0.72 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 89.4 mt -92.87 105.75 17.82 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.906 0.882 . . . . 0.0 109.634 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.6 t -93.93 126.21 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.37 1.068 . . . . 0.0 108.675 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -93.5 170.26 9.73 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.022 0.529 . . . . 0.0 110.792 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.7 tt -57.8 -36.61 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.19 0.996 . . . . 0.0 112.444 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.99 -40.0 95.4 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.378 0.671 . . . . 0.0 111.315 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.29 -34.75 77.19 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.235 1.014 . . . . 0.0 111.689 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.5 mt -58.75 -47.28 85.19 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.919 0.762 . . . . 0.0 110.01 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -71.62 -39.09 70.69 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.835 -174.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -62.22 -47.05 86.12 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.017 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -68.17 -35.39 77.96 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.333 0.653 . . . . 0.0 110.826 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 56.1 t30 -60.54 -42.97 97.62 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.267 178.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -78.16 -23.02 47.84 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.743 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -72.86 -36.59 67.43 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.903 0.881 . . . . 0.0 111.864 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 139.85 33.14 0.16 Allowed Glycine 0 N--CA 1.48 1.604 0 CA-C-N 116.968 -0.106 . . . . 0.0 113.121 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 35' ' ' ASN . . . -150.61 -178.31 25.35 Favored Glycine 0 C--N 1.343 0.948 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -134.59 110.23 9.18 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 117.582 0.691 . . . . 0.0 109.525 175.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 17.9 m0 -98.13 144.3 27.76 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.145 0.578 . . . . 0.0 110.508 174.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -136.87 141.84 42.79 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.192 0.997 . . . . 0.0 108.885 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.1 t -96.46 110.79 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 175.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 77.6 mt -131.24 130.22 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.1 t70 62.47 30.96 17.27 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 124.629 1.172 . . . . 0.0 111.617 175.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.55 12.83 77.71 Favored Glycine 0 N--CA 1.479 1.532 0 CA-C-N 116.198 -0.455 . . . . 0.0 113.378 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -119.14 160.33 22.32 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.724 1.21 . . . . 0.0 108.974 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.1 t -111.81 116.76 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.124 0.57 . . . . 0.0 109.525 176.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.435 ' HB2' HD21 ' A' ' 77' ' ' LEU . 49.8 m-85 -112.32 152.73 28.21 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.967 0.907 . . . . 0.0 109.352 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -100.88 107.25 18.72 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.571 0.348 . . . . 0.0 110.439 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.4 mm -60.31 -36.24 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 124.806 1.242 . . . . 0.0 111.724 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.44 ' HG3' ' HA2' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -58.49 -47.3 84.53 Favored 'General case' 0 CA--C 1.553 1.065 0 O-C-N 123.944 0.777 . . . . 0.0 109.184 -178.048 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 39.1 t70 -74.46 -34.41 63.14 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.706 0.402 . . . . 0.0 110.797 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -52.98 -55.97 19.51 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.928 0.891 . . . . 0.0 111.002 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -67.64 -28.24 67.55 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.413 0.685 . . . . 0.0 111.277 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.5 m -67.69 -37.44 82.3 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 123.505 0.722 . . . . 0.0 110.876 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 30.9 mm-40 -77.45 -28.07 52.3 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.437 0.695 . . . . 0.0 110.704 177.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.2 t -74.36 -3.63 31.51 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.732 0.813 . . . . 0.0 111.576 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.4 tt -63.2 -38.28 90.54 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.29 1.036 . . . . 0.0 110.129 172.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.6 m -76.81 135.33 38.93 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.495 0.718 . . . . 0.0 111.026 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -73.39 -35.23 65.86 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.997 0.919 . . . . 0.0 110.391 -178.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -87.78 60.41 5.91 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.526 0.679 . . . . 0.0 109.536 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.6 t -133.0 155.12 49.75 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.796 0.838 . . . . 0.0 109.419 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.567 ' HB ' HG22 ' A' ' 86' ' ' THR . 27.3 pt -75.3 -10.71 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.587 0.755 . . . . 0.0 110.614 173.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.9 mt -93.46 -8.86 40.36 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.916 0.886 . . . . 0.0 110.734 176.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.07 -26.19 64.83 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.745 0.818 . . . . 0.0 111.46 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -74.65 -13.48 60.64 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.455 0.702 . . . . 0.0 110.963 174.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.527 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 67.6 m-85 -115.55 12.25 16.1 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.684 1.194 . . . . 0.0 110.963 177.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.73 -28.52 69.11 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.522 0.729 . . . . 0.0 112.109 -175.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.24 27.42 15.22 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.738 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -132.89 155.0 49.84 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.983 0.913 . . . . 0.0 109.499 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -54.39 129.05 60.8 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 124.305 1.042 . . . . 0.0 109.459 172.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.1 -35.32 90.25 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 123.433 2.755 . . . . 0.0 114.461 -172.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.0 t -74.66 -48.92 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 122.638 0.375 . . . . 0.0 110.441 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.0 t -63.08 -33.86 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.715 0.806 . . . . 0.0 110.713 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -64.71 -44.5 90.02 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.464 176.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.435 HD21 ' HB2' ' A' ' 49' ' ' TYR . 56.8 tp -66.89 -43.12 84.25 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.839 0.855 . . . . 0.0 111.306 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -58.89 -52.15 66.98 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.313 0.645 . . . . 0.0 110.259 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.14 -34.67 76.81 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.716 0.806 . . . . 0.0 111.229 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.99 -24.04 61.52 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.716 0.807 . . . . 0.0 112.291 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 81' ' ' LEU . 2.0 mm? -70.81 -42.1 70.73 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 172.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -73.22 -28.34 62.11 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.049 0.54 . . . . 0.0 111.053 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -85.51 117.67 24.56 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -66.08 -27.56 68.17 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.908 0.883 . . . . 0.0 113.175 -169.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -76.16 -22.01 55.9 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.383 0.673 . . . . 0.0 112.423 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.567 HG22 ' HB ' ' A' ' 64' ' ' ILE . 19.1 p -109.28 -20.99 12.75 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -174.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.499 ' HA ' ' HG2' ' A' ' 90' ' ' MET . 40.3 ptt180 -67.66 -13.57 62.21 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -55.48 -49.58 72.17 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.414 1.086 . . . . 0.0 112.339 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.9 t -77.4 -15.72 59.21 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.932 0.493 . . . . 0.0 111.033 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.499 ' HG2' ' HA ' ' A' ' 87' ' ' ARG . 12.7 mmt -69.03 -16.81 63.8 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.828 0.451 . . . . 0.0 111.243 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -62.24 -39.72 93.78 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.941 0.496 . . . . 0.0 109.798 169.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.89 -37.13 62.2 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.75 0.82 . . . . 0.0 111.065 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.488 ' HD2' ' SD ' ' A' ' 90' ' ' MET . 45.9 m-85 -71.37 -23.93 61.99 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.012 0.525 . . . . 0.0 111.221 177.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 46.1 t -72.17 99.85 2.43 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.0 m -71.15 -26.32 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 123.408 0.683 . . . . 0.0 110.251 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 175.42 175.11 42.58 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.319 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -85.18 136.66 33.43 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 177.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -76.83 132.44 39.19 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.46 126.15 32.35 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 170.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 42.2 mt-10 -70.34 136.08 86.56 Favored Pre-proline 0 C--O 1.246 0.898 0 O-C-N 123.851 0.72 . . . . 0.0 110.3 177.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -59.27 -22.05 63.26 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.765 2.31 . . . . 0.0 112.609 175.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -86.61 -38.83 16.71 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.824 1.25 . . . . 0.0 111.224 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.522 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 8.5 tp-100 . . . . . 0 N--CA 1.492 1.631 0 C-N-CA 124.33 1.052 . . . . 0.0 111.586 -176.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 77.7 m . . . . . 0 CA--C 1.538 0.502 0 CA-C-O 121.247 0.546 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.436 HD13 HD13 ' A' ' 99' ' ' LEU . 72.2 mt -85.64 106.55 17.01 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.215 -177.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.456 HG21 HG23 ' A' ' 95' ' ' VAL . 46.2 t -102.16 128.99 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.183 0.993 . . . . 0.0 109.043 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -101.98 170.28 8.23 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.379 0.672 . . . . 0.0 110.073 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.432 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 18.6 tt -67.96 -32.15 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.348 0.659 . . . . 0.0 111.98 -173.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.64 -35.58 72.73 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.199 0.6 . . . . 0.0 111.453 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -68.27 -42.26 79.83 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.788 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.4 mt -55.24 -40.64 71.13 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.785 0.834 . . . . 0.0 111.422 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 7.0 mm-40 -65.89 -41.6 91.33 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.444 -178.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -59.29 -50.62 73.29 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.569 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -64.41 -34.64 78.66 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.173 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -59.21 -39.16 81.79 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.07 0.548 . . . . 0.0 110.416 174.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -75.96 -19.49 58.69 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.017 0.927 . . . . 0.0 111.886 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -84.3 -20.16 32.58 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 122.665 0.386 . . . . 0.0 110.823 170.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.99 -13.48 52.66 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-N 116.456 -0.338 . . . . 0.0 112.414 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.413 ' HA2' ' HD3' ' A' ' 52' ' ' LYS . . . -76.72 88.59 0.95 Allowed Glycine 0 C--N 1.35 1.309 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 176.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -75.63 111.1 10.61 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -173.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 39.5 m0 -99.77 177.73 5.04 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.941 0.896 . . . . 0.0 110.066 175.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.9 t -157.6 151.27 23.99 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.71 0.804 . . . . 0.0 109.869 -178.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 p -103.0 112.12 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 171.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.5 mt -124.18 116.96 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.359 1.064 . . . . 0.0 109.223 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.3 t70 53.31 53.63 11.47 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.27 1.428 . . . . 0.0 111.834 175.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.55 -0.46 55.61 Favored Glycine 0 N--CA 1.475 1.273 0 N-CA-C 114.815 0.686 . . . . 0.0 114.815 176.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.401 ' HB2' ' CE1' ' A' ' 49' ' ' TYR . 44.9 mmtm -112.59 167.83 10.15 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.131 0.972 . . . . 0.0 109.461 178.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 90.7 t -115.61 121.97 68.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 171.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.428 ' HB3' HD21 ' A' ' 77' ' ' LEU . 76.7 m-85 -115.3 170.62 8.25 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.831 1.253 . . . . 0.0 109.301 174.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -99.21 159.42 15.0 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.241 0.617 . . . . 0.0 109.835 171.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 35.1 mm -117.28 -29.21 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.359 1.064 . . . . 0.0 108.934 168.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.413 ' HD3' ' HA2' ' A' ' 39' ' ' GLY . 25.1 ttpt -53.89 -57.97 9.01 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.469 1.108 . . . . 0.0 111.965 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.449 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 27.4 t70 -74.39 -35.54 63.49 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.995 0.518 . . . . 0.0 110.121 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -51.09 -53.51 33.43 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.85 1.26 . . . . 0.0 111.775 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -67.62 -27.89 67.28 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.923 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.9 m -68.32 -42.15 79.79 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.932 174.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 77.7 mm-40 -68.56 -28.36 66.89 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 123.12 0.568 . . . . 0.0 110.519 178.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.0 t -72.71 -26.98 61.79 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.672 0.789 . . . . 0.0 110.996 175.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 47.5 tp -67.37 -27.29 66.99 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.876 0.87 . . . . 0.0 112.095 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.0 t -88.11 151.64 22.58 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.219 0.533 . . . . 0.0 111.478 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -79.05 155.46 28.79 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.434 1.093 . . . . 0.0 109.95 176.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 71.88 5.76 5.44 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.032 1.333 . . . . 0.0 112.095 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 37.7 t -74.81 155.33 37.7 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.386 0.674 . . . . 0.0 109.686 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.566 ' HB ' HG22 ' A' ' 86' ' ' THR . 47.5 pt -68.83 -19.76 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 122.788 0.435 . . . . 0.0 110.518 170.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 57' ' ' GLN . 63.4 mt -96.94 0.32 48.78 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.783 1.233 . . . . 0.0 111.613 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.02 -27.68 68.98 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 122.983 0.513 . . . . 0.0 110.944 176.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -82.16 -24.79 34.83 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.88 0.872 . . . . 0.0 111.372 173.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.587 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 54.8 m-85 -91.84 2.53 56.46 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.979 0.911 . . . . 0.0 112.066 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.97 -29.77 69.71 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.371 0.668 . . . . 0.0 111.092 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.31 26.85 9.3 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-N 116.017 -0.538 . . . . 0.0 113.114 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -141.47 152.32 44.11 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.326 1.05 . . . . 0.0 108.611 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -52.61 127.86 42.7 Favored Pre-proline 0 N--CA 1.478 0.94 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.871 174.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.08 -34.2 86.45 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 123.215 2.61 . . . . 0.0 114.476 -172.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.7 t -73.0 -48.56 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.1 t -62.53 -34.76 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.934 0.894 . . . . 0.0 110.78 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -71.41 -35.18 70.9 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.994 1.318 . . . . 0.0 110.876 -178.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.428 HD21 ' HB3' ' A' ' 49' ' ' TYR . 17.2 tp -73.36 -40.01 64.72 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.682 176.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -62.31 -36.48 82.28 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.193 0.597 . . . . 0.0 110.267 172.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.5 -32.72 68.55 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.112 0.965 . . . . 0.0 110.612 176.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.23 -43.6 86.15 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.562 0.745 . . . . 0.0 111.151 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.83 -30.64 69.23 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.514 0.326 . . . . 0.0 111.504 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -72.91 -27.72 62.04 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.027 0.531 . . . . 0.0 110.734 176.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -95.96 119.49 34.54 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.294 0.638 . . . . 0.0 110.046 -176.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -58.88 -27.99 65.72 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.514 1.125 . . . . 0.0 113.067 -175.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -79.64 -20.01 47.8 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.029 0.932 . . . . 0.0 112.248 -174.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.566 HG22 ' HB ' ' A' ' 64' ' ' ILE . 41.5 p -123.61 -12.2 7.7 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -173.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -68.58 -26.56 65.45 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.554 0.742 . . . . 0.0 111.195 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -60.07 -54.4 46.36 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.258 1.023 . . . . 0.0 110.481 -172.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.8 m -64.52 -20.0 65.94 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.907 0.883 . . . . 0.0 112.48 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 20.6 mmt -74.09 -4.02 33.01 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.301 0.641 . . . . 0.0 112.495 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.94 -21.4 65.1 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.765 0.426 . . . . 0.0 110.565 169.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -89.06 -29.51 19.37 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.757 0.823 . . . . 0.0 111.086 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -80.8 -24.03 38.83 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.171 0.588 . . . . 0.0 111.443 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.9 p -76.25 110.98 11.21 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 173.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.456 HG23 HG21 ' A' ' 26' ' ' VAL . 27.5 m -70.29 -24.88 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.132 0.573 . . . . 0.0 110.122 174.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 167.59 -159.32 32.58 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.612 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 53.8 tt0 -102.14 139.92 37.12 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.093 0.957 . . . . 0.0 109.807 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.427 ' OH ' ' HB ' ' A' ' 28' ' ' ILE . 84.2 t80 -78.94 124.25 28.06 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.378 0.671 . . . . 0.0 110.379 178.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.436 HD13 HD13 ' A' ' 25' ' ' LEU . 9.5 tt -115.86 120.9 40.76 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 172.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.734 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 42.9 mt-10 -68.86 143.09 94.32 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 123.613 0.765 . . . . 0.0 110.585 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -54.73 -31.18 70.41 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.856 2.371 . . . . 0.0 113.053 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -82.71 -29.01 30.15 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.86 0.864 . . . . 0.0 111.222 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.734 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 33.3 tt0 . . . . . 0 N--CA 1.483 1.179 0 C-N-CA 123.737 0.815 . . . . 0.0 112.036 -174.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.2 m . . . . . 0 CA--C 1.541 0.615 0 CA-C-O 120.731 0.3 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 83.6 mt -95.93 104.33 16.27 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.756 0.822 . . . . 0.0 109.727 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.52 ' HB ' HG21 ' A' ' 48' ' ' VAL . 59.2 t -95.5 121.78 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.568 1.147 . . . . 0.0 108.688 178.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -78.6 168.95 19.01 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 123.322 0.649 . . . . 0.0 110.312 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.44 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 11.4 tt -56.4 -46.08 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.877 174.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.98 -38.01 81.31 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.8 0.84 . . . . 0.0 111.707 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -66.34 -46.75 75.72 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.017 0.527 . . . . 0.0 111.593 -176.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 pp -72.11 -32.56 67.09 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.282 0.233 . . . . 0.0 111.61 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 68.2 mm-40 -63.73 -47.75 79.84 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.191 0.597 . . . . 0.0 110.816 174.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -77.32 -23.66 50.97 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.404 -175.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -72.63 -28.34 62.68 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -59.63 -47.58 85.04 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.115 0.566 . . . . 0.0 110.034 173.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -70.9 -26.7 63.34 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.101 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.71 -30.0 69.39 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.905 0.882 . . . . 0.0 111.276 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.58 34.88 0.68 Allowed Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.46 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.585 ' HA2' ' HD2' ' A' ' 52' ' ' LYS . . . -162.23 100.0 0.18 Allowed Glycine 0 C--N 1.346 1.131 0 CA-C-O 120.05 -0.306 . . . . 0.0 112.635 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -75.73 110.0 9.79 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -176.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -103.32 157.24 17.15 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.564 174.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.5 t -148.25 143.54 27.04 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.648 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 p -96.64 120.41 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-O 121.027 0.441 . . . . 0.0 110.623 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 78.6 mt -136.89 125.22 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 124.906 1.282 . . . . 0.0 108.194 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.1 t70 62.45 32.9 16.51 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.386 1.074 . . . . 0.0 111.548 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.14 19.57 77.39 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-N 115.818 -0.628 . . . . 0.0 113.401 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -125.24 145.35 50.03 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.187 0.995 . . . . 0.0 108.674 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.52 HG21 ' HB ' ' A' ' 26' ' ' VAL . 25.4 t -99.8 119.64 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -112.54 165.75 11.95 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.035 0.934 . . . . 0.0 109.056 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -93.76 161.55 14.28 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.565 0.698 . . . . 0.0 110.065 170.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.436 HG23 ' HB2' ' A' ' 73' ' ' PRO . 29.3 mm -115.88 -29.92 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.502 1.121 . . . . 0.0 109.744 172.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.585 ' HD2' ' HA2' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -57.36 -52.27 66.04 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 123.891 0.876 . . . . 0.0 112.655 -177.006 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -78.34 -31.38 48.62 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.278 1.031 . . . . 0.0 110.224 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -52.47 -60.81 2.79 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.843 1.257 . . . . 0.0 111.346 175.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -64.89 -28.65 69.69 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.558 -0.747 . . . . 0.0 112.177 -174.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.0 m -63.46 -45.04 92.65 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.298 0.639 . . . . 0.0 110.055 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -77.65 -13.54 59.88 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.369 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.6 m -71.15 -19.64 62.4 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.697 0.399 . . . . 0.0 111.015 172.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 61.0 mt -82.25 -5.89 58.85 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.993 0.917 . . . . 0.0 111.497 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 79.4 m -91.58 133.24 35.71 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.759 0.824 . . . . 0.0 109.722 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -62.91 -49.59 74.2 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.276 1.03 . . . . 0.0 111.644 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -86.51 45.41 1.24 Allowed 'General case' 0 CA--C 1.557 1.218 0 CA-C-O 121.91 0.862 . . . . 0.0 110.642 -177.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 75.7 m -122.81 144.74 48.99 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.181 0.992 . . . . 0.0 109.306 172.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.487 ' HB ' HG22 ' A' ' 86' ' ' THR . 35.0 pt -59.26 -25.92 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 124.029 0.932 . . . . 0.0 110.759 169.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.513 HD21 ' HE1' ' A' ' 90' ' ' MET . 36.7 mt -76.82 -10.15 59.17 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.276 1.031 . . . . 0.0 111.902 -178.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.84 -20.54 59.71 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.214 0.606 . . . . 0.0 111.535 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 9.7 pt20 -77.19 -29.37 54.3 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 171.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -87.94 2.78 50.81 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.402 1.081 . . . . 0.0 111.177 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.54 126.15 28.4 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.782 0.433 . . . . 0.0 110.112 177.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.31 -21.7 38.64 Favored Glycine 0 C--N 1.345 1.037 0 O-C-N 123.481 0.488 . . . . 0.0 112.528 -173.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -89.91 158.49 17.4 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.219 1.008 . . . . 0.0 109.809 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -61.23 132.55 92.57 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 123.204 0.602 . . . . 0.0 109.817 173.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.436 ' HB2' HG23 ' A' ' 51' ' ' ILE . 52.6 Cg_endo -64.53 -32.12 59.65 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.976 2.451 . . . . 0.0 113.899 -172.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.6 t -73.93 -45.82 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.8 t -61.15 -40.35 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.52 0.728 . . . . 0.0 110.478 177.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.02 -40.05 95.46 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.305 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 37.6 tp -71.81 -37.9 70.28 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.666 0.786 . . . . 0.0 110.917 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.23 -44.42 91.91 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.987 0.515 . . . . 0.0 110.318 176.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.51 -33.55 75.83 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.823 0.849 . . . . 0.0 110.873 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.79 -41.78 82.65 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.924 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.13 -23.28 64.88 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -82.76 -9.46 59.34 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.492 0.717 . . . . 0.0 112.071 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -125.89 124.85 41.77 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.206 0.602 . . . . 0.0 109.752 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.09 -42.0 84.71 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.411 1.084 . . . . 0.0 113.901 -169.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.42 -35.85 78.71 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.45 0.7 . . . . 0.0 111.285 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.487 HG22 ' HB ' ' A' ' 64' ' ' ILE . 31.6 p -98.26 -6.01 31.99 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.854 -174.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -90.48 -25.68 20.18 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 118.584 0.629 . . . . 0.0 110.433 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -75.72 -24.83 56.22 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.8 0.666 . . . . 0.0 112.8 -172.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.2 t -71.71 -23.97 61.73 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.145 171.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.513 ' HE1' HD21 ' A' ' 65' ' ' LEU . 12.6 mmt -75.58 -8.92 58.0 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.263 0.625 . . . . 0.0 111.663 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -70.3 -16.81 63.06 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.611 0.764 . . . . 0.0 110.507 169.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -88.66 -37.38 15.62 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.958 0.903 . . . . 0.0 110.857 170.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.427 ' HD2' ' HA ' ' A' ' 90' ' ' MET . 97.5 m-85 -80.79 -14.22 58.27 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.456 0.702 . . . . 0.0 112.192 -176.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 27.1 p -69.5 102.37 1.79 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.736 0.414 . . . . 0.0 110.647 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 26.2 m -77.56 -15.13 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 123.344 0.657 . . . . 0.0 111.201 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 168.84 -172.13 43.09 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.808 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -99.31 150.44 22.11 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 174.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -86.25 152.19 22.99 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.946 0.498 . . . . 0.0 110.553 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -146.65 121.34 9.84 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 172.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 38.3 mt-10 -71.46 129.01 89.32 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 123.232 0.613 . . . . 0.0 109.631 173.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.9 -32.27 56.29 Favored 'Trans proline' 0 CA--C 1.561 1.847 0 C-N-CA 122.848 2.365 . . . . 0.0 112.645 176.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -76.64 -32.47 58.02 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.624 0.77 . . . . 0.0 111.552 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 50.3 tp60 . . . . . 0 N--CA 1.479 0.994 0 C-N-CA 122.829 0.452 . . . . 0.0 110.262 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.1 m . . . . . 0 N--CA 1.468 0.455 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.4 mt -78.34 100.32 6.7 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.357 0.598 . . . . 0.0 109.64 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -92.53 114.37 29.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 38.3 mtp-105 -85.99 176.3 8.12 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.785 -175.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.5 tt -58.02 -37.44 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.728 175.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.75 -40.25 94.98 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.818 0.847 . . . . 0.0 111.264 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -74.28 -39.79 62.72 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.165 0.586 . . . . 0.0 110.788 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 45.6 tp -66.77 -50.15 63.6 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.035 0.534 . . . . 0.0 110.604 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -64.85 -48.11 75.52 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.63 0.772 . . . . 0.0 112.069 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -67.09 -47.96 69.62 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 123.488 0.493 . . . . 0.0 111.643 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -64.2 -36.77 85.16 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.525 0.33 . . . . 0.0 110.61 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -65.56 -39.69 91.96 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.067 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -67.79 -29.15 68.26 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.52 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -65.38 -23.2 66.91 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.184 0.594 . . . . 0.0 111.588 175.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.92 -26.74 6.09 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.574 ' HA2' ' HD2' ' A' ' 52' ' ' LYS . . . -69.62 89.55 0.29 Allowed Glycine 0 C--N 1.345 1.073 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 176.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -74.11 112.84 10.65 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -171.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 32.6 m0 -105.27 155.21 19.28 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.69 171.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.6 t -129.55 160.72 32.35 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.516 0.726 . . . . 0.0 109.408 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 p -116.34 109.43 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 172.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.3 mt -134.37 133.76 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.002 1.321 . . . . 0.0 107.696 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.0 t70 63.2 29.4 16.0 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 124.473 1.109 . . . . 0.0 110.631 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.5 19.0 64.17 Favored Glycine 0 C--N 1.353 1.487 0 CA-C-N 115.121 -0.945 . . . . 0.0 113.497 -174.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.471 ' HB2' ' CE2' ' A' ' 49' ' ' TYR . 42.9 mmtm -116.82 152.33 34.65 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.449 1.1 . . . . 0.0 108.51 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.8 t -102.12 122.59 54.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' A' ' 47' ' ' LYS . 96.4 m-85 -114.47 155.3 26.64 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.923 0.889 . . . . 0.0 110.427 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -94.63 107.12 19.12 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.436 0.694 . . . . 0.0 109.47 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.491 HG23 ' HB2' ' A' ' 73' ' ' PRO . 15.6 mm -75.77 -39.87 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.925 0.89 . . . . 0.0 112.288 -177.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.574 ' HD2' ' HA2' ' A' ' 39' ' ' GLY . 18.0 ptmt -67.08 -32.06 72.97 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 121.161 -0.216 . . . . 0.0 110.954 -174.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -73.7 -38.45 64.84 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -53.19 -54.17 39.88 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.503 1.121 . . . . 0.0 111.12 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -70.34 -27.56 64.45 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.411 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.1 m -72.52 -33.08 66.63 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 120.946 0.403 . . . . 0.0 110.241 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.529 ' HB2' HD12 ' A' ' 65' ' ' LEU . 82.6 mm-40 -69.65 -35.42 75.17 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 172.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.4 m -65.31 -27.12 68.38 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.301 0.64 . . . . 0.0 111.099 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.3 tt -61.63 -44.73 96.43 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.238 1.015 . . . . 0.0 109.297 173.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 88.8 m -66.91 120.31 13.38 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.38 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -65.49 -31.52 72.64 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.956 0.903 . . . . 0.0 111.308 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -69.66 -18.16 63.55 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.331 1.053 . . . . 0.0 111.766 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.8 t -76.04 152.66 36.84 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.877 0.471 . . . . 0.0 110.762 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.447 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 32.4 pt -61.2 -26.8 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.711 170.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.529 HD12 ' HB2' ' A' ' 57' ' ' GLN . 46.6 mt -77.21 0.76 20.69 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.144 0.978 . . . . 0.0 111.971 -176.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.99 -30.4 70.91 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.363 0.665 . . . . 0.0 111.21 172.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 11.2 pt20 -73.99 -27.06 60.78 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.31 0.644 . . . . 0.0 110.689 175.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.515 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 41.8 m-85 -92.69 -6.44 49.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.255 1.022 . . . . 0.0 111.45 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.27 104.22 0.9 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.153 0.581 . . . . 0.0 109.824 174.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.47 -32.13 3.62 Favored Glycine 0 N--CA 1.472 1.046 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -174.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -77.62 151.14 34.5 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.425 0.69 . . . . 0.0 109.649 175.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -55.37 128.1 66.54 Favored Pre-proline 0 N--CA 1.48 1.067 0 CA-C-O 118.476 -0.773 . . . . 0.0 108.955 171.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.491 ' HB2' HG23 ' A' ' 51' ' ' ILE . 28.6 Cg_endo -58.0 -31.51 93.07 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.836 2.357 . . . . 0.0 113.973 -170.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.9 t -75.38 -50.27 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 123.058 0.543 . . . . 0.0 110.097 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.1 t -58.58 -35.26 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 124.035 0.934 . . . . 0.0 111.022 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.515 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -73.27 -34.98 66.1 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.701 1.2 . . . . 0.0 111.213 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.546 ' HG ' ' SD ' ' A' ' 90' ' ' MET . 4.6 tt -71.58 -35.78 70.67 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.504 0.722 . . . . 0.0 109.889 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -66.53 -40.72 89.29 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.426 0.69 . . . . 0.0 110.36 175.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.18 -32.95 74.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.638 0.775 . . . . 0.0 110.619 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.41 -40.82 73.65 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.878 177.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.9 mt -64.67 -36.68 85.04 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.251 0.621 . . . . 0.0 110.856 173.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -65.87 -36.81 84.46 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.637 0.775 . . . . 0.0 111.074 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.492 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 29.9 t80 -95.96 132.12 41.62 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -176.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -65.85 -36.81 84.49 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.174 0.99 . . . . 0.0 113.193 -168.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -74.98 -32.2 61.63 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.713 0.405 . . . . 0.0 111.063 -177.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.492 ' OG1' ' HB3' ' A' ' 83' ' ' PHE . 37.8 p -93.57 -10.65 34.02 Favored 'General case' 0 CA--C 1.555 1.161 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -172.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -78.51 -15.07 59.0 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -26.24 55.44 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.01 0.524 . . . . 0.0 112.198 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.6 t -73.73 -29.57 62.33 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.324 0.25 . . . . 0.0 110.38 171.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.546 ' SD ' ' HG ' ' A' ' 77' ' ' LEU . 32.1 mmt -64.94 -26.05 68.14 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.052 0.541 . . . . 0.0 110.406 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -59.91 -37.02 78.24 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.707 0.803 . . . . 0.0 110.63 174.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.36 -32.8 60.96 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.834 178.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -78.24 -24.09 47.1 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.255 0.222 . . . . 0.0 111.16 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 39.1 t -70.77 95.27 1.11 Allowed 'General case' 0 C--N 1.349 0.556 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 33.3 m -71.0 -22.77 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.238 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 169.75 -160.66 33.81 Favored Glycine 0 C--N 1.351 1.396 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.836 174.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -97.22 145.69 25.82 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.647 1.179 . . . . 0.0 109.133 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -80.26 108.79 14.16 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 173.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 3.0 tm? -92.31 114.58 27.17 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 103' ' ' GLN . 30.6 tt0 -80.03 140.71 53.86 Favored Pre-proline 0 CA--C 1.554 1.102 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 174.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -39.1 -51.2 2.56 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 124.356 3.371 . . . . 0.0 114.644 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -103.1 23.06 12.93 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.291 0.637 . . . . 0.0 111.655 -175.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.561 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 8.9 tp-100 . . . . . 0 N--CA 1.485 1.312 0 O-C-N 121.861 -0.524 . . . . 0.0 110.088 174.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.1 m . . . . . 0 CA--C 1.536 0.428 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.433 HD22 ' HB2' ' A' ' 99' ' ' LEU . 64.3 mt -79.35 110.59 14.79 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.1 t -91.87 119.31 39.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 124.069 0.948 . . . . 0.0 108.583 -176.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.531 ' HG2' ' HB2' ' A' ' 30' ' ' ASP . 1.5 ptm180 -81.27 162.0 23.69 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.421 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.5 tt -60.12 -36.8 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.757 0.823 . . . . 0.0 111.836 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.09 -32.21 64.84 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.485 0.714 . . . . 0.0 111.922 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.531 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 29.1 t70 -58.81 -43.26 90.51 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.403 0.681 . . . . 0.0 110.454 -176.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.9 mt -52.35 -43.85 64.86 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.511 1.124 . . . . 0.0 111.691 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -72.18 -37.83 69.22 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.506 -175.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -69.09 -40.06 78.65 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.934 0.494 . . . . 0.0 110.821 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -66.74 -40.4 88.3 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.17 0.588 . . . . 0.0 110.05 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -59.79 -40.49 88.49 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.973 0.509 . . . . 0.0 110.143 176.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -69.27 -31.64 70.3 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.753 0.821 . . . . 0.0 111.388 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -74.28 -30.44 62.1 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.783 0.833 . . . . 0.0 111.274 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 112.06 -7.15 27.21 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.688 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.515 ' HA2' ' HD2' ' A' ' 52' ' ' LYS . . . -75.36 83.46 0.87 Allowed Glycine 0 C--N 1.349 1.268 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 172.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -75.71 107.32 7.8 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -172.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 28.7 m0 -111.44 160.71 16.85 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.643 1.177 . . . . 0.0 110.425 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.8 t -149.36 144.75 26.61 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.421 1.088 . . . . 0.0 109.126 -177.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.573 HG22 HG22 ' A' ' 48' ' ' VAL . 95.9 t -111.36 119.17 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.3 0.64 . . . . 0.0 109.925 178.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.9 mt -127.54 106.12 14.67 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 124.031 0.932 . . . . 0.0 109.008 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.5 t70 55.94 54.55 7.91 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 124.599 1.16 . . . . 0.0 111.61 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.64 9.43 62.01 Favored Glycine 0 N--CA 1.475 1.296 0 CA-C-N 115.081 -0.963 . . . . 0.0 114.428 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -117.76 124.5 48.59 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.767 0.827 . . . . 0.0 108.866 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.573 HG22 HG22 ' A' ' 43' ' ' VAL . 15.2 t -97.11 127.51 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.534 ' HB2' HD21 ' A' ' 77' ' ' LEU . 79.7 m-85 -127.7 163.71 23.7 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.291 1.036 . . . . 0.0 109.035 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -93.39 160.23 14.9 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.529 0.68 . . . . 0.0 110.066 170.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.8 mm -113.14 -27.77 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.494 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.515 ' HD2' ' HA2' ' A' ' 39' ' ' GLY . 21.0 ptmt -70.26 -48.75 55.45 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.069 0.548 . . . . 0.0 112.252 -173.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.457 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 34.6 t70 -75.04 -36.78 61.85 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -49.81 -55.43 14.17 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.934 1.293 . . . . 0.0 112.217 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -67.65 -27.28 66.74 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.111 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.3 m -68.6 -32.05 71.67 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.296 0.638 . . . . 0.0 110.895 172.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 22.5 mm-40 -76.13 -21.4 56.66 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 121.908 -0.495 . . . . 0.0 111.123 178.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.0 m -68.84 -17.66 64.03 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.124 0.57 . . . . 0.0 111.081 172.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.3 tp -69.71 -25.59 63.93 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.709 0.804 . . . . 0.0 110.709 173.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.7 m -86.15 117.47 25.0 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -67.55 -28.36 67.73 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.404 0.681 . . . . 0.0 111.207 -177.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -88.78 63.43 6.85 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-O 121.924 0.869 . . . . 0.0 108.943 173.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 61.2 m -147.55 153.23 39.2 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.923 1.289 . . . . 0.0 108.304 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.476 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 31.8 pt -61.4 -25.6 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.465 0.706 . . . . 0.0 110.902 170.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 57' ' ' GLN . 58.8 mt -84.31 0.34 49.47 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.368 1.067 . . . . 0.0 112.298 -175.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.91 -29.82 61.09 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.006 0.522 . . . . 0.0 110.744 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 10.6 pt20 -85.43 -6.82 59.18 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.223 0.609 . . . . 0.0 110.846 173.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -108.91 7.97 26.25 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.07 0.948 . . . . 0.0 110.477 174.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.21 126.53 30.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.076 0.55 . . . . 0.0 109.76 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.65 -31.85 8.09 Favored Glycine 0 N--CA 1.474 1.227 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 -173.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -75.28 152.8 38.21 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.948 0.899 . . . . 0.0 109.945 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -56.19 124.47 60.23 Favored Pre-proline 0 N--CA 1.476 0.858 0 C-N-CA 123.927 0.891 . . . . 0.0 109.749 175.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.13 -23.95 52.4 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.979 2.453 . . . . 0.0 113.938 -172.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.2 t -74.6 -47.58 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 176.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.88 -34.0 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.816 0.847 . . . . 0.0 111.085 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.08 -35.74 71.97 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.146 0.979 . . . . 0.0 110.516 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.619 HD12 ' SD ' ' A' ' 90' ' ' MET . 58.8 tp -68.99 -42.6 76.29 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.469 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -65.91 -42.38 90.26 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.604 0.761 . . . . 0.0 110.478 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.96 -37.36 86.77 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.607 0.763 . . . . 0.0 110.328 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.07 -42.47 89.39 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.293 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.4 HD23 ' HG3' ' A' ' 90' ' ' MET . 93.7 mt -67.64 -33.41 74.9 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.88 0.872 . . . . 0.0 111.848 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -89.14 2.55 53.98 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.321 0.649 . . . . 0.0 111.809 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.403 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 30.2 t80 -129.82 125.46 35.78 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.93 0.492 . . . . 0.0 109.821 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -58.23 -38.96 77.85 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.758 1.223 . . . . 0.0 113.73 -169.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -71.46 -30.6 66.21 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.353 0.661 . . . . 0.0 111.473 -176.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.426 HG22 ' HB ' ' A' ' 64' ' ' ILE . 24.6 p -101.67 -7.88 22.28 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.366 0.666 . . . . 0.0 112.67 -173.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.69 1.02 53.47 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 118.305 0.502 . . . . 0.0 111.323 177.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -72.56 -49.66 30.94 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.022 0.929 . . . . 0.0 110.782 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 32.8 t -71.58 -18.86 62.21 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.608 0.763 . . . . 0.0 111.162 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.619 ' SD ' HD12 ' A' ' 77' ' ' LEU . 37.4 mmt -64.79 -21.01 66.69 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.456 0.702 . . . . 0.0 111.979 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -60.39 -34.44 73.9 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.446 0.699 . . . . 0.0 110.895 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.99 -45.71 69.91 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.126 0.57 . . . . 0.0 110.97 176.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.418 ' HD2' ' HA ' ' A' ' 90' ' ' MET . 60.1 m-85 -73.61 -16.21 61.24 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.294 0.638 . . . . 0.0 111.395 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 45.8 t -70.65 87.98 0.69 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.441 0.696 . . . . 0.0 109.608 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.8 m -77.1 -25.55 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.383 -176.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 172.82 177.7 42.33 Favored Glycine 0 C--N 1.343 0.921 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.462 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -98.61 133.93 42.26 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -72.55 129.23 37.82 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 173.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.433 ' HB2' HD22 ' A' ' 25' ' ' LEU . 3.0 tm? -132.59 127.87 35.94 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 43.4 mt-10 -82.33 141.95 46.51 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 123.718 0.807 . . . . 0.0 110.4 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -59.18 -34.6 98.43 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.773 2.315 . . . . 0.0 111.658 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -70.57 -39.75 73.71 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.211 175.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 55.6 tp60 . . . . . 0 N--CA 1.482 1.137 0 C-N-CA 123.285 0.634 . . . . 0.0 111.775 -176.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.0 m . . . . . 0 CA--C 1.541 0.634 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.545 HD13 HD22 ' A' ' 99' ' ' LEU . 92.3 mt -79.98 100.92 8.35 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.504 ' HB ' HG21 ' A' ' 48' ' ' VAL . 58.2 t -94.57 116.98 37.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 55.6 mtm180 -95.76 172.93 7.73 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.191 0.597 . . . . 0.0 110.84 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.493 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 19.9 tt -60.52 -36.65 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 123.757 0.661 . . . . 0.0 111.451 -174.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.39 -45.12 72.81 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.081 0.952 . . . . 0.0 110.761 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.2 -44.98 93.84 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.04 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.4 mt -59.21 -42.7 91.55 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.858 0.863 . . . . 0.0 111.972 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 9.9 mm-40 -63.45 -50.5 69.49 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 123.496 0.497 . . . . 0.0 111.162 -174.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -71.85 -33.96 68.87 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.575 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -72.29 -35.06 68.58 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.852 0.461 . . . . 0.0 110.442 -177.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -66.45 -39.2 88.73 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.915 0.886 . . . . 0.0 110.399 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -61.78 -32.42 72.7 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.72 0.808 . . . . 0.0 111.52 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -66.12 -34.15 77.41 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.916 0.487 . . . . 0.0 111.058 176.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.05 -18.83 7.41 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.789 -175.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.88 89.02 0.23 Allowed Glycine 0 C--N 1.353 1.506 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 174.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -77.46 108.77 10.86 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.171 0.589 . . . . 0.0 109.573 -175.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -105.83 165.65 11.04 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.264 1.026 . . . . 0.0 109.907 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.8 t -143.03 160.29 40.65 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.868 0.867 . . . . 0.0 109.859 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 47' ' ' LYS . 1.5 p -114.49 112.38 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 123.443 0.697 . . . . 0.0 109.468 170.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.737 HD12 HD23 ' A' ' 77' ' ' LEU . 39.9 mt -134.52 136.98 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.749 1.219 . . . . 0.0 107.872 175.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.0 t70 62.85 29.41 16.61 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 124.327 1.051 . . . . 0.0 110.447 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.48 23.24 68.41 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.11 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.409 ' HB2' ' CE1' ' A' ' 49' ' ' TYR . 27.5 mmtp -124.67 153.19 42.68 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.562 1.145 . . . . 0.0 108.671 -176.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.504 HG21 ' HB ' ' A' ' 26' ' ' VAL . 91.7 t -104.07 132.27 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 175.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.409 ' CE1' ' HB2' ' A' ' 47' ' ' LYS . 66.7 m-85 -127.72 153.18 46.82 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.841 0.856 . . . . 0.0 109.908 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -92.42 106.18 18.23 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.527 HD11 HD22 ' A' ' 77' ' ' LEU . 35.8 mm -83.37 -29.6 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.75 0.82 . . . . 0.0 111.533 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.24 -47.56 84.9 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 28.5 t70 -69.37 -40.84 77.22 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.555 177.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -52.84 -55.0 26.25 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.421 1.089 . . . . 0.0 112.055 -177.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -66.44 -28.01 68.27 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.718 0.807 . . . . 0.0 111.583 -176.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.8 m -66.85 -37.06 83.74 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 122.918 0.487 . . . . 0.0 109.827 173.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 49.7 mm-40 -76.51 -24.63 53.73 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.285 0.634 . . . . 0.0 110.711 176.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.3 m -76.84 -19.69 57.22 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.52 0.728 . . . . 0.0 111.252 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.8 tt -74.05 -24.79 59.58 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.617 0.767 . . . . 0.0 110.321 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.7 m -58.8 137.47 57.7 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.904 0.881 . . . . 0.0 112.693 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -54.28 -45.69 72.55 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.016 1.327 . . . . 0.0 112.04 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -118.12 112.04 19.66 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 38.9 t -163.41 158.58 21.29 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.465 ' HB ' HG22 ' A' ' 86' ' ' THR . 35.9 pt -65.22 -24.63 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 166.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.5 mt -91.6 -2.04 57.26 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 124.759 1.224 . . . . 0.0 111.619 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.17 -31.97 68.33 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.938 0.495 . . . . 0.0 110.376 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 9.6 pt20 -76.51 -23.21 53.7 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.993 0.517 . . . . 0.0 110.652 172.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.541 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 29.4 m-85 -96.24 6.82 47.96 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.369 1.068 . . . . 0.0 111.688 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.52 -22.43 63.58 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.316 0.646 . . . . 0.0 112.1 -177.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.44 11.43 71.36 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-O 120.231 -0.205 . . . . 0.0 112.775 177.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -125.84 156.74 39.11 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.411 1.084 . . . . 0.0 109.694 -177.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -55.46 128.67 68.34 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 124.235 1.014 . . . . 0.0 109.354 170.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -59.74 -30.4 91.98 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.923 2.415 . . . . 0.0 113.946 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.9 t -75.18 -39.02 42.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 C-N-CA 122.588 0.355 . . . . 0.0 110.346 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.6 t -69.76 -39.8 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-O 121.49 0.662 . . . . 0.0 110.116 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.541 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -63.56 -34.49 77.93 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.114 1.366 . . . . 0.0 111.135 178.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.737 HD23 HD12 ' A' ' 44' ' ' ILE . 64.8 tp -61.09 -44.07 97.92 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.81 175.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.468 ' HG2' HG21 ' A' ' 44' ' ' ILE . 42.1 mt-10 -64.44 -40.82 96.47 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.77 0.828 . . . . 0.0 111.399 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.3 -38.5 91.38 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.529 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.434 ' HB1' ' SD ' ' A' ' 90' ' ' MET . . . -75.81 -26.13 56.96 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.74 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 79.6 mt -72.13 -39.48 68.78 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.502 0.721 . . . . 0.0 109.95 174.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -67.91 -44.78 76.13 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.114 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -84.76 131.48 34.55 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 120.823 0.344 . . . . 0.0 110.209 -176.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -66.58 -41.33 88.71 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.263 1.025 . . . . 0.0 112.916 -171.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.58 -26.57 65.45 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.14 0.576 . . . . 0.0 111.412 -176.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.465 HG22 ' HB ' ' A' ' 64' ' ' ILE . 28.1 p -91.09 -34.22 15.16 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.21 0.604 . . . . 0.0 111.977 -177.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -66.83 -14.27 62.49 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -171.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -57.75 -36.88 72.7 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.252 0.621 . . . . 0.0 111.09 173.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.2 t -77.12 -35.44 56.27 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.346 0.659 . . . . 0.0 110.451 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.479 ' SD ' ' N ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -67.95 -21.64 65.08 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.71 0.804 . . . . 0.0 111.2 175.627 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -67.62 -21.57 65.38 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.35 1.06 . . . . 0.0 110.249 172.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -92.65 -29.95 15.84 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.872 0.869 . . . . 0.0 111.272 172.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -74.95 -23.35 58.3 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 122.962 0.505 . . . . 0.0 111.527 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 27.1 p -69.86 101.05 1.65 Allowed 'General case' 0 C--N 1.354 0.789 0 C-N-CA 122.869 0.468 . . . . 0.0 110.133 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.4 t -67.66 -31.07 50.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 123.91 0.884 . . . . 0.0 110.179 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 172.28 -160.29 31.63 Favored Glycine 0 C--N 1.339 0.721 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.465 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -102.89 133.79 47.38 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 175.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -75.65 131.07 39.68 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 123.273 0.358 . . . . 0.0 110.444 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.545 HD22 HD13 ' A' ' 25' ' ' LEU . 66.5 tp -121.56 134.97 55.03 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 33.4 mt-10 -85.66 137.89 35.93 Favored Pre-proline 0 C--O 1.244 0.815 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 171.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -60.85 -22.53 74.18 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.946 2.43 . . . . 0.0 112.635 175.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -85.1 -37.55 20.14 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.269 1.028 . . . . 0.0 110.853 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.551 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 9.5 tp-100 . . . . . 0 N--CA 1.491 1.615 0 C-N-CA 123.83 0.852 . . . . 0.0 111.277 -173.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.9 p . . . . . 0 CA--C 1.542 0.638 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.2 mt -81.73 117.66 22.23 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.3 t -92.13 125.3 44.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -175.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -67.97 152.7 45.13 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.471 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 18.9 tt -60.63 -44.56 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 117.711 0.232 . . . . 0.0 110.836 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.71 -31.45 69.47 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.457 0.703 . . . . 0.0 110.613 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.5 -37.78 80.39 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.927 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.4 tp -64.9 -51.66 60.71 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.664 0.786 . . . . 0.0 110.205 175.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 58.8 mm-40 -64.17 -53.57 47.3 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.997 0.919 . . . . 0.0 112.473 -171.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -74.55 -29.68 61.46 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -173.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -72.53 -37.49 68.29 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -63.12 -42.76 99.6 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.887 0.875 . . . . 0.0 109.486 174.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -68.6 -26.58 65.44 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.178 1.391 . . . . 0.0 111.671 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -66.53 -35.26 79.81 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.548 0.739 . . . . 0.0 111.538 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 129.64 -26.63 4.28 Favored Glycine 0 N--CA 1.467 0.738 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.24 81.55 0.36 Allowed Glycine 0 C--N 1.351 1.408 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 167.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -74.63 113.69 12.18 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -164.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 33.4 m0 -106.61 171.44 7.36 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.396 1.078 . . . . 0.0 110.548 177.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.8 t -157.66 142.17 16.36 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.335 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -104.03 112.8 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.107 0.563 . . . . 0.0 109.525 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.429 HD13 ' HG2' ' A' ' 78' ' ' GLU . 55.7 mt -127.39 120.18 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.109 0.964 . . . . 0.0 108.942 176.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 62.06 40.08 12.44 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 125.12 1.368 . . . . 0.0 110.691 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.59 15.59 73.33 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.033 -0.985 . . . . 0.0 113.551 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.444 ' HD3' ' HG3' ' A' ' 97' ' ' GLN . 35.6 mmtp -118.65 148.17 43.0 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.086 0.955 . . . . 0.0 109.411 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.9 t -106.1 120.98 57.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.416 ' HB2' HD21 ' A' ' 77' ' ' LEU . 75.6 m-85 -118.08 171.17 8.28 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.972 1.309 . . . . 0.0 108.887 173.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -102.14 159.41 15.41 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.4 0.619 . . . . 0.0 110.39 170.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.1 mm -114.28 -21.4 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 124.437 1.095 . . . . 0.0 109.136 168.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -56.99 6.99 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 122.994 0.517 . . . . 0.0 111.614 -175.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.418 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 23.7 t70 -67.43 -37.12 82.53 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -53.17 -52.21 59.55 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.637 1.575 . . . . 0.0 112.7 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -69.6 -27.13 64.83 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.778 -176.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.8 m -70.27 -34.36 72.7 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-O 121.056 0.455 . . . . 0.0 110.423 174.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 33.3 mm-40 -72.19 -24.27 61.39 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.649 0.78 . . . . 0.0 112.195 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.6 p -77.57 -6.82 55.05 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.34 -2.49 38.39 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.761 0.424 . . . . 0.0 111.134 168.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' A' ' 63' ' ' SER . 19.4 m -77.44 120.24 22.17 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 168.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.5 -36.9 84.01 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.417 0.687 . . . . 0.0 111.801 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -111.24 87.32 2.52 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.513 ' HB3' ' HB ' ' A' ' 60' ' ' THR . 91.9 p -147.13 164.7 32.25 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.994 0.917 . . . . 0.0 109.601 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.557 ' HB ' HG22 ' A' ' 86' ' ' THR . 29.5 pt -68.43 -17.77 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 122.694 0.397 . . . . 0.0 111.019 171.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.6 mt -96.65 -8.87 30.49 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.978 0.911 . . . . 0.0 111.35 -177.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.54 -33.4 74.04 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.469 0.708 . . . . 0.0 110.773 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -76.69 -19.83 57.28 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.663 0.785 . . . . 0.0 111.239 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.499 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 25.5 m-85 -107.38 7.28 29.01 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.128 0.971 . . . . 0.0 111.1 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.26 -38.07 89.16 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.303 0.641 . . . . 0.0 111.539 -175.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -79.18 -8.3 87.91 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.594 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -95.66 155.46 16.73 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.454 0.702 . . . . 0.0 109.437 175.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -49.22 131.16 16.86 Favored Pre-proline 0 N--CA 1.485 1.324 0 C-N-CA 124.432 1.093 . . . . 0.0 110.417 172.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -61.72 -33.41 85.83 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.748 2.299 . . . . 0.0 113.859 -172.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.1 t -74.55 -41.27 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.66 -32.56 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 123.633 0.773 . . . . 0.0 110.373 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.499 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -68.83 -36.72 78.54 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.554 1.142 . . . . 0.0 110.505 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.7 HD12 ' SD ' ' A' ' 90' ' ' MET . 59.0 tp -64.77 -42.74 94.87 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.079 175.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.429 ' HG2' HD13 ' A' ' 44' ' ' ILE . 48.1 mt-10 -63.49 -40.87 98.22 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.44 0.696 . . . . 0.0 111.594 177.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.11 -34.39 77.96 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.669 0.787 . . . . 0.0 110.307 177.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.36 -26.32 51.86 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.324 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 92.0 mt -75.53 -30.92 59.91 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.1 0.56 . . . . 0.0 110.612 172.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -75.0 -45.87 38.99 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.724 -176.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.418 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 35.3 t80 -82.04 137.88 34.98 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 122.579 0.352 . . . . 0.0 110.579 -174.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.11 -37.15 85.04 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.368 1.067 . . . . 0.0 113.493 -169.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -66.04 -44.26 85.14 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.381 0.61 . . . . 0.0 110.624 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.557 HG22 ' HB ' ' A' ' 64' ' ' ILE . 25.5 p -81.89 -28.6 32.83 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.921 -169.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -64.87 -27.1 68.63 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.124 0.569 . . . . 0.0 111.964 -173.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -79.54 -22.77 43.46 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.392 0.677 . . . . 0.0 110.698 -178.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.5 t -80.68 -28.67 36.7 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.59 0.756 . . . . 0.0 110.381 171.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.7 ' SD ' HD12 ' A' ' 77' ' ' LEU . 36.2 mmt -64.45 -16.71 62.91 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.72 0.808 . . . . 0.0 111.889 176.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -57.79 -33.96 69.11 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.772 1.229 . . . . 0.0 111.531 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.6 -37.24 84.47 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.486 0.714 . . . . 0.0 111.254 176.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.471 ' HD2' ' HA ' ' A' ' 90' ' ' MET . 63.6 m-85 -85.66 -13.03 49.83 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.518 0.727 . . . . 0.0 111.326 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.4 t -71.54 92.61 1.14 Allowed 'General case' 0 C--N 1.351 0.66 0 C-N-CA 123.239 0.615 . . . . 0.0 109.605 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.9 m -83.16 -12.53 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.582 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 165.86 -169.46 40.18 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.772 172.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.444 ' HG3' ' HD3' ' A' ' 47' ' ' LYS . 30.6 tt0 -108.84 139.9 43.04 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.411 1.084 . . . . 0.0 108.156 172.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -71.62 136.62 47.45 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.002 0.43 . . . . 0.0 110.439 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -117.15 121.75 42.13 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 171.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.678 ' HB3' ' HB2' ' A' ' 103' ' ' GLN . 33.1 tt0 -73.5 133.16 80.55 Favored Pre-proline 0 CA--C 1.552 1.056 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.25 174.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.408 ' HD3' ' HB ' ' A' ' 28' ' ' ILE . 73.3 Cg_endo -66.58 -13.85 41.59 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.239 2.626 . . . . 0.0 113.762 -170.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -104.19 -18.32 14.54 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.876 0.471 . . . . 0.0 110.626 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.678 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 8.5 tp-100 . . . . . 0 N--CA 1.478 0.963 0 C-N-CA 124.068 0.947 . . . . 0.0 112.748 -170.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.7 m . . . . . 0 CA--C 1.542 0.645 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.547 HD13 HD12 ' A' ' 99' ' ' LEU . 83.1 mt -92.93 103.11 15.47 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.114 0.565 . . . . 0.0 109.558 -178.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.413 ' HB ' HG21 ' A' ' 48' ' ' VAL . 69.0 t -92.97 115.92 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 124.02 0.928 . . . . 0.0 108.618 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -84.26 164.83 18.8 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.01 0.924 . . . . 0.0 108.975 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.521 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 17.2 tt -51.23 -44.99 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.455 0.702 . . . . 0.0 112.412 -176.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.43 -44.2 92.95 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.159 0.584 . . . . 0.0 111.641 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -67.63 -35.11 78.32 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.718 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.8 tp -62.91 -42.56 99.83 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.037 0.535 . . . . 0.0 110.203 176.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 12.0 mm-40 -67.55 -55.36 13.78 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.675 0.79 . . . . 0.0 111.578 -175.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -71.13 -35.35 71.7 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.891 -173.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -70.17 -36.66 74.83 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.544 0.338 . . . . 0.0 110.207 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -56.59 -40.69 75.71 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.691 0.619 . . . . 0.0 110.125 175.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -86.89 -15.72 38.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.285 1.034 . . . . 0.0 111.929 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -67.52 -32.18 72.8 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.633 0.773 . . . . 0.0 110.474 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 142.29 -28.6 2.21 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.467 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.486 ' HA2' ' HZ2' ' A' ' 52' ' ' LYS . . . -83.0 98.03 2.02 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 174.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -73.28 118.26 16.03 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 -173.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.4 m0 -119.38 154.65 33.29 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.882 0.873 . . . . 0.0 111.554 -169.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.5 t -150.88 151.98 33.02 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.892 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 47' ' ' LYS . 1.6 p -97.77 117.94 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 169.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.7 mt -138.37 131.92 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.8 t70 61.39 29.27 18.43 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 122.31 1.052 . . . . 0.0 110.722 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.87 1.59 47.9 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 114.984 -1.007 . . . . 0.0 114.068 -176.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 41.2 mmtm -96.96 172.69 7.7 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.129 0.972 . . . . 0.0 109.145 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.413 HG21 ' HB ' ' A' ' 26' ' ' VAL . 85.0 t -120.38 119.33 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 172.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -112.34 148.92 33.24 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.236 0.615 . . . . 0.0 110.346 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -92.2 98.79 11.74 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 123.055 0.542 . . . . 0.0 109.736 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.1 mm -61.79 -27.72 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 124.941 1.297 . . . . 0.0 112.122 175.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.486 ' HZ2' ' HA2' ' A' ' 39' ' ' GLY . 5.8 ttpm? -59.39 -51.67 68.89 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-O 120.889 0.376 . . . . 0.0 110.325 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 31.4 t70 -67.61 -39.57 84.73 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.652 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.411 ' HA ' ' HE2' ' A' ' 93' ' ' PHE . 54.5 t80 -49.05 -48.29 44.09 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.197 0.999 . . . . 0.0 110.886 174.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.406 ' HA ' ' OG ' ' A' ' 58' ' ' SER . 16.0 mm100 -71.83 -31.21 66.3 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.41 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.0 m -62.47 -37.83 87.48 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-O 121.052 0.453 . . . . 0.0 110.106 172.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.616 ' HB2' HD12 ' A' ' 65' ' ' LEU . 66.3 mm-40 -78.37 -25.96 46.47 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.311 0.644 . . . . 0.0 111.693 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.406 ' OG ' ' HA ' ' A' ' 55' ' ' GLN . 92.7 p -85.79 -8.84 57.86 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.903 -0.498 . . . . 0.0 110.995 174.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.6 tt -75.86 -42.54 49.13 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.007 0.923 . . . . 0.0 109.179 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.2 t -75.64 157.49 33.65 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.054 -176.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -67.87 -73.56 0.14 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.363 1.065 . . . . 0.0 111.06 -171.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -86.2 100.58 12.33 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.58 0.705 . . . . 0.0 109.414 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 48.1 t -155.72 163.94 39.22 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.609 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.612 ' HB ' HG22 ' A' ' 86' ' ' THR . 43.2 pt -67.79 -18.54 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 123.572 0.749 . . . . 0.0 111.48 173.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.616 HD12 ' HB2' ' A' ' 57' ' ' GLN . 82.6 mt -104.33 6.33 35.16 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.761 0.825 . . . . 0.0 112.388 -174.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.54 -27.23 62.1 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.108 0.48 . . . . 0.0 110.13 173.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -80.19 -4.97 55.21 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.917 0.887 . . . . 0.0 111.842 173.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.496 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 64.8 m-85 -117.06 9.28 13.58 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.151 0.98 . . . . 0.0 110.56 177.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.98 103.39 2.24 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.684 0.793 . . . . 0.0 110.722 -177.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.45 -37.21 2.39 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -70.1 147.08 50.41 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.017 0.927 . . . . 0.0 110.345 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -53.1 131.22 50.56 Favored Pre-proline 0 N--CA 1.484 1.234 0 C-N-CA 123.625 0.77 . . . . 0.0 110.558 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -47.23 -45.86 20.99 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 123.921 3.081 . . . . 0.0 114.52 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.83 -44.17 45.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.433 -173.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.6 t -66.4 -37.61 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 123.502 0.721 . . . . 0.0 111.052 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.496 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -67.22 -31.84 72.49 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.612 1.165 . . . . 0.0 111.002 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 tt -72.18 -36.46 69.26 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.024 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.69 -39.26 80.62 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.634 0.374 . . . . 0.0 110.763 175.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.62 -32.44 74.01 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.836 0.855 . . . . 0.0 110.525 174.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.08 -35.13 69.16 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.392 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 66.0 mt -74.84 -24.14 58.55 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.588 0.355 . . . . 0.0 111.242 177.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -74.97 -39.6 61.2 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.064 0.546 . . . . 0.0 109.957 173.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -81.98 114.07 20.3 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.919 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -56.62 -32.57 65.44 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.476 1.11 . . . . 0.0 113.263 -172.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -68.05 -40.95 82.69 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.632 0.773 . . . . 0.0 111.744 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.612 HG22 ' HB ' ' A' ' 64' ' ' ILE . 34.9 p -95.75 -17.98 20.8 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -171.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -71.92 -35.45 69.68 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 122.99 0.516 . . . . 0.0 111.34 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.69 -25.99 64.14 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.023 0.929 . . . . 0.0 111.27 -175.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.8 t -80.92 -17.28 51.06 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.483 0.713 . . . . 0.0 110.862 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.424 ' HE1' HD21 ' A' ' 65' ' ' LEU . 23.8 mmt -72.21 0.49 9.66 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.292 0.637 . . . . 0.0 112.684 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.428 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 31.8 p-80 -62.56 -33.36 74.79 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.376 0.67 . . . . 0.0 110.819 171.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.41 -23.26 46.79 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.23 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.421 ' HD1' ' HA ' ' A' ' 90' ' ' MET . 54.4 m-85 -90.55 -25.21 20.34 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.325 0.65 . . . . 0.0 110.933 -178.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.428 ' SG ' ' HA ' ' A' ' 91' ' ' HIS . 28.5 p -79.82 106.99 12.25 Favored 'General case' 0 C--N 1.357 0.922 0 CA-C-O 121.042 0.449 . . . . 0.0 109.896 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.0 t -75.7 -29.22 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.274 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -177.91 -166.64 34.74 Favored Glycine 0 C--N 1.345 1.064 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.425 177.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -98.83 138.68 35.62 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.876 0.87 . . . . 0.0 108.961 170.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -78.95 118.8 21.3 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.569 0.748 . . . . 0.0 110.061 173.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.547 HD12 HD13 ' A' ' 25' ' ' LEU . 2.2 tt -99.55 114.36 27.31 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 170.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -80.92 129.68 66.68 Favored Pre-proline 0 CA--C 1.548 0.902 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -53.0 -33.09 61.02 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 123.518 2.812 . . . . 0.0 113.539 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -65.66 -44.68 85.57 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.79 0.836 . . . . 0.0 110.489 178.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 . . . . . 0 N--CA 1.485 1.304 0 C-N-CA 124.032 0.933 . . . . 0.0 111.081 -179.969 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.1 m . . . . . 0 C--O 1.238 0.493 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.414 HD13 HD12 ' A' ' 99' ' ' LEU . 96.0 mt -78.6 101.28 7.36 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.435 ' HB ' HG21 ' A' ' 48' ' ' VAL . 60.9 t -94.94 136.12 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.683 -177.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -106.45 166.86 10.24 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.732 0.813 . . . . 0.0 109.128 -178.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.7 tt -54.7 -41.53 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.438 1.095 . . . . 0.0 113.447 -171.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.83 -34.73 71.99 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.252 0.221 . . . . 0.0 111.408 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.49 -34.06 76.94 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.257 0.623 . . . . 0.0 110.598 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.5 mt -61.89 -57.06 13.24 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.38 0.672 . . . . 0.0 110.027 174.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -62.14 -40.29 95.45 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 124.208 0.943 . . . . 0.0 111.71 -174.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -72.84 -38.08 67.21 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.682 0.793 . . . . 0.0 111.366 -176.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -73.06 -39.25 66.05 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.886 0.474 . . . . 0.0 109.993 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -67.75 -50.05 59.29 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.595 1.158 . . . . 0.0 110.756 -175.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -69.11 -28.52 66.55 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.652 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -68.68 -23.99 64.46 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.208 0.603 . . . . 0.0 111.223 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 139.64 -26.86 2.63 Favored Glycine 0 C--N 1.355 1.585 0 CA-C-N 116.651 -0.25 . . . . 0.0 113.447 174.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.62 103.57 2.91 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -75.12 108.23 7.73 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 117.659 0.73 . . . . 0.0 109.591 -168.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -107.93 138.55 43.99 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.038 0.935 . . . . 0.0 110.147 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.3 t -145.21 156.13 43.67 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.909 0.884 . . . . 0.0 109.038 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.47 HG22 HG22 ' A' ' 48' ' ' VAL . 88.7 t -108.47 118.31 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.263 0.625 . . . . 0.0 110.169 -177.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.48 HD12 HD22 ' A' ' 77' ' ' LEU . 34.5 mt -126.25 127.51 70.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 174.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.8 t70 63.23 30.71 15.82 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 124.656 1.182 . . . . 0.0 111.156 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.1 1.66 80.58 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.318 -0.856 . . . . 0.0 113.603 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.485 ' HD2' ' SG ' ' A' ' 94' ' ' CYS . 69.9 mmtt -109.09 149.65 29.0 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.925 0.89 . . . . 0.0 109.802 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.47 HG22 HG22 ' A' ' 43' ' ' VAL . 47.9 t -99.5 134.41 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.885 0.874 . . . . 0.0 109.992 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -134.1 157.97 44.8 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.097 0.959 . . . . 0.0 109.573 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -106.61 115.97 31.12 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.3 mm -70.73 -33.68 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.568 1.147 . . . . 0.0 112.027 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -69.03 -44.27 73.05 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.937 0.495 . . . . 0.0 110.392 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -66.58 -40.6 89.01 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.068 0.947 . . . . 0.0 110.103 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -52.47 -49.77 64.02 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.08 1.352 . . . . 0.0 111.199 172.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -71.29 -31.36 67.37 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.686 0.795 . . . . 0.0 112.242 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.5 m -64.33 -35.27 80.33 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.308 174.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -74.89 -28.39 60.62 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.684 0.794 . . . . 0.0 111.258 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.453 ' HA ' ' HB2' ' A' ' 65' ' ' LEU . 15.5 m -68.75 -27.55 66.01 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.166 0.586 . . . . 0.0 111.159 177.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.0 tp -63.2 -27.12 69.14 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.782 0.833 . . . . 0.0 111.162 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.4 m -77.87 132.04 37.78 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 122.833 0.453 . . . . 0.0 110.349 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -75.55 -35.34 60.7 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.395 0.678 . . . . 0.0 112.042 -173.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -80.13 -7.75 59.07 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.844 0.457 . . . . 0.0 111.97 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 74.4 m -75.41 151.52 38.13 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.439 0.696 . . . . 0.0 110.656 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.453 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 15.2 pt -63.39 -23.25 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.842 0.857 . . . . 0.0 112.176 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 82.8 mt -78.51 1.9 20.86 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.811 0.845 . . . . 0.0 112.228 -178.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.71 -33.33 75.63 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.4 0.68 . . . . 0.0 110.77 172.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 9.8 pt20 -77.17 -22.7 52.09 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.019 0.528 . . . . 0.0 110.617 176.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.61 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 46.3 m-85 -97.66 4.53 50.06 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.408 1.083 . . . . 0.0 111.444 -178.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.24 -19.86 60.98 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.174 0.589 . . . . 0.0 111.291 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.65 0.02 73.21 Favored Glycine 0 C--N 1.352 1.421 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.896 174.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -109.75 157.76 18.81 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.335 1.054 . . . . 0.0 109.768 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -57.01 130.86 79.83 Favored Pre-proline 0 CA--C 1.551 0.993 0 CA-C-O 118.177 -0.915 . . . . 0.0 109.265 171.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -45.41 -50.22 9.43 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 124.189 3.259 . . . . 0.0 115.431 -177.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.9 t -74.38 -42.32 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -174.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.3 t -64.96 -29.73 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 123.864 0.865 . . . . 0.0 111.217 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.61 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -71.61 -35.91 70.64 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.693 1.197 . . . . 0.0 110.364 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.48 HD22 HD12 ' A' ' 44' ' ' ILE . 3.7 tt -72.01 -37.74 69.74 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.544 177.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -63.63 -43.54 96.5 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.362 0.665 . . . . 0.0 110.375 175.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.16 -34.87 78.49 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.028 0.931 . . . . 0.0 110.942 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.423 ' HB1' ' SD ' ' A' ' 90' ' ' MET . . . -70.1 -42.44 72.69 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.215 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 72.6 mt -61.62 -46.5 89.54 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.306 0.642 . . . . 0.0 110.46 174.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -61.07 -37.58 83.19 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.314 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -89.64 117.93 28.88 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 121.207 0.527 . . . . 0.0 109.951 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -53.63 -30.32 42.29 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.956 1.702 . . . . 0.0 113.93 -173.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -77.7 -48.34 16.96 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.743 0.417 . . . . 0.0 110.613 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.4 p -84.53 -9.36 58.41 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -169.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -67.04 -16.87 64.63 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 122.731 0.412 . . . . 0.0 111.953 -178.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -23.51 65.85 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.111 0.964 . . . . 0.0 113.205 -176.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.4 ' CB ' HD11 ' A' ' 64' ' ' ILE . 48.0 t -82.01 -32.21 30.68 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 118.089 0.404 . . . . 0.0 110.64 174.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.485 ' SD ' ' N ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -74.54 -15.57 60.85 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.546 0.738 . . . . 0.0 110.814 177.536 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -57.64 -43.82 85.16 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.917 0.887 . . . . 0.0 109.651 167.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.95 -38.86 66.61 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.335 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -71.65 -16.9 62.27 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 122.596 0.358 . . . . 0.0 111.951 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.485 ' SG ' ' HD2' ' A' ' 47' ' ' LYS . 43.5 t -71.35 83.86 0.78 Allowed 'General case' 0 C--N 1.354 0.761 0 C-N-CA 123.883 0.873 . . . . 0.0 109.537 175.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.62 -32.24 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.397 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -176.37 -175.77 43.99 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.291 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -107.53 137.61 45.24 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.226 1.01 . . . . 0.0 109.113 175.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -74.59 121.23 21.27 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.218 0.607 . . . . 0.0 110.259 173.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.414 HD12 HD13 ' A' ' 25' ' ' LEU . 6.4 tt -100.81 117.48 34.98 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 168.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 103' ' ' GLN . 38.9 tt0 -70.87 129.51 89.58 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.54 0.736 . . . . 0.0 109.626 176.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -57.01 -25.8 65.03 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 123.033 2.489 . . . . 0.0 113.117 -177.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -86.16 -27.91 24.27 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.301 0.64 . . . . 0.0 111.604 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.568 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 56.9 tp60 . . . . . 0 N--CA 1.494 1.731 0 C-N-CA 124.4 1.08 . . . . 0.0 112.35 -175.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.6 m . . . . . 0 N--CA 1.466 0.355 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.445 HD13 HD12 ' A' ' 99' ' ' LEU . 84.0 mt -99.12 103.22 15.11 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 177.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.543 ' HB ' HG21 ' A' ' 48' ' ' VAL . 58.5 t -93.22 117.35 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -176.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.402 HH21 ' HB3' ' A' ' 101' ' ' PRO . 74.9 mtp180 -90.64 164.62 14.1 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.302 0.641 . . . . 0.0 109.906 174.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.46 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 11.8 tt -58.72 -33.62 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.15 0.58 . . . . 0.0 111.604 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.18 -50.29 74.25 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.451 0.7 . . . . 0.0 110.512 176.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -67.0 -33.42 75.53 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.746 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 43.5 tp -61.22 -45.43 94.61 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.995 0.918 . . . . 0.0 110.435 178.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 16.2 mm-40 -62.9 -54.26 41.33 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.032 0.933 . . . . 0.0 110.973 178.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -59.22 -49.22 78.68 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.572 -174.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -69.64 -32.45 71.13 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.047 -175.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -64.23 -47.62 78.97 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.258 177.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 -72.31 -24.11 61.27 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.713 0.805 . . . . 0.0 111.218 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -67.79 -24.62 65.33 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.094 0.958 . . . . 0.0 110.681 174.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 129.94 -27.72 4.03 Favored Glycine 0 C--N 1.344 1.019 0 N-CA-C 112.022 -0.431 . . . . 0.0 112.022 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.24 91.62 1.14 Allowed Glycine 0 C--N 1.341 0.813 0 N-CA-C 111.364 -0.695 . . . . 0.0 111.364 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -74.95 109.92 8.81 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -175.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 47.5 m0 -104.97 172.93 6.53 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.111 0.965 . . . . 0.0 110.188 175.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.9 t -158.9 135.51 9.4 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.265 1.026 . . . . 0.0 108.945 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.529 HG22 HG22 ' A' ' 48' ' ' VAL . 61.7 t -92.95 111.74 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 122.985 0.514 . . . . 0.0 109.891 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.3 mt -123.67 113.08 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 123.974 0.91 . . . . 0.0 109.213 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 63.15 45.23 5.26 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.882 1.273 . . . . 0.0 111.89 172.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.09 7.86 77.57 Favored Glycine 0 N--CA 1.476 1.337 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.545 177.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -118.51 156.13 29.63 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.237 1.015 . . . . 0.0 108.742 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.543 HG21 ' HB ' ' A' ' 26' ' ' VAL . 24.3 t -115.53 116.02 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -111.15 156.61 21.13 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.166 0.986 . . . . 0.0 108.847 174.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -93.34 149.96 20.84 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.233 0.54 . . . . 0.0 110.227 173.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.9 mm -103.91 -22.97 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 124.288 1.035 . . . . 0.0 108.909 167.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.64 -59.42 5.23 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.175 0.99 . . . . 0.0 111.015 -175.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 20.8 t70 -76.38 -30.87 57.7 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.301 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -52.21 -54.77 26.77 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.689 1.196 . . . . 0.0 112.255 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -67.34 -26.86 66.7 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.084 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 51.7 m -67.86 -36.11 79.71 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.509 172.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 22.7 mm-40 -77.39 -25.4 50.82 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.945 0.498 . . . . 0.0 111.994 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.5 p -74.68 -7.23 52.61 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.7 tt -63.46 -40.45 97.15 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.991 0.916 . . . . 0.0 109.134 167.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.578 ' HB ' ' HB3' ' A' ' 63' ' ' SER . 27.1 m -65.51 119.29 10.8 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.532 0.733 . . . . 0.0 109.478 -177.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -74.27 -14.91 60.98 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 120.768 0.318 . . . . 0.0 111.119 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -101.06 10.4 41.06 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.794 0.838 . . . . 0.0 111.189 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.578 ' HB3' ' HB ' ' A' ' 60' ' ' THR . 81.8 p -87.17 162.22 17.62 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.569 ' HB ' HG22 ' A' ' 86' ' ' THR . 45.9 pt -66.9 -22.25 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.067 0.547 . . . . 0.0 110.816 170.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.438 HD21 ' HE1' ' A' ' 90' ' ' MET . 51.8 mt -85.26 -7.76 58.85 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.978 0.911 . . . . 0.0 111.721 -178.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.24 -33.04 74.85 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.492 0.717 . . . . 0.0 111.785 177.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 11.3 pt20 -76.06 -26.39 56.48 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.286 175.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -87.63 -5.39 58.74 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.881 0.872 . . . . 0.0 111.387 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.26 99.14 0.67 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.057 0.543 . . . . 0.0 110.188 176.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 142.86 -29.41 2.1 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -172.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -93.81 153.95 18.01 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.253 1.021 . . . . 0.0 109.765 172.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -57.74 127.76 79.12 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 124.051 0.94 . . . . 0.0 110.231 175.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -46.31 -39.81 21.74 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 123.984 3.123 . . . . 0.0 115.88 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.44 -49.42 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 122.559 0.344 . . . . 0.0 110.355 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.0 t -61.65 -40.87 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.871 0.868 . . . . 0.0 110.503 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.72 -33.46 74.93 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.463 -1.244 . . . . 0.0 111.429 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.421 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 5.1 tt -68.6 -46.7 68.61 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.692 0.797 . . . . 0.0 109.49 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -63.92 -40.98 97.74 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.382 0.673 . . . . 0.0 111.265 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.27 -37.74 88.45 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.613 0.765 . . . . 0.0 110.545 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.03 -22.81 59.42 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.434 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 87.2 mt -74.59 -37.16 62.97 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 120.878 0.371 . . . . 0.0 110.06 173.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -73.04 -26.98 61.49 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.472 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -95.43 121.08 36.73 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 123.123 0.569 . . . . 0.0 109.531 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.1 -35.97 82.49 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.088 0.955 . . . . 0.0 113.032 -172.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.26 -12.81 61.32 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.283 0.633 . . . . 0.0 112.175 -176.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.569 HG22 ' HB ' ' A' ' 64' ' ' ILE . 24.6 p -117.8 -13.9 10.13 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.272 0.629 . . . . 0.0 112.577 -177.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -75.12 -21.23 59.01 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.035 0.445 . . . . 0.0 111.238 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -35.7 80.97 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.768 0.827 . . . . 0.0 112.121 -176.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.7 t -78.3 -22.09 48.72 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.438 ' HE1' HD21 ' A' ' 65' ' ' LEU . 21.3 mmt -71.54 -4.74 28.56 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.29 0.636 . . . . 0.0 111.785 177.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -69.55 -27.83 65.48 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.114 0.565 . . . . 0.0 109.809 169.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.76 -41.08 15.4 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.807 0.843 . . . . 0.0 110.746 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -66.79 -22.97 66.01 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.089 0.556 . . . . 0.0 111.594 177.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 43.8 t -71.13 92.57 0.99 Allowed 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.9 m -69.82 -19.05 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.243 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 171.94 177.59 41.64 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.328 175.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -96.97 138.56 34.31 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 174.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -72.85 145.6 46.82 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.065 0.46 . . . . 0.0 111.105 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.445 HD12 HD13 ' A' ' 25' ' ' LEU . 5.7 tt -136.07 121.81 19.77 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.722 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 23.3 mt-10 -79.53 132.52 61.67 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 123.41 0.684 . . . . 0.0 109.947 175.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.402 ' HB3' HH21 ' A' ' 27' ' ' ARG . 17.7 Cg_endo -57.8 -30.04 87.99 Favored 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 122.305 2.003 . . . . 0.0 112.258 175.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -76.37 -26.58 55.8 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.076 0.95 . . . . 0.0 111.634 177.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.722 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 6.2 tp-100 . . . . . 0 N--CA 1.485 1.291 0 C-N-CA 123.857 0.863 . . . . 0.0 110.343 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.52 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 17.4 m . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 110.517 -0.179 . . . . 0.0 110.517 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.478 HD13 HD22 ' A' ' 99' ' ' LEU . 72.7 mt -83.24 100.01 10.33 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.276 0.56 . . . . 0.0 109.562 177.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.423 HG21 HG23 ' A' ' 95' ' ' VAL . 84.6 t -95.48 116.05 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.164 177.033 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.477 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 18.4 mtm180 -91.41 172.44 8.52 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.338 0.655 . . . . 0.0 110.143 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.508 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 15.7 tt -61.9 -31.2 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 122.458 0.303 . . . . 0.0 110.552 177.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.38 -52.24 59.94 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.767 0.827 . . . . 0.0 110.804 172.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.26 -42.22 99.13 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.398 1.079 . . . . 0.0 110.703 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 44.1 tp -59.71 -44.83 93.53 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.969 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 20.4 mm-40 -71.05 -48.97 49.75 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.755 -176.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.08 -33.4 67.89 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.1 0.25 . . . . 0.0 111.33 -174.036 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -73.82 -35.94 64.92 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.792 0.437 . . . . 0.0 110.189 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -69.47 -34.21 74.03 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.694 0.398 . . . . 0.0 110.429 176.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -73.16 -26.89 61.37 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.072 0.549 . . . . 0.0 110.434 175.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.07 -28.63 68.98 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.457 1.103 . . . . 0.0 110.603 172.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.65 -24.14 6.88 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 -177.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.62 ' HA2' ' HD2' ' A' ' 52' ' ' LYS . . . -70.03 89.97 0.33 Allowed Glycine 0 C--N 1.347 1.144 0 O-C-N 123.895 0.409 . . . . 0.0 112.113 177.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -75.55 107.74 7.9 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -175.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 34.5 m0 -104.31 166.28 10.5 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.247 175.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.1 t -147.67 139.29 23.91 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.175 0.99 . . . . 0.0 108.579 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.468 HG22 HG22 ' A' ' 48' ' ' VAL . 95.8 t -98.18 111.39 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.465 HG21 ' HG2' ' A' ' 78' ' ' GLU . 70.7 mt -140.59 139.14 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.572 1.149 . . . . 0.0 108.28 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.5 t70 63.07 30.85 16.16 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 124.537 1.135 . . . . 0.0 111.177 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.43 15.45 68.18 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.898 -0.592 . . . . 0.0 113.32 -177.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HB2' ' CE1' ' A' ' 49' ' ' TYR . 25.6 mmtp -119.21 176.74 5.17 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.805 1.242 . . . . 0.0 108.283 -178.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.468 HG22 HG22 ' A' ' 43' ' ' VAL . 53.1 t -125.06 115.48 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 171.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.445 ' CE1' ' HB2' ' A' ' 47' ' ' LYS . 85.2 m-85 -108.16 159.41 16.62 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.347 1.059 . . . . 0.0 109.467 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -90.89 160.72 15.55 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 120.958 0.409 . . . . 0.0 110.081 171.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 28.1 mm -120.97 -26.71 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.998 0.919 . . . . 0.0 109.958 173.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.62 ' HD2' ' HA2' ' A' ' 39' ' ' GLY . 19.2 ptmt -67.96 -47.04 69.72 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 122.915 0.486 . . . . 0.0 111.953 -175.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -76.81 -33.27 58.0 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.67 0.388 . . . . 0.0 109.99 177.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -53.05 -50.05 65.11 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.616 1.566 . . . . 0.0 111.849 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -67.8 -28.33 67.49 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.145 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.0 m -73.02 -33.68 65.89 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.052 0.541 . . . . 0.0 110.08 176.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -73.9 -29.34 62.02 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.148 0.979 . . . . 0.0 111.838 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.7 p -73.6 -8.59 56.57 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.936 0.494 . . . . 0.0 112.236 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.0 mt -77.86 -12.38 59.97 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.4 0.68 . . . . 0.0 111.683 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.426 HG22 ' H ' ' A' ' 62' ' ' ASN . 35.4 m -82.32 132.02 35.22 Favored 'General case' 0 C--N 1.361 1.074 0 C-N-CA 122.777 0.431 . . . . 0.0 110.061 178.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -67.77 -30.54 70.02 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.618 0.767 . . . . 0.0 111.528 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.426 ' H ' HG22 ' A' ' 60' ' ' THR . 25.1 t-20 -112.52 74.26 0.85 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -178.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.4 m -150.91 165.05 34.85 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.137 0.975 . . . . 0.0 109.962 178.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.563 HD13 ' HB3' ' A' ' 89' ' ' SER . 9.3 pt -67.1 -25.73 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.194 177.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.461 ' HG ' HG13 ' A' ' 64' ' ' ILE . 71.0 mt -95.21 2.65 54.99 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.863 0.865 . . . . 0.0 111.588 -176.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.41 -34.53 70.42 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.315 0.579 . . . . 0.0 110.422 176.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -72.28 -23.42 61.19 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.395 173.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -100.0 7.34 44.82 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.574 1.15 . . . . 0.0 111.038 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.01 80.21 3.55 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.478 0.711 . . . . 0.0 110.057 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 147.77 -24.14 1.48 Allowed Glycine 0 N--CA 1.471 0.993 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.001 -170.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -84.16 151.91 24.59 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.919 0.888 . . . . 0.0 109.902 175.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -55.69 125.57 61.64 Favored Pre-proline 0 N--CA 1.481 1.125 0 CA-C-O 118.27 -0.871 . . . . 0.0 109.589 174.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.71 -36.83 91.23 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 123.191 2.594 . . . . 0.0 114.86 -175.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.0 t -74.73 -36.22 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.262 0.625 . . . . 0.0 110.314 -177.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.7 t -72.3 -36.91 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.979 0.912 . . . . 0.0 110.622 175.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.26 -29.19 65.92 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.638 1.175 . . . . 0.0 110.572 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.537 HD22 ' SD ' ' A' ' 90' ' ' MET . 1.8 tm? -63.36 -48.85 76.21 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.48 1.112 . . . . 0.0 109.156 173.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.465 ' HG2' HG21 ' A' ' 44' ' ' ILE . 23.2 mt-10 -68.44 -39.72 81.39 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.291 -178.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.98 -34.19 77.42 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.863 0.865 . . . . 0.0 110.453 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.28 -39.65 82.07 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.892 174.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 66.5 mt -67.29 -29.38 68.96 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.366 0.666 . . . . 0.0 112.157 177.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -72.3 -43.42 64.22 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.686 0.795 . . . . 0.0 110.519 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -85.35 114.66 22.59 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -54.66 -33.39 60.64 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.541 1.136 . . . . 0.0 113.077 -172.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -64.79 -52.63 55.85 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.708 0.803 . . . . 0.0 111.115 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.496 HG22 ' HB ' ' A' ' 64' ' ' ILE . 38.5 p -81.23 -13.99 57.95 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.567 -171.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.56 -18.16 57.19 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 120.956 0.408 . . . . 0.0 110.927 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -64.72 -45.29 87.18 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.939 0.896 . . . . 0.0 110.061 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.563 ' HB3' HD13 ' A' ' 64' ' ' ILE . 46.6 t -71.27 -17.6 62.47 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.949 0.899 . . . . 0.0 112.325 -178.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.537 ' SD ' HD22 ' A' ' 77' ' ' LEU . 30.3 mmt -63.49 -15.23 57.25 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.551 0.741 . . . . 0.0 112.123 177.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.476 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 3.3 p80 -57.89 -33.09 68.36 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.681 0.793 . . . . 0.0 111.194 175.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.09 -33.46 70.21 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.103 0.961 . . . . 0.0 111.193 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -90.89 -26.11 19.5 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.494 -174.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.476 ' SG ' ' HA ' ' A' ' 91' ' ' HIS . 26.8 p -76.84 105.4 7.88 Favored 'General case' 0 C--N 1.358 0.971 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.423 HG23 HG21 ' A' ' 26' ' ' VAL . 35.9 m -69.48 -25.46 29.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 123.114 0.565 . . . . 0.0 110.692 174.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.52 ' HA3' ' HB ' ' A' ' 24' ' ' THR . . . 170.07 -165.69 38.99 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.557 174.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -88.58 140.57 29.32 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.18 0.992 . . . . 0.0 109.609 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -77.16 135.82 38.55 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 122.706 0.402 . . . . 0.0 110.782 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.478 HD22 HD13 ' A' ' 25' ' ' LEU . 66.4 tp -121.97 130.84 53.65 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.66 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 37.9 mt-10 -83.37 148.37 55.51 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 171.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.13 -7.28 20.44 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.51 2.14 . . . . 0.0 112.716 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -109.62 -16.93 13.83 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.359 1.064 . . . . 0.0 110.847 178.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.66 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 9.1 tp-100 . . . . . 0 N--CA 1.484 1.271 0 C-N-CA 123.773 0.829 . . . . 0.0 112.355 -172.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.6 p . . . . . 0 CA--C 1.545 0.782 0 CA-C-O 121.109 0.481 . . . . 0.0 111.453 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.3 mt -78.78 106.58 10.88 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.566 0.746 . . . . 0.0 109.521 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.8 t -93.61 121.33 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 123.69 0.796 . . . . 0.0 109.074 -175.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -72.13 151.18 43.19 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.778 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.5 tt -61.3 -39.23 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 120.724 0.297 . . . . 0.0 111.41 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.26 -29.27 70.63 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.922 0.889 . . . . 0.0 111.328 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 34' ' ' HIS . 11.0 t70 -62.54 -47.42 83.96 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.077 0.551 . . . . 0.0 109.789 178.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.0 mp -58.54 -48.36 81.13 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 123.76 0.663 . . . . 0.0 110.28 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -55.04 -44.75 74.96 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 124.375 1.047 . . . . 0.0 111.358 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -73.9 -39.79 63.62 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.755 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 30' ' ' ASP . 7.4 t-80 -68.32 -39.15 82.05 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.34 0.656 . . . . 0.0 111.44 -167.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -70.07 -33.01 71.37 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.545 0.338 . . . . 0.0 110.97 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -68.53 -30.46 69.27 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.495 0.718 . . . . 0.0 110.074 178.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -70.3 -33.74 71.91 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.402 0.681 . . . . 0.0 110.429 173.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 134.96 -27.55 3.16 Favored Glycine 0 C--N 1.344 1.019 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.95 87.99 0.97 Allowed Glycine 0 C--N 1.347 1.154 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.418 ' HB3' ' HB ' ' A' ' 51' ' ' ILE . 26.3 t80 -74.8 109.37 8.22 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -171.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 36.6 m0 -105.15 146.83 28.66 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.598 0.759 . . . . 0.0 109.783 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.0 t -144.22 136.95 26.99 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.173 0.589 . . . . 0.0 110.352 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -88.02 112.05 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 121.466 0.651 . . . . 0.0 109.696 174.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.461 HD12 HD23 ' A' ' 77' ' ' LEU . 84.6 mt -132.38 131.18 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.149 1.38 . . . . 0.0 107.794 175.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.2 t70 60.53 29.89 19.35 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-O 121.819 0.818 . . . . 0.0 111.634 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.23 4.33 73.08 Favored Glycine 0 C--N 1.353 1.499 0 CA-C-N 115.565 -0.743 . . . . 0.0 114.01 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.455 ' HD2' ' SG ' ' A' ' 94' ' ' CYS . 71.8 mmtt -111.56 139.3 47.12 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.212 1.005 . . . . 0.0 109.142 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 52.9 t -89.96 123.22 42.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 170.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -110.71 169.76 8.54 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.686 0.795 . . . . 0.0 109.815 177.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -105.03 142.46 34.78 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.706 172.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.418 ' HB ' ' HB3' ' A' ' 40' ' ' PHE . 25.6 mm -112.56 -29.81 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.876 0.87 . . . . 0.0 110.982 -175.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -66.76 -30.73 71.02 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.578 0.627 . . . . 0.0 109.727 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.488 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 37.1 t70 -74.81 -49.59 20.16 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.847 0.859 . . . . 0.0 110.048 172.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.403 ' HA ' ' HE2' ' A' ' 93' ' ' PHE . 48.6 t80 -48.45 -50.93 29.34 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.814 1.246 . . . . 0.0 112.117 -178.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -68.64 -27.92 66.43 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.438 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 89.2 m -70.23 -36.44 74.52 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.284 0.634 . . . . 0.0 110.37 173.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 84.3 mm-40 -73.76 -23.53 59.74 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.695 0.798 . . . . 0.0 112.213 -176.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 64.3 p -75.04 -13.75 60.53 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.5 mp -71.67 -24.81 61.9 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.253 0.621 . . . . 0.0 110.568 173.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.5 m -71.22 121.96 19.35 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 122.638 0.375 . . . . 0.0 110.08 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.62 -37.62 85.24 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.346 0.659 . . . . 0.0 110.958 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -91.14 78.36 5.88 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 175.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.6 t -157.38 158.52 36.07 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.914 0.886 . . . . 0.0 109.299 -178.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.557 ' HB ' HG22 ' A' ' 86' ' ' THR . 38.9 pt -68.07 -23.5 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.832 170.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.6 mt -88.2 -0.34 56.98 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.697 0.799 . . . . 0.0 112.441 -177.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.36 -36.63 81.77 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.061 0.544 . . . . 0.0 110.914 176.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -73.0 -27.3 61.71 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.148 0.579 . . . . 0.0 110.853 175.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -90.62 1.54 56.69 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.822 0.849 . . . . 0.0 111.489 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.65 94.39 0.43 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.07 0.548 . . . . 0.0 110.652 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.64 -27.87 2.69 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.547 -176.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -77.43 151.8 34.58 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.65 0.78 . . . . 0.0 109.882 175.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -56.16 130.15 74.17 Favored Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 123.463 0.705 . . . . 0.0 109.697 173.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.99 -40.92 58.29 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.334 2.69 . . . . 0.0 114.69 -174.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.45 HG13 HD11 ' A' ' 44' ' ' ILE . 65.1 t -73.98 -43.04 52.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 122.959 0.504 . . . . 0.0 110.509 -176.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.8 t -65.4 -39.48 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 123.44 0.696 . . . . 0.0 110.901 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.86 -36.21 82.81 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.556 1.142 . . . . 0.0 110.76 177.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.461 HD23 HD12 ' A' ' 44' ' ' ILE . 31.5 tp -69.44 -38.94 78.04 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.618 178.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -60.74 -48.45 81.73 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.868 0.467 . . . . 0.0 110.249 175.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.78 -32.68 73.88 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.871 0.868 . . . . 0.0 111.242 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.07 -33.35 73.42 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.281 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.6 -38.96 70.8 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.298 0.239 . . . . 0.0 110.619 174.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -66.82 -29.2 69.07 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.293 0.637 . . . . 0.0 111.582 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.407 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 65.4 t80 -98.53 139.22 34.58 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.032 0.444 . . . . 0.0 110.163 177.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -62.07 -54.24 44.15 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.603 1.161 . . . . 0.0 113.945 -170.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.57 -38.37 90.79 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.228 0.611 . . . . 0.0 111.277 -175.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.557 HG22 ' HB ' ' A' ' 64' ' ' ILE . 36.6 p -80.54 -17.67 50.76 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 115.254 -0.884 . . . . 0.0 112.051 -172.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.9 ptt-85 -78.82 -23.17 45.24 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.158 0.504 . . . . 0.0 110.201 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -67.83 -38.03 82.67 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.258 1.023 . . . . 0.0 112.262 -173.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 32.0 t -73.91 -24.17 59.65 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.558 175.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 18.8 mmt -72.19 -7.84 51.45 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -65.23 -33.81 76.88 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.705 0.402 . . . . 0.0 109.955 169.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.05 -37.79 64.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.42 0.688 . . . . 0.0 111.448 175.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.403 ' HE2' ' HA ' ' A' ' 54' ' ' PHE . 90.4 m-85 -73.9 -23.71 59.6 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 122.895 0.478 . . . . 0.0 111.446 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.455 ' SG ' ' HD2' ' A' ' 47' ' ' LYS . 53.1 t -70.09 102.7 2.11 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.251 0.62 . . . . 0.0 109.714 177.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.3 m -73.2 -20.65 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.453 0.701 . . . . 0.0 110.677 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 170.46 -177.67 43.53 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.996 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -85.65 150.61 24.5 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 173.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -77.6 142.58 38.85 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.136 0.574 . . . . 0.0 110.124 173.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -133.76 130.0 37.44 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.839 0.856 . . . . 0.0 108.747 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 43.8 mt-10 -85.99 129.61 53.48 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.489 1.116 . . . . 0.0 109.482 175.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -55.29 -35.21 90.89 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 123.112 2.541 . . . . 0.0 112.752 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -71.47 -36.23 71.1 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.011 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.454 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 51.5 tp60 . . . . . 0 N--CA 1.485 1.31 0 C-N-CA 123.874 0.87 . . . . 0.0 111.393 -175.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.2 m . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.465 HD22 ' HB2' ' A' ' 99' ' ' LEU . 45.9 mt -97.55 119.07 35.45 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.146 0.498 . . . . 0.0 109.95 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.508 HG13 ' HB2' ' A' ' 30' ' ' ASP . 86.3 t -106.69 131.35 56.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -104.06 170.28 8.01 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 173.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.4 tt -58.15 -31.53 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.065 0.546 . . . . 0.0 111.974 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.69 -42.44 83.67 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.545 0.738 . . . . 0.0 111.319 177.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.508 ' HB2' HG13 ' A' ' 26' ' ' VAL . 38.4 m-20 -63.59 -36.27 83.25 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.165 0.586 . . . . 0.0 111.325 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.8 mt -63.88 -51.58 63.91 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 123.904 0.752 . . . . 0.0 109.748 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -59.18 -46.26 88.87 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.555 -1.202 . . . . 0.0 112.262 -172.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -77.08 -30.17 55.3 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 111.479 0.178 . . . . 0.0 111.479 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -73.44 -26.36 60.91 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.745 0.418 . . . . 0.0 110.844 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -61.28 -37.56 83.61 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.745 0.818 . . . . 0.0 110.377 172.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -70.62 -32.97 70.51 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.988 0.915 . . . . 0.0 110.789 174.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -64.56 -33.42 75.87 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.94 0.896 . . . . 0.0 110.819 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 125.46 -27.14 5.32 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 116.434 -0.348 . . . . 0.0 112.271 175.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.09 107.85 2.36 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 175.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -80.27 108.02 13.54 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -99.79 154.8 18.04 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.055 0.942 . . . . 0.0 110.031 176.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.3 t -147.96 164.63 33.18 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.093 0.957 . . . . 0.0 109.093 172.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.527 HG22 HG22 ' A' ' 48' ' ' VAL . 98.2 t -120.68 117.39 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.201 0.601 . . . . 0.0 110.796 -176.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.6 mt -138.77 138.13 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.698 1.199 . . . . 0.0 107.919 174.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.6 t70 63.08 30.64 16.16 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.475 1.11 . . . . 0.0 111.004 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.43 18.08 69.28 Favored Glycine 0 C--N 1.355 1.627 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.539 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.431 ' HD2' ' SG ' ' A' ' 94' ' ' CYS . 75.0 mmtt -124.15 148.75 46.97 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.273 1.029 . . . . 0.0 109.203 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.527 HG22 HG22 ' A' ' 43' ' ' VAL . 39.1 t -100.08 128.94 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.509 0.724 . . . . 0.0 109.212 174.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -122.33 144.9 48.72 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.856 0.862 . . . . 0.0 109.254 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -87.43 104.62 16.62 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 174.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.493 HG23 ' HB2' ' A' ' 73' ' ' PRO . 24.6 mm -62.59 -31.89 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.223 1.009 . . . . 0.0 111.082 174.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.0 ttpp -60.01 -36.97 78.36 Favored 'General case' 0 CA--C 1.554 1.125 0 O-C-N 123.597 0.561 . . . . 0.0 110.291 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.425 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 33.0 t70 -75.3 -42.5 54.52 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.281 0.633 . . . . 0.0 111.209 174.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.409 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 50.5 t80 -51.08 -51.76 50.15 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.704 1.202 . . . . 0.0 111.21 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -67.66 -27.73 67.11 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.837 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 58.8 m -68.34 -38.82 81.87 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.599 0.36 . . . . 0.0 110.773 174.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.464 ' HB2' HD12 ' A' ' 65' ' ' LEU . 78.6 mm-40 -74.39 -27.24 60.55 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.305 0.642 . . . . 0.0 111.345 -177.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.0 p -74.06 -10.42 59.61 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.023 0.529 . . . . 0.0 112.168 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.8 mp -71.32 -17.21 62.46 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 122.974 0.51 . . . . 0.0 111.352 171.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.3 m -88.04 133.44 33.97 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -75.11 -31.9 61.26 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.135 0.493 . . . . 0.0 109.719 173.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -83.49 63.12 7.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.79 0.836 . . . . 0.0 109.664 174.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.8 p -146.49 160.19 42.43 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.547 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.63 ' HB ' HG22 ' A' ' 86' ' ' THR . 40.0 pt -68.03 -22.73 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.688 170.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.464 HD12 ' HB2' ' A' ' 57' ' ' GLN . 44.3 mt -91.49 2.49 56.39 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.186 0.995 . . . . 0.0 112.208 -174.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.38 -33.34 75.32 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.067 0.547 . . . . 0.0 110.989 174.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -75.82 -29.87 58.8 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.679 0.792 . . . . 0.0 110.659 175.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -90.8 1.54 56.83 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.369 1.068 . . . . 0.0 111.688 -178.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.3 -25.87 67.82 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.624 0.77 . . . . 0.0 111.394 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -103.97 30.7 9.72 Favored Glycine 0 C--N 1.35 1.309 0 CA-C-N 116.547 -0.297 . . . . 0.0 112.431 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -139.11 154.49 48.15 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.403 1.081 . . . . 0.0 108.717 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -59.79 131.68 88.92 Favored Pre-proline 0 N--CA 1.48 1.052 0 CA-C-O 118.209 -0.9 . . . . 0.0 109.788 175.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.493 ' HB2' HG23 ' A' ' 51' ' ' ILE . 27.7 Cg_endo -58.29 -36.98 97.14 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 123.208 2.605 . . . . 0.0 114.329 -173.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.1 t -74.67 -45.68 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 122.893 0.477 . . . . 0.0 110.439 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.8 t -66.3 -35.83 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.686 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.81 -34.68 74.02 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.229 1.011 . . . . 0.0 110.627 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.614 HD12 ' SD ' ' A' ' 90' ' ' MET . 51.0 tp -66.15 -38.59 88.49 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.845 0.858 . . . . 0.0 110.486 177.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -58.73 -50.18 74.85 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.78 0.432 . . . . 0.0 110.049 174.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.47 -34.08 76.12 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.956 0.903 . . . . 0.0 111.012 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.73 -28.74 61.86 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.818 0.847 . . . . 0.0 111.506 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 81' ' ' LEU . 2.9 mm? -71.83 -28.99 63.94 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.333 0.253 . . . . 0.0 111.107 172.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -90.45 -25.01 20.56 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.529 0.732 . . . . 0.0 111.728 -174.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.418 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 40.7 t80 -91.57 133.78 35.24 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.653 0.381 . . . . 0.0 110.576 -176.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.14 -36.98 85.41 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.957 1.303 . . . . 0.0 113.96 -168.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -74.23 -27.27 60.7 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.32 0.648 . . . . 0.0 111.309 -176.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.63 HG22 ' HB ' ' A' ' 64' ' ' ILE . 39.4 p -101.53 -31.02 11.07 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.588 -170.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.409 ' HD2' ' N ' ' A' ' 88' ' ' GLU . 6.0 ppt_? -60.12 -32.03 70.61 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 123.794 0.837 . . . . 0.0 112.387 -174.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.409 ' N ' ' HD2' ' A' ' 87' ' ' ARG . 7.8 pt-20 -64.45 -43.4 94.39 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.49 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.0 t -78.43 -16.69 57.33 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.621 0.768 . . . . 0.0 111.632 -176.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.614 ' SD ' HD12 ' A' ' 77' ' ' LEU . 36.1 mmt -61.11 -28.24 68.95 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.282 0.633 . . . . 0.0 111.556 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -64.52 -25.64 68.08 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.673 0.789 . . . . 0.0 111.416 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.46 -25.68 57.62 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.535 0.734 . . . . 0.0 111.454 175.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.409 ' CE1' ' HA ' ' A' ' 54' ' ' PHE . 98.5 m-85 -86.44 -20.65 27.84 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.472 0.709 . . . . 0.0 111.374 176.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.431 ' SG ' ' HD2' ' A' ' 47' ' ' LYS . 47.6 t -67.07 97.88 0.54 Allowed 'General case' 0 C--N 1.351 0.646 0 O-C-N 123.814 0.696 . . . . 0.0 110.749 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.7 m -74.76 -10.58 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.874 0.869 . . . . 0.0 111.42 177.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 169.18 175.68 38.64 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 174.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.407 ' HG2' ' NZ ' ' A' ' 47' ' ' LYS . 61.5 mt-30 -80.53 163.51 23.67 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.362 0.665 . . . . 0.0 109.753 171.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -118.23 146.57 44.16 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.774 0.429 . . . . 0.0 109.891 175.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.465 ' HB2' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -142.43 125.76 16.57 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 174.112 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.7 mp0 -69.8 137.93 87.91 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 123.167 0.587 . . . . 0.0 110.479 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -51.69 -42.55 56.15 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.868 2.378 . . . . 0.0 112.013 169.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -59.23 -52.32 66.2 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.774 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 . . . . . 0 N--CA 1.481 1.087 0 C-N-CA 124.381 1.072 . . . . 0.0 110.97 -178.49 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.3 m . . . . . 0 CA--C 1.542 0.641 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.5 mt -77.22 102.39 6.63 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.539 ' HB ' HG21 ' A' ' 48' ' ' VAL . 94.6 t -93.51 116.74 35.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.042 -177.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.413 ' HD2' ' HB3' ' A' ' 101' ' ' PRO . 71.6 mtm180 -82.34 166.49 19.43 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.223 176.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.0 tt -56.28 -37.69 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.296 0.639 . . . . 0.0 110.609 172.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.61 -47.55 83.97 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.969 0.908 . . . . 0.0 111.212 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -67.18 -37.47 83.77 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.83 0.852 . . . . 0.0 110.935 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 36.3 tp -59.13 -45.14 91.71 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.75 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -72.28 -49.69 32.82 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.131 0.973 . . . . 0.0 112.11 -177.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.67 -33.68 71.19 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -170.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.401 ' CE1' ' HA3' ' A' ' 39' ' ' GLY . 43.4 t-80 -73.59 -30.91 63.3 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 120.564 0.221 . . . . 0.0 110.708 178.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -66.99 -38.64 86.38 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 173.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -65.4 -34.12 77.56 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.444 0.698 . . . . 0.0 110.363 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -65.16 -34.17 77.75 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.9 0.88 . . . . 0.0 110.514 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 139.08 -27.19 2.67 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 111.999 -0.44 . . . . 0.0 111.999 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.401 ' HA3' ' CE1' ' A' ' 34' ' ' HIS . . . -81.13 97.74 1.8 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 112.014 -0.434 . . . . 0.0 112.014 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -75.58 113.51 13.08 Favored 'General case' 0 C--N 1.347 0.469 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -98.09 164.5 12.31 Favored 'General case' 0 C--O 1.24 0.591 0 O-C-N 123.863 0.727 . . . . 0.0 109.799 176.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.405 HG21 HD11 ' A' ' 51' ' ' ILE . 15.3 t -147.05 133.9 20.13 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.659 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.541 HG22 HG22 ' A' ' 48' ' ' VAL . 82.2 t -95.95 107.03 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.6 mt -118.25 113.86 43.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 123.938 0.895 . . . . 0.0 108.844 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.3 t70 62.04 32.84 17.48 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.334 1.053 . . . . 0.0 111.272 174.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.99 5.66 85.85 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 115.255 -0.884 . . . . 0.0 114.081 177.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -115.65 150.4 36.8 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.495 0.718 . . . . 0.0 109.341 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.541 HG22 HG22 ' A' ' 43' ' ' VAL . 60.4 t -113.68 121.4 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 123.674 0.79 . . . . 0.0 109.856 -175.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -124.46 155.39 38.98 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.928 0.891 . . . . 0.0 109.175 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.431 ' HB3' ' HB2' ' A' ' 53' ' ' ASP . 7.7 t70 -97.09 120.29 37.17 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.438 ' O ' ' HG3' ' A' ' 55' ' ' GLN . 33.4 mm -73.68 -32.73 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.589 0.756 . . . . 0.0 111.599 -178.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -63.71 -45.99 87.48 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.431 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . 2.1 m-20 -65.51 -36.73 84.69 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.644 175.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -58.69 -51.88 68.06 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.609 0.764 . . . . 0.0 110.499 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.476 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 28.0 mt-30 -63.26 -29.23 70.6 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.889 -174.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.3 m -56.12 -36.75 68.57 Favored 'General case' 0 CA--C 1.553 1.088 0 O-C-N 123.862 0.726 . . . . 0.0 111.73 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -76.67 -30.99 56.99 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.281 0.632 . . . . 0.0 111.701 178.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 62.8 p -81.42 1.35 33.48 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 55' ' ' GLN . 83.1 mt -82.18 9.27 9.0 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.367 0.667 . . . . 0.0 112.33 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.5 t -128.53 165.5 20.63 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.226 0.61 . . . . 0.0 110.736 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -70.95 -60.83 2.02 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.73 0.812 . . . . 0.0 110.484 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -83.05 90.4 7.03 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.276 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.5 t -143.48 149.86 38.15 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.651 -1.158 . . . . 0.0 108.907 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.546 ' HB ' HG22 ' A' ' 86' ' ' THR . 37.2 pt -67.79 -19.94 25.53 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 C-N-CA 122.834 0.454 . . . . 0.0 110.843 171.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 60.1 mt -95.71 -1.76 49.3 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.351 1.06 . . . . 0.0 111.755 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.2 -29.68 69.41 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.947 0.499 . . . . 0.0 111.014 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -71.66 -19.96 62.02 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.786 0.834 . . . . 0.0 111.671 175.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.587 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 78.1 m-85 -99.89 10.72 40.83 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.344 1.058 . . . . 0.0 111.613 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.21 -26.1 68.36 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.309 0.643 . . . . 0.0 112.408 -176.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.57 18.84 53.98 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 116.393 -0.367 . . . . 0.0 113.245 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -132.88 151.11 52.09 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.788 0.835 . . . . 0.0 109.721 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -55.38 128.46 67.38 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 124.488 1.115 . . . . 0.0 109.924 172.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -54.76 -29.44 62.37 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.431 2.754 . . . . 0.0 114.626 -173.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.424 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 34.0 t -74.72 -49.37 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.5 t -68.8 -30.01 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 123.991 0.916 . . . . 0.0 111.017 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -68.74 -40.63 79.74 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.865 1.266 . . . . 0.0 109.895 176.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.527 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 41.4 tp -63.5 -40.85 98.17 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.684 175.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 35.3 mt-10 -58.39 -47.66 83.16 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.283 0.633 . . . . 0.0 111.384 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.99 -35.33 80.86 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.954 175.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.54 -18.1 59.89 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.126 0.97 . . . . 0.0 112.629 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 89.1 mt -77.06 -36.56 55.82 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 173.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -76.21 -21.21 56.69 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.577 175.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -90.84 115.9 28.25 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.842 0.857 . . . . 0.0 110.099 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.75 -23.24 65.22 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.164 0.985 . . . . 0.0 113.366 -173.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.89 -14.49 57.97 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.286 0.634 . . . . 0.0 112.044 -178.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.546 HG22 ' HB ' ' A' ' 64' ' ' ILE . 7.2 p -110.47 -29.78 7.94 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.328 0.651 . . . . 0.0 112.682 -177.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -50.62 -27.39 6.77 Favored 'General case' 0 N--CA 1.507 2.397 0 C-N-CA 124.32 1.048 . . . . 0.0 113.247 -174.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -55.15 -48.54 73.57 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.245 1.418 . . . . 0.0 112.648 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.7 m -76.88 -20.25 56.48 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.116 0.566 . . . . 0.0 111.787 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.552 ' SD ' ' N ' ' A' ' 90' ' ' MET . 0.1 OUTLIER -74.76 -13.27 60.57 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.774 0.829 . . . . 0.0 111.274 176.52 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.448 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 28.4 m170 -75.0 -23.19 58.2 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.061 0.544 . . . . 0.0 110.017 171.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.86 -30.22 23.08 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.56 0.744 . . . . 0.0 110.728 172.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -83.59 -23.91 31.73 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.439 0.296 . . . . 0.0 111.481 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.448 ' SG ' ' HA ' ' A' ' 91' ' ' HIS . 31.0 p -73.42 109.93 7.31 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-O 120.959 0.409 . . . . 0.0 109.98 -177.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.8 t -68.96 -45.89 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.938 172.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 175.0 -150.12 10.89 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.857 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -115.46 137.57 51.92 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.035 1.334 . . . . 0.0 109.044 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -71.14 134.03 46.66 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.132 0.573 . . . . 0.0 110.37 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -143.78 122.89 12.88 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.418 ' HB2' ' CB ' ' A' ' 103' ' ' GLN . 47.1 mt-10 -66.12 133.83 94.76 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.446 0.699 . . . . 0.0 110.687 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.413 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 17.4 Cg_endo -57.48 -25.49 66.76 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 123.263 2.642 . . . . 0.0 113.139 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -79.66 -43.12 23.37 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.388 0.675 . . . . 0.0 110.4 173.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.418 ' CB ' ' HB2' ' A' ' 100' ' ' GLU . 9.6 tt0 . . . . . 0 N--CA 1.483 1.209 0 C-N-CA 123.874 0.87 . . . . 0.0 111.846 -175.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.8 m . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.4 mt -86.86 111.01 20.36 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.6 t -91.19 114.15 28.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.8 ptp85 -70.67 158.05 36.9 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.484 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.45 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 10.1 tt -55.64 -44.68 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 123.352 0.407 . . . . 0.0 111.214 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.9 -33.41 75.26 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.578 0.751 . . . . 0.0 111.496 -177.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -74.55 -40.83 61.44 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.594 0.358 . . . . 0.0 110.105 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 57.2 tp -60.81 -53.25 59.6 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.115 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 51.4 mm-40 -58.88 -51.87 68.18 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.096 0.958 . . . . 0.0 111.827 -177.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -68.51 -41.06 80.51 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -175.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 66.2 t-80 -71.74 -42.66 67.0 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 118.033 0.379 . . . . 0.0 110.631 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -64.08 -51.14 65.47 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.823 0.849 . . . . 0.0 110.883 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -79.44 5.99 11.37 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.795 0.838 . . . . 0.0 111.994 -177.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -91.44 -8.42 47.83 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.884 0.874 . . . . 0.0 110.844 174.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.49 -26.26 12.23 Favored Glycine 0 C--N 1.344 0.987 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -175.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.596 ' HA2' ' HD3' ' A' ' 52' ' ' LYS . . . -75.35 77.73 1.18 Allowed Glycine 0 C--N 1.348 1.249 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 171.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -72.96 117.91 15.27 Favored 'General case' 0 C--N 1.345 0.404 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -163.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 29.0 m0 -110.26 172.0 7.12 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.883 1.273 . . . . 0.0 109.912 175.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.7 t -147.51 149.49 32.74 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.0 175.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 p -109.98 110.01 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.488 HD12 HD23 ' A' ' 77' ' ' LEU . 57.8 mt -124.77 124.0 67.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 124.076 0.95 . . . . 0.0 108.761 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.9 t70 63.0 32.91 15.23 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.483 1.113 . . . . 0.0 111.025 174.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.35 2.35 87.44 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.914 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 97' ' ' GLN . 46.4 mmtm -110.2 147.76 33.13 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.071 0.949 . . . . 0.0 109.261 177.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.8 t -102.43 127.66 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 122.842 0.457 . . . . 0.0 109.922 175.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -121.82 169.49 10.72 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.851 1.261 . . . . 0.0 108.987 175.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -94.64 157.07 16.13 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.65 0.738 . . . . 0.0 109.715 168.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.474 HG23 ' HB2' ' A' ' 73' ' ' PRO . 30.8 mm -121.05 -30.02 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.144 1.378 . . . . 0.0 108.911 172.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.596 ' HD3' ' HA2' ' A' ' 39' ' ' GLY . 35.7 ttpt -54.97 -58.0 9.39 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.86 0.864 . . . . 0.0 111.044 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -74.27 -36.34 63.8 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.149 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -51.95 -55.99 16.93 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.721 1.208 . . . . 0.0 111.846 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -68.33 -26.78 65.78 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.987 -176.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.9 m -66.78 -47.38 72.31 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 172.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -76.75 -13.67 60.01 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.025 0.93 . . . . 0.0 112.844 -176.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.553 ' HA ' ' HB2' ' A' ' 65' ' ' LEU . 90.8 p -67.96 -20.13 65.02 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.142 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -91.47 -0.16 57.58 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.612 0.365 . . . . 0.0 111.862 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.8 m -75.23 126.35 30.85 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 175.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -57.31 -48.4 79.05 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.389 1.076 . . . . 0.0 111.888 -170.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -82.59 -12.27 57.82 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.041 0.536 . . . . 0.0 112.431 -173.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 65.8 m -67.61 151.44 47.3 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 120.995 0.426 . . . . 0.0 111.232 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.57 ' HB ' HG22 ' A' ' 86' ' ' THR . 43.5 pt -61.04 -23.61 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.211 1.004 . . . . 0.0 111.468 174.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.553 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 63.1 mt -86.1 0.22 54.02 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.304 1.041 . . . . 0.0 111.961 -175.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.91 -33.24 71.92 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 122.969 0.507 . . . . 0.0 111.007 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -74.67 -25.58 59.27 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.582 0.753 . . . . 0.0 110.565 172.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.552 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 38.2 m-85 -95.99 3.7 53.25 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.317 1.047 . . . . 0.0 111.531 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.47 -29.35 69.45 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.57 0.748 . . . . 0.0 111.011 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.12 23.22 22.12 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.88 176.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -135.06 155.84 50.05 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.316 1.046 . . . . 0.0 108.912 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.84 131.28 78.98 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 124.222 1.009 . . . . 0.0 109.901 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.474 ' HB2' HG23 ' A' ' 51' ' ' ILE . 18.9 Cg_endo -55.4 -33.59 86.2 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 123.484 2.79 . . . . 0.0 114.303 -174.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.8 t -74.51 -46.99 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.4 t -64.1 -35.26 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 123.465 0.706 . . . . 0.0 110.58 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.552 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -67.41 -37.49 83.15 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.065 1.346 . . . . 0.0 110.56 178.036 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.69 HD12 ' SD ' ' A' ' 90' ' ' MET . 58.3 tp -67.2 -43.4 82.2 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.08 0.952 . . . . 0.0 110.466 176.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -64.6 -37.61 88.16 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.83 0.852 . . . . 0.0 111.2 178.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.29 -33.42 69.7 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.824 0.85 . . . . 0.0 110.473 176.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.49 -23.38 53.78 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.481 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.446 HD23 ' HG3' ' A' ' 90' ' ' MET . 90.1 mt -72.28 -39.96 67.93 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.891 0.476 . . . . 0.0 109.83 170.041 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -68.65 -43.0 77.16 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.605 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.422 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 5.1 t80 -82.58 124.6 30.29 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -176.068 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.31 -27.97 69.39 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.712 1.205 . . . . 0.0 112.737 -172.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -71.0 -35.9 72.24 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.471 0.709 . . . . 0.0 110.935 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.57 HG22 ' HB ' ' A' ' 64' ' ' ILE . 30.9 p -94.96 -21.25 18.74 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.534 0.734 . . . . 0.0 112.959 -171.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -66.01 -24.44 66.77 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.452 0.701 . . . . 0.0 112.078 -174.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -66.26 -37.54 85.72 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.724 0.81 . . . . 0.0 111.329 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.5 t -76.7 -24.19 53.15 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.452 0.701 . . . . 0.0 110.943 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.69 ' SD ' HD12 ' A' ' 77' ' ' LEU . 33.1 mmt -63.27 -20.88 65.86 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.737 0.815 . . . . 0.0 111.686 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 27.7 m170 -64.46 -31.78 73.13 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.638 0.775 . . . . 0.0 111.036 176.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.82 -43.84 74.72 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.796 175.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -73.33 -23.82 60.29 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.555 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 35.5 t -74.29 104.32 5.01 Favored 'General case' 0 C--N 1.349 0.581 0 C-N-CA 123.291 0.636 . . . . 0.0 109.346 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.2 m -80.65 -9.43 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 123.302 0.641 . . . . 0.0 110.483 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 156.6 -164.77 32.74 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.577 172.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 43.1 tt0 -99.13 142.5 30.54 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.517 1.127 . . . . 0.0 109.228 171.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -74.57 137.82 42.62 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 122.901 0.481 . . . . 0.0 110.158 172.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -135.23 120.08 18.48 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 44.7 mt-10 -80.78 146.31 59.78 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 123.704 0.802 . . . . 0.0 110.026 174.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.6 -24.84 41.28 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.497 2.131 . . . . 0.0 111.865 -176.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -84.14 -28.35 27.5 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.956 0.902 . . . . 0.0 110.663 175.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 61.0 tp60 . . . . . 0 N--CA 1.479 1.024 0 C-N-CA 123.077 0.551 . . . . 0.0 111.577 -176.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.4 m . . . . . 0 CA--C 1.544 0.747 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.459 HD22 HD23 ' A' ' 99' ' ' LEU . 86.4 mt -81.9 104.2 12.1 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 172.05 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.9 t -93.84 118.99 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -85.33 165.7 17.06 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.5 tt -57.0 -36.25 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 123.085 0.554 . . . . 0.0 112.244 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.11 -41.57 83.84 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.426 0.69 . . . . 0.0 111.077 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -64.71 -34.4 78.23 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.809 0.844 . . . . 0.0 111.495 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.7 mt -60.76 -47.15 87.63 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 123.545 0.528 . . . . 0.0 109.83 175.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -65.69 -44.75 85.25 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.828 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -62.65 -49.91 73.26 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.988 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -69.26 -35.21 75.85 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.757 0.423 . . . . 0.0 110.232 -174.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -62.99 -42.91 99.97 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.438 0.695 . . . . 0.0 109.766 174.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -67.31 -31.64 72.07 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.892 0.877 . . . . 0.0 111.096 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -72.03 -18.49 61.95 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.348 0.659 . . . . 0.0 111.078 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.93 32.56 3.51 Favored Glycine 0 C--N 1.345 1.049 0 O-C-N 123.144 0.278 . . . . 0.0 112.804 176.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -140.36 104.81 0.42 Allowed Glycine 0 C--N 1.343 0.927 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 177.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -75.6 110.63 10.16 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.769 0.428 . . . . 0.0 110.076 -168.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -100.04 145.38 27.98 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.176 0.99 . . . . 0.0 110.375 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.3 t -140.56 151.51 44.77 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.257 1.023 . . . . 0.0 109.358 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.4 p -102.96 120.35 52.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 172.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.432 HD13 ' HG2' ' A' ' 78' ' ' GLU . 63.6 mt -131.49 123.82 53.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.614 1.166 . . . . 0.0 108.446 176.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.7 t70 62.33 31.81 17.22 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.413 1.085 . . . . 0.0 111.721 175.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.95 7.13 87.56 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-N 115.673 -0.694 . . . . 0.0 113.337 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -110.69 159.54 17.51 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.664 1.186 . . . . 0.0 108.442 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 75.6 t -114.96 139.8 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 122.957 0.503 . . . . 0.0 109.698 174.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -133.92 155.73 49.38 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.324 1.05 . . . . 0.0 110.289 -175.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -102.52 106.91 17.7 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 173.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.533 HG23 ' HB2' ' A' ' 73' ' ' PRO . 30.8 mm -68.02 -34.31 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.636 1.174 . . . . 0.0 112.183 -178.022 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -59.82 -41.4 91.19 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 123.667 0.604 . . . . 0.0 110.29 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.425 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 33.7 t70 -68.83 -45.53 70.92 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.943 0.897 . . . . 0.0 110.655 177.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.448 ' HA ' ' HE2' ' A' ' 93' ' ' PHE . 77.2 t80 -47.56 -60.57 2.44 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.544 1.138 . . . . 0.0 111.704 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -63.57 -29.81 71.02 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.521 -178.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 96.9 m -69.37 -35.08 75.47 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 122.788 0.435 . . . . 0.0 111.168 178.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 23.2 mm-40 -70.74 -14.35 62.41 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.787 0.435 . . . . 0.0 111.479 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.2 t -84.63 12.37 7.23 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.85 0.86 . . . . 0.0 111.588 174.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -64.75 -28.89 69.89 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.095 0.558 . . . . 0.0 111.365 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.6 m -88.9 133.2 34.37 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.729 0.812 . . . . 0.0 109.646 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -28.11 68.12 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.51 0.724 . . . . 0.0 111.207 178.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -103.72 89.33 3.3 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.94 0.896 . . . . 0.0 108.982 171.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.3 p -147.6 169.55 19.39 Favored 'General case' 0 C--O 1.245 0.838 0 C-N-CA 123.835 0.854 . . . . 0.0 109.241 177.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.655 ' HB ' HG22 ' A' ' 86' ' ' THR . 48.2 pt -68.49 -22.29 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.658 172.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.438 ' HG ' HG13 ' A' ' 64' ' ' ILE . 66.5 mt -101.4 5.51 42.15 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.248 1.019 . . . . 0.0 111.715 -176.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.11 -30.19 71.27 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.261 0.625 . . . . 0.0 110.779 173.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -79.56 -23.84 42.53 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.224 1.01 . . . . 0.0 111.079 174.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.556 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 55.1 m-85 -99.3 0.39 42.91 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.226 1.01 . . . . 0.0 111.801 -177.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.73 -23.28 64.33 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.794 0.838 . . . . 0.0 111.87 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -101.86 24.39 31.53 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 116.61 -0.268 . . . . 0.0 113.063 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -136.12 158.89 43.33 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.034 0.934 . . . . 0.0 109.665 -175.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -56.24 129.74 74.35 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 123.947 0.899 . . . . 0.0 109.728 174.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.533 ' HB2' HG23 ' A' ' 51' ' ' ILE . 37.3 Cg_endo -60.62 -31.49 92.24 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.648 2.232 . . . . 0.0 114.064 -170.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.469 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 37.0 t -75.31 -53.27 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.3 t -61.47 -36.14 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 123.59 0.756 . . . . 0.0 111.308 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.556 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -66.92 -37.09 83.69 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.506 1.122 . . . . 0.0 111.105 178.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.3 tp -68.39 -38.56 81.45 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.881 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 35.9 mt-10 -65.23 -41.64 94.2 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.211 0.604 . . . . 0.0 110.041 177.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.23 -33.42 75.71 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.707 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.12 -34.88 71.5 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.856 0.862 . . . . 0.0 111.643 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.4 mt -67.42 -40.57 85.54 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.144 0.578 . . . . 0.0 110.15 175.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -73.52 -25.0 60.23 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.235 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -79.46 114.39 18.35 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -54.57 -29.61 51.85 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.665 1.586 . . . . 0.0 112.933 -177.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -70.88 -58.45 3.58 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.274 0.63 . . . . 0.0 110.83 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.655 HG22 ' HB ' ' A' ' 64' ' ' ILE . 67.4 p -87.72 -10.81 50.06 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -166.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -65.8 -31.99 73.26 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.103 0.561 . . . . 0.0 111.907 -172.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -29.39 64.27 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.516 -173.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.6 t -74.93 -23.87 58.4 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.581 0.752 . . . . 0.0 110.995 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.43 ' HA ' ' HD1' ' A' ' 93' ' ' PHE . 21.8 mmt -73.91 0.35 13.68 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.833 0.853 . . . . 0.0 112.669 -177.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -63.83 -31.13 72.2 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.616 0.766 . . . . 0.0 110.778 170.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.06 -31.08 39.45 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.17 0.988 . . . . 0.0 111.052 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.448 ' HE2' ' HA ' ' A' ' 54' ' ' PHE . 60.2 m-85 -81.27 -24.83 37.03 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.527 0.731 . . . . 0.0 110.685 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.1 t -78.31 108.65 11.79 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 123.437 0.695 . . . . 0.0 109.341 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.3 p -79.28 -19.55 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.495 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 155.35 -156.53 27.03 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 116.387 -0.369 . . . . 0.0 112.391 176.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.431 ' HB2' HD23 ' A' ' 25' ' ' LEU . 16.6 mm100 -78.58 164.77 24.39 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.778 1.231 . . . . 0.0 111.306 174.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -109.62 143.33 39.49 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 162.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.459 HD23 HD22 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -137.64 123.95 20.6 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.17 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.63 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 1.7 mp0 -73.24 143.3 83.09 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 123.212 0.605 . . . . 0.0 110.397 178.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -58.82 -32.5 97.31 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.918 2.412 . . . . 0.0 112.739 175.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -82.78 -29.13 29.86 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.082 0.553 . . . . 0.0 110.446 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.63 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 55.9 tp60 . . . . . 0 N--CA 1.484 1.257 0 C-N-CA 123.333 0.653 . . . . 0.0 110.903 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.4 m . . . . . 0 CA--C 1.545 0.771 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.517 HD13 HD22 ' A' ' 99' ' ' LEU . 85.8 mt -83.31 106.07 14.78 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.417 ' HB ' HG21 ' A' ' 48' ' ' VAL . 59.7 t -94.31 124.76 46.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 124.216 1.006 . . . . 0.0 110.164 -170.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.551 ' HB2' ' HB2' ' A' ' 30' ' ' ASP . 54.0 mtm180 -73.25 164.23 26.97 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.909 1.283 . . . . 0.0 110.521 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.5 tt -66.87 -42.61 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 118.203 0.456 . . . . 0.0 111.598 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.35 -29.45 68.18 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.763 177.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.551 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 23.3 t0 -59.28 -38.64 80.67 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.596 1.159 . . . . 0.0 110.944 -175.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.8 mp -57.46 -48.35 79.4 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 123.844 0.715 . . . . 0.0 110.727 173.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -67.92 -42.47 81.02 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.284 1.033 . . . . 0.0 111.479 -172.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -71.76 -40.35 69.37 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.374 0.67 . . . . 0.0 111.109 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -66.79 -33.39 75.52 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 176.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -64.52 -44.29 91.34 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.237 1.015 . . . . 0.0 111.029 175.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -64.59 -31.56 72.83 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.432 0.693 . . . . 0.0 110.521 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -66.93 -34.69 78.32 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.048 0.939 . . . . 0.0 110.846 176.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 128.19 25.43 1.08 Allowed Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.028 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -134.59 100.4 0.37 Allowed Glycine 0 C--N 1.344 0.997 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -178.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -75.1 107.57 7.27 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -170.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 25.7 m0 -103.22 131.71 50.05 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.742 0.817 . . . . 0.0 109.852 177.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -127.78 144.81 51.07 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.818 1.247 . . . . 0.0 109.106 177.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 p -96.28 112.35 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 120.976 0.417 . . . . 0.0 110.197 176.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.4 mt -122.26 118.62 55.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 123.81 0.844 . . . . 0.0 109.113 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.2 t70 62.57 32.84 16.26 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.832 1.253 . . . . 0.0 112.577 172.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.02 7.29 85.64 Favored Glycine 0 N--CA 1.477 1.408 0 CA-C-N 116.073 -0.512 . . . . 0.0 113.635 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.418 ' HB2' ' CE1' ' A' ' 49' ' ' TYR . 32.4 mmtp -117.87 161.78 19.19 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.269 1.027 . . . . 0.0 108.853 176.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.417 HG21 ' HB ' ' A' ' 26' ' ' VAL . 96.4 t -113.54 124.41 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 174.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.418 ' CE1' ' HB2' ' A' ' 47' ' ' LYS . 76.9 m-85 -117.79 156.25 28.65 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.34 1.056 . . . . 0.0 109.366 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -98.79 147.1 25.24 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 173.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.4 ' O ' ' HB3' ' A' ' 54' ' ' PHE . 24.5 mm -109.46 -33.6 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.305 1.042 . . . . 0.0 111.402 -172.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.1 -29.29 62.82 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 118.566 0.621 . . . . 0.0 110.081 176.111 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -70.9 -39.15 72.95 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.118 0.967 . . . . 0.0 110.712 172.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.4 ' HB3' ' O ' ' A' ' 51' ' ' ILE . 13.0 t80 -54.1 -54.51 38.51 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.935 0.894 . . . . 0.0 109.852 171.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -66.86 -28.55 68.43 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.952 0.901 . . . . 0.0 112.398 -173.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.4 m -58.25 -47.75 82.58 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.136 0.493 . . . . 0.0 110.195 171.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -77.31 -18.18 57.72 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.578 0.751 . . . . 0.0 111.523 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.492 ' HA ' ' HB2' ' A' ' 65' ' ' LEU . 25.9 t -75.6 -22.36 56.96 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.688 0.395 . . . . 0.0 111.031 177.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.8 mt -83.81 7.65 17.26 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.025 0.53 . . . . 0.0 110.986 172.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.9 m -105.97 134.36 49.21 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.892 0.877 . . . . 0.0 109.657 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -75.26 -40.33 58.94 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.717 0.807 . . . . 0.0 112.715 -173.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -82.15 0.77 39.38 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.293 0.637 . . . . 0.0 111.944 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.9 m -81.33 151.08 28.18 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 122.679 0.392 . . . . 0.0 109.996 170.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.533 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 24.5 pt -55.3 -30.61 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.577 0.751 . . . . 0.0 110.986 170.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 49.5 mt -73.88 -0.93 17.52 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.261 1.024 . . . . 0.0 113.049 -173.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.48 -41.26 96.58 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.649 0.78 . . . . 0.0 110.905 171.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.533 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 8.2 pt20 -76.65 -20.79 56.29 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.16 0.584 . . . . 0.0 110.937 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.458 ' HD2' ' HA ' ' A' ' 65' ' ' LEU . 75.5 m-85 -92.51 2.62 56.58 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.03 0.932 . . . . 0.0 111.33 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.39 111.83 4.88 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.153 0.581 . . . . 0.0 110.349 177.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.61 -29.33 7.93 Favored Glycine 0 N--CA 1.474 1.232 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 -175.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -79.92 151.62 30.01 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.618 0.767 . . . . 0.0 109.299 173.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.543 ' HB3' HG12 ' A' ' 75' ' ' VAL . 26.3 t70 -59.32 126.74 82.93 Favored Pre-proline 0 N--CA 1.483 1.182 0 CA-C-O 118.908 -0.568 . . . . 0.0 110.154 -178.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.07 -34.8 88.62 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 123.319 2.68 . . . . 0.0 114.11 -174.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.462 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 60.2 t -73.63 -49.66 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.182 -178.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.543 HG12 ' HB3' ' A' ' 72' ' ' ASP . 3.8 p -68.43 -28.59 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 122.791 0.436 . . . . 0.0 111.126 -177.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.06 -36.56 75.06 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.059 0.943 . . . . 0.0 109.767 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.648 ' HG ' ' SD ' ' A' ' 90' ' ' MET . 4.4 tt -71.81 -37.98 70.28 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.178 0.991 . . . . 0.0 110.029 176.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 44.3 mt-10 -64.34 -49.29 72.29 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.094 0.958 . . . . 0.0 110.87 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.03 -29.55 69.39 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.812 0.845 . . . . 0.0 111.019 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.62 -35.03 72.74 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.904 177.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.0 mt -63.34 -35.53 80.69 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.742 0.417 . . . . 0.0 110.771 175.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -67.07 -47.73 70.38 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.388 175.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.462 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 23.1 t80 -81.87 119.82 24.41 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 121.205 0.526 . . . . 0.0 110.936 -173.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -53.99 -34.21 59.21 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.785 1.634 . . . . 0.0 114.682 -171.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -79.87 -33.73 39.81 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.934 0.494 . . . . 0.0 111.735 -177.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.462 ' OG1' ' HB3' ' A' ' 83' ' ' PHE . 25.3 p -93.33 -13.53 28.02 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.393 0.677 . . . . 0.0 112.805 -173.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -73.82 -20.02 60.58 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 122.779 0.432 . . . . 0.0 110.385 178.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -63.74 -38.12 89.93 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.358 1.063 . . . . 0.0 111.314 -175.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.402 ' HB3' HD11 ' A' ' 64' ' ' ILE . 22.6 t -77.4 -31.4 54.11 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.009 0.524 . . . . 0.0 110.389 177.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.648 ' SD ' ' HG ' ' A' ' 77' ' ' LEU . 15.7 mmt -70.46 -21.84 62.75 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.221 0.608 . . . . 0.0 111.149 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -60.74 -35.6 76.78 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.656 0.782 . . . . 0.0 109.724 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.2 -38.57 42.99 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.615 0.766 . . . . 0.0 111.06 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.516 ' HD2' ' SD ' ' A' ' 90' ' ' MET . 29.8 m-85 -72.16 -14.39 61.8 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 122.761 0.425 . . . . 0.0 111.886 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 49.2 t -68.89 83.19 0.31 Allowed 'General case' 0 C--N 1.36 1.031 0 C-N-CA 123.397 0.679 . . . . 0.0 109.593 175.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.3 m -73.51 -16.39 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.12 0.968 . . . . 0.0 111.754 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.29 -175.58 41.16 Favored Glycine 0 C--N 1.343 0.972 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.146 174.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -119.1 134.42 55.21 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -76.37 143.02 40.97 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.213 0.605 . . . . 0.0 111.755 -171.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.517 HD22 HD13 ' A' ' 25' ' ' LEU . 54.8 tp -140.78 128.92 22.17 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.507 1.123 . . . . 0.0 108.243 176.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.663 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 46.9 mt-10 -91.89 140.84 24.96 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 123.732 0.813 . . . . 0.0 110.657 -178.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.81 -26.45 67.7 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 123.188 2.592 . . . . 0.0 112.434 173.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -78.97 -24.58 43.76 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.121 0.568 . . . . 0.0 110.485 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.663 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 47.3 tp60 . . . . . 0 N--CA 1.479 0.995 0 C-N-CA 123.674 0.79 . . . . 0.0 111.036 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.6 m . . . . . 0 CA--C 1.539 0.552 0 N-CA-C 110.718 -0.105 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.5 mt -77.94 103.24 7.76 Favored 'General case' 0 C--N 1.347 0.466 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 174.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.459 ' HB ' HG21 ' A' ' 48' ' ' VAL . 44.6 t -98.47 139.16 21.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.052 0.941 . . . . 0.0 108.989 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.569 ' HD3' ' H ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -112.43 162.05 16.02 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.987 0.915 . . . . 0.0 109.31 178.743 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.5 tt -56.31 -38.1 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 C-N-CA 123.412 0.685 . . . . 0.0 111.93 -176.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.03 -37.47 79.89 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.543 0.737 . . . . 0.0 111.196 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -70.93 -34.67 71.72 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.105 -178.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.493 HD21 HG23 ' A' ' 43' ' ' VAL . 8.3 mp -59.99 -46.65 88.77 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 122.665 0.386 . . . . 0.0 110.707 171.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -64.27 -42.76 96.31 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.296 1.038 . . . . 0.0 112.224 -173.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -69.7 -41.22 75.7 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.95 177.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -66.96 -28.46 68.29 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.209 0.603 . . . . 0.0 110.95 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -65.11 -49.84 68.41 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.912 0.885 . . . . 0.0 110.049 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -75.08 -14.94 60.63 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.599 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -68.33 -34.31 75.88 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.555 0.742 . . . . 0.0 110.184 170.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 119.95 36.68 0.81 Allowed Glycine 0 C--N 1.348 1.226 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.27 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.53 107.66 0.36 Allowed Glycine 0 C--N 1.342 0.909 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -75.05 125.01 28.02 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -174.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 9.5 m0 -115.72 151.83 34.36 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.216 1.006 . . . . 0.0 110.183 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.6 t -143.13 164.69 29.45 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.559 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.504 HG22 HG22 ' A' ' 48' ' ' VAL . 72.1 t -116.82 111.43 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 176.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.432 HG13 ' HG ' ' A' ' 77' ' ' LEU . 14.8 mm -108.49 103.79 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 175.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.2 t70 60.21 41.81 16.21 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 124.472 1.109 . . . . 0.0 112.298 171.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.63 12.31 75.41 Favored Glycine 0 N--CA 1.475 1.28 0 CA-C-N 116.09 -0.505 . . . . 0.0 113.87 175.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -124.2 144.2 50.08 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.853 0.861 . . . . 0.0 108.84 172.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.504 HG22 HG22 ' A' ' 43' ' ' VAL . 45.0 t -99.09 137.23 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 122.967 0.507 . . . . 0.0 109.761 178.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -127.74 154.95 44.76 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.532 1.133 . . . . 0.0 110.327 -175.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -96.52 101.68 13.34 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.7 mm -64.09 -33.09 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 124.1 0.96 . . . . 0.0 111.901 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -64.19 -43.66 94.41 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.431 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 24.6 t70 -66.94 -40.05 87.48 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.86 0.864 . . . . 0.0 110.211 177.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -55.85 -55.24 34.8 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.809 1.244 . . . . 0.0 111.613 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -69.82 -26.2 64.13 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.506 0.722 . . . . 0.0 111.23 -177.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.7 m -62.87 -41.82 99.52 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 122.717 0.407 . . . . 0.0 111.023 171.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 31.0 mm-40 -70.22 -26.8 64.03 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.133 0.573 . . . . 0.0 110.76 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.3 t -77.86 10.64 2.65 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.961 0.904 . . . . 0.0 111.501 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 45.2 tp -67.59 -39.65 84.8 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.273 0.629 . . . . 0.0 110.779 171.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.2 t -99.7 146.98 25.9 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.158 0.583 . . . . 0.0 111.829 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.38 -19.41 53.4 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.764 175.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -63.73 -28.05 69.62 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 123.435 0.694 . . . . 0.0 110.182 175.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.3 t -66.96 152.24 46.12 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.462 0.705 . . . . 0.0 110.46 175.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.549 ' HB ' HG22 ' A' ' 86' ' ' THR . 26.4 pt -63.24 -17.76 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.475 1.11 . . . . 0.0 111.612 172.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.9 mt -85.19 9.58 14.67 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.64 1.176 . . . . 0.0 111.657 -178.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.57 -40.51 97.16 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.117 0.967 . . . . 0.0 111.24 174.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -73.77 -13.61 60.98 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.323 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.551 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 28.7 m-85 -110.13 4.91 21.56 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.567 1.147 . . . . 0.0 111.888 -176.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.74 -36.83 85.56 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.765 0.826 . . . . 0.0 112.589 -172.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -101.16 6.7 56.43 Favored Glycine 0 N--CA 1.479 1.53 0 CA-C-N 116.405 -0.361 . . . . 0.0 113.027 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -98.52 152.54 19.45 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.336 1.054 . . . . 0.0 109.065 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -54.12 124.88 47.61 Favored Pre-proline 0 N--CA 1.48 1.038 0 CA-C-O 118.354 -0.831 . . . . 0.0 109.08 172.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -57.5 -31.03 90.34 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.136 2.557 . . . . 0.0 114.03 -170.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 67.5 t -74.43 -48.55 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 122.868 0.467 . . . . 0.0 110.211 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.71 -38.15 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 123.504 0.722 . . . . 0.0 110.564 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.551 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -63.14 -40.89 98.89 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 114.074 -1.421 . . . . 0.0 110.944 177.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.432 ' HG ' HG13 ' A' ' 44' ' ' ILE . 37.1 tp -71.38 -36.82 71.56 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.027 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 82' ' ' GLN . 48.4 mt-10 -60.92 -47.07 88.1 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.866 0.466 . . . . 0.0 110.085 174.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.19 -32.11 73.63 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.843 0.857 . . . . 0.0 111.046 177.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.49 -28.57 64.01 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.477 0.711 . . . . 0.0 111.752 178.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.535 ' HA ' ' HB3' ' A' ' 87' ' ' ARG . 3.8 mm? -75.26 -28.34 59.79 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.267 0.227 . . . . 0.0 111.008 173.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 71.5 mt-30 -78.24 -41.22 34.86 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.979 0.512 . . . . 0.0 110.579 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -79.71 123.36 27.6 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -59.91 -41.35 91.49 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.044 0.937 . . . . 0.0 113.135 -169.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -68.18 -36.31 79.4 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.893 0.477 . . . . 0.0 111.572 -175.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.549 HG22 ' HB ' ' A' ' 64' ' ' ILE . 12.8 p -81.64 -30.46 32.79 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.133 -175.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.535 ' HB3' ' HA ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -74.96 -12.66 60.39 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.276 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.403 ' HG2' HH11 ' A' ' 87' ' ' ARG . 30.4 mt-10 -67.2 -35.88 80.56 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.237 0.615 . . . . 0.0 110.319 175.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.8 t -77.86 -29.91 50.63 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.428 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 14.9 mmt -70.95 -9.7 58.36 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.628 0.771 . . . . 0.0 112.104 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -62.07 -30.92 71.32 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.936 0.894 . . . . 0.0 110.662 171.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.17 -35.98 25.07 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.463 0.705 . . . . 0.0 111.466 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -75.03 -23.16 58.13 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.245 0.618 . . . . 0.0 111.762 -173.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 25.9 p -71.48 99.44 2.02 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.4 m -69.47 -30.06 44.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 123.902 0.881 . . . . 0.0 111.502 -177.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.14 179.94 44.23 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.005 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -91.03 136.47 33.05 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.55 0.74 . . . . 0.0 109.094 176.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -82.45 142.84 31.58 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 174.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.0 tt -136.27 112.81 10.03 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 170.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.558 ' HB3' ' HB2' ' A' ' 103' ' ' GLN . 26.0 tt0 -72.65 141.96 83.11 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.571 0.748 . . . . 0.0 109.96 -177.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -42.21 -60.86 0.61 Allowed 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 123.598 2.865 . . . . 0.0 114.113 176.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -81.88 -8.18 59.66 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.822 0.849 . . . . 0.0 112.377 -172.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.558 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 54.4 tp60 . . . . . 0 N--CA 1.495 1.796 0 C-N-CA 123.845 0.858 . . . . 0.0 110.898 175.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.5 m . . . . . 0 CA--C 1.542 0.662 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.506 HD13 HD22 ' A' ' 99' ' ' LEU . 92.6 mt -86.93 111.95 21.32 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.512 -178.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.504 ' HB ' HG21 ' A' ' 48' ' ' VAL . 48.4 t -94.72 125.82 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 174.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -92.32 167.62 11.88 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.29 0.636 . . . . 0.0 111.123 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.0 tt -67.65 -34.2 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.194 -177.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.95 -33.5 71.99 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.41 0.684 . . . . 0.0 110.589 177.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.08 -44.43 63.29 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.144 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.1 mt -57.35 -52.8 63.89 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.883 0.873 . . . . 0.0 112.03 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -63.89 -48.94 74.67 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.901 0.88 . . . . 0.0 111.789 -173.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -63.53 -34.32 77.53 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.062 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 50.7 t60 -73.4 -34.6 65.59 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.312 0.645 . . . . 0.0 110.721 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -60.64 -40.5 92.23 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.207 1.003 . . . . 0.0 110.107 176.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -69.7 -26.43 64.35 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.117 0.967 . . . . 0.0 111.409 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -70.14 -19.91 63.19 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.004 0.522 . . . . 0.0 111.518 174.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 114.88 -21.47 13.65 Favored Glycine 0 C--N 1.341 0.83 0 N-CA-C 111.796 -0.521 . . . . 0.0 111.796 -175.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.51 ' HA2' ' HG2' ' A' ' 52' ' ' LYS . . . -73.65 92.23 0.69 Allowed Glycine 0 C--N 1.345 1.048 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -78.33 110.95 13.82 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 38.9 m0 -105.23 174.09 6.03 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.198 0.999 . . . . 0.0 109.399 170.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.4 t -151.13 162.92 39.96 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.811 0.844 . . . . 0.0 108.862 172.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.492 HG22 HG22 ' A' ' 48' ' ' VAL . 73.8 t -119.79 113.52 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.296 0.638 . . . . 0.0 109.338 175.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.683 HD12 HD23 ' A' ' 77' ' ' LEU . 51.3 mt -135.79 133.48 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 176.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.1 t70 63.07 30.33 16.21 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 125.048 1.339 . . . . 0.0 110.477 -175.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.13 26.49 67.64 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.729 -175.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.453 ' HB2' ' CE2' ' A' ' 49' ' ' TYR . 44.3 mmtm -121.16 134.1 55.21 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.681 0.792 . . . . 0.0 108.891 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.504 HG21 ' HB ' ' A' ' 26' ' ' VAL . 93.1 t -84.66 111.15 19.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 174.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.453 ' CE2' ' HB2' ' A' ' 47' ' ' LYS . 85.0 m-85 -108.46 150.17 27.78 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.674 0.79 . . . . 0.0 110.351 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -88.12 138.98 30.97 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.836 175.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.538 HD11 HD22 ' A' ' 77' ' ' LEU . 33.6 mm -116.32 -40.18 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.552 0.741 . . . . 0.0 111.513 -174.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.51 ' HG2' ' HA2' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -69.25 -32.33 71.47 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.299 0.24 . . . . 0.0 111.02 -179.245 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.432 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 33.6 t70 -76.03 -37.85 57.9 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.252 0.621 . . . . 0.0 110.687 172.333 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -55.34 -48.48 74.14 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.18 0.992 . . . . 0.0 111.527 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -69.83 -27.25 64.71 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.794 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.3 m -66.74 -38.19 86.16 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.95 0.5 . . . . 0.0 110.04 172.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.501 ' HB2' HD12 ' A' ' 65' ' ' LEU . 52.7 mm-40 -76.49 -15.3 59.93 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.09 0.556 . . . . 0.0 110.892 176.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.5 t -90.67 -9.9 45.15 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.008 0.923 . . . . 0.0 111.199 175.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.4 tp -83.05 -5.87 59.27 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.843 0.857 . . . . 0.0 111.489 -178.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.0 t -119.54 152.67 36.6 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.611 0.764 . . . . 0.0 110.848 -174.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -73.89 -51.09 17.31 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.69 1.196 . . . . 0.0 111.362 -174.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -78.21 72.47 4.74 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.592 0.71 . . . . 0.0 109.589 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.2 m -163.16 147.59 11.17 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.884 1.273 . . . . 0.0 108.726 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.622 ' HB ' HG22 ' A' ' 86' ' ' THR . 33.2 pt -67.26 -19.91 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 124.274 1.03 . . . . 0.0 111.558 175.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.501 HD12 ' HB2' ' A' ' 57' ' ' GLN . 65.6 mt -92.53 7.99 40.81 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.001 0.92 . . . . 0.0 111.669 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.51 -23.52 64.55 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.562 0.345 . . . . 0.0 110.772 175.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -75.52 -11.87 60.11 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.606 0.763 . . . . 0.0 111.408 172.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -112.97 20.88 15.98 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.024 0.93 . . . . 0.0 110.953 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.36 -26.03 68.57 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.675 0.79 . . . . 0.0 112.752 -174.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -111.87 5.27 27.45 Favored Glycine 0 N--CA 1.478 1.481 0 C-N-CA 122.753 0.216 . . . . 0.0 113.137 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -96.03 151.07 19.79 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.075 0.95 . . . . 0.0 109.961 -177.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -63.39 127.1 90.73 Favored Pre-proline 0 N--CA 1.48 1.051 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 171.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.425 ' HB2' HG23 ' A' ' 51' ' ' ILE . 18.7 Cg_endo -56.68 -34.0 94.92 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.501 2.801 . . . . 0.0 114.729 -174.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.2 t -75.05 -39.35 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 121.052 0.453 . . . . 0.0 110.445 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.1 t -68.16 -40.76 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.309 0.644 . . . . 0.0 110.017 177.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.5 -33.06 75.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.065 1.346 . . . . 0.0 111.208 176.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.683 HD23 HD12 ' A' ' 44' ' ' ILE . 34.0 tp -59.69 -51.89 67.84 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 124.164 0.915 . . . . 0.0 111.185 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -63.06 -39.67 95.42 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.056 0.543 . . . . 0.0 111.655 -178.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.93 -42.64 99.87 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.555 177.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.6 -17.69 50.57 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.99 0.916 . . . . 0.0 112.176 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.1 mp -70.51 -45.4 65.67 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.922 0.889 . . . . 0.0 109.004 171.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -75.33 -27.98 59.45 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.781 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.407 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 3.0 t80 -81.81 114.28 20.33 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -64.99 -26.46 68.3 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.098 0.959 . . . . 0.0 112.653 -172.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -65.94 -41.97 90.65 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.387 0.675 . . . . 0.0 110.676 177.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.622 HG22 ' HB ' ' A' ' 64' ' ' ILE . 20.1 p -95.86 -18.87 20.02 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.004 0.921 . . . . 0.0 113.152 -171.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -63.33 -21.18 66.11 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -176.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -54.27 -48.4 71.25 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.898 0.879 . . . . 0.0 111.682 177.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.4 t -73.6 -15.69 61.26 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.671 0.788 . . . . 0.0 111.785 -172.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 24.7 mmt -64.4 -17.63 63.94 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.736 0.815 . . . . 0.0 112.211 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.405 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 2.4 p80 -61.06 -29.33 69.67 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.211 0.605 . . . . 0.0 110.894 174.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.64 -32.39 19.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.101 0.96 . . . . 0.0 111.413 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -79.93 -26.06 40.26 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.599 0.36 . . . . 0.0 110.936 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.405 ' SG ' ' HA ' ' A' ' 91' ' ' HIS . 28.6 p -79.76 103.25 9.53 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.29 -35.75 72.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 124.372 1.069 . . . . 0.0 110.21 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 174.31 -170.57 43.7 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.293 176.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -89.67 135.96 33.31 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -78.9 128.58 33.51 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.272 0.629 . . . . 0.0 110.774 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.506 HD22 HD13 ' A' ' 25' ' ' LEU . 64.0 tp -105.32 117.1 33.15 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 166.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -73.48 133.1 80.65 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 173.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.52 -42.76 64.7 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.271 2.648 . . . . 0.0 113.632 -174.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -87.76 -7.7 56.98 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.71 0.404 . . . . 0.0 111.252 -176.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 . . . . . 0 N--CA 1.484 1.257 0 C-N-CA 123.65 0.78 . . . . 0.0 110.728 174.376 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.98 151.22 49.39 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.028 0.931 . . . . 0.0 109.733 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.1 p -94.0 112.78 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-O 121.193 0.52 . . . . 0.0 109.907 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.7 m -70.95 109.06 4.85 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 173.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.42 HD22 ' HB2' ' A' ' 99' ' ' LEU . 92.4 mt -98.47 108.83 21.62 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.092 0.557 . . . . 0.0 110.209 -177.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.9 t -94.38 132.84 37.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.493 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -102.24 171.18 7.63 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.499 0.72 . . . . 0.0 109.593 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.474 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 13.0 tt -60.72 -34.09 57.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.848 174.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.42 -49.79 76.02 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.352 0.661 . . . . 0.0 110.743 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.11 -42.98 95.89 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.626 0.77 . . . . 0.0 110.879 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 46.9 tp -58.24 -45.82 87.08 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.333 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 17.0 mm-40 -72.68 -52.97 13.05 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.541 0.736 . . . . 0.0 112.397 -177.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -71.16 -29.87 65.74 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -172.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -73.47 -27.46 61.41 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 120.553 0.216 . . . . 0.0 110.5 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -61.3 -39.31 89.99 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 120.961 0.41 . . . . 0.0 110.205 172.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -68.57 -32.3 72.11 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.534 0.733 . . . . 0.0 110.78 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -65.77 -19.52 65.92 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.897 0.879 . . . . 0.0 111.41 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.74 4.09 26.53 Favored Glycine 0 N--CA 1.475 1.234 0 CA-C-N 116.695 -0.23 . . . . 0.0 112.764 176.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -111.93 95.86 0.83 Allowed Glycine 0 C--N 1.34 0.776 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.415 ' H ' ' HB2' ' A' ' 52' ' ' LYS . 89.7 t80 -75.8 116.6 16.67 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -104.66 -179.76 4.04 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.275 1.03 . . . . 0.0 109.961 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.4 t -155.83 159.15 39.14 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.698 0.799 . . . . 0.0 109.211 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 98.4 t -107.99 111.57 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 123.572 0.749 . . . . 0.0 109.258 177.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.729 HD12 HD23 ' A' ' 77' ' ' LEU . 48.8 mt -140.6 135.48 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.275 1.03 . . . . 0.0 108.631 175.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 63.59 32.31 14.1 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.675 1.19 . . . . 0.0 111.062 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.44 20.78 70.0 Favored Glycine 0 C--N 1.352 1.457 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.927 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.516 ' HD3' ' HA ' ' A' ' 97' ' ' GLN . 32.8 mmtp -128.59 162.98 26.02 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.792 1.237 . . . . 0.0 109.23 -177.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 90.9 t -119.28 119.28 60.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 123.629 0.772 . . . . 0.0 109.037 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -112.27 148.15 34.77 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.526 0.73 . . . . 0.0 109.909 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -86.56 100.7 12.6 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.518 HD11 HD22 ' A' ' 77' ' ' LEU . 31.5 mm -76.45 -29.64 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.418 0.687 . . . . 0.0 111.689 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.415 ' HB2' ' H ' ' A' ' 40' ' ' PHE . 1.7 tmmm? -61.55 -47.7 84.34 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.472 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 27.5 t70 -73.97 -36.07 64.54 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.521 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -52.55 -53.31 48.09 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.958 0.903 . . . . 0.0 111.154 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.487 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 20.2 pt20 -67.36 -28.53 68.03 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.233 -177.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.8 m -64.01 -40.38 96.22 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.042 0.449 . . . . 0.0 110.407 175.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.607 ' HB2' HD12 ' A' ' 65' ' ' LEU . 51.9 mm-40 -72.46 -32.35 66.17 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.315 0.646 . . . . 0.0 109.974 177.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.5 t -68.09 -27.32 66.38 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.726 0.81 . . . . 0.0 111.283 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 55' ' ' GLN . 96.9 mt -80.75 -15.42 56.52 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.448 0.699 . . . . 0.0 111.597 175.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 45.1 m -90.16 124.68 35.04 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.207 0.603 . . . . 0.0 110.321 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -64.29 147.96 51.31 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.936 0.894 . . . . 0.0 110.284 175.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 75.45 -3.56 2.56 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.367 1.467 . . . . 0.0 112.854 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.0 m -81.06 149.85 29.06 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 172.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.645 ' HB ' HG22 ' A' ' 86' ' ' THR . 42.9 pt -61.97 -20.04 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.58 0.752 . . . . 0.0 112.478 -178.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.607 HD12 ' HB2' ' A' ' 57' ' ' GLN . 60.0 mt -95.05 -8.68 35.98 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.575 0.75 . . . . 0.0 111.725 -176.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.87 -25.76 65.68 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.272 0.629 . . . . 0.0 111.549 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -75.73 -20.53 58.27 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.806 0.842 . . . . 0.0 111.042 173.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.423 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 52.4 m-85 -102.89 12.82 35.65 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.275 1.03 . . . . 0.0 110.987 178.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.62 -26.16 64.3 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.329 0.651 . . . . 0.0 112.534 -175.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.53 -3.87 90.53 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-N 116.472 -0.331 . . . . 0.0 112.639 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -108.08 150.55 27.04 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.176 0.99 . . . . 0.0 110.136 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -55.98 124.72 60.18 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 123.723 0.809 . . . . 0.0 110.52 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -51.13 -33.51 44.05 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 123.549 2.832 . . . . 0.0 115.145 -173.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.2 t -70.79 -38.87 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.111 0.564 . . . . 0.0 110.49 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.5 t -74.13 -40.11 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.894 0.877 . . . . 0.0 110.062 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.423 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -65.49 -29.3 69.93 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.832 1.253 . . . . 0.0 110.896 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.729 HD23 HD12 ' A' ' 44' ' ' ILE . 48.4 tp -63.98 -41.75 97.44 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.925 0.89 . . . . 0.0 110.536 174.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -65.65 -40.8 92.87 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.631 0.772 . . . . 0.0 110.998 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.43 -31.95 73.03 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.782 0.833 . . . . 0.0 110.688 175.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.14 -33.49 61.53 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.468 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.492 HD23 ' HG3' ' A' ' 90' ' ' MET . 95.6 mt -67.74 -40.12 84.2 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.156 0.582 . . . . 0.0 109.857 174.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -66.4 -41.5 89.24 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.858 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.444 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 9.8 t80 -87.5 127.7 35.24 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 120.982 0.42 . . . . 0.0 110.606 -175.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.81 -32.28 72.57 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.885 1.274 . . . . 0.0 113.63 -170.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -68.69 -51.4 42.1 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.154 0.502 . . . . 0.0 109.864 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.645 HG22 ' HB ' ' A' ' 64' ' ' ILE . 27.7 p -78.71 -16.78 56.83 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.197 -0.91 . . . . 0.0 113.149 -168.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.4 ptt85 -74.96 -11.42 60.11 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -75.34 -38.08 60.35 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.056 0.942 . . . . 0.0 111.256 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.407 ' HB3' HD11 ' A' ' 64' ' ' ILE . 24.2 t -77.64 -18.73 56.45 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.912 0.485 . . . . 0.0 110.743 175.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.592 ' SD ' HD12 ' A' ' 77' ' ' LEU . 37.4 mmt -65.01 -24.18 67.43 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.566 0.346 . . . . 0.0 110.887 176.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.468 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 86.2 m-70 -64.43 -26.57 68.51 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.841 0.856 . . . . 0.0 111.62 173.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.44 -35.95 46.17 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.476 0.71 . . . . 0.0 110.834 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -83.7 -24.37 31.29 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.477 0.311 . . . . 0.0 111.606 -176.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.468 ' SG ' ' HA ' ' A' ' 91' ' ' HIS . 29.5 p -72.05 101.32 2.71 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.001 0.429 . . . . 0.0 109.882 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.6 t -68.83 -37.71 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.056 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.02 -171.67 44.17 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.551 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.516 ' HA ' ' HD3' ' A' ' 47' ' ' LYS . 29.0 tt0 -88.78 135.68 33.39 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.909 0.884 . . . . 0.0 109.81 176.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -83.86 136.29 34.17 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.42 ' HB2' HD22 ' A' ' 25' ' ' LEU . 2.9 tt -139.7 122.88 16.91 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 173.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 46.7 mt-10 -70.74 145.05 91.73 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 123.973 0.909 . . . . 0.0 111.974 -176.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.5 -47.61 23.87 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 123.306 2.671 . . . . 0.0 112.303 173.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -67.61 -38.47 83.98 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.212 1.005 . . . . 0.0 111.846 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.468 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 26.4 tp60 -59.85 -45.51 92.19 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.032 0.933 . . . . 0.0 112.864 -168.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -90.13 -8.37 51.47 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -101.69 24.95 29.73 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 123.188 0.305 . . . . 0.0 113.234 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.21 138.8 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.34 0.656 . . . . 0.0 110.391 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.6 t -89.75 119.75 30.41 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 167.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.4 mt -104.9 109.45 63.16 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.05 150.74 87.56 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.841 2.361 . . . . 0.0 110.902 168.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -75.19 84.14 2.38 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 122.205 1.002 . . . . 0.0 110.048 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.4 tp -132.07 -20.1 2.49 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.19 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.383 0 CA-C-O 119.118 -0.823 . . . . 0.0 111.452 175.711 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.471 0.177 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -107.97 90.18 3.22 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.806 0.842 . . . . 0.0 109.189 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.82 143.91 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.078 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.9 m -65.4 109.15 2.19 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 89.4 mt -92.87 105.75 17.82 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.906 0.882 . . . . 0.0 109.634 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.6 t -93.93 126.21 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.37 1.068 . . . . 0.0 108.675 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -93.5 170.26 9.73 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.022 0.529 . . . . 0.0 110.792 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.7 tt -57.8 -36.61 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.19 0.996 . . . . 0.0 112.444 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.99 -40.0 95.4 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.378 0.671 . . . . 0.0 111.315 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.29 -34.75 77.19 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.235 1.014 . . . . 0.0 111.689 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.5 mt -58.75 -47.28 85.19 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.919 0.762 . . . . 0.0 110.01 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -71.62 -39.09 70.69 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.835 -174.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -62.22 -47.05 86.12 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.017 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -68.17 -35.39 77.96 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.333 0.653 . . . . 0.0 110.826 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 56.1 t30 -60.54 -42.97 97.62 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.267 178.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -78.16 -23.02 47.84 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.743 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -72.86 -36.59 67.43 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.903 0.881 . . . . 0.0 111.864 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 139.85 33.14 0.16 Allowed Glycine 0 N--CA 1.48 1.604 0 CA-C-N 116.968 -0.106 . . . . 0.0 113.121 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 35' ' ' ASN . . . -150.61 -178.31 25.35 Favored Glycine 0 C--N 1.343 0.948 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -134.59 110.23 9.18 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 117.582 0.691 . . . . 0.0 109.525 175.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 17.9 m0 -98.13 144.3 27.76 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.145 0.578 . . . . 0.0 110.508 174.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -136.87 141.84 42.79 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.192 0.997 . . . . 0.0 108.885 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.1 t -96.46 110.79 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 175.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 77.6 mt -131.24 130.22 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.1 t70 62.47 30.96 17.27 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 124.629 1.172 . . . . 0.0 111.617 175.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.55 12.83 77.71 Favored Glycine 0 N--CA 1.479 1.532 0 CA-C-N 116.198 -0.455 . . . . 0.0 113.378 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -119.14 160.33 22.32 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.724 1.21 . . . . 0.0 108.974 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.1 t -111.81 116.76 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.124 0.57 . . . . 0.0 109.525 176.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.435 ' HB2' HD21 ' A' ' 77' ' ' LEU . 49.8 m-85 -112.32 152.73 28.21 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.967 0.907 . . . . 0.0 109.352 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -100.88 107.25 18.72 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.571 0.348 . . . . 0.0 110.439 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.4 mm -60.31 -36.24 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 124.806 1.242 . . . . 0.0 111.724 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.44 ' HG3' ' HA2' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -58.49 -47.3 84.53 Favored 'General case' 0 CA--C 1.553 1.065 0 O-C-N 123.944 0.777 . . . . 0.0 109.184 -178.048 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 39.1 t70 -74.46 -34.41 63.14 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.706 0.402 . . . . 0.0 110.797 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -52.98 -55.97 19.51 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.928 0.891 . . . . 0.0 111.002 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -67.64 -28.24 67.55 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.413 0.685 . . . . 0.0 111.277 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.5 m -67.69 -37.44 82.3 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 123.505 0.722 . . . . 0.0 110.876 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 30.9 mm-40 -77.45 -28.07 52.3 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.437 0.695 . . . . 0.0 110.704 177.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.2 t -74.36 -3.63 31.51 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.732 0.813 . . . . 0.0 111.576 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.4 tt -63.2 -38.28 90.54 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.29 1.036 . . . . 0.0 110.129 172.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.6 m -76.81 135.33 38.93 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.495 0.718 . . . . 0.0 111.026 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -73.39 -35.23 65.86 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.997 0.919 . . . . 0.0 110.391 -178.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -87.78 60.41 5.91 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.526 0.679 . . . . 0.0 109.536 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.6 t -133.0 155.12 49.75 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.796 0.838 . . . . 0.0 109.419 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.567 ' HB ' HG22 ' A' ' 86' ' ' THR . 27.3 pt -75.3 -10.71 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.587 0.755 . . . . 0.0 110.614 173.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.9 mt -93.46 -8.86 40.36 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.916 0.886 . . . . 0.0 110.734 176.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.07 -26.19 64.83 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.745 0.818 . . . . 0.0 111.46 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -74.65 -13.48 60.64 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.455 0.702 . . . . 0.0 110.963 174.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.527 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 67.6 m-85 -115.55 12.25 16.1 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.684 1.194 . . . . 0.0 110.963 177.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.73 -28.52 69.11 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.522 0.729 . . . . 0.0 112.109 -175.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.24 27.42 15.22 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.738 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -132.89 155.0 49.84 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.983 0.913 . . . . 0.0 109.499 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -54.39 129.05 60.8 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 124.305 1.042 . . . . 0.0 109.459 172.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.1 -35.32 90.25 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 123.433 2.755 . . . . 0.0 114.461 -172.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.0 t -74.66 -48.92 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 122.638 0.375 . . . . 0.0 110.441 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.0 t -63.08 -33.86 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.715 0.806 . . . . 0.0 110.713 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -64.71 -44.5 90.02 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.464 176.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.435 HD21 ' HB2' ' A' ' 49' ' ' TYR . 56.8 tp -66.89 -43.12 84.25 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.839 0.855 . . . . 0.0 111.306 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -58.89 -52.15 66.98 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.313 0.645 . . . . 0.0 110.259 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.14 -34.67 76.81 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.716 0.806 . . . . 0.0 111.229 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.99 -24.04 61.52 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.716 0.807 . . . . 0.0 112.291 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 81' ' ' LEU . 2.0 mm? -70.81 -42.1 70.73 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 172.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -73.22 -28.34 62.11 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.049 0.54 . . . . 0.0 111.053 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -85.51 117.67 24.56 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -66.08 -27.56 68.17 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.908 0.883 . . . . 0.0 113.175 -169.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -76.16 -22.01 55.9 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.383 0.673 . . . . 0.0 112.423 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.567 HG22 ' HB ' ' A' ' 64' ' ' ILE . 19.1 p -109.28 -20.99 12.75 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -174.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.499 ' HA ' ' HG2' ' A' ' 90' ' ' MET . 40.3 ptt180 -67.66 -13.57 62.21 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -55.48 -49.58 72.17 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.414 1.086 . . . . 0.0 112.339 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.9 t -77.4 -15.72 59.21 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.932 0.493 . . . . 0.0 111.033 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.499 ' HG2' ' HA ' ' A' ' 87' ' ' ARG . 12.7 mmt -69.03 -16.81 63.8 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.828 0.451 . . . . 0.0 111.243 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -62.24 -39.72 93.78 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.941 0.496 . . . . 0.0 109.798 169.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.89 -37.13 62.2 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.75 0.82 . . . . 0.0 111.065 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.488 ' HD2' ' SD ' ' A' ' 90' ' ' MET . 45.9 m-85 -71.37 -23.93 61.99 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.012 0.525 . . . . 0.0 111.221 177.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 46.1 t -72.17 99.85 2.43 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.0 m -71.15 -26.32 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 123.408 0.683 . . . . 0.0 110.251 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 175.42 175.11 42.58 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.319 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -85.18 136.66 33.43 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 177.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -76.83 132.44 39.19 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.486 HD12 ' HG3' ' A' ' 104' ' ' GLU . 0.1 OUTLIER -132.46 126.15 32.35 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 170.821 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 42.2 mt-10 -70.34 136.08 86.56 Favored Pre-proline 0 C--O 1.246 0.898 0 O-C-N 123.851 0.72 . . . . 0.0 110.3 177.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -59.27 -22.05 63.26 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.765 2.31 . . . . 0.0 112.609 175.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -86.61 -38.83 16.71 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.824 1.25 . . . . 0.0 111.224 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.522 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 8.5 tp-100 -61.78 -30.73 71.0 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 124.33 1.052 . . . . 0.0 111.586 -176.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.486 ' HG3' HD12 ' A' ' 99' ' ' LEU . 40.9 mt-10 -61.25 -34.51 75.27 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.868 0.867 . . . . 0.0 112.069 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -84.44 -80.69 1.06 Allowed Glycine 0 C--N 1.341 0.848 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.8 p -87.21 107.92 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.7 t -95.58 129.54 42.73 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 122.856 0.463 . . . . 0.0 109.973 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 56.7 mt -103.95 110.82 64.67 Favored Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -79.15 172.02 15.4 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 122.722 2.282 . . . . 0.0 111.852 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.26 83.47 0.55 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.455 0.702 . . . . 0.0 110.237 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 34.7 tp -176.76 -57.59 0.01 OUTLIER 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.073 1.349 . . . . 0.0 107.813 -178.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.328 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.284 -176.924 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 121.162 0.506 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -88.34 97.95 11.32 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 124.137 0.975 . . . . 0.0 109.391 -174.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.0 p -68.72 110.73 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.27 175.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 77.7 m -71.03 108.16 4.46 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.247 0.546 . . . . 0.0 109.575 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.436 HD13 HD13 ' A' ' 99' ' ' LEU . 72.2 mt -85.64 106.55 17.01 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.215 -177.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.456 HG21 HG23 ' A' ' 95' ' ' VAL . 46.2 t -102.16 128.99 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.183 0.993 . . . . 0.0 109.043 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -101.98 170.28 8.23 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.379 0.672 . . . . 0.0 110.073 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.432 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 18.6 tt -67.96 -32.15 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.348 0.659 . . . . 0.0 111.98 -173.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.64 -35.58 72.73 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.199 0.6 . . . . 0.0 111.453 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -68.27 -42.26 79.83 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.788 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.4 mt -55.24 -40.64 71.13 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.785 0.834 . . . . 0.0 111.422 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 7.0 mm-40 -65.89 -41.6 91.33 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.444 -178.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -59.29 -50.62 73.29 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.569 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -64.41 -34.64 78.66 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.173 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -59.21 -39.16 81.79 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.07 0.548 . . . . 0.0 110.416 174.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -75.96 -19.49 58.69 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.017 0.927 . . . . 0.0 111.886 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -84.3 -20.16 32.58 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 122.665 0.386 . . . . 0.0 110.823 170.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.99 -13.48 52.66 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-N 116.456 -0.338 . . . . 0.0 112.414 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.413 ' HA2' ' HD3' ' A' ' 52' ' ' LYS . . . -76.72 88.59 0.95 Allowed Glycine 0 C--N 1.35 1.309 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 176.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -75.63 111.1 10.61 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -173.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 39.5 m0 -99.77 177.73 5.04 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.941 0.896 . . . . 0.0 110.066 175.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.9 t -157.6 151.27 23.99 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.71 0.804 . . . . 0.0 109.869 -178.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 p -103.0 112.12 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 171.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.5 mt -124.18 116.96 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.359 1.064 . . . . 0.0 109.223 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.3 t70 53.31 53.63 11.47 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.27 1.428 . . . . 0.0 111.834 175.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.55 -0.46 55.61 Favored Glycine 0 N--CA 1.475 1.273 0 N-CA-C 114.815 0.686 . . . . 0.0 114.815 176.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.401 ' HB2' ' CE1' ' A' ' 49' ' ' TYR . 44.9 mmtm -112.59 167.83 10.15 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.131 0.972 . . . . 0.0 109.461 178.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 90.7 t -115.61 121.97 68.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 171.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.428 ' HB3' HD21 ' A' ' 77' ' ' LEU . 76.7 m-85 -115.3 170.62 8.25 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.831 1.253 . . . . 0.0 109.301 174.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -99.21 159.42 15.0 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.241 0.617 . . . . 0.0 109.835 171.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 35.1 mm -117.28 -29.21 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.359 1.064 . . . . 0.0 108.934 168.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.413 ' HD3' ' HA2' ' A' ' 39' ' ' GLY . 25.1 ttpt -53.89 -57.97 9.01 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.469 1.108 . . . . 0.0 111.965 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.449 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 27.4 t70 -74.39 -35.54 63.49 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.995 0.518 . . . . 0.0 110.121 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -51.09 -53.51 33.43 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.85 1.26 . . . . 0.0 111.775 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -67.62 -27.89 67.28 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.923 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.9 m -68.32 -42.15 79.79 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.932 174.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 77.7 mm-40 -68.56 -28.36 66.89 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 123.12 0.568 . . . . 0.0 110.519 178.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.0 t -72.71 -26.98 61.79 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.672 0.789 . . . . 0.0 110.996 175.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 47.5 tp -67.37 -27.29 66.99 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.876 0.87 . . . . 0.0 112.095 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.0 t -88.11 151.64 22.58 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.219 0.533 . . . . 0.0 111.478 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -79.05 155.46 28.79 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.434 1.093 . . . . 0.0 109.95 176.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 71.88 5.76 5.44 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.032 1.333 . . . . 0.0 112.095 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 37.7 t -74.81 155.33 37.7 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.386 0.674 . . . . 0.0 109.686 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.566 ' HB ' HG22 ' A' ' 86' ' ' THR . 47.5 pt -68.83 -19.76 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 122.788 0.435 . . . . 0.0 110.518 170.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 57' ' ' GLN . 63.4 mt -96.94 0.32 48.78 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.783 1.233 . . . . 0.0 111.613 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.02 -27.68 68.98 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 122.983 0.513 . . . . 0.0 110.944 176.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -82.16 -24.79 34.83 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.88 0.872 . . . . 0.0 111.372 173.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.587 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 54.8 m-85 -91.84 2.53 56.46 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.979 0.911 . . . . 0.0 112.066 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.97 -29.77 69.71 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.371 0.668 . . . . 0.0 111.092 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.31 26.85 9.3 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-N 116.017 -0.538 . . . . 0.0 113.114 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -141.47 152.32 44.11 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.326 1.05 . . . . 0.0 108.611 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -52.61 127.86 42.7 Favored Pre-proline 0 N--CA 1.478 0.94 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.871 174.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.08 -34.2 86.45 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 123.215 2.61 . . . . 0.0 114.476 -172.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.7 t -73.0 -48.56 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.1 t -62.53 -34.76 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.934 0.894 . . . . 0.0 110.78 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -71.41 -35.18 70.9 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.994 1.318 . . . . 0.0 110.876 -178.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.428 HD21 ' HB3' ' A' ' 49' ' ' TYR . 17.2 tp -73.36 -40.01 64.72 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.682 176.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -62.31 -36.48 82.28 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.193 0.597 . . . . 0.0 110.267 172.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.5 -32.72 68.55 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.112 0.965 . . . . 0.0 110.612 176.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.23 -43.6 86.15 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.562 0.745 . . . . 0.0 111.151 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.83 -30.64 69.23 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.514 0.326 . . . . 0.0 111.504 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -72.91 -27.72 62.04 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.027 0.531 . . . . 0.0 110.734 176.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -95.96 119.49 34.54 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.294 0.638 . . . . 0.0 110.046 -176.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -58.88 -27.99 65.72 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.514 1.125 . . . . 0.0 113.067 -175.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -79.64 -20.01 47.8 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.029 0.932 . . . . 0.0 112.248 -174.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.566 HG22 ' HB ' ' A' ' 64' ' ' ILE . 41.5 p -123.61 -12.2 7.7 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -173.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -68.58 -26.56 65.45 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.554 0.742 . . . . 0.0 111.195 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -60.07 -54.4 46.36 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.258 1.023 . . . . 0.0 110.481 -172.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.8 m -64.52 -20.0 65.94 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.907 0.883 . . . . 0.0 112.48 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 20.6 mmt -74.09 -4.02 33.01 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.301 0.641 . . . . 0.0 112.495 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.94 -21.4 65.1 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.765 0.426 . . . . 0.0 110.565 169.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -89.06 -29.51 19.37 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.757 0.823 . . . . 0.0 111.086 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -80.8 -24.03 38.83 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.171 0.588 . . . . 0.0 111.443 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.9 p -76.25 110.98 11.21 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 173.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.456 HG23 HG21 ' A' ' 26' ' ' VAL . 27.5 m -70.29 -24.88 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.132 0.573 . . . . 0.0 110.122 174.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 167.59 -159.32 32.58 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.612 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 53.8 tt0 -102.14 139.92 37.12 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.093 0.957 . . . . 0.0 109.807 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.427 ' OH ' ' HB ' ' A' ' 28' ' ' ILE . 84.2 t80 -78.94 124.25 28.06 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.378 0.671 . . . . 0.0 110.379 178.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.436 HD13 HD13 ' A' ' 25' ' ' LEU . 9.5 tt -115.86 120.9 40.76 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 172.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.734 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 42.9 mt-10 -68.86 143.09 94.32 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 123.613 0.765 . . . . 0.0 110.585 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -54.73 -31.18 70.41 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.856 2.371 . . . . 0.0 113.053 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -82.71 -29.01 30.15 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.86 0.864 . . . . 0.0 111.222 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.734 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 33.3 tt0 -68.09 -22.65 64.9 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.737 0.815 . . . . 0.0 112.036 -174.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -61.57 -34.44 75.6 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 120.919 0.39 . . . . 0.0 110.324 173.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.32 -64.15 1.95 Allowed Glycine 0 C--N 1.343 0.929 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.107 177.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.2 p -100.79 147.0 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-O 121.119 0.485 . . . . 0.0 111.519 -174.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 t -107.89 131.75 54.19 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 168.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 55.1 mt -82.01 122.93 80.17 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 122.954 0.502 . . . . 0.0 109.815 -175.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.19 126.05 11.39 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.664 2.242 . . . . 0.0 112.2 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -81.97 108.0 15.12 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 pp -96.31 -12.38 24.54 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.317 0.647 . . . . 0.0 110.943 174.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.351 1.391 0 CA-C-O 118.951 -0.916 . . . . 0.0 112.35 179.535 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.485 1.317 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -141.63 156.94 45.64 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.775 1.23 . . . . 0.0 109.549 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.8 p -147.4 126.22 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 122.568 0.347 . . . . 0.0 111.264 -177.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.2 m -72.25 116.02 12.19 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.397 0.679 . . . . 0.0 110.548 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 83.6 mt -95.93 104.33 16.27 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.756 0.822 . . . . 0.0 109.727 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.52 ' HB ' HG21 ' A' ' 48' ' ' VAL . 59.2 t -95.5 121.78 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.568 1.147 . . . . 0.0 108.688 178.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -78.6 168.95 19.01 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 123.322 0.649 . . . . 0.0 110.312 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.44 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 11.4 tt -56.4 -46.08 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.877 174.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.98 -38.01 81.31 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.8 0.84 . . . . 0.0 111.707 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -66.34 -46.75 75.72 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.017 0.527 . . . . 0.0 111.593 -176.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 pp -72.11 -32.56 67.09 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.282 0.233 . . . . 0.0 111.61 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 68.2 mm-40 -63.73 -47.75 79.84 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.191 0.597 . . . . 0.0 110.816 174.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -77.32 -23.66 50.97 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.404 -175.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -72.63 -28.34 62.68 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -59.63 -47.58 85.04 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.115 0.566 . . . . 0.0 110.034 173.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -70.9 -26.7 63.34 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.101 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.71 -30.0 69.39 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.905 0.882 . . . . 0.0 111.276 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.58 34.88 0.68 Allowed Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.46 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.585 ' HA2' ' HD2' ' A' ' 52' ' ' LYS . . . -162.23 100.0 0.18 Allowed Glycine 0 C--N 1.346 1.131 0 CA-C-O 120.05 -0.306 . . . . 0.0 112.635 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -75.73 110.0 9.79 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -176.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -103.32 157.24 17.15 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.564 174.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.5 t -148.25 143.54 27.04 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.648 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 p -96.64 120.41 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-O 121.027 0.441 . . . . 0.0 110.623 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 78.6 mt -136.89 125.22 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 124.906 1.282 . . . . 0.0 108.194 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.1 t70 62.45 32.9 16.51 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.386 1.074 . . . . 0.0 111.548 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.14 19.57 77.39 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-N 115.818 -0.628 . . . . 0.0 113.401 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -125.24 145.35 50.03 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.187 0.995 . . . . 0.0 108.674 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.52 HG21 ' HB ' ' A' ' 26' ' ' VAL . 25.4 t -99.8 119.64 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -112.54 165.75 11.95 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.035 0.934 . . . . 0.0 109.056 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -93.76 161.55 14.28 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.565 0.698 . . . . 0.0 110.065 170.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.436 HG23 ' HB2' ' A' ' 73' ' ' PRO . 29.3 mm -115.88 -29.92 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.502 1.121 . . . . 0.0 109.744 172.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.585 ' HD2' ' HA2' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -57.36 -52.27 66.04 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 123.891 0.876 . . . . 0.0 112.655 -177.006 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -78.34 -31.38 48.62 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.278 1.031 . . . . 0.0 110.224 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -52.47 -60.81 2.79 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.843 1.257 . . . . 0.0 111.346 175.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -64.89 -28.65 69.69 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.558 -0.747 . . . . 0.0 112.177 -174.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.0 m -63.46 -45.04 92.65 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.298 0.639 . . . . 0.0 110.055 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -77.65 -13.54 59.88 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.369 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.6 m -71.15 -19.64 62.4 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.697 0.399 . . . . 0.0 111.015 172.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 61.0 mt -82.25 -5.89 58.85 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.993 0.917 . . . . 0.0 111.497 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 79.4 m -91.58 133.24 35.71 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.759 0.824 . . . . 0.0 109.722 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -62.91 -49.59 74.2 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.276 1.03 . . . . 0.0 111.644 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -86.51 45.41 1.24 Allowed 'General case' 0 CA--C 1.557 1.218 0 CA-C-O 121.91 0.862 . . . . 0.0 110.642 -177.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 75.7 m -122.81 144.74 48.99 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.181 0.992 . . . . 0.0 109.306 172.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.487 ' HB ' HG22 ' A' ' 86' ' ' THR . 35.0 pt -59.26 -25.92 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 124.029 0.932 . . . . 0.0 110.759 169.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.513 HD21 ' HE1' ' A' ' 90' ' ' MET . 36.7 mt -76.82 -10.15 59.17 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.276 1.031 . . . . 0.0 111.902 -178.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.84 -20.54 59.71 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.214 0.606 . . . . 0.0 111.535 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 9.7 pt20 -77.19 -29.37 54.3 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 171.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -87.94 2.78 50.81 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.402 1.081 . . . . 0.0 111.177 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.54 126.15 28.4 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.782 0.433 . . . . 0.0 110.112 177.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.31 -21.7 38.64 Favored Glycine 0 C--N 1.345 1.037 0 O-C-N 123.481 0.488 . . . . 0.0 112.528 -173.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -89.91 158.49 17.4 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.219 1.008 . . . . 0.0 109.809 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -61.23 132.55 92.57 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 123.204 0.602 . . . . 0.0 109.817 173.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.436 ' HB2' HG23 ' A' ' 51' ' ' ILE . 52.6 Cg_endo -64.53 -32.12 59.65 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.976 2.451 . . . . 0.0 113.899 -172.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.6 t -73.93 -45.82 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.8 t -61.15 -40.35 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.52 0.728 . . . . 0.0 110.478 177.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.02 -40.05 95.46 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.305 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 37.6 tp -71.81 -37.9 70.28 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.666 0.786 . . . . 0.0 110.917 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.23 -44.42 91.91 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.987 0.515 . . . . 0.0 110.318 176.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.51 -33.55 75.83 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.823 0.849 . . . . 0.0 110.873 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.79 -41.78 82.65 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.924 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.13 -23.28 64.88 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -82.76 -9.46 59.34 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.492 0.717 . . . . 0.0 112.071 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -125.89 124.85 41.77 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.206 0.602 . . . . 0.0 109.752 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.09 -42.0 84.71 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.411 1.084 . . . . 0.0 113.901 -169.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.42 -35.85 78.71 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.45 0.7 . . . . 0.0 111.285 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.487 HG22 ' HB ' ' A' ' 64' ' ' ILE . 31.6 p -98.26 -6.01 31.99 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.854 -174.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -90.48 -25.68 20.18 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 118.584 0.629 . . . . 0.0 110.433 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -75.72 -24.83 56.22 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.8 0.666 . . . . 0.0 112.8 -172.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.2 t -71.71 -23.97 61.73 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.145 171.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.513 ' HE1' HD21 ' A' ' 65' ' ' LEU . 12.6 mmt -75.58 -8.92 58.0 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.263 0.625 . . . . 0.0 111.663 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -70.3 -16.81 63.06 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.611 0.764 . . . . 0.0 110.507 169.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -88.66 -37.38 15.62 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.958 0.903 . . . . 0.0 110.857 170.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.427 ' HD2' ' HA ' ' A' ' 90' ' ' MET . 97.5 m-85 -80.79 -14.22 58.27 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.456 0.702 . . . . 0.0 112.192 -176.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 27.1 p -69.5 102.37 1.79 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.736 0.414 . . . . 0.0 110.647 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 26.2 m -77.56 -15.13 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 123.344 0.657 . . . . 0.0 111.201 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 168.84 -172.13 43.09 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.808 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -99.31 150.44 22.11 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 174.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -86.25 152.19 22.99 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.946 0.498 . . . . 0.0 110.553 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -146.65 121.34 9.84 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 172.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 38.3 mt-10 -71.46 129.01 89.32 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 123.232 0.613 . . . . 0.0 109.631 173.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.9 -32.27 56.29 Favored 'Trans proline' 0 CA--C 1.561 1.847 0 C-N-CA 122.848 2.365 . . . . 0.0 112.645 176.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -76.64 -32.47 58.02 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.624 0.77 . . . . 0.0 111.552 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 50.3 tp60 -63.46 -31.05 72.11 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.829 0.452 . . . . 0.0 110.262 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -71.84 98.43 1.99 Allowed 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 167.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -175.21 -168.8 36.24 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.32 147.6 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.125 0.97 . . . . 0.0 110.791 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.1 t -104.53 128.56 52.53 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 170.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 75.6 mt -86.79 120.69 71.87 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.85 103.13 0.27 Allowed 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.435 2.09 . . . . 0.0 111.492 171.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -75.7 86.77 2.74 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.469 0.708 . . . . 0.0 109.666 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.3 tt -74.06 -37.64 64.19 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.03 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.487 0 CA-C-O 118.43 -1.205 . . . . 0.0 111.171 -176.01 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.55 148.48 40.82 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.772 0.429 . . . . 0.0 110.306 176.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.5 p -108.33 130.97 60.05 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.1 m -80.05 118.43 21.76 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.625 0.77 . . . . 0.0 110.169 -177.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.4 mt -78.34 100.32 6.7 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.357 0.598 . . . . 0.0 109.64 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -92.53 114.37 29.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 38.3 mtp-105 -85.99 176.3 8.12 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.785 -175.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.5 tt -58.02 -37.44 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.728 175.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.75 -40.25 94.98 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.818 0.847 . . . . 0.0 111.264 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -74.28 -39.79 62.72 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.165 0.586 . . . . 0.0 110.788 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 45.6 tp -66.77 -50.15 63.6 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.035 0.534 . . . . 0.0 110.604 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -64.85 -48.11 75.52 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.63 0.772 . . . . 0.0 112.069 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -67.09 -47.96 69.62 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 123.488 0.493 . . . . 0.0 111.643 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -64.2 -36.77 85.16 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.525 0.33 . . . . 0.0 110.61 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -65.56 -39.69 91.96 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.067 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -67.79 -29.15 68.26 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.52 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -65.38 -23.2 66.91 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.184 0.594 . . . . 0.0 111.588 175.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.92 -26.74 6.09 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.574 ' HA2' ' HD2' ' A' ' 52' ' ' LYS . . . -69.62 89.55 0.29 Allowed Glycine 0 C--N 1.345 1.073 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 176.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -74.11 112.84 10.65 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -171.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 32.6 m0 -105.27 155.21 19.28 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.69 171.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.6 t -129.55 160.72 32.35 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.516 0.726 . . . . 0.0 109.408 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 p -116.34 109.43 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 172.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.3 mt -134.37 133.76 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.002 1.321 . . . . 0.0 107.696 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.0 t70 63.2 29.4 16.0 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 124.473 1.109 . . . . 0.0 110.631 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.5 19.0 64.17 Favored Glycine 0 C--N 1.353 1.487 0 CA-C-N 115.121 -0.945 . . . . 0.0 113.497 -174.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.471 ' HB2' ' CE2' ' A' ' 49' ' ' TYR . 42.9 mmtm -116.82 152.33 34.65 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.449 1.1 . . . . 0.0 108.51 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.8 t -102.12 122.59 54.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' A' ' 47' ' ' LYS . 96.4 m-85 -114.47 155.3 26.64 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.923 0.889 . . . . 0.0 110.427 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -94.63 107.12 19.12 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.436 0.694 . . . . 0.0 109.47 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.491 HG23 ' HB2' ' A' ' 73' ' ' PRO . 15.6 mm -75.77 -39.87 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.925 0.89 . . . . 0.0 112.288 -177.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.574 ' HD2' ' HA2' ' A' ' 39' ' ' GLY . 18.0 ptmt -67.08 -32.06 72.97 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 121.161 -0.216 . . . . 0.0 110.954 -174.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -73.7 -38.45 64.84 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -53.19 -54.17 39.88 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.503 1.121 . . . . 0.0 111.12 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -70.34 -27.56 64.45 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.411 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.1 m -72.52 -33.08 66.63 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 120.946 0.403 . . . . 0.0 110.241 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.529 ' HB2' HD12 ' A' ' 65' ' ' LEU . 82.6 mm-40 -69.65 -35.42 75.17 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 172.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.4 m -65.31 -27.12 68.38 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.301 0.64 . . . . 0.0 111.099 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.3 tt -61.63 -44.73 96.43 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.238 1.015 . . . . 0.0 109.297 173.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 88.8 m -66.91 120.31 13.38 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.38 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -65.49 -31.52 72.64 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.956 0.903 . . . . 0.0 111.308 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -69.66 -18.16 63.55 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.331 1.053 . . . . 0.0 111.766 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.8 t -76.04 152.66 36.84 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.877 0.471 . . . . 0.0 110.762 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.447 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 32.4 pt -61.2 -26.8 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.711 170.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.529 HD12 ' HB2' ' A' ' 57' ' ' GLN . 46.6 mt -77.21 0.76 20.69 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.144 0.978 . . . . 0.0 111.971 -176.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.99 -30.4 70.91 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.363 0.665 . . . . 0.0 111.21 172.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 11.2 pt20 -73.99 -27.06 60.78 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.31 0.644 . . . . 0.0 110.689 175.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.515 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 41.8 m-85 -92.69 -6.44 49.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.255 1.022 . . . . 0.0 111.45 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.27 104.22 0.9 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.153 0.581 . . . . 0.0 109.824 174.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.47 -32.13 3.62 Favored Glycine 0 N--CA 1.472 1.046 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -174.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -77.62 151.14 34.5 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.425 0.69 . . . . 0.0 109.649 175.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -55.37 128.1 66.54 Favored Pre-proline 0 N--CA 1.48 1.067 0 CA-C-O 118.476 -0.773 . . . . 0.0 108.955 171.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.491 ' HB2' HG23 ' A' ' 51' ' ' ILE . 28.6 Cg_endo -58.0 -31.51 93.07 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.836 2.357 . . . . 0.0 113.973 -170.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.9 t -75.38 -50.27 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 123.058 0.543 . . . . 0.0 110.097 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.1 t -58.58 -35.26 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 124.035 0.934 . . . . 0.0 111.022 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.515 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -73.27 -34.98 66.1 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.701 1.2 . . . . 0.0 111.213 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.546 ' HG ' ' SD ' ' A' ' 90' ' ' MET . 4.6 tt -71.58 -35.78 70.67 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.504 0.722 . . . . 0.0 109.889 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -66.53 -40.72 89.29 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.426 0.69 . . . . 0.0 110.36 175.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.18 -32.95 74.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.638 0.775 . . . . 0.0 110.619 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.41 -40.82 73.65 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.878 177.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.9 mt -64.67 -36.68 85.04 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.251 0.621 . . . . 0.0 110.856 173.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -65.87 -36.81 84.46 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.637 0.775 . . . . 0.0 111.074 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.492 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 29.9 t80 -95.96 132.12 41.62 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -176.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -65.85 -36.81 84.49 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.174 0.99 . . . . 0.0 113.193 -168.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -74.98 -32.2 61.63 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.713 0.405 . . . . 0.0 111.063 -177.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.492 ' OG1' ' HB3' ' A' ' 83' ' ' PHE . 37.8 p -93.57 -10.65 34.02 Favored 'General case' 0 CA--C 1.555 1.161 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -172.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -78.51 -15.07 59.0 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -26.24 55.44 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.01 0.524 . . . . 0.0 112.198 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.6 t -73.73 -29.57 62.33 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.324 0.25 . . . . 0.0 110.38 171.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.546 ' SD ' ' HG ' ' A' ' 77' ' ' LEU . 32.1 mmt -64.94 -26.05 68.14 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.052 0.541 . . . . 0.0 110.406 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -59.91 -37.02 78.24 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.707 0.803 . . . . 0.0 110.63 174.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.36 -32.8 60.96 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.834 178.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -78.24 -24.09 47.1 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.255 0.222 . . . . 0.0 111.16 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 39.1 t -70.77 95.27 1.11 Allowed 'General case' 0 C--N 1.349 0.556 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 33.3 m -71.0 -22.77 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.238 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 169.75 -160.66 33.81 Favored Glycine 0 C--N 1.351 1.396 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.836 174.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -97.22 145.69 25.82 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.647 1.179 . . . . 0.0 109.133 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -80.26 108.79 14.16 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 173.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 3.0 tm? -92.31 114.58 27.17 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 103' ' ' GLN . 30.6 tt0 -80.03 140.71 53.86 Favored Pre-proline 0 CA--C 1.554 1.102 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 174.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -39.1 -51.2 2.56 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 124.356 3.371 . . . . 0.0 114.644 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -103.1 23.06 12.93 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.291 0.637 . . . . 0.0 111.655 -175.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.561 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 8.9 tp-100 -81.09 -27.59 35.58 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.861 -0.524 . . . . 0.0 110.088 174.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -69.63 96.52 0.95 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.695 0.798 . . . . 0.0 109.449 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 117.15 38.89 0.84 Allowed Glycine 0 C--N 1.341 0.854 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.339 -174.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.5 p -61.27 124.66 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.398 0.679 . . . . 0.0 110.982 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.0 t -77.64 125.97 30.15 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.254 0.55 . . . . 0.0 110.094 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.4 mt -111.76 93.64 21.12 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.96 87.08 1.52 Allowed 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.651 2.234 . . . . 0.0 111.374 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -81.86 93.59 6.91 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.076 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.0 mp -76.9 -15.58 59.64 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.041 172.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.164 0 CA-C-O 118.861 -0.966 . . . . 0.0 112.71 172.801 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.55 153.94 42.73 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 172.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.1 p -132.35 150.92 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 120.959 0.409 . . . . 0.0 110.859 -173.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.1 m -90.92 115.3 27.84 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.861 0.865 . . . . 0.0 108.712 173.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.433 HD22 ' HB2' ' A' ' 99' ' ' LEU . 64.3 mt -79.35 110.59 14.79 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.1 t -91.87 119.31 39.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 124.069 0.948 . . . . 0.0 108.583 -176.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.531 ' HG2' ' HB2' ' A' ' 30' ' ' ASP . 1.5 ptm180 -81.27 162.0 23.69 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.421 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.5 tt -60.12 -36.8 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.757 0.823 . . . . 0.0 111.836 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.09 -32.21 64.84 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.485 0.714 . . . . 0.0 111.922 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.531 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 29.1 t70 -58.81 -43.26 90.51 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.403 0.681 . . . . 0.0 110.454 -176.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.9 mt -52.35 -43.85 64.86 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.511 1.124 . . . . 0.0 111.691 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -72.18 -37.83 69.22 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.506 -175.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -69.09 -40.06 78.65 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.934 0.494 . . . . 0.0 110.821 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -66.74 -40.4 88.3 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.17 0.588 . . . . 0.0 110.05 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -59.79 -40.49 88.49 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.973 0.509 . . . . 0.0 110.143 176.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -69.27 -31.64 70.3 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.753 0.821 . . . . 0.0 111.388 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -74.28 -30.44 62.1 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.783 0.833 . . . . 0.0 111.274 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 112.06 -7.15 27.21 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.688 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.515 ' HA2' ' HD2' ' A' ' 52' ' ' LYS . . . -75.36 83.46 0.87 Allowed Glycine 0 C--N 1.349 1.268 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 172.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -75.71 107.32 7.8 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -172.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 28.7 m0 -111.44 160.71 16.85 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.643 1.177 . . . . 0.0 110.425 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.8 t -149.36 144.75 26.61 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.421 1.088 . . . . 0.0 109.126 -177.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.573 HG22 HG22 ' A' ' 48' ' ' VAL . 95.9 t -111.36 119.17 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.3 0.64 . . . . 0.0 109.925 178.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.9 mt -127.54 106.12 14.67 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 124.031 0.932 . . . . 0.0 109.008 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.5 t70 55.94 54.55 7.91 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 124.599 1.16 . . . . 0.0 111.61 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.64 9.43 62.01 Favored Glycine 0 N--CA 1.475 1.296 0 CA-C-N 115.081 -0.963 . . . . 0.0 114.428 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -117.76 124.5 48.59 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.767 0.827 . . . . 0.0 108.866 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.573 HG22 HG22 ' A' ' 43' ' ' VAL . 15.2 t -97.11 127.51 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.534 ' HB2' HD21 ' A' ' 77' ' ' LEU . 79.7 m-85 -127.7 163.71 23.7 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.291 1.036 . . . . 0.0 109.035 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -93.39 160.23 14.9 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.529 0.68 . . . . 0.0 110.066 170.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.8 mm -113.14 -27.77 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.494 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.515 ' HD2' ' HA2' ' A' ' 39' ' ' GLY . 21.0 ptmt -70.26 -48.75 55.45 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.069 0.548 . . . . 0.0 112.252 -173.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.457 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 34.6 t70 -75.04 -36.78 61.85 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -49.81 -55.43 14.17 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.934 1.293 . . . . 0.0 112.217 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -67.65 -27.28 66.74 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.111 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.3 m -68.6 -32.05 71.67 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.296 0.638 . . . . 0.0 110.895 172.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 22.5 mm-40 -76.13 -21.4 56.66 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 121.908 -0.495 . . . . 0.0 111.123 178.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.0 m -68.84 -17.66 64.03 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.124 0.57 . . . . 0.0 111.081 172.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.3 tp -69.71 -25.59 63.93 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.709 0.804 . . . . 0.0 110.709 173.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.7 m -86.15 117.47 25.0 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -67.55 -28.36 67.73 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.404 0.681 . . . . 0.0 111.207 -177.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -88.78 63.43 6.85 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-O 121.924 0.869 . . . . 0.0 108.943 173.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 61.2 m -147.55 153.23 39.2 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.923 1.289 . . . . 0.0 108.304 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.476 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 31.8 pt -61.4 -25.6 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.465 0.706 . . . . 0.0 110.902 170.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 57' ' ' GLN . 58.8 mt -84.31 0.34 49.47 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.368 1.067 . . . . 0.0 112.298 -175.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.91 -29.82 61.09 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.006 0.522 . . . . 0.0 110.744 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 10.6 pt20 -85.43 -6.82 59.18 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.223 0.609 . . . . 0.0 110.846 173.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -108.91 7.97 26.25 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.07 0.948 . . . . 0.0 110.477 174.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.21 126.53 30.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.076 0.55 . . . . 0.0 109.76 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.65 -31.85 8.09 Favored Glycine 0 N--CA 1.474 1.227 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 -173.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -75.28 152.8 38.21 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.948 0.899 . . . . 0.0 109.945 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -56.19 124.47 60.23 Favored Pre-proline 0 N--CA 1.476 0.858 0 C-N-CA 123.927 0.891 . . . . 0.0 109.749 175.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.13 -23.95 52.4 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.979 2.453 . . . . 0.0 113.938 -172.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.2 t -74.6 -47.58 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 176.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.88 -34.0 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.816 0.847 . . . . 0.0 111.085 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.08 -35.74 71.97 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.146 0.979 . . . . 0.0 110.516 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.619 HD12 ' SD ' ' A' ' 90' ' ' MET . 58.8 tp -68.99 -42.6 76.29 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.469 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -65.91 -42.38 90.26 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.604 0.761 . . . . 0.0 110.478 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.96 -37.36 86.77 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.607 0.763 . . . . 0.0 110.328 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.07 -42.47 89.39 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.293 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.4 HD23 ' HG3' ' A' ' 90' ' ' MET . 93.7 mt -67.64 -33.41 74.9 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.88 0.872 . . . . 0.0 111.848 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -89.14 2.55 53.98 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.321 0.649 . . . . 0.0 111.809 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.403 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 30.2 t80 -129.82 125.46 35.78 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.93 0.492 . . . . 0.0 109.821 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -58.23 -38.96 77.85 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.758 1.223 . . . . 0.0 113.73 -169.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -71.46 -30.6 66.21 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.353 0.661 . . . . 0.0 111.473 -176.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.426 HG22 ' HB ' ' A' ' 64' ' ' ILE . 24.6 p -101.67 -7.88 22.28 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.366 0.666 . . . . 0.0 112.67 -173.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.69 1.02 53.47 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 118.305 0.502 . . . . 0.0 111.323 177.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -72.56 -49.66 30.94 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.022 0.929 . . . . 0.0 110.782 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 32.8 t -71.58 -18.86 62.21 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.608 0.763 . . . . 0.0 111.162 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.619 ' SD ' HD12 ' A' ' 77' ' ' LEU . 37.4 mmt -64.79 -21.01 66.69 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.456 0.702 . . . . 0.0 111.979 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -60.39 -34.44 73.9 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.446 0.699 . . . . 0.0 110.895 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.99 -45.71 69.91 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.126 0.57 . . . . 0.0 110.97 176.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.418 ' HD2' ' HA ' ' A' ' 90' ' ' MET . 60.1 m-85 -73.61 -16.21 61.24 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.294 0.638 . . . . 0.0 111.395 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 45.8 t -70.65 87.98 0.69 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.441 0.696 . . . . 0.0 109.608 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.8 m -77.1 -25.55 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.383 -176.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 172.82 177.7 42.33 Favored Glycine 0 C--N 1.343 0.921 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.462 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -98.61 133.93 42.26 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -72.55 129.23 37.82 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 173.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.433 ' HB2' HD22 ' A' ' 25' ' ' LEU . 3.0 tm? -132.59 127.87 35.94 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 43.4 mt-10 -82.33 141.95 46.51 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 123.718 0.807 . . . . 0.0 110.4 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -59.18 -34.6 98.43 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.773 2.315 . . . . 0.0 111.658 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -70.57 -39.75 73.71 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.211 175.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 55.6 tp60 -67.11 -32.39 73.5 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.285 0.634 . . . . 0.0 111.775 -176.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.38 -49.78 68.0 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -69.44 -37.62 79.26 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 114.858 -1.065 . . . . 0.0 113.826 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.4 p -149.95 136.33 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.426 0.69 . . . . 0.0 110.361 -175.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.2 t -106.19 125.0 50.46 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 172.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.1 mt -71.32 127.53 91.22 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 123.554 0.742 . . . . 0.0 109.961 -175.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.87 170.64 8.44 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.76 2.307 . . . . 0.0 112.548 176.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -86.24 23.22 1.6 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.543 0.737 . . . . 0.0 111.679 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.3 mt -78.88 85.71 4.83 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.211 1.004 . . . . 0.0 109.913 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.13 0 CA-C-O 118.785 -1.008 . . . . 0.0 111.848 178.154 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -89.39 96.29 10.65 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 170.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.1 p -84.12 124.45 39.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.0 m -69.46 109.92 4.47 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 122.711 0.405 . . . . 0.0 109.973 -177.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.545 HD13 HD22 ' A' ' 99' ' ' LEU . 92.3 mt -79.98 100.92 8.35 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.504 ' HB ' HG21 ' A' ' 48' ' ' VAL . 58.2 t -94.57 116.98 37.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 55.6 mtm180 -95.76 172.93 7.73 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.191 0.597 . . . . 0.0 110.84 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.493 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 19.9 tt -60.52 -36.65 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 123.757 0.661 . . . . 0.0 111.451 -174.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.39 -45.12 72.81 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.081 0.952 . . . . 0.0 110.761 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.2 -44.98 93.84 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.04 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.4 mt -59.21 -42.7 91.55 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.858 0.863 . . . . 0.0 111.972 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 9.9 mm-40 -63.45 -50.5 69.49 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 123.496 0.497 . . . . 0.0 111.162 -174.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -71.85 -33.96 68.87 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.575 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -72.29 -35.06 68.58 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.852 0.461 . . . . 0.0 110.442 -177.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -66.45 -39.2 88.73 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.915 0.886 . . . . 0.0 110.399 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -61.78 -32.42 72.7 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.72 0.808 . . . . 0.0 111.52 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -66.12 -34.15 77.41 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.916 0.487 . . . . 0.0 111.058 176.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.05 -18.83 7.41 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.789 -175.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.88 89.02 0.23 Allowed Glycine 0 C--N 1.353 1.506 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 174.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -77.46 108.77 10.86 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.171 0.589 . . . . 0.0 109.573 -175.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -105.83 165.65 11.04 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.264 1.026 . . . . 0.0 109.907 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.8 t -143.03 160.29 40.65 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.868 0.867 . . . . 0.0 109.859 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 47' ' ' LYS . 1.5 p -114.49 112.38 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 123.443 0.697 . . . . 0.0 109.468 170.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.737 HD12 HD23 ' A' ' 77' ' ' LEU . 39.9 mt -134.52 136.98 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.749 1.219 . . . . 0.0 107.872 175.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.0 t70 62.85 29.41 16.61 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 124.327 1.051 . . . . 0.0 110.447 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.48 23.24 68.41 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.11 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.409 ' HB2' ' CE1' ' A' ' 49' ' ' TYR . 27.5 mmtp -124.67 153.19 42.68 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.562 1.145 . . . . 0.0 108.671 -176.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.504 HG21 ' HB ' ' A' ' 26' ' ' VAL . 91.7 t -104.07 132.27 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 175.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.409 ' CE1' ' HB2' ' A' ' 47' ' ' LYS . 66.7 m-85 -127.72 153.18 46.82 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.841 0.856 . . . . 0.0 109.908 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -92.42 106.18 18.23 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.527 HD11 HD22 ' A' ' 77' ' ' LEU . 35.8 mm -83.37 -29.6 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.75 0.82 . . . . 0.0 111.533 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.24 -47.56 84.9 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 28.5 t70 -69.37 -40.84 77.22 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.555 177.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -52.84 -55.0 26.25 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.421 1.089 . . . . 0.0 112.055 -177.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -66.44 -28.01 68.27 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.718 0.807 . . . . 0.0 111.583 -176.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.8 m -66.85 -37.06 83.74 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 122.918 0.487 . . . . 0.0 109.827 173.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 49.7 mm-40 -76.51 -24.63 53.73 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.285 0.634 . . . . 0.0 110.711 176.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.3 m -76.84 -19.69 57.22 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.52 0.728 . . . . 0.0 111.252 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.8 tt -74.05 -24.79 59.58 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.617 0.767 . . . . 0.0 110.321 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.7 m -58.8 137.47 57.7 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.904 0.881 . . . . 0.0 112.693 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -54.28 -45.69 72.55 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.016 1.327 . . . . 0.0 112.04 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -118.12 112.04 19.66 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 38.9 t -163.41 158.58 21.29 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.465 ' HB ' HG22 ' A' ' 86' ' ' THR . 35.9 pt -65.22 -24.63 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 166.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.5 mt -91.6 -2.04 57.26 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 124.759 1.224 . . . . 0.0 111.619 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.17 -31.97 68.33 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.938 0.495 . . . . 0.0 110.376 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 9.6 pt20 -76.51 -23.21 53.7 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.993 0.517 . . . . 0.0 110.652 172.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.541 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 29.4 m-85 -96.24 6.82 47.96 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.369 1.068 . . . . 0.0 111.688 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.52 -22.43 63.58 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.316 0.646 . . . . 0.0 112.1 -177.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.44 11.43 71.36 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-O 120.231 -0.205 . . . . 0.0 112.775 177.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -125.84 156.74 39.11 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.411 1.084 . . . . 0.0 109.694 -177.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -55.46 128.67 68.34 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 124.235 1.014 . . . . 0.0 109.354 170.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -59.74 -30.4 91.98 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.923 2.415 . . . . 0.0 113.946 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.9 t -75.18 -39.02 42.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 C-N-CA 122.588 0.355 . . . . 0.0 110.346 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.6 t -69.76 -39.8 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-O 121.49 0.662 . . . . 0.0 110.116 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.541 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -63.56 -34.49 77.93 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.114 1.366 . . . . 0.0 111.135 178.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.737 HD23 HD12 ' A' ' 44' ' ' ILE . 64.8 tp -61.09 -44.07 97.92 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.81 175.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.468 ' HG2' HG21 ' A' ' 44' ' ' ILE . 42.1 mt-10 -64.44 -40.82 96.47 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.77 0.828 . . . . 0.0 111.399 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.3 -38.5 91.38 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.529 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.434 ' HB1' ' SD ' ' A' ' 90' ' ' MET . . . -75.81 -26.13 56.96 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.74 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 79.6 mt -72.13 -39.48 68.78 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.502 0.721 . . . . 0.0 109.95 174.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -67.91 -44.78 76.13 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.114 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -84.76 131.48 34.55 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 120.823 0.344 . . . . 0.0 110.209 -176.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -66.58 -41.33 88.71 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.263 1.025 . . . . 0.0 112.916 -171.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.58 -26.57 65.45 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.14 0.576 . . . . 0.0 111.412 -176.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.465 HG22 ' HB ' ' A' ' 64' ' ' ILE . 28.1 p -91.09 -34.22 15.16 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.21 0.604 . . . . 0.0 111.977 -177.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -66.83 -14.27 62.49 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -171.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -57.75 -36.88 72.7 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.252 0.621 . . . . 0.0 111.09 173.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.2 t -77.12 -35.44 56.27 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.346 0.659 . . . . 0.0 110.451 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.479 ' SD ' ' N ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -67.95 -21.64 65.08 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.71 0.804 . . . . 0.0 111.2 175.627 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -67.62 -21.57 65.38 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.35 1.06 . . . . 0.0 110.249 172.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -92.65 -29.95 15.84 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.872 0.869 . . . . 0.0 111.272 172.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -74.95 -23.35 58.3 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 122.962 0.505 . . . . 0.0 111.527 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 27.1 p -69.86 101.05 1.65 Allowed 'General case' 0 C--N 1.354 0.789 0 C-N-CA 122.869 0.468 . . . . 0.0 110.133 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.4 t -67.66 -31.07 50.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 123.91 0.884 . . . . 0.0 110.179 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 172.28 -160.29 31.63 Favored Glycine 0 C--N 1.339 0.721 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.465 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -102.89 133.79 47.38 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 175.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -75.65 131.07 39.68 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 123.273 0.358 . . . . 0.0 110.444 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.545 HD22 HD13 ' A' ' 25' ' ' LEU . 66.5 tp -121.56 134.97 55.03 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 33.4 mt-10 -85.66 137.89 35.93 Favored Pre-proline 0 C--O 1.244 0.815 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 171.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -60.85 -22.53 74.18 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.946 2.43 . . . . 0.0 112.635 175.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -85.1 -37.55 20.14 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.269 1.028 . . . . 0.0 110.853 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.551 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 9.5 tp-100 -63.16 -41.86 99.33 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.83 0.852 . . . . 0.0 111.277 -173.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -61.6 -37.03 82.41 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.288 0.635 . . . . 0.0 111.215 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.52 78.85 1.32 Allowed Glycine 0 C--N 1.348 1.234 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.8 p -144.58 137.4 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.156 0.582 . . . . 0.0 110.073 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.9 t -126.1 133.5 51.64 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 172.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 63.4 mt -96.4 116.69 66.28 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.19 154.46 51.83 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 122.599 2.199 . . . . 0.0 111.602 171.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -61.91 113.31 2.72 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.212 0.605 . . . . 0.0 111.073 -174.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -169.2 103.28 0.37 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.33 0 CA-C-O 119.007 -0.885 . . . . 0.0 112.236 173.736 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -68.48 137.9 54.8 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.994 0.518 . . . . 0.0 110.836 174.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.7 p -119.86 141.2 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.12 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.9 p -71.86 108.01 4.93 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.2 mt -81.73 117.66 22.23 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.3 t -92.13 125.3 44.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -175.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -67.97 152.7 45.13 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.471 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 18.9 tt -60.63 -44.56 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 117.711 0.232 . . . . 0.0 110.836 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.71 -31.45 69.47 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.457 0.703 . . . . 0.0 110.613 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.5 -37.78 80.39 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.927 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.4 tp -64.9 -51.66 60.71 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.664 0.786 . . . . 0.0 110.205 175.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 58.8 mm-40 -64.17 -53.57 47.3 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.997 0.919 . . . . 0.0 112.473 -171.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -74.55 -29.68 61.46 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -173.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -72.53 -37.49 68.29 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -63.12 -42.76 99.6 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.887 0.875 . . . . 0.0 109.486 174.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -68.6 -26.58 65.44 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.178 1.391 . . . . 0.0 111.671 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -66.53 -35.26 79.81 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.548 0.739 . . . . 0.0 111.538 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 129.64 -26.63 4.28 Favored Glycine 0 N--CA 1.467 0.738 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.24 81.55 0.36 Allowed Glycine 0 C--N 1.351 1.408 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 167.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -74.63 113.69 12.18 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -164.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 33.4 m0 -106.61 171.44 7.36 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.396 1.078 . . . . 0.0 110.548 177.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.8 t -157.66 142.17 16.36 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.335 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -104.03 112.8 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.107 0.563 . . . . 0.0 109.525 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.429 HD13 ' HG2' ' A' ' 78' ' ' GLU . 55.7 mt -127.39 120.18 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.109 0.964 . . . . 0.0 108.942 176.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 62.06 40.08 12.44 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 125.12 1.368 . . . . 0.0 110.691 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.59 15.59 73.33 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.033 -0.985 . . . . 0.0 113.551 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.444 ' HD3' ' HG3' ' A' ' 97' ' ' GLN . 35.6 mmtp -118.65 148.17 43.0 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.086 0.955 . . . . 0.0 109.411 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.9 t -106.1 120.98 57.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.416 ' HB2' HD21 ' A' ' 77' ' ' LEU . 75.6 m-85 -118.08 171.17 8.28 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.972 1.309 . . . . 0.0 108.887 173.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -102.14 159.41 15.41 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.4 0.619 . . . . 0.0 110.39 170.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.1 mm -114.28 -21.4 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 124.437 1.095 . . . . 0.0 109.136 168.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -56.99 6.99 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 122.994 0.517 . . . . 0.0 111.614 -175.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.418 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 23.7 t70 -67.43 -37.12 82.53 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -53.17 -52.21 59.55 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.637 1.575 . . . . 0.0 112.7 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -69.6 -27.13 64.83 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.778 -176.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.8 m -70.27 -34.36 72.7 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-O 121.056 0.455 . . . . 0.0 110.423 174.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 33.3 mm-40 -72.19 -24.27 61.39 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.649 0.78 . . . . 0.0 112.195 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.6 p -77.57 -6.82 55.05 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.34 -2.49 38.39 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.761 0.424 . . . . 0.0 111.134 168.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' A' ' 63' ' ' SER . 19.4 m -77.44 120.24 22.17 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 168.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.5 -36.9 84.01 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.417 0.687 . . . . 0.0 111.801 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -111.24 87.32 2.52 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.513 ' HB3' ' HB ' ' A' ' 60' ' ' THR . 91.9 p -147.13 164.7 32.25 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.994 0.917 . . . . 0.0 109.601 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.557 ' HB ' HG22 ' A' ' 86' ' ' THR . 29.5 pt -68.43 -17.77 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 122.694 0.397 . . . . 0.0 111.019 171.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.6 mt -96.65 -8.87 30.49 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.978 0.911 . . . . 0.0 111.35 -177.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.54 -33.4 74.04 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.469 0.708 . . . . 0.0 110.773 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -76.69 -19.83 57.28 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.663 0.785 . . . . 0.0 111.239 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.499 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 25.5 m-85 -107.38 7.28 29.01 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.128 0.971 . . . . 0.0 111.1 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.26 -38.07 89.16 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.303 0.641 . . . . 0.0 111.539 -175.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -79.18 -8.3 87.91 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.594 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -95.66 155.46 16.73 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.454 0.702 . . . . 0.0 109.437 175.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -49.22 131.16 16.86 Favored Pre-proline 0 N--CA 1.485 1.324 0 C-N-CA 124.432 1.093 . . . . 0.0 110.417 172.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -61.72 -33.41 85.83 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.748 2.299 . . . . 0.0 113.859 -172.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.1 t -74.55 -41.27 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.66 -32.56 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 123.633 0.773 . . . . 0.0 110.373 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.499 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -68.83 -36.72 78.54 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.554 1.142 . . . . 0.0 110.505 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.7 HD12 ' SD ' ' A' ' 90' ' ' MET . 59.0 tp -64.77 -42.74 94.87 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.079 175.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.429 ' HG2' HD13 ' A' ' 44' ' ' ILE . 48.1 mt-10 -63.49 -40.87 98.22 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.44 0.696 . . . . 0.0 111.594 177.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.11 -34.39 77.96 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.669 0.787 . . . . 0.0 110.307 177.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.36 -26.32 51.86 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.324 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 92.0 mt -75.53 -30.92 59.91 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.1 0.56 . . . . 0.0 110.612 172.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -75.0 -45.87 38.99 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.724 -176.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.418 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 35.3 t80 -82.04 137.88 34.98 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 122.579 0.352 . . . . 0.0 110.579 -174.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.11 -37.15 85.04 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.368 1.067 . . . . 0.0 113.493 -169.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -66.04 -44.26 85.14 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.381 0.61 . . . . 0.0 110.624 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.557 HG22 ' HB ' ' A' ' 64' ' ' ILE . 25.5 p -81.89 -28.6 32.83 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.921 -169.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -64.87 -27.1 68.63 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.124 0.569 . . . . 0.0 111.964 -173.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -79.54 -22.77 43.46 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.392 0.677 . . . . 0.0 110.698 -178.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.5 t -80.68 -28.67 36.7 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.59 0.756 . . . . 0.0 110.381 171.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.7 ' SD ' HD12 ' A' ' 77' ' ' LEU . 36.2 mmt -64.45 -16.71 62.91 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.72 0.808 . . . . 0.0 111.889 176.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -57.79 -33.96 69.11 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.772 1.229 . . . . 0.0 111.531 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.6 -37.24 84.47 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.486 0.714 . . . . 0.0 111.254 176.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.471 ' HD2' ' HA ' ' A' ' 90' ' ' MET . 63.6 m-85 -85.66 -13.03 49.83 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.518 0.727 . . . . 0.0 111.326 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.4 t -71.54 92.61 1.14 Allowed 'General case' 0 C--N 1.351 0.66 0 C-N-CA 123.239 0.615 . . . . 0.0 109.605 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.9 m -83.16 -12.53 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.582 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 165.86 -169.46 40.18 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.772 172.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.444 ' HG3' ' HD3' ' A' ' 47' ' ' LYS . 30.6 tt0 -108.84 139.9 43.04 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.411 1.084 . . . . 0.0 108.156 172.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -71.62 136.62 47.45 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.002 0.43 . . . . 0.0 110.439 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -117.15 121.75 42.13 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 171.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.678 ' HB3' ' HB2' ' A' ' 103' ' ' GLN . 33.1 tt0 -73.5 133.16 80.55 Favored Pre-proline 0 CA--C 1.552 1.056 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.25 174.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.408 ' HD3' ' HB ' ' A' ' 28' ' ' ILE . 73.3 Cg_endo -66.58 -13.85 41.59 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.239 2.626 . . . . 0.0 113.762 -170.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -104.19 -18.32 14.54 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.876 0.471 . . . . 0.0 110.626 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.678 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 8.5 tp-100 -65.26 -28.92 69.68 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.068 0.947 . . . . 0.0 112.748 -170.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -76.21 -2.88 33.46 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -167.69 51.8 0.23 Allowed Glycine 0 C--N 1.349 1.303 0 N-CA-C 112.212 -0.355 . . . . 0.0 112.212 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.4 p -90.36 113.0 25.66 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 123.183 0.593 . . . . 0.0 111.27 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.0 t -98.1 150.92 20.92 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 167.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 71.2 mt -121.3 127.38 26.16 Favored Pre-proline 0 N--CA 1.482 1.153 0 C-N-CA 122.955 0.502 . . . . 0.0 109.693 -175.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.98 138.49 57.44 Favored 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 122.698 2.266 . . . . 0.0 111.261 173.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 60.57 28.91 18.6 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.304 1.042 . . . . 0.0 111.869 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 43.6 tp -66.52 -42.21 87.63 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.338 0.655 . . . . 0.0 109.941 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.045 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.734 176.572 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.59 147.94 27.45 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 169.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.75 136.61 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-O 121.32 0.581 . . . . 0.0 112.295 -173.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.7 m -82.2 108.86 15.98 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 168.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.547 HD13 HD12 ' A' ' 99' ' ' LEU . 83.1 mt -92.93 103.11 15.47 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.114 0.565 . . . . 0.0 109.558 -178.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.413 ' HB ' HG21 ' A' ' 48' ' ' VAL . 69.0 t -92.97 115.92 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 124.02 0.928 . . . . 0.0 108.618 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -84.26 164.83 18.8 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.01 0.924 . . . . 0.0 108.975 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.521 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 17.2 tt -51.23 -44.99 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.455 0.702 . . . . 0.0 112.412 -176.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.43 -44.2 92.95 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.159 0.584 . . . . 0.0 111.641 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -67.63 -35.11 78.32 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.718 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.8 tp -62.91 -42.56 99.83 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.037 0.535 . . . . 0.0 110.203 176.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 12.0 mm-40 -67.55 -55.36 13.78 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.675 0.79 . . . . 0.0 111.578 -175.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -71.13 -35.35 71.7 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.891 -173.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -70.17 -36.66 74.83 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.544 0.338 . . . . 0.0 110.207 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -56.59 -40.69 75.71 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.691 0.619 . . . . 0.0 110.125 175.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -86.89 -15.72 38.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.285 1.034 . . . . 0.0 111.929 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -67.52 -32.18 72.8 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.633 0.773 . . . . 0.0 110.474 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 142.29 -28.6 2.21 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.467 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.486 ' HA2' ' HZ2' ' A' ' 52' ' ' LYS . . . -83.0 98.03 2.02 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 174.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -73.28 118.26 16.03 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 -173.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.4 m0 -119.38 154.65 33.29 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.882 0.873 . . . . 0.0 111.554 -169.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.5 t -150.88 151.98 33.02 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.892 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 47' ' ' LYS . 1.6 p -97.77 117.94 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 169.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.7 mt -138.37 131.92 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.8 t70 61.39 29.27 18.43 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 122.31 1.052 . . . . 0.0 110.722 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.87 1.59 47.9 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 114.984 -1.007 . . . . 0.0 114.068 -176.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 41.2 mmtm -96.96 172.69 7.7 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.129 0.972 . . . . 0.0 109.145 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.413 HG21 ' HB ' ' A' ' 26' ' ' VAL . 85.0 t -120.38 119.33 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 172.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -112.34 148.92 33.24 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.236 0.615 . . . . 0.0 110.346 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -92.2 98.79 11.74 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 123.055 0.542 . . . . 0.0 109.736 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.1 mm -61.79 -27.72 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 124.941 1.297 . . . . 0.0 112.122 175.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.486 ' HZ2' ' HA2' ' A' ' 39' ' ' GLY . 5.8 ttpm? -59.39 -51.67 68.89 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-O 120.889 0.376 . . . . 0.0 110.325 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 31.4 t70 -67.61 -39.57 84.73 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.652 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.411 ' HA ' ' HE2' ' A' ' 93' ' ' PHE . 54.5 t80 -49.05 -48.29 44.09 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.197 0.999 . . . . 0.0 110.886 174.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.406 ' HA ' ' OG ' ' A' ' 58' ' ' SER . 16.0 mm100 -71.83 -31.21 66.3 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.41 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.0 m -62.47 -37.83 87.48 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-O 121.052 0.453 . . . . 0.0 110.106 172.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.616 ' HB2' HD12 ' A' ' 65' ' ' LEU . 66.3 mm-40 -78.37 -25.96 46.47 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.311 0.644 . . . . 0.0 111.693 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.406 ' OG ' ' HA ' ' A' ' 55' ' ' GLN . 92.7 p -85.79 -8.84 57.86 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.903 -0.498 . . . . 0.0 110.995 174.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.6 tt -75.86 -42.54 49.13 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.007 0.923 . . . . 0.0 109.179 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.2 t -75.64 157.49 33.65 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.054 -176.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -67.87 -73.56 0.14 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.363 1.065 . . . . 0.0 111.06 -171.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -86.2 100.58 12.33 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.58 0.705 . . . . 0.0 109.414 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 48.1 t -155.72 163.94 39.22 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.609 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.612 ' HB ' HG22 ' A' ' 86' ' ' THR . 43.2 pt -67.79 -18.54 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 123.572 0.749 . . . . 0.0 111.48 173.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.616 HD12 ' HB2' ' A' ' 57' ' ' GLN . 82.6 mt -104.33 6.33 35.16 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.761 0.825 . . . . 0.0 112.388 -174.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.54 -27.23 62.1 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.108 0.48 . . . . 0.0 110.13 173.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -80.19 -4.97 55.21 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.917 0.887 . . . . 0.0 111.842 173.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.496 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 64.8 m-85 -117.06 9.28 13.58 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.151 0.98 . . . . 0.0 110.56 177.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.98 103.39 2.24 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.684 0.793 . . . . 0.0 110.722 -177.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.45 -37.21 2.39 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -70.1 147.08 50.41 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.017 0.927 . . . . 0.0 110.345 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -53.1 131.22 50.56 Favored Pre-proline 0 N--CA 1.484 1.234 0 C-N-CA 123.625 0.77 . . . . 0.0 110.558 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -47.23 -45.86 20.99 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 123.921 3.081 . . . . 0.0 114.52 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.83 -44.17 45.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.433 -173.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.6 t -66.4 -37.61 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 123.502 0.721 . . . . 0.0 111.052 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.496 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -67.22 -31.84 72.49 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.612 1.165 . . . . 0.0 111.002 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 tt -72.18 -36.46 69.26 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.024 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.69 -39.26 80.62 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.634 0.374 . . . . 0.0 110.763 175.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.62 -32.44 74.01 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.836 0.855 . . . . 0.0 110.525 174.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.08 -35.13 69.16 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.392 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 66.0 mt -74.84 -24.14 58.55 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.588 0.355 . . . . 0.0 111.242 177.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -74.97 -39.6 61.2 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.064 0.546 . . . . 0.0 109.957 173.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -81.98 114.07 20.3 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.919 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -56.62 -32.57 65.44 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.476 1.11 . . . . 0.0 113.263 -172.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -68.05 -40.95 82.69 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.632 0.773 . . . . 0.0 111.744 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.612 HG22 ' HB ' ' A' ' 64' ' ' ILE . 34.9 p -95.75 -17.98 20.8 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -171.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -71.92 -35.45 69.68 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 122.99 0.516 . . . . 0.0 111.34 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.69 -25.99 64.14 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.023 0.929 . . . . 0.0 111.27 -175.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.8 t -80.92 -17.28 51.06 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.483 0.713 . . . . 0.0 110.862 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.424 ' HE1' HD21 ' A' ' 65' ' ' LEU . 23.8 mmt -72.21 0.49 9.66 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.292 0.637 . . . . 0.0 112.684 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.428 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 31.8 p-80 -62.56 -33.36 74.79 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.376 0.67 . . . . 0.0 110.819 171.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.41 -23.26 46.79 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.23 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.421 ' HD1' ' HA ' ' A' ' 90' ' ' MET . 54.4 m-85 -90.55 -25.21 20.34 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.325 0.65 . . . . 0.0 110.933 -178.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.428 ' SG ' ' HA ' ' A' ' 91' ' ' HIS . 28.5 p -79.82 106.99 12.25 Favored 'General case' 0 C--N 1.357 0.922 0 CA-C-O 121.042 0.449 . . . . 0.0 109.896 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.0 t -75.7 -29.22 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.274 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -177.91 -166.64 34.74 Favored Glycine 0 C--N 1.345 1.064 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.425 177.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -98.83 138.68 35.62 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.876 0.87 . . . . 0.0 108.961 170.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -78.95 118.8 21.3 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.569 0.748 . . . . 0.0 110.061 173.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.547 HD12 HD13 ' A' ' 25' ' ' LEU . 2.2 tt -99.55 114.36 27.31 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 170.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -80.92 129.68 66.68 Favored Pre-proline 0 CA--C 1.548 0.902 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -53.0 -33.09 61.02 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 123.518 2.812 . . . . 0.0 113.539 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -65.66 -44.68 85.57 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.79 0.836 . . . . 0.0 110.489 178.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -58.67 -34.68 71.52 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.032 0.933 . . . . 0.0 111.081 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.445 ' HB2' HD21 ' A' ' 99' ' ' LEU . 13.2 tp10 -78.94 -40.71 31.23 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.042 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.21 -63.91 3.37 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.899 -0.591 . . . . 0.0 113.04 -176.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.5 p -159.21 135.72 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 123.811 0.844 . . . . 0.0 110.13 177.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 t -114.81 124.96 53.08 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.052 0.941 . . . . 0.0 108.894 173.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 64.3 mt -90.8 118.14 68.43 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 122.846 0.458 . . . . 0.0 110.0 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -87.62 101.82 0.49 Allowed 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.835 2.357 . . . . 0.0 112.096 174.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -73.62 138.77 45.05 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.409 0.684 . . . . 0.0 111.185 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.6 mp -90.94 -40.23 11.82 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.564 0.746 . . . . 0.0 109.469 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.058 0 CA-C-O 118.641 -1.088 . . . . 0.0 112.247 -177.008 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 . . . . . 0 N--CA 1.484 1.268 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.79 174.75 9.19 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.566 0.746 . . . . 0.0 110.217 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.4 p -124.48 93.25 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 170.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.1 m -72.48 109.32 6.08 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.106 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.414 HD13 HD12 ' A' ' 99' ' ' LEU . 96.0 mt -78.6 101.28 7.36 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.435 ' HB ' HG21 ' A' ' 48' ' ' VAL . 60.9 t -94.94 136.12 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.683 -177.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -106.45 166.86 10.24 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.732 0.813 . . . . 0.0 109.128 -178.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.7 tt -54.7 -41.53 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.438 1.095 . . . . 0.0 113.447 -171.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.83 -34.73 71.99 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.252 0.221 . . . . 0.0 111.408 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.49 -34.06 76.94 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.257 0.623 . . . . 0.0 110.598 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.5 mt -61.89 -57.06 13.24 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.38 0.672 . . . . 0.0 110.027 174.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -62.14 -40.29 95.45 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 124.208 0.943 . . . . 0.0 111.71 -174.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -72.84 -38.08 67.21 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.682 0.793 . . . . 0.0 111.366 -176.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -73.06 -39.25 66.05 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.886 0.474 . . . . 0.0 109.993 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -67.75 -50.05 59.29 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.595 1.158 . . . . 0.0 110.756 -175.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -69.11 -28.52 66.55 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.652 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -68.68 -23.99 64.46 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.208 0.603 . . . . 0.0 111.223 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 139.64 -26.86 2.63 Favored Glycine 0 C--N 1.355 1.585 0 CA-C-N 116.651 -0.25 . . . . 0.0 113.447 174.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.62 103.57 2.91 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -75.12 108.23 7.73 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 117.659 0.73 . . . . 0.0 109.591 -168.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -107.93 138.55 43.99 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.038 0.935 . . . . 0.0 110.147 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.3 t -145.21 156.13 43.67 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.909 0.884 . . . . 0.0 109.038 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.47 HG22 HG22 ' A' ' 48' ' ' VAL . 88.7 t -108.47 118.31 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.263 0.625 . . . . 0.0 110.169 -177.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.48 HD12 HD22 ' A' ' 77' ' ' LEU . 34.5 mt -126.25 127.51 70.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 174.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.8 t70 63.23 30.71 15.82 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 124.656 1.182 . . . . 0.0 111.156 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.1 1.66 80.58 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.318 -0.856 . . . . 0.0 113.603 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.485 ' HD2' ' SG ' ' A' ' 94' ' ' CYS . 69.9 mmtt -109.09 149.65 29.0 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.925 0.89 . . . . 0.0 109.802 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.47 HG22 HG22 ' A' ' 43' ' ' VAL . 47.9 t -99.5 134.41 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.885 0.874 . . . . 0.0 109.992 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -134.1 157.97 44.8 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.097 0.959 . . . . 0.0 109.573 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -106.61 115.97 31.12 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.3 mm -70.73 -33.68 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.568 1.147 . . . . 0.0 112.027 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -69.03 -44.27 73.05 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.937 0.495 . . . . 0.0 110.392 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -66.58 -40.6 89.01 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.068 0.947 . . . . 0.0 110.103 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -52.47 -49.77 64.02 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.08 1.352 . . . . 0.0 111.199 172.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -71.29 -31.36 67.37 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.686 0.795 . . . . 0.0 112.242 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.5 m -64.33 -35.27 80.33 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.308 174.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -74.89 -28.39 60.62 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.684 0.794 . . . . 0.0 111.258 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.453 ' HA ' ' HB2' ' A' ' 65' ' ' LEU . 15.5 m -68.75 -27.55 66.01 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.166 0.586 . . . . 0.0 111.159 177.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.0 tp -63.2 -27.12 69.14 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.782 0.833 . . . . 0.0 111.162 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.4 m -77.87 132.04 37.78 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 122.833 0.453 . . . . 0.0 110.349 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -75.55 -35.34 60.7 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.395 0.678 . . . . 0.0 112.042 -173.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -80.13 -7.75 59.07 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.844 0.457 . . . . 0.0 111.97 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 74.4 m -75.41 151.52 38.13 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.439 0.696 . . . . 0.0 110.656 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.453 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 15.2 pt -63.39 -23.25 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.842 0.857 . . . . 0.0 112.176 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 82.8 mt -78.51 1.9 20.86 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.811 0.845 . . . . 0.0 112.228 -178.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.71 -33.33 75.63 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.4 0.68 . . . . 0.0 110.77 172.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 9.8 pt20 -77.17 -22.7 52.09 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.019 0.528 . . . . 0.0 110.617 176.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.61 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 46.3 m-85 -97.66 4.53 50.06 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.408 1.083 . . . . 0.0 111.444 -178.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.24 -19.86 60.98 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.174 0.589 . . . . 0.0 111.291 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.65 0.02 73.21 Favored Glycine 0 C--N 1.352 1.421 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.896 174.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -109.75 157.76 18.81 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.335 1.054 . . . . 0.0 109.768 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -57.01 130.86 79.83 Favored Pre-proline 0 CA--C 1.551 0.993 0 CA-C-O 118.177 -0.915 . . . . 0.0 109.265 171.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -45.41 -50.22 9.43 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 124.189 3.259 . . . . 0.0 115.431 -177.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.9 t -74.38 -42.32 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -174.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.3 t -64.96 -29.73 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 123.864 0.865 . . . . 0.0 111.217 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.61 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -71.61 -35.91 70.64 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.693 1.197 . . . . 0.0 110.364 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.48 HD22 HD12 ' A' ' 44' ' ' ILE . 3.7 tt -72.01 -37.74 69.74 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.544 177.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -63.63 -43.54 96.5 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.362 0.665 . . . . 0.0 110.375 175.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.16 -34.87 78.49 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.028 0.931 . . . . 0.0 110.942 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.423 ' HB1' ' SD ' ' A' ' 90' ' ' MET . . . -70.1 -42.44 72.69 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.215 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 72.6 mt -61.62 -46.5 89.54 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.306 0.642 . . . . 0.0 110.46 174.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -61.07 -37.58 83.19 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.314 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -89.64 117.93 28.88 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 121.207 0.527 . . . . 0.0 109.951 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -53.63 -30.32 42.29 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.956 1.702 . . . . 0.0 113.93 -173.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -77.7 -48.34 16.96 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.743 0.417 . . . . 0.0 110.613 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.4 p -84.53 -9.36 58.41 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -169.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -67.04 -16.87 64.63 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 122.731 0.412 . . . . 0.0 111.953 -178.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -23.51 65.85 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.111 0.964 . . . . 0.0 113.205 -176.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.4 ' CB ' HD11 ' A' ' 64' ' ' ILE . 48.0 t -82.01 -32.21 30.68 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 118.089 0.404 . . . . 0.0 110.64 174.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.485 ' SD ' ' N ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -74.54 -15.57 60.85 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.546 0.738 . . . . 0.0 110.814 177.536 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -57.64 -43.82 85.16 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.917 0.887 . . . . 0.0 109.651 167.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.95 -38.86 66.61 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.335 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -71.65 -16.9 62.27 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 122.596 0.358 . . . . 0.0 111.951 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.485 ' SG ' ' HD2' ' A' ' 47' ' ' LYS . 43.5 t -71.35 83.86 0.78 Allowed 'General case' 0 C--N 1.354 0.761 0 C-N-CA 123.883 0.873 . . . . 0.0 109.537 175.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.62 -32.24 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.397 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -176.37 -175.77 43.99 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.291 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -107.53 137.61 45.24 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.226 1.01 . . . . 0.0 109.113 175.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -74.59 121.23 21.27 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.218 0.607 . . . . 0.0 110.259 173.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.414 HD12 HD13 ' A' ' 25' ' ' LEU . 6.4 tt -100.81 117.48 34.98 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 168.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 103' ' ' GLN . 38.9 tt0 -70.87 129.51 89.58 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.54 0.736 . . . . 0.0 109.626 176.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -57.01 -25.8 65.03 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 123.033 2.489 . . . . 0.0 113.117 -177.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -86.16 -27.91 24.27 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.301 0.64 . . . . 0.0 111.604 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.568 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 56.9 tp60 -53.86 -31.65 50.35 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.4 1.08 . . . . 0.0 112.35 -175.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -66.85 -40.83 88.02 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.99 0.916 . . . . 0.0 111.703 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.73 -32.62 9.9 Favored Glycine 0 N--CA 1.473 1.15 0 N-CA-C 114.473 0.549 . . . . 0.0 114.473 -173.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.3 p -76.55 109.57 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 CA-C-O 121.659 0.742 . . . . 0.0 110.79 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.5 t -134.08 134.94 42.9 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.498 1.119 . . . . 0.0 109.054 175.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 53.9 mt -89.87 113.17 55.99 Favored Pre-proline 0 N--CA 1.477 0.923 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -79.5 178.14 7.71 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 122.58 2.186 . . . . 0.0 111.655 175.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -78.15 134.71 37.62 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -162.5 -55.92 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.276 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.934 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.464 ' HG3' ' HG3' ' A' ' 22' ' ' LYS . 10.6 pt-20 . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.472 0.177 . . . . 0.0 110.969 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.464 ' HG3' ' HG3' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -153.59 170.04 21.79 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.515 0.726 . . . . 0.0 111.199 -177.742 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.47 135.62 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 123.608 0.763 . . . . 0.0 109.146 171.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.6 m -111.98 109.45 19.22 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 173.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.445 HD13 HD12 ' A' ' 99' ' ' LEU . 84.0 mt -99.12 103.22 15.11 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 177.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.543 ' HB ' HG21 ' A' ' 48' ' ' VAL . 58.5 t -93.22 117.35 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -176.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.402 HH21 ' HB3' ' A' ' 101' ' ' PRO . 74.9 mtp180 -90.64 164.62 14.1 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.302 0.641 . . . . 0.0 109.906 174.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.46 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 11.8 tt -58.72 -33.62 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.15 0.58 . . . . 0.0 111.604 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.18 -50.29 74.25 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.451 0.7 . . . . 0.0 110.512 176.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -67.0 -33.42 75.53 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.746 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 43.5 tp -61.22 -45.43 94.61 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.995 0.918 . . . . 0.0 110.435 178.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 16.2 mm-40 -62.9 -54.26 41.33 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.032 0.933 . . . . 0.0 110.973 178.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -59.22 -49.22 78.68 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.572 -174.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -69.64 -32.45 71.13 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.047 -175.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -64.23 -47.62 78.97 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.258 177.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 -72.31 -24.11 61.27 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.713 0.805 . . . . 0.0 111.218 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -67.79 -24.62 65.33 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.094 0.958 . . . . 0.0 110.681 174.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 129.94 -27.72 4.03 Favored Glycine 0 C--N 1.344 1.019 0 N-CA-C 112.022 -0.431 . . . . 0.0 112.022 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.24 91.62 1.14 Allowed Glycine 0 C--N 1.341 0.813 0 N-CA-C 111.364 -0.695 . . . . 0.0 111.364 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -74.95 109.92 8.81 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -175.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 47.5 m0 -104.97 172.93 6.53 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.111 0.965 . . . . 0.0 110.188 175.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.9 t -158.9 135.51 9.4 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.265 1.026 . . . . 0.0 108.945 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.529 HG22 HG22 ' A' ' 48' ' ' VAL . 61.7 t -92.95 111.74 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 122.985 0.514 . . . . 0.0 109.891 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.3 mt -123.67 113.08 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 123.974 0.91 . . . . 0.0 109.213 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 63.15 45.23 5.26 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.882 1.273 . . . . 0.0 111.89 172.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.09 7.86 77.57 Favored Glycine 0 N--CA 1.476 1.337 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.545 177.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -118.51 156.13 29.63 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.237 1.015 . . . . 0.0 108.742 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.543 HG21 ' HB ' ' A' ' 26' ' ' VAL . 24.3 t -115.53 116.02 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -111.15 156.61 21.13 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.166 0.986 . . . . 0.0 108.847 174.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -93.34 149.96 20.84 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.233 0.54 . . . . 0.0 110.227 173.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.9 mm -103.91 -22.97 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 124.288 1.035 . . . . 0.0 108.909 167.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.64 -59.42 5.23 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.175 0.99 . . . . 0.0 111.015 -175.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 20.8 t70 -76.38 -30.87 57.7 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.301 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -52.21 -54.77 26.77 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.689 1.196 . . . . 0.0 112.255 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -67.34 -26.86 66.7 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.084 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 51.7 m -67.86 -36.11 79.71 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.509 172.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 22.7 mm-40 -77.39 -25.4 50.82 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.945 0.498 . . . . 0.0 111.994 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.5 p -74.68 -7.23 52.61 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.7 tt -63.46 -40.45 97.15 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.991 0.916 . . . . 0.0 109.134 167.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.578 ' HB ' ' HB3' ' A' ' 63' ' ' SER . 27.1 m -65.51 119.29 10.8 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.532 0.733 . . . . 0.0 109.478 -177.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -74.27 -14.91 60.98 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 120.768 0.318 . . . . 0.0 111.119 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -101.06 10.4 41.06 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.794 0.838 . . . . 0.0 111.189 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.578 ' HB3' ' HB ' ' A' ' 60' ' ' THR . 81.8 p -87.17 162.22 17.62 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.569 ' HB ' HG22 ' A' ' 86' ' ' THR . 45.9 pt -66.9 -22.25 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.067 0.547 . . . . 0.0 110.816 170.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.438 HD21 ' HE1' ' A' ' 90' ' ' MET . 51.8 mt -85.26 -7.76 58.85 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.978 0.911 . . . . 0.0 111.721 -178.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.24 -33.04 74.85 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.492 0.717 . . . . 0.0 111.785 177.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 11.3 pt20 -76.06 -26.39 56.48 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.286 175.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -87.63 -5.39 58.74 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.881 0.872 . . . . 0.0 111.387 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.26 99.14 0.67 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.057 0.543 . . . . 0.0 110.188 176.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 142.86 -29.41 2.1 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -172.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -93.81 153.95 18.01 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.253 1.021 . . . . 0.0 109.765 172.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -57.74 127.76 79.12 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 124.051 0.94 . . . . 0.0 110.231 175.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -46.31 -39.81 21.74 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 123.984 3.123 . . . . 0.0 115.88 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.44 -49.42 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 122.559 0.344 . . . . 0.0 110.355 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.0 t -61.65 -40.87 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.871 0.868 . . . . 0.0 110.503 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.72 -33.46 74.93 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.463 -1.244 . . . . 0.0 111.429 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.421 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 5.1 tt -68.6 -46.7 68.61 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.692 0.797 . . . . 0.0 109.49 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -63.92 -40.98 97.74 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.382 0.673 . . . . 0.0 111.265 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.27 -37.74 88.45 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.613 0.765 . . . . 0.0 110.545 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.03 -22.81 59.42 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.434 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 87.2 mt -74.59 -37.16 62.97 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 120.878 0.371 . . . . 0.0 110.06 173.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -73.04 -26.98 61.49 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.472 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -95.43 121.08 36.73 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 123.123 0.569 . . . . 0.0 109.531 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.1 -35.97 82.49 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.088 0.955 . . . . 0.0 113.032 -172.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.26 -12.81 61.32 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.283 0.633 . . . . 0.0 112.175 -176.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.569 HG22 ' HB ' ' A' ' 64' ' ' ILE . 24.6 p -117.8 -13.9 10.13 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.272 0.629 . . . . 0.0 112.577 -177.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -75.12 -21.23 59.01 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.035 0.445 . . . . 0.0 111.238 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -35.7 80.97 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.768 0.827 . . . . 0.0 112.121 -176.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.7 t -78.3 -22.09 48.72 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.438 ' HE1' HD21 ' A' ' 65' ' ' LEU . 21.3 mmt -71.54 -4.74 28.56 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.29 0.636 . . . . 0.0 111.785 177.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -69.55 -27.83 65.48 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.114 0.565 . . . . 0.0 109.809 169.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.76 -41.08 15.4 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.807 0.843 . . . . 0.0 110.746 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -66.79 -22.97 66.01 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.089 0.556 . . . . 0.0 111.594 177.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 43.8 t -71.13 92.57 0.99 Allowed 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.9 m -69.82 -19.05 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.243 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 171.94 177.59 41.64 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.328 175.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -96.97 138.56 34.31 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 174.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -72.85 145.6 46.82 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.065 0.46 . . . . 0.0 111.105 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.445 HD12 HD13 ' A' ' 25' ' ' LEU . 5.7 tt -136.07 121.81 19.77 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.722 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 23.3 mt-10 -79.53 132.52 61.67 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 123.41 0.684 . . . . 0.0 109.947 175.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.402 ' HB3' HH21 ' A' ' 27' ' ' ARG . 17.7 Cg_endo -57.8 -30.04 87.99 Favored 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 122.305 2.003 . . . . 0.0 112.258 175.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -76.37 -26.58 55.8 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.076 0.95 . . . . 0.0 111.634 177.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.722 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 6.2 tp-100 -66.53 -28.89 68.9 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.857 0.863 . . . . 0.0 110.343 177.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -65.56 103.71 0.89 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.883 171.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 83.59 38.88 10.14 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.138 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.32 129.04 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 123.289 0.636 . . . . 0.0 110.673 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.2 t -85.0 132.05 34.39 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.952 0.501 . . . . 0.0 110.137 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 76.9 mt -98.69 121.63 55.68 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 123.646 0.778 . . . . 0.0 109.305 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -87.75 166.11 7.43 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.882 2.388 . . . . 0.0 112.581 175.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -99.81 -21.23 15.83 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.3 0.64 . . . . 0.0 110.64 174.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.9 mp -79.35 79.5 5.79 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 170.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.944 0 CA-C-O 118.942 -0.921 . . . . 0.0 112.683 179.617 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 N--CA 1.484 1.228 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -114.2 89.2 3.03 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.441 0.697 . . . . 0.0 109.253 176.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.3 p -86.8 143.32 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 122.994 0.518 . . . . 0.0 110.228 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.52 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 17.4 m -69.77 111.08 5.28 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.817 0.847 . . . . 0.0 110.517 -179.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.478 HD13 HD22 ' A' ' 99' ' ' LEU . 72.7 mt -83.24 100.01 10.33 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.276 0.56 . . . . 0.0 109.562 177.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.423 HG21 HG23 ' A' ' 95' ' ' VAL . 84.6 t -95.48 116.05 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.164 177.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.477 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 18.4 mtm180 -91.41 172.44 8.52 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.338 0.655 . . . . 0.0 110.143 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.508 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 15.7 tt -61.9 -31.2 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 122.458 0.303 . . . . 0.0 110.552 177.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.38 -52.24 59.94 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.767 0.827 . . . . 0.0 110.804 172.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.26 -42.22 99.13 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.398 1.079 . . . . 0.0 110.703 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 44.1 tp -59.71 -44.83 93.53 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.969 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 20.4 mm-40 -71.05 -48.97 49.75 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.755 -176.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.08 -33.4 67.89 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.1 0.25 . . . . 0.0 111.33 -174.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -73.82 -35.94 64.92 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.792 0.437 . . . . 0.0 110.189 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -69.47 -34.21 74.03 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.694 0.398 . . . . 0.0 110.429 176.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -73.16 -26.89 61.37 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.072 0.549 . . . . 0.0 110.434 175.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.07 -28.63 68.98 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.457 1.103 . . . . 0.0 110.603 172.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.65 -24.14 6.88 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 -177.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.62 ' HA2' ' HD2' ' A' ' 52' ' ' LYS . . . -70.03 89.97 0.33 Allowed Glycine 0 C--N 1.347 1.144 0 O-C-N 123.895 0.409 . . . . 0.0 112.113 177.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -75.55 107.74 7.9 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -175.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 34.5 m0 -104.31 166.28 10.5 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.247 175.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.1 t -147.67 139.29 23.91 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.175 0.99 . . . . 0.0 108.579 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.468 HG22 HG22 ' A' ' 48' ' ' VAL . 95.8 t -98.18 111.39 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.465 HG21 ' HG2' ' A' ' 78' ' ' GLU . 70.7 mt -140.59 139.14 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.572 1.149 . . . . 0.0 108.28 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.5 t70 63.07 30.85 16.16 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 124.537 1.135 . . . . 0.0 111.177 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.43 15.45 68.18 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.898 -0.592 . . . . 0.0 113.32 -177.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HB2' ' CE1' ' A' ' 49' ' ' TYR . 25.6 mmtp -119.21 176.74 5.17 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.805 1.242 . . . . 0.0 108.283 -178.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.468 HG22 HG22 ' A' ' 43' ' ' VAL . 53.1 t -125.06 115.48 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 171.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.445 ' CE1' ' HB2' ' A' ' 47' ' ' LYS . 85.2 m-85 -108.16 159.41 16.62 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.347 1.059 . . . . 0.0 109.467 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -90.89 160.72 15.55 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 120.958 0.409 . . . . 0.0 110.081 171.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 28.1 mm -120.97 -26.71 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.998 0.919 . . . . 0.0 109.958 173.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.62 ' HD2' ' HA2' ' A' ' 39' ' ' GLY . 19.2 ptmt -67.96 -47.04 69.72 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 122.915 0.486 . . . . 0.0 111.953 -175.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -76.81 -33.27 58.0 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.67 0.388 . . . . 0.0 109.99 177.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -53.05 -50.05 65.11 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.616 1.566 . . . . 0.0 111.849 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -67.8 -28.33 67.49 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.145 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.0 m -73.02 -33.68 65.89 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.052 0.541 . . . . 0.0 110.08 176.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -73.9 -29.34 62.02 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.148 0.979 . . . . 0.0 111.838 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.7 p -73.6 -8.59 56.57 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.936 0.494 . . . . 0.0 112.236 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.0 mt -77.86 -12.38 59.97 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.4 0.68 . . . . 0.0 111.683 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.426 HG22 ' H ' ' A' ' 62' ' ' ASN . 35.4 m -82.32 132.02 35.22 Favored 'General case' 0 C--N 1.361 1.074 0 C-N-CA 122.777 0.431 . . . . 0.0 110.061 178.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -67.77 -30.54 70.02 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.618 0.767 . . . . 0.0 111.528 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.426 ' H ' HG22 ' A' ' 60' ' ' THR . 25.1 t-20 -112.52 74.26 0.85 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -178.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.4 m -150.91 165.05 34.85 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.137 0.975 . . . . 0.0 109.962 178.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.563 HD13 ' HB3' ' A' ' 89' ' ' SER . 9.3 pt -67.1 -25.73 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.194 177.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.461 ' HG ' HG13 ' A' ' 64' ' ' ILE . 71.0 mt -95.21 2.65 54.99 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.863 0.865 . . . . 0.0 111.588 -176.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.41 -34.53 70.42 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.315 0.579 . . . . 0.0 110.422 176.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -72.28 -23.42 61.19 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.395 173.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -100.0 7.34 44.82 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.574 1.15 . . . . 0.0 111.038 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.01 80.21 3.55 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.478 0.711 . . . . 0.0 110.057 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 147.77 -24.14 1.48 Allowed Glycine 0 N--CA 1.471 0.993 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.001 -170.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -84.16 151.91 24.59 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.919 0.888 . . . . 0.0 109.902 175.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -55.69 125.57 61.64 Favored Pre-proline 0 N--CA 1.481 1.125 0 CA-C-O 118.27 -0.871 . . . . 0.0 109.589 174.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.71 -36.83 91.23 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 123.191 2.594 . . . . 0.0 114.86 -175.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.0 t -74.73 -36.22 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.262 0.625 . . . . 0.0 110.314 -177.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.7 t -72.3 -36.91 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.979 0.912 . . . . 0.0 110.622 175.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.26 -29.19 65.92 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.638 1.175 . . . . 0.0 110.572 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.537 HD22 ' SD ' ' A' ' 90' ' ' MET . 1.8 tm? -63.36 -48.85 76.21 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.48 1.112 . . . . 0.0 109.156 173.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.465 ' HG2' HG21 ' A' ' 44' ' ' ILE . 23.2 mt-10 -68.44 -39.72 81.39 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.291 -178.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.98 -34.19 77.42 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.863 0.865 . . . . 0.0 110.453 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.28 -39.65 82.07 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.892 174.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 66.5 mt -67.29 -29.38 68.96 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.366 0.666 . . . . 0.0 112.157 177.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -72.3 -43.42 64.22 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.686 0.795 . . . . 0.0 110.519 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -85.35 114.66 22.59 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -54.66 -33.39 60.64 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.541 1.136 . . . . 0.0 113.077 -172.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -64.79 -52.63 55.85 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.708 0.803 . . . . 0.0 111.115 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.496 HG22 ' HB ' ' A' ' 64' ' ' ILE . 38.5 p -81.23 -13.99 57.95 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.567 -171.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.56 -18.16 57.19 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 120.956 0.408 . . . . 0.0 110.927 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -64.72 -45.29 87.18 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.939 0.896 . . . . 0.0 110.061 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.563 ' HB3' HD13 ' A' ' 64' ' ' ILE . 46.6 t -71.27 -17.6 62.47 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.949 0.899 . . . . 0.0 112.325 -178.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.537 ' SD ' HD22 ' A' ' 77' ' ' LEU . 30.3 mmt -63.49 -15.23 57.25 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.551 0.741 . . . . 0.0 112.123 177.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.476 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 3.3 p80 -57.89 -33.09 68.36 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.681 0.793 . . . . 0.0 111.194 175.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.09 -33.46 70.21 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.103 0.961 . . . . 0.0 111.193 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -90.89 -26.11 19.5 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.494 -174.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.476 ' SG ' ' HA ' ' A' ' 91' ' ' HIS . 26.8 p -76.84 105.4 7.88 Favored 'General case' 0 C--N 1.358 0.971 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.423 HG23 HG21 ' A' ' 26' ' ' VAL . 35.9 m -69.48 -25.46 29.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 123.114 0.565 . . . . 0.0 110.692 174.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.52 ' HA3' ' HB ' ' A' ' 24' ' ' THR . . . 170.07 -165.69 38.99 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.557 174.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -88.58 140.57 29.32 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.18 0.992 . . . . 0.0 109.609 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -77.16 135.82 38.55 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 122.706 0.402 . . . . 0.0 110.782 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.478 HD22 HD13 ' A' ' 25' ' ' LEU . 66.4 tp -121.97 130.84 53.65 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.66 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 37.9 mt-10 -83.37 148.37 55.51 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 171.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.13 -7.28 20.44 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.51 2.14 . . . . 0.0 112.716 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -109.62 -16.93 13.83 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.359 1.064 . . . . 0.0 110.847 178.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.66 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 9.1 tp-100 -73.94 -31.13 62.9 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.773 0.829 . . . . 0.0 112.355 -172.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -64.18 -33.37 75.63 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.102 0.477 . . . . 0.0 110.331 174.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -102.74 31.84 8.27 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.944 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.5 p -70.24 147.7 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.087 0.555 . . . . 0.0 110.866 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.4 t -126.22 148.75 49.4 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 171.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 62.7 mt -120.64 97.48 48.56 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -83.44 155.02 14.11 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.75 2.3 . . . . 0.0 112.178 175.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -70.78 123.38 21.8 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.542 0.737 . . . . 0.0 110.545 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -145.09 -71.17 0.27 Allowed 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.258 0 CA-C-O 118.802 -0.999 . . . . 0.0 111.464 -175.563 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -84.06 136.76 33.89 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.666 176.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.8 p -147.81 97.05 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.6 p -63.02 113.14 2.93 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.537 0.735 . . . . 0.0 111.453 -175.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.3 mt -78.78 106.58 10.88 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.566 0.746 . . . . 0.0 109.521 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.8 t -93.61 121.33 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 123.69 0.796 . . . . 0.0 109.074 -175.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -72.13 151.18 43.19 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.778 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.5 tt -61.3 -39.23 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 120.724 0.297 . . . . 0.0 111.41 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.26 -29.27 70.63 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.922 0.889 . . . . 0.0 111.328 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 34' ' ' HIS . 11.0 t70 -62.54 -47.42 83.96 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.077 0.551 . . . . 0.0 109.789 178.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.0 mp -58.54 -48.36 81.13 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 123.76 0.663 . . . . 0.0 110.28 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -55.04 -44.75 74.96 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 124.375 1.047 . . . . 0.0 111.358 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -73.9 -39.79 63.62 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.755 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 30' ' ' ASP . 7.4 t-80 -68.32 -39.15 82.05 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.34 0.656 . . . . 0.0 111.44 -167.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -70.07 -33.01 71.37 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.545 0.338 . . . . 0.0 110.97 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -68.53 -30.46 69.27 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.495 0.718 . . . . 0.0 110.074 178.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -70.3 -33.74 71.91 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.402 0.681 . . . . 0.0 110.429 173.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 134.96 -27.55 3.16 Favored Glycine 0 C--N 1.344 1.019 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.95 87.99 0.97 Allowed Glycine 0 C--N 1.347 1.154 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.418 ' HB3' ' HB ' ' A' ' 51' ' ' ILE . 26.3 t80 -74.8 109.37 8.22 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -171.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 36.6 m0 -105.15 146.83 28.66 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.598 0.759 . . . . 0.0 109.783 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.0 t -144.22 136.95 26.99 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.173 0.589 . . . . 0.0 110.352 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -88.02 112.05 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 121.466 0.651 . . . . 0.0 109.696 174.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.461 HD12 HD23 ' A' ' 77' ' ' LEU . 84.6 mt -132.38 131.18 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.149 1.38 . . . . 0.0 107.794 175.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.2 t70 60.53 29.89 19.35 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-O 121.819 0.818 . . . . 0.0 111.634 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.23 4.33 73.08 Favored Glycine 0 C--N 1.353 1.499 0 CA-C-N 115.565 -0.743 . . . . 0.0 114.01 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.455 ' HD2' ' SG ' ' A' ' 94' ' ' CYS . 71.8 mmtt -111.56 139.3 47.12 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.212 1.005 . . . . 0.0 109.142 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 52.9 t -89.96 123.22 42.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 170.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -110.71 169.76 8.54 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.686 0.795 . . . . 0.0 109.815 177.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -105.03 142.46 34.78 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.706 172.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.418 ' HB ' ' HB3' ' A' ' 40' ' ' PHE . 25.6 mm -112.56 -29.81 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.876 0.87 . . . . 0.0 110.982 -175.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -66.76 -30.73 71.02 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.578 0.627 . . . . 0.0 109.727 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.488 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 37.1 t70 -74.81 -49.59 20.16 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.847 0.859 . . . . 0.0 110.048 172.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.403 ' HA ' ' HE2' ' A' ' 93' ' ' PHE . 48.6 t80 -48.45 -50.93 29.34 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.814 1.246 . . . . 0.0 112.117 -178.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -68.64 -27.92 66.43 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.438 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 89.2 m -70.23 -36.44 74.52 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.284 0.634 . . . . 0.0 110.37 173.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 84.3 mm-40 -73.76 -23.53 59.74 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.695 0.798 . . . . 0.0 112.213 -176.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 64.3 p -75.04 -13.75 60.53 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.5 mp -71.67 -24.81 61.9 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.253 0.621 . . . . 0.0 110.568 173.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.5 m -71.22 121.96 19.35 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 122.638 0.375 . . . . 0.0 110.08 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.62 -37.62 85.24 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.346 0.659 . . . . 0.0 110.958 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -91.14 78.36 5.88 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 175.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.6 t -157.38 158.52 36.07 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.914 0.886 . . . . 0.0 109.299 -178.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.557 ' HB ' HG22 ' A' ' 86' ' ' THR . 38.9 pt -68.07 -23.5 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.832 170.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.6 mt -88.2 -0.34 56.98 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.697 0.799 . . . . 0.0 112.441 -177.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.36 -36.63 81.77 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.061 0.544 . . . . 0.0 110.914 176.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -73.0 -27.3 61.71 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.148 0.579 . . . . 0.0 110.853 175.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -90.62 1.54 56.69 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.822 0.849 . . . . 0.0 111.489 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.65 94.39 0.43 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.07 0.548 . . . . 0.0 110.652 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.64 -27.87 2.69 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.547 -176.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -77.43 151.8 34.58 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.65 0.78 . . . . 0.0 109.882 175.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -56.16 130.15 74.17 Favored Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 123.463 0.705 . . . . 0.0 109.697 173.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.99 -40.92 58.29 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.334 2.69 . . . . 0.0 114.69 -174.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.45 HG13 HD11 ' A' ' 44' ' ' ILE . 65.1 t -73.98 -43.04 52.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 122.959 0.504 . . . . 0.0 110.509 -176.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.8 t -65.4 -39.48 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 123.44 0.696 . . . . 0.0 110.901 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.86 -36.21 82.81 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.556 1.142 . . . . 0.0 110.76 177.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.461 HD23 HD12 ' A' ' 44' ' ' ILE . 31.5 tp -69.44 -38.94 78.04 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.618 178.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -60.74 -48.45 81.73 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.868 0.467 . . . . 0.0 110.249 175.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.78 -32.68 73.88 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.871 0.868 . . . . 0.0 111.242 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.07 -33.35 73.42 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.281 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.6 -38.96 70.8 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.298 0.239 . . . . 0.0 110.619 174.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -66.82 -29.2 69.07 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.293 0.637 . . . . 0.0 111.582 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.407 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 65.4 t80 -98.53 139.22 34.58 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.032 0.444 . . . . 0.0 110.163 177.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -62.07 -54.24 44.15 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.603 1.161 . . . . 0.0 113.945 -170.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.57 -38.37 90.79 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.228 0.611 . . . . 0.0 111.277 -175.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.557 HG22 ' HB ' ' A' ' 64' ' ' ILE . 36.6 p -80.54 -17.67 50.76 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 115.254 -0.884 . . . . 0.0 112.051 -172.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.9 ptt-85 -78.82 -23.17 45.24 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.158 0.504 . . . . 0.0 110.201 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -67.83 -38.03 82.67 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.258 1.023 . . . . 0.0 112.262 -173.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 32.0 t -73.91 -24.17 59.65 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.558 175.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 18.8 mmt -72.19 -7.84 51.45 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -65.23 -33.81 76.88 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.705 0.402 . . . . 0.0 109.955 169.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.05 -37.79 64.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.42 0.688 . . . . 0.0 111.448 175.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.403 ' HE2' ' HA ' ' A' ' 54' ' ' PHE . 90.4 m-85 -73.9 -23.71 59.6 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 122.895 0.478 . . . . 0.0 111.446 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.455 ' SG ' ' HD2' ' A' ' 47' ' ' LYS . 53.1 t -70.09 102.7 2.11 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.251 0.62 . . . . 0.0 109.714 177.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.3 m -73.2 -20.65 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.453 0.701 . . . . 0.0 110.677 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 170.46 -177.67 43.53 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.996 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -85.65 150.61 24.5 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 173.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -77.6 142.58 38.85 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.136 0.574 . . . . 0.0 110.124 173.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -133.76 130.0 37.44 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.839 0.856 . . . . 0.0 108.747 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 43.8 mt-10 -85.99 129.61 53.48 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.489 1.116 . . . . 0.0 109.482 175.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -55.29 -35.21 90.89 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 123.112 2.541 . . . . 0.0 112.752 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -71.47 -36.23 71.1 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.011 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.454 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 51.5 tp60 -63.29 -35.76 81.43 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.874 0.87 . . . . 0.0 111.393 -175.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -66.96 102.34 0.96 Allowed 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.921 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 149.34 -84.47 0.17 Allowed Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.064 172.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.0 p -124.97 155.12 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.874 0.87 . . . . 0.0 110.42 -172.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.5 t -122.06 133.67 54.78 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.828 0.851 . . . . 0.0 109.587 175.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.9 mm -101.86 128.14 29.45 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 123.747 0.819 . . . . 0.0 108.898 175.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -81.8 -168.05 0.56 Allowed 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.653 2.236 . . . . 0.0 111.581 174.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -91.09 129.32 37.1 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 172.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -159.46 -45.88 0.05 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.5 0.72 . . . . 0.0 110.748 175.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.232 0 CA-C-O 119.064 -0.853 . . . . 0.0 111.405 -179.153 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.248 0.071 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.34 149.66 50.04 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 173.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -103.15 137.39 31.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 121.007 0.432 . . . . 0.0 110.781 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.2 m -114.45 107.45 15.56 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 166.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.465 HD22 ' HB2' ' A' ' 99' ' ' LEU . 45.9 mt -97.55 119.07 35.45 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.146 0.498 . . . . 0.0 109.95 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.508 HG13 ' HB2' ' A' ' 30' ' ' ASP . 86.3 t -106.69 131.35 56.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -104.06 170.28 8.01 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 173.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.4 tt -58.15 -31.53 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.065 0.546 . . . . 0.0 111.974 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.69 -42.44 83.67 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.545 0.738 . . . . 0.0 111.319 177.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.508 ' HB2' HG13 ' A' ' 26' ' ' VAL . 38.4 m-20 -63.59 -36.27 83.25 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.165 0.586 . . . . 0.0 111.325 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.8 mt -63.88 -51.58 63.91 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 123.904 0.752 . . . . 0.0 109.748 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -59.18 -46.26 88.87 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.555 -1.202 . . . . 0.0 112.262 -172.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -77.08 -30.17 55.3 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 111.479 0.178 . . . . 0.0 111.479 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -73.44 -26.36 60.91 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.745 0.418 . . . . 0.0 110.844 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -61.28 -37.56 83.61 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.745 0.818 . . . . 0.0 110.377 172.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -70.62 -32.97 70.51 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.988 0.915 . . . . 0.0 110.789 174.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -64.56 -33.42 75.87 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.94 0.896 . . . . 0.0 110.819 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 125.46 -27.14 5.32 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 116.434 -0.348 . . . . 0.0 112.271 175.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.09 107.85 2.36 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 175.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -80.27 108.02 13.54 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -99.79 154.8 18.04 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.055 0.942 . . . . 0.0 110.031 176.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.3 t -147.96 164.63 33.18 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.093 0.957 . . . . 0.0 109.093 172.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.527 HG22 HG22 ' A' ' 48' ' ' VAL . 98.2 t -120.68 117.39 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.201 0.601 . . . . 0.0 110.796 -176.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.6 mt -138.77 138.13 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.698 1.199 . . . . 0.0 107.919 174.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.6 t70 63.08 30.64 16.16 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.475 1.11 . . . . 0.0 111.004 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.43 18.08 69.28 Favored Glycine 0 C--N 1.355 1.627 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.539 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.431 ' HD2' ' SG ' ' A' ' 94' ' ' CYS . 75.0 mmtt -124.15 148.75 46.97 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.273 1.029 . . . . 0.0 109.203 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.527 HG22 HG22 ' A' ' 43' ' ' VAL . 39.1 t -100.08 128.94 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.509 0.724 . . . . 0.0 109.212 174.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -122.33 144.9 48.72 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.856 0.862 . . . . 0.0 109.254 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -87.43 104.62 16.62 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 174.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.493 HG23 ' HB2' ' A' ' 73' ' ' PRO . 24.6 mm -62.59 -31.89 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.223 1.009 . . . . 0.0 111.082 174.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.0 ttpp -60.01 -36.97 78.36 Favored 'General case' 0 CA--C 1.554 1.125 0 O-C-N 123.597 0.561 . . . . 0.0 110.291 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.425 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 33.0 t70 -75.3 -42.5 54.52 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.281 0.633 . . . . 0.0 111.209 174.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.409 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 50.5 t80 -51.08 -51.76 50.15 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.704 1.202 . . . . 0.0 111.21 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -67.66 -27.73 67.11 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.837 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 58.8 m -68.34 -38.82 81.87 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.599 0.36 . . . . 0.0 110.773 174.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.464 ' HB2' HD12 ' A' ' 65' ' ' LEU . 78.6 mm-40 -74.39 -27.24 60.55 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.305 0.642 . . . . 0.0 111.345 -177.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.0 p -74.06 -10.42 59.61 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.023 0.529 . . . . 0.0 112.168 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.8 mp -71.32 -17.21 62.46 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 122.974 0.51 . . . . 0.0 111.352 171.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.3 m -88.04 133.44 33.97 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -75.11 -31.9 61.26 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.135 0.493 . . . . 0.0 109.719 173.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -83.49 63.12 7.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.79 0.836 . . . . 0.0 109.664 174.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.8 p -146.49 160.19 42.43 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.547 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.63 ' HB ' HG22 ' A' ' 86' ' ' THR . 40.0 pt -68.03 -22.73 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.688 170.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.464 HD12 ' HB2' ' A' ' 57' ' ' GLN . 44.3 mt -91.49 2.49 56.39 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.186 0.995 . . . . 0.0 112.208 -174.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.38 -33.34 75.32 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.067 0.547 . . . . 0.0 110.989 174.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -75.82 -29.87 58.8 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.679 0.792 . . . . 0.0 110.659 175.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -90.8 1.54 56.83 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.369 1.068 . . . . 0.0 111.688 -178.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.3 -25.87 67.82 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.624 0.77 . . . . 0.0 111.394 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -103.97 30.7 9.72 Favored Glycine 0 C--N 1.35 1.309 0 CA-C-N 116.547 -0.297 . . . . 0.0 112.431 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -139.11 154.49 48.15 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.403 1.081 . . . . 0.0 108.717 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -59.79 131.68 88.92 Favored Pre-proline 0 N--CA 1.48 1.052 0 CA-C-O 118.209 -0.9 . . . . 0.0 109.788 175.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.493 ' HB2' HG23 ' A' ' 51' ' ' ILE . 27.7 Cg_endo -58.29 -36.98 97.14 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 123.208 2.605 . . . . 0.0 114.329 -173.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.1 t -74.67 -45.68 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 122.893 0.477 . . . . 0.0 110.439 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.8 t -66.3 -35.83 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.686 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.81 -34.68 74.02 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.229 1.011 . . . . 0.0 110.627 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.614 HD12 ' SD ' ' A' ' 90' ' ' MET . 51.0 tp -66.15 -38.59 88.49 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.845 0.858 . . . . 0.0 110.486 177.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -58.73 -50.18 74.85 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.78 0.432 . . . . 0.0 110.049 174.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.47 -34.08 76.12 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.956 0.903 . . . . 0.0 111.012 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.73 -28.74 61.86 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.818 0.847 . . . . 0.0 111.506 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 81' ' ' LEU . 2.9 mm? -71.83 -28.99 63.94 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.333 0.253 . . . . 0.0 111.107 172.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -90.45 -25.01 20.56 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.529 0.732 . . . . 0.0 111.728 -174.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.418 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 40.7 t80 -91.57 133.78 35.24 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.653 0.381 . . . . 0.0 110.576 -176.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.14 -36.98 85.41 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.957 1.303 . . . . 0.0 113.96 -168.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -74.23 -27.27 60.7 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.32 0.648 . . . . 0.0 111.309 -176.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.63 HG22 ' HB ' ' A' ' 64' ' ' ILE . 39.4 p -101.53 -31.02 11.07 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.588 -170.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.409 ' HD2' ' N ' ' A' ' 88' ' ' GLU . 6.0 ppt_? -60.12 -32.03 70.61 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 123.794 0.837 . . . . 0.0 112.387 -174.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.409 ' N ' ' HD2' ' A' ' 87' ' ' ARG . 7.8 pt-20 -64.45 -43.4 94.39 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.49 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.0 t -78.43 -16.69 57.33 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.621 0.768 . . . . 0.0 111.632 -176.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.614 ' SD ' HD12 ' A' ' 77' ' ' LEU . 36.1 mmt -61.11 -28.24 68.95 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.282 0.633 . . . . 0.0 111.556 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -64.52 -25.64 68.08 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.673 0.789 . . . . 0.0 111.416 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.46 -25.68 57.62 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.535 0.734 . . . . 0.0 111.454 175.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.409 ' CE1' ' HA ' ' A' ' 54' ' ' PHE . 98.5 m-85 -86.44 -20.65 27.84 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.472 0.709 . . . . 0.0 111.374 176.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.431 ' SG ' ' HD2' ' A' ' 47' ' ' LYS . 47.6 t -67.07 97.88 0.54 Allowed 'General case' 0 C--N 1.351 0.646 0 O-C-N 123.814 0.696 . . . . 0.0 110.749 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.7 m -74.76 -10.58 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.874 0.869 . . . . 0.0 111.42 177.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 169.18 175.68 38.64 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 174.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.407 ' HG2' ' NZ ' ' A' ' 47' ' ' LYS . 15.2 mt-30 -80.53 163.51 23.67 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.362 0.665 . . . . 0.0 109.753 171.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -118.23 146.57 44.16 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.774 0.429 . . . . 0.0 109.891 175.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.465 ' HB2' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -142.43 125.76 16.57 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 174.112 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.7 mp0 -69.8 137.93 87.91 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 123.167 0.587 . . . . 0.0 110.479 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -51.69 -42.55 56.15 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.868 2.378 . . . . 0.0 112.013 169.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -59.23 -52.32 66.2 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.774 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -58.91 -35.89 73.82 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.381 1.072 . . . . 0.0 110.97 -178.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.5 -42.05 79.14 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.98 -177.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -73.56 -79.47 0.51 Allowed Glycine 0 C--N 1.346 1.13 0 N-CA-C 112.135 -0.386 . . . . 0.0 112.135 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -139.75 129.61 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.2 t -82.67 139.04 33.93 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.035 0.534 . . . . 0.0 110.19 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.9 mt -93.85 111.05 51.24 Favored Pre-proline 0 CA--C 1.545 0.774 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.65 126.82 13.83 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 122.534 2.156 . . . . 0.0 110.566 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -64.59 105.44 0.96 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.866 0.467 . . . . 0.0 110.292 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.0 tt -165.26 131.57 2.77 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -176.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.278 0 CA-C-O 119.101 -0.833 . . . . 0.0 113.015 -177.829 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 . . . . . 0 N--CA 1.486 1.342 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.52 163.69 33.95 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.603 0.761 . . . . 0.0 109.653 176.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.7 p -153.64 129.08 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 172.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.3 m -68.24 110.87 4.24 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.341 0.656 . . . . 0.0 110.024 -178.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.5 mt -77.22 102.39 6.63 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.539 ' HB ' HG21 ' A' ' 48' ' ' VAL . 94.6 t -93.51 116.74 35.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.042 -177.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.413 ' HD2' ' HB3' ' A' ' 101' ' ' PRO . 71.6 mtm180 -82.34 166.49 19.43 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.223 176.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.0 tt -56.28 -37.69 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.296 0.639 . . . . 0.0 110.609 172.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.61 -47.55 83.97 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.969 0.908 . . . . 0.0 111.212 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -67.18 -37.47 83.77 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.83 0.852 . . . . 0.0 110.935 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 36.3 tp -59.13 -45.14 91.71 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.75 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -72.28 -49.69 32.82 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.131 0.973 . . . . 0.0 112.11 -177.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.67 -33.68 71.19 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -170.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.401 ' CE1' ' HA3' ' A' ' 39' ' ' GLY . 43.4 t-80 -73.59 -30.91 63.3 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 120.564 0.221 . . . . 0.0 110.708 178.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -66.99 -38.64 86.38 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 173.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -65.4 -34.12 77.56 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.444 0.698 . . . . 0.0 110.363 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -65.16 -34.17 77.75 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.9 0.88 . . . . 0.0 110.514 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 139.08 -27.19 2.67 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 111.999 -0.44 . . . . 0.0 111.999 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.401 ' HA3' ' CE1' ' A' ' 34' ' ' HIS . . . -81.13 97.74 1.8 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 112.014 -0.434 . . . . 0.0 112.014 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -75.58 113.51 13.08 Favored 'General case' 0 C--N 1.347 0.469 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -98.09 164.5 12.31 Favored 'General case' 0 C--O 1.24 0.591 0 O-C-N 123.863 0.727 . . . . 0.0 109.799 176.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.405 HG21 HD11 ' A' ' 51' ' ' ILE . 15.3 t -147.05 133.9 20.13 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.659 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.541 HG22 HG22 ' A' ' 48' ' ' VAL . 82.2 t -95.95 107.03 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.6 mt -118.25 113.86 43.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 123.938 0.895 . . . . 0.0 108.844 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.3 t70 62.04 32.84 17.48 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.334 1.053 . . . . 0.0 111.272 174.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.99 5.66 85.85 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 115.255 -0.884 . . . . 0.0 114.081 177.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -115.65 150.4 36.8 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.495 0.718 . . . . 0.0 109.341 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.541 HG22 HG22 ' A' ' 43' ' ' VAL . 60.4 t -113.68 121.4 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 123.674 0.79 . . . . 0.0 109.856 -175.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -124.46 155.39 38.98 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.928 0.891 . . . . 0.0 109.175 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.431 ' HB3' ' HB2' ' A' ' 53' ' ' ASP . 7.7 t70 -97.09 120.29 37.17 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.438 ' O ' ' HG3' ' A' ' 55' ' ' GLN . 33.4 mm -73.68 -32.73 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.589 0.756 . . . . 0.0 111.599 -178.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -63.71 -45.99 87.48 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.431 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . 2.1 m-20 -65.51 -36.73 84.69 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.644 175.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -58.69 -51.88 68.06 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.609 0.764 . . . . 0.0 110.499 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.476 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 28.0 mt-30 -63.26 -29.23 70.6 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.889 -174.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.3 m -56.12 -36.75 68.57 Favored 'General case' 0 CA--C 1.553 1.088 0 O-C-N 123.862 0.726 . . . . 0.0 111.73 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -76.67 -30.99 56.99 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.281 0.632 . . . . 0.0 111.701 178.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 62.8 p -81.42 1.35 33.48 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 55' ' ' GLN . 83.1 mt -82.18 9.27 9.0 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.367 0.667 . . . . 0.0 112.33 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.5 t -128.53 165.5 20.63 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.226 0.61 . . . . 0.0 110.736 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -70.95 -60.83 2.02 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.73 0.812 . . . . 0.0 110.484 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -83.05 90.4 7.03 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.276 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.5 t -143.48 149.86 38.15 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.651 -1.158 . . . . 0.0 108.907 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.546 ' HB ' HG22 ' A' ' 86' ' ' THR . 37.2 pt -67.79 -19.94 25.53 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 C-N-CA 122.834 0.454 . . . . 0.0 110.843 171.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 60.1 mt -95.71 -1.76 49.3 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.351 1.06 . . . . 0.0 111.755 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.2 -29.68 69.41 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.947 0.499 . . . . 0.0 111.014 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -71.66 -19.96 62.02 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.786 0.834 . . . . 0.0 111.671 175.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.587 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 78.1 m-85 -99.89 10.72 40.83 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.344 1.058 . . . . 0.0 111.613 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.21 -26.1 68.36 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.309 0.643 . . . . 0.0 112.408 -176.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.57 18.84 53.98 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 116.393 -0.367 . . . . 0.0 113.245 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -132.88 151.11 52.09 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.788 0.835 . . . . 0.0 109.721 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -55.38 128.46 67.38 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 124.488 1.115 . . . . 0.0 109.924 172.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -54.76 -29.44 62.37 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.431 2.754 . . . . 0.0 114.626 -173.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.424 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 34.0 t -74.72 -49.37 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.5 t -68.8 -30.01 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 123.991 0.916 . . . . 0.0 111.017 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -68.74 -40.63 79.74 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.865 1.266 . . . . 0.0 109.895 176.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.527 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 41.4 tp -63.5 -40.85 98.17 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.684 175.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 35.3 mt-10 -58.39 -47.66 83.16 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.283 0.633 . . . . 0.0 111.384 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.99 -35.33 80.86 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.954 175.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.54 -18.1 59.89 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.126 0.97 . . . . 0.0 112.629 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 89.1 mt -77.06 -36.56 55.82 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 173.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -76.21 -21.21 56.69 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.577 175.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -90.84 115.9 28.25 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.842 0.857 . . . . 0.0 110.099 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.75 -23.24 65.22 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.164 0.985 . . . . 0.0 113.366 -173.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.89 -14.49 57.97 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.286 0.634 . . . . 0.0 112.044 -178.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.546 HG22 ' HB ' ' A' ' 64' ' ' ILE . 7.2 p -110.47 -29.78 7.94 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.328 0.651 . . . . 0.0 112.682 -177.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -50.62 -27.39 6.77 Favored 'General case' 0 N--CA 1.507 2.397 0 C-N-CA 124.32 1.048 . . . . 0.0 113.247 -174.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -55.15 -48.54 73.57 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.245 1.418 . . . . 0.0 112.648 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.7 m -76.88 -20.25 56.48 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.116 0.566 . . . . 0.0 111.787 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.552 ' SD ' ' N ' ' A' ' 90' ' ' MET . 0.1 OUTLIER -74.76 -13.27 60.57 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.774 0.829 . . . . 0.0 111.274 176.52 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.448 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 28.4 m170 -75.0 -23.19 58.2 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.061 0.544 . . . . 0.0 110.017 171.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.86 -30.22 23.08 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.56 0.744 . . . . 0.0 110.728 172.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -83.59 -23.91 31.73 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.439 0.296 . . . . 0.0 111.481 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.448 ' SG ' ' HA ' ' A' ' 91' ' ' HIS . 31.0 p -73.42 109.93 7.31 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-O 120.959 0.409 . . . . 0.0 109.98 -177.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.8 t -68.96 -45.89 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.938 172.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 175.0 -150.12 10.89 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.857 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -115.46 137.57 51.92 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.035 1.334 . . . . 0.0 109.044 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -71.14 134.03 46.66 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.132 0.573 . . . . 0.0 110.37 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -143.78 122.89 12.88 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.418 ' HB2' ' CB ' ' A' ' 103' ' ' GLN . 47.1 mt-10 -66.12 133.83 94.76 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.446 0.699 . . . . 0.0 110.687 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.413 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 17.4 Cg_endo -57.48 -25.49 66.76 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 123.263 2.642 . . . . 0.0 113.139 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -79.66 -43.12 23.37 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.388 0.675 . . . . 0.0 110.4 173.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.418 ' CB ' ' HB2' ' A' ' 100' ' ' GLU . 9.6 tt0 -67.77 -8.93 39.71 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.874 0.87 . . . . 0.0 111.846 -175.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -57.43 -48.51 78.95 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.856 0.862 . . . . 0.0 110.165 173.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -96.81 -8.05 57.29 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.634 -0.712 . . . . 0.0 114.221 -175.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.6 p -132.38 135.39 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 117.699 0.749 . . . . 0.0 110.752 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.8 t -121.31 154.23 36.67 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.961 0.904 . . . . 0.0 110.206 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.3 mm -119.99 104.41 44.08 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -80.81 71.9 6.81 Favored 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 122.391 2.061 . . . . 0.0 111.634 176.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -74.75 147.86 40.94 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.538 -178.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -90.51 -39.92 12.3 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.654 0.782 . . . . 0.0 110.155 -176.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.97 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -177.577 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 110.563 -0.162 . . . . 0.0 110.563 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.23 150.23 45.47 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.671 0.388 . . . . 0.0 110.806 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.1 p -99.01 115.32 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.8 m -72.72 107.92 5.43 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.4 mt -86.86 111.01 20.36 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.6 t -91.19 114.15 28.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.8 ptp85 -70.67 158.05 36.9 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.484 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.45 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 10.1 tt -55.64 -44.68 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 123.352 0.407 . . . . 0.0 111.214 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.9 -33.41 75.26 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.578 0.751 . . . . 0.0 111.496 -177.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -74.55 -40.83 61.44 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.594 0.358 . . . . 0.0 110.105 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 57.2 tp -60.81 -53.25 59.6 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.115 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 51.4 mm-40 -58.88 -51.87 68.18 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.096 0.958 . . . . 0.0 111.827 -177.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -68.51 -41.06 80.51 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -175.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 66.2 t-80 -71.74 -42.66 67.0 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 118.033 0.379 . . . . 0.0 110.631 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -64.08 -51.14 65.47 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.823 0.849 . . . . 0.0 110.883 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -79.44 5.99 11.37 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.795 0.838 . . . . 0.0 111.994 -177.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -91.44 -8.42 47.83 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.884 0.874 . . . . 0.0 110.844 174.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.49 -26.26 12.23 Favored Glycine 0 C--N 1.344 0.987 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -175.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.596 ' HA2' ' HD3' ' A' ' 52' ' ' LYS . . . -75.35 77.73 1.18 Allowed Glycine 0 C--N 1.348 1.249 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 171.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -72.96 117.91 15.27 Favored 'General case' 0 C--N 1.345 0.404 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -163.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 29.0 m0 -110.26 172.0 7.12 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.883 1.273 . . . . 0.0 109.912 175.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.7 t -147.51 149.49 32.74 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.0 175.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 p -109.98 110.01 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.488 HD12 HD23 ' A' ' 77' ' ' LEU . 57.8 mt -124.77 124.0 67.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 124.076 0.95 . . . . 0.0 108.761 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.9 t70 63.0 32.91 15.23 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.483 1.113 . . . . 0.0 111.025 174.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.35 2.35 87.44 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.914 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 97' ' ' GLN . 46.4 mmtm -110.2 147.76 33.13 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.071 0.949 . . . . 0.0 109.261 177.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.8 t -102.43 127.66 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 122.842 0.457 . . . . 0.0 109.922 175.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -121.82 169.49 10.72 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.851 1.261 . . . . 0.0 108.987 175.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -94.64 157.07 16.13 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.65 0.738 . . . . 0.0 109.715 168.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.474 HG23 ' HB2' ' A' ' 73' ' ' PRO . 30.8 mm -121.05 -30.02 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.144 1.378 . . . . 0.0 108.911 172.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.596 ' HD3' ' HA2' ' A' ' 39' ' ' GLY . 35.7 ttpt -54.97 -58.0 9.39 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.86 0.864 . . . . 0.0 111.044 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -74.27 -36.34 63.8 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.149 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -51.95 -55.99 16.93 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.721 1.208 . . . . 0.0 111.846 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -68.33 -26.78 65.78 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.987 -176.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.9 m -66.78 -47.38 72.31 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 172.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -76.75 -13.67 60.01 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.025 0.93 . . . . 0.0 112.844 -176.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.553 ' HA ' ' HB2' ' A' ' 65' ' ' LEU . 90.8 p -67.96 -20.13 65.02 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -91.47 -0.16 57.58 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.612 0.365 . . . . 0.0 111.862 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.8 m -75.23 126.35 30.85 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 175.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -57.31 -48.4 79.05 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.389 1.076 . . . . 0.0 111.888 -170.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -82.59 -12.27 57.82 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.041 0.536 . . . . 0.0 112.431 -173.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 65.8 m -67.61 151.44 47.3 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 120.995 0.426 . . . . 0.0 111.232 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.57 ' HB ' HG22 ' A' ' 86' ' ' THR . 43.5 pt -61.04 -23.61 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.211 1.004 . . . . 0.0 111.468 174.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.553 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 63.1 mt -86.1 0.22 54.02 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.304 1.041 . . . . 0.0 111.961 -175.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.91 -33.24 71.92 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 122.969 0.507 . . . . 0.0 111.007 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -74.67 -25.58 59.27 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.582 0.753 . . . . 0.0 110.565 172.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.552 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 38.2 m-85 -95.99 3.7 53.25 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.317 1.047 . . . . 0.0 111.531 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.47 -29.35 69.45 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.57 0.748 . . . . 0.0 111.011 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.12 23.22 22.12 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.88 176.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -135.06 155.84 50.05 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.316 1.046 . . . . 0.0 108.912 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.84 131.28 78.98 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 124.222 1.009 . . . . 0.0 109.901 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.474 ' HB2' HG23 ' A' ' 51' ' ' ILE . 18.9 Cg_endo -55.4 -33.59 86.2 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 123.484 2.79 . . . . 0.0 114.303 -174.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.8 t -74.51 -46.99 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.4 t -64.1 -35.26 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 123.465 0.706 . . . . 0.0 110.58 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.552 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -67.41 -37.49 83.15 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.065 1.346 . . . . 0.0 110.56 178.036 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.69 HD12 ' SD ' ' A' ' 90' ' ' MET . 58.3 tp -67.2 -43.4 82.2 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.08 0.952 . . . . 0.0 110.466 176.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -64.6 -37.61 88.16 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.83 0.852 . . . . 0.0 111.2 178.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.29 -33.42 69.7 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.824 0.85 . . . . 0.0 110.473 176.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.49 -23.38 53.78 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.481 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.446 HD23 ' HG3' ' A' ' 90' ' ' MET . 90.1 mt -72.28 -39.96 67.93 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.891 0.476 . . . . 0.0 109.83 170.041 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -68.65 -43.0 77.16 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.605 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.422 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 5.1 t80 -82.58 124.6 30.29 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -176.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.31 -27.97 69.39 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.712 1.205 . . . . 0.0 112.737 -172.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -71.0 -35.9 72.24 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.471 0.709 . . . . 0.0 110.935 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.57 HG22 ' HB ' ' A' ' 64' ' ' ILE . 30.9 p -94.96 -21.25 18.74 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.534 0.734 . . . . 0.0 112.959 -171.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -66.01 -24.44 66.77 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.452 0.701 . . . . 0.0 112.078 -174.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -66.26 -37.54 85.72 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.724 0.81 . . . . 0.0 111.329 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.5 t -76.7 -24.19 53.15 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.452 0.701 . . . . 0.0 110.943 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.69 ' SD ' HD12 ' A' ' 77' ' ' LEU . 33.1 mmt -63.27 -20.88 65.86 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.737 0.815 . . . . 0.0 111.686 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 27.7 m170 -64.46 -31.78 73.13 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.638 0.775 . . . . 0.0 111.036 176.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.82 -43.84 74.72 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.796 175.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -73.33 -23.82 60.29 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.555 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 35.5 t -74.29 104.32 5.01 Favored 'General case' 0 C--N 1.349 0.581 0 C-N-CA 123.291 0.636 . . . . 0.0 109.346 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.2 m -80.65 -9.43 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 123.302 0.641 . . . . 0.0 110.483 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 156.6 -164.77 32.74 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.577 172.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 43.1 tt0 -99.13 142.5 30.54 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.517 1.127 . . . . 0.0 109.228 171.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -74.57 137.82 42.62 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 122.901 0.481 . . . . 0.0 110.158 172.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.438 HD11 ' HB2' ' A' ' 104' ' ' GLU . 3.2 tm? -135.23 120.08 18.48 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 44.7 mt-10 -80.78 146.31 59.78 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 123.704 0.802 . . . . 0.0 110.026 174.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.6 -24.84 41.28 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.497 2.131 . . . . 0.0 111.865 -176.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -84.14 -28.35 27.5 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.956 0.902 . . . . 0.0 110.663 175.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 61.0 tp60 -66.25 -36.54 83.27 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.077 0.551 . . . . 0.0 111.577 -176.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.438 ' HB2' HD11 ' A' ' 99' ' ' LEU . 34.2 tt0 -85.97 -33.73 21.03 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.18 176.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.83 -33.65 86.07 Favored Glycine 0 C--N 1.354 1.562 0 CA-C-N 116.124 -0.489 . . . . 0.0 113.099 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -152.82 127.98 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 124.838 1.255 . . . . 0.0 107.861 172.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.7 t -129.99 145.62 51.65 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.9 mt -84.74 118.11 70.28 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -83.98 51.23 3.34 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.847 2.364 . . . . 0.0 112.501 -177.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 37.8 t70 63.38 26.58 15.03 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.381 1.073 . . . . 0.0 110.542 -176.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.5 tt -71.41 -44.09 65.57 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.0 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.299 0 CA-C-O 118.864 -0.965 . . . . 0.0 111.651 179.36 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.925 0.393 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.77 143.69 28.84 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.206 1.003 . . . . 0.0 109.101 177.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.6 p -111.37 150.87 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 123.492 0.717 . . . . 0.0 110.029 -176.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.4 m -78.72 110.96 14.34 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.827 0.851 . . . . 0.0 110.147 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.459 HD22 HD23 ' A' ' 99' ' ' LEU . 86.4 mt -81.9 104.2 12.1 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 172.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.9 t -93.84 118.99 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -85.33 165.7 17.06 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.5 tt -57.0 -36.25 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 123.085 0.554 . . . . 0.0 112.244 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.11 -41.57 83.84 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.426 0.69 . . . . 0.0 111.077 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -64.71 -34.4 78.23 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.809 0.844 . . . . 0.0 111.495 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.7 mt -60.76 -47.15 87.63 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 123.545 0.528 . . . . 0.0 109.83 175.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -65.69 -44.75 85.25 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.828 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -62.65 -49.91 73.26 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.988 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -69.26 -35.21 75.85 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.757 0.423 . . . . 0.0 110.232 -174.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -62.99 -42.91 99.97 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.438 0.695 . . . . 0.0 109.766 174.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -67.31 -31.64 72.07 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.892 0.877 . . . . 0.0 111.096 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -72.03 -18.49 61.95 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.348 0.659 . . . . 0.0 111.078 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.93 32.56 3.51 Favored Glycine 0 C--N 1.345 1.049 0 O-C-N 123.144 0.278 . . . . 0.0 112.804 176.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -140.36 104.81 0.42 Allowed Glycine 0 C--N 1.343 0.927 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 177.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -75.6 110.63 10.16 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.769 0.428 . . . . 0.0 110.076 -168.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -100.04 145.38 27.98 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.176 0.99 . . . . 0.0 110.375 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.3 t -140.56 151.51 44.77 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.257 1.023 . . . . 0.0 109.358 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.4 p -102.96 120.35 52.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 172.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.432 HD13 ' HG2' ' A' ' 78' ' ' GLU . 63.6 mt -131.49 123.82 53.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.614 1.166 . . . . 0.0 108.446 176.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.7 t70 62.33 31.81 17.22 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.413 1.085 . . . . 0.0 111.721 175.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.95 7.13 87.56 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-N 115.673 -0.694 . . . . 0.0 113.337 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -110.69 159.54 17.51 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.664 1.186 . . . . 0.0 108.442 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 75.6 t -114.96 139.8 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 122.957 0.503 . . . . 0.0 109.698 174.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -133.92 155.73 49.38 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.324 1.05 . . . . 0.0 110.289 -175.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -102.52 106.91 17.7 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 173.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.533 HG23 ' HB2' ' A' ' 73' ' ' PRO . 30.8 mm -68.02 -34.31 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.636 1.174 . . . . 0.0 112.183 -178.022 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -59.82 -41.4 91.19 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 123.667 0.604 . . . . 0.0 110.29 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.425 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 33.7 t70 -68.83 -45.53 70.92 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.943 0.897 . . . . 0.0 110.655 177.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.448 ' HA ' ' HE2' ' A' ' 93' ' ' PHE . 77.2 t80 -47.56 -60.57 2.44 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.544 1.138 . . . . 0.0 111.704 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -63.57 -29.81 71.02 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.521 -178.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 96.9 m -69.37 -35.08 75.47 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 122.788 0.435 . . . . 0.0 111.168 178.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 23.2 mm-40 -70.74 -14.35 62.41 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.787 0.435 . . . . 0.0 111.479 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.2 t -84.63 12.37 7.23 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.85 0.86 . . . . 0.0 111.588 174.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -64.75 -28.89 69.89 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.095 0.558 . . . . 0.0 111.365 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.6 m -88.9 133.2 34.37 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.729 0.812 . . . . 0.0 109.646 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -28.11 68.12 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.51 0.724 . . . . 0.0 111.207 178.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -103.72 89.33 3.3 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.94 0.896 . . . . 0.0 108.982 171.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.3 p -147.6 169.55 19.39 Favored 'General case' 0 C--O 1.245 0.838 0 C-N-CA 123.835 0.854 . . . . 0.0 109.241 177.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.655 ' HB ' HG22 ' A' ' 86' ' ' THR . 48.2 pt -68.49 -22.29 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.658 172.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.438 ' HG ' HG13 ' A' ' 64' ' ' ILE . 66.5 mt -101.4 5.51 42.15 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.248 1.019 . . . . 0.0 111.715 -176.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.11 -30.19 71.27 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.261 0.625 . . . . 0.0 110.779 173.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -79.56 -23.84 42.53 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.224 1.01 . . . . 0.0 111.079 174.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.556 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 55.1 m-85 -99.3 0.39 42.91 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.226 1.01 . . . . 0.0 111.801 -177.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.73 -23.28 64.33 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.794 0.838 . . . . 0.0 111.87 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -101.86 24.39 31.53 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 116.61 -0.268 . . . . 0.0 113.063 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -136.12 158.89 43.33 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.034 0.934 . . . . 0.0 109.665 -175.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -56.24 129.74 74.35 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 123.947 0.899 . . . . 0.0 109.728 174.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.533 ' HB2' HG23 ' A' ' 51' ' ' ILE . 37.3 Cg_endo -60.62 -31.49 92.24 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.648 2.232 . . . . 0.0 114.064 -170.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.469 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 37.0 t -75.31 -53.27 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.3 t -61.47 -36.14 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 123.59 0.756 . . . . 0.0 111.308 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.556 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -66.92 -37.09 83.69 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.506 1.122 . . . . 0.0 111.105 178.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.3 tp -68.39 -38.56 81.45 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.881 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 35.9 mt-10 -65.23 -41.64 94.2 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.211 0.604 . . . . 0.0 110.041 177.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.23 -33.42 75.71 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.707 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.12 -34.88 71.5 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.856 0.862 . . . . 0.0 111.643 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.4 mt -67.42 -40.57 85.54 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.144 0.578 . . . . 0.0 110.15 175.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -73.52 -25.0 60.23 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.235 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -79.46 114.39 18.35 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -54.57 -29.61 51.85 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.665 1.586 . . . . 0.0 112.933 -177.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -70.88 -58.45 3.58 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.274 0.63 . . . . 0.0 110.83 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.655 HG22 ' HB ' ' A' ' 64' ' ' ILE . 67.4 p -87.72 -10.81 50.06 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -166.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -65.8 -31.99 73.26 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.103 0.561 . . . . 0.0 111.907 -172.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -29.39 64.27 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.516 -173.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.6 t -74.93 -23.87 58.4 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.581 0.752 . . . . 0.0 110.995 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.43 ' HA ' ' HD1' ' A' ' 93' ' ' PHE . 21.8 mmt -73.91 0.35 13.68 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.833 0.853 . . . . 0.0 112.669 -177.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -63.83 -31.13 72.2 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.616 0.766 . . . . 0.0 110.778 170.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.06 -31.08 39.45 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.17 0.988 . . . . 0.0 111.052 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.448 ' HE2' ' HA ' ' A' ' 54' ' ' PHE . 60.2 m-85 -81.27 -24.83 37.03 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.527 0.731 . . . . 0.0 110.685 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.1 t -78.31 108.65 11.79 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 123.437 0.695 . . . . 0.0 109.341 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.3 p -79.28 -19.55 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.495 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 155.35 -156.53 27.03 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 116.387 -0.369 . . . . 0.0 112.391 176.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.431 ' HB2' HD23 ' A' ' 25' ' ' LEU . 16.6 mm100 -78.58 164.77 24.39 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.778 1.231 . . . . 0.0 111.306 174.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -109.62 143.33 39.49 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 162.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.459 HD23 HD22 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -137.64 123.95 20.6 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.17 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.63 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 1.7 mp0 -73.24 143.3 83.09 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 123.212 0.605 . . . . 0.0 110.397 178.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -58.82 -32.5 97.31 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.918 2.412 . . . . 0.0 112.739 175.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -82.78 -29.13 29.86 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.082 0.553 . . . . 0.0 110.446 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.63 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 55.9 tp60 -66.75 -24.7 66.25 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.333 0.653 . . . . 0.0 110.903 -177.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -63.35 -34.34 77.49 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.568 0.747 . . . . 0.0 111.537 176.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -129.95 31.82 3.27 Favored Glycine 0 C--N 1.349 1.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 113.094 -177.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.4 p -84.48 131.06 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-O 121.11 0.481 . . . . 0.0 110.24 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.3 t -132.87 131.9 41.48 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.041 0.936 . . . . 0.0 108.869 173.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.5 mt -110.8 122.8 37.16 Favored Pre-proline 0 N--CA 1.473 0.704 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -72.73 158.52 50.28 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 123.046 2.497 . . . . 0.0 112.061 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -75.05 86.11 2.33 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 52.9 tp -99.35 -56.64 2.35 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.359 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.262 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 176.465 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 119.627 -0.225 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -54.91 101.89 0.06 Allowed 'General case' 0 C--N 1.364 1.22 0 C-N-CA 124.435 1.094 . . . . 0.0 110.887 -178.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 p -77.36 139.22 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.526 0.731 . . . . 0.0 110.905 -174.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.4 m -75.46 110.34 9.75 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.497 0.719 . . . . 0.0 109.978 177.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.517 HD13 HD22 ' A' ' 99' ' ' LEU . 85.8 mt -83.31 106.07 14.78 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.417 ' HB ' HG21 ' A' ' 48' ' ' VAL . 59.7 t -94.31 124.76 46.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 124.216 1.006 . . . . 0.0 110.164 -170.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.551 ' HB2' ' HB2' ' A' ' 30' ' ' ASP . 54.0 mtm180 -73.25 164.23 26.97 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.909 1.283 . . . . 0.0 110.521 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.5 tt -66.87 -42.61 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 118.203 0.456 . . . . 0.0 111.598 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.35 -29.45 68.18 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.763 177.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.551 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 23.3 t0 -59.28 -38.64 80.67 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.596 1.159 . . . . 0.0 110.944 -175.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.8 mp -57.46 -48.35 79.4 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 123.844 0.715 . . . . 0.0 110.727 173.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -67.92 -42.47 81.02 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.284 1.033 . . . . 0.0 111.479 -172.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -71.76 -40.35 69.37 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.374 0.67 . . . . 0.0 111.109 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -66.79 -33.39 75.52 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 176.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -64.52 -44.29 91.34 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.237 1.015 . . . . 0.0 111.029 175.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -64.59 -31.56 72.83 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.432 0.693 . . . . 0.0 110.521 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -66.93 -34.69 78.32 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.048 0.939 . . . . 0.0 110.846 176.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 128.19 25.43 1.08 Allowed Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.028 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -134.59 100.4 0.37 Allowed Glycine 0 C--N 1.344 0.997 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -178.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -75.1 107.57 7.27 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -170.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 25.7 m0 -103.22 131.71 50.05 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.742 0.817 . . . . 0.0 109.852 177.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -127.78 144.81 51.07 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.818 1.247 . . . . 0.0 109.106 177.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 p -96.28 112.35 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 120.976 0.417 . . . . 0.0 110.197 176.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.4 mt -122.26 118.62 55.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 123.81 0.844 . . . . 0.0 109.113 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.2 t70 62.57 32.84 16.26 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.832 1.253 . . . . 0.0 112.577 172.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.02 7.29 85.64 Favored Glycine 0 N--CA 1.477 1.408 0 CA-C-N 116.073 -0.512 . . . . 0.0 113.635 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.418 ' HB2' ' CE1' ' A' ' 49' ' ' TYR . 32.4 mmtp -117.87 161.78 19.19 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.269 1.027 . . . . 0.0 108.853 176.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.417 HG21 ' HB ' ' A' ' 26' ' ' VAL . 96.4 t -113.54 124.41 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 174.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.418 ' CE1' ' HB2' ' A' ' 47' ' ' LYS . 76.9 m-85 -117.79 156.25 28.65 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.34 1.056 . . . . 0.0 109.366 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -98.79 147.1 25.24 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 173.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.4 ' O ' ' HB3' ' A' ' 54' ' ' PHE . 24.5 mm -109.46 -33.6 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.305 1.042 . . . . 0.0 111.402 -172.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.1 -29.29 62.82 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 118.566 0.621 . . . . 0.0 110.081 176.111 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -70.9 -39.15 72.95 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.118 0.967 . . . . 0.0 110.712 172.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.4 ' HB3' ' O ' ' A' ' 51' ' ' ILE . 13.0 t80 -54.1 -54.51 38.51 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.935 0.894 . . . . 0.0 109.852 171.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -66.86 -28.55 68.43 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.952 0.901 . . . . 0.0 112.398 -173.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.4 m -58.25 -47.75 82.58 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.136 0.493 . . . . 0.0 110.195 171.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -77.31 -18.18 57.72 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.578 0.751 . . . . 0.0 111.523 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.492 ' HA ' ' HB2' ' A' ' 65' ' ' LEU . 25.9 t -75.6 -22.36 56.96 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.688 0.395 . . . . 0.0 111.031 177.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.8 mt -83.81 7.65 17.26 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.025 0.53 . . . . 0.0 110.986 172.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.9 m -105.97 134.36 49.21 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.892 0.877 . . . . 0.0 109.657 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -75.26 -40.33 58.94 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.717 0.807 . . . . 0.0 112.715 -173.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -82.15 0.77 39.38 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.293 0.637 . . . . 0.0 111.944 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.9 m -81.33 151.08 28.18 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 122.679 0.392 . . . . 0.0 109.996 170.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.533 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 24.5 pt -55.3 -30.61 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.577 0.751 . . . . 0.0 110.986 170.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 49.5 mt -73.88 -0.93 17.52 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.261 1.024 . . . . 0.0 113.049 -173.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.48 -41.26 96.58 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.649 0.78 . . . . 0.0 110.905 171.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.533 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 8.2 pt20 -76.65 -20.79 56.29 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.16 0.584 . . . . 0.0 110.937 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.458 ' HD2' ' HA ' ' A' ' 65' ' ' LEU . 75.5 m-85 -92.51 2.62 56.58 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.03 0.932 . . . . 0.0 111.33 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.39 111.83 4.88 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.153 0.581 . . . . 0.0 110.349 177.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.61 -29.33 7.93 Favored Glycine 0 N--CA 1.474 1.232 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 -175.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -79.92 151.62 30.01 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.618 0.767 . . . . 0.0 109.299 173.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.543 ' HB3' HG12 ' A' ' 75' ' ' VAL . 26.3 t70 -59.32 126.74 82.93 Favored Pre-proline 0 N--CA 1.483 1.182 0 CA-C-O 118.908 -0.568 . . . . 0.0 110.154 -178.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.07 -34.8 88.62 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 123.319 2.68 . . . . 0.0 114.11 -174.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.462 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 60.2 t -73.63 -49.66 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.182 -178.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.543 HG12 ' HB3' ' A' ' 72' ' ' ASP . 3.8 p -68.43 -28.59 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 122.791 0.436 . . . . 0.0 111.126 -177.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.06 -36.56 75.06 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.059 0.943 . . . . 0.0 109.767 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.648 ' HG ' ' SD ' ' A' ' 90' ' ' MET . 4.4 tt -71.81 -37.98 70.28 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.178 0.991 . . . . 0.0 110.029 176.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 44.3 mt-10 -64.34 -49.29 72.29 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.094 0.958 . . . . 0.0 110.87 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.03 -29.55 69.39 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.812 0.845 . . . . 0.0 111.019 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.62 -35.03 72.74 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.904 177.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.0 mt -63.34 -35.53 80.69 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.742 0.417 . . . . 0.0 110.771 175.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -67.07 -47.73 70.38 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.388 175.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.462 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 23.1 t80 -81.87 119.82 24.41 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 121.205 0.526 . . . . 0.0 110.936 -173.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -53.99 -34.21 59.21 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.785 1.634 . . . . 0.0 114.682 -171.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -79.87 -33.73 39.81 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.934 0.494 . . . . 0.0 111.735 -177.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.462 ' OG1' ' HB3' ' A' ' 83' ' ' PHE . 25.3 p -93.33 -13.53 28.02 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.393 0.677 . . . . 0.0 112.805 -173.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -73.82 -20.02 60.58 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 122.779 0.432 . . . . 0.0 110.385 178.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -63.74 -38.12 89.93 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.358 1.063 . . . . 0.0 111.314 -175.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.402 ' HB3' HD11 ' A' ' 64' ' ' ILE . 22.6 t -77.4 -31.4 54.11 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.009 0.524 . . . . 0.0 110.389 177.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.648 ' SD ' ' HG ' ' A' ' 77' ' ' LEU . 15.7 mmt -70.46 -21.84 62.75 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.221 0.608 . . . . 0.0 111.149 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -60.74 -35.6 76.78 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.656 0.782 . . . . 0.0 109.724 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.2 -38.57 42.99 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.615 0.766 . . . . 0.0 111.06 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.516 ' HD2' ' SD ' ' A' ' 90' ' ' MET . 29.8 m-85 -72.16 -14.39 61.8 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 122.761 0.425 . . . . 0.0 111.886 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 49.2 t -68.89 83.19 0.31 Allowed 'General case' 0 C--N 1.36 1.031 0 C-N-CA 123.397 0.679 . . . . 0.0 109.593 175.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.3 m -73.51 -16.39 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.12 0.968 . . . . 0.0 111.754 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.29 -175.58 41.16 Favored Glycine 0 C--N 1.343 0.972 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.146 174.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -119.1 134.42 55.21 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -76.37 143.02 40.97 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.213 0.605 . . . . 0.0 111.755 -171.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.517 HD22 HD13 ' A' ' 25' ' ' LEU . 54.8 tp -140.78 128.92 22.17 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.507 1.123 . . . . 0.0 108.243 176.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.663 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 46.9 mt-10 -91.89 140.84 24.96 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 123.732 0.813 . . . . 0.0 110.657 -178.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.81 -26.45 67.7 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 123.188 2.592 . . . . 0.0 112.434 173.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -78.97 -24.58 43.76 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.121 0.568 . . . . 0.0 110.485 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.663 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 47.3 tp60 -74.41 -6.81 50.38 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.674 0.79 . . . . 0.0 111.036 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -63.63 -23.82 67.54 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.23 0.612 . . . . 0.0 111.641 171.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -166.53 66.53 0.2 Allowed Glycine 0 C--N 1.349 1.286 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.9 p -85.05 140.86 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 122.981 0.512 . . . . 0.0 109.981 176.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.6 t -118.08 119.45 34.78 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.408 0.683 . . . . 0.0 109.648 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 55.4 mt -121.49 99.42 45.39 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 123.533 0.733 . . . . 0.0 109.144 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -59.93 147.55 92.28 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 123.271 2.647 . . . . 0.0 113.295 173.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -73.74 104.28 4.59 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.202 0.601 . . . . 0.0 109.87 174.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 83.5 mt -115.94 25.85 10.41 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.77 0.828 . . . . 0.0 109.447 176.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 1.541 0 CA-C-O 119.525 -0.597 . . . . 0.0 112.58 -177.68 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 N--CA 1.479 1.025 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.9 mmmm -74.28 98.95 3.33 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 172.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.8 p -67.27 132.01 32.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.6 m -64.87 112.77 3.43 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.269 0.628 . . . . 0.0 110.718 -176.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.5 mt -77.94 103.24 7.76 Favored 'General case' 0 C--N 1.347 0.466 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 174.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.459 ' HB ' HG21 ' A' ' 48' ' ' VAL . 44.6 t -98.47 139.16 21.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.052 0.941 . . . . 0.0 108.989 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.569 ' HD3' ' H ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -112.43 162.05 16.02 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.987 0.915 . . . . 0.0 109.31 178.743 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.5 tt -56.31 -38.1 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 C-N-CA 123.412 0.685 . . . . 0.0 111.93 -176.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.03 -37.47 79.89 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.543 0.737 . . . . 0.0 111.196 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -70.93 -34.67 71.72 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.105 -178.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.493 HD21 HG23 ' A' ' 43' ' ' VAL . 8.3 mp -59.99 -46.65 88.77 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 122.665 0.386 . . . . 0.0 110.707 171.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -64.27 -42.76 96.31 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.296 1.038 . . . . 0.0 112.224 -173.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -69.7 -41.22 75.7 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.95 177.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -66.96 -28.46 68.29 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.209 0.603 . . . . 0.0 110.95 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -65.11 -49.84 68.41 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.912 0.885 . . . . 0.0 110.049 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -75.08 -14.94 60.63 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.599 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -68.33 -34.31 75.88 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.555 0.742 . . . . 0.0 110.184 170.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 119.95 36.68 0.81 Allowed Glycine 0 C--N 1.348 1.226 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.27 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.53 107.66 0.36 Allowed Glycine 0 C--N 1.342 0.909 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -75.05 125.01 28.02 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -174.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 9.5 m0 -115.72 151.83 34.36 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.216 1.006 . . . . 0.0 110.183 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.6 t -143.13 164.69 29.45 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.559 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.504 HG22 HG22 ' A' ' 48' ' ' VAL . 72.1 t -116.82 111.43 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 176.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.432 HG13 ' HG ' ' A' ' 77' ' ' LEU . 14.8 mm -108.49 103.79 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 175.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.2 t70 60.21 41.81 16.21 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 124.472 1.109 . . . . 0.0 112.298 171.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.63 12.31 75.41 Favored Glycine 0 N--CA 1.475 1.28 0 CA-C-N 116.09 -0.505 . . . . 0.0 113.87 175.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -124.2 144.2 50.08 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.853 0.861 . . . . 0.0 108.84 172.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.504 HG22 HG22 ' A' ' 43' ' ' VAL . 45.0 t -99.09 137.23 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 122.967 0.507 . . . . 0.0 109.761 178.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -127.74 154.95 44.76 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.532 1.133 . . . . 0.0 110.327 -175.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -96.52 101.68 13.34 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.7 mm -64.09 -33.09 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 124.1 0.96 . . . . 0.0 111.901 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -64.19 -43.66 94.41 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.431 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 24.6 t70 -66.94 -40.05 87.48 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.86 0.864 . . . . 0.0 110.211 177.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -55.85 -55.24 34.8 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.809 1.244 . . . . 0.0 111.613 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -69.82 -26.2 64.13 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.506 0.722 . . . . 0.0 111.23 -177.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.7 m -62.87 -41.82 99.52 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 122.717 0.407 . . . . 0.0 111.023 171.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 31.0 mm-40 -70.22 -26.8 64.03 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.133 0.573 . . . . 0.0 110.76 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.3 t -77.86 10.64 2.65 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.961 0.904 . . . . 0.0 111.501 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 45.2 tp -67.59 -39.65 84.8 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.273 0.629 . . . . 0.0 110.779 171.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.2 t -99.7 146.98 25.9 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.158 0.583 . . . . 0.0 111.829 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.38 -19.41 53.4 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.764 175.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -63.73 -28.05 69.62 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 123.435 0.694 . . . . 0.0 110.182 175.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.3 t -66.96 152.24 46.12 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.462 0.705 . . . . 0.0 110.46 175.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.549 ' HB ' HG22 ' A' ' 86' ' ' THR . 26.4 pt -63.24 -17.76 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.475 1.11 . . . . 0.0 111.612 172.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.9 mt -85.19 9.58 14.67 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.64 1.176 . . . . 0.0 111.657 -178.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.57 -40.51 97.16 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.117 0.967 . . . . 0.0 111.24 174.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -73.77 -13.61 60.98 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.323 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.551 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 28.7 m-85 -110.13 4.91 21.56 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.567 1.147 . . . . 0.0 111.888 -176.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.74 -36.83 85.56 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.765 0.826 . . . . 0.0 112.589 -172.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -101.16 6.7 56.43 Favored Glycine 0 N--CA 1.479 1.53 0 CA-C-N 116.405 -0.361 . . . . 0.0 113.027 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -98.52 152.54 19.45 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.336 1.054 . . . . 0.0 109.065 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -54.12 124.88 47.61 Favored Pre-proline 0 N--CA 1.48 1.038 0 CA-C-O 118.354 -0.831 . . . . 0.0 109.08 172.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -57.5 -31.03 90.34 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.136 2.557 . . . . 0.0 114.03 -170.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 67.5 t -74.43 -48.55 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 122.868 0.467 . . . . 0.0 110.211 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.71 -38.15 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 123.504 0.722 . . . . 0.0 110.564 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.551 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -63.14 -40.89 98.89 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 114.074 -1.421 . . . . 0.0 110.944 177.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.432 ' HG ' HG13 ' A' ' 44' ' ' ILE . 37.1 tp -71.38 -36.82 71.56 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.027 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 82' ' ' GLN . 48.4 mt-10 -60.92 -47.07 88.1 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.866 0.466 . . . . 0.0 110.085 174.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.19 -32.11 73.63 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.843 0.857 . . . . 0.0 111.046 177.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.49 -28.57 64.01 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.477 0.711 . . . . 0.0 111.752 178.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.535 ' HA ' ' HB3' ' A' ' 87' ' ' ARG . 3.8 mm? -75.26 -28.34 59.79 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.267 0.227 . . . . 0.0 111.008 173.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 71.5 mt-30 -78.24 -41.22 34.86 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.979 0.512 . . . . 0.0 110.579 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -79.71 123.36 27.6 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -59.91 -41.35 91.49 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.044 0.937 . . . . 0.0 113.135 -169.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -68.18 -36.31 79.4 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.893 0.477 . . . . 0.0 111.572 -175.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.549 HG22 ' HB ' ' A' ' 64' ' ' ILE . 12.8 p -81.64 -30.46 32.79 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.133 -175.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.535 ' HB3' ' HA ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -74.96 -12.66 60.39 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.276 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.403 ' HG2' HH11 ' A' ' 87' ' ' ARG . 30.4 mt-10 -67.2 -35.88 80.56 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.237 0.615 . . . . 0.0 110.319 175.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.8 t -77.86 -29.91 50.63 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.428 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 14.9 mmt -70.95 -9.7 58.36 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.628 0.771 . . . . 0.0 112.104 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -62.07 -30.92 71.32 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.936 0.894 . . . . 0.0 110.662 171.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.17 -35.98 25.07 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.463 0.705 . . . . 0.0 111.466 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -75.03 -23.16 58.13 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.245 0.618 . . . . 0.0 111.762 -173.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 25.9 p -71.48 99.44 2.02 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.4 m -69.47 -30.06 44.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 123.902 0.881 . . . . 0.0 111.502 -177.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.14 179.94 44.23 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.005 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -91.03 136.47 33.05 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.55 0.74 . . . . 0.0 109.094 176.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -82.45 142.84 31.58 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 174.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.0 tt -136.27 112.81 10.03 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 170.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.558 ' HB3' ' HB2' ' A' ' 103' ' ' GLN . 26.0 tt0 -72.65 141.96 83.11 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.571 0.748 . . . . 0.0 109.96 -177.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -42.21 -60.86 0.61 Allowed 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 123.598 2.865 . . . . 0.0 114.113 176.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -81.88 -8.18 59.66 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.822 0.849 . . . . 0.0 112.377 -172.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.558 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 54.4 tp60 -54.81 -34.8 63.2 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.845 0.858 . . . . 0.0 110.898 175.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.48 -27.05 68.21 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.854 -178.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.5 -88.83 0.34 Allowed Glycine 0 C--N 1.345 1.035 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 175.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.7 p -149.72 123.08 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 123.514 0.726 . . . . 0.0 109.432 172.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.4 t -84.1 121.54 27.57 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 175.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.8 mm -95.29 113.93 62.69 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.362 0.665 . . . . 0.0 109.556 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.52 170.16 13.25 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 123.067 2.511 . . . . 0.0 112.296 175.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -109.81 106.96 16.77 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.222 1.009 . . . . 0.0 109.963 -175.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.7 mp -89.35 -63.32 1.31 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.858 0.863 . . . . 0.0 109.782 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.904 0 CA-C-O 118.918 -0.935 . . . . 0.0 112.286 179.69 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.248 0.071 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.43 143.39 38.63 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 122.615 0.366 . . . . 0.0 110.191 176.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.6 p -84.01 116.15 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 CA-C-O 121.176 0.512 . . . . 0.0 110.155 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.5 m -82.7 110.11 17.46 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 175.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.506 HD13 HD22 ' A' ' 99' ' ' LEU . 92.6 mt -86.93 111.95 21.32 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.512 -178.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.504 ' HB ' HG21 ' A' ' 48' ' ' VAL . 48.4 t -94.72 125.82 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 174.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -92.32 167.62 11.88 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.29 0.636 . . . . 0.0 111.123 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.0 tt -67.65 -34.2 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.194 -177.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.95 -33.5 71.99 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.41 0.684 . . . . 0.0 110.589 177.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.08 -44.43 63.29 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.144 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.1 mt -57.35 -52.8 63.89 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.883 0.873 . . . . 0.0 112.03 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -63.89 -48.94 74.67 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.901 0.88 . . . . 0.0 111.789 -173.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -63.53 -34.32 77.53 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.062 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 50.7 t60 -73.4 -34.6 65.59 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.312 0.645 . . . . 0.0 110.721 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -60.64 -40.5 92.23 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.207 1.003 . . . . 0.0 110.107 176.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -69.7 -26.43 64.35 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.117 0.967 . . . . 0.0 111.409 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -70.14 -19.91 63.19 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.004 0.522 . . . . 0.0 111.518 174.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 114.88 -21.47 13.65 Favored Glycine 0 C--N 1.341 0.83 0 N-CA-C 111.796 -0.521 . . . . 0.0 111.796 -175.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.51 ' HA2' ' HG2' ' A' ' 52' ' ' LYS . . . -73.65 92.23 0.69 Allowed Glycine 0 C--N 1.345 1.048 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -78.33 110.95 13.82 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 38.9 m0 -105.23 174.09 6.03 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.198 0.999 . . . . 0.0 109.399 170.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.4 t -151.13 162.92 39.96 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.811 0.844 . . . . 0.0 108.862 172.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.492 HG22 HG22 ' A' ' 48' ' ' VAL . 73.8 t -119.79 113.52 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.296 0.638 . . . . 0.0 109.338 175.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.683 HD12 HD23 ' A' ' 77' ' ' LEU . 51.3 mt -135.79 133.48 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 176.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.1 t70 63.07 30.33 16.21 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 125.048 1.339 . . . . 0.0 110.477 -175.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.13 26.49 67.64 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.729 -175.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.453 ' HB2' ' CE2' ' A' ' 49' ' ' TYR . 44.3 mmtm -121.16 134.1 55.21 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.681 0.792 . . . . 0.0 108.891 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.504 HG21 ' HB ' ' A' ' 26' ' ' VAL . 93.1 t -84.66 111.15 19.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 174.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.453 ' CE2' ' HB2' ' A' ' 47' ' ' LYS . 85.0 m-85 -108.46 150.17 27.78 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.674 0.79 . . . . 0.0 110.351 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -88.12 138.98 30.97 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.836 175.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.538 HD11 HD22 ' A' ' 77' ' ' LEU . 33.6 mm -116.32 -40.18 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.552 0.741 . . . . 0.0 111.513 -174.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.51 ' HG2' ' HA2' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -69.25 -32.33 71.47 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.299 0.24 . . . . 0.0 111.02 -179.245 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.432 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 33.6 t70 -76.03 -37.85 57.9 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.252 0.621 . . . . 0.0 110.687 172.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -55.34 -48.48 74.14 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.18 0.992 . . . . 0.0 111.527 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -69.83 -27.25 64.71 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.794 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.3 m -66.74 -38.19 86.16 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.95 0.5 . . . . 0.0 110.04 172.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.501 ' HB2' HD12 ' A' ' 65' ' ' LEU . 52.7 mm-40 -76.49 -15.3 59.93 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.09 0.556 . . . . 0.0 110.892 176.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.5 t -90.67 -9.9 45.15 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.008 0.923 . . . . 0.0 111.199 175.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.4 tp -83.05 -5.87 59.27 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.843 0.857 . . . . 0.0 111.489 -178.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.0 t -119.54 152.67 36.6 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.611 0.764 . . . . 0.0 110.848 -174.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -73.89 -51.09 17.31 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.69 1.196 . . . . 0.0 111.362 -174.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -78.21 72.47 4.74 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.592 0.71 . . . . 0.0 109.589 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.2 m -163.16 147.59 11.17 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.884 1.273 . . . . 0.0 108.726 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.622 ' HB ' HG22 ' A' ' 86' ' ' THR . 33.2 pt -67.26 -19.91 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 124.274 1.03 . . . . 0.0 111.558 175.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.501 HD12 ' HB2' ' A' ' 57' ' ' GLN . 65.6 mt -92.53 7.99 40.81 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.001 0.92 . . . . 0.0 111.669 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.51 -23.52 64.55 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.562 0.345 . . . . 0.0 110.772 175.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -75.52 -11.87 60.11 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.606 0.763 . . . . 0.0 111.408 172.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -112.97 20.88 15.98 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.024 0.93 . . . . 0.0 110.953 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.36 -26.03 68.57 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.675 0.79 . . . . 0.0 112.752 -174.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -111.87 5.27 27.45 Favored Glycine 0 N--CA 1.478 1.481 0 C-N-CA 122.753 0.216 . . . . 0.0 113.137 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -96.03 151.07 19.79 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.075 0.95 . . . . 0.0 109.961 -177.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -63.39 127.1 90.73 Favored Pre-proline 0 N--CA 1.48 1.051 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 171.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.425 ' HB2' HG23 ' A' ' 51' ' ' ILE . 18.7 Cg_endo -56.68 -34.0 94.92 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.501 2.801 . . . . 0.0 114.729 -174.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.2 t -75.05 -39.35 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 121.052 0.453 . . . . 0.0 110.445 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.1 t -68.16 -40.76 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.309 0.644 . . . . 0.0 110.017 177.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.5 -33.06 75.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.065 1.346 . . . . 0.0 111.208 176.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.683 HD23 HD12 ' A' ' 44' ' ' ILE . 34.0 tp -59.69 -51.89 67.84 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 124.164 0.915 . . . . 0.0 111.185 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -63.06 -39.67 95.42 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.056 0.543 . . . . 0.0 111.655 -178.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.93 -42.64 99.87 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.555 177.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.6 -17.69 50.57 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.99 0.916 . . . . 0.0 112.176 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.1 mp -70.51 -45.4 65.67 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.922 0.889 . . . . 0.0 109.004 171.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -75.33 -27.98 59.45 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.781 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.407 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 3.0 t80 -81.81 114.28 20.33 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -64.99 -26.46 68.3 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.098 0.959 . . . . 0.0 112.653 -172.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -65.94 -41.97 90.65 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.387 0.675 . . . . 0.0 110.676 177.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.622 HG22 ' HB ' ' A' ' 64' ' ' ILE . 20.1 p -95.86 -18.87 20.02 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.004 0.921 . . . . 0.0 113.152 -171.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -63.33 -21.18 66.11 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -176.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -54.27 -48.4 71.25 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.898 0.879 . . . . 0.0 111.682 177.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.4 t -73.6 -15.69 61.26 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.671 0.788 . . . . 0.0 111.785 -172.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 24.7 mmt -64.4 -17.63 63.94 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.736 0.815 . . . . 0.0 112.211 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.405 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 2.4 p80 -61.06 -29.33 69.67 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.211 0.605 . . . . 0.0 110.894 174.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.64 -32.39 19.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.101 0.96 . . . . 0.0 111.413 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -79.93 -26.06 40.26 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.599 0.36 . . . . 0.0 110.936 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.405 ' SG ' ' HA ' ' A' ' 91' ' ' HIS . 28.6 p -79.76 103.25 9.53 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.29 -35.75 72.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 124.372 1.069 . . . . 0.0 110.21 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 174.31 -170.57 43.7 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.293 176.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -89.67 135.96 33.31 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -78.9 128.58 33.51 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.272 0.629 . . . . 0.0 110.774 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.506 HD22 HD13 ' A' ' 25' ' ' LEU . 64.0 tp -105.32 117.1 33.15 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 166.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -73.48 133.1 80.65 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 173.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.52 -42.76 64.7 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.271 2.648 . . . . 0.0 113.632 -174.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -87.76 -7.7 56.98 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.71 0.404 . . . . 0.0 111.252 -176.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -76.5 -20.53 56.86 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.65 0.78 . . . . 0.0 110.728 174.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -51.02 -53.94 29.04 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.826 1.25 . . . . 0.0 111.184 -173.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -67.84 -87.76 0.08 OUTLIER Glycine 0 C--N 1.345 1.074 0 O-C-N 123.79 0.681 . . . . 0.0 112.967 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.5 p -161.56 132.51 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 123.338 0.655 . . . . 0.0 110.286 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.9 t -104.27 97.66 7.57 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 174.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.8 mt -71.26 124.6 91.24 Favored Pre-proline 0 CA--C 1.555 1.148 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.45 168.39 24.92 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.654 2.236 . . . . 0.0 112.037 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -75.98 71.72 2.79 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.408 0.683 . . . . 0.0 109.821 175.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -68.48 -31.85 71.43 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.298 -171.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.192 0 CA-C-O 119.203 -0.776 . . . . 0.0 111.862 -178.607 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.7 m . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.42 HD22 ' HB2' ' A' ' 99' ' ' LEU . 92.4 mt -98.47 108.83 21.62 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.092 0.557 . . . . 0.0 110.209 -177.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.9 t -94.38 132.84 37.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.493 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -102.24 171.18 7.63 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.499 0.72 . . . . 0.0 109.593 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.474 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 13.0 tt -60.72 -34.09 57.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.848 174.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.42 -49.79 76.02 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.352 0.661 . . . . 0.0 110.743 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.11 -42.98 95.89 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.626 0.77 . . . . 0.0 110.879 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 46.9 tp -58.24 -45.82 87.08 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.333 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 17.0 mm-40 -72.68 -52.97 13.05 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.541 0.736 . . . . 0.0 112.397 -177.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -71.16 -29.87 65.74 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -172.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -73.47 -27.46 61.41 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 120.553 0.216 . . . . 0.0 110.5 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -61.3 -39.31 89.99 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 120.961 0.41 . . . . 0.0 110.205 172.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -68.57 -32.3 72.11 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.534 0.733 . . . . 0.0 110.78 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -65.77 -19.52 65.92 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.897 0.879 . . . . 0.0 111.41 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.74 4.09 26.53 Favored Glycine 0 N--CA 1.475 1.234 0 CA-C-N 116.695 -0.23 . . . . 0.0 112.764 176.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -111.93 95.86 0.83 Allowed Glycine 0 C--N 1.34 0.776 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.415 ' H ' ' HB2' ' A' ' 52' ' ' LYS . 89.7 t80 -75.8 116.6 16.67 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -104.66 -179.76 4.04 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.275 1.03 . . . . 0.0 109.961 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.4 t -155.83 159.15 39.14 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.698 0.799 . . . . 0.0 109.211 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 98.4 t -107.99 111.57 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 123.572 0.749 . . . . 0.0 109.258 177.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.729 HD12 HD23 ' A' ' 77' ' ' LEU . 48.8 mt -140.6 135.48 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.275 1.03 . . . . 0.0 108.631 175.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 63.59 32.31 14.1 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.675 1.19 . . . . 0.0 111.062 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.44 20.78 70.0 Favored Glycine 0 C--N 1.352 1.457 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.927 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.516 ' HD3' ' HA ' ' A' ' 97' ' ' GLN . 32.8 mmtp -128.59 162.98 26.02 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.792 1.237 . . . . 0.0 109.23 -177.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 90.9 t -119.28 119.28 60.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 123.629 0.772 . . . . 0.0 109.037 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -112.27 148.15 34.77 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.526 0.73 . . . . 0.0 109.909 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -86.56 100.7 12.6 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.518 HD11 HD22 ' A' ' 77' ' ' LEU . 31.5 mm -76.45 -29.64 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.418 0.687 . . . . 0.0 111.689 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.415 ' HB2' ' H ' ' A' ' 40' ' ' PHE . 1.7 tmmm? -61.55 -47.7 84.34 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.472 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 27.5 t70 -73.97 -36.07 64.54 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.521 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -52.55 -53.31 48.09 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.958 0.903 . . . . 0.0 111.154 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.487 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 10.6 pt20 -67.36 -28.53 68.03 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.233 -177.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.8 m -64.01 -40.38 96.22 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.042 0.449 . . . . 0.0 110.407 175.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.607 ' HB2' HD12 ' A' ' 65' ' ' LEU . 51.9 mm-40 -72.46 -32.35 66.17 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.315 0.646 . . . . 0.0 109.974 177.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.5 t -68.09 -27.32 66.38 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.726 0.81 . . . . 0.0 111.283 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 55' ' ' GLN . 96.9 mt -80.75 -15.42 56.52 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.448 0.699 . . . . 0.0 111.597 175.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 45.1 m -90.16 124.68 35.04 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.207 0.603 . . . . 0.0 110.321 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -64.29 147.96 51.31 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.936 0.894 . . . . 0.0 110.284 175.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 75.45 -3.56 2.56 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.367 1.467 . . . . 0.0 112.854 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.0 m -81.06 149.85 29.06 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 172.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.645 ' HB ' HG22 ' A' ' 86' ' ' THR . 42.9 pt -61.97 -20.04 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.58 0.752 . . . . 0.0 112.478 -178.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.607 HD12 ' HB2' ' A' ' 57' ' ' GLN . 60.0 mt -95.05 -8.68 35.98 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.575 0.75 . . . . 0.0 111.725 -176.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.87 -25.76 65.68 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.272 0.629 . . . . 0.0 111.549 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -75.73 -20.53 58.27 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.806 0.842 . . . . 0.0 111.042 173.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.423 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 52.4 m-85 -102.89 12.82 35.65 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.275 1.03 . . . . 0.0 110.987 178.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.62 -26.16 64.3 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.329 0.651 . . . . 0.0 112.534 -175.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.53 -3.87 90.53 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-N 116.472 -0.331 . . . . 0.0 112.639 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -108.08 150.55 27.04 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.176 0.99 . . . . 0.0 110.136 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -55.98 124.72 60.18 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 123.723 0.809 . . . . 0.0 110.52 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -51.13 -33.51 44.05 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 123.549 2.832 . . . . 0.0 115.145 -173.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.2 t -70.79 -38.87 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.111 0.564 . . . . 0.0 110.49 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.5 t -74.13 -40.11 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.894 0.877 . . . . 0.0 110.062 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.423 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -65.49 -29.3 69.93 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.832 1.253 . . . . 0.0 110.896 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.729 HD23 HD12 ' A' ' 44' ' ' ILE . 48.4 tp -63.98 -41.75 97.44 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.925 0.89 . . . . 0.0 110.536 174.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -65.65 -40.8 92.87 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.631 0.772 . . . . 0.0 110.998 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.43 -31.95 73.03 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.782 0.833 . . . . 0.0 110.688 175.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.14 -33.49 61.53 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.468 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.492 HD23 ' HG3' ' A' ' 90' ' ' MET . 95.6 mt -67.74 -40.12 84.2 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.156 0.582 . . . . 0.0 109.857 174.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -66.4 -41.5 89.24 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.858 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.444 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 9.8 t80 -87.5 127.7 35.24 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 120.982 0.42 . . . . 0.0 110.606 -175.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.81 -32.28 72.57 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.885 1.274 . . . . 0.0 113.63 -170.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -68.69 -51.4 42.1 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.154 0.502 . . . . 0.0 109.864 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.645 HG22 ' HB ' ' A' ' 64' ' ' ILE . 27.7 p -78.71 -16.78 56.83 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.197 -0.91 . . . . 0.0 113.149 -168.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.4 ptt85 -74.96 -11.42 60.11 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -75.34 -38.08 60.35 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.056 0.942 . . . . 0.0 111.256 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.407 ' HB3' HD11 ' A' ' 64' ' ' ILE . 24.2 t -77.64 -18.73 56.45 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.912 0.485 . . . . 0.0 110.743 175.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.592 ' SD ' HD12 ' A' ' 77' ' ' LEU . 37.4 mmt -65.01 -24.18 67.43 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.566 0.346 . . . . 0.0 110.887 176.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.468 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 86.2 m-70 -64.43 -26.57 68.51 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.841 0.856 . . . . 0.0 111.62 173.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.44 -35.95 46.17 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.476 0.71 . . . . 0.0 110.834 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -83.7 -24.37 31.29 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.477 0.311 . . . . 0.0 111.606 -176.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.468 ' SG ' ' HA ' ' A' ' 91' ' ' HIS . 29.5 p -72.05 101.32 2.71 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.001 0.429 . . . . 0.0 109.882 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.6 t -68.83 -37.71 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.056 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.02 -171.67 44.17 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.551 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.516 ' HA ' ' HD3' ' A' ' 47' ' ' LYS . 29.0 tt0 -88.78 135.68 33.39 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.909 0.884 . . . . 0.0 109.81 176.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -83.86 136.29 34.17 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.42 ' HB2' HD22 ' A' ' 25' ' ' LEU . 2.9 tt -139.7 122.88 16.91 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 173.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 46.7 mt-10 -70.74 145.05 91.73 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 123.973 0.909 . . . . 0.0 111.974 -176.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.5 -47.61 23.87 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 123.306 2.671 . . . . 0.0 112.303 173.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -67.61 -38.47 83.98 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.212 1.005 . . . . 0.0 111.846 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.468 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 26.4 tp60 . . . . . 0 N--CA 1.48 1.074 0 C-N-CA 124.032 0.933 . . . . 0.0 112.864 -168.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.9 m . . . . . 0 CA--C 1.544 0.72 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 89.4 mt -92.87 105.75 17.82 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.906 0.882 . . . . 0.0 109.634 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.6 t -93.93 126.21 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.37 1.068 . . . . 0.0 108.675 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -93.5 170.26 9.73 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.022 0.529 . . . . 0.0 110.792 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.7 tt -57.8 -36.61 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.19 0.996 . . . . 0.0 112.444 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.99 -40.0 95.4 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.378 0.671 . . . . 0.0 111.315 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.29 -34.75 77.19 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.235 1.014 . . . . 0.0 111.689 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.5 mt -58.75 -47.28 85.19 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.919 0.762 . . . . 0.0 110.01 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -71.62 -39.09 70.69 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.835 -174.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -62.22 -47.05 86.12 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.017 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -68.17 -35.39 77.96 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.333 0.653 . . . . 0.0 110.826 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 56.1 t30 -60.54 -42.97 97.62 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.267 178.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -78.16 -23.02 47.84 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.743 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -72.86 -36.59 67.43 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.903 0.881 . . . . 0.0 111.864 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 139.85 33.14 0.16 Allowed Glycine 0 N--CA 1.48 1.604 0 CA-C-N 116.968 -0.106 . . . . 0.0 113.121 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 35' ' ' ASN . . . -150.61 -178.31 25.35 Favored Glycine 0 C--N 1.343 0.948 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -134.59 110.23 9.18 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 117.582 0.691 . . . . 0.0 109.525 175.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 17.9 m0 -98.13 144.3 27.76 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.145 0.578 . . . . 0.0 110.508 174.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -136.87 141.84 42.79 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.192 0.997 . . . . 0.0 108.885 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.1 t -96.46 110.79 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 175.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 77.6 mt -131.24 130.22 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.1 t70 62.47 30.96 17.27 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 124.629 1.172 . . . . 0.0 111.617 175.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.55 12.83 77.71 Favored Glycine 0 N--CA 1.479 1.532 0 CA-C-N 116.198 -0.455 . . . . 0.0 113.378 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -119.14 160.33 22.32 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.724 1.21 . . . . 0.0 108.974 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.1 t -111.81 116.76 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.124 0.57 . . . . 0.0 109.525 176.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.435 ' HB2' HD21 ' A' ' 77' ' ' LEU . 49.8 m-85 -112.32 152.73 28.21 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.967 0.907 . . . . 0.0 109.352 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -100.88 107.25 18.72 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.571 0.348 . . . . 0.0 110.439 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.4 mm -60.31 -36.24 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 124.806 1.242 . . . . 0.0 111.724 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.44 ' HG3' ' HA2' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -58.49 -47.3 84.53 Favored 'General case' 0 CA--C 1.553 1.065 0 O-C-N 123.944 0.777 . . . . 0.0 109.184 -178.048 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 39.1 t70 -74.46 -34.41 63.14 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.706 0.402 . . . . 0.0 110.797 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -52.98 -55.97 19.51 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.928 0.891 . . . . 0.0 111.002 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -67.64 -28.24 67.55 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.413 0.685 . . . . 0.0 111.277 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.5 m -67.69 -37.44 82.3 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 123.505 0.722 . . . . 0.0 110.876 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 30.9 mm-40 -77.45 -28.07 52.3 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.437 0.695 . . . . 0.0 110.704 177.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.2 t -74.36 -3.63 31.51 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.732 0.813 . . . . 0.0 111.576 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.4 tt -63.2 -38.28 90.54 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.29 1.036 . . . . 0.0 110.129 172.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.6 m -76.81 135.33 38.93 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.495 0.718 . . . . 0.0 111.026 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -73.39 -35.23 65.86 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.997 0.919 . . . . 0.0 110.391 -178.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -87.78 60.41 5.91 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.526 0.679 . . . . 0.0 109.536 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.6 t -133.0 155.12 49.75 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.796 0.838 . . . . 0.0 109.419 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.567 ' HB ' HG22 ' A' ' 86' ' ' THR . 27.3 pt -75.3 -10.71 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.587 0.755 . . . . 0.0 110.614 173.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.9 mt -93.46 -8.86 40.36 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.916 0.886 . . . . 0.0 110.734 176.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.07 -26.19 64.83 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.745 0.818 . . . . 0.0 111.46 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -74.65 -13.48 60.64 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.455 0.702 . . . . 0.0 110.963 174.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.527 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 67.6 m-85 -115.55 12.25 16.1 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.684 1.194 . . . . 0.0 110.963 177.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.73 -28.52 69.11 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.522 0.729 . . . . 0.0 112.109 -175.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.24 27.42 15.22 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.738 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -132.89 155.0 49.84 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.983 0.913 . . . . 0.0 109.499 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -54.39 129.05 60.8 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 124.305 1.042 . . . . 0.0 109.459 172.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.1 -35.32 90.25 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 123.433 2.755 . . . . 0.0 114.461 -172.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.0 t -74.66 -48.92 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 122.638 0.375 . . . . 0.0 110.441 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.0 t -63.08 -33.86 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.715 0.806 . . . . 0.0 110.713 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -64.71 -44.5 90.02 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.464 176.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.435 HD21 ' HB2' ' A' ' 49' ' ' TYR . 56.8 tp -66.89 -43.12 84.25 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.839 0.855 . . . . 0.0 111.306 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -58.89 -52.15 66.98 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.313 0.645 . . . . 0.0 110.259 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.14 -34.67 76.81 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.716 0.806 . . . . 0.0 111.229 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.99 -24.04 61.52 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.716 0.807 . . . . 0.0 112.291 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 81' ' ' LEU . 2.0 mm? -70.81 -42.1 70.73 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 172.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -73.22 -28.34 62.11 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.049 0.54 . . . . 0.0 111.053 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -85.51 117.67 24.56 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -66.08 -27.56 68.17 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.908 0.883 . . . . 0.0 113.175 -169.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -76.16 -22.01 55.9 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.383 0.673 . . . . 0.0 112.423 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.567 HG22 ' HB ' ' A' ' 64' ' ' ILE . 19.1 p -109.28 -20.99 12.75 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -174.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.499 ' HA ' ' HG2' ' A' ' 90' ' ' MET . 40.3 ptt180 -67.66 -13.57 62.21 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -55.48 -49.58 72.17 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.414 1.086 . . . . 0.0 112.339 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.9 t -77.4 -15.72 59.21 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.932 0.493 . . . . 0.0 111.033 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.499 ' HG2' ' HA ' ' A' ' 87' ' ' ARG . 12.7 mmt -69.03 -16.81 63.8 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.828 0.451 . . . . 0.0 111.243 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -62.24 -39.72 93.78 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.941 0.496 . . . . 0.0 109.798 169.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.89 -37.13 62.2 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.75 0.82 . . . . 0.0 111.065 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.488 ' HD2' ' SD ' ' A' ' 90' ' ' MET . 45.9 m-85 -71.37 -23.93 61.99 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.012 0.525 . . . . 0.0 111.221 177.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 46.1 t -72.17 99.85 2.43 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.0 m -71.15 -26.32 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 123.408 0.683 . . . . 0.0 110.251 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 175.42 175.11 42.58 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.319 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -85.18 136.66 33.43 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 177.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -76.83 132.44 39.19 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.46 126.15 32.35 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 170.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 42.2 mt-10 -70.34 136.08 86.56 Favored Pre-proline 0 C--O 1.246 0.898 0 O-C-N 123.851 0.72 . . . . 0.0 110.3 177.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -59.27 -22.05 63.26 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.765 2.31 . . . . 0.0 112.609 175.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -86.61 -38.83 16.71 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.824 1.25 . . . . 0.0 111.224 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.522 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 8.5 tp-100 . . . . . 0 N--CA 1.492 1.631 0 C-N-CA 124.33 1.052 . . . . 0.0 111.586 -176.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 77.7 m . . . . . 0 CA--C 1.538 0.502 0 CA-C-O 121.247 0.546 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.436 HD13 HD13 ' A' ' 99' ' ' LEU . 72.2 mt -85.64 106.55 17.01 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.215 -177.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.456 HG21 HG23 ' A' ' 95' ' ' VAL . 46.2 t -102.16 128.99 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.183 0.993 . . . . 0.0 109.043 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -101.98 170.28 8.23 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.379 0.672 . . . . 0.0 110.073 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.432 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 18.6 tt -67.96 -32.15 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.348 0.659 . . . . 0.0 111.98 -173.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.64 -35.58 72.73 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.199 0.6 . . . . 0.0 111.453 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -68.27 -42.26 79.83 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.788 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.4 mt -55.24 -40.64 71.13 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.785 0.834 . . . . 0.0 111.422 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 7.0 mm-40 -65.89 -41.6 91.33 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.444 -178.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -59.29 -50.62 73.29 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.569 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -64.41 -34.64 78.66 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.173 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -59.21 -39.16 81.79 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.07 0.548 . . . . 0.0 110.416 174.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -75.96 -19.49 58.69 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.017 0.927 . . . . 0.0 111.886 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -84.3 -20.16 32.58 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 122.665 0.386 . . . . 0.0 110.823 170.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.99 -13.48 52.66 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-N 116.456 -0.338 . . . . 0.0 112.414 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.413 ' HA2' ' HD3' ' A' ' 52' ' ' LYS . . . -76.72 88.59 0.95 Allowed Glycine 0 C--N 1.35 1.309 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 176.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -75.63 111.1 10.61 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -173.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 39.5 m0 -99.77 177.73 5.04 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.941 0.896 . . . . 0.0 110.066 175.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.9 t -157.6 151.27 23.99 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.71 0.804 . . . . 0.0 109.869 -178.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 p -103.0 112.12 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 171.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.5 mt -124.18 116.96 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.359 1.064 . . . . 0.0 109.223 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.3 t70 53.31 53.63 11.47 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.27 1.428 . . . . 0.0 111.834 175.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.55 -0.46 55.61 Favored Glycine 0 N--CA 1.475 1.273 0 N-CA-C 114.815 0.686 . . . . 0.0 114.815 176.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 97' ' ' GLN . 44.9 mmtm -112.59 167.83 10.15 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.131 0.972 . . . . 0.0 109.461 178.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 90.7 t -115.61 121.97 68.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 171.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.428 ' HB3' HD21 ' A' ' 77' ' ' LEU . 76.7 m-85 -115.3 170.62 8.25 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.831 1.253 . . . . 0.0 109.301 174.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -99.21 159.42 15.0 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.241 0.617 . . . . 0.0 109.835 171.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 35.1 mm -117.28 -29.21 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.359 1.064 . . . . 0.0 108.934 168.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.413 ' HD3' ' HA2' ' A' ' 39' ' ' GLY . 25.1 ttpt -53.89 -57.97 9.01 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.469 1.108 . . . . 0.0 111.965 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.449 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 27.4 t70 -74.39 -35.54 63.49 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.995 0.518 . . . . 0.0 110.121 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -51.09 -53.51 33.43 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.85 1.26 . . . . 0.0 111.775 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -67.62 -27.89 67.28 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.923 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.9 m -68.32 -42.15 79.79 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.932 174.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 77.7 mm-40 -68.56 -28.36 66.89 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 123.12 0.568 . . . . 0.0 110.519 178.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.0 t -72.71 -26.98 61.79 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.672 0.789 . . . . 0.0 110.996 175.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 47.5 tp -67.37 -27.29 66.99 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.876 0.87 . . . . 0.0 112.095 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.0 t -88.11 151.64 22.58 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.219 0.533 . . . . 0.0 111.478 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -79.05 155.46 28.79 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.434 1.093 . . . . 0.0 109.95 176.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 71.88 5.76 5.44 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.032 1.333 . . . . 0.0 112.095 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 37.7 t -74.81 155.33 37.7 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.386 0.674 . . . . 0.0 109.686 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.566 ' HB ' HG22 ' A' ' 86' ' ' THR . 47.5 pt -68.83 -19.76 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 122.788 0.435 . . . . 0.0 110.518 170.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 57' ' ' GLN . 63.4 mt -96.94 0.32 48.78 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.783 1.233 . . . . 0.0 111.613 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.02 -27.68 68.98 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 122.983 0.513 . . . . 0.0 110.944 176.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -82.16 -24.79 34.83 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.88 0.872 . . . . 0.0 111.372 173.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.587 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 54.8 m-85 -91.84 2.53 56.46 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.979 0.911 . . . . 0.0 112.066 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.97 -29.77 69.71 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.371 0.668 . . . . 0.0 111.092 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.31 26.85 9.3 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-N 116.017 -0.538 . . . . 0.0 113.114 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -141.47 152.32 44.11 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.326 1.05 . . . . 0.0 108.611 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -52.61 127.86 42.7 Favored Pre-proline 0 N--CA 1.478 0.94 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.871 174.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.08 -34.2 86.45 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 123.215 2.61 . . . . 0.0 114.476 -172.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.7 t -73.0 -48.56 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.1 t -62.53 -34.76 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.934 0.894 . . . . 0.0 110.78 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -71.41 -35.18 70.9 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.994 1.318 . . . . 0.0 110.876 -178.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.428 HD21 ' HB3' ' A' ' 49' ' ' TYR . 17.2 tp -73.36 -40.01 64.72 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.682 176.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -62.31 -36.48 82.28 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.193 0.597 . . . . 0.0 110.267 172.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.5 -32.72 68.55 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.112 0.965 . . . . 0.0 110.612 176.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.23 -43.6 86.15 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.562 0.745 . . . . 0.0 111.151 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.83 -30.64 69.23 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.514 0.326 . . . . 0.0 111.504 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -72.91 -27.72 62.04 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.027 0.531 . . . . 0.0 110.734 176.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -95.96 119.49 34.54 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.294 0.638 . . . . 0.0 110.046 -176.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -58.88 -27.99 65.72 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.514 1.125 . . . . 0.0 113.067 -175.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -79.64 -20.01 47.8 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.029 0.932 . . . . 0.0 112.248 -174.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.566 HG22 ' HB ' ' A' ' 64' ' ' ILE . 41.5 p -123.61 -12.2 7.7 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -173.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -68.58 -26.56 65.45 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.554 0.742 . . . . 0.0 111.195 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -60.07 -54.4 46.36 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.258 1.023 . . . . 0.0 110.481 -172.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.8 m -64.52 -20.0 65.94 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.907 0.883 . . . . 0.0 112.48 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 20.6 mmt -74.09 -4.02 33.01 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.301 0.641 . . . . 0.0 112.495 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.94 -21.4 65.1 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.765 0.426 . . . . 0.0 110.565 169.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -89.06 -29.51 19.37 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.757 0.823 . . . . 0.0 111.086 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -80.8 -24.03 38.83 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.171 0.588 . . . . 0.0 111.443 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.9 p -76.25 110.98 11.21 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 173.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.456 HG23 HG21 ' A' ' 26' ' ' VAL . 27.5 m -70.29 -24.88 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.132 0.573 . . . . 0.0 110.122 174.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 167.59 -159.32 32.58 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.612 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 53.8 tt0 -102.14 139.92 37.12 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.093 0.957 . . . . 0.0 109.807 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.427 ' OH ' ' HB ' ' A' ' 28' ' ' ILE . 84.2 t80 -78.94 124.25 28.06 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.378 0.671 . . . . 0.0 110.379 178.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.436 HD13 HD13 ' A' ' 25' ' ' LEU . 9.5 tt -115.86 120.9 40.76 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 172.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.734 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 42.9 mt-10 -68.86 143.09 94.32 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 123.613 0.765 . . . . 0.0 110.585 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -54.73 -31.18 70.41 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.856 2.371 . . . . 0.0 113.053 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -82.71 -29.01 30.15 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.86 0.864 . . . . 0.0 111.222 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.734 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 33.3 tt0 . . . . . 0 N--CA 1.483 1.179 0 C-N-CA 123.737 0.815 . . . . 0.0 112.036 -174.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.2 m . . . . . 0 CA--C 1.541 0.615 0 CA-C-O 120.731 0.3 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 83.6 mt -95.93 104.33 16.27 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.756 0.822 . . . . 0.0 109.727 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.52 ' HB ' HG21 ' A' ' 48' ' ' VAL . 59.2 t -95.5 121.78 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.568 1.147 . . . . 0.0 108.688 178.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -78.6 168.95 19.01 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 123.322 0.649 . . . . 0.0 110.312 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.44 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 11.4 tt -56.4 -46.08 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.877 174.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.98 -38.01 81.31 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.8 0.84 . . . . 0.0 111.707 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -66.34 -46.75 75.72 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.017 0.527 . . . . 0.0 111.593 -176.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 pp -72.11 -32.56 67.09 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.282 0.233 . . . . 0.0 111.61 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 68.2 mm-40 -63.73 -47.75 79.84 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.191 0.597 . . . . 0.0 110.816 174.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -77.32 -23.66 50.97 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.404 -175.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -72.63 -28.34 62.68 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -59.63 -47.58 85.04 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.115 0.566 . . . . 0.0 110.034 173.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -70.9 -26.7 63.34 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.101 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.71 -30.0 69.39 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.905 0.882 . . . . 0.0 111.276 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.58 34.88 0.68 Allowed Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.46 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.585 ' HA2' ' HD2' ' A' ' 52' ' ' LYS . . . -162.23 100.0 0.18 Allowed Glycine 0 C--N 1.346 1.131 0 CA-C-O 120.05 -0.306 . . . . 0.0 112.635 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -75.73 110.0 9.79 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -176.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -103.32 157.24 17.15 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.564 174.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.5 t -148.25 143.54 27.04 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.648 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 p -96.64 120.41 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-O 121.027 0.441 . . . . 0.0 110.623 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 78.6 mt -136.89 125.22 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 124.906 1.282 . . . . 0.0 108.194 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.1 t70 62.45 32.9 16.51 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.386 1.074 . . . . 0.0 111.548 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.14 19.57 77.39 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-N 115.818 -0.628 . . . . 0.0 113.401 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -125.24 145.35 50.03 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.187 0.995 . . . . 0.0 108.674 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.52 HG21 ' HB ' ' A' ' 26' ' ' VAL . 25.4 t -99.8 119.64 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -112.54 165.75 11.95 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.035 0.934 . . . . 0.0 109.056 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -93.76 161.55 14.28 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.565 0.698 . . . . 0.0 110.065 170.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.436 HG23 ' HB2' ' A' ' 73' ' ' PRO . 29.3 mm -115.88 -29.92 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.502 1.121 . . . . 0.0 109.744 172.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.585 ' HD2' ' HA2' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -57.36 -52.27 66.04 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 123.891 0.876 . . . . 0.0 112.655 -177.006 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -78.34 -31.38 48.62 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.278 1.031 . . . . 0.0 110.224 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -52.47 -60.81 2.79 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.843 1.257 . . . . 0.0 111.346 175.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -64.89 -28.65 69.69 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.558 -0.747 . . . . 0.0 112.177 -174.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.0 m -63.46 -45.04 92.65 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.298 0.639 . . . . 0.0 110.055 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -77.65 -13.54 59.88 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.369 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.6 m -71.15 -19.64 62.4 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.697 0.399 . . . . 0.0 111.015 172.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 61.0 mt -82.25 -5.89 58.85 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.993 0.917 . . . . 0.0 111.497 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 79.4 m -91.58 133.24 35.71 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.759 0.824 . . . . 0.0 109.722 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -62.91 -49.59 74.2 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.276 1.03 . . . . 0.0 111.644 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -86.51 45.41 1.24 Allowed 'General case' 0 CA--C 1.557 1.218 0 CA-C-O 121.91 0.862 . . . . 0.0 110.642 -177.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 75.7 m -122.81 144.74 48.99 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.181 0.992 . . . . 0.0 109.306 172.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.487 ' HB ' HG22 ' A' ' 86' ' ' THR . 35.0 pt -59.26 -25.92 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 124.029 0.932 . . . . 0.0 110.759 169.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.513 HD21 ' HE1' ' A' ' 90' ' ' MET . 36.7 mt -76.82 -10.15 59.17 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.276 1.031 . . . . 0.0 111.902 -178.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.84 -20.54 59.71 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.214 0.606 . . . . 0.0 111.535 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 2.2 pt20 -77.19 -29.37 54.3 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 171.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -87.94 2.78 50.81 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.402 1.081 . . . . 0.0 111.177 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.54 126.15 28.4 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.782 0.433 . . . . 0.0 110.112 177.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.31 -21.7 38.64 Favored Glycine 0 C--N 1.345 1.037 0 O-C-N 123.481 0.488 . . . . 0.0 112.528 -173.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -89.91 158.49 17.4 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.219 1.008 . . . . 0.0 109.809 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -61.23 132.55 92.57 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 123.204 0.602 . . . . 0.0 109.817 173.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.436 ' HB2' HG23 ' A' ' 51' ' ' ILE . 52.6 Cg_endo -64.53 -32.12 59.65 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.976 2.451 . . . . 0.0 113.899 -172.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.6 t -73.93 -45.82 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.8 t -61.15 -40.35 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.52 0.728 . . . . 0.0 110.478 177.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.02 -40.05 95.46 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.305 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 37.6 tp -71.81 -37.9 70.28 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.666 0.786 . . . . 0.0 110.917 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.23 -44.42 91.91 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.987 0.515 . . . . 0.0 110.318 176.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.51 -33.55 75.83 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.823 0.849 . . . . 0.0 110.873 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.79 -41.78 82.65 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.924 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.13 -23.28 64.88 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -82.76 -9.46 59.34 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.492 0.717 . . . . 0.0 112.071 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -125.89 124.85 41.77 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.206 0.602 . . . . 0.0 109.752 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.09 -42.0 84.71 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.411 1.084 . . . . 0.0 113.901 -169.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.42 -35.85 78.71 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.45 0.7 . . . . 0.0 111.285 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.487 HG22 ' HB ' ' A' ' 64' ' ' ILE . 31.6 p -98.26 -6.01 31.99 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.854 -174.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -90.48 -25.68 20.18 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 118.584 0.629 . . . . 0.0 110.433 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -75.72 -24.83 56.22 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.8 0.666 . . . . 0.0 112.8 -172.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.2 t -71.71 -23.97 61.73 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.145 171.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.513 ' HE1' HD21 ' A' ' 65' ' ' LEU . 12.6 mmt -75.58 -8.92 58.0 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.263 0.625 . . . . 0.0 111.663 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -70.3 -16.81 63.06 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.611 0.764 . . . . 0.0 110.507 169.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -88.66 -37.38 15.62 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.958 0.903 . . . . 0.0 110.857 170.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.427 ' HD2' ' HA ' ' A' ' 90' ' ' MET . 97.5 m-85 -80.79 -14.22 58.27 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.456 0.702 . . . . 0.0 112.192 -176.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 27.1 p -69.5 102.37 1.79 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.736 0.414 . . . . 0.0 110.647 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 26.2 m -77.56 -15.13 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 123.344 0.657 . . . . 0.0 111.201 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 168.84 -172.13 43.09 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.808 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -99.31 150.44 22.11 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 174.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -86.25 152.19 22.99 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.946 0.498 . . . . 0.0 110.553 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -146.65 121.34 9.84 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 172.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 38.3 mt-10 -71.46 129.01 89.32 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 123.232 0.613 . . . . 0.0 109.631 173.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.9 -32.27 56.29 Favored 'Trans proline' 0 CA--C 1.561 1.847 0 C-N-CA 122.848 2.365 . . . . 0.0 112.645 176.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -76.64 -32.47 58.02 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.624 0.77 . . . . 0.0 111.552 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 50.3 tp60 . . . . . 0 N--CA 1.479 0.994 0 C-N-CA 122.829 0.452 . . . . 0.0 110.262 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.1 m . . . . . 0 N--CA 1.468 0.455 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.4 mt -78.34 100.32 6.7 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.357 0.598 . . . . 0.0 109.64 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -92.53 114.37 29.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 38.3 mtp-105 -85.99 176.3 8.12 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.785 -175.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.5 tt -58.02 -37.44 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.728 175.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.75 -40.25 94.98 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.818 0.847 . . . . 0.0 111.264 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -74.28 -39.79 62.72 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.165 0.586 . . . . 0.0 110.788 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 45.6 tp -66.77 -50.15 63.6 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.035 0.534 . . . . 0.0 110.604 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -64.85 -48.11 75.52 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.63 0.772 . . . . 0.0 112.069 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -67.09 -47.96 69.62 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 123.488 0.493 . . . . 0.0 111.643 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -64.2 -36.77 85.16 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.525 0.33 . . . . 0.0 110.61 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -65.56 -39.69 91.96 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.067 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -67.79 -29.15 68.26 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.52 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -65.38 -23.2 66.91 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.184 0.594 . . . . 0.0 111.588 175.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.92 -26.74 6.09 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.574 ' HA2' ' HD2' ' A' ' 52' ' ' LYS . . . -69.62 89.55 0.29 Allowed Glycine 0 C--N 1.345 1.073 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 176.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -74.11 112.84 10.65 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -171.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 32.6 m0 -105.27 155.21 19.28 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.69 171.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.6 t -129.55 160.72 32.35 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.516 0.726 . . . . 0.0 109.408 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 p -116.34 109.43 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 172.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.3 mt -134.37 133.76 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.002 1.321 . . . . 0.0 107.696 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.0 t70 63.2 29.4 16.0 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 124.473 1.109 . . . . 0.0 110.631 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.5 19.0 64.17 Favored Glycine 0 C--N 1.353 1.487 0 CA-C-N 115.121 -0.945 . . . . 0.0 113.497 -174.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.471 ' HB2' ' CE2' ' A' ' 49' ' ' TYR . 42.9 mmtm -116.82 152.33 34.65 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.449 1.1 . . . . 0.0 108.51 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.8 t -102.12 122.59 54.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' A' ' 47' ' ' LYS . 96.4 m-85 -114.47 155.3 26.64 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.923 0.889 . . . . 0.0 110.427 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -94.63 107.12 19.12 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.436 0.694 . . . . 0.0 109.47 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.491 HG23 ' HB2' ' A' ' 73' ' ' PRO . 15.6 mm -75.77 -39.87 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.925 0.89 . . . . 0.0 112.288 -177.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.574 ' HD2' ' HA2' ' A' ' 39' ' ' GLY . 18.0 ptmt -67.08 -32.06 72.97 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 121.161 -0.216 . . . . 0.0 110.954 -174.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -73.7 -38.45 64.84 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -53.19 -54.17 39.88 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.503 1.121 . . . . 0.0 111.12 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -70.34 -27.56 64.45 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.411 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.1 m -72.52 -33.08 66.63 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 120.946 0.403 . . . . 0.0 110.241 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.529 ' HB2' HD12 ' A' ' 65' ' ' LEU . 82.6 mm-40 -69.65 -35.42 75.17 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 172.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.4 m -65.31 -27.12 68.38 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.301 0.64 . . . . 0.0 111.099 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.3 tt -61.63 -44.73 96.43 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.238 1.015 . . . . 0.0 109.297 173.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 88.8 m -66.91 120.31 13.38 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.38 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -65.49 -31.52 72.64 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.956 0.903 . . . . 0.0 111.308 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -69.66 -18.16 63.55 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.331 1.053 . . . . 0.0 111.766 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.8 t -76.04 152.66 36.84 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.877 0.471 . . . . 0.0 110.762 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.447 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 32.4 pt -61.2 -26.8 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.711 170.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.529 HD12 ' HB2' ' A' ' 57' ' ' GLN . 46.6 mt -77.21 0.76 20.69 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.144 0.978 . . . . 0.0 111.971 -176.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.99 -30.4 70.91 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.363 0.665 . . . . 0.0 111.21 172.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 11.2 pt20 -73.99 -27.06 60.78 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.31 0.644 . . . . 0.0 110.689 175.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.515 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 41.8 m-85 -92.69 -6.44 49.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.255 1.022 . . . . 0.0 111.45 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.27 104.22 0.9 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.153 0.581 . . . . 0.0 109.824 174.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.47 -32.13 3.62 Favored Glycine 0 N--CA 1.472 1.046 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -174.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -77.62 151.14 34.5 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.425 0.69 . . . . 0.0 109.649 175.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -55.37 128.1 66.54 Favored Pre-proline 0 N--CA 1.48 1.067 0 CA-C-O 118.476 -0.773 . . . . 0.0 108.955 171.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.491 ' HB2' HG23 ' A' ' 51' ' ' ILE . 28.6 Cg_endo -58.0 -31.51 93.07 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.836 2.357 . . . . 0.0 113.973 -170.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.9 t -75.38 -50.27 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 123.058 0.543 . . . . 0.0 110.097 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.1 t -58.58 -35.26 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 124.035 0.934 . . . . 0.0 111.022 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.515 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -73.27 -34.98 66.1 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.701 1.2 . . . . 0.0 111.213 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.546 ' HG ' ' SD ' ' A' ' 90' ' ' MET . 4.6 tt -71.58 -35.78 70.67 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.504 0.722 . . . . 0.0 109.889 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -66.53 -40.72 89.29 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.426 0.69 . . . . 0.0 110.36 175.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.18 -32.95 74.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.638 0.775 . . . . 0.0 110.619 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.41 -40.82 73.65 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.878 177.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.9 mt -64.67 -36.68 85.04 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.251 0.621 . . . . 0.0 110.856 173.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -65.87 -36.81 84.46 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.637 0.775 . . . . 0.0 111.074 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.492 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 29.9 t80 -95.96 132.12 41.62 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -176.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -65.85 -36.81 84.49 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.174 0.99 . . . . 0.0 113.193 -168.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -74.98 -32.2 61.63 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.713 0.405 . . . . 0.0 111.063 -177.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.492 ' OG1' ' HB3' ' A' ' 83' ' ' PHE . 37.8 p -93.57 -10.65 34.02 Favored 'General case' 0 CA--C 1.555 1.161 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -172.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -78.51 -15.07 59.0 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -26.24 55.44 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.01 0.524 . . . . 0.0 112.198 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.6 t -73.73 -29.57 62.33 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.324 0.25 . . . . 0.0 110.38 171.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.546 ' SD ' ' HG ' ' A' ' 77' ' ' LEU . 32.1 mmt -64.94 -26.05 68.14 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.052 0.541 . . . . 0.0 110.406 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -59.91 -37.02 78.24 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.707 0.803 . . . . 0.0 110.63 174.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.36 -32.8 60.96 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.834 178.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -78.24 -24.09 47.1 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.255 0.222 . . . . 0.0 111.16 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 39.1 t -70.77 95.27 1.11 Allowed 'General case' 0 C--N 1.349 0.556 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 33.3 m -71.0 -22.77 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.238 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 169.75 -160.66 33.81 Favored Glycine 0 C--N 1.351 1.396 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.836 174.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -97.22 145.69 25.82 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.647 1.179 . . . . 0.0 109.133 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -80.26 108.79 14.16 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 173.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 3.0 tm? -92.31 114.58 27.17 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 103' ' ' GLN . 30.6 tt0 -80.03 140.71 53.86 Favored Pre-proline 0 CA--C 1.554 1.102 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 174.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -39.1 -51.2 2.56 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 124.356 3.371 . . . . 0.0 114.644 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -103.1 23.06 12.93 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.291 0.637 . . . . 0.0 111.655 -175.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.561 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 8.9 tp-100 . . . . . 0 N--CA 1.485 1.312 0 O-C-N 121.861 -0.524 . . . . 0.0 110.088 174.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.1 m . . . . . 0 CA--C 1.536 0.428 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.433 HD22 ' HB2' ' A' ' 99' ' ' LEU . 64.3 mt -79.35 110.59 14.79 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.1 t -91.87 119.31 39.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 124.069 0.948 . . . . 0.0 108.583 -176.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.531 ' HG2' ' HB2' ' A' ' 30' ' ' ASP . 1.5 ptm180 -81.27 162.0 23.69 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.421 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.5 tt -60.12 -36.8 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.757 0.823 . . . . 0.0 111.836 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.09 -32.21 64.84 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.485 0.714 . . . . 0.0 111.922 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.531 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 29.1 t70 -58.81 -43.26 90.51 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.403 0.681 . . . . 0.0 110.454 -176.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.9 mt -52.35 -43.85 64.86 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.511 1.124 . . . . 0.0 111.691 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -72.18 -37.83 69.22 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.506 -175.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -69.09 -40.06 78.65 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.934 0.494 . . . . 0.0 110.821 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -66.74 -40.4 88.3 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.17 0.588 . . . . 0.0 110.05 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -59.79 -40.49 88.49 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.973 0.509 . . . . 0.0 110.143 176.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -69.27 -31.64 70.3 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.753 0.821 . . . . 0.0 111.388 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -74.28 -30.44 62.1 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.783 0.833 . . . . 0.0 111.274 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 112.06 -7.15 27.21 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.688 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.515 ' HA2' ' HD2' ' A' ' 52' ' ' LYS . . . -75.36 83.46 0.87 Allowed Glycine 0 C--N 1.349 1.268 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 172.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -75.71 107.32 7.8 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -172.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 28.7 m0 -111.44 160.71 16.85 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.643 1.177 . . . . 0.0 110.425 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.8 t -149.36 144.75 26.61 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.421 1.088 . . . . 0.0 109.126 -177.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.573 HG22 HG22 ' A' ' 48' ' ' VAL . 95.9 t -111.36 119.17 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.3 0.64 . . . . 0.0 109.925 178.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.9 mt -127.54 106.12 14.67 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 124.031 0.932 . . . . 0.0 109.008 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.5 t70 55.94 54.55 7.91 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 124.599 1.16 . . . . 0.0 111.61 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.64 9.43 62.01 Favored Glycine 0 N--CA 1.475 1.296 0 CA-C-N 115.081 -0.963 . . . . 0.0 114.428 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -117.76 124.5 48.59 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.767 0.827 . . . . 0.0 108.866 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.573 HG22 HG22 ' A' ' 43' ' ' VAL . 15.2 t -97.11 127.51 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.534 ' HB2' HD21 ' A' ' 77' ' ' LEU . 79.7 m-85 -127.7 163.71 23.7 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.291 1.036 . . . . 0.0 109.035 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -93.39 160.23 14.9 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.529 0.68 . . . . 0.0 110.066 170.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.8 mm -113.14 -27.77 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.494 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.515 ' HD2' ' HA2' ' A' ' 39' ' ' GLY . 21.0 ptmt -70.26 -48.75 55.45 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.069 0.548 . . . . 0.0 112.252 -173.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.457 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 34.6 t70 -75.04 -36.78 61.85 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -49.81 -55.43 14.17 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.934 1.293 . . . . 0.0 112.217 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -67.65 -27.28 66.74 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.111 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.3 m -68.6 -32.05 71.67 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.296 0.638 . . . . 0.0 110.895 172.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 22.5 mm-40 -76.13 -21.4 56.66 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 121.908 -0.495 . . . . 0.0 111.123 178.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.0 m -68.84 -17.66 64.03 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.124 0.57 . . . . 0.0 111.081 172.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.3 tp -69.71 -25.59 63.93 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.709 0.804 . . . . 0.0 110.709 173.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.7 m -86.15 117.47 25.0 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -67.55 -28.36 67.73 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.404 0.681 . . . . 0.0 111.207 -177.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -88.78 63.43 6.85 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-O 121.924 0.869 . . . . 0.0 108.943 173.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 61.2 m -147.55 153.23 39.2 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.923 1.289 . . . . 0.0 108.304 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.476 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 31.8 pt -61.4 -25.6 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.465 0.706 . . . . 0.0 110.902 170.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 57' ' ' GLN . 58.8 mt -84.31 0.34 49.47 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.368 1.067 . . . . 0.0 112.298 -175.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.91 -29.82 61.09 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.006 0.522 . . . . 0.0 110.744 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 10.6 pt20 -85.43 -6.82 59.18 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.223 0.609 . . . . 0.0 110.846 173.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -108.91 7.97 26.25 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.07 0.948 . . . . 0.0 110.477 174.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.21 126.53 30.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.076 0.55 . . . . 0.0 109.76 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.65 -31.85 8.09 Favored Glycine 0 N--CA 1.474 1.227 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 -173.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -75.28 152.8 38.21 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.948 0.899 . . . . 0.0 109.945 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -56.19 124.47 60.23 Favored Pre-proline 0 N--CA 1.476 0.858 0 C-N-CA 123.927 0.891 . . . . 0.0 109.749 175.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.13 -23.95 52.4 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.979 2.453 . . . . 0.0 113.938 -172.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.2 t -74.6 -47.58 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 176.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.88 -34.0 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.816 0.847 . . . . 0.0 111.085 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.08 -35.74 71.97 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.146 0.979 . . . . 0.0 110.516 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.619 HD12 ' SD ' ' A' ' 90' ' ' MET . 58.8 tp -68.99 -42.6 76.29 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.469 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -65.91 -42.38 90.26 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.604 0.761 . . . . 0.0 110.478 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.96 -37.36 86.77 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.607 0.763 . . . . 0.0 110.328 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.07 -42.47 89.39 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.293 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.4 HD23 ' HG3' ' A' ' 90' ' ' MET . 93.7 mt -67.64 -33.41 74.9 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.88 0.872 . . . . 0.0 111.848 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -89.14 2.55 53.98 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.321 0.649 . . . . 0.0 111.809 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.403 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 30.2 t80 -129.82 125.46 35.78 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.93 0.492 . . . . 0.0 109.821 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -58.23 -38.96 77.85 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.758 1.223 . . . . 0.0 113.73 -169.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -71.46 -30.6 66.21 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.353 0.661 . . . . 0.0 111.473 -176.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.426 HG22 ' HB ' ' A' ' 64' ' ' ILE . 24.6 p -101.67 -7.88 22.28 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.366 0.666 . . . . 0.0 112.67 -173.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.69 1.02 53.47 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 118.305 0.502 . . . . 0.0 111.323 177.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -72.56 -49.66 30.94 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.022 0.929 . . . . 0.0 110.782 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 32.8 t -71.58 -18.86 62.21 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.608 0.763 . . . . 0.0 111.162 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.619 ' SD ' HD12 ' A' ' 77' ' ' LEU . 37.4 mmt -64.79 -21.01 66.69 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.456 0.702 . . . . 0.0 111.979 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -60.39 -34.44 73.9 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.446 0.699 . . . . 0.0 110.895 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.99 -45.71 69.91 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.126 0.57 . . . . 0.0 110.97 176.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.418 ' HD2' ' HA ' ' A' ' 90' ' ' MET . 60.1 m-85 -73.61 -16.21 61.24 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.294 0.638 . . . . 0.0 111.395 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 45.8 t -70.65 87.98 0.69 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.441 0.696 . . . . 0.0 109.608 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.8 m -77.1 -25.55 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.383 -176.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 172.82 177.7 42.33 Favored Glycine 0 C--N 1.343 0.921 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.462 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -98.61 133.93 42.26 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -72.55 129.23 37.82 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 173.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.433 ' HB2' HD22 ' A' ' 25' ' ' LEU . 3.0 tm? -132.59 127.87 35.94 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 43.4 mt-10 -82.33 141.95 46.51 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 123.718 0.807 . . . . 0.0 110.4 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -59.18 -34.6 98.43 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.773 2.315 . . . . 0.0 111.658 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -70.57 -39.75 73.71 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.211 175.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 55.6 tp60 . . . . . 0 N--CA 1.482 1.137 0 C-N-CA 123.285 0.634 . . . . 0.0 111.775 -176.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.0 m . . . . . 0 CA--C 1.541 0.634 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.545 HD13 HD22 ' A' ' 99' ' ' LEU . 92.3 mt -79.98 100.92 8.35 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.504 ' HB ' HG21 ' A' ' 48' ' ' VAL . 58.2 t -94.57 116.98 37.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 55.6 mtm180 -95.76 172.93 7.73 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.191 0.597 . . . . 0.0 110.84 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.493 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 19.9 tt -60.52 -36.65 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 123.757 0.661 . . . . 0.0 111.451 -174.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.39 -45.12 72.81 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.081 0.952 . . . . 0.0 110.761 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.2 -44.98 93.84 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.04 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.4 mt -59.21 -42.7 91.55 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.858 0.863 . . . . 0.0 111.972 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 9.9 mm-40 -63.45 -50.5 69.49 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 123.496 0.497 . . . . 0.0 111.162 -174.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -71.85 -33.96 68.87 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.575 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -72.29 -35.06 68.58 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.852 0.461 . . . . 0.0 110.442 -177.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -66.45 -39.2 88.73 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.915 0.886 . . . . 0.0 110.399 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -61.78 -32.42 72.7 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.72 0.808 . . . . 0.0 111.52 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -66.12 -34.15 77.41 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.916 0.487 . . . . 0.0 111.058 176.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.05 -18.83 7.41 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.789 -175.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.88 89.02 0.23 Allowed Glycine 0 C--N 1.353 1.506 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 174.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -77.46 108.77 10.86 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.171 0.589 . . . . 0.0 109.573 -175.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -105.83 165.65 11.04 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.264 1.026 . . . . 0.0 109.907 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.8 t -143.03 160.29 40.65 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.868 0.867 . . . . 0.0 109.859 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 47' ' ' LYS . 1.5 p -114.49 112.38 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 123.443 0.697 . . . . 0.0 109.468 170.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.737 HD12 HD23 ' A' ' 77' ' ' LEU . 39.9 mt -134.52 136.98 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.749 1.219 . . . . 0.0 107.872 175.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.0 t70 62.85 29.41 16.61 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 124.327 1.051 . . . . 0.0 110.447 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.48 23.24 68.41 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.11 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.409 ' HB2' ' CE1' ' A' ' 49' ' ' TYR . 27.5 mmtp -124.67 153.19 42.68 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.562 1.145 . . . . 0.0 108.671 -176.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.504 HG21 ' HB ' ' A' ' 26' ' ' VAL . 91.7 t -104.07 132.27 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 175.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.409 ' CE1' ' HB2' ' A' ' 47' ' ' LYS . 66.7 m-85 -127.72 153.18 46.82 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.841 0.856 . . . . 0.0 109.908 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -92.42 106.18 18.23 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.527 HD11 HD22 ' A' ' 77' ' ' LEU . 35.8 mm -83.37 -29.6 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.75 0.82 . . . . 0.0 111.533 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.24 -47.56 84.9 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 28.5 t70 -69.37 -40.84 77.22 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.555 177.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -52.84 -55.0 26.25 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.421 1.089 . . . . 0.0 112.055 -177.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -66.44 -28.01 68.27 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.718 0.807 . . . . 0.0 111.583 -176.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.8 m -66.85 -37.06 83.74 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 122.918 0.487 . . . . 0.0 109.827 173.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 49.7 mm-40 -76.51 -24.63 53.73 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.285 0.634 . . . . 0.0 110.711 176.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.3 m -76.84 -19.69 57.22 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.52 0.728 . . . . 0.0 111.252 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.8 tt -74.05 -24.79 59.58 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.617 0.767 . . . . 0.0 110.321 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.7 m -58.8 137.47 57.7 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.904 0.881 . . . . 0.0 112.693 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -54.28 -45.69 72.55 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.016 1.327 . . . . 0.0 112.04 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -118.12 112.04 19.66 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 38.9 t -163.41 158.58 21.29 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.465 ' HB ' HG22 ' A' ' 86' ' ' THR . 35.9 pt -65.22 -24.63 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 166.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.5 mt -91.6 -2.04 57.26 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 124.759 1.224 . . . . 0.0 111.619 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.17 -31.97 68.33 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.938 0.495 . . . . 0.0 110.376 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 9.6 pt20 -76.51 -23.21 53.7 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.993 0.517 . . . . 0.0 110.652 172.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.541 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 29.4 m-85 -96.24 6.82 47.96 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.369 1.068 . . . . 0.0 111.688 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.52 -22.43 63.58 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.316 0.646 . . . . 0.0 112.1 -177.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.44 11.43 71.36 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-O 120.231 -0.205 . . . . 0.0 112.775 177.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -125.84 156.74 39.11 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.411 1.084 . . . . 0.0 109.694 -177.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -55.46 128.67 68.34 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 124.235 1.014 . . . . 0.0 109.354 170.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -59.74 -30.4 91.98 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.923 2.415 . . . . 0.0 113.946 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.9 t -75.18 -39.02 42.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 C-N-CA 122.588 0.355 . . . . 0.0 110.346 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.6 t -69.76 -39.8 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-O 121.49 0.662 . . . . 0.0 110.116 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.541 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -63.56 -34.49 77.93 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.114 1.366 . . . . 0.0 111.135 178.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.737 HD23 HD12 ' A' ' 44' ' ' ILE . 64.8 tp -61.09 -44.07 97.92 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.81 175.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.468 ' HG2' HG21 ' A' ' 44' ' ' ILE . 42.1 mt-10 -64.44 -40.82 96.47 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.77 0.828 . . . . 0.0 111.399 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.3 -38.5 91.38 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.529 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.434 ' HB1' ' SD ' ' A' ' 90' ' ' MET . . . -75.81 -26.13 56.96 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.74 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 79.6 mt -72.13 -39.48 68.78 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.502 0.721 . . . . 0.0 109.95 174.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -67.91 -44.78 76.13 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.114 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -84.76 131.48 34.55 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 120.823 0.344 . . . . 0.0 110.209 -176.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -66.58 -41.33 88.71 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.263 1.025 . . . . 0.0 112.916 -171.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.58 -26.57 65.45 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.14 0.576 . . . . 0.0 111.412 -176.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.465 HG22 ' HB ' ' A' ' 64' ' ' ILE . 28.1 p -91.09 -34.22 15.16 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.21 0.604 . . . . 0.0 111.977 -177.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -66.83 -14.27 62.49 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -171.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -57.75 -36.88 72.7 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.252 0.621 . . . . 0.0 111.09 173.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.2 t -77.12 -35.44 56.27 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.346 0.659 . . . . 0.0 110.451 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.479 ' N ' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -67.95 -21.64 65.08 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.71 0.804 . . . . 0.0 111.2 175.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -67.62 -21.57 65.38 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.35 1.06 . . . . 0.0 110.249 172.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -92.65 -29.95 15.84 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.872 0.869 . . . . 0.0 111.272 172.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -74.95 -23.35 58.3 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 122.962 0.505 . . . . 0.0 111.527 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 27.1 p -69.86 101.05 1.65 Allowed 'General case' 0 C--N 1.354 0.789 0 C-N-CA 122.869 0.468 . . . . 0.0 110.133 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.4 t -67.66 -31.07 50.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 123.91 0.884 . . . . 0.0 110.179 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 172.28 -160.29 31.63 Favored Glycine 0 C--N 1.339 0.721 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.465 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -102.89 133.79 47.38 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 175.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -75.65 131.07 39.68 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 123.273 0.358 . . . . 0.0 110.444 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.545 HD22 HD13 ' A' ' 25' ' ' LEU . 66.5 tp -121.56 134.97 55.03 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 33.4 mt-10 -85.66 137.89 35.93 Favored Pre-proline 0 C--O 1.244 0.815 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 171.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -60.85 -22.53 74.18 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.946 2.43 . . . . 0.0 112.635 175.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -85.1 -37.55 20.14 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.269 1.028 . . . . 0.0 110.853 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.551 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 9.5 tp-100 . . . . . 0 N--CA 1.491 1.615 0 C-N-CA 123.83 0.852 . . . . 0.0 111.277 -173.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.9 p . . . . . 0 CA--C 1.542 0.638 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.2 mt -81.73 117.66 22.23 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.3 t -92.13 125.3 44.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -175.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -67.97 152.7 45.13 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.471 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 18.9 tt -60.63 -44.56 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 117.711 0.232 . . . . 0.0 110.836 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.71 -31.45 69.47 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.457 0.703 . . . . 0.0 110.613 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.5 -37.78 80.39 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.927 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.4 tp -64.9 -51.66 60.71 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.664 0.786 . . . . 0.0 110.205 175.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 58.8 mm-40 -64.17 -53.57 47.3 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.997 0.919 . . . . 0.0 112.473 -171.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -74.55 -29.68 61.46 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -173.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -72.53 -37.49 68.29 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -63.12 -42.76 99.6 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.887 0.875 . . . . 0.0 109.486 174.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -68.6 -26.58 65.44 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.178 1.391 . . . . 0.0 111.671 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -66.53 -35.26 79.81 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.548 0.739 . . . . 0.0 111.538 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 129.64 -26.63 4.28 Favored Glycine 0 N--CA 1.467 0.738 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.24 81.55 0.36 Allowed Glycine 0 C--N 1.351 1.408 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 167.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -74.63 113.69 12.18 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -164.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 33.4 m0 -106.61 171.44 7.36 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.396 1.078 . . . . 0.0 110.548 177.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.8 t -157.66 142.17 16.36 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.335 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -104.03 112.8 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.107 0.563 . . . . 0.0 109.525 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.429 HD13 ' HG2' ' A' ' 78' ' ' GLU . 55.7 mt -127.39 120.18 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.109 0.964 . . . . 0.0 108.942 176.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 62.06 40.08 12.44 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 125.12 1.368 . . . . 0.0 110.691 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.59 15.59 73.33 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.033 -0.985 . . . . 0.0 113.551 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.444 ' HD3' ' HG3' ' A' ' 97' ' ' GLN . 35.6 mmtp -118.65 148.17 43.0 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.086 0.955 . . . . 0.0 109.411 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.9 t -106.1 120.98 57.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.416 ' HB2' HD21 ' A' ' 77' ' ' LEU . 75.6 m-85 -118.08 171.17 8.28 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.972 1.309 . . . . 0.0 108.887 173.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -102.14 159.41 15.41 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.4 0.619 . . . . 0.0 110.39 170.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.1 mm -114.28 -21.4 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 124.437 1.095 . . . . 0.0 109.136 168.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -56.99 6.99 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 122.994 0.517 . . . . 0.0 111.614 -175.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.418 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 23.7 t70 -67.43 -37.12 82.53 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -53.17 -52.21 59.55 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.637 1.575 . . . . 0.0 112.7 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -69.6 -27.13 64.83 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.778 -176.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.8 m -70.27 -34.36 72.7 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-O 121.056 0.455 . . . . 0.0 110.423 174.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 33.3 mm-40 -72.19 -24.27 61.39 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.649 0.78 . . . . 0.0 112.195 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.6 p -77.57 -6.82 55.05 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.34 -2.49 38.39 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.761 0.424 . . . . 0.0 111.134 168.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' A' ' 63' ' ' SER . 19.4 m -77.44 120.24 22.17 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 168.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.476 ' HG3' HD22 ' A' ' 62' ' ' ASN . 9.5 pt-20 -62.5 -36.9 84.01 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.417 0.687 . . . . 0.0 111.801 -178.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.476 HD22 ' HG3' ' A' ' 61' ' ' GLU . 34.5 m-80 -111.24 87.32 2.52 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.513 ' HB3' ' HB ' ' A' ' 60' ' ' THR . 91.9 p -147.13 164.7 32.25 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.994 0.917 . . . . 0.0 109.601 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.557 ' HB ' HG22 ' A' ' 86' ' ' THR . 29.5 pt -68.43 -17.77 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 122.694 0.397 . . . . 0.0 111.019 171.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.6 mt -96.65 -8.87 30.49 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.978 0.911 . . . . 0.0 111.35 -177.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.54 -33.4 74.04 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.469 0.708 . . . . 0.0 110.773 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -76.69 -19.83 57.28 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.663 0.785 . . . . 0.0 111.239 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.499 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 25.5 m-85 -107.38 7.28 29.01 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.128 0.971 . . . . 0.0 111.1 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.26 -38.07 89.16 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.303 0.641 . . . . 0.0 111.539 -175.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -79.18 -8.3 87.91 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.594 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -95.66 155.46 16.73 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.454 0.702 . . . . 0.0 109.437 175.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -49.22 131.16 16.86 Favored Pre-proline 0 N--CA 1.485 1.324 0 C-N-CA 124.432 1.093 . . . . 0.0 110.417 172.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -61.72 -33.41 85.83 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.748 2.299 . . . . 0.0 113.859 -172.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.1 t -74.55 -41.27 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.66 -32.56 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 123.633 0.773 . . . . 0.0 110.373 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.499 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -68.83 -36.72 78.54 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.554 1.142 . . . . 0.0 110.505 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.7 HD12 ' SD ' ' A' ' 90' ' ' MET . 59.0 tp -64.77 -42.74 94.87 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.079 175.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.429 ' HG2' HD13 ' A' ' 44' ' ' ILE . 48.1 mt-10 -63.49 -40.87 98.22 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.44 0.696 . . . . 0.0 111.594 177.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.11 -34.39 77.96 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.669 0.787 . . . . 0.0 110.307 177.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.36 -26.32 51.86 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.324 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 92.0 mt -75.53 -30.92 59.91 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.1 0.56 . . . . 0.0 110.612 172.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -75.0 -45.87 38.99 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.724 -176.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.418 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 35.3 t80 -82.04 137.88 34.98 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 122.579 0.352 . . . . 0.0 110.579 -174.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.11 -37.15 85.04 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.368 1.067 . . . . 0.0 113.493 -169.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -66.04 -44.26 85.14 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.381 0.61 . . . . 0.0 110.624 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.557 HG22 ' HB ' ' A' ' 64' ' ' ILE . 25.5 p -81.89 -28.6 32.83 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.921 -169.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -64.87 -27.1 68.63 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.124 0.569 . . . . 0.0 111.964 -173.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -79.54 -22.77 43.46 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.392 0.677 . . . . 0.0 110.698 -178.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.5 t -80.68 -28.67 36.7 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.59 0.756 . . . . 0.0 110.381 171.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.7 ' SD ' HD12 ' A' ' 77' ' ' LEU . 36.2 mmt -64.45 -16.71 62.91 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.72 0.808 . . . . 0.0 111.889 176.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -57.79 -33.96 69.11 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.772 1.229 . . . . 0.0 111.531 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.6 -37.24 84.47 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.486 0.714 . . . . 0.0 111.254 176.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.471 ' HD2' ' HA ' ' A' ' 90' ' ' MET . 63.6 m-85 -85.66 -13.03 49.83 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.518 0.727 . . . . 0.0 111.326 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.4 t -71.54 92.61 1.14 Allowed 'General case' 0 C--N 1.351 0.66 0 C-N-CA 123.239 0.615 . . . . 0.0 109.605 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.9 m -83.16 -12.53 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.582 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 165.86 -169.46 40.18 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.772 172.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.444 ' HG3' ' HD3' ' A' ' 47' ' ' LYS . 30.6 tt0 -108.84 139.9 43.04 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.411 1.084 . . . . 0.0 108.156 172.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -71.62 136.62 47.45 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.002 0.43 . . . . 0.0 110.439 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -117.15 121.75 42.13 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 171.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.678 ' HB3' ' HB2' ' A' ' 103' ' ' GLN . 33.1 tt0 -73.5 133.16 80.55 Favored Pre-proline 0 CA--C 1.552 1.056 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.25 174.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.408 ' HD3' ' HB ' ' A' ' 28' ' ' ILE . 73.3 Cg_endo -66.58 -13.85 41.59 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.239 2.626 . . . . 0.0 113.762 -170.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -104.19 -18.32 14.54 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.876 0.471 . . . . 0.0 110.626 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.678 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 8.5 tp-100 . . . . . 0 N--CA 1.478 0.963 0 C-N-CA 124.068 0.947 . . . . 0.0 112.748 -170.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.7 m . . . . . 0 CA--C 1.542 0.645 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.547 HD13 HD12 ' A' ' 99' ' ' LEU . 83.1 mt -92.93 103.11 15.47 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.114 0.565 . . . . 0.0 109.558 -178.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.413 ' HB ' HG21 ' A' ' 48' ' ' VAL . 69.0 t -92.97 115.92 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 124.02 0.928 . . . . 0.0 108.618 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -84.26 164.83 18.8 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.01 0.924 . . . . 0.0 108.975 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.521 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 17.2 tt -51.23 -44.99 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.455 0.702 . . . . 0.0 112.412 -176.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.43 -44.2 92.95 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.159 0.584 . . . . 0.0 111.641 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -67.63 -35.11 78.32 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.718 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.8 tp -62.91 -42.56 99.83 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.037 0.535 . . . . 0.0 110.203 176.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 12.0 mm-40 -67.55 -55.36 13.78 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.675 0.79 . . . . 0.0 111.578 -175.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -71.13 -35.35 71.7 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.891 -173.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -70.17 -36.66 74.83 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.544 0.338 . . . . 0.0 110.207 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -56.59 -40.69 75.71 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.691 0.619 . . . . 0.0 110.125 175.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -86.89 -15.72 38.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.285 1.034 . . . . 0.0 111.929 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -67.52 -32.18 72.8 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.633 0.773 . . . . 0.0 110.474 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 142.29 -28.6 2.21 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.467 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.486 ' HA2' ' HZ2' ' A' ' 52' ' ' LYS . . . -83.0 98.03 2.02 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 174.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -73.28 118.26 16.03 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 -173.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.4 m0 -119.38 154.65 33.29 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.882 0.873 . . . . 0.0 111.554 -169.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.5 t -150.88 151.98 33.02 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.892 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 47' ' ' LYS . 1.6 p -97.77 117.94 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 169.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.7 mt -138.37 131.92 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.8 t70 61.39 29.27 18.43 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 122.31 1.052 . . . . 0.0 110.722 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.87 1.59 47.9 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 114.984 -1.007 . . . . 0.0 114.068 -176.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 41.2 mmtm -96.96 172.69 7.7 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.129 0.972 . . . . 0.0 109.145 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.413 HG21 ' HB ' ' A' ' 26' ' ' VAL . 85.0 t -120.38 119.33 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 172.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -112.34 148.92 33.24 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.236 0.615 . . . . 0.0 110.346 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -92.2 98.79 11.74 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 123.055 0.542 . . . . 0.0 109.736 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.1 mm -61.79 -27.72 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 124.941 1.297 . . . . 0.0 112.122 175.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.486 ' HZ2' ' HA2' ' A' ' 39' ' ' GLY . 5.8 ttpm? -59.39 -51.67 68.89 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-O 120.889 0.376 . . . . 0.0 110.325 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 31.4 t70 -67.61 -39.57 84.73 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.652 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.411 ' HA ' ' HE2' ' A' ' 93' ' ' PHE . 54.5 t80 -49.05 -48.29 44.09 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.197 0.999 . . . . 0.0 110.886 174.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.406 ' HA ' ' OG ' ' A' ' 58' ' ' SER . 16.0 mm100 -71.83 -31.21 66.3 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.41 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.0 m -62.47 -37.83 87.48 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-O 121.052 0.453 . . . . 0.0 110.106 172.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.616 ' HB2' HD12 ' A' ' 65' ' ' LEU . 66.3 mm-40 -78.37 -25.96 46.47 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.311 0.644 . . . . 0.0 111.693 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.406 ' OG ' ' HA ' ' A' ' 55' ' ' GLN . 92.7 p -85.79 -8.84 57.86 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.903 -0.498 . . . . 0.0 110.995 174.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.6 tt -75.86 -42.54 49.13 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.007 0.923 . . . . 0.0 109.179 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.2 t -75.64 157.49 33.65 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.054 -176.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -67.87 -73.56 0.14 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.363 1.065 . . . . 0.0 111.06 -171.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -86.2 100.58 12.33 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.58 0.705 . . . . 0.0 109.414 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 48.1 t -155.72 163.94 39.22 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.609 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.612 ' HB ' HG22 ' A' ' 86' ' ' THR . 43.2 pt -67.79 -18.54 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 123.572 0.749 . . . . 0.0 111.48 173.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.616 HD12 ' HB2' ' A' ' 57' ' ' GLN . 82.6 mt -104.33 6.33 35.16 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.761 0.825 . . . . 0.0 112.388 -174.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.54 -27.23 62.1 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.108 0.48 . . . . 0.0 110.13 173.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -80.19 -4.97 55.21 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.917 0.887 . . . . 0.0 111.842 173.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.496 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 64.8 m-85 -117.06 9.28 13.58 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.151 0.98 . . . . 0.0 110.56 177.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.98 103.39 2.24 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.684 0.793 . . . . 0.0 110.722 -177.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.45 -37.21 2.39 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -70.1 147.08 50.41 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.017 0.927 . . . . 0.0 110.345 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -53.1 131.22 50.56 Favored Pre-proline 0 N--CA 1.484 1.234 0 C-N-CA 123.625 0.77 . . . . 0.0 110.558 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -47.23 -45.86 20.99 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 123.921 3.081 . . . . 0.0 114.52 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.83 -44.17 45.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.433 -173.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.6 t -66.4 -37.61 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 123.502 0.721 . . . . 0.0 111.052 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.496 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -67.22 -31.84 72.49 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.612 1.165 . . . . 0.0 111.002 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 tt -72.18 -36.46 69.26 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.024 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.69 -39.26 80.62 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.634 0.374 . . . . 0.0 110.763 175.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.62 -32.44 74.01 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.836 0.855 . . . . 0.0 110.525 174.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.08 -35.13 69.16 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.392 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 66.0 mt -74.84 -24.14 58.55 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.588 0.355 . . . . 0.0 111.242 177.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -74.97 -39.6 61.2 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.064 0.546 . . . . 0.0 109.957 173.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -81.98 114.07 20.3 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.919 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -56.62 -32.57 65.44 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.476 1.11 . . . . 0.0 113.263 -172.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -68.05 -40.95 82.69 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.632 0.773 . . . . 0.0 111.744 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.612 HG22 ' HB ' ' A' ' 64' ' ' ILE . 34.9 p -95.75 -17.98 20.8 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -171.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -71.92 -35.45 69.68 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 122.99 0.516 . . . . 0.0 111.34 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.69 -25.99 64.14 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.023 0.929 . . . . 0.0 111.27 -175.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.8 t -80.92 -17.28 51.06 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.483 0.713 . . . . 0.0 110.862 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.424 ' HE1' HD21 ' A' ' 65' ' ' LEU . 23.8 mmt -72.21 0.49 9.66 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.292 0.637 . . . . 0.0 112.684 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.428 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 9.1 p80 -62.56 -33.36 74.79 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.376 0.67 . . . . 0.0 110.819 171.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.41 -23.26 46.79 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.23 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.421 ' HD1' ' HA ' ' A' ' 90' ' ' MET . 54.4 m-85 -90.55 -25.21 20.34 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.325 0.65 . . . . 0.0 110.933 -178.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.428 ' SG ' ' HA ' ' A' ' 91' ' ' HIS . 28.5 p -79.82 106.99 12.25 Favored 'General case' 0 C--N 1.357 0.922 0 CA-C-O 121.042 0.449 . . . . 0.0 109.896 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.0 t -75.7 -29.22 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.274 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -177.91 -166.64 34.74 Favored Glycine 0 C--N 1.345 1.064 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.425 177.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -98.83 138.68 35.62 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.876 0.87 . . . . 0.0 108.961 170.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -78.95 118.8 21.3 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.569 0.748 . . . . 0.0 110.061 173.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.547 HD12 HD13 ' A' ' 25' ' ' LEU . 2.2 tt -99.55 114.36 27.31 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 170.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -80.92 129.68 66.68 Favored Pre-proline 0 CA--C 1.548 0.902 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -53.0 -33.09 61.02 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 123.518 2.812 . . . . 0.0 113.539 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -65.66 -44.68 85.57 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.79 0.836 . . . . 0.0 110.489 178.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 . . . . . 0 N--CA 1.485 1.304 0 C-N-CA 124.032 0.933 . . . . 0.0 111.081 -179.969 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.1 m . . . . . 0 C--O 1.238 0.493 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.414 HD13 HD12 ' A' ' 99' ' ' LEU . 96.0 mt -78.6 101.28 7.36 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.435 ' HB ' HG21 ' A' ' 48' ' ' VAL . 60.9 t -94.94 136.12 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.683 -177.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -106.45 166.86 10.24 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.732 0.813 . . . . 0.0 109.128 -178.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.7 tt -54.7 -41.53 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.438 1.095 . . . . 0.0 113.447 -171.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.83 -34.73 71.99 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.252 0.221 . . . . 0.0 111.408 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.49 -34.06 76.94 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.257 0.623 . . . . 0.0 110.598 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.5 mt -61.89 -57.06 13.24 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.38 0.672 . . . . 0.0 110.027 174.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -62.14 -40.29 95.45 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 124.208 0.943 . . . . 0.0 111.71 -174.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -72.84 -38.08 67.21 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.682 0.793 . . . . 0.0 111.366 -176.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -73.06 -39.25 66.05 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.886 0.474 . . . . 0.0 109.993 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -67.75 -50.05 59.29 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.595 1.158 . . . . 0.0 110.756 -175.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -69.11 -28.52 66.55 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.652 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -68.68 -23.99 64.46 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.208 0.603 . . . . 0.0 111.223 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 139.64 -26.86 2.63 Favored Glycine 0 C--N 1.355 1.585 0 CA-C-N 116.651 -0.25 . . . . 0.0 113.447 174.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.62 103.57 2.91 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -75.12 108.23 7.73 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 117.659 0.73 . . . . 0.0 109.591 -168.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -107.93 138.55 43.99 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.038 0.935 . . . . 0.0 110.147 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.3 t -145.21 156.13 43.67 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.909 0.884 . . . . 0.0 109.038 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.47 HG22 HG22 ' A' ' 48' ' ' VAL . 88.7 t -108.47 118.31 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.263 0.625 . . . . 0.0 110.169 -177.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.48 HD12 HD22 ' A' ' 77' ' ' LEU . 34.5 mt -126.25 127.51 70.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 174.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.8 t70 63.23 30.71 15.82 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 124.656 1.182 . . . . 0.0 111.156 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.1 1.66 80.58 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.318 -0.856 . . . . 0.0 113.603 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.485 ' HD2' ' SG ' ' A' ' 94' ' ' CYS . 69.9 mmtt -109.09 149.65 29.0 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.925 0.89 . . . . 0.0 109.802 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.47 HG22 HG22 ' A' ' 43' ' ' VAL . 47.9 t -99.5 134.41 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.885 0.874 . . . . 0.0 109.992 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -134.1 157.97 44.8 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.097 0.959 . . . . 0.0 109.573 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -106.61 115.97 31.12 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.3 mm -70.73 -33.68 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.568 1.147 . . . . 0.0 112.027 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -69.03 -44.27 73.05 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.937 0.495 . . . . 0.0 110.392 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -66.58 -40.6 89.01 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.068 0.947 . . . . 0.0 110.103 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -52.47 -49.77 64.02 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.08 1.352 . . . . 0.0 111.199 172.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -71.29 -31.36 67.37 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.686 0.795 . . . . 0.0 112.242 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.5 m -64.33 -35.27 80.33 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.308 174.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -74.89 -28.39 60.62 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.684 0.794 . . . . 0.0 111.258 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.453 ' HA ' ' HB2' ' A' ' 65' ' ' LEU . 15.5 m -68.75 -27.55 66.01 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.166 0.586 . . . . 0.0 111.159 177.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.0 tp -63.2 -27.12 69.14 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.782 0.833 . . . . 0.0 111.162 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.4 m -77.87 132.04 37.78 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 122.833 0.453 . . . . 0.0 110.349 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -75.55 -35.34 60.7 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.395 0.678 . . . . 0.0 112.042 -173.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -80.13 -7.75 59.07 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.844 0.457 . . . . 0.0 111.97 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 74.4 m -75.41 151.52 38.13 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.439 0.696 . . . . 0.0 110.656 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.453 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 15.2 pt -63.39 -23.25 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.842 0.857 . . . . 0.0 112.176 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 82.8 mt -78.51 1.9 20.86 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.811 0.845 . . . . 0.0 112.228 -178.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.71 -33.33 75.63 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.4 0.68 . . . . 0.0 110.77 172.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 9.8 pt20 -77.17 -22.7 52.09 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.019 0.528 . . . . 0.0 110.617 176.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.61 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 46.3 m-85 -97.66 4.53 50.06 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.408 1.083 . . . . 0.0 111.444 -178.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.24 -19.86 60.98 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.174 0.589 . . . . 0.0 111.291 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.65 0.02 73.21 Favored Glycine 0 C--N 1.352 1.421 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.896 174.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -109.75 157.76 18.81 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.335 1.054 . . . . 0.0 109.768 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -57.01 130.86 79.83 Favored Pre-proline 0 CA--C 1.551 0.993 0 CA-C-O 118.177 -0.915 . . . . 0.0 109.265 171.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -45.41 -50.22 9.43 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 124.189 3.259 . . . . 0.0 115.431 -177.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.9 t -74.38 -42.32 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -174.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.3 t -64.96 -29.73 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 123.864 0.865 . . . . 0.0 111.217 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.61 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -71.61 -35.91 70.64 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.693 1.197 . . . . 0.0 110.364 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.48 HD22 HD12 ' A' ' 44' ' ' ILE . 3.7 tt -72.01 -37.74 69.74 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.544 177.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -63.63 -43.54 96.5 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.362 0.665 . . . . 0.0 110.375 175.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.16 -34.87 78.49 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.028 0.931 . . . . 0.0 110.942 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.423 ' HB1' ' SD ' ' A' ' 90' ' ' MET . . . -70.1 -42.44 72.69 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.215 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 72.6 mt -61.62 -46.5 89.54 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.306 0.642 . . . . 0.0 110.46 174.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -61.07 -37.58 83.19 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.314 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -89.64 117.93 28.88 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 121.207 0.527 . . . . 0.0 109.951 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -53.63 -30.32 42.29 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.956 1.702 . . . . 0.0 113.93 -173.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -77.7 -48.34 16.96 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.743 0.417 . . . . 0.0 110.613 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.4 p -84.53 -9.36 58.41 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -169.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -67.04 -16.87 64.63 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 122.731 0.412 . . . . 0.0 111.953 -178.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -23.51 65.85 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.111 0.964 . . . . 0.0 113.205 -176.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.4 ' CB ' HD11 ' A' ' 64' ' ' ILE . 48.0 t -82.01 -32.21 30.68 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 118.089 0.404 . . . . 0.0 110.64 174.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.485 ' N ' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -74.54 -15.57 60.85 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.546 0.738 . . . . 0.0 110.814 177.536 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -57.64 -43.82 85.16 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.917 0.887 . . . . 0.0 109.651 167.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.95 -38.86 66.61 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.335 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -71.65 -16.9 62.27 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 122.596 0.358 . . . . 0.0 111.951 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.485 ' SG ' ' HD2' ' A' ' 47' ' ' LYS . 43.5 t -71.35 83.86 0.78 Allowed 'General case' 0 C--N 1.354 0.761 0 C-N-CA 123.883 0.873 . . . . 0.0 109.537 175.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.62 -32.24 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.397 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -176.37 -175.77 43.99 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.291 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -107.53 137.61 45.24 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.226 1.01 . . . . 0.0 109.113 175.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -74.59 121.23 21.27 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.218 0.607 . . . . 0.0 110.259 173.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.414 HD12 HD13 ' A' ' 25' ' ' LEU . 6.4 tt -100.81 117.48 34.98 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 168.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 103' ' ' GLN . 38.9 tt0 -70.87 129.51 89.58 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.54 0.736 . . . . 0.0 109.626 176.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -57.01 -25.8 65.03 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 123.033 2.489 . . . . 0.0 113.117 -177.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -86.16 -27.91 24.27 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.301 0.64 . . . . 0.0 111.604 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.568 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 56.9 tp60 . . . . . 0 N--CA 1.494 1.731 0 C-N-CA 124.4 1.08 . . . . 0.0 112.35 -175.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.6 m . . . . . 0 N--CA 1.466 0.355 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.445 HD13 HD12 ' A' ' 99' ' ' LEU . 84.0 mt -99.12 103.22 15.11 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 177.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.543 ' HB ' HG21 ' A' ' 48' ' ' VAL . 58.5 t -93.22 117.35 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -176.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.402 HH21 ' HB3' ' A' ' 101' ' ' PRO . 74.9 mtp180 -90.64 164.62 14.1 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.302 0.641 . . . . 0.0 109.906 174.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.46 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 11.8 tt -58.72 -33.62 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.15 0.58 . . . . 0.0 111.604 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.18 -50.29 74.25 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.451 0.7 . . . . 0.0 110.512 176.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -67.0 -33.42 75.53 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.746 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 43.5 tp -61.22 -45.43 94.61 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.995 0.918 . . . . 0.0 110.435 178.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 16.2 mm-40 -62.9 -54.26 41.33 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.032 0.933 . . . . 0.0 110.973 178.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -59.22 -49.22 78.68 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.572 -174.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -69.64 -32.45 71.13 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.047 -175.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -64.23 -47.62 78.97 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.258 177.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 -72.31 -24.11 61.27 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.713 0.805 . . . . 0.0 111.218 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -67.79 -24.62 65.33 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.094 0.958 . . . . 0.0 110.681 174.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 129.94 -27.72 4.03 Favored Glycine 0 C--N 1.344 1.019 0 N-CA-C 112.022 -0.431 . . . . 0.0 112.022 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.24 91.62 1.14 Allowed Glycine 0 C--N 1.341 0.813 0 N-CA-C 111.364 -0.695 . . . . 0.0 111.364 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -74.95 109.92 8.81 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -175.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 47.5 m0 -104.97 172.93 6.53 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.111 0.965 . . . . 0.0 110.188 175.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.9 t -158.9 135.51 9.4 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.265 1.026 . . . . 0.0 108.945 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.529 HG22 HG22 ' A' ' 48' ' ' VAL . 61.7 t -92.95 111.74 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 122.985 0.514 . . . . 0.0 109.891 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.3 mt -123.67 113.08 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 123.974 0.91 . . . . 0.0 109.213 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 63.15 45.23 5.26 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.882 1.273 . . . . 0.0 111.89 172.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.09 7.86 77.57 Favored Glycine 0 N--CA 1.476 1.337 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.545 177.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -118.51 156.13 29.63 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.237 1.015 . . . . 0.0 108.742 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.543 HG21 ' HB ' ' A' ' 26' ' ' VAL . 24.3 t -115.53 116.02 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -111.15 156.61 21.13 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.166 0.986 . . . . 0.0 108.847 174.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -93.34 149.96 20.84 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.233 0.54 . . . . 0.0 110.227 173.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.9 mm -103.91 -22.97 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 124.288 1.035 . . . . 0.0 108.909 167.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.64 -59.42 5.23 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.175 0.99 . . . . 0.0 111.015 -175.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 20.8 t70 -76.38 -30.87 57.7 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.301 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -52.21 -54.77 26.77 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.689 1.196 . . . . 0.0 112.255 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -67.34 -26.86 66.7 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.084 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 51.7 m -67.86 -36.11 79.71 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.509 172.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 22.7 mm-40 -77.39 -25.4 50.82 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.945 0.498 . . . . 0.0 111.994 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.5 p -74.68 -7.23 52.61 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.7 tt -63.46 -40.45 97.15 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.991 0.916 . . . . 0.0 109.134 167.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.578 ' HB ' ' HB3' ' A' ' 63' ' ' SER . 27.1 m -65.51 119.29 10.8 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.532 0.733 . . . . 0.0 109.478 -177.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -74.27 -14.91 60.98 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 120.768 0.318 . . . . 0.0 111.119 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -101.06 10.4 41.06 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.794 0.838 . . . . 0.0 111.189 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.578 ' HB3' ' HB ' ' A' ' 60' ' ' THR . 81.8 p -87.17 162.22 17.62 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.569 ' HB ' HG22 ' A' ' 86' ' ' THR . 45.9 pt -66.9 -22.25 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.067 0.547 . . . . 0.0 110.816 170.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.438 HD21 ' HE1' ' A' ' 90' ' ' MET . 51.8 mt -85.26 -7.76 58.85 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.978 0.911 . . . . 0.0 111.721 -178.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.24 -33.04 74.85 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.492 0.717 . . . . 0.0 111.785 177.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 11.3 pt20 -76.06 -26.39 56.48 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.286 175.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -87.63 -5.39 58.74 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.881 0.872 . . . . 0.0 111.387 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.26 99.14 0.67 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.057 0.543 . . . . 0.0 110.188 176.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 142.86 -29.41 2.1 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -172.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -93.81 153.95 18.01 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.253 1.021 . . . . 0.0 109.765 172.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -57.74 127.76 79.12 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 124.051 0.94 . . . . 0.0 110.231 175.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -46.31 -39.81 21.74 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 123.984 3.123 . . . . 0.0 115.88 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.44 -49.42 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 122.559 0.344 . . . . 0.0 110.355 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.0 t -61.65 -40.87 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.871 0.868 . . . . 0.0 110.503 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.72 -33.46 74.93 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.463 -1.244 . . . . 0.0 111.429 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.421 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 5.1 tt -68.6 -46.7 68.61 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.692 0.797 . . . . 0.0 109.49 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -63.92 -40.98 97.74 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.382 0.673 . . . . 0.0 111.265 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.27 -37.74 88.45 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.613 0.765 . . . . 0.0 110.545 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.03 -22.81 59.42 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.434 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 87.2 mt -74.59 -37.16 62.97 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 120.878 0.371 . . . . 0.0 110.06 173.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -73.04 -26.98 61.49 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.472 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -95.43 121.08 36.73 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 123.123 0.569 . . . . 0.0 109.531 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.1 -35.97 82.49 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.088 0.955 . . . . 0.0 113.032 -172.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.26 -12.81 61.32 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.283 0.633 . . . . 0.0 112.175 -176.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.569 HG22 ' HB ' ' A' ' 64' ' ' ILE . 24.6 p -117.8 -13.9 10.13 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.272 0.629 . . . . 0.0 112.577 -177.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -75.12 -21.23 59.01 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.035 0.445 . . . . 0.0 111.238 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -35.7 80.97 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.768 0.827 . . . . 0.0 112.121 -176.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.7 t -78.3 -22.09 48.72 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.438 ' HE1' HD21 ' A' ' 65' ' ' LEU . 21.3 mmt -71.54 -4.74 28.56 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.29 0.636 . . . . 0.0 111.785 177.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -69.55 -27.83 65.48 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.114 0.565 . . . . 0.0 109.809 169.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.76 -41.08 15.4 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.807 0.843 . . . . 0.0 110.746 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -66.79 -22.97 66.01 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.089 0.556 . . . . 0.0 111.594 177.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 43.8 t -71.13 92.57 0.99 Allowed 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.9 m -69.82 -19.05 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.243 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 171.94 177.59 41.64 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.328 175.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -96.97 138.56 34.31 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 174.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -72.85 145.6 46.82 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.065 0.46 . . . . 0.0 111.105 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.445 HD12 HD13 ' A' ' 25' ' ' LEU . 5.7 tt -136.07 121.81 19.77 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.722 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 23.3 mt-10 -79.53 132.52 61.67 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 123.41 0.684 . . . . 0.0 109.947 175.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.402 ' HB3' HH21 ' A' ' 27' ' ' ARG . 17.7 Cg_endo -57.8 -30.04 87.99 Favored 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 122.305 2.003 . . . . 0.0 112.258 175.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -76.37 -26.58 55.8 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.076 0.95 . . . . 0.0 111.634 177.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.722 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 6.2 tp-100 . . . . . 0 N--CA 1.485 1.291 0 C-N-CA 123.857 0.863 . . . . 0.0 110.343 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.52 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 17.4 m . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 110.517 -0.179 . . . . 0.0 110.517 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.478 HD13 HD22 ' A' ' 99' ' ' LEU . 72.7 mt -83.24 100.01 10.33 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.276 0.56 . . . . 0.0 109.562 177.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.423 HG21 HG23 ' A' ' 95' ' ' VAL . 84.6 t -95.48 116.05 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.164 177.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.477 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 18.4 mtm180 -91.41 172.44 8.52 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.338 0.655 . . . . 0.0 110.143 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.508 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 15.7 tt -61.9 -31.2 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 122.458 0.303 . . . . 0.0 110.552 177.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.38 -52.24 59.94 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.767 0.827 . . . . 0.0 110.804 172.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.419 ' HA ' ' ND2' ' A' ' 33' ' ' ASN . 3.4 m-20 -62.26 -42.22 99.13 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.398 1.079 . . . . 0.0 110.703 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 44.1 tp -59.71 -44.83 93.53 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.969 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 20.4 mm-40 -71.05 -48.97 49.75 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.755 -176.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.419 ' ND2' ' HA ' ' A' ' 30' ' ' ASP . 10.2 p30 -72.08 -33.4 67.89 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.1 0.25 . . . . 0.0 111.33 -174.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -73.82 -35.94 64.92 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.792 0.437 . . . . 0.0 110.189 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -69.47 -34.21 74.03 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.694 0.398 . . . . 0.0 110.429 176.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -73.16 -26.89 61.37 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.072 0.549 . . . . 0.0 110.434 175.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.07 -28.63 68.98 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.457 1.103 . . . . 0.0 110.603 172.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.65 -24.14 6.88 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 -177.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.62 ' HA2' ' HD2' ' A' ' 52' ' ' LYS . . . -70.03 89.97 0.33 Allowed Glycine 0 C--N 1.347 1.144 0 O-C-N 123.895 0.409 . . . . 0.0 112.113 177.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -75.55 107.74 7.9 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -175.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 34.5 m0 -104.31 166.28 10.5 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.247 175.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.1 t -147.67 139.29 23.91 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.175 0.99 . . . . 0.0 108.579 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.468 HG22 HG22 ' A' ' 48' ' ' VAL . 95.8 t -98.18 111.39 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.465 HG21 ' HG2' ' A' ' 78' ' ' GLU . 70.7 mt -140.59 139.14 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.572 1.149 . . . . 0.0 108.28 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.5 t70 63.07 30.85 16.16 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 124.537 1.135 . . . . 0.0 111.177 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.43 15.45 68.18 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.898 -0.592 . . . . 0.0 113.32 -177.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HB2' ' CE1' ' A' ' 49' ' ' TYR . 25.6 mmtp -119.21 176.74 5.17 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.805 1.242 . . . . 0.0 108.283 -178.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.468 HG22 HG22 ' A' ' 43' ' ' VAL . 53.1 t -125.06 115.48 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 171.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.445 ' CE1' ' HB2' ' A' ' 47' ' ' LYS . 85.2 m-85 -108.16 159.41 16.62 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.347 1.059 . . . . 0.0 109.467 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -90.89 160.72 15.55 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 120.958 0.409 . . . . 0.0 110.081 171.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 28.1 mm -120.97 -26.71 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.998 0.919 . . . . 0.0 109.958 173.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.62 ' HD2' ' HA2' ' A' ' 39' ' ' GLY . 19.2 ptmt -67.96 -47.04 69.72 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 122.915 0.486 . . . . 0.0 111.953 -175.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -76.81 -33.27 58.0 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.67 0.388 . . . . 0.0 109.99 177.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -53.05 -50.05 65.11 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.616 1.566 . . . . 0.0 111.849 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -67.8 -28.33 67.49 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.145 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.0 m -73.02 -33.68 65.89 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.052 0.541 . . . . 0.0 110.08 176.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -73.9 -29.34 62.02 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.148 0.979 . . . . 0.0 111.838 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.7 p -73.6 -8.59 56.57 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.936 0.494 . . . . 0.0 112.236 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.0 mt -77.86 -12.38 59.97 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.4 0.68 . . . . 0.0 111.683 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.426 HG22 ' H ' ' A' ' 62' ' ' ASN . 35.4 m -82.32 132.02 35.22 Favored 'General case' 0 C--N 1.361 1.074 0 C-N-CA 122.777 0.431 . . . . 0.0 110.061 178.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -67.77 -30.54 70.02 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.618 0.767 . . . . 0.0 111.528 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.426 ' H ' HG22 ' A' ' 60' ' ' THR . 25.1 t-20 -112.52 74.26 0.85 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -178.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.4 m -150.91 165.05 34.85 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.137 0.975 . . . . 0.0 109.962 178.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.563 HD13 ' HB3' ' A' ' 89' ' ' SER . 9.3 pt -67.1 -25.73 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.194 177.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.461 ' HG ' HG13 ' A' ' 64' ' ' ILE . 71.0 mt -95.21 2.65 54.99 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.863 0.865 . . . . 0.0 111.588 -176.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.41 -34.53 70.42 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.315 0.579 . . . . 0.0 110.422 176.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -72.28 -23.42 61.19 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.395 173.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -100.0 7.34 44.82 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.574 1.15 . . . . 0.0 111.038 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.01 80.21 3.55 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.478 0.711 . . . . 0.0 110.057 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 147.77 -24.14 1.48 Allowed Glycine 0 N--CA 1.471 0.993 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.001 -170.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -84.16 151.91 24.59 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.919 0.888 . . . . 0.0 109.902 175.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -55.69 125.57 61.64 Favored Pre-proline 0 N--CA 1.481 1.125 0 CA-C-O 118.27 -0.871 . . . . 0.0 109.589 174.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.71 -36.83 91.23 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 123.191 2.594 . . . . 0.0 114.86 -175.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.0 t -74.73 -36.22 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.262 0.625 . . . . 0.0 110.314 -177.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.7 t -72.3 -36.91 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.979 0.912 . . . . 0.0 110.622 175.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.26 -29.19 65.92 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.638 1.175 . . . . 0.0 110.572 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.537 HD22 ' SD ' ' A' ' 90' ' ' MET . 1.8 tm? -63.36 -48.85 76.21 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.48 1.112 . . . . 0.0 109.156 173.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.465 ' HG2' HG21 ' A' ' 44' ' ' ILE . 23.2 mt-10 -68.44 -39.72 81.39 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.291 -178.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.98 -34.19 77.42 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.863 0.865 . . . . 0.0 110.453 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.28 -39.65 82.07 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.892 174.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 66.5 mt -67.29 -29.38 68.96 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.366 0.666 . . . . 0.0 112.157 177.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -72.3 -43.42 64.22 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.686 0.795 . . . . 0.0 110.519 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -85.35 114.66 22.59 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -54.66 -33.39 60.64 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.541 1.136 . . . . 0.0 113.077 -172.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -64.79 -52.63 55.85 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.708 0.803 . . . . 0.0 111.115 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.496 HG22 ' HB ' ' A' ' 64' ' ' ILE . 38.5 p -81.23 -13.99 57.95 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.567 -171.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.56 -18.16 57.19 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 120.956 0.408 . . . . 0.0 110.927 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -64.72 -45.29 87.18 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.939 0.896 . . . . 0.0 110.061 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.563 ' HB3' HD13 ' A' ' 64' ' ' ILE . 46.6 t -71.27 -17.6 62.47 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.949 0.899 . . . . 0.0 112.325 -178.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.537 ' SD ' HD22 ' A' ' 77' ' ' LEU . 30.3 mmt -63.49 -15.23 57.25 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.551 0.741 . . . . 0.0 112.123 177.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.476 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 3.3 p80 -57.89 -33.09 68.36 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.681 0.793 . . . . 0.0 111.194 175.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.09 -33.46 70.21 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.103 0.961 . . . . 0.0 111.193 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -90.89 -26.11 19.5 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.494 -174.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.476 ' SG ' ' HA ' ' A' ' 91' ' ' HIS . 26.8 p -76.84 105.4 7.88 Favored 'General case' 0 C--N 1.358 0.971 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.423 HG23 HG21 ' A' ' 26' ' ' VAL . 35.9 m -69.48 -25.46 29.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 123.114 0.565 . . . . 0.0 110.692 174.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.52 ' HA3' ' HB ' ' A' ' 24' ' ' THR . . . 170.07 -165.69 38.99 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.557 174.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -88.58 140.57 29.32 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.18 0.992 . . . . 0.0 109.609 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -77.16 135.82 38.55 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 122.706 0.402 . . . . 0.0 110.782 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.478 HD22 HD13 ' A' ' 25' ' ' LEU . 66.4 tp -121.97 130.84 53.65 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.66 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 37.9 mt-10 -83.37 148.37 55.51 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 171.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.13 -7.28 20.44 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.51 2.14 . . . . 0.0 112.716 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -109.62 -16.93 13.83 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.359 1.064 . . . . 0.0 110.847 178.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.66 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 9.1 tp-100 . . . . . 0 N--CA 1.484 1.271 0 C-N-CA 123.773 0.829 . . . . 0.0 112.355 -172.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.6 p . . . . . 0 CA--C 1.545 0.782 0 CA-C-O 121.109 0.481 . . . . 0.0 111.453 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.3 mt -78.78 106.58 10.88 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.566 0.746 . . . . 0.0 109.521 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.8 t -93.61 121.33 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 123.69 0.796 . . . . 0.0 109.074 -175.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -72.13 151.18 43.19 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.778 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.5 tt -61.3 -39.23 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 120.724 0.297 . . . . 0.0 111.41 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.26 -29.27 70.63 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.922 0.889 . . . . 0.0 111.328 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 34' ' ' HIS . 11.0 t70 -62.54 -47.42 83.96 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.077 0.551 . . . . 0.0 109.789 178.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.0 mp -58.54 -48.36 81.13 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 123.76 0.663 . . . . 0.0 110.28 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -55.04 -44.75 74.96 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 124.375 1.047 . . . . 0.0 111.358 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -73.9 -39.79 63.62 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.755 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 30' ' ' ASP . 1.6 t60 -68.32 -39.15 82.05 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.34 0.656 . . . . 0.0 111.44 -167.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -70.07 -33.01 71.37 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.545 0.338 . . . . 0.0 110.97 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -68.53 -30.46 69.27 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.495 0.718 . . . . 0.0 110.074 178.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -70.3 -33.74 71.91 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.402 0.681 . . . . 0.0 110.429 173.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 134.96 -27.55 3.16 Favored Glycine 0 C--N 1.344 1.019 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.95 87.99 0.97 Allowed Glycine 0 C--N 1.347 1.154 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.418 ' HB3' ' HB ' ' A' ' 51' ' ' ILE . 26.3 t80 -74.8 109.37 8.22 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -171.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 36.6 m0 -105.15 146.83 28.66 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.598 0.759 . . . . 0.0 109.783 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.0 t -144.22 136.95 26.99 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.173 0.589 . . . . 0.0 110.352 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -88.02 112.05 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 121.466 0.651 . . . . 0.0 109.696 174.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.461 HD12 HD23 ' A' ' 77' ' ' LEU . 84.6 mt -132.38 131.18 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.149 1.38 . . . . 0.0 107.794 175.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.2 t70 60.53 29.89 19.35 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-O 121.819 0.818 . . . . 0.0 111.634 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.23 4.33 73.08 Favored Glycine 0 C--N 1.353 1.499 0 CA-C-N 115.565 -0.743 . . . . 0.0 114.01 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.455 ' HD2' ' SG ' ' A' ' 94' ' ' CYS . 71.8 mmtt -111.56 139.3 47.12 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.212 1.005 . . . . 0.0 109.142 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 52.9 t -89.96 123.22 42.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 170.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -110.71 169.76 8.54 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.686 0.795 . . . . 0.0 109.815 177.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -105.03 142.46 34.78 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.706 172.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.418 ' HB ' ' HB3' ' A' ' 40' ' ' PHE . 25.6 mm -112.56 -29.81 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.876 0.87 . . . . 0.0 110.982 -175.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -66.76 -30.73 71.02 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.578 0.627 . . . . 0.0 109.727 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.488 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 37.1 t70 -74.81 -49.59 20.16 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.847 0.859 . . . . 0.0 110.048 172.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.403 ' HA ' ' HE2' ' A' ' 93' ' ' PHE . 48.6 t80 -48.45 -50.93 29.34 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.814 1.246 . . . . 0.0 112.117 -178.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -68.64 -27.92 66.43 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.438 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 89.2 m -70.23 -36.44 74.52 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.284 0.634 . . . . 0.0 110.37 173.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 84.3 mm-40 -73.76 -23.53 59.74 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.695 0.798 . . . . 0.0 112.213 -176.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 64.3 p -75.04 -13.75 60.53 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.5 mp -71.67 -24.81 61.9 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.253 0.621 . . . . 0.0 110.568 173.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.5 m -71.22 121.96 19.35 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 122.638 0.375 . . . . 0.0 110.08 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.62 -37.62 85.24 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.346 0.659 . . . . 0.0 110.958 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -91.14 78.36 5.88 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 175.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.6 t -157.38 158.52 36.07 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.914 0.886 . . . . 0.0 109.299 -178.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.557 ' HB ' HG22 ' A' ' 86' ' ' THR . 38.9 pt -68.07 -23.5 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.832 170.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.6 mt -88.2 -0.34 56.98 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.697 0.799 . . . . 0.0 112.441 -177.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.36 -36.63 81.77 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.061 0.544 . . . . 0.0 110.914 176.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -73.0 -27.3 61.71 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.148 0.579 . . . . 0.0 110.853 175.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -90.62 1.54 56.69 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.822 0.849 . . . . 0.0 111.489 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.65 94.39 0.43 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.07 0.548 . . . . 0.0 110.652 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.64 -27.87 2.69 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.547 -176.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -77.43 151.8 34.58 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.65 0.78 . . . . 0.0 109.882 175.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -56.16 130.15 74.17 Favored Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 123.463 0.705 . . . . 0.0 109.697 173.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.99 -40.92 58.29 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.334 2.69 . . . . 0.0 114.69 -174.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.45 HG13 HD11 ' A' ' 44' ' ' ILE . 65.1 t -73.98 -43.04 52.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 122.959 0.504 . . . . 0.0 110.509 -176.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.8 t -65.4 -39.48 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 123.44 0.696 . . . . 0.0 110.901 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.86 -36.21 82.81 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.556 1.142 . . . . 0.0 110.76 177.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.461 HD23 HD12 ' A' ' 44' ' ' ILE . 31.5 tp -69.44 -38.94 78.04 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.618 178.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -60.74 -48.45 81.73 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.868 0.467 . . . . 0.0 110.249 175.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.78 -32.68 73.88 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.871 0.868 . . . . 0.0 111.242 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.07 -33.35 73.42 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.281 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.6 -38.96 70.8 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.298 0.239 . . . . 0.0 110.619 174.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -66.82 -29.2 69.07 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.293 0.637 . . . . 0.0 111.582 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.407 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 65.4 t80 -98.53 139.22 34.58 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.032 0.444 . . . . 0.0 110.163 177.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -62.07 -54.24 44.15 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.603 1.161 . . . . 0.0 113.945 -170.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.57 -38.37 90.79 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.228 0.611 . . . . 0.0 111.277 -175.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.557 HG22 ' HB ' ' A' ' 64' ' ' ILE . 36.6 p -80.54 -17.67 50.76 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 115.254 -0.884 . . . . 0.0 112.051 -172.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.9 ptt-85 -78.82 -23.17 45.24 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.158 0.504 . . . . 0.0 110.201 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -67.83 -38.03 82.67 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.258 1.023 . . . . 0.0 112.262 -173.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 32.0 t -73.91 -24.17 59.65 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.558 175.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 18.8 mmt -72.19 -7.84 51.45 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -65.23 -33.81 76.88 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.705 0.402 . . . . 0.0 109.955 169.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.05 -37.79 64.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.42 0.688 . . . . 0.0 111.448 175.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.403 ' HE2' ' HA ' ' A' ' 54' ' ' PHE . 90.4 m-85 -73.9 -23.71 59.6 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 122.895 0.478 . . . . 0.0 111.446 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.455 ' SG ' ' HD2' ' A' ' 47' ' ' LYS . 53.1 t -70.09 102.7 2.11 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.251 0.62 . . . . 0.0 109.714 177.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.3 m -73.2 -20.65 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.453 0.701 . . . . 0.0 110.677 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 170.46 -177.67 43.53 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.996 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -85.65 150.61 24.5 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 173.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -77.6 142.58 38.85 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.136 0.574 . . . . 0.0 110.124 173.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -133.76 130.0 37.44 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.839 0.856 . . . . 0.0 108.747 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 43.8 mt-10 -85.99 129.61 53.48 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.489 1.116 . . . . 0.0 109.482 175.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -55.29 -35.21 90.89 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 123.112 2.541 . . . . 0.0 112.752 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -71.47 -36.23 71.1 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.011 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.454 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 51.5 tp60 . . . . . 0 N--CA 1.485 1.31 0 C-N-CA 123.874 0.87 . . . . 0.0 111.393 -175.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.2 m . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.465 HD22 ' HB2' ' A' ' 99' ' ' LEU . 45.9 mt -97.55 119.07 35.45 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.146 0.498 . . . . 0.0 109.95 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.508 HG13 ' HB2' ' A' ' 30' ' ' ASP . 86.3 t -106.69 131.35 56.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -104.06 170.28 8.01 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 173.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.4 tt -58.15 -31.53 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.065 0.546 . . . . 0.0 111.974 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.69 -42.44 83.67 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.545 0.738 . . . . 0.0 111.319 177.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.508 ' HB2' HG13 ' A' ' 26' ' ' VAL . 38.4 m-20 -63.59 -36.27 83.25 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.165 0.586 . . . . 0.0 111.325 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.8 mt -63.88 -51.58 63.91 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 123.904 0.752 . . . . 0.0 109.748 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -59.18 -46.26 88.87 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.555 -1.202 . . . . 0.0 112.262 -172.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -77.08 -30.17 55.3 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 111.479 0.178 . . . . 0.0 111.479 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -73.44 -26.36 60.91 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.745 0.418 . . . . 0.0 110.844 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -61.28 -37.56 83.61 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.745 0.818 . . . . 0.0 110.377 172.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -70.62 -32.97 70.51 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.988 0.915 . . . . 0.0 110.789 174.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -64.56 -33.42 75.87 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.94 0.896 . . . . 0.0 110.819 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 125.46 -27.14 5.32 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 116.434 -0.348 . . . . 0.0 112.271 175.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.09 107.85 2.36 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 175.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -80.27 108.02 13.54 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -99.79 154.8 18.04 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.055 0.942 . . . . 0.0 110.031 176.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.3 t -147.96 164.63 33.18 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.093 0.957 . . . . 0.0 109.093 172.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.527 HG22 HG22 ' A' ' 48' ' ' VAL . 98.2 t -120.68 117.39 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.201 0.601 . . . . 0.0 110.796 -176.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.6 mt -138.77 138.13 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.698 1.199 . . . . 0.0 107.919 174.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.6 t70 63.08 30.64 16.16 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.475 1.11 . . . . 0.0 111.004 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.43 18.08 69.28 Favored Glycine 0 C--N 1.355 1.627 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.539 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.431 ' HD2' ' SG ' ' A' ' 94' ' ' CYS . 75.0 mmtt -124.15 148.75 46.97 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.273 1.029 . . . . 0.0 109.203 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.527 HG22 HG22 ' A' ' 43' ' ' VAL . 39.1 t -100.08 128.94 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.509 0.724 . . . . 0.0 109.212 174.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -122.33 144.9 48.72 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.856 0.862 . . . . 0.0 109.254 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -87.43 104.62 16.62 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 174.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.493 HG23 ' HB2' ' A' ' 73' ' ' PRO . 24.6 mm -62.59 -31.89 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.223 1.009 . . . . 0.0 111.082 174.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.0 ttpp -60.01 -36.97 78.36 Favored 'General case' 0 CA--C 1.554 1.125 0 O-C-N 123.597 0.561 . . . . 0.0 110.291 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.425 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 33.0 t70 -75.3 -42.5 54.52 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.281 0.633 . . . . 0.0 111.209 174.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.409 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 50.5 t80 -51.08 -51.76 50.15 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.704 1.202 . . . . 0.0 111.21 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -67.66 -27.73 67.11 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.837 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 58.8 m -68.34 -38.82 81.87 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.599 0.36 . . . . 0.0 110.773 174.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.464 ' HB2' HD12 ' A' ' 65' ' ' LEU . 78.6 mm-40 -74.39 -27.24 60.55 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.305 0.642 . . . . 0.0 111.345 -177.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.0 p -74.06 -10.42 59.61 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.023 0.529 . . . . 0.0 112.168 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.8 mp -71.32 -17.21 62.46 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 122.974 0.51 . . . . 0.0 111.352 171.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.3 m -88.04 133.44 33.97 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -75.11 -31.9 61.26 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.135 0.493 . . . . 0.0 109.719 173.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -83.49 63.12 7.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.79 0.836 . . . . 0.0 109.664 174.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.8 p -146.49 160.19 42.43 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.547 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.63 ' HB ' HG22 ' A' ' 86' ' ' THR . 40.0 pt -68.03 -22.73 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.688 170.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.464 HD12 ' HB2' ' A' ' 57' ' ' GLN . 44.3 mt -91.49 2.49 56.39 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.186 0.995 . . . . 0.0 112.208 -174.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.38 -33.34 75.32 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.067 0.547 . . . . 0.0 110.989 174.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -75.82 -29.87 58.8 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.679 0.792 . . . . 0.0 110.659 175.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -90.8 1.54 56.83 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.369 1.068 . . . . 0.0 111.688 -178.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.3 -25.87 67.82 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.624 0.77 . . . . 0.0 111.394 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -103.97 30.7 9.72 Favored Glycine 0 C--N 1.35 1.309 0 CA-C-N 116.547 -0.297 . . . . 0.0 112.431 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -139.11 154.49 48.15 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.403 1.081 . . . . 0.0 108.717 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -59.79 131.68 88.92 Favored Pre-proline 0 N--CA 1.48 1.052 0 CA-C-O 118.209 -0.9 . . . . 0.0 109.788 175.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.493 ' HB2' HG23 ' A' ' 51' ' ' ILE . 27.7 Cg_endo -58.29 -36.98 97.14 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 123.208 2.605 . . . . 0.0 114.329 -173.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.1 t -74.67 -45.68 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 122.893 0.477 . . . . 0.0 110.439 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.8 t -66.3 -35.83 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.686 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.81 -34.68 74.02 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.229 1.011 . . . . 0.0 110.627 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.614 HD12 ' SD ' ' A' ' 90' ' ' MET . 51.0 tp -66.15 -38.59 88.49 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.845 0.858 . . . . 0.0 110.486 177.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -58.73 -50.18 74.85 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.78 0.432 . . . . 0.0 110.049 174.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.47 -34.08 76.12 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.956 0.903 . . . . 0.0 111.012 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.73 -28.74 61.86 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.818 0.847 . . . . 0.0 111.506 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 81' ' ' LEU . 2.9 mm? -71.83 -28.99 63.94 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.333 0.253 . . . . 0.0 111.107 172.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -90.45 -25.01 20.56 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.529 0.732 . . . . 0.0 111.728 -174.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.418 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 40.7 t80 -91.57 133.78 35.24 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.653 0.381 . . . . 0.0 110.576 -176.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.14 -36.98 85.41 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.957 1.303 . . . . 0.0 113.96 -168.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -74.23 -27.27 60.7 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.32 0.648 . . . . 0.0 111.309 -176.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.63 HG22 ' HB ' ' A' ' 64' ' ' ILE . 39.4 p -101.53 -31.02 11.07 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.588 -170.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.409 ' HD2' ' N ' ' A' ' 88' ' ' GLU . 6.0 ppt_? -60.12 -32.03 70.61 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 123.794 0.837 . . . . 0.0 112.387 -174.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.409 ' N ' ' HD2' ' A' ' 87' ' ' ARG . 7.8 pt-20 -64.45 -43.4 94.39 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.49 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.0 t -78.43 -16.69 57.33 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.621 0.768 . . . . 0.0 111.632 -176.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.614 ' SD ' HD12 ' A' ' 77' ' ' LEU . 36.1 mmt -61.11 -28.24 68.95 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.282 0.633 . . . . 0.0 111.556 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -64.52 -25.64 68.08 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.673 0.789 . . . . 0.0 111.416 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.46 -25.68 57.62 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.535 0.734 . . . . 0.0 111.454 175.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.409 ' CE1' ' HA ' ' A' ' 54' ' ' PHE . 98.5 m-85 -86.44 -20.65 27.84 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.472 0.709 . . . . 0.0 111.374 176.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.431 ' SG ' ' HD2' ' A' ' 47' ' ' LYS . 47.6 t -67.07 97.88 0.54 Allowed 'General case' 0 C--N 1.351 0.646 0 O-C-N 123.814 0.696 . . . . 0.0 110.749 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.7 m -74.76 -10.58 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.874 0.869 . . . . 0.0 111.42 177.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 169.18 175.68 38.64 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 174.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.407 ' HG2' ' NZ ' ' A' ' 47' ' ' LYS . 15.2 mt-30 -80.53 163.51 23.67 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.362 0.665 . . . . 0.0 109.753 171.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -118.23 146.57 44.16 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.774 0.429 . . . . 0.0 109.891 175.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.465 ' HB2' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -142.43 125.76 16.57 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 174.112 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.7 mp0 -69.8 137.93 87.91 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 123.167 0.587 . . . . 0.0 110.479 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -51.69 -42.55 56.15 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.868 2.378 . . . . 0.0 112.013 169.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -59.23 -52.32 66.2 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.774 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 . . . . . 0 N--CA 1.481 1.087 0 C-N-CA 124.381 1.072 . . . . 0.0 110.97 -178.49 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.3 m . . . . . 0 CA--C 1.542 0.641 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.5 mt -77.22 102.39 6.63 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.539 ' HB ' HG21 ' A' ' 48' ' ' VAL . 94.6 t -93.51 116.74 35.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.042 -177.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.413 ' HD2' ' HB3' ' A' ' 101' ' ' PRO . 71.6 mtm180 -82.34 166.49 19.43 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.223 176.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.0 tt -56.28 -37.69 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.296 0.639 . . . . 0.0 110.609 172.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.61 -47.55 83.97 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.969 0.908 . . . . 0.0 111.212 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.522 ' HA ' ' ND2' ' A' ' 33' ' ' ASN . 53.7 m-20 -67.18 -37.47 83.77 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.83 0.852 . . . . 0.0 110.935 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 36.3 tp -59.13 -45.14 91.71 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.75 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -72.28 -49.69 32.82 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.131 0.973 . . . . 0.0 112.11 -177.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.522 ' ND2' ' HA ' ' A' ' 30' ' ' ASP . 14.2 p30 -70.67 -33.68 71.19 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -170.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.401 ' CE1' ' HA3' ' A' ' 39' ' ' GLY . 43.4 t-80 -73.59 -30.91 63.3 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 120.564 0.221 . . . . 0.0 110.708 178.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -66.99 -38.64 86.38 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 173.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -65.4 -34.12 77.56 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.444 0.698 . . . . 0.0 110.363 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -65.16 -34.17 77.75 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.9 0.88 . . . . 0.0 110.514 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 139.08 -27.19 2.67 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 111.999 -0.44 . . . . 0.0 111.999 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.401 ' HA3' ' CE1' ' A' ' 34' ' ' HIS . . . -81.13 97.74 1.8 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 112.014 -0.434 . . . . 0.0 112.014 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -75.58 113.51 13.08 Favored 'General case' 0 C--N 1.347 0.469 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -98.09 164.5 12.31 Favored 'General case' 0 C--O 1.24 0.591 0 O-C-N 123.863 0.727 . . . . 0.0 109.799 176.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.405 HG21 HD11 ' A' ' 51' ' ' ILE . 15.3 t -147.05 133.9 20.13 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.659 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.541 HG22 HG22 ' A' ' 48' ' ' VAL . 82.2 t -95.95 107.03 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.6 mt -118.25 113.86 43.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 123.938 0.895 . . . . 0.0 108.844 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.3 t70 62.04 32.84 17.48 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.334 1.053 . . . . 0.0 111.272 174.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.99 5.66 85.85 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 115.255 -0.884 . . . . 0.0 114.081 177.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -115.65 150.4 36.8 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.495 0.718 . . . . 0.0 109.341 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.541 HG22 HG22 ' A' ' 43' ' ' VAL . 60.4 t -113.68 121.4 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 123.674 0.79 . . . . 0.0 109.856 -175.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -124.46 155.39 38.98 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.928 0.891 . . . . 0.0 109.175 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.431 ' HB3' ' HB2' ' A' ' 53' ' ' ASP . 7.7 t70 -97.09 120.29 37.17 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.438 ' O ' ' HG3' ' A' ' 55' ' ' GLN . 33.4 mm -73.68 -32.73 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.589 0.756 . . . . 0.0 111.599 -178.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -63.71 -45.99 87.48 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.431 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . 2.1 m-20 -65.51 -36.73 84.69 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.644 175.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -58.69 -51.88 68.06 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.609 0.764 . . . . 0.0 110.499 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.476 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 28.0 mt-30 -63.26 -29.23 70.6 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.889 -174.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.3 m -56.12 -36.75 68.57 Favored 'General case' 0 CA--C 1.553 1.088 0 O-C-N 123.862 0.726 . . . . 0.0 111.73 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -76.67 -30.99 56.99 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.281 0.632 . . . . 0.0 111.701 178.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 62.8 p -81.42 1.35 33.48 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 55' ' ' GLN . 83.1 mt -82.18 9.27 9.0 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.367 0.667 . . . . 0.0 112.33 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.5 t -128.53 165.5 20.63 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.226 0.61 . . . . 0.0 110.736 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -70.95 -60.83 2.02 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.73 0.812 . . . . 0.0 110.484 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -83.05 90.4 7.03 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.276 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.5 t -143.48 149.86 38.15 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.651 -1.158 . . . . 0.0 108.907 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.546 ' HB ' HG22 ' A' ' 86' ' ' THR . 37.2 pt -67.79 -19.94 25.53 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 C-N-CA 122.834 0.454 . . . . 0.0 110.843 171.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 60.1 mt -95.71 -1.76 49.3 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.351 1.06 . . . . 0.0 111.755 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.2 -29.68 69.41 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.947 0.499 . . . . 0.0 111.014 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -71.66 -19.96 62.02 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.786 0.834 . . . . 0.0 111.671 175.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.587 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 78.1 m-85 -99.89 10.72 40.83 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.344 1.058 . . . . 0.0 111.613 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.21 -26.1 68.36 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.309 0.643 . . . . 0.0 112.408 -176.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.57 18.84 53.98 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 116.393 -0.367 . . . . 0.0 113.245 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -132.88 151.11 52.09 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.788 0.835 . . . . 0.0 109.721 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -55.38 128.46 67.38 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 124.488 1.115 . . . . 0.0 109.924 172.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -54.76 -29.44 62.37 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.431 2.754 . . . . 0.0 114.626 -173.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.424 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 34.0 t -74.72 -49.37 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.5 t -68.8 -30.01 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 123.991 0.916 . . . . 0.0 111.017 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -68.74 -40.63 79.74 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.865 1.266 . . . . 0.0 109.895 176.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.527 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 41.4 tp -63.5 -40.85 98.17 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.684 175.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 35.3 mt-10 -58.39 -47.66 83.16 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.283 0.633 . . . . 0.0 111.384 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.99 -35.33 80.86 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.954 175.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.54 -18.1 59.89 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.126 0.97 . . . . 0.0 112.629 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 89.1 mt -77.06 -36.56 55.82 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 173.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -76.21 -21.21 56.69 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.577 175.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -90.84 115.9 28.25 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.842 0.857 . . . . 0.0 110.099 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.75 -23.24 65.22 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.164 0.985 . . . . 0.0 113.366 -173.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.89 -14.49 57.97 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.286 0.634 . . . . 0.0 112.044 -178.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.546 HG22 ' HB ' ' A' ' 64' ' ' ILE . 7.2 p -110.47 -29.78 7.94 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.328 0.651 . . . . 0.0 112.682 -177.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -50.62 -27.39 6.77 Favored 'General case' 0 N--CA 1.507 2.397 0 C-N-CA 124.32 1.048 . . . . 0.0 113.247 -174.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -55.15 -48.54 73.57 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.245 1.418 . . . . 0.0 112.648 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.7 m -76.88 -20.25 56.48 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.116 0.566 . . . . 0.0 111.787 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.552 ' N ' ' SD ' ' A' ' 90' ' ' MET . 0.1 OUTLIER -74.76 -13.27 60.57 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.774 0.829 . . . . 0.0 111.274 176.52 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.448 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 28.4 m170 -75.0 -23.19 58.2 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.061 0.544 . . . . 0.0 110.017 171.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.86 -30.22 23.08 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.56 0.744 . . . . 0.0 110.728 172.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -83.59 -23.91 31.73 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.439 0.296 . . . . 0.0 111.481 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.448 ' SG ' ' HA ' ' A' ' 91' ' ' HIS . 31.0 p -73.42 109.93 7.31 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-O 120.959 0.409 . . . . 0.0 109.98 -177.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.8 t -68.96 -45.89 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.938 172.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 175.0 -150.12 10.89 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.857 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -115.46 137.57 51.92 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.035 1.334 . . . . 0.0 109.044 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -71.14 134.03 46.66 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.132 0.573 . . . . 0.0 110.37 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -143.78 122.89 12.88 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.418 ' HB2' ' CB ' ' A' ' 103' ' ' GLN . 47.1 mt-10 -66.12 133.83 94.76 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.446 0.699 . . . . 0.0 110.687 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.413 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 17.4 Cg_endo -57.48 -25.49 66.76 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 123.263 2.642 . . . . 0.0 113.139 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -79.66 -43.12 23.37 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.388 0.675 . . . . 0.0 110.4 173.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.418 ' CB ' ' HB2' ' A' ' 100' ' ' GLU . 9.6 tt0 . . . . . 0 N--CA 1.483 1.209 0 C-N-CA 123.874 0.87 . . . . 0.0 111.846 -175.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.8 m . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.4 mt -86.86 111.01 20.36 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.6 t -91.19 114.15 28.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.8 ptp85 -70.67 158.05 36.9 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.484 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.45 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 10.1 tt -55.64 -44.68 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 123.352 0.407 . . . . 0.0 111.214 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.9 -33.41 75.26 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.578 0.751 . . . . 0.0 111.496 -177.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -74.55 -40.83 61.44 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.594 0.358 . . . . 0.0 110.105 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 57.2 tp -60.81 -53.25 59.6 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.115 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 51.4 mm-40 -58.88 -51.87 68.18 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.096 0.958 . . . . 0.0 111.827 -177.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -68.51 -41.06 80.51 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -175.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 66.2 t-80 -71.74 -42.66 67.0 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 118.033 0.379 . . . . 0.0 110.631 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -64.08 -51.14 65.47 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.823 0.849 . . . . 0.0 110.883 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -79.44 5.99 11.37 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.795 0.838 . . . . 0.0 111.994 -177.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -91.44 -8.42 47.83 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.884 0.874 . . . . 0.0 110.844 174.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.49 -26.26 12.23 Favored Glycine 0 C--N 1.344 0.987 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -175.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.596 ' HA2' ' HD3' ' A' ' 52' ' ' LYS . . . -75.35 77.73 1.18 Allowed Glycine 0 C--N 1.348 1.249 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 171.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -72.96 117.91 15.27 Favored 'General case' 0 C--N 1.345 0.404 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -163.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 29.0 m0 -110.26 172.0 7.12 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.883 1.273 . . . . 0.0 109.912 175.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.7 t -147.51 149.49 32.74 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.0 175.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 p -109.98 110.01 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.488 HD12 HD23 ' A' ' 77' ' ' LEU . 57.8 mt -124.77 124.0 67.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 124.076 0.95 . . . . 0.0 108.761 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.9 t70 63.0 32.91 15.23 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.483 1.113 . . . . 0.0 111.025 174.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.35 2.35 87.44 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.914 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 97' ' ' GLN . 46.4 mmtm -110.2 147.76 33.13 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.071 0.949 . . . . 0.0 109.261 177.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.8 t -102.43 127.66 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 122.842 0.457 . . . . 0.0 109.922 175.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -121.82 169.49 10.72 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.851 1.261 . . . . 0.0 108.987 175.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -94.64 157.07 16.13 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.65 0.738 . . . . 0.0 109.715 168.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.474 HG23 ' HB2' ' A' ' 73' ' ' PRO . 30.8 mm -121.05 -30.02 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.144 1.378 . . . . 0.0 108.911 172.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.596 ' HD3' ' HA2' ' A' ' 39' ' ' GLY . 35.7 ttpt -54.97 -58.0 9.39 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.86 0.864 . . . . 0.0 111.044 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -74.27 -36.34 63.8 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.149 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -51.95 -55.99 16.93 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.721 1.208 . . . . 0.0 111.846 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -68.33 -26.78 65.78 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.987 -176.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.9 m -66.78 -47.38 72.31 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 172.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -76.75 -13.67 60.01 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.025 0.93 . . . . 0.0 112.844 -176.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.553 ' HA ' ' HB2' ' A' ' 65' ' ' LEU . 90.8 p -67.96 -20.13 65.02 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -91.47 -0.16 57.58 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.612 0.365 . . . . 0.0 111.862 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.8 m -75.23 126.35 30.85 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 175.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -57.31 -48.4 79.05 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.389 1.076 . . . . 0.0 111.888 -170.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -82.59 -12.27 57.82 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.041 0.536 . . . . 0.0 112.431 -173.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 65.8 m -67.61 151.44 47.3 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 120.995 0.426 . . . . 0.0 111.232 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.57 ' HB ' HG22 ' A' ' 86' ' ' THR . 43.5 pt -61.04 -23.61 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.211 1.004 . . . . 0.0 111.468 174.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.553 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 63.1 mt -86.1 0.22 54.02 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.304 1.041 . . . . 0.0 111.961 -175.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.91 -33.24 71.92 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 122.969 0.507 . . . . 0.0 111.007 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -74.67 -25.58 59.27 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.582 0.753 . . . . 0.0 110.565 172.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.552 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 38.2 m-85 -95.99 3.7 53.25 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.317 1.047 . . . . 0.0 111.531 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.47 -29.35 69.45 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.57 0.748 . . . . 0.0 111.011 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.12 23.22 22.12 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.88 176.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -135.06 155.84 50.05 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.316 1.046 . . . . 0.0 108.912 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.84 131.28 78.98 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 124.222 1.009 . . . . 0.0 109.901 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.474 ' HB2' HG23 ' A' ' 51' ' ' ILE . 18.9 Cg_endo -55.4 -33.59 86.2 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 123.484 2.79 . . . . 0.0 114.303 -174.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.8 t -74.51 -46.99 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.4 t -64.1 -35.26 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 123.465 0.706 . . . . 0.0 110.58 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.552 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -67.41 -37.49 83.15 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.065 1.346 . . . . 0.0 110.56 178.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.69 HD12 ' SD ' ' A' ' 90' ' ' MET . 58.3 tp -67.2 -43.4 82.2 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.08 0.952 . . . . 0.0 110.466 176.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -64.6 -37.61 88.16 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.83 0.852 . . . . 0.0 111.2 178.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.29 -33.42 69.7 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.824 0.85 . . . . 0.0 110.473 176.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.49 -23.38 53.78 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.481 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.446 HD23 ' HG3' ' A' ' 90' ' ' MET . 90.1 mt -72.28 -39.96 67.93 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.891 0.476 . . . . 0.0 109.83 170.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -68.65 -43.0 77.16 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.605 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.422 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 5.1 t80 -82.58 124.6 30.29 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -176.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.31 -27.97 69.39 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.712 1.205 . . . . 0.0 112.737 -172.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -71.0 -35.9 72.24 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.471 0.709 . . . . 0.0 110.935 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.57 HG22 ' HB ' ' A' ' 64' ' ' ILE . 30.9 p -94.96 -21.25 18.74 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.534 0.734 . . . . 0.0 112.959 -171.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -66.01 -24.44 66.77 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.452 0.701 . . . . 0.0 112.078 -174.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -66.26 -37.54 85.72 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.724 0.81 . . . . 0.0 111.329 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.5 t -76.7 -24.19 53.15 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.452 0.701 . . . . 0.0 110.943 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.69 ' SD ' HD12 ' A' ' 77' ' ' LEU . 33.1 mmt -63.27 -20.88 65.86 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.737 0.815 . . . . 0.0 111.686 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 27.7 m170 -64.46 -31.78 73.13 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.638 0.775 . . . . 0.0 111.036 176.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.82 -43.84 74.72 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.796 175.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -73.33 -23.82 60.29 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.555 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 35.5 t -74.29 104.32 5.01 Favored 'General case' 0 C--N 1.349 0.581 0 C-N-CA 123.291 0.636 . . . . 0.0 109.346 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.2 m -80.65 -9.43 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 123.302 0.641 . . . . 0.0 110.483 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 156.6 -164.77 32.74 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.577 172.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 43.1 tt0 -99.13 142.5 30.54 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.517 1.127 . . . . 0.0 109.228 171.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -74.57 137.82 42.62 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 122.901 0.481 . . . . 0.0 110.158 172.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -135.23 120.08 18.48 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 44.7 mt-10 -80.78 146.31 59.78 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 123.704 0.802 . . . . 0.0 110.026 174.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.6 -24.84 41.28 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.497 2.131 . . . . 0.0 111.865 -176.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -84.14 -28.35 27.5 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.956 0.902 . . . . 0.0 110.663 175.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 61.0 tp60 . . . . . 0 N--CA 1.479 1.024 0 C-N-CA 123.077 0.551 . . . . 0.0 111.577 -176.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.4 m . . . . . 0 CA--C 1.544 0.747 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.459 HD22 HD23 ' A' ' 99' ' ' LEU . 86.4 mt -81.9 104.2 12.1 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 172.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.9 t -93.84 118.99 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -85.33 165.7 17.06 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.5 tt -57.0 -36.25 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 123.085 0.554 . . . . 0.0 112.244 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.11 -41.57 83.84 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.426 0.69 . . . . 0.0 111.077 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -64.71 -34.4 78.23 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.809 0.844 . . . . 0.0 111.495 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.7 mt -60.76 -47.15 87.63 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 123.545 0.528 . . . . 0.0 109.83 175.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -65.69 -44.75 85.25 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.828 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -62.65 -49.91 73.26 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.988 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -69.26 -35.21 75.85 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.757 0.423 . . . . 0.0 110.232 -174.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -62.99 -42.91 99.97 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.438 0.695 . . . . 0.0 109.766 174.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -67.31 -31.64 72.07 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.892 0.877 . . . . 0.0 111.096 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -72.03 -18.49 61.95 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.348 0.659 . . . . 0.0 111.078 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.93 32.56 3.51 Favored Glycine 0 C--N 1.345 1.049 0 O-C-N 123.144 0.278 . . . . 0.0 112.804 176.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -140.36 104.81 0.42 Allowed Glycine 0 C--N 1.343 0.927 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 177.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -75.6 110.63 10.16 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.769 0.428 . . . . 0.0 110.076 -168.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -100.04 145.38 27.98 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.176 0.99 . . . . 0.0 110.375 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.3 t -140.56 151.51 44.77 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.257 1.023 . . . . 0.0 109.358 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.4 p -102.96 120.35 52.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 172.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.432 HD13 ' HG2' ' A' ' 78' ' ' GLU . 63.6 mt -131.49 123.82 53.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.614 1.166 . . . . 0.0 108.446 176.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.7 t70 62.33 31.81 17.22 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.413 1.085 . . . . 0.0 111.721 175.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.95 7.13 87.56 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-N 115.673 -0.694 . . . . 0.0 113.337 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -110.69 159.54 17.51 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.664 1.186 . . . . 0.0 108.442 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 75.6 t -114.96 139.8 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 122.957 0.503 . . . . 0.0 109.698 174.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -133.92 155.73 49.38 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.324 1.05 . . . . 0.0 110.289 -175.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -102.52 106.91 17.7 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 173.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.533 HG23 ' HB2' ' A' ' 73' ' ' PRO . 30.8 mm -68.02 -34.31 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.636 1.174 . . . . 0.0 112.183 -178.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -59.82 -41.4 91.19 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 123.667 0.604 . . . . 0.0 110.29 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.425 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 33.7 t70 -68.83 -45.53 70.92 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.943 0.897 . . . . 0.0 110.655 177.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.448 ' HA ' ' HE2' ' A' ' 93' ' ' PHE . 77.2 t80 -47.56 -60.57 2.44 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.544 1.138 . . . . 0.0 111.704 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -63.57 -29.81 71.02 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.521 -178.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 96.9 m -69.37 -35.08 75.47 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 122.788 0.435 . . . . 0.0 111.168 178.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 23.2 mm-40 -70.74 -14.35 62.41 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.787 0.435 . . . . 0.0 111.479 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.2 t -84.63 12.37 7.23 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.85 0.86 . . . . 0.0 111.588 174.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -64.75 -28.89 69.89 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.095 0.558 . . . . 0.0 111.365 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.6 m -88.9 133.2 34.37 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.729 0.812 . . . . 0.0 109.646 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -28.11 68.12 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.51 0.724 . . . . 0.0 111.207 178.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -103.72 89.33 3.3 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.94 0.896 . . . . 0.0 108.982 171.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.3 p -147.6 169.55 19.39 Favored 'General case' 0 C--O 1.245 0.838 0 C-N-CA 123.835 0.854 . . . . 0.0 109.241 177.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.655 ' HB ' HG22 ' A' ' 86' ' ' THR . 48.2 pt -68.49 -22.29 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.658 172.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.438 ' HG ' HG13 ' A' ' 64' ' ' ILE . 66.5 mt -101.4 5.51 42.15 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.248 1.019 . . . . 0.0 111.715 -176.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.11 -30.19 71.27 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.261 0.625 . . . . 0.0 110.779 173.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -79.56 -23.84 42.53 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.224 1.01 . . . . 0.0 111.079 174.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.556 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 55.1 m-85 -99.3 0.39 42.91 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.226 1.01 . . . . 0.0 111.801 -177.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.73 -23.28 64.33 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.794 0.838 . . . . 0.0 111.87 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -101.86 24.39 31.53 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 116.61 -0.268 . . . . 0.0 113.063 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -136.12 158.89 43.33 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.034 0.934 . . . . 0.0 109.665 -175.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -56.24 129.74 74.35 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 123.947 0.899 . . . . 0.0 109.728 174.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.533 ' HB2' HG23 ' A' ' 51' ' ' ILE . 37.3 Cg_endo -60.62 -31.49 92.24 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.648 2.232 . . . . 0.0 114.064 -170.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.469 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 37.0 t -75.31 -53.27 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.3 t -61.47 -36.14 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 123.59 0.756 . . . . 0.0 111.308 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.556 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -66.92 -37.09 83.69 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.506 1.122 . . . . 0.0 111.105 178.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.3 tp -68.39 -38.56 81.45 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.881 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 35.9 mt-10 -65.23 -41.64 94.2 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.211 0.604 . . . . 0.0 110.041 177.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.23 -33.42 75.71 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.707 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.12 -34.88 71.5 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.856 0.862 . . . . 0.0 111.643 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.4 mt -67.42 -40.57 85.54 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.144 0.578 . . . . 0.0 110.15 175.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -73.52 -25.0 60.23 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.235 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -79.46 114.39 18.35 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -54.57 -29.61 51.85 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.665 1.586 . . . . 0.0 112.933 -177.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -70.88 -58.45 3.58 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.274 0.63 . . . . 0.0 110.83 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.655 HG22 ' HB ' ' A' ' 64' ' ' ILE . 67.4 p -87.72 -10.81 50.06 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -166.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -65.8 -31.99 73.26 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.103 0.561 . . . . 0.0 111.907 -172.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -29.39 64.27 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.516 -173.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.6 t -74.93 -23.87 58.4 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.581 0.752 . . . . 0.0 110.995 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.43 ' HA ' ' HD1' ' A' ' 93' ' ' PHE . 21.8 mmt -73.91 0.35 13.68 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.833 0.853 . . . . 0.0 112.669 -177.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -63.83 -31.13 72.2 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.616 0.766 . . . . 0.0 110.778 170.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.06 -31.08 39.45 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.17 0.988 . . . . 0.0 111.052 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.448 ' HE2' ' HA ' ' A' ' 54' ' ' PHE . 60.2 m-85 -81.27 -24.83 37.03 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.527 0.731 . . . . 0.0 110.685 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.1 t -78.31 108.65 11.79 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 123.437 0.695 . . . . 0.0 109.341 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.3 p -79.28 -19.55 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.495 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 155.35 -156.53 27.03 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 116.387 -0.369 . . . . 0.0 112.391 176.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.431 ' HB2' HD23 ' A' ' 25' ' ' LEU . 16.6 mm100 -78.58 164.77 24.39 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.778 1.231 . . . . 0.0 111.306 174.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -109.62 143.33 39.49 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 162.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.459 HD23 HD22 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -137.64 123.95 20.6 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.17 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.63 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 1.7 mp0 -73.24 143.3 83.09 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 123.212 0.605 . . . . 0.0 110.397 178.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -58.82 -32.5 97.31 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.918 2.412 . . . . 0.0 112.739 175.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -82.78 -29.13 29.86 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.082 0.553 . . . . 0.0 110.446 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.63 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 55.9 tp60 . . . . . 0 N--CA 1.484 1.257 0 C-N-CA 123.333 0.653 . . . . 0.0 110.903 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.4 m . . . . . 0 CA--C 1.545 0.771 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.517 HD13 HD22 ' A' ' 99' ' ' LEU . 85.8 mt -83.31 106.07 14.78 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.417 ' HB ' HG21 ' A' ' 48' ' ' VAL . 59.7 t -94.31 124.76 46.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 124.216 1.006 . . . . 0.0 110.164 -170.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.551 ' HB2' ' HB2' ' A' ' 30' ' ' ASP . 54.0 mtm180 -73.25 164.23 26.97 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.909 1.283 . . . . 0.0 110.521 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.5 tt -66.87 -42.61 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 118.203 0.456 . . . . 0.0 111.598 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.35 -29.45 68.18 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.763 177.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.551 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 23.3 t0 -59.28 -38.64 80.67 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.596 1.159 . . . . 0.0 110.944 -175.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.8 mp -57.46 -48.35 79.4 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 123.844 0.715 . . . . 0.0 110.727 173.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -67.92 -42.47 81.02 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.284 1.033 . . . . 0.0 111.479 -172.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -71.76 -40.35 69.37 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.374 0.67 . . . . 0.0 111.109 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -66.79 -33.39 75.52 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 176.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -64.52 -44.29 91.34 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.237 1.015 . . . . 0.0 111.029 175.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -64.59 -31.56 72.83 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.432 0.693 . . . . 0.0 110.521 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -66.93 -34.69 78.32 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.048 0.939 . . . . 0.0 110.846 176.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 128.19 25.43 1.08 Allowed Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.028 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -134.59 100.4 0.37 Allowed Glycine 0 C--N 1.344 0.997 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -178.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -75.1 107.57 7.27 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -170.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 25.7 m0 -103.22 131.71 50.05 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.742 0.817 . . . . 0.0 109.852 177.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -127.78 144.81 51.07 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.818 1.247 . . . . 0.0 109.106 177.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 p -96.28 112.35 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 120.976 0.417 . . . . 0.0 110.197 176.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.4 mt -122.26 118.62 55.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 123.81 0.844 . . . . 0.0 109.113 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.2 t70 62.57 32.84 16.26 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.832 1.253 . . . . 0.0 112.577 172.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.02 7.29 85.64 Favored Glycine 0 N--CA 1.477 1.408 0 CA-C-N 116.073 -0.512 . . . . 0.0 113.635 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.418 ' HB2' ' CE1' ' A' ' 49' ' ' TYR . 32.4 mmtp -117.87 161.78 19.19 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.269 1.027 . . . . 0.0 108.853 176.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.417 HG21 ' HB ' ' A' ' 26' ' ' VAL . 96.4 t -113.54 124.41 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 174.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.418 ' CE1' ' HB2' ' A' ' 47' ' ' LYS . 76.9 m-85 -117.79 156.25 28.65 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.34 1.056 . . . . 0.0 109.366 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -98.79 147.1 25.24 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 173.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.4 ' O ' ' HB3' ' A' ' 54' ' ' PHE . 24.5 mm -109.46 -33.6 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.305 1.042 . . . . 0.0 111.402 -172.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.1 -29.29 62.82 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 118.566 0.621 . . . . 0.0 110.081 176.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -70.9 -39.15 72.95 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.118 0.967 . . . . 0.0 110.712 172.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.4 ' HB3' ' O ' ' A' ' 51' ' ' ILE . 13.0 t80 -54.1 -54.51 38.51 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.935 0.894 . . . . 0.0 109.852 171.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -66.86 -28.55 68.43 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.952 0.901 . . . . 0.0 112.398 -173.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.4 m -58.25 -47.75 82.58 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.136 0.493 . . . . 0.0 110.195 171.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -77.31 -18.18 57.72 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.578 0.751 . . . . 0.0 111.523 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.492 ' HA ' ' HB2' ' A' ' 65' ' ' LEU . 25.9 t -75.6 -22.36 56.96 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.688 0.395 . . . . 0.0 111.031 177.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.8 mt -83.81 7.65 17.26 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.025 0.53 . . . . 0.0 110.986 172.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.9 m -105.97 134.36 49.21 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.892 0.877 . . . . 0.0 109.657 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -75.26 -40.33 58.94 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.717 0.807 . . . . 0.0 112.715 -173.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -82.15 0.77 39.38 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.293 0.637 . . . . 0.0 111.944 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.9 m -81.33 151.08 28.18 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 122.679 0.392 . . . . 0.0 109.996 170.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.533 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 24.5 pt -55.3 -30.61 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.577 0.751 . . . . 0.0 110.986 170.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 49.5 mt -73.88 -0.93 17.52 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.261 1.024 . . . . 0.0 113.049 -173.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.48 -41.26 96.58 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.649 0.78 . . . . 0.0 110.905 171.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.533 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 8.2 pt20 -76.65 -20.79 56.29 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.16 0.584 . . . . 0.0 110.937 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.458 ' HD2' ' HA ' ' A' ' 65' ' ' LEU . 75.5 m-85 -92.51 2.62 56.58 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.03 0.932 . . . . 0.0 111.33 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.39 111.83 4.88 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.153 0.581 . . . . 0.0 110.349 177.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.61 -29.33 7.93 Favored Glycine 0 N--CA 1.474 1.232 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 -175.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -79.92 151.62 30.01 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.618 0.767 . . . . 0.0 109.299 173.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.543 ' HB3' HG12 ' A' ' 75' ' ' VAL . 26.3 t70 -59.32 126.74 82.93 Favored Pre-proline 0 N--CA 1.483 1.182 0 CA-C-O 118.908 -0.568 . . . . 0.0 110.154 -178.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.07 -34.8 88.62 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 123.319 2.68 . . . . 0.0 114.11 -174.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.462 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 60.2 t -73.63 -49.66 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.182 -178.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.543 HG12 ' HB3' ' A' ' 72' ' ' ASP . 3.8 p -68.43 -28.59 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 122.791 0.436 . . . . 0.0 111.126 -177.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.06 -36.56 75.06 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.059 0.943 . . . . 0.0 109.767 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.648 ' HG ' ' SD ' ' A' ' 90' ' ' MET . 4.4 tt -71.81 -37.98 70.28 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.178 0.991 . . . . 0.0 110.029 176.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 44.3 mt-10 -64.34 -49.29 72.29 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.094 0.958 . . . . 0.0 110.87 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.03 -29.55 69.39 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.812 0.845 . . . . 0.0 111.019 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.62 -35.03 72.74 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.904 177.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.0 mt -63.34 -35.53 80.69 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.742 0.417 . . . . 0.0 110.771 175.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -67.07 -47.73 70.38 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.388 175.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.462 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 23.1 t80 -81.87 119.82 24.41 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 121.205 0.526 . . . . 0.0 110.936 -173.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -53.99 -34.21 59.21 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.785 1.634 . . . . 0.0 114.682 -171.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -79.87 -33.73 39.81 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.934 0.494 . . . . 0.0 111.735 -177.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.462 ' OG1' ' HB3' ' A' ' 83' ' ' PHE . 25.3 p -93.33 -13.53 28.02 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.393 0.677 . . . . 0.0 112.805 -173.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -73.82 -20.02 60.58 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 122.779 0.432 . . . . 0.0 110.385 178.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -63.74 -38.12 89.93 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.358 1.063 . . . . 0.0 111.314 -175.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.402 ' HB3' HD11 ' A' ' 64' ' ' ILE . 22.6 t -77.4 -31.4 54.11 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.009 0.524 . . . . 0.0 110.389 177.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.648 ' SD ' ' HG ' ' A' ' 77' ' ' LEU . 15.7 mmt -70.46 -21.84 62.75 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.221 0.608 . . . . 0.0 111.149 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -60.74 -35.6 76.78 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.656 0.782 . . . . 0.0 109.724 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.2 -38.57 42.99 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.615 0.766 . . . . 0.0 111.06 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.516 ' HD2' ' SD ' ' A' ' 90' ' ' MET . 29.8 m-85 -72.16 -14.39 61.8 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 122.761 0.425 . . . . 0.0 111.886 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 49.2 t -68.89 83.19 0.31 Allowed 'General case' 0 C--N 1.36 1.031 0 C-N-CA 123.397 0.679 . . . . 0.0 109.593 175.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.3 m -73.51 -16.39 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.12 0.968 . . . . 0.0 111.754 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.29 -175.58 41.16 Favored Glycine 0 C--N 1.343 0.972 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.146 174.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -119.1 134.42 55.21 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -76.37 143.02 40.97 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.213 0.605 . . . . 0.0 111.755 -171.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.517 HD22 HD13 ' A' ' 25' ' ' LEU . 54.8 tp -140.78 128.92 22.17 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.507 1.123 . . . . 0.0 108.243 176.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.663 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 46.9 mt-10 -91.89 140.84 24.96 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 123.732 0.813 . . . . 0.0 110.657 -178.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.81 -26.45 67.7 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 123.188 2.592 . . . . 0.0 112.434 173.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -78.97 -24.58 43.76 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.121 0.568 . . . . 0.0 110.485 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.663 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 47.3 tp60 . . . . . 0 N--CA 1.479 0.995 0 C-N-CA 123.674 0.79 . . . . 0.0 111.036 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.6 m . . . . . 0 CA--C 1.539 0.552 0 N-CA-C 110.718 -0.105 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.5 mt -77.94 103.24 7.76 Favored 'General case' 0 C--N 1.347 0.466 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 174.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.459 ' HB ' HG21 ' A' ' 48' ' ' VAL . 44.6 t -98.47 139.16 21.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.052 0.941 . . . . 0.0 108.989 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.569 ' HD3' ' H ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -112.43 162.05 16.02 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.987 0.915 . . . . 0.0 109.31 178.743 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.5 tt -56.31 -38.1 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 C-N-CA 123.412 0.685 . . . . 0.0 111.93 -176.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.03 -37.47 79.89 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.543 0.737 . . . . 0.0 111.196 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -70.93 -34.67 71.72 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.105 -178.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.493 HD21 HG23 ' A' ' 43' ' ' VAL . 8.3 mp -59.99 -46.65 88.77 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 122.665 0.386 . . . . 0.0 110.707 171.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -64.27 -42.76 96.31 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.296 1.038 . . . . 0.0 112.224 -173.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -69.7 -41.22 75.7 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.95 177.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -66.96 -28.46 68.29 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.209 0.603 . . . . 0.0 110.95 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -65.11 -49.84 68.41 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.912 0.885 . . . . 0.0 110.049 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -75.08 -14.94 60.63 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.599 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -68.33 -34.31 75.88 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.555 0.742 . . . . 0.0 110.184 170.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 119.95 36.68 0.81 Allowed Glycine 0 C--N 1.348 1.226 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.27 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.53 107.66 0.36 Allowed Glycine 0 C--N 1.342 0.909 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -75.05 125.01 28.02 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -174.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 9.5 m0 -115.72 151.83 34.36 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.216 1.006 . . . . 0.0 110.183 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.6 t -143.13 164.69 29.45 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.559 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.504 HG22 HG22 ' A' ' 48' ' ' VAL . 72.1 t -116.82 111.43 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 176.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.432 HG13 ' HG ' ' A' ' 77' ' ' LEU . 14.8 mm -108.49 103.79 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 175.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.2 t70 60.21 41.81 16.21 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 124.472 1.109 . . . . 0.0 112.298 171.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.63 12.31 75.41 Favored Glycine 0 N--CA 1.475 1.28 0 CA-C-N 116.09 -0.505 . . . . 0.0 113.87 175.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -124.2 144.2 50.08 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.853 0.861 . . . . 0.0 108.84 172.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.504 HG22 HG22 ' A' ' 43' ' ' VAL . 45.0 t -99.09 137.23 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 122.967 0.507 . . . . 0.0 109.761 178.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -127.74 154.95 44.76 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.532 1.133 . . . . 0.0 110.327 -175.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -96.52 101.68 13.34 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.7 mm -64.09 -33.09 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 124.1 0.96 . . . . 0.0 111.901 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -64.19 -43.66 94.41 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.431 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 24.6 t70 -66.94 -40.05 87.48 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.86 0.864 . . . . 0.0 110.211 177.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -55.85 -55.24 34.8 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.809 1.244 . . . . 0.0 111.613 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -69.82 -26.2 64.13 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.506 0.722 . . . . 0.0 111.23 -177.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.7 m -62.87 -41.82 99.52 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 122.717 0.407 . . . . 0.0 111.023 171.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 31.0 mm-40 -70.22 -26.8 64.03 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.133 0.573 . . . . 0.0 110.76 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.3 t -77.86 10.64 2.65 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.961 0.904 . . . . 0.0 111.501 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 45.2 tp -67.59 -39.65 84.8 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.273 0.629 . . . . 0.0 110.779 171.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.2 t -99.7 146.98 25.9 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.158 0.583 . . . . 0.0 111.829 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.38 -19.41 53.4 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.764 175.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -63.73 -28.05 69.62 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 123.435 0.694 . . . . 0.0 110.182 175.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.3 t -66.96 152.24 46.12 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.462 0.705 . . . . 0.0 110.46 175.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.549 ' HB ' HG22 ' A' ' 86' ' ' THR . 26.4 pt -63.24 -17.76 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.475 1.11 . . . . 0.0 111.612 172.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.9 mt -85.19 9.58 14.67 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.64 1.176 . . . . 0.0 111.657 -178.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.57 -40.51 97.16 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.117 0.967 . . . . 0.0 111.24 174.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -73.77 -13.61 60.98 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.323 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.551 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 28.7 m-85 -110.13 4.91 21.56 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.567 1.147 . . . . 0.0 111.888 -176.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.74 -36.83 85.56 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.765 0.826 . . . . 0.0 112.589 -172.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -101.16 6.7 56.43 Favored Glycine 0 N--CA 1.479 1.53 0 CA-C-N 116.405 -0.361 . . . . 0.0 113.027 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -98.52 152.54 19.45 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.336 1.054 . . . . 0.0 109.065 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -54.12 124.88 47.61 Favored Pre-proline 0 N--CA 1.48 1.038 0 CA-C-O 118.354 -0.831 . . . . 0.0 109.08 172.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -57.5 -31.03 90.34 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.136 2.557 . . . . 0.0 114.03 -170.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 67.5 t -74.43 -48.55 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 122.868 0.467 . . . . 0.0 110.211 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.71 -38.15 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 123.504 0.722 . . . . 0.0 110.564 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.551 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -63.14 -40.89 98.89 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 114.074 -1.421 . . . . 0.0 110.944 177.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.432 ' HG ' HG13 ' A' ' 44' ' ' ILE . 37.1 tp -71.38 -36.82 71.56 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.027 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 82' ' ' GLN . 48.4 mt-10 -60.92 -47.07 88.1 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.866 0.466 . . . . 0.0 110.085 174.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.19 -32.11 73.63 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.843 0.857 . . . . 0.0 111.046 177.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.49 -28.57 64.01 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.477 0.711 . . . . 0.0 111.752 178.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.535 ' HA ' ' HB3' ' A' ' 87' ' ' ARG . 3.8 mm? -75.26 -28.34 59.79 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.267 0.227 . . . . 0.0 111.008 173.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 71.5 mt-30 -78.24 -41.22 34.86 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.979 0.512 . . . . 0.0 110.579 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -79.71 123.36 27.6 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -59.91 -41.35 91.49 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.044 0.937 . . . . 0.0 113.135 -169.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -68.18 -36.31 79.4 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.893 0.477 . . . . 0.0 111.572 -175.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.549 HG22 ' HB ' ' A' ' 64' ' ' ILE . 12.8 p -81.64 -30.46 32.79 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.133 -175.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.535 ' HB3' ' HA ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -74.96 -12.66 60.39 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.403 ' HG2' HH11 ' A' ' 87' ' ' ARG . 30.4 mt-10 -67.2 -35.88 80.56 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.237 0.615 . . . . 0.0 110.319 175.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.8 t -77.86 -29.91 50.63 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.428 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 14.9 mmt -70.95 -9.7 58.36 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.628 0.771 . . . . 0.0 112.104 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -62.07 -30.92 71.32 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.936 0.894 . . . . 0.0 110.662 171.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.17 -35.98 25.07 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.463 0.705 . . . . 0.0 111.466 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -75.03 -23.16 58.13 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.245 0.618 . . . . 0.0 111.762 -173.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 25.9 p -71.48 99.44 2.02 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.4 m -69.47 -30.06 44.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 123.902 0.881 . . . . 0.0 111.502 -177.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.14 179.94 44.23 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.005 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -91.03 136.47 33.05 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.55 0.74 . . . . 0.0 109.094 176.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -82.45 142.84 31.58 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 174.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.0 tt -136.27 112.81 10.03 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 170.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.558 ' HB3' ' HB2' ' A' ' 103' ' ' GLN . 26.0 tt0 -72.65 141.96 83.11 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.571 0.748 . . . . 0.0 109.96 -177.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -42.21 -60.86 0.61 Allowed 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 123.598 2.865 . . . . 0.0 114.113 176.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -81.88 -8.18 59.66 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.822 0.849 . . . . 0.0 112.377 -172.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.558 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 54.4 tp60 . . . . . 0 N--CA 1.495 1.796 0 C-N-CA 123.845 0.858 . . . . 0.0 110.898 175.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.5 m . . . . . 0 CA--C 1.542 0.662 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.506 HD13 HD22 ' A' ' 99' ' ' LEU . 92.6 mt -86.93 111.95 21.32 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.512 -178.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.504 ' HB ' HG21 ' A' ' 48' ' ' VAL . 48.4 t -94.72 125.82 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 174.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -92.32 167.62 11.88 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.29 0.636 . . . . 0.0 111.123 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.0 tt -67.65 -34.2 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.194 -177.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.95 -33.5 71.99 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.41 0.684 . . . . 0.0 110.589 177.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.08 -44.43 63.29 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.144 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.1 mt -57.35 -52.8 63.89 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.883 0.873 . . . . 0.0 112.03 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -63.89 -48.94 74.67 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.901 0.88 . . . . 0.0 111.789 -173.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -63.53 -34.32 77.53 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.062 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 50.7 t60 -73.4 -34.6 65.59 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.312 0.645 . . . . 0.0 110.721 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -60.64 -40.5 92.23 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.207 1.003 . . . . 0.0 110.107 176.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -69.7 -26.43 64.35 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.117 0.967 . . . . 0.0 111.409 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -70.14 -19.91 63.19 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.004 0.522 . . . . 0.0 111.518 174.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 114.88 -21.47 13.65 Favored Glycine 0 C--N 1.341 0.83 0 N-CA-C 111.796 -0.521 . . . . 0.0 111.796 -175.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.51 ' HA2' ' HG2' ' A' ' 52' ' ' LYS . . . -73.65 92.23 0.69 Allowed Glycine 0 C--N 1.345 1.048 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -78.33 110.95 13.82 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 38.9 m0 -105.23 174.09 6.03 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.198 0.999 . . . . 0.0 109.399 170.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.4 t -151.13 162.92 39.96 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.811 0.844 . . . . 0.0 108.862 172.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.492 HG22 HG22 ' A' ' 48' ' ' VAL . 73.8 t -119.79 113.52 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.296 0.638 . . . . 0.0 109.338 175.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.683 HD12 HD23 ' A' ' 77' ' ' LEU . 51.3 mt -135.79 133.48 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 176.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.1 t70 63.07 30.33 16.21 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 125.048 1.339 . . . . 0.0 110.477 -175.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.13 26.49 67.64 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.729 -175.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.453 ' HB2' ' CE2' ' A' ' 49' ' ' TYR . 44.3 mmtm -121.16 134.1 55.21 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.681 0.792 . . . . 0.0 108.891 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.504 HG21 ' HB ' ' A' ' 26' ' ' VAL . 93.1 t -84.66 111.15 19.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 174.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.453 ' CE2' ' HB2' ' A' ' 47' ' ' LYS . 85.0 m-85 -108.46 150.17 27.78 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.674 0.79 . . . . 0.0 110.351 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -88.12 138.98 30.97 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.836 175.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.538 HD11 HD22 ' A' ' 77' ' ' LEU . 33.6 mm -116.32 -40.18 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.552 0.741 . . . . 0.0 111.513 -174.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.51 ' HG2' ' HA2' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -69.25 -32.33 71.47 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.299 0.24 . . . . 0.0 111.02 -179.245 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.432 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 33.6 t70 -76.03 -37.85 57.9 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.252 0.621 . . . . 0.0 110.687 172.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -55.34 -48.48 74.14 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.18 0.992 . . . . 0.0 111.527 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -69.83 -27.25 64.71 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.794 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.3 m -66.74 -38.19 86.16 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.95 0.5 . . . . 0.0 110.04 172.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.501 ' HB2' HD12 ' A' ' 65' ' ' LEU . 52.7 mm-40 -76.49 -15.3 59.93 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.09 0.556 . . . . 0.0 110.892 176.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.5 t -90.67 -9.9 45.15 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.008 0.923 . . . . 0.0 111.199 175.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.4 tp -83.05 -5.87 59.27 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.843 0.857 . . . . 0.0 111.489 -178.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.0 t -119.54 152.67 36.6 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.611 0.764 . . . . 0.0 110.848 -174.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -73.89 -51.09 17.31 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.69 1.196 . . . . 0.0 111.362 -174.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -78.21 72.47 4.74 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.592 0.71 . . . . 0.0 109.589 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.2 m -163.16 147.59 11.17 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.884 1.273 . . . . 0.0 108.726 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.622 ' HB ' HG22 ' A' ' 86' ' ' THR . 33.2 pt -67.26 -19.91 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 124.274 1.03 . . . . 0.0 111.558 175.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.501 HD12 ' HB2' ' A' ' 57' ' ' GLN . 65.6 mt -92.53 7.99 40.81 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.001 0.92 . . . . 0.0 111.669 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.51 -23.52 64.55 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.562 0.345 . . . . 0.0 110.772 175.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -75.52 -11.87 60.11 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.606 0.763 . . . . 0.0 111.408 172.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -112.97 20.88 15.98 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.024 0.93 . . . . 0.0 110.953 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.36 -26.03 68.57 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.675 0.79 . . . . 0.0 112.752 -174.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -111.87 5.27 27.45 Favored Glycine 0 N--CA 1.478 1.481 0 C-N-CA 122.753 0.216 . . . . 0.0 113.137 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -96.03 151.07 19.79 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.075 0.95 . . . . 0.0 109.961 -177.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -63.39 127.1 90.73 Favored Pre-proline 0 N--CA 1.48 1.051 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 171.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.425 ' HB2' HG23 ' A' ' 51' ' ' ILE . 18.7 Cg_endo -56.68 -34.0 94.92 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.501 2.801 . . . . 0.0 114.729 -174.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.2 t -75.05 -39.35 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 121.052 0.453 . . . . 0.0 110.445 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.1 t -68.16 -40.76 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.309 0.644 . . . . 0.0 110.017 177.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.5 -33.06 75.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.065 1.346 . . . . 0.0 111.208 176.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.683 HD23 HD12 ' A' ' 44' ' ' ILE . 34.0 tp -59.69 -51.89 67.84 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 124.164 0.915 . . . . 0.0 111.185 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -63.06 -39.67 95.42 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.056 0.543 . . . . 0.0 111.655 -178.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.93 -42.64 99.87 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.555 177.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.6 -17.69 50.57 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.99 0.916 . . . . 0.0 112.176 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.1 mp -70.51 -45.4 65.67 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.922 0.889 . . . . 0.0 109.004 171.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -75.33 -27.98 59.45 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.781 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.407 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 3.0 t80 -81.81 114.28 20.33 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -64.99 -26.46 68.3 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.098 0.959 . . . . 0.0 112.653 -172.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -65.94 -41.97 90.65 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.387 0.675 . . . . 0.0 110.676 177.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.622 HG22 ' HB ' ' A' ' 64' ' ' ILE . 20.1 p -95.86 -18.87 20.02 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.004 0.921 . . . . 0.0 113.152 -171.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -63.33 -21.18 66.11 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -176.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -54.27 -48.4 71.25 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.898 0.879 . . . . 0.0 111.682 177.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.4 t -73.6 -15.69 61.26 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.671 0.788 . . . . 0.0 111.785 -172.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 24.7 mmt -64.4 -17.63 63.94 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.736 0.815 . . . . 0.0 112.211 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.405 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 2.4 p80 -61.06 -29.33 69.67 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.211 0.605 . . . . 0.0 110.894 174.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.64 -32.39 19.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.101 0.96 . . . . 0.0 111.413 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -79.93 -26.06 40.26 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.599 0.36 . . . . 0.0 110.936 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.405 ' SG ' ' HA ' ' A' ' 91' ' ' HIS . 28.6 p -79.76 103.25 9.53 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.29 -35.75 72.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 124.372 1.069 . . . . 0.0 110.21 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 174.31 -170.57 43.7 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.293 176.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -89.67 135.96 33.31 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -78.9 128.58 33.51 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.272 0.629 . . . . 0.0 110.774 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.506 HD22 HD13 ' A' ' 25' ' ' LEU . 64.0 tp -105.32 117.1 33.15 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 166.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -73.48 133.1 80.65 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 173.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.52 -42.76 64.7 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.271 2.648 . . . . 0.0 113.632 -174.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -87.76 -7.7 56.98 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.71 0.404 . . . . 0.0 111.252 -176.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 . . . . . 0 N--CA 1.484 1.257 0 C-N-CA 123.65 0.78 . . . . 0.0 110.728 174.376 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.98 151.22 49.39 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.028 0.931 . . . . 0.0 109.733 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.1 p -94.0 112.78 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-O 121.193 0.52 . . . . 0.0 109.907 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.7 m -70.95 109.06 4.85 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 173.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.42 HD22 ' HB2' ' A' ' 99' ' ' LEU . 92.4 mt -98.47 108.83 21.62 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.092 0.557 . . . . 0.0 110.209 -177.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.9 t -94.38 132.84 37.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.493 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -102.24 171.18 7.63 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.499 0.72 . . . . 0.0 109.593 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.474 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 13.0 tt -60.72 -34.09 57.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.848 174.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.42 -49.79 76.02 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.352 0.661 . . . . 0.0 110.743 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.11 -42.98 95.89 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.626 0.77 . . . . 0.0 110.879 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 46.9 tp -58.24 -45.82 87.08 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.333 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 17.0 mm-40 -72.68 -52.97 13.05 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.541 0.736 . . . . 0.0 112.397 -177.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -71.16 -29.87 65.74 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -172.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -73.47 -27.46 61.41 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 120.553 0.216 . . . . 0.0 110.5 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -61.3 -39.31 89.99 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 120.961 0.41 . . . . 0.0 110.205 172.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -68.57 -32.3 72.11 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.534 0.733 . . . . 0.0 110.78 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -65.77 -19.52 65.92 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.897 0.879 . . . . 0.0 111.41 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.74 4.09 26.53 Favored Glycine 0 N--CA 1.475 1.234 0 CA-C-N 116.695 -0.23 . . . . 0.0 112.764 176.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -111.93 95.86 0.83 Allowed Glycine 0 C--N 1.34 0.776 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.415 ' H ' ' HB2' ' A' ' 52' ' ' LYS . 89.7 t80 -75.8 116.6 16.67 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -104.66 -179.76 4.04 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.275 1.03 . . . . 0.0 109.961 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.4 t -155.83 159.15 39.14 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.698 0.799 . . . . 0.0 109.211 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 98.4 t -107.99 111.57 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 123.572 0.749 . . . . 0.0 109.258 177.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.729 HD12 HD23 ' A' ' 77' ' ' LEU . 48.8 mt -140.6 135.48 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.275 1.03 . . . . 0.0 108.631 175.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 63.59 32.31 14.1 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.675 1.19 . . . . 0.0 111.062 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.44 20.78 70.0 Favored Glycine 0 C--N 1.352 1.457 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.927 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.516 ' HD3' ' HA ' ' A' ' 97' ' ' GLN . 32.8 mmtp -128.59 162.98 26.02 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.792 1.237 . . . . 0.0 109.23 -177.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 90.9 t -119.28 119.28 60.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 123.629 0.772 . . . . 0.0 109.037 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -112.27 148.15 34.77 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.526 0.73 . . . . 0.0 109.909 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -86.56 100.7 12.6 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.518 HD11 HD22 ' A' ' 77' ' ' LEU . 31.5 mm -76.45 -29.64 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.418 0.687 . . . . 0.0 111.689 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.415 ' HB2' ' H ' ' A' ' 40' ' ' PHE . 1.7 tmmm? -61.55 -47.7 84.34 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.472 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 27.5 t70 -73.97 -36.07 64.54 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.521 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -52.55 -53.31 48.09 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.958 0.903 . . . . 0.0 111.154 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.487 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 10.6 pt20 -67.36 -28.53 68.03 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.233 -177.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.8 m -64.01 -40.38 96.22 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.042 0.449 . . . . 0.0 110.407 175.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.607 ' HB2' HD12 ' A' ' 65' ' ' LEU . 51.9 mm-40 -72.46 -32.35 66.17 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.315 0.646 . . . . 0.0 109.974 177.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.5 t -68.09 -27.32 66.38 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.726 0.81 . . . . 0.0 111.283 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 55' ' ' GLN . 96.9 mt -80.75 -15.42 56.52 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.448 0.699 . . . . 0.0 111.597 175.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 45.1 m -90.16 124.68 35.04 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.207 0.603 . . . . 0.0 110.321 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -64.29 147.96 51.31 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.936 0.894 . . . . 0.0 110.284 175.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 75.45 -3.56 2.56 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.367 1.467 . . . . 0.0 112.854 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.0 m -81.06 149.85 29.06 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 172.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.645 ' HB ' HG22 ' A' ' 86' ' ' THR . 42.9 pt -61.97 -20.04 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.58 0.752 . . . . 0.0 112.478 -178.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.607 HD12 ' HB2' ' A' ' 57' ' ' GLN . 60.0 mt -95.05 -8.68 35.98 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.575 0.75 . . . . 0.0 111.725 -176.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.87 -25.76 65.68 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.272 0.629 . . . . 0.0 111.549 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -75.73 -20.53 58.27 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.806 0.842 . . . . 0.0 111.042 173.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.423 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 52.4 m-85 -102.89 12.82 35.65 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.275 1.03 . . . . 0.0 110.987 178.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.62 -26.16 64.3 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.329 0.651 . . . . 0.0 112.534 -175.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.53 -3.87 90.53 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-N 116.472 -0.331 . . . . 0.0 112.639 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -108.08 150.55 27.04 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.176 0.99 . . . . 0.0 110.136 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -55.98 124.72 60.18 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 123.723 0.809 . . . . 0.0 110.52 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -51.13 -33.51 44.05 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 123.549 2.832 . . . . 0.0 115.145 -173.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.2 t -70.79 -38.87 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.111 0.564 . . . . 0.0 110.49 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.5 t -74.13 -40.11 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.894 0.877 . . . . 0.0 110.062 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.423 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -65.49 -29.3 69.93 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.832 1.253 . . . . 0.0 110.896 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.729 HD23 HD12 ' A' ' 44' ' ' ILE . 48.4 tp -63.98 -41.75 97.44 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.925 0.89 . . . . 0.0 110.536 174.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -65.65 -40.8 92.87 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.631 0.772 . . . . 0.0 110.998 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.43 -31.95 73.03 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.782 0.833 . . . . 0.0 110.688 175.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.14 -33.49 61.53 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.468 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.492 HD23 ' HG3' ' A' ' 90' ' ' MET . 95.6 mt -67.74 -40.12 84.2 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.156 0.582 . . . . 0.0 109.857 174.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -66.4 -41.5 89.24 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.858 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.444 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 9.8 t80 -87.5 127.7 35.24 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 120.982 0.42 . . . . 0.0 110.606 -175.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.81 -32.28 72.57 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.885 1.274 . . . . 0.0 113.63 -170.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -68.69 -51.4 42.1 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.154 0.502 . . . . 0.0 109.864 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.645 HG22 ' HB ' ' A' ' 64' ' ' ILE . 27.7 p -78.71 -16.78 56.83 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.197 -0.91 . . . . 0.0 113.149 -168.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.4 ptt85 -74.96 -11.42 60.11 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -75.34 -38.08 60.35 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.056 0.942 . . . . 0.0 111.256 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.407 ' HB3' HD11 ' A' ' 64' ' ' ILE . 24.2 t -77.64 -18.73 56.45 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.912 0.485 . . . . 0.0 110.743 175.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.592 ' SD ' HD12 ' A' ' 77' ' ' LEU . 37.4 mmt -65.01 -24.18 67.43 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.566 0.346 . . . . 0.0 110.887 176.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.468 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 86.2 m-70 -64.43 -26.57 68.51 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.841 0.856 . . . . 0.0 111.62 173.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.44 -35.95 46.17 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.476 0.71 . . . . 0.0 110.834 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -83.7 -24.37 31.29 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.477 0.311 . . . . 0.0 111.606 -176.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.468 ' SG ' ' HA ' ' A' ' 91' ' ' HIS . 29.5 p -72.05 101.32 2.71 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.001 0.429 . . . . 0.0 109.882 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.6 t -68.83 -37.71 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.056 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.02 -171.67 44.17 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.551 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.516 ' HA ' ' HD3' ' A' ' 47' ' ' LYS . 29.0 tt0 -88.78 135.68 33.39 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.909 0.884 . . . . 0.0 109.81 176.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -83.86 136.29 34.17 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.42 ' HB2' HD22 ' A' ' 25' ' ' LEU . 2.9 tt -139.7 122.88 16.91 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 173.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 46.7 mt-10 -70.74 145.05 91.73 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 123.973 0.909 . . . . 0.0 111.974 -176.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.5 -47.61 23.87 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 123.306 2.671 . . . . 0.0 112.303 173.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -67.61 -38.47 83.98 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.212 1.005 . . . . 0.0 111.846 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.468 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 26.4 tp60 -59.85 -45.51 92.19 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.032 0.933 . . . . 0.0 112.864 -168.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -90.13 -8.37 51.47 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -101.69 24.95 29.73 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 123.188 0.305 . . . . 0.0 113.234 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.21 138.8 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.34 0.656 . . . . 0.0 110.391 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.6 t -89.75 119.75 30.41 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 167.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.4 mt -104.9 109.45 63.16 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.05 150.74 87.56 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.841 2.361 . . . . 0.0 110.902 168.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -75.19 84.14 2.38 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 122.205 1.002 . . . . 0.0 110.048 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.4 tp -132.07 -20.1 2.49 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.19 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.383 0 CA-C-O 119.118 -0.823 . . . . 0.0 111.452 175.711 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.471 0.177 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -107.97 90.18 3.22 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.806 0.842 . . . . 0.0 109.189 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.82 143.91 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.078 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.9 m -65.4 109.15 2.19 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 89.4 mt -92.87 105.75 17.82 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.906 0.882 . . . . 0.0 109.634 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.6 t -93.93 126.21 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.37 1.068 . . . . 0.0 108.675 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -93.5 170.26 9.73 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.022 0.529 . . . . 0.0 110.792 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.7 tt -57.8 -36.61 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.19 0.996 . . . . 0.0 112.444 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.99 -40.0 95.4 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.378 0.671 . . . . 0.0 111.315 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.29 -34.75 77.19 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.235 1.014 . . . . 0.0 111.689 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.5 mt -58.75 -47.28 85.19 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.919 0.762 . . . . 0.0 110.01 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -71.62 -39.09 70.69 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.835 -174.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -62.22 -47.05 86.12 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.017 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -68.17 -35.39 77.96 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.333 0.653 . . . . 0.0 110.826 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 56.1 t30 -60.54 -42.97 97.62 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.267 178.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -78.16 -23.02 47.84 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.743 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -72.86 -36.59 67.43 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.903 0.881 . . . . 0.0 111.864 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 139.85 33.14 0.16 Allowed Glycine 0 N--CA 1.48 1.604 0 CA-C-N 116.968 -0.106 . . . . 0.0 113.121 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 35' ' ' ASN . . . -150.61 -178.31 25.35 Favored Glycine 0 C--N 1.343 0.948 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -134.59 110.23 9.18 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 117.582 0.691 . . . . 0.0 109.525 175.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 17.9 m0 -98.13 144.3 27.76 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.145 0.578 . . . . 0.0 110.508 174.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -136.87 141.84 42.79 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.192 0.997 . . . . 0.0 108.885 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.1 t -96.46 110.79 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 175.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 77.6 mt -131.24 130.22 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.1 t70 62.47 30.96 17.27 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 124.629 1.172 . . . . 0.0 111.617 175.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.55 12.83 77.71 Favored Glycine 0 N--CA 1.479 1.532 0 CA-C-N 116.198 -0.455 . . . . 0.0 113.378 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -119.14 160.33 22.32 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.724 1.21 . . . . 0.0 108.974 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.1 t -111.81 116.76 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.124 0.57 . . . . 0.0 109.525 176.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.435 ' HB2' HD21 ' A' ' 77' ' ' LEU . 49.8 m-85 -112.32 152.73 28.21 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.967 0.907 . . . . 0.0 109.352 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -100.88 107.25 18.72 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.571 0.348 . . . . 0.0 110.439 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.4 mm -60.31 -36.24 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 124.806 1.242 . . . . 0.0 111.724 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.44 ' HG3' ' HA2' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -58.49 -47.3 84.53 Favored 'General case' 0 CA--C 1.553 1.065 0 O-C-N 123.944 0.777 . . . . 0.0 109.184 -178.048 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 39.1 t70 -74.46 -34.41 63.14 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.706 0.402 . . . . 0.0 110.797 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -52.98 -55.97 19.51 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.928 0.891 . . . . 0.0 111.002 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -67.64 -28.24 67.55 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.413 0.685 . . . . 0.0 111.277 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.5 m -67.69 -37.44 82.3 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 123.505 0.722 . . . . 0.0 110.876 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 30.9 mm-40 -77.45 -28.07 52.3 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.437 0.695 . . . . 0.0 110.704 177.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.2 t -74.36 -3.63 31.51 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.732 0.813 . . . . 0.0 111.576 178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.4 tt -63.2 -38.28 90.54 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.29 1.036 . . . . 0.0 110.129 172.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.6 m -76.81 135.33 38.93 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.495 0.718 . . . . 0.0 111.026 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -73.39 -35.23 65.86 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.997 0.919 . . . . 0.0 110.391 -178.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -87.78 60.41 5.91 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.526 0.679 . . . . 0.0 109.536 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.6 t -133.0 155.12 49.75 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.796 0.838 . . . . 0.0 109.419 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.567 ' HB ' HG22 ' A' ' 86' ' ' THR . 27.3 pt -75.3 -10.71 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.587 0.755 . . . . 0.0 110.614 173.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.9 mt -93.46 -8.86 40.36 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.916 0.886 . . . . 0.0 110.734 176.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.07 -26.19 64.83 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.745 0.818 . . . . 0.0 111.46 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -74.65 -13.48 60.64 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.455 0.702 . . . . 0.0 110.963 174.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.527 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 67.6 m-85 -115.55 12.25 16.1 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.684 1.194 . . . . 0.0 110.963 177.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.73 -28.52 69.11 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.522 0.729 . . . . 0.0 112.109 -175.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -95.24 27.42 15.22 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.738 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -132.89 155.0 49.84 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.983 0.913 . . . . 0.0 109.499 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -54.39 129.05 60.8 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 124.305 1.042 . . . . 0.0 109.459 172.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.1 -35.32 90.25 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 123.433 2.755 . . . . 0.0 114.461 -172.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.0 t -74.66 -48.92 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 122.638 0.375 . . . . 0.0 110.441 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.0 t -63.08 -33.86 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.715 0.806 . . . . 0.0 110.713 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -64.71 -44.5 90.02 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.464 176.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.435 HD21 ' HB2' ' A' ' 49' ' ' TYR . 56.8 tp -66.89 -43.12 84.25 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.839 0.855 . . . . 0.0 111.306 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -58.89 -52.15 66.98 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.313 0.645 . . . . 0.0 110.259 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.14 -34.67 76.81 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.716 0.806 . . . . 0.0 111.229 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.99 -24.04 61.52 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.716 0.807 . . . . 0.0 112.291 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 81' ' ' LEU . 2.0 mm? -70.81 -42.1 70.73 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 172.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -73.22 -28.34 62.11 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.049 0.54 . . . . 0.0 111.053 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -85.51 117.67 24.56 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -66.08 -27.56 68.17 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.908 0.883 . . . . 0.0 113.175 -169.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -76.16 -22.01 55.9 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.383 0.673 . . . . 0.0 112.423 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.567 HG22 ' HB ' ' A' ' 64' ' ' ILE . 19.1 p -109.28 -20.99 12.75 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -174.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.499 ' HA ' ' HG2' ' A' ' 90' ' ' MET . 40.3 ptt180 -67.66 -13.57 62.21 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -55.48 -49.58 72.17 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.414 1.086 . . . . 0.0 112.339 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.9 t -77.4 -15.72 59.21 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.932 0.493 . . . . 0.0 111.033 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.499 ' HG2' ' HA ' ' A' ' 87' ' ' ARG . 12.7 mmt -69.03 -16.81 63.8 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.828 0.451 . . . . 0.0 111.243 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -62.24 -39.72 93.78 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.941 0.496 . . . . 0.0 109.798 169.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.89 -37.13 62.2 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.75 0.82 . . . . 0.0 111.065 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.488 ' HD2' ' SD ' ' A' ' 90' ' ' MET . 45.9 m-85 -71.37 -23.93 61.99 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.012 0.525 . . . . 0.0 111.221 177.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 46.1 t -72.17 99.85 2.43 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.0 m -71.15 -26.32 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 123.408 0.683 . . . . 0.0 110.251 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 175.42 175.11 42.58 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.319 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -85.18 136.66 33.43 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 177.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -76.83 132.44 39.19 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.486 HD12 ' HG3' ' A' ' 104' ' ' GLU . 0.1 OUTLIER -132.46 126.15 32.35 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 170.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 42.2 mt-10 -70.34 136.08 86.56 Favored Pre-proline 0 C--O 1.246 0.898 0 O-C-N 123.851 0.72 . . . . 0.0 110.3 177.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -59.27 -22.05 63.26 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.765 2.31 . . . . 0.0 112.609 175.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -86.61 -38.83 16.71 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.824 1.25 . . . . 0.0 111.224 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.522 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 8.5 tp-100 -61.78 -30.73 71.0 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 124.33 1.052 . . . . 0.0 111.586 -176.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.486 ' HG3' HD12 ' A' ' 99' ' ' LEU . 40.9 mt-10 -61.25 -34.51 75.27 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.868 0.867 . . . . 0.0 112.069 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -84.44 -80.69 1.06 Allowed Glycine 0 C--N 1.341 0.848 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.8 p -87.21 107.92 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.7 t -95.58 129.54 42.73 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 122.856 0.463 . . . . 0.0 109.973 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 56.7 mt -103.95 110.82 64.67 Favored Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -79.15 172.02 15.4 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 122.722 2.282 . . . . 0.0 111.852 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.26 83.47 0.55 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.455 0.702 . . . . 0.0 110.237 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 34.7 tp -176.76 -57.59 0.01 OUTLIER 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.073 1.349 . . . . 0.0 107.813 -178.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.328 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.284 -176.924 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 121.162 0.506 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -88.34 97.95 11.32 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 124.137 0.975 . . . . 0.0 109.391 -174.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.0 p -68.72 110.73 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.27 175.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 77.7 m -71.03 108.16 4.46 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.247 0.546 . . . . 0.0 109.575 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.436 HD13 HD13 ' A' ' 99' ' ' LEU . 72.2 mt -85.64 106.55 17.01 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.215 -177.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.456 HG21 HG23 ' A' ' 95' ' ' VAL . 46.2 t -102.16 128.99 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 124.183 0.993 . . . . 0.0 109.043 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -101.98 170.28 8.23 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.379 0.672 . . . . 0.0 110.073 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.432 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 18.6 tt -67.96 -32.15 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.348 0.659 . . . . 0.0 111.98 -173.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.64 -35.58 72.73 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.199 0.6 . . . . 0.0 111.453 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -68.27 -42.26 79.83 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.788 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.4 mt -55.24 -40.64 71.13 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.785 0.834 . . . . 0.0 111.422 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 7.0 mm-40 -65.89 -41.6 91.33 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.444 -178.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -59.29 -50.62 73.29 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.569 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -64.41 -34.64 78.66 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.173 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -59.21 -39.16 81.79 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.07 0.548 . . . . 0.0 110.416 174.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -75.96 -19.49 58.69 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.017 0.927 . . . . 0.0 111.886 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -84.3 -20.16 32.58 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 122.665 0.386 . . . . 0.0 110.823 170.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.99 -13.48 52.66 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-N 116.456 -0.338 . . . . 0.0 112.414 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.413 ' HA2' ' HD3' ' A' ' 52' ' ' LYS . . . -76.72 88.59 0.95 Allowed Glycine 0 C--N 1.35 1.309 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 176.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -75.63 111.1 10.61 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -173.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 39.5 m0 -99.77 177.73 5.04 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.941 0.896 . . . . 0.0 110.066 175.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.9 t -157.6 151.27 23.99 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.71 0.804 . . . . 0.0 109.869 -178.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 p -103.0 112.12 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 171.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.5 mt -124.18 116.96 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.359 1.064 . . . . 0.0 109.223 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.3 t70 53.31 53.63 11.47 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.27 1.428 . . . . 0.0 111.834 175.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.55 -0.46 55.61 Favored Glycine 0 N--CA 1.475 1.273 0 N-CA-C 114.815 0.686 . . . . 0.0 114.815 176.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 97' ' ' GLN . 44.9 mmtm -112.59 167.83 10.15 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.131 0.972 . . . . 0.0 109.461 178.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 90.7 t -115.61 121.97 68.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 171.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.428 ' HB3' HD21 ' A' ' 77' ' ' LEU . 76.7 m-85 -115.3 170.62 8.25 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.831 1.253 . . . . 0.0 109.301 174.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -99.21 159.42 15.0 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.241 0.617 . . . . 0.0 109.835 171.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 35.1 mm -117.28 -29.21 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.359 1.064 . . . . 0.0 108.934 168.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.413 ' HD3' ' HA2' ' A' ' 39' ' ' GLY . 25.1 ttpt -53.89 -57.97 9.01 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.469 1.108 . . . . 0.0 111.965 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.449 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 27.4 t70 -74.39 -35.54 63.49 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.995 0.518 . . . . 0.0 110.121 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -51.09 -53.51 33.43 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.85 1.26 . . . . 0.0 111.775 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -67.62 -27.89 67.28 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.923 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.9 m -68.32 -42.15 79.79 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.932 174.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 77.7 mm-40 -68.56 -28.36 66.89 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 123.12 0.568 . . . . 0.0 110.519 178.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.0 t -72.71 -26.98 61.79 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.672 0.789 . . . . 0.0 110.996 175.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 47.5 tp -67.37 -27.29 66.99 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.876 0.87 . . . . 0.0 112.095 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.0 t -88.11 151.64 22.58 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.219 0.533 . . . . 0.0 111.478 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -79.05 155.46 28.79 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.434 1.093 . . . . 0.0 109.95 176.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 71.88 5.76 5.44 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.032 1.333 . . . . 0.0 112.095 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 37.7 t -74.81 155.33 37.7 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.386 0.674 . . . . 0.0 109.686 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.566 ' HB ' HG22 ' A' ' 86' ' ' THR . 47.5 pt -68.83 -19.76 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 122.788 0.435 . . . . 0.0 110.518 170.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 57' ' ' GLN . 63.4 mt -96.94 0.32 48.78 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.783 1.233 . . . . 0.0 111.613 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.02 -27.68 68.98 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 122.983 0.513 . . . . 0.0 110.944 176.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -82.16 -24.79 34.83 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.88 0.872 . . . . 0.0 111.372 173.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.587 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 54.8 m-85 -91.84 2.53 56.46 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.979 0.911 . . . . 0.0 112.066 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.97 -29.77 69.71 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.371 0.668 . . . . 0.0 111.092 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.31 26.85 9.3 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-N 116.017 -0.538 . . . . 0.0 113.114 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -141.47 152.32 44.11 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.326 1.05 . . . . 0.0 108.611 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -52.61 127.86 42.7 Favored Pre-proline 0 N--CA 1.478 0.94 0 CA-C-O 118.11 -0.948 . . . . 0.0 109.871 174.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.08 -34.2 86.45 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 123.215 2.61 . . . . 0.0 114.476 -172.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.7 t -73.0 -48.56 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.1 t -62.53 -34.76 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.934 0.894 . . . . 0.0 110.78 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -71.41 -35.18 70.9 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.994 1.318 . . . . 0.0 110.876 -178.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.428 HD21 ' HB3' ' A' ' 49' ' ' TYR . 17.2 tp -73.36 -40.01 64.72 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.682 176.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -62.31 -36.48 82.28 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.193 0.597 . . . . 0.0 110.267 172.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.5 -32.72 68.55 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.112 0.965 . . . . 0.0 110.612 176.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.23 -43.6 86.15 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.562 0.745 . . . . 0.0 111.151 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.83 -30.64 69.23 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.514 0.326 . . . . 0.0 111.504 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -72.91 -27.72 62.04 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.027 0.531 . . . . 0.0 110.734 176.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -95.96 119.49 34.54 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.294 0.638 . . . . 0.0 110.046 -176.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -58.88 -27.99 65.72 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.514 1.125 . . . . 0.0 113.067 -175.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -79.64 -20.01 47.8 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.029 0.932 . . . . 0.0 112.248 -174.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.566 HG22 ' HB ' ' A' ' 64' ' ' ILE . 41.5 p -123.61 -12.2 7.7 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -173.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -68.58 -26.56 65.45 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.554 0.742 . . . . 0.0 111.195 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -60.07 -54.4 46.36 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.258 1.023 . . . . 0.0 110.481 -172.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.8 m -64.52 -20.0 65.94 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.907 0.883 . . . . 0.0 112.48 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 20.6 mmt -74.09 -4.02 33.01 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.301 0.641 . . . . 0.0 112.495 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.94 -21.4 65.1 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.765 0.426 . . . . 0.0 110.565 169.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -89.06 -29.51 19.37 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.757 0.823 . . . . 0.0 111.086 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -80.8 -24.03 38.83 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.171 0.588 . . . . 0.0 111.443 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.9 p -76.25 110.98 11.21 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 173.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.456 HG23 HG21 ' A' ' 26' ' ' VAL . 27.5 m -70.29 -24.88 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 123.132 0.573 . . . . 0.0 110.122 174.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 167.59 -159.32 32.58 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.612 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 53.8 tt0 -102.14 139.92 37.12 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.093 0.957 . . . . 0.0 109.807 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.427 ' OH ' ' HB ' ' A' ' 28' ' ' ILE . 84.2 t80 -78.94 124.25 28.06 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.378 0.671 . . . . 0.0 110.379 178.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.436 HD13 HD13 ' A' ' 25' ' ' LEU . 9.5 tt -115.86 120.9 40.76 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 172.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.734 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 42.9 mt-10 -68.86 143.09 94.32 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 123.613 0.765 . . . . 0.0 110.585 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -54.73 -31.18 70.41 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.856 2.371 . . . . 0.0 113.053 175.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -82.71 -29.01 30.15 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.86 0.864 . . . . 0.0 111.222 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.734 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 33.3 tt0 -68.09 -22.65 64.9 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.737 0.815 . . . . 0.0 112.036 -174.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -61.57 -34.44 75.6 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 120.919 0.39 . . . . 0.0 110.324 173.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.32 -64.15 1.95 Allowed Glycine 0 C--N 1.343 0.929 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.107 177.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.2 p -100.79 147.0 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-O 121.119 0.485 . . . . 0.0 111.519 -174.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 t -107.89 131.75 54.19 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 168.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 55.1 mt -82.01 122.93 80.17 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 122.954 0.502 . . . . 0.0 109.815 -175.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.19 126.05 11.39 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.664 2.242 . . . . 0.0 112.2 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -81.97 108.0 15.12 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 pp -96.31 -12.38 24.54 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.317 0.647 . . . . 0.0 110.943 174.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.351 1.391 0 CA-C-O 118.951 -0.916 . . . . 0.0 112.35 179.535 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.485 1.317 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -141.63 156.94 45.64 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.775 1.23 . . . . 0.0 109.549 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.8 p -147.4 126.22 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 122.568 0.347 . . . . 0.0 111.264 -177.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.2 m -72.25 116.02 12.19 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.397 0.679 . . . . 0.0 110.548 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 83.6 mt -95.93 104.33 16.27 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.756 0.822 . . . . 0.0 109.727 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.52 ' HB ' HG21 ' A' ' 48' ' ' VAL . 59.2 t -95.5 121.78 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.568 1.147 . . . . 0.0 108.688 178.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -78.6 168.95 19.01 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 123.322 0.649 . . . . 0.0 110.312 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.44 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 11.4 tt -56.4 -46.08 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.877 174.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.98 -38.01 81.31 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.8 0.84 . . . . 0.0 111.707 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -66.34 -46.75 75.72 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.017 0.527 . . . . 0.0 111.593 -176.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 pp -72.11 -32.56 67.09 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.282 0.233 . . . . 0.0 111.61 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 68.2 mm-40 -63.73 -47.75 79.84 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.191 0.597 . . . . 0.0 110.816 174.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -77.32 -23.66 50.97 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.404 -175.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -72.63 -28.34 62.68 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -59.63 -47.58 85.04 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.115 0.566 . . . . 0.0 110.034 173.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -70.9 -26.7 63.34 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.101 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -67.71 -30.0 69.39 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.905 0.882 . . . . 0.0 111.276 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.58 34.88 0.68 Allowed Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.46 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.585 ' HA2' ' HD2' ' A' ' 52' ' ' LYS . . . -162.23 100.0 0.18 Allowed Glycine 0 C--N 1.346 1.131 0 CA-C-O 120.05 -0.306 . . . . 0.0 112.635 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -75.73 110.0 9.79 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -176.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -103.32 157.24 17.15 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.564 174.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.5 t -148.25 143.54 27.04 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.648 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 p -96.64 120.41 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-O 121.027 0.441 . . . . 0.0 110.623 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 78.6 mt -136.89 125.22 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 124.906 1.282 . . . . 0.0 108.194 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.1 t70 62.45 32.9 16.51 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.386 1.074 . . . . 0.0 111.548 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.14 19.57 77.39 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-N 115.818 -0.628 . . . . 0.0 113.401 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -125.24 145.35 50.03 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.187 0.995 . . . . 0.0 108.674 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.52 HG21 ' HB ' ' A' ' 26' ' ' VAL . 25.4 t -99.8 119.64 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -112.54 165.75 11.95 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.035 0.934 . . . . 0.0 109.056 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -93.76 161.55 14.28 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.565 0.698 . . . . 0.0 110.065 170.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.436 HG23 ' HB2' ' A' ' 73' ' ' PRO . 29.3 mm -115.88 -29.92 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.502 1.121 . . . . 0.0 109.744 172.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.585 ' HD2' ' HA2' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -57.36 -52.27 66.04 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 123.891 0.876 . . . . 0.0 112.655 -177.006 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -78.34 -31.38 48.62 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.278 1.031 . . . . 0.0 110.224 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -52.47 -60.81 2.79 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.843 1.257 . . . . 0.0 111.346 175.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -64.89 -28.65 69.69 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.558 -0.747 . . . . 0.0 112.177 -174.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.0 m -63.46 -45.04 92.65 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.298 0.639 . . . . 0.0 110.055 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -77.65 -13.54 59.88 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.369 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.6 m -71.15 -19.64 62.4 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.697 0.399 . . . . 0.0 111.015 172.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 61.0 mt -82.25 -5.89 58.85 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.993 0.917 . . . . 0.0 111.497 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 79.4 m -91.58 133.24 35.71 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.759 0.824 . . . . 0.0 109.722 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -62.91 -49.59 74.2 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.276 1.03 . . . . 0.0 111.644 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -86.51 45.41 1.24 Allowed 'General case' 0 CA--C 1.557 1.218 0 CA-C-O 121.91 0.862 . . . . 0.0 110.642 -177.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 75.7 m -122.81 144.74 48.99 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.181 0.992 . . . . 0.0 109.306 172.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.487 ' HB ' HG22 ' A' ' 86' ' ' THR . 35.0 pt -59.26 -25.92 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 124.029 0.932 . . . . 0.0 110.759 169.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.513 HD21 ' HE1' ' A' ' 90' ' ' MET . 36.7 mt -76.82 -10.15 59.17 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.276 1.031 . . . . 0.0 111.902 -178.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.84 -20.54 59.71 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.214 0.606 . . . . 0.0 111.535 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 2.2 pt20 -77.19 -29.37 54.3 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 171.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -87.94 2.78 50.81 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.402 1.081 . . . . 0.0 111.177 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.54 126.15 28.4 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.782 0.433 . . . . 0.0 110.112 177.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.31 -21.7 38.64 Favored Glycine 0 C--N 1.345 1.037 0 O-C-N 123.481 0.488 . . . . 0.0 112.528 -173.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -89.91 158.49 17.4 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.219 1.008 . . . . 0.0 109.809 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -61.23 132.55 92.57 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 123.204 0.602 . . . . 0.0 109.817 173.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.436 ' HB2' HG23 ' A' ' 51' ' ' ILE . 52.6 Cg_endo -64.53 -32.12 59.65 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.976 2.451 . . . . 0.0 113.899 -172.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.6 t -73.93 -45.82 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.8 t -61.15 -40.35 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 123.52 0.728 . . . . 0.0 110.478 177.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.02 -40.05 95.46 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.305 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 37.6 tp -71.81 -37.9 70.28 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.666 0.786 . . . . 0.0 110.917 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.23 -44.42 91.91 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.987 0.515 . . . . 0.0 110.318 176.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.51 -33.55 75.83 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.823 0.849 . . . . 0.0 110.873 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.79 -41.78 82.65 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.924 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.13 -23.28 64.88 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -82.76 -9.46 59.34 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.492 0.717 . . . . 0.0 112.071 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -125.89 124.85 41.77 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.206 0.602 . . . . 0.0 109.752 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.09 -42.0 84.71 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.411 1.084 . . . . 0.0 113.901 -169.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.42 -35.85 78.71 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.45 0.7 . . . . 0.0 111.285 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.487 HG22 ' HB ' ' A' ' 64' ' ' ILE . 31.6 p -98.26 -6.01 31.99 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.854 -174.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -90.48 -25.68 20.18 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 118.584 0.629 . . . . 0.0 110.433 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -75.72 -24.83 56.22 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.8 0.666 . . . . 0.0 112.8 -172.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.2 t -71.71 -23.97 61.73 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.145 171.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.513 ' HE1' HD21 ' A' ' 65' ' ' LEU . 12.6 mmt -75.58 -8.92 58.0 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.263 0.625 . . . . 0.0 111.663 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -70.3 -16.81 63.06 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.611 0.764 . . . . 0.0 110.507 169.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -88.66 -37.38 15.62 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.958 0.903 . . . . 0.0 110.857 170.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.427 ' HD2' ' HA ' ' A' ' 90' ' ' MET . 97.5 m-85 -80.79 -14.22 58.27 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.456 0.702 . . . . 0.0 112.192 -176.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 27.1 p -69.5 102.37 1.79 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.736 0.414 . . . . 0.0 110.647 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 26.2 m -77.56 -15.13 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 123.344 0.657 . . . . 0.0 111.201 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 168.84 -172.13 43.09 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.808 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -99.31 150.44 22.11 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 174.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -86.25 152.19 22.99 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.946 0.498 . . . . 0.0 110.553 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -146.65 121.34 9.84 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 172.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 38.3 mt-10 -71.46 129.01 89.32 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 123.232 0.613 . . . . 0.0 109.631 173.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.9 -32.27 56.29 Favored 'Trans proline' 0 CA--C 1.561 1.847 0 C-N-CA 122.848 2.365 . . . . 0.0 112.645 176.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -76.64 -32.47 58.02 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.624 0.77 . . . . 0.0 111.552 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 50.3 tp60 -63.46 -31.05 72.11 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.829 0.452 . . . . 0.0 110.262 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -71.84 98.43 1.99 Allowed 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 167.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -175.21 -168.8 36.24 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.32 147.6 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.125 0.97 . . . . 0.0 110.791 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.1 t -104.53 128.56 52.53 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 170.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 75.6 mt -86.79 120.69 71.87 Favored Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.85 103.13 0.27 Allowed 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.435 2.09 . . . . 0.0 111.492 171.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -75.7 86.77 2.74 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.469 0.708 . . . . 0.0 109.666 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.3 tt -74.06 -37.64 64.19 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.03 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.487 0 CA-C-O 118.43 -1.205 . . . . 0.0 111.171 -176.01 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.55 148.48 40.82 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.772 0.429 . . . . 0.0 110.306 176.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.5 p -108.33 130.97 60.05 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.1 m -80.05 118.43 21.76 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.625 0.77 . . . . 0.0 110.169 -177.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.4 mt -78.34 100.32 6.7 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.357 0.598 . . . . 0.0 109.64 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -92.53 114.37 29.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 38.3 mtp-105 -85.99 176.3 8.12 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.785 -175.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.5 tt -58.02 -37.44 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.728 175.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.75 -40.25 94.98 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.818 0.847 . . . . 0.0 111.264 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -74.28 -39.79 62.72 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.165 0.586 . . . . 0.0 110.788 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 45.6 tp -66.77 -50.15 63.6 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.035 0.534 . . . . 0.0 110.604 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -64.85 -48.11 75.52 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.63 0.772 . . . . 0.0 112.069 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -67.09 -47.96 69.62 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 123.488 0.493 . . . . 0.0 111.643 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -64.2 -36.77 85.16 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.525 0.33 . . . . 0.0 110.61 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -65.56 -39.69 91.96 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.067 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -67.79 -29.15 68.26 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.52 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -65.38 -23.2 66.91 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.184 0.594 . . . . 0.0 111.588 175.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.92 -26.74 6.09 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.574 ' HA2' ' HD2' ' A' ' 52' ' ' LYS . . . -69.62 89.55 0.29 Allowed Glycine 0 C--N 1.345 1.073 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 176.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -74.11 112.84 10.65 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -171.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 32.6 m0 -105.27 155.21 19.28 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.69 171.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.6 t -129.55 160.72 32.35 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.516 0.726 . . . . 0.0 109.408 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 p -116.34 109.43 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 172.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 54.3 mt -134.37 133.76 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.002 1.321 . . . . 0.0 107.696 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.0 t70 63.2 29.4 16.0 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 124.473 1.109 . . . . 0.0 110.631 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.5 19.0 64.17 Favored Glycine 0 C--N 1.353 1.487 0 CA-C-N 115.121 -0.945 . . . . 0.0 113.497 -174.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.471 ' HB2' ' CE2' ' A' ' 49' ' ' TYR . 42.9 mmtm -116.82 152.33 34.65 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.449 1.1 . . . . 0.0 108.51 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.8 t -102.12 122.59 54.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' A' ' 47' ' ' LYS . 96.4 m-85 -114.47 155.3 26.64 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.923 0.889 . . . . 0.0 110.427 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -94.63 107.12 19.12 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.436 0.694 . . . . 0.0 109.47 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.491 HG23 ' HB2' ' A' ' 73' ' ' PRO . 15.6 mm -75.77 -39.87 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.925 0.89 . . . . 0.0 112.288 -177.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.574 ' HD2' ' HA2' ' A' ' 39' ' ' GLY . 18.0 ptmt -67.08 -32.06 72.97 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 121.161 -0.216 . . . . 0.0 110.954 -174.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -73.7 -38.45 64.84 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -53.19 -54.17 39.88 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.503 1.121 . . . . 0.0 111.12 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -70.34 -27.56 64.45 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.411 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.1 m -72.52 -33.08 66.63 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 120.946 0.403 . . . . 0.0 110.241 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.529 ' HB2' HD12 ' A' ' 65' ' ' LEU . 82.6 mm-40 -69.65 -35.42 75.17 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 172.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.4 m -65.31 -27.12 68.38 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.301 0.64 . . . . 0.0 111.099 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.3 tt -61.63 -44.73 96.43 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.238 1.015 . . . . 0.0 109.297 173.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 88.8 m -66.91 120.31 13.38 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.38 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -65.49 -31.52 72.64 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.956 0.903 . . . . 0.0 111.308 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -69.66 -18.16 63.55 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.331 1.053 . . . . 0.0 111.766 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.8 t -76.04 152.66 36.84 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.877 0.471 . . . . 0.0 110.762 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.447 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 32.4 pt -61.2 -26.8 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.711 170.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.529 HD12 ' HB2' ' A' ' 57' ' ' GLN . 46.6 mt -77.21 0.76 20.69 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.144 0.978 . . . . 0.0 111.971 -176.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.99 -30.4 70.91 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.363 0.665 . . . . 0.0 111.21 172.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 11.2 pt20 -73.99 -27.06 60.78 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.31 0.644 . . . . 0.0 110.689 175.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.515 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 41.8 m-85 -92.69 -6.44 49.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.255 1.022 . . . . 0.0 111.45 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.27 104.22 0.9 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.153 0.581 . . . . 0.0 109.824 174.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.47 -32.13 3.62 Favored Glycine 0 N--CA 1.472 1.046 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -174.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -77.62 151.14 34.5 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.425 0.69 . . . . 0.0 109.649 175.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -55.37 128.1 66.54 Favored Pre-proline 0 N--CA 1.48 1.067 0 CA-C-O 118.476 -0.773 . . . . 0.0 108.955 171.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.491 ' HB2' HG23 ' A' ' 51' ' ' ILE . 28.6 Cg_endo -58.0 -31.51 93.07 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.836 2.357 . . . . 0.0 113.973 -170.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.9 t -75.38 -50.27 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 123.058 0.543 . . . . 0.0 110.097 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.1 t -58.58 -35.26 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 124.035 0.934 . . . . 0.0 111.022 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.515 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -73.27 -34.98 66.1 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.701 1.2 . . . . 0.0 111.213 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.546 ' HG ' ' SD ' ' A' ' 90' ' ' MET . 4.6 tt -71.58 -35.78 70.67 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.504 0.722 . . . . 0.0 109.889 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -66.53 -40.72 89.29 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.426 0.69 . . . . 0.0 110.36 175.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.18 -32.95 74.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.638 0.775 . . . . 0.0 110.619 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.41 -40.82 73.65 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.878 177.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.9 mt -64.67 -36.68 85.04 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.251 0.621 . . . . 0.0 110.856 173.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -65.87 -36.81 84.46 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.637 0.775 . . . . 0.0 111.074 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.492 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 29.9 t80 -95.96 132.12 41.62 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -176.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -65.85 -36.81 84.49 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.174 0.99 . . . . 0.0 113.193 -168.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -74.98 -32.2 61.63 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.713 0.405 . . . . 0.0 111.063 -177.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.492 ' OG1' ' HB3' ' A' ' 83' ' ' PHE . 37.8 p -93.57 -10.65 34.02 Favored 'General case' 0 CA--C 1.555 1.161 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -172.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -78.51 -15.07 59.0 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -26.24 55.44 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.01 0.524 . . . . 0.0 112.198 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.6 t -73.73 -29.57 62.33 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.324 0.25 . . . . 0.0 110.38 171.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.546 ' SD ' ' HG ' ' A' ' 77' ' ' LEU . 32.1 mmt -64.94 -26.05 68.14 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.052 0.541 . . . . 0.0 110.406 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -59.91 -37.02 78.24 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.707 0.803 . . . . 0.0 110.63 174.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.36 -32.8 60.96 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.834 178.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -78.24 -24.09 47.1 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.255 0.222 . . . . 0.0 111.16 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 39.1 t -70.77 95.27 1.11 Allowed 'General case' 0 C--N 1.349 0.556 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 33.3 m -71.0 -22.77 23.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.238 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 169.75 -160.66 33.81 Favored Glycine 0 C--N 1.351 1.396 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.836 174.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -97.22 145.69 25.82 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.647 1.179 . . . . 0.0 109.133 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -80.26 108.79 14.16 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 173.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 27' ' ' ARG . 3.0 tm? -92.31 114.58 27.17 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 103' ' ' GLN . 30.6 tt0 -80.03 140.71 53.86 Favored Pre-proline 0 CA--C 1.554 1.102 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 174.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -39.1 -51.2 2.56 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 124.356 3.371 . . . . 0.0 114.644 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -103.1 23.06 12.93 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.291 0.637 . . . . 0.0 111.655 -175.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.561 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 8.9 tp-100 -81.09 -27.59 35.58 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.861 -0.524 . . . . 0.0 110.088 174.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -69.63 96.52 0.95 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.695 0.798 . . . . 0.0 109.449 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 117.15 38.89 0.84 Allowed Glycine 0 C--N 1.341 0.854 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.339 -174.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.5 p -61.27 124.66 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.398 0.679 . . . . 0.0 110.982 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.0 t -77.64 125.97 30.15 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.254 0.55 . . . . 0.0 110.094 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.4 mt -111.76 93.64 21.12 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.96 87.08 1.52 Allowed 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.651 2.234 . . . . 0.0 111.374 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -81.86 93.59 6.91 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.076 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.0 mp -76.9 -15.58 59.64 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.041 172.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.164 0 CA-C-O 118.861 -0.966 . . . . 0.0 112.71 172.801 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.55 153.94 42.73 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 172.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.1 p -132.35 150.92 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 120.959 0.409 . . . . 0.0 110.859 -173.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.1 m -90.92 115.3 27.84 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.861 0.865 . . . . 0.0 108.712 173.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.433 HD22 ' HB2' ' A' ' 99' ' ' LEU . 64.3 mt -79.35 110.59 14.79 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.1 t -91.87 119.31 39.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 124.069 0.948 . . . . 0.0 108.583 -176.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.531 ' HG2' ' HB2' ' A' ' 30' ' ' ASP . 1.5 ptm180 -81.27 162.0 23.69 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.421 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.5 tt -60.12 -36.8 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.757 0.823 . . . . 0.0 111.836 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.09 -32.21 64.84 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.485 0.714 . . . . 0.0 111.922 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.531 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 29.1 t70 -58.81 -43.26 90.51 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.403 0.681 . . . . 0.0 110.454 -176.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.9 mt -52.35 -43.85 64.86 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.511 1.124 . . . . 0.0 111.691 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -72.18 -37.83 69.22 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.506 -175.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -69.09 -40.06 78.65 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.934 0.494 . . . . 0.0 110.821 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -66.74 -40.4 88.3 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.17 0.588 . . . . 0.0 110.05 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -59.79 -40.49 88.49 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.973 0.509 . . . . 0.0 110.143 176.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -69.27 -31.64 70.3 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.753 0.821 . . . . 0.0 111.388 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -74.28 -30.44 62.1 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.783 0.833 . . . . 0.0 111.274 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 112.06 -7.15 27.21 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.688 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.515 ' HA2' ' HD2' ' A' ' 52' ' ' LYS . . . -75.36 83.46 0.87 Allowed Glycine 0 C--N 1.349 1.268 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 172.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -75.71 107.32 7.8 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -172.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 28.7 m0 -111.44 160.71 16.85 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.643 1.177 . . . . 0.0 110.425 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.8 t -149.36 144.75 26.61 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.421 1.088 . . . . 0.0 109.126 -177.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.573 HG22 HG22 ' A' ' 48' ' ' VAL . 95.9 t -111.36 119.17 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.3 0.64 . . . . 0.0 109.925 178.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.9 mt -127.54 106.12 14.67 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 124.031 0.932 . . . . 0.0 109.008 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.5 t70 55.94 54.55 7.91 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 124.599 1.16 . . . . 0.0 111.61 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.64 9.43 62.01 Favored Glycine 0 N--CA 1.475 1.296 0 CA-C-N 115.081 -0.963 . . . . 0.0 114.428 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -117.76 124.5 48.59 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.767 0.827 . . . . 0.0 108.866 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.573 HG22 HG22 ' A' ' 43' ' ' VAL . 15.2 t -97.11 127.51 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -178.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.534 ' HB2' HD21 ' A' ' 77' ' ' LEU . 79.7 m-85 -127.7 163.71 23.7 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.291 1.036 . . . . 0.0 109.035 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -93.39 160.23 14.9 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.529 0.68 . . . . 0.0 110.066 170.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 29.8 mm -113.14 -27.77 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.494 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.515 ' HD2' ' HA2' ' A' ' 39' ' ' GLY . 21.0 ptmt -70.26 -48.75 55.45 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.069 0.548 . . . . 0.0 112.252 -173.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.457 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 34.6 t70 -75.04 -36.78 61.85 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -49.81 -55.43 14.17 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.934 1.293 . . . . 0.0 112.217 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -67.65 -27.28 66.74 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.111 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.3 m -68.6 -32.05 71.67 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.296 0.638 . . . . 0.0 110.895 172.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 22.5 mm-40 -76.13 -21.4 56.66 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 121.908 -0.495 . . . . 0.0 111.123 178.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.0 m -68.84 -17.66 64.03 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.124 0.57 . . . . 0.0 111.081 172.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.3 tp -69.71 -25.59 63.93 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.709 0.804 . . . . 0.0 110.709 173.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.7 m -86.15 117.47 25.0 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -67.55 -28.36 67.73 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.404 0.681 . . . . 0.0 111.207 -177.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -88.78 63.43 6.85 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-O 121.924 0.869 . . . . 0.0 108.943 173.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 61.2 m -147.55 153.23 39.2 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.923 1.289 . . . . 0.0 108.304 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.476 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 31.8 pt -61.4 -25.6 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.465 0.706 . . . . 0.0 110.902 170.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.431 HD12 ' HB2' ' A' ' 57' ' ' GLN . 58.8 mt -84.31 0.34 49.47 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.368 1.067 . . . . 0.0 112.298 -175.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.91 -29.82 61.09 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.006 0.522 . . . . 0.0 110.744 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 10.6 pt20 -85.43 -6.82 59.18 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.223 0.609 . . . . 0.0 110.846 173.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -108.91 7.97 26.25 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.07 0.948 . . . . 0.0 110.477 174.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.21 126.53 30.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.076 0.55 . . . . 0.0 109.76 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.65 -31.85 8.09 Favored Glycine 0 N--CA 1.474 1.227 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 -173.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -75.28 152.8 38.21 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.948 0.899 . . . . 0.0 109.945 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -56.19 124.47 60.23 Favored Pre-proline 0 N--CA 1.476 0.858 0 C-N-CA 123.927 0.891 . . . . 0.0 109.749 175.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.13 -23.95 52.4 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.979 2.453 . . . . 0.0 113.938 -172.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.2 t -74.6 -47.58 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 176.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.3 t -64.88 -34.0 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.816 0.847 . . . . 0.0 111.085 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.08 -35.74 71.97 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.146 0.979 . . . . 0.0 110.516 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.619 HD12 ' SD ' ' A' ' 90' ' ' MET . 58.8 tp -68.99 -42.6 76.29 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.469 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -65.91 -42.38 90.26 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.604 0.761 . . . . 0.0 110.478 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.96 -37.36 86.77 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.607 0.763 . . . . 0.0 110.328 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.07 -42.47 89.39 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.293 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.4 HD23 ' HG3' ' A' ' 90' ' ' MET . 93.7 mt -67.64 -33.41 74.9 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.88 0.872 . . . . 0.0 111.848 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -89.14 2.55 53.98 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.321 0.649 . . . . 0.0 111.809 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.403 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 30.2 t80 -129.82 125.46 35.78 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.93 0.492 . . . . 0.0 109.821 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -58.23 -38.96 77.85 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.758 1.223 . . . . 0.0 113.73 -169.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -71.46 -30.6 66.21 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.353 0.661 . . . . 0.0 111.473 -176.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.426 HG22 ' HB ' ' A' ' 64' ' ' ILE . 24.6 p -101.67 -7.88 22.28 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.366 0.666 . . . . 0.0 112.67 -173.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.69 1.02 53.47 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 118.305 0.502 . . . . 0.0 111.323 177.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -72.56 -49.66 30.94 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.022 0.929 . . . . 0.0 110.782 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 32.8 t -71.58 -18.86 62.21 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.608 0.763 . . . . 0.0 111.162 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.619 ' SD ' HD12 ' A' ' 77' ' ' LEU . 37.4 mmt -64.79 -21.01 66.69 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.456 0.702 . . . . 0.0 111.979 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -60.39 -34.44 73.9 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.446 0.699 . . . . 0.0 110.895 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.99 -45.71 69.91 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.126 0.57 . . . . 0.0 110.97 176.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.418 ' HD2' ' HA ' ' A' ' 90' ' ' MET . 60.1 m-85 -73.61 -16.21 61.24 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.294 0.638 . . . . 0.0 111.395 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 45.8 t -70.65 87.98 0.69 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.441 0.696 . . . . 0.0 109.608 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.8 m -77.1 -25.55 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.383 -176.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 172.82 177.7 42.33 Favored Glycine 0 C--N 1.343 0.921 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.462 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -98.61 133.93 42.26 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -72.55 129.23 37.82 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 173.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.433 ' HB2' HD22 ' A' ' 25' ' ' LEU . 3.0 tm? -132.59 127.87 35.94 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 43.4 mt-10 -82.33 141.95 46.51 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 123.718 0.807 . . . . 0.0 110.4 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -59.18 -34.6 98.43 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.773 2.315 . . . . 0.0 111.658 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -70.57 -39.75 73.71 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.211 175.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 55.6 tp60 -67.11 -32.39 73.5 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.285 0.634 . . . . 0.0 111.775 -176.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.38 -49.78 68.0 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -69.44 -37.62 79.26 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 114.858 -1.065 . . . . 0.0 113.826 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.4 p -149.95 136.33 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.426 0.69 . . . . 0.0 110.361 -175.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.2 t -106.19 125.0 50.46 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 172.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.1 mt -71.32 127.53 91.22 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 123.554 0.742 . . . . 0.0 109.961 -175.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.87 170.64 8.44 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.76 2.307 . . . . 0.0 112.548 176.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -86.24 23.22 1.6 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.543 0.737 . . . . 0.0 111.679 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.3 mt -78.88 85.71 4.83 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.211 1.004 . . . . 0.0 109.913 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.13 0 CA-C-O 118.785 -1.008 . . . . 0.0 111.848 178.154 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -89.39 96.29 10.65 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 170.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.1 p -84.12 124.45 39.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.0 m -69.46 109.92 4.47 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 122.711 0.405 . . . . 0.0 109.973 -177.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.545 HD13 HD22 ' A' ' 99' ' ' LEU . 92.3 mt -79.98 100.92 8.35 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.504 ' HB ' HG21 ' A' ' 48' ' ' VAL . 58.2 t -94.57 116.98 37.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 55.6 mtm180 -95.76 172.93 7.73 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.191 0.597 . . . . 0.0 110.84 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.493 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 19.9 tt -60.52 -36.65 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 123.757 0.661 . . . . 0.0 111.451 -174.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.39 -45.12 72.81 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.081 0.952 . . . . 0.0 110.761 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.2 -44.98 93.84 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.04 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.4 mt -59.21 -42.7 91.55 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.858 0.863 . . . . 0.0 111.972 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 9.9 mm-40 -63.45 -50.5 69.49 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 123.496 0.497 . . . . 0.0 111.162 -174.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -71.85 -33.96 68.87 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.575 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -72.29 -35.06 68.58 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.852 0.461 . . . . 0.0 110.442 -177.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -66.45 -39.2 88.73 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.915 0.886 . . . . 0.0 110.399 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -61.78 -32.42 72.7 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.72 0.808 . . . . 0.0 111.52 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -66.12 -34.15 77.41 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.916 0.487 . . . . 0.0 111.058 176.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.05 -18.83 7.41 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.789 -175.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.88 89.02 0.23 Allowed Glycine 0 C--N 1.353 1.506 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 174.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -77.46 108.77 10.86 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.171 0.589 . . . . 0.0 109.573 -175.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -105.83 165.65 11.04 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.264 1.026 . . . . 0.0 109.907 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.8 t -143.03 160.29 40.65 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.868 0.867 . . . . 0.0 109.859 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 47' ' ' LYS . 1.5 p -114.49 112.38 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 123.443 0.697 . . . . 0.0 109.468 170.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.737 HD12 HD23 ' A' ' 77' ' ' LEU . 39.9 mt -134.52 136.98 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.749 1.219 . . . . 0.0 107.872 175.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.0 t70 62.85 29.41 16.61 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 124.327 1.051 . . . . 0.0 110.447 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.48 23.24 68.41 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.11 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.409 ' HB2' ' CE1' ' A' ' 49' ' ' TYR . 27.5 mmtp -124.67 153.19 42.68 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.562 1.145 . . . . 0.0 108.671 -176.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.504 HG21 ' HB ' ' A' ' 26' ' ' VAL . 91.7 t -104.07 132.27 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 175.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.409 ' CE1' ' HB2' ' A' ' 47' ' ' LYS . 66.7 m-85 -127.72 153.18 46.82 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.841 0.856 . . . . 0.0 109.908 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -92.42 106.18 18.23 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.527 HD11 HD22 ' A' ' 77' ' ' LEU . 35.8 mm -83.37 -29.6 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.75 0.82 . . . . 0.0 111.533 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.24 -47.56 84.9 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 28.5 t70 -69.37 -40.84 77.22 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.555 177.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -52.84 -55.0 26.25 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.421 1.089 . . . . 0.0 112.055 -177.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -66.44 -28.01 68.27 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.718 0.807 . . . . 0.0 111.583 -176.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.8 m -66.85 -37.06 83.74 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 122.918 0.487 . . . . 0.0 109.827 173.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 49.7 mm-40 -76.51 -24.63 53.73 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.285 0.634 . . . . 0.0 110.711 176.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.3 m -76.84 -19.69 57.22 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.52 0.728 . . . . 0.0 111.252 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.8 tt -74.05 -24.79 59.58 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.617 0.767 . . . . 0.0 110.321 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.7 m -58.8 137.47 57.7 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.904 0.881 . . . . 0.0 112.693 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -54.28 -45.69 72.55 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.016 1.327 . . . . 0.0 112.04 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -118.12 112.04 19.66 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 38.9 t -163.41 158.58 21.29 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.465 ' HB ' HG22 ' A' ' 86' ' ' THR . 35.9 pt -65.22 -24.63 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 166.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.5 mt -91.6 -2.04 57.26 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 124.759 1.224 . . . . 0.0 111.619 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.17 -31.97 68.33 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.938 0.495 . . . . 0.0 110.376 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 9.6 pt20 -76.51 -23.21 53.7 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.993 0.517 . . . . 0.0 110.652 172.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.541 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 29.4 m-85 -96.24 6.82 47.96 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.369 1.068 . . . . 0.0 111.688 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.52 -22.43 63.58 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.316 0.646 . . . . 0.0 112.1 -177.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.44 11.43 71.36 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-O 120.231 -0.205 . . . . 0.0 112.775 177.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -125.84 156.74 39.11 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.411 1.084 . . . . 0.0 109.694 -177.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -55.46 128.67 68.34 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 124.235 1.014 . . . . 0.0 109.354 170.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -59.74 -30.4 91.98 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.923 2.415 . . . . 0.0 113.946 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.9 t -75.18 -39.02 42.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 C-N-CA 122.588 0.355 . . . . 0.0 110.346 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.6 t -69.76 -39.8 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-O 121.49 0.662 . . . . 0.0 110.116 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.541 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -63.56 -34.49 77.93 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.114 1.366 . . . . 0.0 111.135 178.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.737 HD23 HD12 ' A' ' 44' ' ' ILE . 64.8 tp -61.09 -44.07 97.92 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.81 175.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.468 ' HG2' HG21 ' A' ' 44' ' ' ILE . 42.1 mt-10 -64.44 -40.82 96.47 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.77 0.828 . . . . 0.0 111.399 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.3 -38.5 91.38 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.529 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.434 ' HB1' ' SD ' ' A' ' 90' ' ' MET . . . -75.81 -26.13 56.96 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.74 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 79.6 mt -72.13 -39.48 68.78 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.502 0.721 . . . . 0.0 109.95 174.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -67.91 -44.78 76.13 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.114 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -84.76 131.48 34.55 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 120.823 0.344 . . . . 0.0 110.209 -176.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -66.58 -41.33 88.71 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.263 1.025 . . . . 0.0 112.916 -171.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.58 -26.57 65.45 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.14 0.576 . . . . 0.0 111.412 -176.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.465 HG22 ' HB ' ' A' ' 64' ' ' ILE . 28.1 p -91.09 -34.22 15.16 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.21 0.604 . . . . 0.0 111.977 -177.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -66.83 -14.27 62.49 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -171.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -57.75 -36.88 72.7 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.252 0.621 . . . . 0.0 111.09 173.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.2 t -77.12 -35.44 56.27 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.346 0.659 . . . . 0.0 110.451 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.479 ' N ' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -67.95 -21.64 65.08 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.71 0.804 . . . . 0.0 111.2 175.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -67.62 -21.57 65.38 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.35 1.06 . . . . 0.0 110.249 172.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -92.65 -29.95 15.84 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.872 0.869 . . . . 0.0 111.272 172.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -74.95 -23.35 58.3 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 122.962 0.505 . . . . 0.0 111.527 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 27.1 p -69.86 101.05 1.65 Allowed 'General case' 0 C--N 1.354 0.789 0 C-N-CA 122.869 0.468 . . . . 0.0 110.133 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.4 t -67.66 -31.07 50.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 123.91 0.884 . . . . 0.0 110.179 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 172.28 -160.29 31.63 Favored Glycine 0 C--N 1.339 0.721 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.465 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -102.89 133.79 47.38 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 175.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -75.65 131.07 39.68 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 123.273 0.358 . . . . 0.0 110.444 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.545 HD22 HD13 ' A' ' 25' ' ' LEU . 66.5 tp -121.56 134.97 55.03 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 33.4 mt-10 -85.66 137.89 35.93 Favored Pre-proline 0 C--O 1.244 0.815 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 171.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -60.85 -22.53 74.18 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.946 2.43 . . . . 0.0 112.635 175.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -85.1 -37.55 20.14 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.269 1.028 . . . . 0.0 110.853 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.551 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 9.5 tp-100 -63.16 -41.86 99.33 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.83 0.852 . . . . 0.0 111.277 -173.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -61.6 -37.03 82.41 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.288 0.635 . . . . 0.0 111.215 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.52 78.85 1.32 Allowed Glycine 0 C--N 1.348 1.234 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.8 p -144.58 137.4 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.156 0.582 . . . . 0.0 110.073 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.9 t -126.1 133.5 51.64 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 172.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 63.4 mt -96.4 116.69 66.28 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.19 154.46 51.83 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 122.599 2.199 . . . . 0.0 111.602 171.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -61.91 113.31 2.72 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.212 0.605 . . . . 0.0 111.073 -174.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -169.2 103.28 0.37 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.33 0 CA-C-O 119.007 -0.885 . . . . 0.0 112.236 173.736 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -68.48 137.9 54.8 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.994 0.518 . . . . 0.0 110.836 174.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.7 p -119.86 141.2 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.12 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.9 p -71.86 108.01 4.93 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.2 mt -81.73 117.66 22.23 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.3 t -92.13 125.3 44.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -175.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 53.9 mtm180 -67.97 152.7 45.13 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.471 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 18.9 tt -60.63 -44.56 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 117.711 0.232 . . . . 0.0 110.836 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.71 -31.45 69.47 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.457 0.703 . . . . 0.0 110.613 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.5 -37.78 80.39 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.927 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.4 tp -64.9 -51.66 60.71 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.664 0.786 . . . . 0.0 110.205 175.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 58.8 mm-40 -64.17 -53.57 47.3 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.997 0.919 . . . . 0.0 112.473 -171.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -74.55 -29.68 61.46 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -173.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -72.53 -37.49 68.29 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -63.12 -42.76 99.6 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.887 0.875 . . . . 0.0 109.486 174.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -68.6 -26.58 65.44 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.178 1.391 . . . . 0.0 111.671 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -66.53 -35.26 79.81 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.548 0.739 . . . . 0.0 111.538 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 129.64 -26.63 4.28 Favored Glycine 0 N--CA 1.467 0.738 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.24 81.55 0.36 Allowed Glycine 0 C--N 1.351 1.408 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 167.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -74.63 113.69 12.18 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -164.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 33.4 m0 -106.61 171.44 7.36 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.396 1.078 . . . . 0.0 110.548 177.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.8 t -157.66 142.17 16.36 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.335 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -104.03 112.8 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.107 0.563 . . . . 0.0 109.525 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.429 HD13 ' HG2' ' A' ' 78' ' ' GLU . 55.7 mt -127.39 120.18 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.109 0.964 . . . . 0.0 108.942 176.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 62.06 40.08 12.44 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 125.12 1.368 . . . . 0.0 110.691 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.59 15.59 73.33 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.033 -0.985 . . . . 0.0 113.551 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.444 ' HD3' ' HG3' ' A' ' 97' ' ' GLN . 35.6 mmtp -118.65 148.17 43.0 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.086 0.955 . . . . 0.0 109.411 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.9 t -106.1 120.98 57.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.416 ' HB2' HD21 ' A' ' 77' ' ' LEU . 75.6 m-85 -118.08 171.17 8.28 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.972 1.309 . . . . 0.0 108.887 173.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -102.14 159.41 15.41 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.4 0.619 . . . . 0.0 110.39 170.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.1 mm -114.28 -21.4 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 124.437 1.095 . . . . 0.0 109.136 168.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -56.99 6.99 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 122.994 0.517 . . . . 0.0 111.614 -175.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.418 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 23.7 t70 -67.43 -37.12 82.53 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -53.17 -52.21 59.55 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.637 1.575 . . . . 0.0 112.7 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -69.6 -27.13 64.83 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.778 -176.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.8 m -70.27 -34.36 72.7 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-O 121.056 0.455 . . . . 0.0 110.423 174.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 33.3 mm-40 -72.19 -24.27 61.39 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.649 0.78 . . . . 0.0 112.195 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.6 p -77.57 -6.82 55.05 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.34 -2.49 38.39 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.761 0.424 . . . . 0.0 111.134 168.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' A' ' 63' ' ' SER . 19.4 m -77.44 120.24 22.17 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 168.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.476 ' HG3' HD22 ' A' ' 62' ' ' ASN . 9.5 pt-20 -62.5 -36.9 84.01 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.417 0.687 . . . . 0.0 111.801 -178.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.476 HD22 ' HG3' ' A' ' 61' ' ' GLU . 34.5 m-80 -111.24 87.32 2.52 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.513 ' HB3' ' HB ' ' A' ' 60' ' ' THR . 91.9 p -147.13 164.7 32.25 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.994 0.917 . . . . 0.0 109.601 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.557 ' HB ' HG22 ' A' ' 86' ' ' THR . 29.5 pt -68.43 -17.77 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 122.694 0.397 . . . . 0.0 111.019 171.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.6 mt -96.65 -8.87 30.49 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.978 0.911 . . . . 0.0 111.35 -177.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.54 -33.4 74.04 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.469 0.708 . . . . 0.0 110.773 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -76.69 -19.83 57.28 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.663 0.785 . . . . 0.0 111.239 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.499 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 25.5 m-85 -107.38 7.28 29.01 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.128 0.971 . . . . 0.0 111.1 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.26 -38.07 89.16 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.303 0.641 . . . . 0.0 111.539 -175.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -79.18 -8.3 87.91 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.594 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -95.66 155.46 16.73 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.454 0.702 . . . . 0.0 109.437 175.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -49.22 131.16 16.86 Favored Pre-proline 0 N--CA 1.485 1.324 0 C-N-CA 124.432 1.093 . . . . 0.0 110.417 172.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -61.72 -33.41 85.83 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.748 2.299 . . . . 0.0 113.859 -172.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.1 t -74.55 -41.27 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.66 -32.56 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 123.633 0.773 . . . . 0.0 110.373 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.499 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -68.83 -36.72 78.54 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.554 1.142 . . . . 0.0 110.505 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.7 HD12 ' SD ' ' A' ' 90' ' ' MET . 59.0 tp -64.77 -42.74 94.87 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.079 175.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.429 ' HG2' HD13 ' A' ' 44' ' ' ILE . 48.1 mt-10 -63.49 -40.87 98.22 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.44 0.696 . . . . 0.0 111.594 177.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.11 -34.39 77.96 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.669 0.787 . . . . 0.0 110.307 177.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.36 -26.32 51.86 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.324 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 92.0 mt -75.53 -30.92 59.91 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.1 0.56 . . . . 0.0 110.612 172.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -75.0 -45.87 38.99 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.724 -176.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.418 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 35.3 t80 -82.04 137.88 34.98 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 122.579 0.352 . . . . 0.0 110.579 -174.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.11 -37.15 85.04 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.368 1.067 . . . . 0.0 113.493 -169.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -66.04 -44.26 85.14 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.381 0.61 . . . . 0.0 110.624 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.557 HG22 ' HB ' ' A' ' 64' ' ' ILE . 25.5 p -81.89 -28.6 32.83 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.921 -169.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -64.87 -27.1 68.63 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.124 0.569 . . . . 0.0 111.964 -173.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -79.54 -22.77 43.46 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.392 0.677 . . . . 0.0 110.698 -178.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.5 t -80.68 -28.67 36.7 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.59 0.756 . . . . 0.0 110.381 171.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.7 ' SD ' HD12 ' A' ' 77' ' ' LEU . 36.2 mmt -64.45 -16.71 62.91 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.72 0.808 . . . . 0.0 111.889 176.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -57.79 -33.96 69.11 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.772 1.229 . . . . 0.0 111.531 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.6 -37.24 84.47 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.486 0.714 . . . . 0.0 111.254 176.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.471 ' HD2' ' HA ' ' A' ' 90' ' ' MET . 63.6 m-85 -85.66 -13.03 49.83 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.518 0.727 . . . . 0.0 111.326 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.4 t -71.54 92.61 1.14 Allowed 'General case' 0 C--N 1.351 0.66 0 C-N-CA 123.239 0.615 . . . . 0.0 109.605 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.9 m -83.16 -12.53 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.582 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 165.86 -169.46 40.18 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.772 172.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.444 ' HG3' ' HD3' ' A' ' 47' ' ' LYS . 30.6 tt0 -108.84 139.9 43.04 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.411 1.084 . . . . 0.0 108.156 172.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -71.62 136.62 47.45 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.002 0.43 . . . . 0.0 110.439 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -117.15 121.75 42.13 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 171.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.678 ' HB3' ' HB2' ' A' ' 103' ' ' GLN . 33.1 tt0 -73.5 133.16 80.55 Favored Pre-proline 0 CA--C 1.552 1.056 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.25 174.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.408 ' HD3' ' HB ' ' A' ' 28' ' ' ILE . 73.3 Cg_endo -66.58 -13.85 41.59 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.239 2.626 . . . . 0.0 113.762 -170.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -104.19 -18.32 14.54 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.876 0.471 . . . . 0.0 110.626 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.678 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 8.5 tp-100 -65.26 -28.92 69.68 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.068 0.947 . . . . 0.0 112.748 -170.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -76.21 -2.88 33.46 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -167.69 51.8 0.23 Allowed Glycine 0 C--N 1.349 1.303 0 N-CA-C 112.212 -0.355 . . . . 0.0 112.212 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.4 p -90.36 113.0 25.66 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 123.183 0.593 . . . . 0.0 111.27 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.0 t -98.1 150.92 20.92 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 167.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 71.2 mt -121.3 127.38 26.16 Favored Pre-proline 0 N--CA 1.482 1.153 0 C-N-CA 122.955 0.502 . . . . 0.0 109.693 -175.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.98 138.49 57.44 Favored 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 122.698 2.266 . . . . 0.0 111.261 173.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 60.57 28.91 18.6 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.304 1.042 . . . . 0.0 111.869 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 43.6 tp -66.52 -42.21 87.63 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.338 0.655 . . . . 0.0 109.941 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.045 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.734 176.572 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.59 147.94 27.45 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 169.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.75 136.61 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-O 121.32 0.581 . . . . 0.0 112.295 -173.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.7 m -82.2 108.86 15.98 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 168.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.547 HD13 HD12 ' A' ' 99' ' ' LEU . 83.1 mt -92.93 103.11 15.47 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.114 0.565 . . . . 0.0 109.558 -178.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.413 ' HB ' HG21 ' A' ' 48' ' ' VAL . 69.0 t -92.97 115.92 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 124.02 0.928 . . . . 0.0 108.618 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -84.26 164.83 18.8 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.01 0.924 . . . . 0.0 108.975 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.521 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 17.2 tt -51.23 -44.99 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.455 0.702 . . . . 0.0 112.412 -176.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.43 -44.2 92.95 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.159 0.584 . . . . 0.0 111.641 -177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -67.63 -35.11 78.32 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.718 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.8 tp -62.91 -42.56 99.83 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.037 0.535 . . . . 0.0 110.203 176.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 12.0 mm-40 -67.55 -55.36 13.78 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.675 0.79 . . . . 0.0 111.578 -175.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -71.13 -35.35 71.7 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.891 -173.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -70.17 -36.66 74.83 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.544 0.338 . . . . 0.0 110.207 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -56.59 -40.69 75.71 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.691 0.619 . . . . 0.0 110.125 175.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -86.89 -15.72 38.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.285 1.034 . . . . 0.0 111.929 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -67.52 -32.18 72.8 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.633 0.773 . . . . 0.0 110.474 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 142.29 -28.6 2.21 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.467 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.486 ' HA2' ' HZ2' ' A' ' 52' ' ' LYS . . . -83.0 98.03 2.02 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 174.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -73.28 118.26 16.03 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 -173.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.4 m0 -119.38 154.65 33.29 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.882 0.873 . . . . 0.0 111.554 -169.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.5 t -150.88 151.98 33.02 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.892 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 47' ' ' LYS . 1.6 p -97.77 117.94 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 169.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.7 mt -138.37 131.92 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.8 t70 61.39 29.27 18.43 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 122.31 1.052 . . . . 0.0 110.722 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.87 1.59 47.9 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 114.984 -1.007 . . . . 0.0 114.068 -176.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 41.2 mmtm -96.96 172.69 7.7 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.129 0.972 . . . . 0.0 109.145 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.413 HG21 ' HB ' ' A' ' 26' ' ' VAL . 85.0 t -120.38 119.33 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 172.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -112.34 148.92 33.24 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.236 0.615 . . . . 0.0 110.346 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -92.2 98.79 11.74 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 123.055 0.542 . . . . 0.0 109.736 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.1 mm -61.79 -27.72 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 124.941 1.297 . . . . 0.0 112.122 175.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.486 ' HZ2' ' HA2' ' A' ' 39' ' ' GLY . 5.8 ttpm? -59.39 -51.67 68.89 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-O 120.889 0.376 . . . . 0.0 110.325 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 31.4 t70 -67.61 -39.57 84.73 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.652 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.411 ' HA ' ' HE2' ' A' ' 93' ' ' PHE . 54.5 t80 -49.05 -48.29 44.09 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.197 0.999 . . . . 0.0 110.886 174.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.406 ' HA ' ' OG ' ' A' ' 58' ' ' SER . 16.0 mm100 -71.83 -31.21 66.3 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.41 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.0 m -62.47 -37.83 87.48 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-O 121.052 0.453 . . . . 0.0 110.106 172.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.616 ' HB2' HD12 ' A' ' 65' ' ' LEU . 66.3 mm-40 -78.37 -25.96 46.47 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.311 0.644 . . . . 0.0 111.693 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.406 ' OG ' ' HA ' ' A' ' 55' ' ' GLN . 92.7 p -85.79 -8.84 57.86 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.903 -0.498 . . . . 0.0 110.995 174.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.6 tt -75.86 -42.54 49.13 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.007 0.923 . . . . 0.0 109.179 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.2 t -75.64 157.49 33.65 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.054 -176.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -67.87 -73.56 0.14 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.363 1.065 . . . . 0.0 111.06 -171.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -86.2 100.58 12.33 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.58 0.705 . . . . 0.0 109.414 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 48.1 t -155.72 163.94 39.22 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.609 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.612 ' HB ' HG22 ' A' ' 86' ' ' THR . 43.2 pt -67.79 -18.54 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 123.572 0.749 . . . . 0.0 111.48 173.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.616 HD12 ' HB2' ' A' ' 57' ' ' GLN . 82.6 mt -104.33 6.33 35.16 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.761 0.825 . . . . 0.0 112.388 -174.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.54 -27.23 62.1 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.108 0.48 . . . . 0.0 110.13 173.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -80.19 -4.97 55.21 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.917 0.887 . . . . 0.0 111.842 173.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.496 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 64.8 m-85 -117.06 9.28 13.58 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.151 0.98 . . . . 0.0 110.56 177.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.98 103.39 2.24 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.684 0.793 . . . . 0.0 110.722 -177.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.45 -37.21 2.39 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -70.1 147.08 50.41 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.017 0.927 . . . . 0.0 110.345 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -53.1 131.22 50.56 Favored Pre-proline 0 N--CA 1.484 1.234 0 C-N-CA 123.625 0.77 . . . . 0.0 110.558 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -47.23 -45.86 20.99 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 123.921 3.081 . . . . 0.0 114.52 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.83 -44.17 45.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.433 -173.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.6 t -66.4 -37.61 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 123.502 0.721 . . . . 0.0 111.052 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.496 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -67.22 -31.84 72.49 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.612 1.165 . . . . 0.0 111.002 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 tt -72.18 -36.46 69.26 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.024 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.69 -39.26 80.62 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.634 0.374 . . . . 0.0 110.763 175.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.62 -32.44 74.01 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.836 0.855 . . . . 0.0 110.525 174.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.08 -35.13 69.16 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.392 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 66.0 mt -74.84 -24.14 58.55 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.588 0.355 . . . . 0.0 111.242 177.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -74.97 -39.6 61.2 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.064 0.546 . . . . 0.0 109.957 173.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -81.98 114.07 20.3 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.919 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -56.62 -32.57 65.44 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.476 1.11 . . . . 0.0 113.263 -172.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -68.05 -40.95 82.69 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.632 0.773 . . . . 0.0 111.744 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.612 HG22 ' HB ' ' A' ' 64' ' ' ILE . 34.9 p -95.75 -17.98 20.8 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -171.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -71.92 -35.45 69.68 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 122.99 0.516 . . . . 0.0 111.34 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -69.69 -25.99 64.14 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.023 0.929 . . . . 0.0 111.27 -175.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.8 t -80.92 -17.28 51.06 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.483 0.713 . . . . 0.0 110.862 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.424 ' HE1' HD21 ' A' ' 65' ' ' LEU . 23.8 mmt -72.21 0.49 9.66 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.292 0.637 . . . . 0.0 112.684 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.428 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 9.1 p80 -62.56 -33.36 74.79 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.376 0.67 . . . . 0.0 110.819 171.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.41 -23.26 46.79 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.23 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.421 ' HD1' ' HA ' ' A' ' 90' ' ' MET . 54.4 m-85 -90.55 -25.21 20.34 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.325 0.65 . . . . 0.0 110.933 -178.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.428 ' SG ' ' HA ' ' A' ' 91' ' ' HIS . 28.5 p -79.82 106.99 12.25 Favored 'General case' 0 C--N 1.357 0.922 0 CA-C-O 121.042 0.449 . . . . 0.0 109.896 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.0 t -75.7 -29.22 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.274 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -177.91 -166.64 34.74 Favored Glycine 0 C--N 1.345 1.064 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.425 177.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -98.83 138.68 35.62 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.876 0.87 . . . . 0.0 108.961 170.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -78.95 118.8 21.3 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.569 0.748 . . . . 0.0 110.061 173.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.547 HD12 HD13 ' A' ' 25' ' ' LEU . 2.2 tt -99.55 114.36 27.31 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 170.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -80.92 129.68 66.68 Favored Pre-proline 0 CA--C 1.548 0.902 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -53.0 -33.09 61.02 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 123.518 2.812 . . . . 0.0 113.539 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -65.66 -44.68 85.57 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.79 0.836 . . . . 0.0 110.489 178.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -58.67 -34.68 71.52 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.032 0.933 . . . . 0.0 111.081 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.445 ' HB2' HD21 ' A' ' 99' ' ' LEU . 13.2 tp10 -78.94 -40.71 31.23 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.042 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -68.21 -63.91 3.37 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.899 -0.591 . . . . 0.0 113.04 -176.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.5 p -159.21 135.72 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 123.811 0.844 . . . . 0.0 110.13 177.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 t -114.81 124.96 53.08 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.052 0.941 . . . . 0.0 108.894 173.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 64.3 mt -90.8 118.14 68.43 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 122.846 0.458 . . . . 0.0 110.0 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -87.62 101.82 0.49 Allowed 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.835 2.357 . . . . 0.0 112.096 174.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -73.62 138.77 45.05 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.409 0.684 . . . . 0.0 111.185 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.6 mp -90.94 -40.23 11.82 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.564 0.746 . . . . 0.0 109.469 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.058 0 CA-C-O 118.641 -1.088 . . . . 0.0 112.247 -177.008 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 . . . . . 0 N--CA 1.484 1.268 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.79 174.75 9.19 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.566 0.746 . . . . 0.0 110.217 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.4 p -124.48 93.25 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 170.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.1 m -72.48 109.32 6.08 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.106 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.414 HD13 HD12 ' A' ' 99' ' ' LEU . 96.0 mt -78.6 101.28 7.36 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.435 ' HB ' HG21 ' A' ' 48' ' ' VAL . 60.9 t -94.94 136.12 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.683 -177.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -106.45 166.86 10.24 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.732 0.813 . . . . 0.0 109.128 -178.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.7 tt -54.7 -41.53 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.438 1.095 . . . . 0.0 113.447 -171.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.83 -34.73 71.99 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.252 0.221 . . . . 0.0 111.408 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.49 -34.06 76.94 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.257 0.623 . . . . 0.0 110.598 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.5 mt -61.89 -57.06 13.24 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.38 0.672 . . . . 0.0 110.027 174.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -62.14 -40.29 95.45 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 124.208 0.943 . . . . 0.0 111.71 -174.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -72.84 -38.08 67.21 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.682 0.793 . . . . 0.0 111.366 -176.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -73.06 -39.25 66.05 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.886 0.474 . . . . 0.0 109.993 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -67.75 -50.05 59.29 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.595 1.158 . . . . 0.0 110.756 -175.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -69.11 -28.52 66.55 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.652 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -68.68 -23.99 64.46 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.208 0.603 . . . . 0.0 111.223 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 139.64 -26.86 2.63 Favored Glycine 0 C--N 1.355 1.585 0 CA-C-N 116.651 -0.25 . . . . 0.0 113.447 174.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.62 103.57 2.91 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -75.12 108.23 7.73 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 117.659 0.73 . . . . 0.0 109.591 -168.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -107.93 138.55 43.99 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.038 0.935 . . . . 0.0 110.147 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.3 t -145.21 156.13 43.67 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.909 0.884 . . . . 0.0 109.038 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.47 HG22 HG22 ' A' ' 48' ' ' VAL . 88.7 t -108.47 118.31 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.263 0.625 . . . . 0.0 110.169 -177.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.48 HD12 HD22 ' A' ' 77' ' ' LEU . 34.5 mt -126.25 127.51 70.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 174.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.8 t70 63.23 30.71 15.82 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 124.656 1.182 . . . . 0.0 111.156 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.1 1.66 80.58 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.318 -0.856 . . . . 0.0 113.603 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.485 ' HD2' ' SG ' ' A' ' 94' ' ' CYS . 69.9 mmtt -109.09 149.65 29.0 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.925 0.89 . . . . 0.0 109.802 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.47 HG22 HG22 ' A' ' 43' ' ' VAL . 47.9 t -99.5 134.41 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.885 0.874 . . . . 0.0 109.992 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -134.1 157.97 44.8 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.097 0.959 . . . . 0.0 109.573 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -106.61 115.97 31.12 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.3 mm -70.73 -33.68 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.568 1.147 . . . . 0.0 112.027 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -69.03 -44.27 73.05 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.937 0.495 . . . . 0.0 110.392 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -66.58 -40.6 89.01 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.068 0.947 . . . . 0.0 110.103 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -52.47 -49.77 64.02 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.08 1.352 . . . . 0.0 111.199 172.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -71.29 -31.36 67.37 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.686 0.795 . . . . 0.0 112.242 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.5 m -64.33 -35.27 80.33 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.308 174.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -74.89 -28.39 60.62 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.684 0.794 . . . . 0.0 111.258 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.453 ' HA ' ' HB2' ' A' ' 65' ' ' LEU . 15.5 m -68.75 -27.55 66.01 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.166 0.586 . . . . 0.0 111.159 177.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.0 tp -63.2 -27.12 69.14 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.782 0.833 . . . . 0.0 111.162 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.4 m -77.87 132.04 37.78 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 122.833 0.453 . . . . 0.0 110.349 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -75.55 -35.34 60.7 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.395 0.678 . . . . 0.0 112.042 -173.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -80.13 -7.75 59.07 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.844 0.457 . . . . 0.0 111.97 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 74.4 m -75.41 151.52 38.13 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.439 0.696 . . . . 0.0 110.656 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.453 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 15.2 pt -63.39 -23.25 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.842 0.857 . . . . 0.0 112.176 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 82.8 mt -78.51 1.9 20.86 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.811 0.845 . . . . 0.0 112.228 -178.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.71 -33.33 75.63 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.4 0.68 . . . . 0.0 110.77 172.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 9.8 pt20 -77.17 -22.7 52.09 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.019 0.528 . . . . 0.0 110.617 176.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.61 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 46.3 m-85 -97.66 4.53 50.06 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.408 1.083 . . . . 0.0 111.444 -178.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.24 -19.86 60.98 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.174 0.589 . . . . 0.0 111.291 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.65 0.02 73.21 Favored Glycine 0 C--N 1.352 1.421 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.896 174.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -109.75 157.76 18.81 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.335 1.054 . . . . 0.0 109.768 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -57.01 130.86 79.83 Favored Pre-proline 0 CA--C 1.551 0.993 0 CA-C-O 118.177 -0.915 . . . . 0.0 109.265 171.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -45.41 -50.22 9.43 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 124.189 3.259 . . . . 0.0 115.431 -177.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.9 t -74.38 -42.32 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -174.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.3 t -64.96 -29.73 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 123.864 0.865 . . . . 0.0 111.217 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.61 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -71.61 -35.91 70.64 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.693 1.197 . . . . 0.0 110.364 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.48 HD22 HD12 ' A' ' 44' ' ' ILE . 3.7 tt -72.01 -37.74 69.74 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.544 177.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -63.63 -43.54 96.5 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.362 0.665 . . . . 0.0 110.375 175.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.16 -34.87 78.49 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.028 0.931 . . . . 0.0 110.942 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.423 ' HB1' ' SD ' ' A' ' 90' ' ' MET . . . -70.1 -42.44 72.69 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.215 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 72.6 mt -61.62 -46.5 89.54 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.306 0.642 . . . . 0.0 110.46 174.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -61.07 -37.58 83.19 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.314 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -89.64 117.93 28.88 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 121.207 0.527 . . . . 0.0 109.951 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -53.63 -30.32 42.29 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.956 1.702 . . . . 0.0 113.93 -173.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -77.7 -48.34 16.96 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.743 0.417 . . . . 0.0 110.613 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.4 p -84.53 -9.36 58.41 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -169.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -67.04 -16.87 64.63 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 122.731 0.412 . . . . 0.0 111.953 -178.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -23.51 65.85 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.111 0.964 . . . . 0.0 113.205 -176.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.4 ' CB ' HD11 ' A' ' 64' ' ' ILE . 48.0 t -82.01 -32.21 30.68 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 118.089 0.404 . . . . 0.0 110.64 174.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.485 ' N ' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -74.54 -15.57 60.85 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.546 0.738 . . . . 0.0 110.814 177.536 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -57.64 -43.82 85.16 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.917 0.887 . . . . 0.0 109.651 167.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.95 -38.86 66.61 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.335 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -71.65 -16.9 62.27 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 122.596 0.358 . . . . 0.0 111.951 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.485 ' SG ' ' HD2' ' A' ' 47' ' ' LYS . 43.5 t -71.35 83.86 0.78 Allowed 'General case' 0 C--N 1.354 0.761 0 C-N-CA 123.883 0.873 . . . . 0.0 109.537 175.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.62 -32.24 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.397 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -176.37 -175.77 43.99 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.291 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -107.53 137.61 45.24 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.226 1.01 . . . . 0.0 109.113 175.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -74.59 121.23 21.27 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.218 0.607 . . . . 0.0 110.259 173.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.414 HD12 HD13 ' A' ' 25' ' ' LEU . 6.4 tt -100.81 117.48 34.98 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 168.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 103' ' ' GLN . 38.9 tt0 -70.87 129.51 89.58 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.54 0.736 . . . . 0.0 109.626 176.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -57.01 -25.8 65.03 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 123.033 2.489 . . . . 0.0 113.117 -177.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -86.16 -27.91 24.27 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.301 0.64 . . . . 0.0 111.604 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.568 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 56.9 tp60 -53.86 -31.65 50.35 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.4 1.08 . . . . 0.0 112.35 -175.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -66.85 -40.83 88.02 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.99 0.916 . . . . 0.0 111.703 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.73 -32.62 9.9 Favored Glycine 0 N--CA 1.473 1.15 0 N-CA-C 114.473 0.549 . . . . 0.0 114.473 -173.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.3 p -76.55 109.57 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 CA-C-O 121.659 0.742 . . . . 0.0 110.79 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.5 t -134.08 134.94 42.9 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.498 1.119 . . . . 0.0 109.054 175.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 53.9 mt -89.87 113.17 55.99 Favored Pre-proline 0 N--CA 1.477 0.923 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -79.5 178.14 7.71 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 122.58 2.186 . . . . 0.0 111.655 175.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -78.15 134.71 37.62 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -162.5 -55.92 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.276 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.934 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.464 ' HG3' ' HG3' ' A' ' 22' ' ' LYS . 10.6 pt-20 . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.472 0.177 . . . . 0.0 110.969 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.464 ' HG3' ' HG3' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -153.59 170.04 21.79 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.515 0.726 . . . . 0.0 111.199 -177.742 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.47 135.62 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 123.608 0.763 . . . . 0.0 109.146 171.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.6 m -111.98 109.45 19.22 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 173.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.445 HD13 HD12 ' A' ' 99' ' ' LEU . 84.0 mt -99.12 103.22 15.11 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 177.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.543 ' HB ' HG21 ' A' ' 48' ' ' VAL . 58.5 t -93.22 117.35 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -176.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.402 HH21 ' HB3' ' A' ' 101' ' ' PRO . 74.9 mtp180 -90.64 164.62 14.1 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.302 0.641 . . . . 0.0 109.906 174.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.46 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 11.8 tt -58.72 -33.62 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.15 0.58 . . . . 0.0 111.604 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.18 -50.29 74.25 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.451 0.7 . . . . 0.0 110.512 176.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -67.0 -33.42 75.53 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.746 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 43.5 tp -61.22 -45.43 94.61 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.995 0.918 . . . . 0.0 110.435 178.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 16.2 mm-40 -62.9 -54.26 41.33 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.032 0.933 . . . . 0.0 110.973 178.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -59.22 -49.22 78.68 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.572 -174.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -69.64 -32.45 71.13 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.047 -175.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -64.23 -47.62 78.97 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.258 177.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 -72.31 -24.11 61.27 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.713 0.805 . . . . 0.0 111.218 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -67.79 -24.62 65.33 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.094 0.958 . . . . 0.0 110.681 174.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 129.94 -27.72 4.03 Favored Glycine 0 C--N 1.344 1.019 0 N-CA-C 112.022 -0.431 . . . . 0.0 112.022 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.24 91.62 1.14 Allowed Glycine 0 C--N 1.341 0.813 0 N-CA-C 111.364 -0.695 . . . . 0.0 111.364 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -74.95 109.92 8.81 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -175.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 47.5 m0 -104.97 172.93 6.53 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.111 0.965 . . . . 0.0 110.188 175.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.9 t -158.9 135.51 9.4 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.265 1.026 . . . . 0.0 108.945 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.529 HG22 HG22 ' A' ' 48' ' ' VAL . 61.7 t -92.95 111.74 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 122.985 0.514 . . . . 0.0 109.891 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.3 mt -123.67 113.08 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 123.974 0.91 . . . . 0.0 109.213 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 63.15 45.23 5.26 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.882 1.273 . . . . 0.0 111.89 172.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.09 7.86 77.57 Favored Glycine 0 N--CA 1.476 1.337 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.545 177.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -118.51 156.13 29.63 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.237 1.015 . . . . 0.0 108.742 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.543 HG21 ' HB ' ' A' ' 26' ' ' VAL . 24.3 t -115.53 116.02 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -111.15 156.61 21.13 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.166 0.986 . . . . 0.0 108.847 174.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -93.34 149.96 20.84 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.233 0.54 . . . . 0.0 110.227 173.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.9 mm -103.91 -22.97 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 124.288 1.035 . . . . 0.0 108.909 167.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.64 -59.42 5.23 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.175 0.99 . . . . 0.0 111.015 -175.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 20.8 t70 -76.38 -30.87 57.7 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.301 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -52.21 -54.77 26.77 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.689 1.196 . . . . 0.0 112.255 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -67.34 -26.86 66.7 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.084 -178.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 51.7 m -67.86 -36.11 79.71 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.509 172.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 22.7 mm-40 -77.39 -25.4 50.82 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.945 0.498 . . . . 0.0 111.994 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.5 p -74.68 -7.23 52.61 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.7 tt -63.46 -40.45 97.15 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.991 0.916 . . . . 0.0 109.134 167.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.578 ' HB ' ' HB3' ' A' ' 63' ' ' SER . 27.1 m -65.51 119.29 10.8 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.532 0.733 . . . . 0.0 109.478 -177.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -74.27 -14.91 60.98 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 120.768 0.318 . . . . 0.0 111.119 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -101.06 10.4 41.06 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.794 0.838 . . . . 0.0 111.189 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.578 ' HB3' ' HB ' ' A' ' 60' ' ' THR . 81.8 p -87.17 162.22 17.62 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.569 ' HB ' HG22 ' A' ' 86' ' ' THR . 45.9 pt -66.9 -22.25 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.067 0.547 . . . . 0.0 110.816 170.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.438 HD21 ' HE1' ' A' ' 90' ' ' MET . 51.8 mt -85.26 -7.76 58.85 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.978 0.911 . . . . 0.0 111.721 -178.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.24 -33.04 74.85 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.492 0.717 . . . . 0.0 111.785 177.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 11.3 pt20 -76.06 -26.39 56.48 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.286 175.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -87.63 -5.39 58.74 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.881 0.872 . . . . 0.0 111.387 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.26 99.14 0.67 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.057 0.543 . . . . 0.0 110.188 176.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 142.86 -29.41 2.1 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -172.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -93.81 153.95 18.01 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.253 1.021 . . . . 0.0 109.765 172.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -57.74 127.76 79.12 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 124.051 0.94 . . . . 0.0 110.231 175.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -46.31 -39.81 21.74 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 123.984 3.123 . . . . 0.0 115.88 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.6 t -69.44 -49.42 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 122.559 0.344 . . . . 0.0 110.355 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.0 t -61.65 -40.87 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.871 0.868 . . . . 0.0 110.503 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.72 -33.46 74.93 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.463 -1.244 . . . . 0.0 111.429 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.421 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 5.1 tt -68.6 -46.7 68.61 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.692 0.797 . . . . 0.0 109.49 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -63.92 -40.98 97.74 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.382 0.673 . . . . 0.0 111.265 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.27 -37.74 88.45 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.613 0.765 . . . . 0.0 110.545 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.03 -22.81 59.42 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.434 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 87.2 mt -74.59 -37.16 62.97 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 120.878 0.371 . . . . 0.0 110.06 173.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -73.04 -26.98 61.49 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.472 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -95.43 121.08 36.73 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 123.123 0.569 . . . . 0.0 109.531 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.1 -35.97 82.49 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.088 0.955 . . . . 0.0 113.032 -172.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.26 -12.81 61.32 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.283 0.633 . . . . 0.0 112.175 -176.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.569 HG22 ' HB ' ' A' ' 64' ' ' ILE . 24.6 p -117.8 -13.9 10.13 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.272 0.629 . . . . 0.0 112.577 -177.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -75.12 -21.23 59.01 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.035 0.445 . . . . 0.0 111.238 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -35.7 80.97 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.768 0.827 . . . . 0.0 112.121 -176.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.7 t -78.3 -22.09 48.72 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.438 ' HE1' HD21 ' A' ' 65' ' ' LEU . 21.3 mmt -71.54 -4.74 28.56 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.29 0.636 . . . . 0.0 111.785 177.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -69.55 -27.83 65.48 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.114 0.565 . . . . 0.0 109.809 169.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.76 -41.08 15.4 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.807 0.843 . . . . 0.0 110.746 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -66.79 -22.97 66.01 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.089 0.556 . . . . 0.0 111.594 177.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 43.8 t -71.13 92.57 0.99 Allowed 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 173.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.9 m -69.82 -19.05 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.243 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 171.94 177.59 41.64 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.328 175.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -96.97 138.56 34.31 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 174.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -72.85 145.6 46.82 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.065 0.46 . . . . 0.0 111.105 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.445 HD12 HD13 ' A' ' 25' ' ' LEU . 5.7 tt -136.07 121.81 19.77 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.722 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 23.3 mt-10 -79.53 132.52 61.67 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 123.41 0.684 . . . . 0.0 109.947 175.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.402 ' HB3' HH21 ' A' ' 27' ' ' ARG . 17.7 Cg_endo -57.8 -30.04 87.99 Favored 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 122.305 2.003 . . . . 0.0 112.258 175.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -76.37 -26.58 55.8 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.076 0.95 . . . . 0.0 111.634 177.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.722 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 6.2 tp-100 -66.53 -28.89 68.9 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.857 0.863 . . . . 0.0 110.343 177.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -65.56 103.71 0.89 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.883 171.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 83.59 38.88 10.14 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.138 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.32 129.04 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 123.289 0.636 . . . . 0.0 110.673 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.2 t -85.0 132.05 34.39 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.952 0.501 . . . . 0.0 110.137 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 76.9 mt -98.69 121.63 55.68 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 123.646 0.778 . . . . 0.0 109.305 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -87.75 166.11 7.43 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.882 2.388 . . . . 0.0 112.581 175.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -99.81 -21.23 15.83 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.3 0.64 . . . . 0.0 110.64 174.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.9 mp -79.35 79.5 5.79 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 170.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.944 0 CA-C-O 118.942 -0.921 . . . . 0.0 112.683 179.617 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 N--CA 1.484 1.228 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -114.2 89.2 3.03 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.441 0.697 . . . . 0.0 109.253 176.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.3 p -86.8 143.32 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 122.994 0.518 . . . . 0.0 110.228 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.52 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 17.4 m -69.77 111.08 5.28 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.817 0.847 . . . . 0.0 110.517 -179.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.478 HD13 HD22 ' A' ' 99' ' ' LEU . 72.7 mt -83.24 100.01 10.33 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.276 0.56 . . . . 0.0 109.562 177.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.423 HG21 HG23 ' A' ' 95' ' ' VAL . 84.6 t -95.48 116.05 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.164 177.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.477 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 18.4 mtm180 -91.41 172.44 8.52 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.338 0.655 . . . . 0.0 110.143 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.508 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 15.7 tt -61.9 -31.2 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 122.458 0.303 . . . . 0.0 110.552 177.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.38 -52.24 59.94 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.767 0.827 . . . . 0.0 110.804 172.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.419 ' HA ' ' ND2' ' A' ' 33' ' ' ASN . 3.4 m-20 -62.26 -42.22 99.13 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.398 1.079 . . . . 0.0 110.703 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 44.1 tp -59.71 -44.83 93.53 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.969 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 20.4 mm-40 -71.05 -48.97 49.75 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.755 -176.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.419 ' ND2' ' HA ' ' A' ' 30' ' ' ASP . 10.2 p30 -72.08 -33.4 67.89 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.1 0.25 . . . . 0.0 111.33 -174.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -73.82 -35.94 64.92 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.792 0.437 . . . . 0.0 110.189 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -69.47 -34.21 74.03 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.694 0.398 . . . . 0.0 110.429 176.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -73.16 -26.89 61.37 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.072 0.549 . . . . 0.0 110.434 175.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.07 -28.63 68.98 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.457 1.103 . . . . 0.0 110.603 172.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.65 -24.14 6.88 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 -177.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.62 ' HA2' ' HD2' ' A' ' 52' ' ' LYS . . . -70.03 89.97 0.33 Allowed Glycine 0 C--N 1.347 1.144 0 O-C-N 123.895 0.409 . . . . 0.0 112.113 177.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -75.55 107.74 7.9 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -175.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 34.5 m0 -104.31 166.28 10.5 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.247 175.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.1 t -147.67 139.29 23.91 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.175 0.99 . . . . 0.0 108.579 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.468 HG22 HG22 ' A' ' 48' ' ' VAL . 95.8 t -98.18 111.39 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.465 HG21 ' HG2' ' A' ' 78' ' ' GLU . 70.7 mt -140.59 139.14 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.572 1.149 . . . . 0.0 108.28 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.5 t70 63.07 30.85 16.16 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 124.537 1.135 . . . . 0.0 111.177 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.43 15.45 68.18 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.898 -0.592 . . . . 0.0 113.32 -177.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HB2' ' CE1' ' A' ' 49' ' ' TYR . 25.6 mmtp -119.21 176.74 5.17 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.805 1.242 . . . . 0.0 108.283 -178.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.468 HG22 HG22 ' A' ' 43' ' ' VAL . 53.1 t -125.06 115.48 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 171.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.445 ' CE1' ' HB2' ' A' ' 47' ' ' LYS . 85.2 m-85 -108.16 159.41 16.62 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.347 1.059 . . . . 0.0 109.467 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -90.89 160.72 15.55 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 120.958 0.409 . . . . 0.0 110.081 171.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 28.1 mm -120.97 -26.71 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.998 0.919 . . . . 0.0 109.958 173.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.62 ' HD2' ' HA2' ' A' ' 39' ' ' GLY . 19.2 ptmt -67.96 -47.04 69.72 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 122.915 0.486 . . . . 0.0 111.953 -175.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -76.81 -33.27 58.0 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.67 0.388 . . . . 0.0 109.99 177.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -53.05 -50.05 65.11 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.616 1.566 . . . . 0.0 111.849 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -67.8 -28.33 67.49 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.145 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.0 m -73.02 -33.68 65.89 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.052 0.541 . . . . 0.0 110.08 176.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -73.9 -29.34 62.02 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.148 0.979 . . . . 0.0 111.838 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.7 p -73.6 -8.59 56.57 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.936 0.494 . . . . 0.0 112.236 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.0 mt -77.86 -12.38 59.97 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.4 0.68 . . . . 0.0 111.683 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.426 HG22 ' H ' ' A' ' 62' ' ' ASN . 35.4 m -82.32 132.02 35.22 Favored 'General case' 0 C--N 1.361 1.074 0 C-N-CA 122.777 0.431 . . . . 0.0 110.061 178.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -67.77 -30.54 70.02 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.618 0.767 . . . . 0.0 111.528 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.426 ' H ' HG22 ' A' ' 60' ' ' THR . 25.1 t-20 -112.52 74.26 0.85 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -178.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.4 m -150.91 165.05 34.85 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.137 0.975 . . . . 0.0 109.962 178.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.563 HD13 ' HB3' ' A' ' 89' ' ' SER . 9.3 pt -67.1 -25.73 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.194 177.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.461 ' HG ' HG13 ' A' ' 64' ' ' ILE . 71.0 mt -95.21 2.65 54.99 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.863 0.865 . . . . 0.0 111.588 -176.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.41 -34.53 70.42 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.315 0.579 . . . . 0.0 110.422 176.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -72.28 -23.42 61.19 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.395 173.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -100.0 7.34 44.82 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.574 1.15 . . . . 0.0 111.038 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.01 80.21 3.55 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.478 0.711 . . . . 0.0 110.057 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 147.77 -24.14 1.48 Allowed Glycine 0 N--CA 1.471 0.993 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.001 -170.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -84.16 151.91 24.59 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.919 0.888 . . . . 0.0 109.902 175.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -55.69 125.57 61.64 Favored Pre-proline 0 N--CA 1.481 1.125 0 CA-C-O 118.27 -0.871 . . . . 0.0 109.589 174.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.71 -36.83 91.23 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 123.191 2.594 . . . . 0.0 114.86 -175.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.0 t -74.73 -36.22 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.262 0.625 . . . . 0.0 110.314 -177.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.7 t -72.3 -36.91 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.979 0.912 . . . . 0.0 110.622 175.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.26 -29.19 65.92 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.638 1.175 . . . . 0.0 110.572 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.537 HD22 ' SD ' ' A' ' 90' ' ' MET . 1.8 tm? -63.36 -48.85 76.21 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.48 1.112 . . . . 0.0 109.156 173.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.465 ' HG2' HG21 ' A' ' 44' ' ' ILE . 23.2 mt-10 -68.44 -39.72 81.39 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.291 -178.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.98 -34.19 77.42 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.863 0.865 . . . . 0.0 110.453 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.28 -39.65 82.07 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.892 174.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 66.5 mt -67.29 -29.38 68.96 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.366 0.666 . . . . 0.0 112.157 177.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -72.3 -43.42 64.22 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.686 0.795 . . . . 0.0 110.519 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -85.35 114.66 22.59 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -54.66 -33.39 60.64 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.541 1.136 . . . . 0.0 113.077 -172.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -64.79 -52.63 55.85 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.708 0.803 . . . . 0.0 111.115 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.496 HG22 ' HB ' ' A' ' 64' ' ' ILE . 38.5 p -81.23 -13.99 57.95 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.567 -171.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.56 -18.16 57.19 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 120.956 0.408 . . . . 0.0 110.927 -178.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -64.72 -45.29 87.18 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.939 0.896 . . . . 0.0 110.061 175.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.563 ' HB3' HD13 ' A' ' 64' ' ' ILE . 46.6 t -71.27 -17.6 62.47 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.949 0.899 . . . . 0.0 112.325 -178.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.537 ' SD ' HD22 ' A' ' 77' ' ' LEU . 30.3 mmt -63.49 -15.23 57.25 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.551 0.741 . . . . 0.0 112.123 177.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.476 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 3.3 p80 -57.89 -33.09 68.36 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.681 0.793 . . . . 0.0 111.194 175.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.09 -33.46 70.21 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.103 0.961 . . . . 0.0 111.193 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -90.89 -26.11 19.5 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.494 -174.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.476 ' SG ' ' HA ' ' A' ' 91' ' ' HIS . 26.8 p -76.84 105.4 7.88 Favored 'General case' 0 C--N 1.358 0.971 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.423 HG23 HG21 ' A' ' 26' ' ' VAL . 35.9 m -69.48 -25.46 29.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 123.114 0.565 . . . . 0.0 110.692 174.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.52 ' HA3' ' HB ' ' A' ' 24' ' ' THR . . . 170.07 -165.69 38.99 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.557 174.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -88.58 140.57 29.32 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.18 0.992 . . . . 0.0 109.609 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -77.16 135.82 38.55 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 122.706 0.402 . . . . 0.0 110.782 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.478 HD22 HD13 ' A' ' 25' ' ' LEU . 66.4 tp -121.97 130.84 53.65 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.66 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 37.9 mt-10 -83.37 148.37 55.51 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 171.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.13 -7.28 20.44 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.51 2.14 . . . . 0.0 112.716 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -109.62 -16.93 13.83 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.359 1.064 . . . . 0.0 110.847 178.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.66 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 9.1 tp-100 -73.94 -31.13 62.9 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.773 0.829 . . . . 0.0 112.355 -172.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -64.18 -33.37 75.63 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.102 0.477 . . . . 0.0 110.331 174.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -102.74 31.84 8.27 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.944 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.5 p -70.24 147.7 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.087 0.555 . . . . 0.0 110.866 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.4 t -126.22 148.75 49.4 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 171.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 62.7 mt -120.64 97.48 48.56 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -83.44 155.02 14.11 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.75 2.3 . . . . 0.0 112.178 175.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -70.78 123.38 21.8 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.542 0.737 . . . . 0.0 110.545 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -145.09 -71.17 0.27 Allowed 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.258 0 CA-C-O 118.802 -0.999 . . . . 0.0 111.464 -175.563 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -84.06 136.76 33.89 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.666 176.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.8 p -147.81 97.05 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.6 p -63.02 113.14 2.93 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.537 0.735 . . . . 0.0 111.453 -175.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.3 mt -78.78 106.58 10.88 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.566 0.746 . . . . 0.0 109.521 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.8 t -93.61 121.33 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 123.69 0.796 . . . . 0.0 109.074 -175.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -72.13 151.18 43.19 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.778 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.5 tt -61.3 -39.23 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 120.724 0.297 . . . . 0.0 111.41 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.26 -29.27 70.63 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.922 0.889 . . . . 0.0 111.328 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 34' ' ' HIS . 11.0 t70 -62.54 -47.42 83.96 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.077 0.551 . . . . 0.0 109.789 178.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.0 mp -58.54 -48.36 81.13 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 123.76 0.663 . . . . 0.0 110.28 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -55.04 -44.75 74.96 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 124.375 1.047 . . . . 0.0 111.358 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -73.9 -39.79 63.62 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.755 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 30' ' ' ASP . 1.6 t60 -68.32 -39.15 82.05 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.34 0.656 . . . . 0.0 111.44 -167.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -70.07 -33.01 71.37 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.545 0.338 . . . . 0.0 110.97 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -68.53 -30.46 69.27 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.495 0.718 . . . . 0.0 110.074 178.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -70.3 -33.74 71.91 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.402 0.681 . . . . 0.0 110.429 173.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 134.96 -27.55 3.16 Favored Glycine 0 C--N 1.344 1.019 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.95 87.99 0.97 Allowed Glycine 0 C--N 1.347 1.154 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.418 ' HB3' ' HB ' ' A' ' 51' ' ' ILE . 26.3 t80 -74.8 109.37 8.22 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -171.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 36.6 m0 -105.15 146.83 28.66 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.598 0.759 . . . . 0.0 109.783 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 12.0 t -144.22 136.95 26.99 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.173 0.589 . . . . 0.0 110.352 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 p -88.02 112.05 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 121.466 0.651 . . . . 0.0 109.696 174.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.461 HD12 HD23 ' A' ' 77' ' ' LEU . 84.6 mt -132.38 131.18 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.149 1.38 . . . . 0.0 107.794 175.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.2 t70 60.53 29.89 19.35 Favored 'General case' 0 CA--C 1.567 1.616 0 CA-C-O 121.819 0.818 . . . . 0.0 111.634 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.23 4.33 73.08 Favored Glycine 0 C--N 1.353 1.499 0 CA-C-N 115.565 -0.743 . . . . 0.0 114.01 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.455 ' HD2' ' SG ' ' A' ' 94' ' ' CYS . 71.8 mmtt -111.56 139.3 47.12 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.212 1.005 . . . . 0.0 109.142 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 52.9 t -89.96 123.22 42.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 170.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -110.71 169.76 8.54 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.686 0.795 . . . . 0.0 109.815 177.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -105.03 142.46 34.78 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.706 172.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.418 ' HB ' ' HB3' ' A' ' 40' ' ' PHE . 25.6 mm -112.56 -29.81 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.876 0.87 . . . . 0.0 110.982 -175.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -66.76 -30.73 71.02 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.578 0.627 . . . . 0.0 109.727 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.488 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 37.1 t70 -74.81 -49.59 20.16 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.847 0.859 . . . . 0.0 110.048 172.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.403 ' HA ' ' HE2' ' A' ' 93' ' ' PHE . 48.6 t80 -48.45 -50.93 29.34 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.814 1.246 . . . . 0.0 112.117 -178.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -68.64 -27.92 66.43 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.438 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 89.2 m -70.23 -36.44 74.52 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.284 0.634 . . . . 0.0 110.37 173.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 84.3 mm-40 -73.76 -23.53 59.74 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.695 0.798 . . . . 0.0 112.213 -176.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 64.3 p -75.04 -13.75 60.53 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.5 mp -71.67 -24.81 61.9 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.253 0.621 . . . . 0.0 110.568 173.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.5 m -71.22 121.96 19.35 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 122.638 0.375 . . . . 0.0 110.08 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.62 -37.62 85.24 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.346 0.659 . . . . 0.0 110.958 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -91.14 78.36 5.88 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 175.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.6 t -157.38 158.52 36.07 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.914 0.886 . . . . 0.0 109.299 -178.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.557 ' HB ' HG22 ' A' ' 86' ' ' THR . 38.9 pt -68.07 -23.5 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.832 170.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.6 mt -88.2 -0.34 56.98 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.697 0.799 . . . . 0.0 112.441 -177.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.36 -36.63 81.77 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.061 0.544 . . . . 0.0 110.914 176.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -73.0 -27.3 61.71 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.148 0.579 . . . . 0.0 110.853 175.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -90.62 1.54 56.69 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.822 0.849 . . . . 0.0 111.489 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.65 94.39 0.43 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.07 0.548 . . . . 0.0 110.652 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.64 -27.87 2.69 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.547 -176.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -77.43 151.8 34.58 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.65 0.78 . . . . 0.0 109.882 175.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -56.16 130.15 74.17 Favored Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 123.463 0.705 . . . . 0.0 109.697 173.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.99 -40.92 58.29 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.334 2.69 . . . . 0.0 114.69 -174.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.45 HG13 HD11 ' A' ' 44' ' ' ILE . 65.1 t -73.98 -43.04 52.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 122.959 0.504 . . . . 0.0 110.509 -176.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.8 t -65.4 -39.48 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 123.44 0.696 . . . . 0.0 110.901 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.86 -36.21 82.81 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.556 1.142 . . . . 0.0 110.76 177.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.461 HD23 HD12 ' A' ' 44' ' ' ILE . 31.5 tp -69.44 -38.94 78.04 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.618 178.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -60.74 -48.45 81.73 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.868 0.467 . . . . 0.0 110.249 175.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.78 -32.68 73.88 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.871 0.868 . . . . 0.0 111.242 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.07 -33.35 73.42 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.281 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.6 -38.96 70.8 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.298 0.239 . . . . 0.0 110.619 174.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -66.82 -29.2 69.07 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.293 0.637 . . . . 0.0 111.582 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.407 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 65.4 t80 -98.53 139.22 34.58 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.032 0.444 . . . . 0.0 110.163 177.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -62.07 -54.24 44.15 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.603 1.161 . . . . 0.0 113.945 -170.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.57 -38.37 90.79 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.228 0.611 . . . . 0.0 111.277 -175.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.557 HG22 ' HB ' ' A' ' 64' ' ' ILE . 36.6 p -80.54 -17.67 50.76 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 115.254 -0.884 . . . . 0.0 112.051 -172.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 19.9 ptt-85 -78.82 -23.17 45.24 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.158 0.504 . . . . 0.0 110.201 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -67.83 -38.03 82.67 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.258 1.023 . . . . 0.0 112.262 -173.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 32.0 t -73.91 -24.17 59.65 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.558 175.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 18.8 mmt -72.19 -7.84 51.45 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -65.23 -33.81 76.88 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.705 0.402 . . . . 0.0 109.955 169.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.05 -37.79 64.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.42 0.688 . . . . 0.0 111.448 175.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.403 ' HE2' ' HA ' ' A' ' 54' ' ' PHE . 90.4 m-85 -73.9 -23.71 59.6 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 122.895 0.478 . . . . 0.0 111.446 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.455 ' SG ' ' HD2' ' A' ' 47' ' ' LYS . 53.1 t -70.09 102.7 2.11 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.251 0.62 . . . . 0.0 109.714 177.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.3 m -73.2 -20.65 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.453 0.701 . . . . 0.0 110.677 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 170.46 -177.67 43.53 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.996 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -85.65 150.61 24.5 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 173.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -77.6 142.58 38.85 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.136 0.574 . . . . 0.0 110.124 173.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -133.76 130.0 37.44 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.839 0.856 . . . . 0.0 108.747 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 43.8 mt-10 -85.99 129.61 53.48 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.489 1.116 . . . . 0.0 109.482 175.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -55.29 -35.21 90.89 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 123.112 2.541 . . . . 0.0 112.752 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -71.47 -36.23 71.1 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.011 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.454 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 51.5 tp60 -63.29 -35.76 81.43 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.874 0.87 . . . . 0.0 111.393 -175.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -66.96 102.34 0.96 Allowed 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.921 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 149.34 -84.47 0.17 Allowed Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.064 172.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.0 p -124.97 155.12 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.874 0.87 . . . . 0.0 110.42 -172.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.5 t -122.06 133.67 54.78 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.828 0.851 . . . . 0.0 109.587 175.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.9 mm -101.86 128.14 29.45 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 123.747 0.819 . . . . 0.0 108.898 175.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -81.8 -168.05 0.56 Allowed 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.653 2.236 . . . . 0.0 111.581 174.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -91.09 129.32 37.1 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 172.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -159.46 -45.88 0.05 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.5 0.72 . . . . 0.0 110.748 175.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.232 0 CA-C-O 119.064 -0.853 . . . . 0.0 111.405 -179.153 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.248 0.071 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.34 149.66 50.04 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 173.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 p -103.15 137.39 31.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 121.007 0.432 . . . . 0.0 110.781 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.2 m -114.45 107.45 15.56 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 166.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.465 HD22 ' HB2' ' A' ' 99' ' ' LEU . 45.9 mt -97.55 119.07 35.45 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.146 0.498 . . . . 0.0 109.95 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.508 HG13 ' HB2' ' A' ' 30' ' ' ASP . 86.3 t -106.69 131.35 56.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -104.06 170.28 8.01 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 173.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.4 tt -58.15 -31.53 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.065 0.546 . . . . 0.0 111.974 -177.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.69 -42.44 83.67 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.545 0.738 . . . . 0.0 111.319 177.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.508 ' HB2' HG13 ' A' ' 26' ' ' VAL . 38.4 m-20 -63.59 -36.27 83.25 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.165 0.586 . . . . 0.0 111.325 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.8 mt -63.88 -51.58 63.91 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 123.904 0.752 . . . . 0.0 109.748 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -59.18 -46.26 88.87 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.555 -1.202 . . . . 0.0 112.262 -172.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -77.08 -30.17 55.3 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 111.479 0.178 . . . . 0.0 111.479 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -73.44 -26.36 60.91 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.745 0.418 . . . . 0.0 110.844 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -61.28 -37.56 83.61 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.745 0.818 . . . . 0.0 110.377 172.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -70.62 -32.97 70.51 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.988 0.915 . . . . 0.0 110.789 174.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -64.56 -33.42 75.87 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.94 0.896 . . . . 0.0 110.819 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 125.46 -27.14 5.32 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 116.434 -0.348 . . . . 0.0 112.271 175.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.09 107.85 2.36 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 175.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -80.27 108.02 13.54 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -99.79 154.8 18.04 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.055 0.942 . . . . 0.0 110.031 176.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.3 t -147.96 164.63 33.18 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.093 0.957 . . . . 0.0 109.093 172.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.527 HG22 HG22 ' A' ' 48' ' ' VAL . 98.2 t -120.68 117.39 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.201 0.601 . . . . 0.0 110.796 -176.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.6 mt -138.77 138.13 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.698 1.199 . . . . 0.0 107.919 174.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.6 t70 63.08 30.64 16.16 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.475 1.11 . . . . 0.0 111.004 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.43 18.08 69.28 Favored Glycine 0 C--N 1.355 1.627 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.539 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.431 ' HD2' ' SG ' ' A' ' 94' ' ' CYS . 75.0 mmtt -124.15 148.75 46.97 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.273 1.029 . . . . 0.0 109.203 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.527 HG22 HG22 ' A' ' 43' ' ' VAL . 39.1 t -100.08 128.94 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.509 0.724 . . . . 0.0 109.212 174.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -122.33 144.9 48.72 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.856 0.862 . . . . 0.0 109.254 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -87.43 104.62 16.62 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 174.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.493 HG23 ' HB2' ' A' ' 73' ' ' PRO . 24.6 mm -62.59 -31.89 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.223 1.009 . . . . 0.0 111.082 174.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.0 ttpp -60.01 -36.97 78.36 Favored 'General case' 0 CA--C 1.554 1.125 0 O-C-N 123.597 0.561 . . . . 0.0 110.291 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.425 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 33.0 t70 -75.3 -42.5 54.52 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.281 0.633 . . . . 0.0 111.209 174.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.409 ' HA ' ' CE1' ' A' ' 93' ' ' PHE . 50.5 t80 -51.08 -51.76 50.15 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.704 1.202 . . . . 0.0 111.21 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -67.66 -27.73 67.11 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.837 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 58.8 m -68.34 -38.82 81.87 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.599 0.36 . . . . 0.0 110.773 174.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.464 ' HB2' HD12 ' A' ' 65' ' ' LEU . 78.6 mm-40 -74.39 -27.24 60.55 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.305 0.642 . . . . 0.0 111.345 -177.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.0 p -74.06 -10.42 59.61 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.023 0.529 . . . . 0.0 112.168 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.8 mp -71.32 -17.21 62.46 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 122.974 0.51 . . . . 0.0 111.352 171.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.3 m -88.04 133.44 33.97 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -75.11 -31.9 61.26 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.135 0.493 . . . . 0.0 109.719 173.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -83.49 63.12 7.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.79 0.836 . . . . 0.0 109.664 174.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.8 p -146.49 160.19 42.43 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.547 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.63 ' HB ' HG22 ' A' ' 86' ' ' THR . 40.0 pt -68.03 -22.73 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.688 170.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.464 HD12 ' HB2' ' A' ' 57' ' ' GLN . 44.3 mt -91.49 2.49 56.39 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.186 0.995 . . . . 0.0 112.208 -174.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.38 -33.34 75.32 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.067 0.547 . . . . 0.0 110.989 174.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -75.82 -29.87 58.8 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.679 0.792 . . . . 0.0 110.659 175.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -90.8 1.54 56.83 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.369 1.068 . . . . 0.0 111.688 -178.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.3 -25.87 67.82 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.624 0.77 . . . . 0.0 111.394 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -103.97 30.7 9.72 Favored Glycine 0 C--N 1.35 1.309 0 CA-C-N 116.547 -0.297 . . . . 0.0 112.431 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -139.11 154.49 48.15 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.403 1.081 . . . . 0.0 108.717 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -59.79 131.68 88.92 Favored Pre-proline 0 N--CA 1.48 1.052 0 CA-C-O 118.209 -0.9 . . . . 0.0 109.788 175.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.493 ' HB2' HG23 ' A' ' 51' ' ' ILE . 27.7 Cg_endo -58.29 -36.98 97.14 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 123.208 2.605 . . . . 0.0 114.329 -173.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.1 t -74.67 -45.68 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 122.893 0.477 . . . . 0.0 110.439 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.8 t -66.3 -35.83 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.686 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.81 -34.68 74.02 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.229 1.011 . . . . 0.0 110.627 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.614 HD12 ' SD ' ' A' ' 90' ' ' MET . 51.0 tp -66.15 -38.59 88.49 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.845 0.858 . . . . 0.0 110.486 177.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -58.73 -50.18 74.85 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.78 0.432 . . . . 0.0 110.049 174.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.47 -34.08 76.12 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.956 0.903 . . . . 0.0 111.012 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.73 -28.74 61.86 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.818 0.847 . . . . 0.0 111.506 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 81' ' ' LEU . 2.9 mm? -71.83 -28.99 63.94 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.333 0.253 . . . . 0.0 111.107 172.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -90.45 -25.01 20.56 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.529 0.732 . . . . 0.0 111.728 -174.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.418 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 40.7 t80 -91.57 133.78 35.24 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.653 0.381 . . . . 0.0 110.576 -176.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.14 -36.98 85.41 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.957 1.303 . . . . 0.0 113.96 -168.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -74.23 -27.27 60.7 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.32 0.648 . . . . 0.0 111.309 -176.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.63 HG22 ' HB ' ' A' ' 64' ' ' ILE . 39.4 p -101.53 -31.02 11.07 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.588 -170.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.409 ' HD2' ' N ' ' A' ' 88' ' ' GLU . 6.0 ppt_? -60.12 -32.03 70.61 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 123.794 0.837 . . . . 0.0 112.387 -174.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.409 ' N ' ' HD2' ' A' ' 87' ' ' ARG . 7.8 pt-20 -64.45 -43.4 94.39 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.49 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.0 t -78.43 -16.69 57.33 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.621 0.768 . . . . 0.0 111.632 -176.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.614 ' SD ' HD12 ' A' ' 77' ' ' LEU . 36.1 mmt -61.11 -28.24 68.95 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.282 0.633 . . . . 0.0 111.556 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -64.52 -25.64 68.08 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.673 0.789 . . . . 0.0 111.416 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.46 -25.68 57.62 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.535 0.734 . . . . 0.0 111.454 175.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.409 ' CE1' ' HA ' ' A' ' 54' ' ' PHE . 98.5 m-85 -86.44 -20.65 27.84 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.472 0.709 . . . . 0.0 111.374 176.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.431 ' SG ' ' HD2' ' A' ' 47' ' ' LYS . 47.6 t -67.07 97.88 0.54 Allowed 'General case' 0 C--N 1.351 0.646 0 O-C-N 123.814 0.696 . . . . 0.0 110.749 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.7 m -74.76 -10.58 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.874 0.869 . . . . 0.0 111.42 177.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 169.18 175.68 38.64 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 174.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.407 ' HG2' ' NZ ' ' A' ' 47' ' ' LYS . 15.2 mt-30 -80.53 163.51 23.67 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.362 0.665 . . . . 0.0 109.753 171.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -118.23 146.57 44.16 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.774 0.429 . . . . 0.0 109.891 175.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.465 ' HB2' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -142.43 125.76 16.57 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 174.112 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.7 mp0 -69.8 137.93 87.91 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 123.167 0.587 . . . . 0.0 110.479 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -51.69 -42.55 56.15 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.868 2.378 . . . . 0.0 112.013 169.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -59.23 -52.32 66.2 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.774 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -58.91 -35.89 73.82 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.381 1.072 . . . . 0.0 110.97 -178.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.5 -42.05 79.14 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.98 -177.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -73.56 -79.47 0.51 Allowed Glycine 0 C--N 1.346 1.13 0 N-CA-C 112.135 -0.386 . . . . 0.0 112.135 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -139.75 129.61 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.2 t -82.67 139.04 33.93 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.035 0.534 . . . . 0.0 110.19 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.9 mt -93.85 111.05 51.24 Favored Pre-proline 0 CA--C 1.545 0.774 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.65 126.82 13.83 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 122.534 2.156 . . . . 0.0 110.566 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -64.59 105.44 0.96 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.866 0.467 . . . . 0.0 110.292 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.0 tt -165.26 131.57 2.77 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -176.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.278 0 CA-C-O 119.101 -0.833 . . . . 0.0 113.015 -177.829 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 . . . . . 0 N--CA 1.486 1.342 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.52 163.69 33.95 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.603 0.761 . . . . 0.0 109.653 176.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.7 p -153.64 129.08 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 172.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.3 m -68.24 110.87 4.24 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.341 0.656 . . . . 0.0 110.024 -178.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.5 mt -77.22 102.39 6.63 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.539 ' HB ' HG21 ' A' ' 48' ' ' VAL . 94.6 t -93.51 116.74 35.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.042 -177.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.413 ' HD2' ' HB3' ' A' ' 101' ' ' PRO . 71.6 mtm180 -82.34 166.49 19.43 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.223 176.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.0 tt -56.28 -37.69 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.296 0.639 . . . . 0.0 110.609 172.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.61 -47.55 83.97 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.969 0.908 . . . . 0.0 111.212 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.522 ' HA ' ' ND2' ' A' ' 33' ' ' ASN . 53.7 m-20 -67.18 -37.47 83.77 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.83 0.852 . . . . 0.0 110.935 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 36.3 tp -59.13 -45.14 91.71 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.75 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -72.28 -49.69 32.82 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.131 0.973 . . . . 0.0 112.11 -177.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.522 ' ND2' ' HA ' ' A' ' 30' ' ' ASP . 14.2 p30 -70.67 -33.68 71.19 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -170.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.401 ' CE1' ' HA3' ' A' ' 39' ' ' GLY . 43.4 t-80 -73.59 -30.91 63.3 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 120.564 0.221 . . . . 0.0 110.708 178.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -66.99 -38.64 86.38 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 173.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -65.4 -34.12 77.56 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.444 0.698 . . . . 0.0 110.363 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -65.16 -34.17 77.75 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.9 0.88 . . . . 0.0 110.514 175.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 139.08 -27.19 2.67 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 111.999 -0.44 . . . . 0.0 111.999 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.401 ' HA3' ' CE1' ' A' ' 34' ' ' HIS . . . -81.13 97.74 1.8 Allowed Glycine 0 C--N 1.34 0.798 0 N-CA-C 112.014 -0.434 . . . . 0.0 112.014 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -75.58 113.51 13.08 Favored 'General case' 0 C--N 1.347 0.469 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -98.09 164.5 12.31 Favored 'General case' 0 C--O 1.24 0.591 0 O-C-N 123.863 0.727 . . . . 0.0 109.799 176.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.405 HG21 HD11 ' A' ' 51' ' ' ILE . 15.3 t -147.05 133.9 20.13 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.659 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.541 HG22 HG22 ' A' ' 48' ' ' VAL . 82.2 t -95.95 107.03 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.6 mt -118.25 113.86 43.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 123.938 0.895 . . . . 0.0 108.844 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.3 t70 62.04 32.84 17.48 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.334 1.053 . . . . 0.0 111.272 174.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.99 5.66 85.85 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 115.255 -0.884 . . . . 0.0 114.081 177.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -115.65 150.4 36.8 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.495 0.718 . . . . 0.0 109.341 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.541 HG22 HG22 ' A' ' 43' ' ' VAL . 60.4 t -113.68 121.4 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 123.674 0.79 . . . . 0.0 109.856 -175.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -124.46 155.39 38.98 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.928 0.891 . . . . 0.0 109.175 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.431 ' HB3' ' HB2' ' A' ' 53' ' ' ASP . 7.7 t70 -97.09 120.29 37.17 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.438 ' O ' ' HG3' ' A' ' 55' ' ' GLN . 33.4 mm -73.68 -32.73 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.589 0.756 . . . . 0.0 111.599 -178.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -63.71 -45.99 87.48 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.431 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . 2.1 m-20 -65.51 -36.73 84.69 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.644 175.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -58.69 -51.88 68.06 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.609 0.764 . . . . 0.0 110.499 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.476 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 28.0 mt-30 -63.26 -29.23 70.6 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.889 -174.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.3 m -56.12 -36.75 68.57 Favored 'General case' 0 CA--C 1.553 1.088 0 O-C-N 123.862 0.726 . . . . 0.0 111.73 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -76.67 -30.99 56.99 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.281 0.632 . . . . 0.0 111.701 178.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 62.8 p -81.42 1.35 33.48 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 55' ' ' GLN . 83.1 mt -82.18 9.27 9.0 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.367 0.667 . . . . 0.0 112.33 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.5 t -128.53 165.5 20.63 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.226 0.61 . . . . 0.0 110.736 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -70.95 -60.83 2.02 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.73 0.812 . . . . 0.0 110.484 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -83.05 90.4 7.03 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.276 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.5 t -143.48 149.86 38.15 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.651 -1.158 . . . . 0.0 108.907 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.546 ' HB ' HG22 ' A' ' 86' ' ' THR . 37.2 pt -67.79 -19.94 25.53 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 C-N-CA 122.834 0.454 . . . . 0.0 110.843 171.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 60.1 mt -95.71 -1.76 49.3 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.351 1.06 . . . . 0.0 111.755 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.2 -29.68 69.41 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.947 0.499 . . . . 0.0 111.014 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -71.66 -19.96 62.02 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.786 0.834 . . . . 0.0 111.671 175.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.587 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 78.1 m-85 -99.89 10.72 40.83 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.344 1.058 . . . . 0.0 111.613 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.21 -26.1 68.36 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.309 0.643 . . . . 0.0 112.408 -176.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -92.57 18.84 53.98 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 116.393 -0.367 . . . . 0.0 113.245 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -132.88 151.11 52.09 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.788 0.835 . . . . 0.0 109.721 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -55.38 128.46 67.38 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 124.488 1.115 . . . . 0.0 109.924 172.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -54.76 -29.44 62.37 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.431 2.754 . . . . 0.0 114.626 -173.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.424 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 34.0 t -74.72 -49.37 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.5 t -68.8 -30.01 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 123.991 0.916 . . . . 0.0 111.017 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -68.74 -40.63 79.74 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.865 1.266 . . . . 0.0 109.895 176.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.527 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 41.4 tp -63.5 -40.85 98.17 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.684 175.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 35.3 mt-10 -58.39 -47.66 83.16 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.283 0.633 . . . . 0.0 111.384 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.99 -35.33 80.86 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.954 175.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.54 -18.1 59.89 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.126 0.97 . . . . 0.0 112.629 -178.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 89.1 mt -77.06 -36.56 55.82 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 173.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -76.21 -21.21 56.69 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.577 175.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -90.84 115.9 28.25 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.842 0.857 . . . . 0.0 110.099 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.75 -23.24 65.22 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.164 0.985 . . . . 0.0 113.366 -173.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -80.89 -14.49 57.97 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.286 0.634 . . . . 0.0 112.044 -178.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.546 HG22 ' HB ' ' A' ' 64' ' ' ILE . 7.2 p -110.47 -29.78 7.94 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.328 0.651 . . . . 0.0 112.682 -177.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -50.62 -27.39 6.77 Favored 'General case' 0 N--CA 1.507 2.397 0 C-N-CA 124.32 1.048 . . . . 0.0 113.247 -174.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -55.15 -48.54 73.57 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.245 1.418 . . . . 0.0 112.648 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.7 m -76.88 -20.25 56.48 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.116 0.566 . . . . 0.0 111.787 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.552 ' N ' ' SD ' ' A' ' 90' ' ' MET . 0.1 OUTLIER -74.76 -13.27 60.57 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.774 0.829 . . . . 0.0 111.274 176.52 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.448 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 28.4 m170 -75.0 -23.19 58.2 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.061 0.544 . . . . 0.0 110.017 171.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.86 -30.22 23.08 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.56 0.744 . . . . 0.0 110.728 172.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -83.59 -23.91 31.73 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.439 0.296 . . . . 0.0 111.481 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.448 ' SG ' ' HA ' ' A' ' 91' ' ' HIS . 31.0 p -73.42 109.93 7.31 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-O 120.959 0.409 . . . . 0.0 109.98 -177.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.8 t -68.96 -45.89 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.938 172.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 175.0 -150.12 10.89 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.857 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -115.46 137.57 51.92 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.035 1.334 . . . . 0.0 109.044 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -71.14 134.03 46.66 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.132 0.573 . . . . 0.0 110.37 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -143.78 122.89 12.88 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.418 ' HB2' ' CB ' ' A' ' 103' ' ' GLN . 47.1 mt-10 -66.12 133.83 94.76 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.446 0.699 . . . . 0.0 110.687 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.413 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 17.4 Cg_endo -57.48 -25.49 66.76 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 123.263 2.642 . . . . 0.0 113.139 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -79.66 -43.12 23.37 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.388 0.675 . . . . 0.0 110.4 173.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.418 ' CB ' ' HB2' ' A' ' 100' ' ' GLU . 9.6 tt0 -67.77 -8.93 39.71 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.874 0.87 . . . . 0.0 111.846 -175.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -57.43 -48.51 78.95 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.856 0.862 . . . . 0.0 110.165 173.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -96.81 -8.05 57.29 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.634 -0.712 . . . . 0.0 114.221 -175.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.6 p -132.38 135.39 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 117.699 0.749 . . . . 0.0 110.752 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.8 t -121.31 154.23 36.67 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.961 0.904 . . . . 0.0 110.206 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.3 mm -119.99 104.41 44.08 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -80.81 71.9 6.81 Favored 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 122.391 2.061 . . . . 0.0 111.634 176.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -74.75 147.86 40.94 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.538 -178.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -90.51 -39.92 12.3 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.654 0.782 . . . . 0.0 110.155 -176.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.97 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -177.577 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 110.563 -0.162 . . . . 0.0 110.563 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.23 150.23 45.47 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.671 0.388 . . . . 0.0 110.806 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.1 p -99.01 115.32 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.8 m -72.72 107.92 5.43 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.4 mt -86.86 111.01 20.36 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.6 t -91.19 114.15 28.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.8 ptp85 -70.67 158.05 36.9 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.484 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.45 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 10.1 tt -55.64 -44.68 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 123.352 0.407 . . . . 0.0 111.214 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.9 -33.41 75.26 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.578 0.751 . . . . 0.0 111.496 -177.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -74.55 -40.83 61.44 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.594 0.358 . . . . 0.0 110.105 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 57.2 tp -60.81 -53.25 59.6 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.115 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 51.4 mm-40 -58.88 -51.87 68.18 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.096 0.958 . . . . 0.0 111.827 -177.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -68.51 -41.06 80.51 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -175.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 66.2 t-80 -71.74 -42.66 67.0 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 118.033 0.379 . . . . 0.0 110.631 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -64.08 -51.14 65.47 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.823 0.849 . . . . 0.0 110.883 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -79.44 5.99 11.37 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.795 0.838 . . . . 0.0 111.994 -177.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -91.44 -8.42 47.83 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.884 0.874 . . . . 0.0 110.844 174.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.49 -26.26 12.23 Favored Glycine 0 C--N 1.344 0.987 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -175.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.596 ' HA2' ' HD3' ' A' ' 52' ' ' LYS . . . -75.35 77.73 1.18 Allowed Glycine 0 C--N 1.348 1.249 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 171.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -72.96 117.91 15.27 Favored 'General case' 0 C--N 1.345 0.404 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -163.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 29.0 m0 -110.26 172.0 7.12 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.883 1.273 . . . . 0.0 109.912 175.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.7 t -147.51 149.49 32.74 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.0 175.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 p -109.98 110.01 30.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.488 HD12 HD23 ' A' ' 77' ' ' LEU . 57.8 mt -124.77 124.0 67.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 124.076 0.95 . . . . 0.0 108.761 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.9 t70 63.0 32.91 15.23 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.483 1.113 . . . . 0.0 111.025 174.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.35 2.35 87.44 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.914 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 97' ' ' GLN . 46.4 mmtm -110.2 147.76 33.13 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.071 0.949 . . . . 0.0 109.261 177.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 47.8 t -102.43 127.66 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 122.842 0.457 . . . . 0.0 109.922 175.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -121.82 169.49 10.72 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.851 1.261 . . . . 0.0 108.987 175.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -94.64 157.07 16.13 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.65 0.738 . . . . 0.0 109.715 168.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.474 HG23 ' HB2' ' A' ' 73' ' ' PRO . 30.8 mm -121.05 -30.02 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 125.144 1.378 . . . . 0.0 108.911 172.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.596 ' HD3' ' HA2' ' A' ' 39' ' ' GLY . 35.7 ttpt -54.97 -58.0 9.39 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.86 0.864 . . . . 0.0 111.044 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -74.27 -36.34 63.8 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.149 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -51.95 -55.99 16.93 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.721 1.208 . . . . 0.0 111.846 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -68.33 -26.78 65.78 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.987 -176.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.9 m -66.78 -47.38 72.31 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 172.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -76.75 -13.67 60.01 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.025 0.93 . . . . 0.0 112.844 -176.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.553 ' HA ' ' HB2' ' A' ' 65' ' ' LEU . 90.8 p -67.96 -20.13 65.02 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -91.47 -0.16 57.58 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.612 0.365 . . . . 0.0 111.862 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.8 m -75.23 126.35 30.85 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 175.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -57.31 -48.4 79.05 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.389 1.076 . . . . 0.0 111.888 -170.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -82.59 -12.27 57.82 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.041 0.536 . . . . 0.0 112.431 -173.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 65.8 m -67.61 151.44 47.3 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 120.995 0.426 . . . . 0.0 111.232 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.57 ' HB ' HG22 ' A' ' 86' ' ' THR . 43.5 pt -61.04 -23.61 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.211 1.004 . . . . 0.0 111.468 174.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.553 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 63.1 mt -86.1 0.22 54.02 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.304 1.041 . . . . 0.0 111.961 -175.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.91 -33.24 71.92 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 122.969 0.507 . . . . 0.0 111.007 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -74.67 -25.58 59.27 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.582 0.753 . . . . 0.0 110.565 172.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.552 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 38.2 m-85 -95.99 3.7 53.25 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.317 1.047 . . . . 0.0 111.531 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.47 -29.35 69.45 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.57 0.748 . . . . 0.0 111.011 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.12 23.22 22.12 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.88 176.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -135.06 155.84 50.05 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.316 1.046 . . . . 0.0 108.912 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.84 131.28 78.98 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 124.222 1.009 . . . . 0.0 109.901 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.474 ' HB2' HG23 ' A' ' 51' ' ' ILE . 18.9 Cg_endo -55.4 -33.59 86.2 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 123.484 2.79 . . . . 0.0 114.303 -174.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.8 t -74.51 -46.99 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.4 t -64.1 -35.26 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 123.465 0.706 . . . . 0.0 110.58 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.552 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -67.41 -37.49 83.15 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.065 1.346 . . . . 0.0 110.56 178.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.69 HD12 ' SD ' ' A' ' 90' ' ' MET . 58.3 tp -67.2 -43.4 82.2 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.08 0.952 . . . . 0.0 110.466 176.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -64.6 -37.61 88.16 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.83 0.852 . . . . 0.0 111.2 178.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.29 -33.42 69.7 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.824 0.85 . . . . 0.0 110.473 176.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -76.49 -23.38 53.78 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.481 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.446 HD23 ' HG3' ' A' ' 90' ' ' MET . 90.1 mt -72.28 -39.96 67.93 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.891 0.476 . . . . 0.0 109.83 170.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -68.65 -43.0 77.16 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.605 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.422 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 5.1 t80 -82.58 124.6 30.29 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -176.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.31 -27.97 69.39 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.712 1.205 . . . . 0.0 112.737 -172.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -71.0 -35.9 72.24 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.471 0.709 . . . . 0.0 110.935 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.57 HG22 ' HB ' ' A' ' 64' ' ' ILE . 30.9 p -94.96 -21.25 18.74 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.534 0.734 . . . . 0.0 112.959 -171.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -66.01 -24.44 66.77 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.452 0.701 . . . . 0.0 112.078 -174.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -66.26 -37.54 85.72 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.724 0.81 . . . . 0.0 111.329 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.5 t -76.7 -24.19 53.15 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.452 0.701 . . . . 0.0 110.943 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.69 ' SD ' HD12 ' A' ' 77' ' ' LEU . 33.1 mmt -63.27 -20.88 65.86 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.737 0.815 . . . . 0.0 111.686 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 27.7 m170 -64.46 -31.78 73.13 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.638 0.775 . . . . 0.0 111.036 176.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.82 -43.84 74.72 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.796 175.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -73.33 -23.82 60.29 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.555 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 35.5 t -74.29 104.32 5.01 Favored 'General case' 0 C--N 1.349 0.581 0 C-N-CA 123.291 0.636 . . . . 0.0 109.346 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.2 m -80.65 -9.43 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 123.302 0.641 . . . . 0.0 110.483 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 156.6 -164.77 32.74 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.577 172.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 43.1 tt0 -99.13 142.5 30.54 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.517 1.127 . . . . 0.0 109.228 171.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -74.57 137.82 42.62 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 122.901 0.481 . . . . 0.0 110.158 172.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.438 HD11 ' HB2' ' A' ' 104' ' ' GLU . 3.2 tm? -135.23 120.08 18.48 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 44.7 mt-10 -80.78 146.31 59.78 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 123.704 0.802 . . . . 0.0 110.026 174.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.6 -24.84 41.28 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.497 2.131 . . . . 0.0 111.865 -176.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -84.14 -28.35 27.5 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.956 0.902 . . . . 0.0 110.663 175.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 61.0 tp60 -66.25 -36.54 83.27 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.077 0.551 . . . . 0.0 111.577 -176.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.438 ' HB2' HD11 ' A' ' 99' ' ' LEU . 34.2 tt0 -85.97 -33.73 21.03 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.18 176.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -61.83 -33.65 86.07 Favored Glycine 0 C--N 1.354 1.562 0 CA-C-N 116.124 -0.489 . . . . 0.0 113.099 176.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.4 p -152.82 127.98 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 124.838 1.255 . . . . 0.0 107.861 172.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.7 t -129.99 145.62 51.65 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.9 mt -84.74 118.11 70.28 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -83.98 51.23 3.34 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.847 2.364 . . . . 0.0 112.501 -177.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 37.8 t70 63.38 26.58 15.03 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.381 1.073 . . . . 0.0 110.542 -176.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.5 tt -71.41 -44.09 65.57 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.0 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.299 0 CA-C-O 118.864 -0.965 . . . . 0.0 111.651 179.36 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.925 0.393 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.77 143.69 28.84 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.206 1.003 . . . . 0.0 109.101 177.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.6 p -111.37 150.87 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 123.492 0.717 . . . . 0.0 110.029 -176.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 32.4 m -78.72 110.96 14.34 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.827 0.851 . . . . 0.0 110.147 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.459 HD22 HD23 ' A' ' 99' ' ' LEU . 86.4 mt -81.9 104.2 12.1 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 172.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.9 t -93.84 118.99 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -85.33 165.7 17.06 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.5 tt -57.0 -36.25 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 123.085 0.554 . . . . 0.0 112.244 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.11 -41.57 83.84 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.426 0.69 . . . . 0.0 111.077 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -64.71 -34.4 78.23 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.809 0.844 . . . . 0.0 111.495 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.7 mt -60.76 -47.15 87.63 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 123.545 0.528 . . . . 0.0 109.83 175.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -65.69 -44.75 85.25 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.828 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -62.65 -49.91 73.26 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.988 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -69.26 -35.21 75.85 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.757 0.423 . . . . 0.0 110.232 -174.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -62.99 -42.91 99.97 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.438 0.695 . . . . 0.0 109.766 174.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -67.31 -31.64 72.07 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.892 0.877 . . . . 0.0 111.096 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -72.03 -18.49 61.95 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.348 0.659 . . . . 0.0 111.078 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.93 32.56 3.51 Favored Glycine 0 C--N 1.345 1.049 0 O-C-N 123.144 0.278 . . . . 0.0 112.804 176.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -140.36 104.81 0.42 Allowed Glycine 0 C--N 1.343 0.927 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 177.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -75.6 110.63 10.16 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.769 0.428 . . . . 0.0 110.076 -168.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -100.04 145.38 27.98 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.176 0.99 . . . . 0.0 110.375 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.3 t -140.56 151.51 44.77 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.257 1.023 . . . . 0.0 109.358 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.4 p -102.96 120.35 52.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 172.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.432 HD13 ' HG2' ' A' ' 78' ' ' GLU . 63.6 mt -131.49 123.82 53.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.614 1.166 . . . . 0.0 108.446 176.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.7 t70 62.33 31.81 17.22 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.413 1.085 . . . . 0.0 111.721 175.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.95 7.13 87.56 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-N 115.673 -0.694 . . . . 0.0 113.337 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -110.69 159.54 17.51 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.664 1.186 . . . . 0.0 108.442 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 75.6 t -114.96 139.8 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 122.957 0.503 . . . . 0.0 109.698 174.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -133.92 155.73 49.38 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.324 1.05 . . . . 0.0 110.289 -175.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -102.52 106.91 17.7 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 173.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.533 HG23 ' HB2' ' A' ' 73' ' ' PRO . 30.8 mm -68.02 -34.31 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.636 1.174 . . . . 0.0 112.183 -178.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -59.82 -41.4 91.19 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 123.667 0.604 . . . . 0.0 110.29 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.425 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 33.7 t70 -68.83 -45.53 70.92 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.943 0.897 . . . . 0.0 110.655 177.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.448 ' HA ' ' HE2' ' A' ' 93' ' ' PHE . 77.2 t80 -47.56 -60.57 2.44 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.544 1.138 . . . . 0.0 111.704 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -63.57 -29.81 71.02 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.521 -178.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 96.9 m -69.37 -35.08 75.47 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 122.788 0.435 . . . . 0.0 111.168 178.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 23.2 mm-40 -70.74 -14.35 62.41 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.787 0.435 . . . . 0.0 111.479 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.2 t -84.63 12.37 7.23 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.85 0.86 . . . . 0.0 111.588 174.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -64.75 -28.89 69.89 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.095 0.558 . . . . 0.0 111.365 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.6 m -88.9 133.2 34.37 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.729 0.812 . . . . 0.0 109.646 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -28.11 68.12 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.51 0.724 . . . . 0.0 111.207 178.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -103.72 89.33 3.3 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.94 0.896 . . . . 0.0 108.982 171.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 89.3 p -147.6 169.55 19.39 Favored 'General case' 0 C--O 1.245 0.838 0 C-N-CA 123.835 0.854 . . . . 0.0 109.241 177.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.655 ' HB ' HG22 ' A' ' 86' ' ' THR . 48.2 pt -68.49 -22.29 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.658 172.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.438 ' HG ' HG13 ' A' ' 64' ' ' ILE . 66.5 mt -101.4 5.51 42.15 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.248 1.019 . . . . 0.0 111.715 -176.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.11 -30.19 71.27 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.261 0.625 . . . . 0.0 110.779 173.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -79.56 -23.84 42.53 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.224 1.01 . . . . 0.0 111.079 174.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.556 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 55.1 m-85 -99.3 0.39 42.91 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.226 1.01 . . . . 0.0 111.801 -177.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.73 -23.28 64.33 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.794 0.838 . . . . 0.0 111.87 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -101.86 24.39 31.53 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 116.61 -0.268 . . . . 0.0 113.063 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -136.12 158.89 43.33 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.034 0.934 . . . . 0.0 109.665 -175.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -56.24 129.74 74.35 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 123.947 0.899 . . . . 0.0 109.728 174.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.533 ' HB2' HG23 ' A' ' 51' ' ' ILE . 37.3 Cg_endo -60.62 -31.49 92.24 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.648 2.232 . . . . 0.0 114.064 -170.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.469 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 37.0 t -75.31 -53.27 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.3 t -61.47 -36.14 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 123.59 0.756 . . . . 0.0 111.308 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.556 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -66.92 -37.09 83.69 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.506 1.122 . . . . 0.0 111.105 178.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 38.3 tp -68.39 -38.56 81.45 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.881 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 35.9 mt-10 -65.23 -41.64 94.2 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.211 0.604 . . . . 0.0 110.041 177.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.23 -33.42 75.71 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.707 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.12 -34.88 71.5 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.856 0.862 . . . . 0.0 111.643 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.4 mt -67.42 -40.57 85.54 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.144 0.578 . . . . 0.0 110.15 175.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -73.52 -25.0 60.23 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.235 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -79.46 114.39 18.35 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -54.57 -29.61 51.85 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.665 1.586 . . . . 0.0 112.933 -177.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -70.88 -58.45 3.58 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.274 0.63 . . . . 0.0 110.83 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.655 HG22 ' HB ' ' A' ' 64' ' ' ILE . 67.4 p -87.72 -10.81 50.06 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -166.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -65.8 -31.99 73.26 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.103 0.561 . . . . 0.0 111.907 -172.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -29.39 64.27 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.516 -173.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.6 t -74.93 -23.87 58.4 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.581 0.752 . . . . 0.0 110.995 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.43 ' HA ' ' HD1' ' A' ' 93' ' ' PHE . 21.8 mmt -73.91 0.35 13.68 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.833 0.853 . . . . 0.0 112.669 -177.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -63.83 -31.13 72.2 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.616 0.766 . . . . 0.0 110.778 170.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.06 -31.08 39.45 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.17 0.988 . . . . 0.0 111.052 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.448 ' HE2' ' HA ' ' A' ' 54' ' ' PHE . 60.2 m-85 -81.27 -24.83 37.03 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.527 0.731 . . . . 0.0 110.685 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.1 t -78.31 108.65 11.79 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 123.437 0.695 . . . . 0.0 109.341 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.3 p -79.28 -19.55 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.495 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 155.35 -156.53 27.03 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 116.387 -0.369 . . . . 0.0 112.391 176.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.431 ' HB2' HD23 ' A' ' 25' ' ' LEU . 16.6 mm100 -78.58 164.77 24.39 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.778 1.231 . . . . 0.0 111.306 174.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -109.62 143.33 39.49 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 162.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.459 HD23 HD22 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -137.64 123.95 20.6 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.17 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.63 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 1.7 mp0 -73.24 143.3 83.09 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 123.212 0.605 . . . . 0.0 110.397 178.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -58.82 -32.5 97.31 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.918 2.412 . . . . 0.0 112.739 175.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -82.78 -29.13 29.86 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.082 0.553 . . . . 0.0 110.446 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.63 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 55.9 tp60 -66.75 -24.7 66.25 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.333 0.653 . . . . 0.0 110.903 -177.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -63.35 -34.34 77.49 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.568 0.747 . . . . 0.0 111.537 176.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -129.95 31.82 3.27 Favored Glycine 0 C--N 1.349 1.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 113.094 -177.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.4 p -84.48 131.06 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-O 121.11 0.481 . . . . 0.0 110.24 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.3 t -132.87 131.9 41.48 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.041 0.936 . . . . 0.0 108.869 173.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.5 mt -110.8 122.8 37.16 Favored Pre-proline 0 N--CA 1.473 0.704 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -72.73 158.52 50.28 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 123.046 2.497 . . . . 0.0 112.061 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -75.05 86.11 2.33 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 52.9 tp -99.35 -56.64 2.35 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.359 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.262 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 176.465 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 119.627 -0.225 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -54.91 101.89 0.06 Allowed 'General case' 0 C--N 1.364 1.22 0 C-N-CA 124.435 1.094 . . . . 0.0 110.887 -178.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 p -77.36 139.22 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.526 0.731 . . . . 0.0 110.905 -174.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.4 m -75.46 110.34 9.75 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.497 0.719 . . . . 0.0 109.978 177.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.517 HD13 HD22 ' A' ' 99' ' ' LEU . 85.8 mt -83.31 106.07 14.78 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.417 ' HB ' HG21 ' A' ' 48' ' ' VAL . 59.7 t -94.31 124.76 46.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 124.216 1.006 . . . . 0.0 110.164 -170.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.551 ' HB2' ' HB2' ' A' ' 30' ' ' ASP . 54.0 mtm180 -73.25 164.23 26.97 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.909 1.283 . . . . 0.0 110.521 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.5 tt -66.87 -42.61 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-N 118.203 0.456 . . . . 0.0 111.598 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.35 -29.45 68.18 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.763 177.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.551 ' HB2' ' HB2' ' A' ' 27' ' ' ARG . 23.3 t0 -59.28 -38.64 80.67 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.596 1.159 . . . . 0.0 110.944 -175.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.8 mp -57.46 -48.35 79.4 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 123.844 0.715 . . . . 0.0 110.727 173.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -67.92 -42.47 81.02 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.284 1.033 . . . . 0.0 111.479 -172.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -71.76 -40.35 69.37 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.374 0.67 . . . . 0.0 111.109 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -66.79 -33.39 75.52 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 176.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -64.52 -44.29 91.34 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.237 1.015 . . . . 0.0 111.029 175.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -64.59 -31.56 72.83 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.432 0.693 . . . . 0.0 110.521 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -66.93 -34.69 78.32 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.048 0.939 . . . . 0.0 110.846 176.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 128.19 25.43 1.08 Allowed Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.028 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -134.59 100.4 0.37 Allowed Glycine 0 C--N 1.344 0.997 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -178.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -75.1 107.57 7.27 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -170.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 25.7 m0 -103.22 131.71 50.05 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.742 0.817 . . . . 0.0 109.852 177.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.8 t -127.78 144.81 51.07 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.818 1.247 . . . . 0.0 109.106 177.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 p -96.28 112.35 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 120.976 0.417 . . . . 0.0 110.197 176.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.4 mt -122.26 118.62 55.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 123.81 0.844 . . . . 0.0 109.113 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.2 t70 62.57 32.84 16.26 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.832 1.253 . . . . 0.0 112.577 172.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.02 7.29 85.64 Favored Glycine 0 N--CA 1.477 1.408 0 CA-C-N 116.073 -0.512 . . . . 0.0 113.635 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.418 ' HB2' ' CE1' ' A' ' 49' ' ' TYR . 32.4 mmtp -117.87 161.78 19.19 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.269 1.027 . . . . 0.0 108.853 176.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.417 HG21 ' HB ' ' A' ' 26' ' ' VAL . 96.4 t -113.54 124.41 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 174.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.418 ' CE1' ' HB2' ' A' ' 47' ' ' LYS . 76.9 m-85 -117.79 156.25 28.65 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.34 1.056 . . . . 0.0 109.366 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -98.79 147.1 25.24 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 173.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.4 ' O ' ' HB3' ' A' ' 54' ' ' PHE . 24.5 mm -109.46 -33.6 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.305 1.042 . . . . 0.0 111.402 -172.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.1 -29.29 62.82 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 118.566 0.621 . . . . 0.0 110.081 176.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -70.9 -39.15 72.95 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.118 0.967 . . . . 0.0 110.712 172.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.4 ' HB3' ' O ' ' A' ' 51' ' ' ILE . 13.0 t80 -54.1 -54.51 38.51 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.935 0.894 . . . . 0.0 109.852 171.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -66.86 -28.55 68.43 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.952 0.901 . . . . 0.0 112.398 -173.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.4 m -58.25 -47.75 82.58 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.136 0.493 . . . . 0.0 110.195 171.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -77.31 -18.18 57.72 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.578 0.751 . . . . 0.0 111.523 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.492 ' HA ' ' HB2' ' A' ' 65' ' ' LEU . 25.9 t -75.6 -22.36 56.96 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.688 0.395 . . . . 0.0 111.031 177.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.8 mt -83.81 7.65 17.26 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.025 0.53 . . . . 0.0 110.986 172.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.9 m -105.97 134.36 49.21 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.892 0.877 . . . . 0.0 109.657 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -75.26 -40.33 58.94 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.717 0.807 . . . . 0.0 112.715 -173.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -82.15 0.77 39.38 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.293 0.637 . . . . 0.0 111.944 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.9 m -81.33 151.08 28.18 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 122.679 0.392 . . . . 0.0 109.996 170.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.533 ' O ' ' HG2' ' A' ' 67' ' ' GLN . 24.5 pt -55.3 -30.61 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.577 0.751 . . . . 0.0 110.986 170.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 58' ' ' SER . 49.5 mt -73.88 -0.93 17.52 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.261 1.024 . . . . 0.0 113.049 -173.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.48 -41.26 96.58 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.649 0.78 . . . . 0.0 110.905 171.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.533 ' HG2' ' O ' ' A' ' 64' ' ' ILE . 8.2 pt20 -76.65 -20.79 56.29 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.16 0.584 . . . . 0.0 110.937 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.458 ' HD2' ' HA ' ' A' ' 65' ' ' LEU . 75.5 m-85 -92.51 2.62 56.58 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.03 0.932 . . . . 0.0 111.33 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.39 111.83 4.88 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.153 0.581 . . . . 0.0 110.349 177.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.61 -29.33 7.93 Favored Glycine 0 N--CA 1.474 1.232 0 N-CA-C 111.96 -0.456 . . . . 0.0 111.96 -175.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -79.92 151.62 30.01 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.618 0.767 . . . . 0.0 109.299 173.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.543 ' HB3' HG12 ' A' ' 75' ' ' VAL . 26.3 t70 -59.32 126.74 82.93 Favored Pre-proline 0 N--CA 1.483 1.182 0 CA-C-O 118.908 -0.568 . . . . 0.0 110.154 -178.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.07 -34.8 88.62 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 123.319 2.68 . . . . 0.0 114.11 -174.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.462 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 60.2 t -73.63 -49.66 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.182 -178.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.543 HG12 ' HB3' ' A' ' 72' ' ' ASP . 3.8 p -68.43 -28.59 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 122.791 0.436 . . . . 0.0 111.126 -177.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.06 -36.56 75.06 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.059 0.943 . . . . 0.0 109.767 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.648 ' HG ' ' SD ' ' A' ' 90' ' ' MET . 4.4 tt -71.81 -37.98 70.28 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.178 0.991 . . . . 0.0 110.029 176.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 74' ' ' VAL . 44.3 mt-10 -64.34 -49.29 72.29 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.094 0.958 . . . . 0.0 110.87 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.03 -29.55 69.39 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.812 0.845 . . . . 0.0 111.019 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.62 -35.03 72.74 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.904 177.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.0 mt -63.34 -35.53 80.69 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.742 0.417 . . . . 0.0 110.771 175.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -67.07 -47.73 70.38 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.388 175.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.462 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 23.1 t80 -81.87 119.82 24.41 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 121.205 0.526 . . . . 0.0 110.936 -173.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -53.99 -34.21 59.21 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.785 1.634 . . . . 0.0 114.682 -171.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -79.87 -33.73 39.81 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.934 0.494 . . . . 0.0 111.735 -177.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.462 ' OG1' ' HB3' ' A' ' 83' ' ' PHE . 25.3 p -93.33 -13.53 28.02 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.393 0.677 . . . . 0.0 112.805 -173.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 37.9 ptt180 -73.82 -20.02 60.58 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 122.779 0.432 . . . . 0.0 110.385 178.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -63.74 -38.12 89.93 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.358 1.063 . . . . 0.0 111.314 -175.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.402 ' HB3' HD11 ' A' ' 64' ' ' ILE . 22.6 t -77.4 -31.4 54.11 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.009 0.524 . . . . 0.0 110.389 177.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.648 ' SD ' ' HG ' ' A' ' 77' ' ' LEU . 15.7 mmt -70.46 -21.84 62.75 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.221 0.608 . . . . 0.0 111.149 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -60.74 -35.6 76.78 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.656 0.782 . . . . 0.0 109.724 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.2 -38.57 42.99 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.615 0.766 . . . . 0.0 111.06 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.516 ' HD2' ' SD ' ' A' ' 90' ' ' MET . 29.8 m-85 -72.16 -14.39 61.8 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 122.761 0.425 . . . . 0.0 111.886 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 49.2 t -68.89 83.19 0.31 Allowed 'General case' 0 C--N 1.36 1.031 0 C-N-CA 123.397 0.679 . . . . 0.0 109.593 175.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.3 m -73.51 -16.39 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.12 0.968 . . . . 0.0 111.754 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.29 -175.58 41.16 Favored Glycine 0 C--N 1.343 0.972 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.146 174.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -119.1 134.42 55.21 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 174.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -76.37 143.02 40.97 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.213 0.605 . . . . 0.0 111.755 -171.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.517 HD22 HD13 ' A' ' 25' ' ' LEU . 54.8 tp -140.78 128.92 22.17 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.507 1.123 . . . . 0.0 108.243 176.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.663 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 46.9 mt-10 -91.89 140.84 24.96 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 123.732 0.813 . . . . 0.0 110.657 -178.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.81 -26.45 67.7 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 123.188 2.592 . . . . 0.0 112.434 173.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -78.97 -24.58 43.76 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.121 0.568 . . . . 0.0 110.485 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.663 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . 47.3 tp60 -74.41 -6.81 50.38 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.674 0.79 . . . . 0.0 111.036 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -63.63 -23.82 67.54 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.23 0.612 . . . . 0.0 111.641 171.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -166.53 66.53 0.2 Allowed Glycine 0 C--N 1.349 1.286 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.9 p -85.05 140.86 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 122.981 0.512 . . . . 0.0 109.981 176.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.6 t -118.08 119.45 34.78 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.408 0.683 . . . . 0.0 109.648 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 55.4 mt -121.49 99.42 45.39 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 123.533 0.733 . . . . 0.0 109.144 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -59.93 147.55 92.28 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 123.271 2.647 . . . . 0.0 113.295 173.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -73.74 104.28 4.59 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.202 0.601 . . . . 0.0 109.87 174.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 83.5 mt -115.94 25.85 10.41 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.77 0.828 . . . . 0.0 109.447 176.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 1.541 0 CA-C-O 119.525 -0.597 . . . . 0.0 112.58 -177.68 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 N--CA 1.479 1.025 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.9 mmmm -74.28 98.95 3.33 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 172.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.8 p -67.27 132.01 32.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.6 m -64.87 112.77 3.43 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.269 0.628 . . . . 0.0 110.718 -176.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.5 mt -77.94 103.24 7.76 Favored 'General case' 0 C--N 1.347 0.466 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 174.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.459 ' HB ' HG21 ' A' ' 48' ' ' VAL . 44.6 t -98.47 139.16 21.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.052 0.941 . . . . 0.0 108.989 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.569 ' HD3' ' H ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -112.43 162.05 16.02 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.987 0.915 . . . . 0.0 109.31 178.743 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.5 tt -56.31 -38.1 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 C-N-CA 123.412 0.685 . . . . 0.0 111.93 -176.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.03 -37.47 79.89 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.543 0.737 . . . . 0.0 111.196 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -70.93 -34.67 71.72 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.105 -178.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.493 HD21 HG23 ' A' ' 43' ' ' VAL . 8.3 mp -59.99 -46.65 88.77 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 122.665 0.386 . . . . 0.0 110.707 171.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -64.27 -42.76 96.31 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.296 1.038 . . . . 0.0 112.224 -173.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -69.7 -41.22 75.7 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.95 177.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -66.96 -28.46 68.29 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.209 0.603 . . . . 0.0 110.95 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -65.11 -49.84 68.41 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.912 0.885 . . . . 0.0 110.049 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -75.08 -14.94 60.63 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.599 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -68.33 -34.31 75.88 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.555 0.742 . . . . 0.0 110.184 170.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 119.95 36.68 0.81 Allowed Glycine 0 C--N 1.348 1.226 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.27 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -149.53 107.66 0.36 Allowed Glycine 0 C--N 1.342 0.909 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -75.05 125.01 28.02 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -174.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 9.5 m0 -115.72 151.83 34.36 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.216 1.006 . . . . 0.0 110.183 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.6 t -143.13 164.69 29.45 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.559 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.504 HG22 HG22 ' A' ' 48' ' ' VAL . 72.1 t -116.82 111.43 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 176.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.432 HG13 ' HG ' ' A' ' 77' ' ' LEU . 14.8 mm -108.49 103.79 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 175.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.2 t70 60.21 41.81 16.21 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 124.472 1.109 . . . . 0.0 112.298 171.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.63 12.31 75.41 Favored Glycine 0 N--CA 1.475 1.28 0 CA-C-N 116.09 -0.505 . . . . 0.0 113.87 175.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -124.2 144.2 50.08 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.853 0.861 . . . . 0.0 108.84 172.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.504 HG22 HG22 ' A' ' 43' ' ' VAL . 45.0 t -99.09 137.23 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 122.967 0.507 . . . . 0.0 109.761 178.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -127.74 154.95 44.76 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.532 1.133 . . . . 0.0 110.327 -175.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -96.52 101.68 13.34 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.7 mm -64.09 -33.09 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 124.1 0.96 . . . . 0.0 111.901 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -64.19 -43.66 94.41 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.431 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 24.6 t70 -66.94 -40.05 87.48 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.86 0.864 . . . . 0.0 110.211 177.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -55.85 -55.24 34.8 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.809 1.244 . . . . 0.0 111.613 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -69.82 -26.2 64.13 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.506 0.722 . . . . 0.0 111.23 -177.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.7 m -62.87 -41.82 99.52 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 122.717 0.407 . . . . 0.0 111.023 171.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 31.0 mm-40 -70.22 -26.8 64.03 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.133 0.573 . . . . 0.0 110.76 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.3 t -77.86 10.64 2.65 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.961 0.904 . . . . 0.0 111.501 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 45.2 tp -67.59 -39.65 84.8 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.273 0.629 . . . . 0.0 110.779 171.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.2 t -99.7 146.98 25.9 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.158 0.583 . . . . 0.0 111.829 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.38 -19.41 53.4 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.764 175.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -63.73 -28.05 69.62 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 123.435 0.694 . . . . 0.0 110.182 175.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.3 t -66.96 152.24 46.12 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.462 0.705 . . . . 0.0 110.46 175.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.549 ' HB ' HG22 ' A' ' 86' ' ' THR . 26.4 pt -63.24 -17.76 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.475 1.11 . . . . 0.0 111.612 172.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.9 mt -85.19 9.58 14.67 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.64 1.176 . . . . 0.0 111.657 -178.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.57 -40.51 97.16 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.117 0.967 . . . . 0.0 111.24 174.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -73.77 -13.61 60.98 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.323 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.551 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 28.7 m-85 -110.13 4.91 21.56 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.567 1.147 . . . . 0.0 111.888 -176.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.74 -36.83 85.56 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.765 0.826 . . . . 0.0 112.589 -172.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -101.16 6.7 56.43 Favored Glycine 0 N--CA 1.479 1.53 0 CA-C-N 116.405 -0.361 . . . . 0.0 113.027 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -98.52 152.54 19.45 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.336 1.054 . . . . 0.0 109.065 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -54.12 124.88 47.61 Favored Pre-proline 0 N--CA 1.48 1.038 0 CA-C-O 118.354 -0.831 . . . . 0.0 109.08 172.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -57.5 -31.03 90.34 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.136 2.557 . . . . 0.0 114.03 -170.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 67.5 t -74.43 -48.55 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 122.868 0.467 . . . . 0.0 110.211 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.71 -38.15 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 123.504 0.722 . . . . 0.0 110.564 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.551 ' HB1' ' HB3' ' A' ' 68' ' ' PHE . . . -63.14 -40.89 98.89 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 114.074 -1.421 . . . . 0.0 110.944 177.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.432 ' HG ' HG13 ' A' ' 44' ' ' ILE . 37.1 tp -71.38 -36.82 71.56 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.027 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 82' ' ' GLN . 48.4 mt-10 -60.92 -47.07 88.1 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.866 0.466 . . . . 0.0 110.085 174.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.19 -32.11 73.63 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.843 0.857 . . . . 0.0 111.046 177.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.49 -28.57 64.01 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.477 0.711 . . . . 0.0 111.752 178.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.535 ' HA ' ' HB3' ' A' ' 87' ' ' ARG . 3.8 mm? -75.26 -28.34 59.79 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.267 0.227 . . . . 0.0 111.008 173.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 71.5 mt-30 -78.24 -41.22 34.86 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.979 0.512 . . . . 0.0 110.579 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -79.71 123.36 27.6 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -59.91 -41.35 91.49 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.044 0.937 . . . . 0.0 113.135 -169.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -68.18 -36.31 79.4 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.893 0.477 . . . . 0.0 111.572 -175.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.549 HG22 ' HB ' ' A' ' 64' ' ' ILE . 12.8 p -81.64 -30.46 32.79 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.133 -175.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.535 ' HB3' ' HA ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -74.96 -12.66 60.39 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.403 ' HG2' HH11 ' A' ' 87' ' ' ARG . 30.4 mt-10 -67.2 -35.88 80.56 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.237 0.615 . . . . 0.0 110.319 175.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.8 t -77.86 -29.91 50.63 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.428 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 14.9 mmt -70.95 -9.7 58.36 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.628 0.771 . . . . 0.0 112.104 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -62.07 -30.92 71.32 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.936 0.894 . . . . 0.0 110.662 171.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.17 -35.98 25.07 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.463 0.705 . . . . 0.0 111.466 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -75.03 -23.16 58.13 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.245 0.618 . . . . 0.0 111.762 -173.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 25.9 p -71.48 99.44 2.02 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.4 m -69.47 -30.06 44.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 123.902 0.881 . . . . 0.0 111.502 -177.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.14 179.94 44.23 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.005 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -91.03 136.47 33.05 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.55 0.74 . . . . 0.0 109.094 176.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -82.45 142.84 31.58 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 174.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.0 tt -136.27 112.81 10.03 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 170.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.558 ' HB3' ' HB2' ' A' ' 103' ' ' GLN . 26.0 tt0 -72.65 141.96 83.11 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.571 0.748 . . . . 0.0 109.96 -177.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -42.21 -60.86 0.61 Allowed 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 123.598 2.865 . . . . 0.0 114.113 176.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -81.88 -8.18 59.66 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.822 0.849 . . . . 0.0 112.377 -172.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.558 ' HB2' ' HB3' ' A' ' 100' ' ' GLU . 54.4 tp60 -54.81 -34.8 63.2 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.845 0.858 . . . . 0.0 110.898 175.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.48 -27.05 68.21 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.854 -178.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.5 -88.83 0.34 Allowed Glycine 0 C--N 1.345 1.035 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 175.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.7 p -149.72 123.08 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 123.514 0.726 . . . . 0.0 109.432 172.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.4 t -84.1 121.54 27.57 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 175.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.8 mm -95.29 113.93 62.69 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.362 0.665 . . . . 0.0 109.556 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.52 170.16 13.25 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 123.067 2.511 . . . . 0.0 112.296 175.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -109.81 106.96 16.77 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.222 1.009 . . . . 0.0 109.963 -175.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.7 mp -89.35 -63.32 1.31 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.858 0.863 . . . . 0.0 109.782 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.904 0 CA-C-O 118.918 -0.935 . . . . 0.0 112.286 179.69 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.248 0.071 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.43 143.39 38.63 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 122.615 0.366 . . . . 0.0 110.191 176.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.6 p -84.01 116.15 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 CA-C-O 121.176 0.512 . . . . 0.0 110.155 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.5 m -82.7 110.11 17.46 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 175.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.506 HD13 HD22 ' A' ' 99' ' ' LEU . 92.6 mt -86.93 111.95 21.32 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.512 -178.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.504 ' HB ' HG21 ' A' ' 48' ' ' VAL . 48.4 t -94.72 125.82 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 174.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -92.32 167.62 11.88 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.29 0.636 . . . . 0.0 111.123 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.0 tt -67.65 -34.2 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.194 -177.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.95 -33.5 71.99 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.41 0.684 . . . . 0.0 110.589 177.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.08 -44.43 63.29 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.144 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 85.1 mt -57.35 -52.8 63.89 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.883 0.873 . . . . 0.0 112.03 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -63.89 -48.94 74.67 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.901 0.88 . . . . 0.0 111.789 -173.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -63.53 -34.32 77.53 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.062 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 50.7 t60 -73.4 -34.6 65.59 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.312 0.645 . . . . 0.0 110.721 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -60.64 -40.5 92.23 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.207 1.003 . . . . 0.0 110.107 176.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -69.7 -26.43 64.35 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.117 0.967 . . . . 0.0 111.409 -178.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -70.14 -19.91 63.19 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.004 0.522 . . . . 0.0 111.518 174.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 114.88 -21.47 13.65 Favored Glycine 0 C--N 1.341 0.83 0 N-CA-C 111.796 -0.521 . . . . 0.0 111.796 -175.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.51 ' HA2' ' HG2' ' A' ' 52' ' ' LYS . . . -73.65 92.23 0.69 Allowed Glycine 0 C--N 1.345 1.048 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -78.33 110.95 13.82 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 38.9 m0 -105.23 174.09 6.03 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.198 0.999 . . . . 0.0 109.399 170.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.4 t -151.13 162.92 39.96 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.811 0.844 . . . . 0.0 108.862 172.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.492 HG22 HG22 ' A' ' 48' ' ' VAL . 73.8 t -119.79 113.52 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.296 0.638 . . . . 0.0 109.338 175.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.683 HD12 HD23 ' A' ' 77' ' ' LEU . 51.3 mt -135.79 133.48 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 176.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.1 t70 63.07 30.33 16.21 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 125.048 1.339 . . . . 0.0 110.477 -175.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.13 26.49 67.64 Favored Glycine 0 C--N 1.351 1.365 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.729 -175.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.453 ' HB2' ' CE2' ' A' ' 49' ' ' TYR . 44.3 mmtm -121.16 134.1 55.21 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.681 0.792 . . . . 0.0 108.891 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.504 HG21 ' HB ' ' A' ' 26' ' ' VAL . 93.1 t -84.66 111.15 19.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 174.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.453 ' CE2' ' HB2' ' A' ' 47' ' ' LYS . 85.0 m-85 -108.46 150.17 27.78 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.674 0.79 . . . . 0.0 110.351 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -88.12 138.98 30.97 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.836 175.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.538 HD11 HD22 ' A' ' 77' ' ' LEU . 33.6 mm -116.32 -40.18 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.552 0.741 . . . . 0.0 111.513 -174.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.51 ' HG2' ' HA2' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -69.25 -32.33 71.47 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.299 0.24 . . . . 0.0 111.02 -179.245 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.432 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 33.6 t70 -76.03 -37.85 57.9 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.252 0.621 . . . . 0.0 110.687 172.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -55.34 -48.48 74.14 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.18 0.992 . . . . 0.0 111.527 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -69.83 -27.25 64.71 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.794 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.3 m -66.74 -38.19 86.16 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.95 0.5 . . . . 0.0 110.04 172.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.501 ' HB2' HD12 ' A' ' 65' ' ' LEU . 52.7 mm-40 -76.49 -15.3 59.93 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.09 0.556 . . . . 0.0 110.892 176.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.5 t -90.67 -9.9 45.15 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.008 0.923 . . . . 0.0 111.199 175.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.4 tp -83.05 -5.87 59.27 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.843 0.857 . . . . 0.0 111.489 -178.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.0 t -119.54 152.67 36.6 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.611 0.764 . . . . 0.0 110.848 -174.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -73.89 -51.09 17.31 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.69 1.196 . . . . 0.0 111.362 -174.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -78.21 72.47 4.74 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.592 0.71 . . . . 0.0 109.589 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.2 m -163.16 147.59 11.17 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.884 1.273 . . . . 0.0 108.726 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.622 ' HB ' HG22 ' A' ' 86' ' ' THR . 33.2 pt -67.26 -19.91 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 124.274 1.03 . . . . 0.0 111.558 175.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.501 HD12 ' HB2' ' A' ' 57' ' ' GLN . 65.6 mt -92.53 7.99 40.81 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.001 0.92 . . . . 0.0 111.669 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.51 -23.52 64.55 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.562 0.345 . . . . 0.0 110.772 175.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -75.52 -11.87 60.11 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.606 0.763 . . . . 0.0 111.408 172.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -112.97 20.88 15.98 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.024 0.93 . . . . 0.0 110.953 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.36 -26.03 68.57 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.675 0.79 . . . . 0.0 112.752 -174.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -111.87 5.27 27.45 Favored Glycine 0 N--CA 1.478 1.481 0 C-N-CA 122.753 0.216 . . . . 0.0 113.137 177.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -96.03 151.07 19.79 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.075 0.95 . . . . 0.0 109.961 -177.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -63.39 127.1 90.73 Favored Pre-proline 0 N--CA 1.48 1.051 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 171.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.425 ' HB2' HG23 ' A' ' 51' ' ' ILE . 18.7 Cg_endo -56.68 -34.0 94.92 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.501 2.801 . . . . 0.0 114.729 -174.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.2 t -75.05 -39.35 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 121.052 0.453 . . . . 0.0 110.445 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.1 t -68.16 -40.76 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.309 0.644 . . . . 0.0 110.017 177.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.5 -33.06 75.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.065 1.346 . . . . 0.0 111.208 176.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.683 HD23 HD12 ' A' ' 44' ' ' ILE . 34.0 tp -59.69 -51.89 67.84 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 124.164 0.915 . . . . 0.0 111.185 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -63.06 -39.67 95.42 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.056 0.543 . . . . 0.0 111.655 -178.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.93 -42.64 99.87 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.555 177.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.6 -17.69 50.57 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.99 0.916 . . . . 0.0 112.176 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.1 mp -70.51 -45.4 65.67 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.922 0.889 . . . . 0.0 109.004 171.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -75.33 -27.98 59.45 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.781 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.407 ' HB3' ' OG1' ' A' ' 86' ' ' THR . 3.0 t80 -81.81 114.28 20.33 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -64.99 -26.46 68.3 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.098 0.959 . . . . 0.0 112.653 -172.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -65.94 -41.97 90.65 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.387 0.675 . . . . 0.0 110.676 177.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.622 HG22 ' HB ' ' A' ' 64' ' ' ILE . 20.1 p -95.86 -18.87 20.02 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.004 0.921 . . . . 0.0 113.152 -171.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -63.33 -21.18 66.11 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -176.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -54.27 -48.4 71.25 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.898 0.879 . . . . 0.0 111.682 177.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.4 t -73.6 -15.69 61.26 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.671 0.788 . . . . 0.0 111.785 -172.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 24.7 mmt -64.4 -17.63 63.94 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.736 0.815 . . . . 0.0 112.211 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.405 ' HA ' ' SG ' ' A' ' 94' ' ' CYS . 2.4 p80 -61.06 -29.33 69.67 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.211 0.605 . . . . 0.0 110.894 174.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.64 -32.39 19.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.101 0.96 . . . . 0.0 111.413 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -79.93 -26.06 40.26 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.599 0.36 . . . . 0.0 110.936 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.405 ' SG ' ' HA ' ' A' ' 91' ' ' HIS . 28.6 p -79.76 103.25 9.53 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.29 -35.75 72.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 124.372 1.069 . . . . 0.0 110.21 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 174.31 -170.57 43.7 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.293 176.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -89.67 135.96 33.31 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -78.9 128.58 33.51 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.272 0.629 . . . . 0.0 110.774 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.506 HD22 HD13 ' A' ' 25' ' ' LEU . 64.0 tp -105.32 117.1 33.15 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 166.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -73.48 133.1 80.65 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 173.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.52 -42.76 64.7 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.271 2.648 . . . . 0.0 113.632 -174.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -87.76 -7.7 56.98 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.71 0.404 . . . . 0.0 111.252 -176.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -76.5 -20.53 56.86 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.65 0.78 . . . . 0.0 110.728 174.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -51.02 -53.94 29.04 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.826 1.25 . . . . 0.0 111.184 -173.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -67.84 -87.76 0.08 OUTLIER Glycine 0 C--N 1.345 1.074 0 O-C-N 123.79 0.681 . . . . 0.0 112.967 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.5 p -161.56 132.51 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 123.338 0.655 . . . . 0.0 110.286 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.9 t -104.27 97.66 7.57 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 174.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.8 mt -71.26 124.6 91.24 Favored Pre-proline 0 CA--C 1.555 1.148 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.45 168.39 24.92 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.654 2.236 . . . . 0.0 112.037 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -75.98 71.72 2.79 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.408 0.683 . . . . 0.0 109.821 175.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -68.48 -31.85 71.43 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.298 -171.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.192 0 CA-C-O 119.203 -0.776 . . . . 0.0 111.862 -178.607 . . . . . . . . 0 0 . 1 stop_ save_